Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,collagen fibril organization (GO:0030199),0.7685210563260731,2.211087868604391,0.0,0.0,0.0,29/88,5.18%,COL15A1;COL4A1;CYP1B1;COL24A1;COL18A1;COL1A2;COL4A2;COL27A1;COL7A1;COL1A1;COL3A1;LUM;COL8A1;TLL2;COL6A3;COL23A1;COL5A2;COL11A2;COL5A3;COL5A1;PLOD2;ADAMTS2;COL13A1;DPT;COL11A1;SERPINH1;DDR2;NF1;BMP1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.8405580851509038,-2.17184567316556,0.0,0.012137840307606734,0.011,5/13,4.05%,ATP1A2;ATP1B3;SLC12A2;ATP1B1;KCNJ2
prerank,external encapsulating structure organization (GO:0045229),0.6970616943665199,2.1181448392944873,0.0,0.0,0.0,65/205,8.73%,MMP3;MMP13;COL15A1;COL4A1;MMP27;COL24A1;COL18A1;COL1A2;COL4A2;IBSP;COL27A1;COL7A1;COL1A1;DCN;COL3A1;MMP2;LAMA2;SPP1;POSTN;LUM;COL8A1;COL6A3;ITGB8;COL23A1;COL5A2;MMP14;HSPG2;LAMB1;FBN2;SPARC;ADAM19;BGN;COL11A2;LAMA1;COL5A3;NID1;COL5A1;ADAMTS2;COL13A1;ADAM12;ITGB5;ST7;LAMC1;ITGA8;VCAN;MMP11;COL11A1;LAMA4;FBN1;DDR2;NF1;ADAMTS15;ADAMTS5;ADAMTS4;ICAM1;ADAMTS14;LOXL1;ADAMTS12;ADAMTS1;ITGA11;ADAMTS9;ADAMTS18;ITGA3;MMP16;PXDN
prerank,extracellular structure organization (GO:0043062),0.6946145735321412,2.112081826123561,0.0,0.00034034955475506273,0.001,66/204,9.03%,MMP3;MMP13;COL15A1;COL4A1;MMP27;COL24A1;COL18A1;COL1A2;COL4A2;IBSP;COL27A1;COL7A1;COL1A1;DCN;COL3A1;MMP2;LAMA2;SPP1;POSTN;LUM;COL8A1;COL6A3;ITGB8;COL23A1;COL5A2;MMP14;HSPG2;LAMB1;FBN2;SPARC;ADAM19;BGN;COL11A2;LAMA1;COL5A3;NID1;COL5A1;ADAMTS2;COL13A1;ADAM12;ITGB5;ST7;LAMC1;ITGA8;VCAN;MMP11;COL11A1;LAMA4;FBN1;DDR2;NF1;ADAMTS15;ADAMTS5;ADAMTS4;ICAM1;ADAMTS14;LOXL1;ADAMTS12;ADAMTS1;ITGA11;ADAMTS9;ADAMTS18;ITGA3;MMP16;PXDN;TGFBR1
prerank,extracellular matrix organization (GO:0030198),0.6862028523005753,2.1062965315241797,0.0,0.0010210486642651883,0.004,83/276,8.76%,MMP3;MMP13;COL15A1;COL4A1;MMP27;SCUBE1;CYP1B1;COL24A1;COL18A1;COL1A2;COL4A2;IBSP;COL27A1;COL7A1;COL1A1;DCN;COL3A1;MMP2;LAMA2;CREB3L1;GPM6B;SPP1;POSTN;LUM;COL8A1;TLL2;COL6A3;ITGB8;COL23A1;COL5A2;MMP14;SH3PXD2B;HSPG2;LAMB1;FBN2;SPARC;ADAM19;BGN;COL11A2;LAMA1;COL5A3;NID1;COL5A1;PLOD2;ADAMTS2;COL13A1;ADAM12;ITGB5;FLRT2;ST7;LAMC1;DPT;TIMP1;ITGA8;VCAN;MMP11;COL11A1;LAMA4;FBN1;KLK2;SERPINH1;CTSS;DDR2;NF1;BMP1;ADAMTS15;ADAMTS5;ADAMTS4;CTSK;ICAM1;ADAMTS14;CTSL;LOXL1;ADAMTS12;CAPN2;ADAMTS1;ITGA11;ADAMTS9;ADAMTS18;ITGA3;MMP16;PXDN;LCP1
prerank,cellular component disassembly (GO:0022411),0.7701018758790628,2.0977120986177122,0.0,0.0008168389314121506,0.004,21/53,8.76%,MMP3;MMP13;SCUBE1;MMP2;TLL2;MMP14;SH3PXD2B;LAMC1;TIMP1;MMP11;KLK2;CTSS;BMP1;ADAMTS15;ADAMTS5;ADAMTS4;CTSK;CTSL;CAPN2;MMP16;LCP1
prerank,extracellular matrix disassembly (GO:0022617),0.7698269721577372,2.0930515005033206,0.0,0.0010210486642651883,0.005,21/53,8.76%,MMP3;MMP13;SCUBE1;MMP2;TLL2;MMP14;SH3PXD2B;LAMC1;TIMP1;MMP11;KLK2;CTSS;BMP1;ADAMTS15;ADAMTS5;ADAMTS4;CTSK;CTSL;CAPN2;MMP16;LCP1
prerank,regulation of humoral immune response (GO:0002920),0.7628780845603139,2.022600737113922,0.0011976047904191617,0.003792466467270699,0.02,8/44,6.33%,C6;CFH;C3;SERPING1;GATA6;PROS1;C1QB;C7
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.7826055190173529,-1.9966108942515284,0.0,0.1358504434428292,0.224,8/12,18.73%,DMD;ATP1B3;ATP1B1;WNK4;WNK3;ANK3;WNK2;FXYD1
prerank,muscle cell development (GO:0055001),-0.5889638911537691,-1.9933077397577705,0.0,0.09554658908808378,0.234,9/30,9.42%,NEBL;DMD;SGCZ;ANK2;MYOF;CXADR;RAMP2;DYSF;IGF1
prerank,regulation of immune effector process (GO:0002697),0.7561345388990139,1.9919899326057842,0.0012062726176115801,0.00701970956682317,0.041,7/41,6.33%,C6;CFH;C3;SERPING1;PROS1;C1QB;C7
prerank,regulation of complement activation (GO:0030449),0.7575832545448193,1.9899801700523028,0.001218026796589525,0.006466641540346193,0.043,7/40,6.33%,C6;CFH;C3;SERPING1;PROS1;C1QB;C7
prerank,chemokine-mediated signaling pathway (GO:0070098),0.7589040046462744,1.9766215626338277,0.0,0.007759969848415431,0.058,9/42,6.32%,CCL11;CXCL5;CCL7;CXCL1;CXCL12;XCL1;CCR1;CCL5;CXCL10
prerank,negative regulation of fat cell differentiation (GO:0045599),0.7628010899721175,1.9711351274685407,0.0,0.008075566708279216,0.067,15/34,14.12%,RORA;ENPP1;ADIPOQ;YAP1;ASXL1;ZFP36L2;ZFPM2;E2F1;RUNX1T1;TRIO;WNT5A;WWTR1;TNF;SMAD3;TRIB3
prerank,response to interferon-gamma (GO:0034341),0.7027730311500808,1.9694129058822851,0.0,0.007657864981988912,0.07,20/67,10.36%,CCL11;CCL7;IL23R;STAT1;SYNCRIP;TLR2;CD40;XCL1;CASP1;AIF1;LGALS9;CYP27B1;TRIM21;SHFL;CCL5;SP100;WNT5A;GBP7;GAPDH;CCL2
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5788010044218158,-1.9516422169430225,0.0,0.1290812632712793,0.384,17/30,9.23%,TJP1;DMD;SLC12A2;TJP2;OCLN;JAM2;PECAM1;CLDN5;ESAM;ACTB;CDH5;GJB6;SLC1A1;WNK3;LSR;CLDN12;VCL
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.7372574761454082,-1.950102343511292,0.0,0.10475889865488273,0.389,5/13,5.26%,DDO;GLUL;MTHFS;ASPA;GLUD1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.679431227901383,-1.9394054869767507,0.0,0.10037060254367106,0.433,5/18,5.18%,UNC13C;UNC13B;GRID2;GRIK4;GRIA2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.7536339555371471,1.9379820772538825,0.0,0.017436369497451674,0.162,7/33,4.31%,RUNX1;IL34;IL23R;ZFP36L1;TNFSF11;PRKCA;CCR1
prerank,endoderm formation (GO:0001706),0.7539386472120453,1.935490625861253,0.0,0.017066099102718144,0.168,10/35,3.96%,COL4A2;COL7A1;MMP2;COL8A1;MMP14;LAMB1;ITGB5;DUSP2;DUSP5;COL11A1
prerank,regulation of acute inflammatory response (GO:0002673),0.8360402551759675,1.931254990156983,0.0,0.017834316669165285,0.187,3/18,2.01%,OSMR;PTGES;CREB3L3
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.8080138148971066,1.9174009026295245,0.0,0.023739381444165628,0.258,5/24,0.97%,RORA;CYP1B1;C3;SULF1;CCBE1
prerank,response to peptide (GO:1901652),0.7599499584972192,1.9112568129714473,0.0,0.025946648409562432,0.29,11/33,11.02%,MMP3;MMP13;MMP2;CACNA1A;STAT1;IRS1;STAT3;STAT5A;ANXA1;GNAI1;ERBIN
prerank,potassium ion homeostasis (GO:0055075),-0.6197427411569101,-1.9106468979867264,0.00423728813559322,0.12244546596025255,0.551,7/23,4.05%,ATP1A2;ATP1B3;SLC12A2;SLC12A7;ATP1B1;SLC12A6;KCNJ2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.7947248403305456,1.908271752490495,0.0,0.026774164974064936,0.314,5/26,0.97%,RORA;CYP1B1;C3;SULF1;CCBE1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.7427392472573009,1.9028362156466372,0.0012706480304955528,0.02869684140619003,0.341,8/38,3.66%,RORA;NR1H4;ADIPOQ;TNIP1;STAT1;TNFAIP3;TLE1;TREM2
prerank,regulation of defense response (GO:0031347),0.6656165582986121,1.8983489166013763,0.0,0.03052935506152913,0.369,24/76,9.14%,CASP4;ZBP1;IL1RL2;SBNO2;PTGES;BCL6;LACC1;IL1R1;JAK2;XCL1;BIRC3;CASP1;TREM2;APOE;CASP12;PIK3AP1;IRF1;ADAMTS12;TIRAP;CELF1;AREL1;PSMA6;ANXA1;WNT5A
prerank,negative regulation of axon extension (GO:0030517),-0.5689203973308099,-1.8961324547992195,0.0,0.12674706321212414,0.62,22/30,30.08%,MAP2;SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;DIP2B;SEMA4D;CDKL3;SEMA5A;MAG;SEMA5B;SEMA3G;TRIM46;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA6B;SEMA4G;SEMA3F;RTN4R
prerank,membrane repolarization (GO:0086009),-0.7028347230054932,-1.8960719186230957,0.003076923076923077,0.11276779841340615,0.621,5/15,4.05%,ATP1A2;ATP1B3;KCND3;ATP1B1;KCNJ2
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5456536081825629,-1.8903211779292037,0.0,0.11036097879685507,0.643,15/37,16.29%,GRM7;GRM1;GRID2;GRIK4;GRM8;PLCB1;GRIN3A;GRIA2;GRM3;HOMER2;CLN3;APP;GRIN2B;GRIK2;GRM5
prerank,establishment of endothelial barrier (GO:0061028),-0.5772322724774201,-1.887421506711463,0.0,0.10423264264154594,0.663,13/29,12.63%,TJP1;TJP2;PECAM1;PPP1R16B;RAPGEF3;EZR;RAPGEF2;RAPGEF6;PDE4D;PDE2A;RAP1A;ROBO4;RDX
prerank,regulation of sodium ion transport (GO:0002028),-0.5552369638293727,-1.8865735345844086,0.004524886877828055,0.09648026911174583,0.665,14/34,8.96%,FGF12;NKAIN2;SLMAP;SNTA1;WNK4;WNK3;PER1;NKAIN3;ATP2B4;NKAIN4;GPD1L;SIK1;NKAIN1;ANK3
prerank,signal release from synapse (GO:0099643),-0.5149142460672421,-1.8802658933455,0.0,0.09703090092057216,0.692,17/43,17.24%,SNAP25;SYN3;NRXN1;LIN7A;PCLO;NRXN2;CPLX1;RIMS1;SNAPIN;DNAJC5;GAD1;SYN2;PTPRN2;LIN7C;NAAA;SNPH;PIP5K1C
prerank,cartilage development (GO:0051216),0.7017295309847716,1.8801656522814643,0.0,0.042932665264102915,0.484,8/49,1.86%,RUNX1;SLC39A14;RUNX2;RUNX3;SULF1;ITGB8;COL11A2;SOX5
prerank,regulation of T cell proliferation (GO:0042129),0.6795534322911069,1.8800554007385335,0.0011337868480725624,0.040981180479370966,0.484,12/61,8.96%,GLMN;IL23R;VSIG4;TNFRSF21;SPN;CD276;NCK1;AIF1;NCK2;CCL5;GPNMB;ANXA1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.525987871169222,-1.8782742288085466,0.0,0.0927010880635899,0.697,11/41,7.30%,ATP1A2;ATP1B3;SLC12A2;SLC12A7;ATP1B1;SLC12A6;KCNJ2;KCNJ3;KCNJ13;ABCC9;KCNJ10
prerank,acute inflammatory response (GO:0002526),0.7919218997037671,1.8759492098064094,0.0,0.042484503117468916,0.508,4/23,2.18%,HP;HPR;LBP;CRP
prerank,response to UV-A (GO:0070141),0.8727251467921355,1.8757034517948064,0.0,0.04084194657060753,0.51,5/14,5.20%,MMP3;MMP2;TIMP1;EGFR;PPID
prerank,chondrocyte differentiation (GO:0002062),0.7566648594441072,1.8754801522186955,0.0,0.03953500428034809,0.514,6/32,1.86%,RUNX1;SLC39A14;RUNX2;RUNX3;SULF1;SOX5
prerank,regulation of steroid metabolic process (GO:0019218),0.7773400249138751,1.873739785433401,0.0,0.039192560266794525,0.527,6/23,4.96%,RORA;NR1H4;APOE;ABCA2;ABCG1;EPHX2
prerank,camera-type eye development (GO:0043010),0.7642549019601911,1.8675631348755841,0.0,0.0428840438991379,0.567,7/25,5.10%,CYP1B1;FBN2;LAMA1;CACNA1C;TENM3;FBN1;NF1
prerank,regulation of protein processing (GO:0070613),0.8098354537278107,1.863928437631874,0.0,0.04437915087181193,0.592,5/21,2.43%,RUNX1;CCBE1;NKD2;SERPINE2;LRRK2
prerank,neurotransmitter secretion (GO:0007269),-0.5005611651003917,-1.85845026655101,0.0,0.11004975212230103,0.778,17/44,17.24%,SNAP25;SYN3;NRXN1;LIN7A;PCLO;NRXN2;CPLX1;RIMS1;SNAPIN;DNAJC5;GAD1;SYN2;PTPRN2;LIN7C;NAAA;SNPH;PIP5K1C
prerank,cellular response to UV-A (GO:0071492),0.8971665189985552,1.8582144417745627,0.0,0.04883429301157986,0.638,4/11,5.20%,MMP3;MMP2;TIMP1;PPID
prerank,response to amyloid-beta (GO:1904645),0.7121612694905127,1.8527642470179735,0.0,0.052549971254181684,0.668,11/44,6.91%,MMP3;MMP13;CASP4;MMP2;CACNA1A;LRP1;CACNA2D1;TREM2;CACNB1;CD36;ICAM1
prerank,positive regulation of lipid transport (GO:0032370),0.8732800505182818,1.8513555385598501,0.0,0.05207348187752459,0.679,4/12,3.78%,ADIPOQ;SPP1;LRP1;APOE
prerank,regulation of fat cell differentiation (GO:0045598),0.6481366869394203,1.850630270885114,0.0,0.051371510920842293,0.684,26/74,14.55%,RORA;ENPP1;ADIPOQ;YAP1;ZFP36L1;ASXL1;CMKLR1;ZFP36L2;ZFPM2;FRZB;E2F1;ASXL2;SFRP1;PPARG;RUNX1T1;CARM1;LPL;TRIO;FTO;WNT5A;WWTR1;TNF;WDFY2;SMAD3;TRIB3;TRPM4
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.7332689406024046,1.8463484691635852,0.0,0.05383711138852811,0.712,7/31,8.49%,GLMN;VSIG4;TNFRSF21;SPN;BLK;ATM;GPNMB
prerank,cellular response to chemokine (GO:1990869),0.7062231659873753,1.8432016404574092,0.0,0.055587090516319514,0.731,9/46,6.32%,CCL11;CXCL5;CCL7;CXCL1;CXCL12;XCL1;CCR1;CCL5;CXCL10
prerank,negative regulation of nervous system development (GO:0051961),0.8092816461566137,1.8381107247026292,0.0014347202295552368,0.059016612794527884,0.758,5/17,6.36%,CCL11;ROBO2;TLR2;SLIT1;PCM1
prerank,regulation of small molecule metabolic process (GO:0062012),0.7303474594327624,1.8333447172034403,0.0,0.06217051866859147,0.783,7/28,5.70%,RORA;NR1H4;ADIPOQ;NCOR2;APOE;EPHX2;FOXK2
prerank,endodermal cell differentiation (GO:0035987),0.7262730935068434,1.8329034262322905,0.0012690355329949238,0.06093176893777124,0.785,8/31,3.96%,COL4A2;COL7A1;MMP2;COL8A1;MMP14;LAMB1;ITGB5;COL11A1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.6397012653934809,-1.83147412462607,0.00909090909090909,0.14011035855078735,0.873,5/16,15.01%,CLDN5;CLDN12;CLDN11;CLDN14;CLDN1
prerank,triglyceride homeostasis (GO:0070328),0.751090591567686,1.829693931228765,0.001336898395721925,0.06263327464216194,0.798,5/26,5.58%,RORA;NR1H4;LIPC;APOE;ANGPTL4
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6873259265871332,-1.829589428299425,0.003048780487804878,0.13379085515533937,0.874,5/15,5.52%,GRM7;GRM1;GRM8;GRM3;HOMER2
prerank,positive regulation of leukocyte migration (GO:0002687),0.7427045385733237,1.828329251973713,0.0025906735751295338,0.0625195951350069,0.805,8/27,7.08%,EDN3;PTN;PLVAP;XCL1;MDK;AIF1;ICAM1;MIA3
prerank,lipid catabolic process (GO:0016042),0.7997229465511547,1.8268729010194158,0.001402524544179523,0.06253923068624279,0.81,5/18,8.79%,CEL;PLA1A;LIPC;LPL;HSD11B1
prerank,cellular response to interferon-gamma (GO:0071346),0.6389244451191306,1.819120266283376,0.0,0.07005389981897499,0.848,25/88,10.36%,CCL11;CCL7;MID1;JAK1;STAT1;SYNCRIP;TLR2;IRF7;JAK2;XCL1;CASP1;CAMK2D;AIF1;LGALS9;TRIM21;CCL5;ICAM1;IRF1;TRIM8;SP100;WNT5A;OASL;GBP7;GAPDH;CCL2
prerank,negative regulation of T cell activation (GO:0050868),0.7137633375816639,1.8176373388655562,0.0,0.0700390762320954,0.854,4/35,1.37%,GLMN;VSIG4;TNFRSF21;SPN
prerank,tight junction assembly (GO:0120192),-0.4751083151517314,-1.8157744050200482,0.0,0.14783267041315892,0.916,18/49,21.14%,OCLN;PECAM1;CLDN5;ESAM;CDH5;RAMP2;APC;LSR;CLDN12;PARD3;PATJ;CLDN11;CLDN14;CLDN1;PARD6G;AFDN;RAB13;MPP7
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.8539475787234878,1.8145967643947005,0.0,0.0720432941251298,0.867,4/13,4.42%,RUNX1;RUNX3;GLI3;SHH
prerank,regulation of lipid storage (GO:0010883),0.7611786765912113,1.8096507061733178,0.005698005698005698,0.07627697635090168,0.883,10/22,12.30%,C3;CRP;IKBKE;VSTM2A;FBXW7;LPL;FTO;MEST;PTPN2;TNF
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.6330940939094991,-1.807232461211465,0.00641025641025641,0.15499088392790136,0.935,12/17,32.21%,ANK2;SNTA1;GPD1L;KCNQ1;NEDD4L;KCNE4;SCN3B;RYR2;KCNJ8;PKP2;KCNH2;SCN5A
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.8420865241271114,1.8055527901668342,0.0030257186081694403,0.0802998049518778,0.896,5/11,7.58%,JAK1;STAT1;JAK2;STAT3;CANX
prerank,regulation of inflammatory response (GO:0050727),0.5948228574979948,1.8023485106848403,0.0,0.08232759773390398,0.903,38/190,9.14%,RORA;MMP3;NR1H4;CASP4;ZBP1;ADIPOQ;IL1RL2;SBNO2;PTGES;TNIP1;IL16;BCL6;TLR2;LACC1;IL1R1;TNFAIP3;JAK2;CCN4;XCL1;BIRC3;CASP1;TSLP;APOE;MDK;CASP12;MVK;CCL5;PPARG;PIK3AP1;TLR7;ADAMTS12;CELF1;AREL1;PLA2G7;LPL;PSMA6;ANXA1;WNT5A
prerank,positive regulation of glial cell differentiation (GO:0045687),0.7812156333250553,1.8005348124917102,0.0028530670470756064,0.0831611550384498,0.913,8/17,9.55%,IL34;SERPINE2;PTN;MDK;PTPRZ1;TENM4;CXCR4;DICER1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.7480250822198805,1.7987581275037696,0.002638522427440633,0.0838323497056064,0.918,3/22,0.90%,NR1H4;IL23R;RFTN1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.7694680407042193,1.79749933689885,0.002890173410404624,0.08362180183053472,0.92,7/19,8.14%,NR1H4;LBP;LGALS9;LY96;PIK3AP1;TIRAP;CD14
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.6295327811768789,1.79447539037915,0.0011074197120708748,0.08607440239755537,0.924,25/72,13.07%,RUNX1;ZBP1;JAK1;STAT1;TNFAIP3;JAK2;BIRC3;CFLAR;TSLP;IRAK3;PTPN6;IRAK2;IFNAR2;PTPN1;ABCE1;CDC37;IL7;LIFR;TNFRSF1A;CBFB;TRIM44;PTPN2;CASP8;TNF;TRAF2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.6697836437168448,-1.7944515897392999,0.002932551319648094,0.1687159802757336,0.951,4/14,1.87%,ATP1B3;ATP1B1;ACTN2;ANK2
prerank,positive regulation of lipid localization (GO:1905954),0.8551518338008619,1.7940091753305925,0.0015360983102918587,0.0849672653164992,0.928,5/11,8.76%,C3;LRP1;IKBKE;VSTM2A;LPL
prerank,regulation of execution phase of apoptosis (GO:1900117),0.8425100989549024,1.7932078663925464,0.0030581039755351682,0.08447214141670845,0.93,2/11,0.27%,FAP;DLC1
prerank,negative regulation of T cell proliferation (GO:0042130),0.7127741877877297,1.7911829938350239,0.001277139208173691,0.08565249738345335,0.936,6/28,8.49%,GLMN;VSIG4;TNFRSF21;SPN;LGALS9;GPNMB
prerank,response to fatty acid (GO:0070542),0.7874190776706517,1.7904454292694094,0.0014285714285714286,0.08497393883718066,0.937,7/17,9.23%,NR1H4;IRS1;CD36;GLDC;PID1;LPL;FOXO3
prerank,pyroptosis (GO:0070269),0.8134853107270034,1.787005490671025,0.002911208151382824,0.08821860459251227,0.946,4/15,3.66%,CASP4;ZBP1;CASP1;TREM2
prerank,regulation of fibrinolysis (GO:0051917),0.8351375985697904,1.7834448927817672,0.0014970059880239522,0.09180321472455755,0.953,3/13,5.63%,FAP;USF1;APOH
prerank,positive regulation of interleukin-12 production (GO:0032735),0.7065749617478928,1.7833392495492482,0.0012738853503184713,0.09030011081685638,0.954,8/31,7.99%,IL23R;IL16;TLR2;CD40;MDK;LGALS9;TIRAP;MAPK11
prerank,regulation of collagen biosynthetic process (GO:0032965),0.7594626040751475,1.7830829714006937,0.004213483146067416,0.08913050667542496,0.956,4/19,6.74%,RUNX1;CREB3L1;TGFB3;EMILIN1
prerank,regulation of B cell activation (GO:0050864),0.7428939214994447,1.7827623920556643,0.002751031636863824,0.08808707967982725,0.956,5/25,6.40%,ZFP36L1;SH3KBP1;ZFP36L2;TNFAIP3;AHR
prerank,regulation of spindle organization (GO:0090224),0.7822087686866745,1.7796725939402143,0.0,0.09089034859733951,0.962,9/18,10.99%,CLTC;PARP3;DYNC1H1;RAE1;GPSM2;BORA;TPX2;SENP6;GNAI1
prerank,response to cytokine (GO:0034097),0.5938383096967919,1.7782829756482776,0.0,0.09134200919500217,0.966,42/141,11.96%,COL3A1;IL23R;ADIPOQ;IL1RL2;OSMR;PTPN7;STAT1;CD40;TIMP1;IL1R1;JAK2;PRKCA;DPYSL3;CASP1;REL;IRAK3;STAT3;IKBKE;PTPN13;ALDH1A2;BCL2;LGALS9;CYP27B1;TRIM21;SHFL;DDOST;EIF2AK2;PTPN6;IRAK2;PTPN18;IFNAR2;PID1;SP100;ANXA1;CXCR4;SETD2;LIFR;PTPN23;PTPN9;PTPN2;CASP8;RHOA
prerank,epithelial cell morphogenesis (GO:0003382),0.7762033107047399,1.7780667304091045,0.0014204545454545455,0.09011577888482435,0.966,3/17,3.31%,COL15A1;COL18A1;SIPA1L3
prerank,negative regulation of blood coagulation (GO:0030195),0.6803957134288736,1.7771071495592607,0.0036188178528347406,0.0900305607935416,0.967,7/38,6.23%,KNG1;PDGFRA;SERPING1;SERPINE2;APOE;APOH;PLAT
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.8228964734570905,1.773754460896963,0.007541478129713424,0.09336213723874817,0.971,5/12,5.97%,ABCA1;ADIPOQ;CRP;ABCG1;PPARG
prerank,T cell differentiation in thymus (GO:0033077),0.8108884660823257,1.7735505168653636,0.005979073243647235,0.09216142328067475,0.971,4/14,4.42%,ZFP36L1;GLI3;ZFP36L2;SHH
prerank,skin development (GO:0043588),0.6414906370044919,1.771965807315583,0.0,0.09307013279120262,0.973,13/65,9.14%,COL1A2;COL1A1;COL3A1;COL5A2;COL5A3;COL5A1;GATA6;UGCG;JAG1;ERRFI1;ITGA3;ANXA1;WNT5A
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5841578994518765,-1.7658843520206668,0.0078125,0.2132791939765183,0.974,16/20,29.80%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;SEMA4D;SEMA5A;SEMA5B;SEMA3G;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA6B;SEMA4G;SEMA3F
prerank,acylglycerol homeostasis (GO:0055090),0.7460210714681462,1.7637280311961077,0.0027434842249657062,0.10457367065951823,0.983,5/20,8.76%,RORA;LIPC;APOE;ANGPTL4;LPL
prerank,sodium ion homeostasis (GO:0055078),-0.5833887407209604,-1.7607636727486538,0.0038461538461538464,0.21436444543259303,0.978,4/21,1.45%,ATP1A2;ATP1B3;SLC12A2;ATP1B1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8450731085817257,1.7604664613657828,0.0015105740181268882,0.10857651310737612,0.984,4/11,5.04%,RUNX1;RUNX3;XCL1;LGALS9
prerank,activin receptor signaling pathway (GO:0032924),0.7774175777268386,1.7570758585837125,0.0014771048744460858,0.1123153530691707,0.986,9/15,18.07%,SMAD2;ACVR1;INHBB;TGFBR1;ACVR1B;ACVR2A;ACVR1C;SMAD3;INHBA
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5239178382965107,-1.7568246815551845,0.004424778761061947,0.21210774450583672,0.979,9/29,6.42%,KCNIP4;FGF12;DPP10;DPP6;SLMAP;SNTA1;WNK3;ATP2B4;SLC30A5
prerank,skeletal system development (GO:0001501),0.5835235516297469,1.753574064934167,0.0,0.11641413413572096,0.988,35/148,10.51%,COL1A2;COL1A1;TRPS1;SULF1;ITGB8;PAX1;MMP14;SH3PXD2B;GLI2;CDH11;COL11A2;DEAF1;COL13A1;PAPSS2;SOX5;CHD7;CMKLR1;ANKRD11;VCAN;EXT1;SUFU;FRZB;FBN1;BMP1;ADAMTS4;PRELP;SPEF2;CREB3L2;MMP16;TGFBR1;TRIP11;WNT5A;BMP5;TBX3;FGFR1
prerank,regulation of extracellular matrix organization (GO:1903053),0.7850413714496043,1.7526715431958892,0.007462686567164179,0.11616945225259423,0.988,4/15,5.07%,RUNX1;FAP;LRP1;DDR2
prerank,toll-like receptor signaling pathway (GO:0002224),0.6154656265510131,1.7483119513642156,0.0011123470522803114,0.1218593218337606,0.995,21/84,9.80%,NR1H4;LBP;RFTN1;COLEC12;TNIP1;TLR2;BIRC3;IRAK3;CTSS;LGALS9;CD36;LY96;PIK3AP1;CTSK;TLR7;IRAK2;CTSL;TIRAP;CD14;IRAK4;CTSB
prerank,regulation of plasminogen activation (GO:0010755),0.8211197028544952,1.74768946582513,0.004341534008683068,0.12122505168748474,0.995,3/12,6.24%,RUNX1;SERPINE2;ENO1
prerank,neutrophil migration (GO:1990266),0.6350759060399206,1.7466041186837213,0.0034285714285714284,0.12169796241647243,0.995,14/58,11.44%,CCL11;CXCL5;CCL7;CXCL1;EDN3;JAML;PRTN3;XCL1;CCL5;CXCL10;GBF1;IRAK4;CCL2;TGFB2
prerank,intestinal lipid absorption (GO:0098856),0.8565313246800628,1.7450907368287791,0.009433962264150943,0.12275727740905602,0.995,4/11,5.55%,CEL;UGCG;LIMA1;CD36
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.7524366939562955,1.7430000304999445,0.0072254335260115606,0.12460824159288975,0.996,10/18,12.92%,IL34;TNFRSF21;PTN;MDK;NF1;PTPRZ1;TENM4;CXCR4;DRD3;OPALIN
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5382411504326576,-1.7417613124920661,0.008264462809917356,0.23633775598945803,0.989,8/25,4.33%,DMD;ATP1B3;ATP1B1;ACTN2;ANK2;SLC6A9;WNK4;WNK3
prerank,neutrophil chemotaxis (GO:0030593),0.640604696730662,1.7417466918092395,0.0023228803716608595,0.12517791416445945,0.996,12/53,11.44%,CCL11;CXCL5;CCL7;CXCL1;EDN3;JAML;XCL1;CCL5;CXCL10;GBF1;CCL2;TGFB2
prerank,embryonic digestive tract development (GO:0048566),0.7530595723140844,1.741062824387122,0.008670520231213872,0.12468575034776819,0.996,8/18,14.64%,PDGFRA;GLI2;GLI3;RARB;SALL1;TGFB2;TNF;NIPBL
prerank,regulation of immune response (GO:0050776),0.582821132689396,1.7403133572670573,0.0,0.12425774504108252,0.996,19/135,7.77%,COL1A2;C3;COL1A1;COL3A1;SPN;ULBP1;COLEC12;JAML;BCL6;CD276;IRF7;CD40;BIRC3;ADCY7;TREM2;AHR;ICAM1;IRF1;TIRAP
prerank,regulation of AMPA receptor activity (GO:2000311),-0.5354168223042175,-1.740200187499977,0.011538461538461539,0.23020814663411662,0.99,13/25,22.90%,MINK1;SHANK3;SHISA6;CACNG2;SHANK1;CACNG7;SHISA7;RELN;NLGN1;ADRB2;MEF2C;SHISA9;CACNG8
prerank,granulocyte chemotaxis (GO:0071621),0.6349975666405258,1.7356657983403538,0.0023094688221709007,0.130770807675764,0.996,13/55,11.44%,CCL11;CXCL5;CCL7;CXCL1;EDN3;JAML;XCL1;CCL5;CXCL10;GBF1;ANXA1;CCL2;TGFB2
prerank,supramolecular fiber organization (GO:0097435),0.5644238995776437,1.7355802025589178,0.0,0.12930761972879382,0.996,58/334,7.53%,COL15A1;COL4A1;LTBP3;LTBP2;CYP1B1;COL24A1;COL18A1;COL1A2;COL4A2;COL27A1;COL7A1;COL1A1;COL3A1;LUM;COL8A1;TLL2;COL6A3;COL23A1;COL5A2;HSPG2;IAPP;COL11A2;MYO1B;PPP1R9B;COL5A3;COL5A1;PLOD2;ADAMTS2;COL13A1;RND3;DPT;USP9X;COL11A1;DYNC1H1;SERF1A;NCKAP5;HOOK2;KIF2A;SERPINH1;DDR2;NF1;BMP1;RHOD;CD36;CARMIL1;MYO5A;PCM1;CDC42;FAT1;SIAH2;MYO1D;EMILIN1;CGNL1;MYO1H;ADAMTS14;LOXL1;TMOD1;MYO7A
prerank,high-density lipoprotein particle assembly (GO:0034380),0.845211200834509,1.7348696106240782,0.0016750418760469012,0.12906304152571557,0.996,3/10,5.18%,ABCA1;APOE;BMP1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.7660507618361152,1.7334371675059332,0.00894187779433681,0.130116044842565,0.996,3/16,6.17%,RUNX1;CREB3L1;TGFB3
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.8478115976781242,1.7322163807967135,0.001607717041800643,0.13054836493104907,0.996,4/10,9.14%,WNT2;FZD1;LRP6;WNT5A
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.6371762846131704,1.7284422686976002,0.0011750881316098707,0.1353309911954307,0.998,20/51,17.65%,IL34;EDN3;CXCL12;PTN;CMKLR1;XCL1;MDK;CCR1;AIF1;LGALS9;CCL5;CXCL10;PLA2G7;PTK2;CALR;VEGFC;IL6R;CREB3;MAPK1;ANO6
prerank,eye morphogenesis (GO:0048592),0.7397100346901834,1.72788583120053,0.014005602240896359,0.13471906038857082,0.998,7/19,5.10%,COL5A2;FBN2;COL5A1;TENM3;STAT3;FBN1;NF1
prerank,lymphocyte chemotaxis (GO:0048247),0.6832325610384177,1.7276539453867414,0.0036991368680641184,0.13358133214559048,0.998,6/34,6.32%,CCL11;CYP7B1;CCL7;XCL1;CCL5;CXCL10
prerank,carnitine shuttle (GO:0006853),-0.6898264562682417,-1.7223441931848211,0.011594202898550725,0.2614304066253758,0.994,2/11,0.67%,PRKAG2;PRKAA2
prerank,regulation of interleukin-12 production (GO:0032655),0.6428454404065707,1.7222454927053457,0.0035460992907801418,0.1418097360755583,0.999,11/47,8.33%,IL23R;IL16;CMKLR1;TLR2;CD40;IRAK3;MDK;LGALS9;TIRAP;MAPK11;MAST2
prerank,bicellular tight junction assembly (GO:0070830),-0.458691325268453,-1.7222361837674178,0.0,0.2518861219390526,0.994,16/46,21.14%,OCLN;PECAM1;CLDN5;ESAM;CDH5;RAMP2;APC;PARD3;PATJ;CLDN11;CLDN14;CLDN1;PARD6G;AFDN;RAB13;MPP7
prerank,protein autoprocessing (GO:0016540),0.7697962851130555,1.7196814055421323,0.009845288326300985,0.14520688700679202,0.999,5/17,7.12%,CASP4;CASP1;FXN;OMA1;CTSL
prerank,response to sterol (GO:0036314),0.8253994988843146,1.7175106731741963,0.0030581039755351682,0.14799533139265977,0.999,4/11,9.03%,RORA;SMAD2;ABCA2;TGFBR1
prerank,cellular response to cytokine stimulus (GO:0071345),0.558010237334864,1.7169824000431146,0.0,0.14745737962388028,0.999,103/416,13.89%,RORA;MMP3;CCL11;COL1A2;MMP2;CCL7;IL34;IL23R;IL1RL2;CXCL1;LBP;OSMR;ZEB1;SBNO2;TNFRSF21;CXCL12;ZFP36L1;TEC;GHR;PTPN7;TNFSF11;JAK1;IL16;BCL6;NUMBL;STAT1;SYNCRIP;GAB2;TLR2;ZFP36L2;CD40;TIMP1;IL1R1;PRTN3;JAK2;XCL1;DPYSL3;BATF;CASP1;IRAK3;STAT3;FSCN1;CCR1;PTPN13;BCL2;CEBPD;AIF1;LGALS9;CD36;CCL5;PTPRZ1;SFRP1;STAT5A;NPR2;PTPN6;CXCL10;IL3RA;ICAM1;IRAK2;PTPN18;IRF1;ADAMTS12;IFNAR2;PID1;MAPK11;SDC1;CBL;GRB2;POU2F1;ANXA1;CXCR4;WNT5A;FOXO3;IL7;IRAK4;JUNB;GREM2;GBP7;LIFR;TCF7;GAPDH;CCL2;TNFRSF1A;PTPRJ;PTPN23;PTPN9;PTPN2;ERBIN;SOCS5;YWHAZ;NFE2L2;RHOA;VAV1;TNF;GSK3B;FGF2;ADAMTS7;UBE2K;TANK;PIK3R1;YBX3;SMAD3;IL20RB
prerank,regulation of interleukin-17 production (GO:0032660),0.6810895742039343,1.714701103416971,0.005025125628140704,0.1504271042983735,0.999,3/31,0.90%,NR1H4;IL23R;RFTN1
prerank,negative regulation of B cell activation (GO:0050869),0.7407704503258076,1.7139348613734458,0.005502063273727648,0.15048939829121435,0.999,6/21,5.95%,PARP3;TNFRSF21;TNFAIP3;BLK;ATM;SFRP1
prerank,regulation of response to external stimulus (GO:0032101),0.5785719169552626,1.7135796209153253,0.0010582010582010583,0.1494424204570262,0.999,27/121,9.14%,CASP4;ZBP1;IL1RL2;PDGFRA;SBNO2;PTGES;BCL6;LACC1;IL1R1;GATA6;JAK2;XCL1;BIRC3;CASP1;TREM2;CASP12;CD36;PIK3AP1;IRF1;ADAMTS12;TIRAP;CELF1;AREL1;PSMA6;ANXA1;CXCR4;WNT5A
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.6622746409133741,-1.713459289640648,0.0030959752321981426,0.26506508957463165,0.996,8/13,24.47%,GLUL;NOS3;ALDH4A1;GLUD1;PRODH;GAD1;GLS;GLS2
prerank,alcohol catabolic process (GO:0046164),0.8266915389603797,1.711405856905327,0.013651877133105802,0.15234046070836607,0.999,3/10,8.44%,CEL;APOE;SRD5A3
prerank,regulation of chemotaxis (GO:0050920),0.6748026910027857,1.7107005530325357,0.002560819462227913,0.1519448043509633,0.999,10/30,13.33%,PDGFRA;MYCBP2;PDGFRB;ZSWIM6;TREM2;AIF1;CXCR4;PTPN2;ZSWIM8;ZSWIM4
prerank,muscle cell differentiation (GO:0042692),0.6692217030336577,1.7087204878129205,0.006570302233902759,0.15438887380183003,0.999,6/32,2.70%,RORA;GLMN;TBX18;MRTFA;FBXO40;GATA6
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.7192714009061069,1.7084756789730766,0.006925207756232687,0.1532510694150679,0.999,5/22,7.77%,LBP;TNFAIP3;TREM2;RAB7B;TIRAP
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.546627550142974,-1.7030258087430858,0.01968503937007874,0.28129525402535815,0.997,6/26,1.88%,ATP1B3;ATP1B1;FHL1;ACTN2;ANK2;WWP2
prerank,cellular response to fatty acid (GO:0071398),0.7909172299372661,1.7027666009127274,0.007598784194528876,0.1631305729563887,0.999,4/12,8.76%,NR1H4;IRS1;PID1;LPL
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.8053544826299336,1.7027341495713983,0.014331210191082803,0.16155031966003808,0.999,1/11,0.03%,MMP3
prerank,positive regulation of cytokine production (GO:0001819),0.5560314270115612,1.7027298010127365,0.0,0.15996092093730765,0.999,48/292,9.53%,RORA;RUNX1;GLMN;NR1H4;CYP1B1;C3;ZBP1;IL23R;ADIPOQ;SULF1;LBP;RFTN1;CCBE1;IL16;CD276;TLR2;IRF7;LACC1;CD40;IL1R1;STOML2;XCL1;BATF;TSLP;STAT3;MDK;AIF1;PRKD2;LGALS9;PLA2R1;NOD1;PAEP;CREBBP;EIF2AK2;HPSE;TLR7;ARNT;IRF1;RAB7B;TIRAP;TMEM106A;MAPK11;CD14;LPL;ANXA1;WNT5A;CRCP;IL7
prerank,cellular response to tumor necrosis factor (GO:0071356),0.5691975892943177,1.700116580586046,0.0,0.1631976115050526,0.999,48/175,17.14%,PSMA7;CCL11;CCL7;MAP3K14;TNFRSF21;ZFP36L1;TNFSF11;STAT1;ZFP36L2;CD40;PLVAP;JAK2;XCL1;BIRC3;LIMS1;CCL5;TNFRSF12A;SFRP1;ADAMTS12;PID1;PYDC1;PSMB8;PSMA6;FOXO3;EDA2R;CCL2;TNFRSF1A;ERBIN;EDA;NFE2L2;TNFRSF4;TNF;PSMF1;ADAMTS7;COMMD7;TANK;TRAF2;YBX3;CX3CL1;RIPK1;PSMA8;PSMD2;PSMD12;PSMD11;TRAF5;BAG4;PSMD14;AKT1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7689669589495357,1.699397890119428,0.005865102639296188,0.1631992636873572,0.999,3/16,3.06%,SLC39A14;C3;PRKCA
prerank,reverse cholesterol transport (GO:0043691),0.7997344466713954,1.698017062746618,0.00782472613458529,0.16412375500501106,1.0,4/13,4.34%,ABCA1;LIPC;APOE;ABCG1
prerank,response to nitric oxide (GO:0071731),0.795207586446039,1.6964600389755606,0.013293943870014771,0.16569188752775751,1.0,1/13,0.03%,MMP3
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.7964122305408798,1.6954709021019578,0.007633587786259542,0.16601673328877847,1.0,3/12,2.90%,IL23R;IL1R1;XCL1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7987433150486924,1.6943432580703714,0.009375,0.16707982301513255,1.0,5/12,10.88%,ADIPOQ;CBLB;APOD;CBL;PTPRJ
prerank,cellular response to organic substance (GO:0071310),0.5802138670857596,1.6939296091911562,0.0010604453870625664,0.16627966580644565,1.0,33/116,12.75%,NR1H4;CYP1B1;IBSP;IL1RL2;ROBO2;GHR;PTPN7;LRRK2;SLIT3;DPYSL3;CASP1;STAT3;IGFBP5;PTPN13;ACVR1;CCL5;SFRP1;PTPN6;PTPN18;PID1;CXCR4;TGFBR1;CYP1A1;RPS6KB1;ACVR1B;CCL2;PTPN23;PTPN9;PTPN2;ACVR2A;RHOA;TNF;ACVR1C
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.8363594867112026,1.693396689038349,0.0016,0.1659250916525622,1.0,5/10,11.00%,ADIPOQ;APOD;LRP1;PTPRJ;PTPN2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.6434086386235582,1.692912244207859,0.003694581280788177,0.16539131908979204,1.0,8/41,6.27%,NR1H4;ADIPOQ;LBP;TNFAIP3;IRAK3;LGALS9;ILRUN;PTPN6
prerank,cellular sodium ion homeostasis (GO:0006883),-0.617339505036541,-1.6925672924729194,0.009316770186335404,0.29952455159078767,0.998,4/15,1.45%,ATP1A2;ATP1B3;SLC12A2;ATP1B1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.6449462965855264,1.691704456436397,0.007228915662650603,0.1661365759035456,1.0,19/43,13.23%,CBLB;SH3KBP1;EGFR;ERRFI1;PTPN3;EGF;CDC42;RAB7A;EPS15L1;CBL;GRB2;MVP;PTPRJ;PTPN2;SOCS5;ZGPAT;SPRY2;EPS15;BTC
prerank,zymogen activation (GO:0031638),0.6500141110450037,1.6910287426083186,0.007462686567164179,0.16619390312102125,1.0,8/39,7.12%,HP;HPR;MMP14;KLK2;APOH;OMA1;PLAT;CTSL
prerank,positive regulation of collagen metabolic process (GO:0010714),0.7417906762917168,1.6899453536196902,0.008771929824561403,0.16699115366623846,1.0,3/17,6.17%,RUNX1;CREB3L1;TGFB3
prerank,regulation of epidermal cell differentiation (GO:0045604),0.7073685495247992,1.6899303014491276,0.012838801711840228,0.16554423211941643,1.0,6/21,7.12%,RUNX1;ZFP36L1;SFRP4;ERRFI1;CTSK;CTSL
prerank,lymphocyte migration (GO:0072676),0.6743095268375331,1.6898676239277768,0.007509386733416771,0.16417574652980518,1.0,6/32,10.36%,CCL11;CCL7;XCL1;CCL5;MSN;CCL2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.833738666950946,1.6869024601295537,0.009615384615384616,0.16865787462056267,1.0,4/10,10.71%,RUNX1;RUNX3;SH3RF1;CBFB
prerank,positive regulation of stem cell differentiation (GO:2000738),0.7410201128306793,1.6849372564957428,0.012658227848101266,0.1715536294198724,1.0,3/16,1.92%,LTBP3;SOX5;PTN
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.7886209792251871,1.683699133140172,0.01649175412293853,0.17299852495469414,1.0,5/13,10.77%,MDFIC;APOD;SUFU;SP100;NUP153
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.6367916456477408,1.6818784369488182,0.0036809815950920245,0.17574907386675506,1.0,8/43,6.27%,NR1H4;ADIPOQ;LBP;TNFAIP3;IRAK3;LGALS9;ILRUN;PTPN6
prerank,cellular lipid catabolic process (GO:0044242),0.6948394021034447,1.6818326989890926,0.01564537157757497,0.17431853320667423,1.0,2/27,0.18%,CEL;CYP1B1
prerank,organic anion transport (GO:0015711),-0.4175180903380827,-1.6816612664522577,0.0,0.3187161938836091,0.999,18/76,10.82%,ABCC4;SLC4A10;ABCG2;SLC26A7;LRRC8D;SLCO1C1;SLC22A6;SLCO3A1;SLC39A8;CA2;SLC52A1;SLC25A42;SLC25A4;SLCO2A1;ABCC6;CA4;SLC4A8;SLC4A3
prerank,eosinophil chemotaxis (GO:0048245),0.7709576019423917,1.6814009058372124,0.008771929824561403,0.17233125447446304,1.0,3/14,5.67%,CCL11;CCL7;CCL5
prerank,eosinophil migration (GO:0072677),0.7709576019423917,1.6814009058372124,0.008771929824561403,0.17233125447446304,1.0,3/14,5.67%,CCL11;CCL7;CCL5
prerank,regulation of interleukin-2 production (GO:0032663),0.6341567411400574,1.680146705955904,0.0036363636363636364,0.17347865842125124,1.0,8/43,5.00%,RUNX1;GLMN;VSIG4;TNFAIP3;STOML2;XCL1;NAV3;PRKD2
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6665626383055565,-1.6777446663780693,0.008522727272727272,0.31891008308207114,0.999,4/11,7.90%,TJP1;TJP2;RAPGEF2;RAPGEF6
prerank,action potential (GO:0001508),-0.4696726390460642,-1.6749436262115118,0.005681818181818182,0.3170268080343437,0.999,25/44,32.21%,DMD;AKAP6;KCND2;SCN2A;KCNJ2;GNA11;GNA14;SCN8A;ANK3;CLN3;SCN9A;SLC4A3;KCNQ1;GPER1;MYH14;CACNA1I;KCNE4;SCN3B;SCN3A;YWHAH;KCNMB2;CHRNA4;KCNH2;KCNB1;SCN5A
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.6345817257220325,1.6730605956875317,0.0085995085995086,0.1874365382634555,1.0,15/40,14.44%,COL1A1;TCF7L2;SNAI1;SMAD2;JAG1;MDK;TGFB3;TGFBR1;TGFB1I1;WWTR1;PDPN;TGFB2;GCNT2;SMAD3;SMAD4
prerank,vasoconstriction (GO:0042310),0.7857271974434834,1.6720494068539096,0.012759170653907496,0.18795463811793586,1.0,3/11,2.89%,EDN3;CRP;EDNRA
prerank,blood vessel morphogenesis (GO:0048514),0.613588146402122,1.66989316556056,0.001182033096926714,0.19127644977234529,1.0,11/54,5.41%,COL4A1;GLMN;CYP1B1;ITGB8;CCBE1;LAMA1;NRP1;SHH;ADM;NF1;CCM2
prerank,ATP transport (GO:0015867),-0.6975954417527601,-1.6695526300308998,0.015503875968992248,0.3225315258209074,0.999,7/10,30.04%,CD47;SLC25A42;SLC25A4;ABCC6;SLC17A9;SLC25A17;SLC25A24
prerank,phosphate ion homeostasis (GO:0055062),0.8232950045482942,1.6695326383102123,0.009950248756218905,0.19059843058058912,1.0,2/10,1.64%,ENPP1;SFRP4
prerank,cholesterol transport (GO:0030301),0.6316960444634809,1.6661488873607149,0.004842615012106538,0.1968789225213212,1.0,14/45,13.62%,CEL;ABCA1;LIPC;APOE;ABCG1;LIMA1;CD36;VPS4A;SOAT1;NPC2;OSBPL5;RELCH;ABCG4;MSR1
prerank,inflammatory response (GO:0006954),0.5532484542571181,1.6658747404688652,0.0,0.19590678673819906,1.0,37/195,12.69%,CCL11;SCUBE1;HP;HPR;CXCL5;CCL7;OLR1;CXCL1;HSPG2;CRP;CMKLR1;TLR2;CD40;XCL1;REL;STAT3;CCR1;AIF1;PTGDR;LGALS9;ADM;NOD1;HRH4;CCL5;CXCL10;PXK;CD14;ANXA1;CXCR4;HRH1;LOXL3;CCL2;TNFRSF1A;TNFRSF4;PJA2;TNF;TPST1
prerank,response to interleukin-1 (GO:0070555),0.5852129732392627,1.6614442200049182,0.002205071664829107,0.2045317558933059,1.0,21/73,15.90%,CCL11;CCL7;CD40;IL1R1;XCL1;PRKCA;IRAK3;LGALS9;CCL5;SFRP1;IRAK2;ADAMTS12;MAPK11;ANXA1;CCL2;ADAMTS7;TANK;SRC;CX3CL1;HIF1A;RBMX
prerank,synaptic vesicle exocytosis (GO:0016079),-0.46528084084236226,-1.6599295405192507,0.0,0.34073985549244135,1.0,15/40,21.36%,UNC13C;SNAP25;UNC13B;PCLO;SYT7;CPLX1;RIMS1;SNAPIN;DNAJC5;STX3;STX2;SNPH;PIP5K1C;RIMS2;BLOC1S6
prerank,regulation of blood coagulation (GO:0030193),0.6828983407161658,1.6597660248776613,0.00392156862745098,0.20697669679055017,1.0,6/27,6.67%,FAP;KNG1;SERPINE2;APOE;APOH;HPSE
prerank,regulation of acrosome reaction (GO:0060046),-0.6765709568591525,-1.6579136702676094,0.0084985835694051,0.336799132979874,1.0,2/10,7.25%,PLCB1;GLRA1
prerank,negative regulation of intracellular protein transport (GO:0090317),0.7023986196570491,1.657183121945272,0.015027322404371584,0.2113029269828193,1.0,7/22,10.58%,ADIPOQ;MDFIC;APOD;LRRK2;SUFU;SP100;LMAN1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.5386286924780164,1.6566258161319807,0.0,0.21102696002497365,1.0,134/532,16.79%,PSMA7;RORA;MMP3;CCL11;COL1A2;MMP2;CXCL5;CCL7;IL34;IL23R;MAP3K14;IL1RL2;CXCL1;LBP;OSMR;ZEB1;MID1;YAP1;CXCL12;TEC;GHR;TNFSF11;JAK1;IL16;BCL6;NUMBL;STAT1;GAB2;IRF7;CD40;PLVAP;TIMP1;IL1R1;IRS1;PRTN3;JAK2;XCL1;UGCG;BIRC3;BATF;CASP1;TSLP;IRAK3;STAT3;FSCN1;CCR1;CUL1;CAMK2D;BCL2;CEBPD;NOD1;LIMS1;TRIM21;CD36;CCL5;RALA;TNFRSF12A;PTPRZ1;STAT5A;PTPN6;CXCL10;CDC42;IL3RA;ICAM1;IRAK2;IRF1;SKP1;IFNAR2;PYDC1;CANX;SDC1;MSN;TRIM8;CBL;GRB2;LMNB1;POU2F1;PSMB8;LCP1;PSMA6;SP100;ANXA1;FOXO3;IP6K2;IL7;IRAK4;PELI3;OASL;JUNB;EDA2R;GREM2;LIFR;BRWD1;CCL2;TNFRSF1A;PTPRJ;SOCS5;YWHAZ;EDA;TNFRSF4;VAV1;FBXW11;TNF;FGF2;PSMF1;COMMD7;TRAF2;SPI1;TALDO1;PIK3R1;ARF1;IL20RB;IRF9;SRC;CDKN1B;SMAD4;CX3CL1;IL22;RIPK1;IL6R;PSMA8;FCGR1A;HIF1A;PSMD2;STAT5B;PSMD12;SQSTM1;PSMD11;PELI2;TRAF3IP2;SMARCA4;TRAF5;BAG4;PSMD14
prerank,cellular response to mechanical stimulus (GO:0071260),0.6047491703841515,1.6554029418681941,0.013142174432497013,0.21245431982867147,1.0,12/46,12.25%,MAP3K14;SLC9A1;CASP8AP2;CD40;CASP1;MAP2K4;PIEZO2;TLR7;IRF1;TNFRSF1A;CASP8;MAP3K2
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.7685461275145039,1.6528422497755157,0.004470938897168405,0.217173269227486,1.0,3/14,4.31%,IL23R;TNFSF11;CCR1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.7916280863791625,1.6527562858551652,0.011128775834658187,0.21582416140905417,1.0,4/11,9.14%,WNT2;FZD1;LRP6;WNT5A
prerank,transition metal ion homeostasis (GO:0055076),0.6673522012447175,1.652491992634258,0.012610340479192938,0.21483012954338723,1.0,3/28,2.42%,SLC39A14;HEPH;CP
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.6268717069102117,-1.6524421001086917,0.017964071856287425,0.3434428411362321,1.0,9/13,22.16%,SLC4A10;SHISA6;CLN3;GRIK2;SHISA7;SYP;SYNGR1;SLC8A2;SHISA9
prerank,cholesterol homeostasis (GO:0042632),0.6018202565306106,1.6518853847311172,0.011273957158962795,0.21461998988652403,1.0,12/64,9.98%,RORA;CYP7B1;ABCA1;LIPC;APOE;ABCA2;ABCG1;LIMA1;EPHX2;SOAT1;LPL;NPC2
prerank,toxin transport (GO:1901998),0.8184469273417327,1.6511017340804846,0.017432646592709985,0.21508867581546023,1.0,2/10,0.71%,ANTXR1;ANTXR2
prerank,sterol homeostasis (GO:0055092),0.6002035676161731,1.6510146245617532,0.010112359550561797,0.21380029709238568,1.0,12/65,9.98%,RORA;CYP7B1;ABCA1;LIPC;APOE;ABCA2;ABCG1;LIMA1;EPHX2;SOAT1;LPL;NPC2
prerank,adenine nucleotide transport (GO:0051503),-0.5924866898294597,-1.6499904264789313,0.022653721682847898,0.3418251707680665,1.0,5/17,8.93%,ABCC4;LRRC8D;SLC25A42;SLC25A4;ABCC6
prerank,response to tumor necrosis factor (GO:0034612),0.5747380406725402,1.6493306411866218,0.003257328990228013,0.21644783386444308,1.0,25/91,17.14%,CCL11;CCL7;ADIPOQ;TNFRSF21;ZFP36L1;ZFP36L2;CD40;JAK2;XCL1;CCL5;SFRP1;ADAMTS12;PID1;CCL2;ERBIN;NFE2L2;CASP8;ADAMTS7;TANK;YBX3;CX3CL1;RIPK1;GGT7;BAG4;AKT1
prerank,regulation of striated muscle contraction (GO:0006942),-0.5151309374885902,-1.6460959752777302,0.021645021645021644,0.34450398821787165,1.0,5/27,5.11%,DMD;ATP1A2;ANK2;CALM1;SLC8A3
prerank,regulation of muscle contraction (GO:0006937),-0.5065104673051526,-1.645058077195584,0.022988505747126436,0.338482350578087,1.0,5/26,1.98%,PLCE1;ATP1A2;CHRM2;CAV1;KCNB2
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.5994155318169748,1.6450574733992247,0.009345794392523364,0.2249974207994507,1.0,15/56,9.80%,LBP;TLR2;LACC1;ALPK1;CTSS;NOD1;CD36;LY96;CTSK;TLR7;IRAK2;CTSL;CD14;IRAK4;CTSB
prerank,regulation of establishment of planar polarity (GO:0090175),0.5717230667164693,1.6450571424456324,0.006493506493506494,0.2234240122623916,1.0,24/88,16.79%,PSMA7;ROR2;CLTC;PRICKLE2;SMURF2;FZD1;CDC42;PRICKLE1;ARHGEF19;PSMB8;PSMA6;WNT5A;NPHP3;RHOA;PSMF1;DACT1;RAC1;AP2A2;PSMA8;SMURF1;PSMD2;PSMD12;PSMD11;PSMD14
prerank,presynaptic endocytosis (GO:0140238),0.6937131905830586,1.64462875140866,0.013605442176870748,0.22300695513753083,1.0,5/24,8.40%,CEL;STON2;OPHN1;CANX;SYT2
prerank,positive regulation of T cell migration (GO:2000406),0.7131512707082548,1.6439482054101044,0.012430939226519336,0.2230674454247768,1.0,8/20,11.96%,CXCL12;SPN;XCL1;AIF1;CCL5;CXCL10;WNT5A;RHOA
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.721427435230867,1.6430452033151663,0.015220700152207,0.22363763141008347,1.0,3/16,3.66%,APOD;ADCY7;TREM2
prerank,phospholipid homeostasis (GO:0055091),0.7943745108489462,1.6425147582682145,0.0109375,0.22334571292140903,1.0,4/11,11.52%,ABCA1;ABCG1;TLCD2;RCN3
prerank,negative regulation of cell development (GO:0010721),0.6677930408350831,1.6419380666667651,0.012396694214876033,0.22323021371370738,1.0,6/25,12.44%,CCL11;FBN1;PCM1;FBXW7;TNF;GSK3B
prerank,xenobiotic transport (GO:0042908),-0.5751413363841754,-1.636785973044447,0.01639344262295082,0.35354591139886404,1.0,6/17,9.83%,ABCG2;SLC47A1;SLC7A5;SLC22A4;SLC22A18;ABCA3
prerank,epithelial cell migration (GO:0010631),0.6302717731180345,1.6355901131771826,0.014354066985645933,0.23749317823784313,1.0,6/37,3.21%,FAP;CYP1B1;ZEB2;STAT1;NRP1;FSTL1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.645487549347056,1.6344557454399984,0.03074866310160428,0.23856461691001368,1.0,9/27,8.81%,SNAI1;SNAI2;SPRED1;KMT5A;SPRED2;PLA2R1;ATM;EEF1E1;ATR
prerank,positive regulation of T cell differentiation (GO:0045582),0.6429526139833966,1.6328804884808987,0.01616915422885572,0.24094719903153283,1.0,7/36,4.42%,IL23R;GLI2;GLI3;BCL6;ZMIZ1;MDK;SHH
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.7281895760948456,1.632361123153324,0.017341040462427744,0.24071222260051814,1.0,4/15,5.07%,FAP;LRP1;FSCN1;DDR2
prerank,skeletal system morphogenesis (GO:0048705),0.6301094675949247,1.632188060174098,0.008760951188986232,0.23949931021666063,1.0,10/42,10.51%,MMP13;PDGFRA;FBN2;SFRP4;ANKRD11;HOXB3;LRP6;SPEF2;TGFBR1;FGFR1
prerank,regulation of T cell differentiation (GO:0045580),0.6454359940172049,1.6315720607314703,0.011553273427471117,0.23951547400376574,1.0,7/33,10.71%,RUNX1;ZMIZ1;MDK;IL7;PRDM1;TCF7;CBFB
prerank,melanocyte differentiation (GO:0030318),0.7695459431969256,1.628782445015183,0.018808777429467086,0.24520318987060066,1.0,4/11,5.49%,ENPP1;LRMDA;MITF;SLC24A5
prerank,regulation of T cell migration (GO:2000404),0.7153967208284324,1.628192952232932,0.021551724137931036,0.2451629475473151,1.0,6/18,6.32%,APOD;CXCL12;SPN;AIF1;CCL5;CXCL10
prerank,regulation of Wnt signaling pathway (GO:0030111),0.5576041884115069,1.6264003478173337,0.003188097768331562,0.24854405606511273,1.0,28/108,10.71%,RUNX1;SULF1;MDFIC;LRP1;NKD2;SFRP4;KREMEN1;TLR2;LRRK2;TNFAIP3;TLE1;TAX1BP3;FRZB;ATP6AP2;SFRP1;CDK14;FAM53B;NXN;MDFI;GSKIP;TERT;ITGA3;CSNK2A1;SALL1;SFRP5;WLS;DISC1;CBFB
prerank,positive regulation of interleukin-2 production (GO:0032743),0.6643730349532513,1.6249499184527738,0.013404825737265416,0.2507385327436032,1.0,4/25,5.00%,RUNX1;GLMN;STOML2;PRKD2
prerank,eye development (GO:0001654),0.5966823791030388,1.6249103602136405,0.0035087719298245615,0.24923219942639133,1.0,11/54,5.29%,COL5A2;SH3PXD2B;FBN2;LAMA1;COL5A1;MEIS2;CACNA1C;SIPA1L3;MEIS1;FBN1;PBX3
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.6321961455051726,1.6248728465366846,0.01856763925729443,0.24775107682979627,1.0,8/33,6.17%,ADIPOQ;APOD;TNFAIP3;IGFBP5;PTEN;AIF1;PPARG;TGFB3
prerank,negative regulation of proteolysis (GO:0045861),0.6351263212473561,1.6237380579966536,0.018656716417910446,0.2489773261514722,1.0,10/34,8.36%,KNG1;SERPINE2;LRRK2;TIMP1;DNAJC1;PTPN3;TRIM21;PLAT;BAG6;GAS1
prerank,dopamine metabolic process (GO:0042417),-0.5538124672063434,-1.6229939722776572,0.016339869281045753,0.38636568598206045,1.0,5/18,4.47%,SNCAIP;MOXD1;PRKN;MAOA;MAOB
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.735852895528659,1.62213886621471,0.017857142857142856,0.25147420157726386,1.0,4/15,4.34%,LIPC;APOE;PLTP;ABCG1
prerank,dorsal/ventral pattern formation (GO:0009953),0.6964720149754908,1.621006980910312,0.01925722145804677,0.2526750918433429,1.0,6/20,6.54%,GLI2;SHH;AIDA;ACVR1;SFRP1;MDFI
prerank,regulation of mitotic spindle organization (GO:0060236),0.6368364562632836,1.6205882394887001,0.013819095477386936,0.25223637551243805,1.0,11/35,10.99%,CLTC;PARP3;CHMP4B;DYNC1H1;RAE1;PLK1;GPSM2;BORA;EML3;TPX2;GNAI1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.5567278346425353,1.6202409436941847,0.0010615711252653928,0.25161114356983366,1.0,33/112,15.51%,LTBP2;COL1A2;COL3A1;PDE3A;WNT2;ZFP36L1;ITGB5;SOX5;ZMIZ1;ZFP36L2;XCL1;SMAD2;USP9X;ACVR1;LIMS1;SFRP1;TGFB3;CBL;TGFBR1;WNT5A;SMAD5;PTK2;TGFB2;GCNT2;TGFBRAP1;RHOA;SMAD3;SRC;ARHGEF18;SMAD4;LRRC32;SMAD1;SMURF1
prerank,aorta development (GO:0035904),0.7415295205663627,1.6174059879656446,0.020710059171597635,0.2575502992175419,1.0,7/14,8.15%,LRP1;ROBO2;PDGFRB;TBX2;JAG1;PKD2;ADAMTS9
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.6664061113259044,1.6170166735853013,0.015873015873015872,0.2570169023935073,1.0,8/26,7.18%,TLR2;IRF7;BIRC3;FLOT2;IRAK3;TREM2;CD36;IRF1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.7318759883745596,1.6167506187387877,0.014265335235378032,0.2560583409175991,1.0,2/16,1.15%,IL23R;TNFRSF21
prerank,purine ribonucleotide transport (GO:0015868),-0.593388678957331,-1.6149238344666774,0.025,0.401699545063908,1.0,5/16,8.93%,ABCC4;LRRC8D;SLC25A42;SLC25A4;ABCC6
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.6837691015089962,1.6145419068824827,0.02051983584131327,0.2601740747293006,1.0,1/22,0.01%,PSMA7
prerank,negative regulation of immune effector process (GO:0002698),-0.6230335979356231,-1.6137942016707718,0.01557632398753894,0.39592277003378745,1.0,7/13,19.06%,CD47;CD55;GRN;RPS19;HAVCR2;RC3H1;FER
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.6792951057311865,1.6136689673068487,0.026836158192090395,0.2610581187781553,1.0,6/18,13.74%,RUNX1;FSCN1;DDR2;EMILIN1;PDPN;SMAD3
prerank,positive regulation of cell development (GO:0010720),0.6446826478642802,1.6133899732252777,0.017654476670870115,0.26018230699819483,1.0,5/31,7.23%,PDE3A;ADIPOQ;NUMBL;NKX6-1;SERPINF1
prerank,bicarbonate transport (GO:0015701),-0.5119230613074096,-1.6131493257091643,0.0149812734082397,0.3889710978576127,1.0,12/25,24.45%,SLC4A10;SLC26A7;SLC39A8;CA2;CA4;SLC4A8;SLC4A3;CYB5R1;SLC26A6;CYB5R4;CYB5RL;CFTR
prerank,regulation of osteoclast differentiation (GO:0045670),0.6340308579608047,1.6125982488593897,0.010178117048346057,0.2605811172475855,1.0,6/33,4.45%,IL23R;TNFSF11;LRRC17;MAFB;CCR1;FBN1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5898110206684973,1.612215570563382,0.007017543859649123,0.2600368965252019,1.0,13/55,8.32%,DCN;CEMIP;LUM;HSPG2;BGN;SLC9A1;GPC6;VCAN;CEMIP2;PRELP;HPSE;SDC1;SDC2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7182311094507408,1.6113960410112564,0.02109704641350211,0.2609835594436451,1.0,3/16,5.70%,RORA;ADIPOQ;FOXK2
prerank,negative regulation of cell junction assembly (GO:1901889),0.6602993466821637,1.6109506318995392,0.02168021680216802,0.2606649721412089,1.0,14/25,19.84%,DLC1;APOD;ROBO2;TLR2;SLIT1;PTEN;TNF;ARHGAP6;SRC;PHLDB2;ITGB1BP1;ACVRL1;BCAS3;CORO1C
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.5657790809466986,1.6109243490979224,0.008705114254624592,0.25923613387892014,1.0,22/85,16.79%,PSMA7;ROR2;CLTC;PRICKLE2;SMURF2;FZD1;CDC42;PRICKLE1;ARHGEF19;PSMB8;PSMA6;WNT5A;RHOA;PSMF1;RAC1;AP2A2;PSMA8;SMURF1;PSMD2;PSMD12;PSMD11;PSMD14
prerank,dopaminergic neuron differentiation (GO:0071542),0.6871313995615017,1.6106893670318938,0.030054644808743168,0.25834261796865643,1.0,3/19,6.00%,WNT2;SHH;LRP6
prerank,negative regulation of lipid storage (GO:0010888),0.689766554952884,1.6104086733176053,0.027065527065527065,0.2575968110458248,1.0,7/19,12.30%,ABCA1;CRP;TREM2;ABCG1;PPARG;PTPN2;TNF
prerank,regulation of monocyte differentiation (GO:0045655),0.7245724605347501,1.6100413366673862,0.02865761689291101,0.25710461700795995,1.0,4/14,5.86%,IL34;ZFP36L1;IRF7;CDK6
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.7272192350944082,1.609710552350745,0.026912181303116147,0.2565101144337323,1.0,4/14,9.14%,CCL7;XCL1;CCL5;WNT5A
prerank,regulation of cytokine production (GO:0001817),0.541986190790465,1.6088047439950452,0.0010471204188481676,0.25740580414596986,1.0,25/126,12.30%,GLMN;IGF2BP1;ZBP1;DTX4;IGF2BP2;BCL6;CD276;CRP;IRF7;SNAI2;CCN4;BATF;TREM2;LGALS9;PLA2R1;TRIM21;EIF2AK2;MAST2;GPNMB;ANXA1;GAPDH;PLD4;CASP8;ATP2B1;TNF
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.7101827490795014,1.6080076476389806,0.01849217638691323,0.2581626174917097,1.0,10/18,15.26%,YAP1;JAK1;STAT1;JAK2;STAT3;CBL;SPI1;SRC;SMAD4;IL6R
prerank,regulation of stem cell differentiation (GO:2000736),0.5575390890635252,1.6061900536269231,0.0044444444444444444,0.2615056275707383,1.0,10/89,6.20%,PSMA7;RUNX1;KMT2A;PDGFRA;YAP1;PTN;ZFP36L2;JAG1;TCF12;EIF2AK2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.7787909907539052,1.6061833075860272,0.03262642740619902,0.26008440133394084,1.0,2/10,3.66%,C3;TREM2
prerank,positive regulation of protein maturation (GO:1903319),0.7819312857211665,1.605755237567252,0.02254428341384863,0.25972166509724987,1.0,2/11,1.01%,CCBE1;NKD2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.7555402934065014,1.6047645201154883,0.02074074074074074,0.26094380782712756,1.0,2/13,2.90%,IL23R;XCL1
prerank,endothelial cell migration (GO:0043542),0.6128285612810042,1.6034720928154396,0.017135862913096694,0.26286815959208,1.0,8/37,6.84%,FAP;CYP1B1;STAT1;EGR3;NRP1;FSTL1;MYH9;PLXND1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.6053822331602652,1.6028679901680094,0.01694915254237288,0.26308839545569146,1.0,11/39,13.50%,LTBP2;ABCA1;ARFGAP3;STEAP3;RAB8B;MIA3;CANX;COPG1;TMEM167A;RCN3;RAB10
prerank,positive regulation of reproductive process (GO:2000243),0.6429407521376274,1.601258853746589,0.0161892901618929,0.26593185448917406,1.0,6/31,10.18%,PDE3A;SYDE1;LHFPL2;SMURF2;INHBB;ACVR1B
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.5276476897335657,1.6007235584236583,0.0,0.26590256793600797,1.0,57/208,17.47%,RORA;NR1H4;ROR1;ADIPOQ;MAP3K14;TRIML2;NEK6;TNIP1;STAT1;ALPK1;CD40;TNFAIP3;BIRC3;CFLAR;CASP1;REL;TLE1;TREM2;LITAF;IKBKE;SLC20A1;UNC5CL;LGALS9;NOD1;TRIM21;VAPA;TIRAP;TRIM13;TMEM106A;TRIM8;WNT5A;IRAK4;WLS;EDA2R;CXXC5;GAPDH;TNFRSF1A;CASP8;ANKRD17;RHOA;TNF;AKAP13;TANK;TRAF2;SPHK2;CX3CL1;TIFA;RIPK1;SQSTM1;PELI2;RBCK1;TRAF3IP2;LAMTOR5;TRAF5;BRD4;MAP3K3;DDX1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.5345989921388027,1.6004039245546637,0.0010309278350515464,0.26543523207727426,1.0,31/151,12.55%,ROR2;CCL11;ROR1;CCL7;PDGFRA;TNFSF11;PDGFRB;XCL1;PRKCA;NRP1;EGFR;TREM2;APOE;CCR1;PRKD2;LGALS9;CD36;CCL5;ICAM1;TIRAP;ANGPT1;FBXW7;GPNMB;MAP2K1;CCL2;BMPER;GCNT2;SPRY2;TNF;FGF2;NTRK3
prerank,regulation of transmembrane transport (GO:0034762),-0.47203336896187814,-1.5999701331244292,0.018433179723502304,0.4212926645897748,1.0,9/31,7.30%,OCLN;SLC2A1;WWP2;ACTB;KCNJ2;KCNJ3;PRKCB;KCNJ13;KCNJ10
prerank,regulation of chemokine production (GO:0032642),0.6240674935129179,1.5995968858069565,0.020356234096692113,0.26605231054439116,1.0,14/36,15.68%,TLR2;SNAI2;TSLP;TREM2;AIF1;LGALS9;EIF2AK2;TLR7;LPL;WNT5A;IL7;TNF;IL6R;HIF1A
prerank,nerve growth factor signaling pathway (GO:0038180),-0.6668994447677423,-1.5991754235150857,0.019553072625698324,0.4146135271032081,1.0,6/10,27.28%,KIDINS220;RAPGEF2;RAP1A;BDNF;MAGI2;NTF3
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5941304038843278,1.5991509150259218,0.016374269005847954,0.26581123879450835,1.0,10/49,8.14%,ADIPOQ;LBP;TLR2;STAT3;PRKD2;LGALS9;NOD1;TLR7;TIRAP;CD14
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.6164313676214804,1.5984779810340037,0.020884520884520884,0.2662621233256488,1.0,16/39,13.23%,SH3KBP1;EGFR;ERRFI1;PTPN3;EGF;CDC42;PTPN18;EPS15L1;CBL;GRB2;MVP;PTPRJ;PTPN2;SPRY2;EPS15;BTC
prerank,negative regulation of peptidase activity (GO:0010466),0.6014741586841862,1.5984430730386843,0.0166270783847981,0.2649699825973107,1.0,11/47,11.22%,KNG1;LRP1;SERPING1;FETUB;SERPINE2;TIMP1;SERPINH1;SERPINF1;SERPINA2;GAPDH;VTN
prerank,sulfur compound transport (GO:0072348),-0.4893197566902786,-1.598173805962334,0.020080321285140562,0.4092436253713751,1.0,8/27,10.23%,SLC13A4;ABCG2;SLC6A6;SLC26A7;LRRC8D;SLC5A6;SLC25A26;SLC27A1
prerank,response to organic cyclic compound (GO:0014070),0.596197708766911,1.5957021048326512,0.008168028004667444,0.270812320468499,1.0,18/52,15.91%,CYP1B1;SPP1;LRRK2;STAT3;IGFBP5;ABCA2;CYP27B1;CCL5;SFRP1;GLDC;ANXA1;CYP1A1;DRD3;CCL2;TNF;STAT5B;GGT7;BGLAP
prerank,regulation of keratinocyte differentiation (GO:0045616),0.6536675022689084,1.5954946802459486,0.017615176151761516,0.26992483952419666,1.0,6/24,7.12%,RUNX1;ZFP36L1;ERRFI1;CYP27B1;CTSK;CTSL
prerank,lipoprotein transport (GO:0042953),0.7969486491783582,1.5954782931284999,0.026813880126182965,0.2685822100046657,1.0,5/10,7.08%,LRP1;VMP1;CD36;PPARG;MIA3
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.6847918470711425,1.5935372217296861,0.03248587570621469,0.2722710923076996,1.0,4/18,4.23%,EDN3;PTN;XCL1;MDK
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.5686050148004805,-1.592220623268051,0.024844720496894408,0.41863163509908935,1.0,7/16,12.49%,ST6GALNAC3;ST8SIA4;ST3GAL5;ST8SIA6;B4GALT6;ST8SIA2;ST6GALNAC5
prerank,regulation of interleukin-8 production (GO:0032677),0.5655586885991282,1.590743895460964,0.008948545861297539,0.27838381306858223,1.0,13/69,8.96%,ADIPOQ;LBP;BCL3;CRP;TLR2;STAT3;PRKD2;LGALS9;NOD1;TLR7;TIRAP;CD14;ANXA1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.578967020185457,1.5903892612369075,0.008027522935779817,0.27804018701438216,1.0,12/63,5.70%,HP;DAP;EIF4G2;TIMP1;EIF4G3;NELL1;KLHL22;TREM2;STAT3;PTPN3;BCL2;FOXK2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.5445509858598907,1.5903580624328686,0.002107481559536354,0.27674462558672797,1.0,30/114,16.79%,PSMA7;MAP3K14;TNFSF11;STAT1;CD40;PLVAP;JAK2;BIRC3;LIMS1;TNFRSF12A;PYDC1;PSMB8;PSMA6;FOXO3;EDA2R;TNFRSF1A;EDA;TNFRSF4;TNF;PSMF1;COMMD7;TRAF2;RIPK1;PSMA8;PSMD2;PSMD12;PSMD11;TRAF5;BAG4;PSMD14
prerank,positive regulation of cholesterol efflux (GO:0010875),0.6810746662885578,1.5897982307189964,0.03206997084548105,0.27683496272163394,1.0,6/21,5.97%,ADIPOQ;LRP1;TREM2;APOE;PLTP;PPARG
prerank,embryonic eye morphogenesis (GO:0048048),0.7672505894802883,1.5881591771197958,0.03442879499217527,0.27971227746303945,1.0,4/11,6.00%,FBN2;TBX2;FBN1;LRP6
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.7396372726693323,1.587194735025701,0.01804511278195489,0.28087803572637443,1.0,3/13,4.42%,COL4A1;NRP1;SHH
prerank,regulation of mononuclear cell migration (GO:0071675),0.6640536605547739,1.586672657416614,0.027434842249657063,0.28093212253343014,1.0,9/23,12.30%,IL34;CMKLR1;MDK;AIF1;CCL5;MSN;BMP5;PTK2;TNF
prerank,regulation of protein autophosphorylation (GO:0031952),0.6153875134203478,1.5865042556327145,0.019851116625310174,0.2800534249387456,1.0,11/36,10.65%,ENPP1;EPHA7;ADIPOQ;TNKS1BP1;ERRFI1;RAP2A;TOM1L1;RASSF2;GPNMB;PPP2R5A;MVP
prerank,regulation of chromatin organization (GO:1902275),-0.6036506347238941,-1.586072926699024,0.021739130434782608,0.4291006652746079,1.0,7/14,19.60%,MLLT3;HNRNPU;TLK1;IGF2;SSRP1;METTL4;SETD1A
prerank,embryonic skeletal system development (GO:0048706),0.633050971876917,1.5853896050288072,0.022556390977443608,0.28177016023472023,1.0,6/35,4.05%,COL1A1;SULF1;PDGFRA;DEAF1;WNT9A;HOXB3
prerank,synaptic vesicle cycle (GO:0099504),-0.485987863257347,-1.5850079300674031,0.024291497975708502,0.42442164683445993,1.0,10/30,19.82%,SNAP25;PCLO;SYNDIG1;SYT7;CPLX1;RIMS1;SNAPIN;DNAJC5;PIP5K1C;NLGN1
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.5498293301057214,-1.5839936017866039,0.033444816053511704,0.4189709552332774,1.0,10/17,31.17%,CAV1;OSR1;KLF7;AJAP1;APOLD1;PRKX;DSPP;CEACAM1;DLL1;SOX9
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.5616493558786374,1.58349202002686,0.011376564277588168,0.28548325236842365,1.0,18/70,16.79%,PSMA7;RUNX1;KMT2A;YAP1;TCF12;EIF2AK2;PSMB8;PSMA6;CBFB;PSMF1;PSMA8;ITCH;PSMD2;PRKDC;PSMD12;PSMD11;TCF3;PSMD14
prerank,bone morphogenesis (GO:0060349),0.7431606603155072,1.5834796281965726,0.02242152466367713,0.2841675675379948,1.0,3/14,6.00%,MMP13;SFRP4;LRP6
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7743081195390922,1.5833811990916762,0.029315960912052116,0.2831063083136046,1.0,5/10,7.37%,GHR;JAK2;STAT3;STAT5A;PTPN1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.6681448582577291,1.5830554503933039,0.028208744710860368,0.28272452212120325,1.0,5/23,5.67%,CYP1B1;MGAT5;GHR;TSLP;CCL5
prerank,positive regulation of bone resorption (GO:0045780),0.7678880471662011,1.5817294196584952,0.023961661341853034,0.284819847117279,1.0,3/11,3.06%,SPP1;TNFSF11;PRKCA
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.7477448876530532,1.5815680923083981,0.028744326777609682,0.28385629992116285,1.0,5/11,5.67%,TNFSF11;JAK1;PRKCA;BLK;CCL5
prerank,embryonic digit morphogenesis (GO:0042733),0.7050618610452039,1.581316620734198,0.025,0.283243648530718,1.0,8/18,10.21%,GLI3;TBX2;SHH;CREBBP;HDAC1;SALL1;WDPCP;TBX3
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.701493514915128,1.5810162716737866,0.03508771929824561,0.28262721568403393,1.0,2/16,2.90%,IL23R;XCL1
prerank,osteoclast differentiation (GO:0030316),0.661457171294416,1.5807075634720027,0.03021978021978022,0.28223761303510964,1.0,5/22,3.66%,SBNO2;TNFSF11;FARP2;GAB2;TREM2
prerank,positive regulation of synapse assembly (GO:0051965),-0.48137488014409396,-1.5804522973392023,0.03017241379310345,0.4219000544657093,1.0,19/27,29.69%,NRXN1;GRID2;IL1RAPL1;AGRN;CLSTN3;SYNDIG1;CUX2;LRRC4B;CLSTN1;SEMA4D;PTPRD;BDNF;EPHB1;NLGN1;VSTM5;SEMA4A;SLITRK2;CLSTN2;NLGN2
prerank,response to lipid (GO:0033993),0.5441818342886207,1.5794609502550063,0.009554140127388535,0.28435268557891674,1.0,22/105,11.09%,IL23R;SPP1;LBP;ASXL1;GATA6;JAK2;RXRG;IRAK3;STAT3;ABCA2;ABCG1;LGALS9;CYP27B1;CD36;PPARG;LY96;TIRAP;ANXA1;FOXO3;HMGB2;ERBIN;TMEM161A
prerank,negative regulation of hemostasis (GO:1900047),0.7506755410636125,1.5791556577692423,0.020895522388059702,0.28389815189240114,1.0,5/12,11.22%,KNG1;SERPINE2;APOE;APOH;VTN
prerank,positive regulation of transporter activity (GO:0032411),0.7369290090599201,1.5783426783697618,0.025356576862123614,0.28477975472414524,1.0,3/13,5.13%,KMT2A;ADIPOQ;TRPC6
prerank,cellular response to sterol (GO:0036315),0.7413758702273181,1.5777067648092322,0.03139013452914798,0.28501580135076676,1.0,5/13,11.03%,RORA;INSIG2;LRP6;GRAMD1A;GRAMD1C
prerank,basement membrane organization (GO:0071711),0.7235614274584767,1.5775229565073392,0.03259259259259259,0.2841458850374024,1.0,6/14,8.73%,COL4A1;LAMB1;NID1;FLRT2;CTSS;PXDN
prerank,membrane assembly (GO:0071709),0.619733520692651,1.5761782756612566,0.032953105196451206,0.28638812489891924,1.0,8/34,6.56%,CEL;RFTN1;UGCG;FLOT2;CHMP4B;TLCD2;PTEN;VPS4A
prerank,artery morphogenesis (GO:0048844),0.6390992933486171,1.5760936527194909,0.025806451612903226,0.28531472786763806,1.0,11/30,11.44%,LRP1;PDGFRB;NRP1;TBX2;JAG1;PKD2;NF1;ADAMTS9;HOXA1;TGFBR1;TGFB2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7417489580156473,1.575997978688435,0.018018018018018018,0.284300790077999,1.0,2/12,3.81%,RUNX1;BLK
prerank,regulation of adaptive immune response (GO:0002819),0.692410857040096,1.5756684505003842,0.034782608695652174,0.2839328511257081,1.0,5/18,7.18%,IRF7;ADCY7;AHR;SASH3;IRF1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7662744637009933,1.5755588502638997,0.0296875,0.2829474283066153,1.0,5/11,6.26%,NOS1AP;CACNA2D1;CACNB1;CAMK2D;SESTD1
prerank,mesonephros development (GO:0001823),-0.6427855190873545,-1.5755469338639623,0.02967359050445104,0.42829977529875557,1.0,4/11,4.86%,ZBTB16;BMP4;FGF1;OSR1
prerank,plasma membrane invagination (GO:0099024),0.6178321322076674,1.5733345594652959,0.029336734693877552,0.2877789833962512,1.0,12/29,15.63%,DOCK1;MYH9;AIF1;CD36;CDC42;SPIRE1;SNX18;SNX33;SNX9;RHOA;MSR1;FCGR1A
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5577300803905371,1.572866434094018,0.015625,0.287708328205414,1.0,23/73,17.60%,CASP4;DLC1;DAP;CASP8AP2;JAK2;CFLAR;CASP1;BBC3;CASP12;IFT57;NOD1;PPARG;HSPE1;CASP8;TNF;TRAF2;SMAD3;BCL2L13;RIPK1;CYCS;AIFM1;HSPD1;EIF2AK3
prerank,negative regulation of cell differentiation (GO:0045596),0.5225099753213475,1.5727897025407651,0.0010235414534288639,0.28667938953153504,1.0,44/181,12.65%,RORA;ABCA1;ENPP1;ADIPOQ;COL5A2;YAP1;COL5A1;ASXL1;TNN;MEIS2;CRP;ZFP36L2;SNAI2;ZFPM2;SPRED1;WNT9A;SUFU;EGFR;MEIS1;JAG1;ABCG1;SHH;E2F1;SPRED2;PTEN;CDK6;SFRP1;PPARG;RUNX1T1;ADAMTS12;TRIO;TGFBR1;WNT5A;BMP5;TBX3;WWTR1;NEPRO;NPHP3;LDLRAD4;NBR1;CALR;SPRY2;TNF;ADAMTS7
prerank,fatty acid transmembrane transport (GO:1902001),-0.5452084885423919,-1.5715328888957527,0.031578947368421054,0.4329728909727409,1.0,5/19,10.23%,PRKAG2;PRKAA2;SLC2A1;ABCD3;SLC27A1
prerank,intracellular lipid transport (GO:0032365),-0.5300023321531956,-1.5712465427852904,0.033582089552238806,0.42619158508659793,1.0,3/21,1.29%,PRKAG2;PRKAA2;CERT1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.7317490956796066,1.5706565176796077,0.03283582089552239,0.29115357365864913,1.0,6/13,9.83%,JAK1;STAT1;JAK2;STAT3;CANX;OASL
prerank,positive regulation of lipid storage (GO:0010884),0.667470369510796,1.5706304397151476,0.042134831460674156,0.28996021636399855,1.0,6/21,8.76%,C3;PLIN2;IKBKE;OSBPL11;VSTM2A;LPL
prerank,cell proliferation in forebrain (GO:0021846),0.7726329740763438,1.5704946495411372,0.030254777070063694,0.28910576621273504,1.0,4/10,12.59%,NUMBL;PCM1;CEP120;NUMB
prerank,bone development (GO:0060348),0.5988713051331002,1.5699707470313753,0.020581113801452784,0.28919239860187873,1.0,5/39,1.94%,MMP13;SULF1;SH3PXD2B;SFRP4;LRRC17
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.5572736138754156,1.5697580140839302,0.009122006841505131,0.28850490364201176,1.0,19/73,16.79%,PSMA7;RUNX1;KMT2A;YAP1;TCF12;EIF2AK2;PSMB8;PSMA6;CBFB;PSMF1;SPI1;PSMA8;ITCH;PSMD2;PRKDC;PSMD12;PSMD11;TCF3;PSMD14
prerank,negative regulation of defense response (GO:0031348),0.5521446514976581,1.5693663719499462,0.016722408026755852,0.2883597181070966,1.0,10/77,5.97%,RORA;NR1H4;ADIPOQ;TNFAIP3;IRAK3;APOE;ILRUN;MVK;TRIM21;PPARG
prerank,epithelial tube morphogenesis (GO:0060562),0.6127103165387722,1.5692644988387314,0.03461538461538462,0.2873928873240598,1.0,7/32,5.41%,COL4A1;GLI2;SHH;PRKD2;PKD2;ACVR1;CCM2
prerank,negative regulation of reproductive process (GO:2000242),0.6860739482859036,1.5687127055934367,0.0480225988700565,0.28763112477167874,1.0,5/17,12.75%,SULF1;TIMP1;PAEP;CALR;ACVR1C
prerank,cholesterol efflux (GO:0033344),0.6762494951743839,1.5680692708113348,0.03225806451612903,0.2880297110659372,1.0,6/20,13.37%,ABCA1;APOE;ABCG1;SOAT1;NPC2;ABCG4
prerank,chondroitin sulfate catabolic process (GO:0030207),0.7263071785927993,1.565417302217305,0.03609022556390978,0.29414284832762855,1.0,3/13,2.84%,DCN;BGN;VCAN
prerank,secretion (GO:0046903),-0.5919916980535687,-1.5653714171886994,0.02786377708978328,0.4365855029941191,1.0,6/14,11.13%,FBLN5;SLC22A6;NPR1;SLC22A4;TPD52;RIMS1
prerank,cellular response to lipid (GO:0071396),0.5199117923436535,1.5641847170836338,0.0010224948875255625,0.29603632517371686,1.0,34/191,11.96%,RORA;NR1H4;CXCL5;WNT2;SPP1;CXCL1;LBP;SBNO2;NRIP1;IRS1;TNFAIP3;WNT9A;CASP1;EGFR;MGST1;ADCY2;NUGGC;ATM;SFRP1;LY96;CD68;CXCL10;AHR;PID1;CD14;MSN;LPL;WNT5A;UBE2L3;HMGB2;CCL2;GNAI1;LCOR;RHOA
prerank,negative regulation of complement activation (GO:0045916),0.7668454866355825,1.5637826827651873,0.02875399361022364,0.29581298719130833,1.0,2/10,1.02%,VSIG4;SERPING1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7068520318899084,1.563609593943181,0.04405286343612335,0.2951124768971244,1.0,3/15,4.42%,IL23R;GLI3;SHH
prerank,regulation of cell size (GO:0008361),0.6427314000703307,1.5635728213731643,0.036684782608695655,0.2940117998002956,1.0,11/23,16.76%,PRR16;VAV2;VAV3;PTEN;RPTOR;MSN;RHOA;VAV1;RAC1;LAMTOR5;PLEK
prerank,odontogenesis (GO:0042476),0.6112081320886169,1.5597032905655994,0.02247191011235955,0.3030305733716342,1.0,9/35,11.51%,COL1A2;GLI2;LAMB1;ANKRD11;LRP6;TGFB3;HDAC1;TGFB2;EDA
prerank,cellular response to leucine starvation (GO:1990253),-0.6373438888023544,-1.5594638481217762,0.047493403693931395,0.44773176720884095,1.0,6/10,17.67%,SESN2;GCN1;SESN3;RRAGB;IMPACT;RRAGD
prerank,positive regulation of chemokine production (GO:0032722),0.5924388599720685,1.559262860361249,0.019393939393939394,0.30302317004881546,1.0,14/44,15.68%,ADIPOQ;TLR2;TSLP;AIF1;LGALS9;EIF2AK2;TLR7;TIRAP;LPL;WNT5A;IL7;TNF;IL6R;HIF1A
prerank,steroid catabolic process (GO:0006706),0.7373735472676086,1.5587881345841723,0.06201550387596899,0.30299515767062957,1.0,3/10,8.79%,SPP1;CYP27B1;HSD11B1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6901656754338517,1.5587037318728034,0.025974025974025976,0.30199161098327243,1.0,10/18,22.34%,MDFIC;APOD;SUFU;ILRUN;GSK3B;CTNNA1;LATS2;MFHAS1;LATS1;POLR1A
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.7023020038260215,1.5581045243401672,0.03025936599423631,0.30255025119202456,1.0,6/17,8.59%,CXCL12;CCR1;AIF1;CCL5;CXCL10;PLA2G7
prerank,anion transport (GO:0006820),-0.45755301210220867,-1.556130758652462,0.0392156862745098,0.4508883260030392,1.0,7/33,7.65%,SLC13A4;ABCG2;SLC13A3;SLC26A7;LRRC8D;SLC22A6;VDAC1
prerank,regulation of necroptotic process (GO:0060544),0.6484461966077399,1.5556685347528483,0.03337783711615487,0.3079360245584096,1.0,10/23,15.12%,ZBP1;BIRC3;FLOT2;CFLAR;OGT;CDC37;MLKL;CASP8;YBX3;RIPK1
prerank,positive regulation of calcium ion import (GO:0090280),0.7446758755781063,1.5541646026084905,0.025525525525525526,0.3105940542389468,1.0,4/12,13.14%,CXCL12;PDGFRB;CCL2;SPHK2
prerank,lipid homeostasis (GO:0055088),0.5641016891244002,1.5539491036612176,0.017321016166281754,0.30991258028696717,1.0,16/57,14.14%,ABCA1;TREM2;APOE;USF1;ABCA2;ABCG1;TLCD2;PPARG;ADCK1;ACOX1;FBXW7;RCN3;ZBTB20;ORMDL3;ACOX3;ABHD8
prerank,growth hormone receptor signaling pathway (GO:0060396),0.7058354062439656,1.5529366733384087,0.040419161676646706,0.31135527035334,1.0,8/14,15.86%,GHR;JAK2;STAT3;STAT5A;PTPN1;PTK2;PIK3R1;STAT5B
prerank,epidermis development (GO:0008544),0.5660136212685238,1.5527706045235001,0.023668639053254437,0.31054752937196295,1.0,10/56,10.01%,COL7A1;EMP1;GATA6;FGF7;UGCG;FLOT2;SVEP1;HDAC1;ATP2A2;EDA2R
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.7042179774807041,1.5521886019131514,0.0410958904109589,0.31081922573954995,1.0,4/14,4.99%,ADIPOQ;LRP1;IGFBP5;AIF1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.7563443775676314,1.5517045444612507,0.03571428571428571,0.3108534796699228,1.0,2/10,7.77%,LBP;TIRAP
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.7296514753964586,1.5505225702077152,0.037037037037037035,0.3129017536972673,1.0,1/12,0.45%,IL23R
prerank,regulation of cellular biosynthetic process (GO:0031326),0.6254824619880518,1.5501918759104827,0.0324254215304799,0.31279707103175175,1.0,7/28,5.67%,NR1H4;C3;ADIPOQ;NOS1AP;JAK2;MITF;CCL5
prerank,neurotrophin signaling pathway (GO:0038179),-0.5085036005151224,-1.5495542326935858,0.025362318840579712,0.46455249577305613,1.0,9/21,14.90%,SORT1;KIDINS220;NTRK2;RAPGEF2;ZFYVE27;CASP3;DDIT4;RAP1A;BDNF
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.45769361896151284,-1.5493322649312333,0.034934497816593885,0.457717498812953,1.0,10/29,15.71%,SORBS1;LDLR;SCARB1;LPGAT1;ELOVL5;CREBL2;SLC27A1;GPLD1;SLC45A3;MFSD2A
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.6928903922395101,1.548533739720525,0.037089871611982884,0.3158785531772682,1.0,5/17,8.66%,SULF1;SFRP4;FSTL1;CASK;ITGA3
prerank,negative regulation of angiogenesis (GO:0016525),0.5380869800552585,1.5480147977168672,0.009793253536452665,0.3159909989285927,1.0,22/84,12.30%,COL4A2;DCN;CREB3L1;SULF1;HSPG2;SPARC;THBS4;STAT1;THBS2;SPRED1;APOH;PPARG;CXCL10;EMILIN1;SERPINF1;ADAMTS1;ADAMTS9;SEMA3E;TGFB2;PTPRM;SPRY2;TNF
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.6035250031283451,-1.5476946281293593,0.07062146892655367,0.4552292489561339,1.0,4/12,3.53%,PCGF5;HNRNPU;YTHDC1;SMCHD1
prerank,regulation of axon guidance (GO:1902667),0.7370534039186222,1.5469947442684777,0.04472843450479233,0.3176282879272765,1.0,5/10,13.33%,MYCBP2;NRP1;ZSWIM6;ZSWIM8;ZSWIM4
prerank,lipoprotein localization (GO:0044872),0.7606368844733316,1.5463262634850723,0.04354587869362364,0.3182787954600684,1.0,5/11,7.08%,LRP1;VMP1;CD36;PPARG;MIA3
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5888475223039057,1.5461120037820462,0.030729833546734954,0.3176548393872318,1.0,15/36,20.64%,CASP4;ZBP1;CASP1;TSLP;CXCR4;WNT5A;IL7;TRIM44;UBE2K;RIPK1;HIF1A;CD300LF;IRGM;TRIM6;PARP14
prerank,regulation of platelet activation (GO:0010543),0.6527024244713032,1.5460480590842645,0.04533333333333334,0.3166063057023204,1.0,5/21,3.81%,PDGFRA;TEC;PRKCA;APOE;BLK
prerank,monocyte chemotaxis (GO:0002548),0.6141715736092703,1.5460312305517847,0.01509433962264151,0.3154539480781868,1.0,7/32,10.36%,CCL11;CCL7;TNFSF11;XCL1;CCL5;ANXA1;CCL2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.5119032363159907,1.5460065542911192,0.0,0.3143217703835308,1.0,44/214,12.57%,ROR2;CCL11;ROR1;EPHA7;CCL7;ADIPOQ;PDGFRA;FBLN1;TNIP1;PDGFRB;XCL1;PRKCA;SPRED1;NRP1;EGFR;TREM2;APOE;CCR1;SPRED2;PTEN;PRKD2;LGALS9;CD36;CCL5;PTPN6;EMILIN1;ICAM1;PTPN1;TIRAP;ANGPT1;FBXW7;GPNMB;MAP2K1;CNKSR3;CCL2;PTPN2;YWHAZ;BMPER;GCNT2;SPRY2;TNF;FGF2;NTRK3;DUSP26
prerank,regulation of neurogenesis (GO:0050767),0.5658472424449256,1.5443162232995298,0.022274325908558032,0.3177526388107069,1.0,10/55,12.59%,CCL11;YAP1;NUMBL;PCM1;SERPINF1;BHLHE40;HEYL;HMGB2;TNF;NUMB
prerank,regulation of macrophage differentiation (GO:0045649),0.7010740303493384,1.54412028067293,0.04229607250755287,0.3171651462789119,1.0,6/15,15.12%,IL34;ADIPOQ;PRKCA;PTPN2;CASP8;RIPK1
prerank,negative regulation of B cell proliferation (GO:0030889),0.7571516591627981,1.5438022727679481,0.046031746031746035,0.3167945820380553,1.0,3/11,5.91%,TNFRSF21;BLK;ATM
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5331107898480129,1.5437699735091404,0.004291845493562232,0.3157120286525157,1.0,26/112,15.12%,NR1H4;ADIPOQ;LBP;SPN;TLR2;TNFAIP3;JAK2;IRAK3;STAT3;ARFGEF2;LGALS9;ILRUN;LY96;PTPN6;TIRAP;TMEM106A;CD14;LPL;WNT5A;DICER1;PTPRJ;MC1R;SPHK2;PSEN1;CX3CL1;RIPK1
prerank,synaptic vesicle recycling (GO:0036465),0.6230739322495918,1.5429284077546241,0.02998696219035202,0.3165853692381797,1.0,5/31,8.40%,CEL;STON2;OPHN1;CANX;SYT2
prerank,regulation of focal adhesion assembly (GO:0051893),0.559170688167655,1.5427546974921844,0.03233256351039261,0.3158156072547594,1.0,23/54,18.78%,DLC1;GPM6B;APOD;MAP4K4;SLC9A1;PEAK1;NRP1;PTEN;LIMS1;SFRP1;EFNA5;PTPRJ;PTK2;RHOA;ARHGAP6;SRC;PHLDB2;RAC1;ITGB1BP1;ACVRL1;PTPRA;BCAS3;COL16A1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.6524203478090056,1.5422701316554315,0.0335195530726257,0.316023911852569,1.0,5/22,10.71%,RUNX1;BCL6;MDK;IRF1;CBFB
prerank,myeloid leukocyte differentiation (GO:0002573),0.554287435093922,1.5408036523186326,0.014874141876430207,0.31887647901400157,1.0,13/65,6.39%,RUNX1;SBNO2;TNFSF11;FARP2;GAB2;PRTN3;BATF;TREM2;MYH9;E2F1;LGALS9;PPARG;CDC42
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.674394707796414,1.540530034185658,0.041666666666666664,0.3184743606448964,1.0,9/17,11.22%,PDGFRB;CCN4;NRP1;IGFBP5;MDK;AIF1;CCL5;ADAMTS1;VTN
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.6207151243252436,1.5404086446128131,0.04594594594594595,0.3176275225234802,1.0,15/25,19.61%,STAT1;STAT3;ARNT;MAPK11;FOXO3;HMGB2;ACVR1B;ACVR2A;BRD1;HIF1A;STAT5B;PRKDC;ETS1;INHBA;MED1
prerank,digestive tract development (GO:0048565),0.598540755492007,1.5399259556202816,0.04198473282442748,0.3177378115920396,1.0,12/33,15.46%,GLI2;CLMP;GLI3;RARB;GATA6;EPHB3;SALL1;TGFB2;TNF;NPY;NIPBL;SMO
prerank,regulation of cholesterol efflux (GO:0010874),0.6227410147195781,1.5395618323323192,0.033647375504710635,0.3176012271403008,1.0,8/30,5.97%,ADIPOQ;LRP1;TREM2;APOE;ABCA2;PLTP;SHH;PPARG
prerank,macrophage activation involved in immune response (GO:0002281),0.7171461198203594,1.5387609119319072,0.038109756097560975,0.3186257380128471,1.0,3/13,3.66%,LBP;SBNO2;TREM2
prerank,protein secretion (GO:0009306),0.5526667777105381,1.5373921333886906,0.011534025374855825,0.3211052185019122,1.0,12/56,11.52%,LTBP2;ABCA1;ARFGAP3;STEAP3;RAB8B;MIA3;CANX;COPG1;ANXA1;WLS;TMEM167A;RCN3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.5479444928436672,1.5370224301788145,0.016666666666666666,0.3208999705904478,1.0,21/74,14.44%,COL1A1;SNAI1;SPRED1;SMAD2;MDK;SPRED2;PTEN;SFRP1;TGFB3;TGFBR1;BMP5;TGFB1I1;WWTR1;PDPN;TGFB2;GCNT2;LDLRAD4;SPRY2;SMAD3;PHLDB2;SMAD4
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.6189041236311373,-1.5368000652226788,0.049586776859504134,0.48326092399321163,1.0,5/11,12.33%,KCND3;ATP1B1;KCNJ2;KCNJ3;KCNQ1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.6145740256451705,1.536689208897117,0.03435114503816794,0.3207179027775952,1.0,5/27,2.84%,DCN;CHSY3;BGN;CHST13;VCAN
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.4375572003923821,-1.5366778210564218,0.0056179775280898875,0.4761184570661699,1.0,12/39,9.96%,DMD;FGF12;FGF14;SLMAP;FXYD5;WNK4;WNK3;OSR1;GPD1L;HECW1;ANK3;FXYD6
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.5367069545883939,-1.535255393854069,0.04377104377104377,0.47310285014359216,1.0,9/18,24.07%,COX16;PET100;COX18;COX14;COX17;TIMM21;BCS1L;SCO1;COA3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.5409515742902353,1.5351070819895472,0.01560758082497213,0.3237626252173178,1.0,19/75,11.91%,COL4A2;DCN;SULF1;HSPG2;SPARC;THBS4;STAT1;THBS2;SPRED1;APOH;PPARG;CXCL10;EMILIN1;SERPINF1;ADAMTS1;SEMA3E;TGFB2;PTPRM;SPRY2
prerank,vasculogenesis (GO:0001570),0.6026265925433465,1.5350503709069516,0.027603513174404015,0.3227915923370472,1.0,7/32,5.41%,GLMN;ITGB8;PDGFRB;SPRED1;SHH;ADM;CCM2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.581503153092684,1.534264485980408,0.019138755980861243,0.32377274012504514,1.0,12/45,9.83%,MID1;JAK1;STAT1;IRF7;JAK2;CAMK2D;TRIM21;ICAM1;IRF1;TRIM8;SP100;OASL
prerank,regulation of cation channel activity (GO:2001257),-0.368750880905667,-1.534188248990773,0.0,0.4691883585572085,1.0,23/89,11.80%,DMD;FGF12;CACNB2;CACNB4;FGF14;LRRC7;ACTN2;DLG2;ANK2;MINK1;CALM1;SLMAP;SHISA6;GRIA2;GRIA1;CACNG2;AHNAK;ANK3;SHANK1;PDE4D;APP;GRIN2B;CAMK2B
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.6809698850130192,1.534183878341206,0.05241379310344828,0.3217050401214073,1.0,9/17,16.59%,JAK1;IRS1;TSLP;STAT3;STAT5A;IL7;BRWD1;STAT5B;SMARCA4
prerank,cellular response to interleukin-7 (GO:0098761),0.6809698850130192,1.534183878341206,0.05241379310344828,0.3217050401214073,1.0,9/17,16.59%,JAK1;IRS1;TSLP;STAT3;STAT5A;IL7;BRWD1;STAT5B;SMARCA4
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.6436964598794372,-1.5329500910436944,0.04884318766066838,0.4657530410572126,1.0,3/10,11.35%,BMP6;NEXMIF;NOTCH4
prerank,apical junction assembly (GO:0043297),-0.39929148695388506,-1.53230703753154,0.012269938650306749,0.46112808698038965,1.0,16/53,19.16%,OCLN;PECAM1;CLDN5;ESAM;CDH5;RAMP2;APC;PARD3;VCL;PATJ;CLDN11;CLDN14;CLDN1;PARD6G;AFDN;RAB13
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.5164049923006797,1.5314480853828036,0.006128702757916241,0.3282742361769821,1.0,44/152,17.00%,PSMA7;COL1A1;ZEB2;SULF1;SFRP4;LYPD6;TLR2;LRRK2;TNFAIP3;EGFR;SMURF2;UBR5;EGF;ATP6AP2;SFRP1;FAM53B;GSKIP;CCAR2;TERT;DKK2;LRRK1;PSMB8;PSMA6;CSNK2A1;SALL1;TBL1X;WLS;DISC1;CSNK1G2;RUVBL1;ZBED3;PSMF1;DACT1;TRPM4;PTK7;PSMA8;DEPDC1B;PSMD2;PSMD12;PSMD11;TNKS2;SMARCA4;PSMD14;CSNK1D
prerank,negative regulation of protein processing (GO:0010955),0.7107290718314374,1.53142769925349,0.05303030303030303,0.3271913347714008,1.0,3/12,8.36%,SERPINE2;LRRK2;GAS1
prerank,positive regulation of cholesterol transport (GO:0032376),0.6282520967932137,1.5313474584567288,0.04619565217391304,0.3263025070969133,1.0,6/27,5.97%,ADIPOQ;LRP1;TREM2;APOE;PLTP;PPARG
prerank,regulation of cellular metabolic process (GO:0031323),0.5705782067429107,1.5312906260582313,0.02962085308056872,0.3253776831041365,1.0,13/45,13.96%,CYP1B1;NCOR2;ABCA2;ABCG1;TBC1D16;PID1;PANK2;SSH1;NPC2;ARF4;KIF16B;ARF1;MKLN1
prerank,postreplication repair (GO:0006301),-0.41762035122355784,-1.5311370375109319,0.027972027972027972,0.45805800697078647,1.0,32/45,35.17%,WDR33;UBE2A;MSH2;UBE2V2;UBC;UBE2B;UBE2N;POLD3;PCNA;NSMCE1;FAAP20;RFC3;UBA52;POLH;PARP10;USP10;POLD2;RPA2;UBE2V1;PRIMPOL;BRCA1;PCLAF;RFC4;ZBTB1;POLD4;RFC2;DTL;RPA3;POLK;USP43;SPRTN;RFC5
prerank,regulation of trophoblast cell migration (GO:1901163),0.7018062505307215,1.531091497532595,0.055152394775036286,0.32470746220433344,1.0,7/14,14.20%,SYDE1;TIMP1;SMURF2;ACVR1B;CALR;ACVR1C;YTHDF3
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5722576015704259,1.5303226698621823,0.026900584795321637,0.3256413429383098,1.0,16/50,15.58%,RORA;GLI3;KCTD21;SUFU;STK36;SHH;CREBBP;SFRP1;GAS1;ZIC1;IFT81;HERC4;RAB34;DLG5;SMO;MOSMO
prerank,positive regulation of chemotaxis (GO:0050921),0.5723109061045022,1.5300709496902452,0.029232643118148598,0.3251762159313396,1.0,12/43,12.55%,EDN3;PTN;PDGFRB;XCL1;NRP1;TREM2;MDK;AIF1;PRKD2;DSCAM;FGF2;NTRK3
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.6477803571283645,1.528923820053262,0.029166666666666667,0.3271578367582174,1.0,5/21,2.84%,DCN;CHSY3;BGN;CHST13;VCAN
prerank,manganese ion transport (GO:0006828),0.703914321423625,1.5288376079541244,0.050073637702503684,0.32626989158622577,1.0,3/14,5.13%,SLC39A14;SLC11A2;TRPC6
prerank,respiratory chain complex IV assembly (GO:0008535),-0.5157839412332432,-1.528179436537705,0.03636363636363636,0.4615046974101022,1.0,11/21,26.57%,COX16;PET100;COX18;COX10;COX14;COX17;TIMM21;BCS1L;SCO1;COA3;COA6
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.550681049623431,1.52771523530706,0.023752969121140142,0.3281863555154323,1.0,19/54,16.30%,CASP4;ADIPOQ;TNFAIP3;BIRC3;CFLAR;CASP1;PYDC1;PELI3;TNFRSF1A;PTPN2;CASP8;TNF;NLRP2B;UBE2K;TRAF2;RIPK1;CCDC3;RBCK1;TRAIP
prerank,sodium ion transport (GO:0006814),-0.36600647400539377,-1.5269013001064842,0.012195121951219513,0.4588445547269926,1.0,17/85,11.47%,ATP1A2;ATP1B3;SLC12A2;SLC6A6;SLC24A2;ATP1B1;SLC6A9;SCN2A;SLC6A1;SLC6A12;SLC8A3;SLC9B2;SLC5A6;SCN8A;SLC4A8;SCN9A;SLC5A5
prerank,negative regulation of protein polymerization (GO:0032272),-0.47436264520379456,-1.52634588606653,0.0379746835443038,0.4540019115056749,1.0,14/27,23.29%,MAP2;EML2;KANK3;CDH5;HIP1R;TWF2;KANK4;STMN2;PFN1;SLIT2;TWF1;TUBB4A;STMN1;SSH3
prerank,dendritic cell differentiation (GO:0097028),0.6400230939238309,1.525770975966445,0.03513513513513514,0.33237189824511604,1.0,5/22,5.04%,PRTN3;BATF;TREM2;BLK;LGALS9
prerank,regulation of tissue remodeling (GO:0034103),0.6723153516674643,1.5257319972656476,0.04488078541374474,0.3313490733856705,1.0,5/18,8.49%,RUNX1;THBS4;MDK;DDR2;GPNMB
prerank,NIK/NF-kappaB signaling (GO:0038061),0.5411022459659766,1.5248994872365524,0.017957351290684626,0.33258618141109975,1.0,22/72,17.74%,PSMA7;MAP3K14;BIRC3;REL;CUL1;SKP1;TIRAP;PSMB8;PSMA6;DICER1;FBXW11;PSMF1;NFKB2;TRAF2;PSMA8;PSMD2;PSMD12;RELB;PSMD11;PSMD14;AKT1;PSMB1
prerank,iron ion transport (GO:0006826),0.5675390039336231,1.5242276124856635,0.026378896882494004,0.33335712403544376,1.0,14/47,18.00%,SLC39A14;HEPH;CLTC;CP;SLC11A2;STEAP3;ATP6V1F;ATP6V1H;IREB2;ATP6V1G2;TTYH1;ATP6V1G1;ATP6V1D;REP15
prerank,regulation of stem cell proliferation (GO:0072091),0.6758177236504607,1.5238637102762098,0.06340057636887608,0.33328110307485165,1.0,6/17,10.06%,FBLN1;YAP1;ZFP36L1;EIF2AK2;TERT;HMGB2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.6195551784406056,1.5233941578328662,0.04633204633204633,0.33350549588667133,1.0,7/27,8.76%,ABCA1;ADIPOQ;CRP;ABCG1;CD36;PPARG;LPL
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.6251076928077423,1.5233670630048513,0.04043126684636118,0.33246217773779496,1.0,6/24,11.09%,CXCL12;SNAI1;SNAI2;BCL2;CCAR2;TMEM161A
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7038575465374644,1.522740920423857,0.050724637681159424,0.3330593788822272,1.0,2/14,0.60%,CREB3L1;SULF1
prerank,cellular defense response (GO:0006968),0.5842459677798998,1.5226734164507307,0.02586206896551724,0.332171155159919,1.0,4/40,5.98%,IL1RL2;LBP;SPN;LY96
prerank,regulation of sequestering of triglyceride (GO:0010889),0.6844389864211333,1.5223093237300376,0.05680119581464873,0.3321168648735934,1.0,5/15,8.76%,PLIN2;TREM2;OSBPL11;PPARG;LPL
prerank,regulation of cardiac conduction (GO:1903779),-0.3977868157202751,-1.5219419697907617,0.024844720496894408,0.46126351196367676,1.0,20/54,20.53%,ATP1A2;ATP1B3;ATP1B1;ANK2;ITPR2;ATP2B4;ATP2B2;SLC8A3;ABCC9;NPR1;ITPR3;DMPK;FXYD6;ATP2A3;STIM1;FXYD1;TRPC1;SLC8A2;ACE2;TMEM65
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5774153877725317,1.52190468292358,0.02586206896551724,0.33205298184239707,1.0,8/40,10.16%,LBP;CRP;TLR2;RNASE7;MPEG1;TIRAP;HMGB2;GBP7
prerank,regulation of hemopoiesis (GO:1903706),0.7688499286125586,1.5218508168915006,0.049689440993788817,0.33112376876597405,1.0,4/10,5.85%,RUNX1;PTN;MAFB;CREBBP
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.7311331180912298,1.5208258613438543,0.04747320061255743,0.33276964080013066,1.0,2/11,2.01%,CREB3L1;CREB3L3
prerank,positive regulation of acute inflammatory response (GO:0002675),0.7005696080529052,1.5205798235591195,0.049079754601226995,0.3323529817756568,1.0,2/14,2.01%,OSMR;CREB3L3
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6998124995201797,1.519531979154369,0.045871559633027525,0.3341872642588725,1.0,9/12,22.60%,NCOR2;SFRP1;PIAS2;HEYL;HDAC1;SMARCA4;ZBTB7A;FOXP1;NCOR1
prerank,negative regulation of neurogenesis (GO:0050768),0.5839845546942036,1.5188796014810697,0.04767879548306148,0.334806097789755,1.0,7/34,12.30%,CCL11;PTN;PTEN;NF1;PCM1;RHOA;TNF
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.5055800283146693,1.5181119003330268,0.003105590062111801,0.33579168890237154,1.0,46/158,17.47%,ROR1;ADIPOQ;MAP3K14;TRIML2;NEK6;ALPK1;CD40;BIRC3;CFLAR;CASP1;REL;LITAF;IKBKE;SLC20A1;UNC5CL;LGALS9;NOD1;TRIM21;VAPA;TIRAP;TRIM13;TMEM106A;TRIM8;IRAK4;WLS;EDA2R;CXXC5;GAPDH;TNFRSF1A;CASP8;ANKRD17;RHOA;TNF;AKAP13;TRAF2;CX3CL1;TIFA;RIPK1;PELI2;RBCK1;TRAF3IP2;LAMTOR5;TRAF5;BRD4;MAP3K3;DDX1
prerank,positive regulation of secretion (GO:0051047),-0.5933820937584576,-1.5181077178699975,0.05013927576601671,0.4666886042596235,1.0,3/11,11.61%,NPR1;GPLD1;ACSL3
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6065812354155962,-1.5180351432871564,0.05511811023622047,0.4607275199427872,1.0,6/10,22.19%,GABRA2;GABRG3;GABRA5;GABRB2;GABRG1;GABRE
prerank,retinoid metabolic process (GO:0001523),0.5319030677024318,1.5177030784384717,0.018244013683010263,0.3357045936887389,1.0,12/71,9.08%,CYP1B1;LRP1;HSPG2;GPC6;APOE;ALDH1A2;RDH12;SDC1;RDH10;SDC2;LPL;CYP1A1
prerank,iron ion transmembrane transport (GO:0034755),0.740185881857213,1.5176355164326374,0.0625,0.3348813437123682,1.0,2/10,2.99%,SLC39A14;SLC11A2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.6692364471079923,1.5171384536857369,0.06736526946107785,0.3352775948286813,1.0,6/16,11.09%,CXCL12;SNAI1;SNAI2;CCAR2;FBH1;TMEM161A
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.527935287914008,1.5167915253844395,0.01642935377875137,0.3352314680543121,1.0,16/88,7.60%,IGF2BP1;KNG1;IGF2BP2;SERPINE2;SYNCRIP;DNAJC1;NELL1;APOE;ILF3;IGFBP5;EIF2AK2;PLAT;BAG6;CAPRIN1;GIGYF2;SAMD4A
prerank,negative regulation of cell population proliferation (GO:0008285),0.49398773441504,1.5158056532830917,0.001002004008016032,0.3368564373811816,1.0,61/351,11.44%,ROR2;GLMN;FAP;CYP1B1;COL18A1;DLC1;RUNX3;CXCL1;IGFBP7;APOD;FBLN1;TNN;SFRP4;TNFAIP3;GATA6;JAK2;NELL1;WNT9A;CDKN2B;TREM2;FRZB;IGFBP5;E2F1;ALDH1A2;PTEN;AIF1;PKD2;NF1;MORC3;CYP27B1;NCK2;NF2;STRN;CDK6;SFRP1;PPARG;TGFB3;EIF2AK2;PTPN6;PDS5B;PINX1;IRF1;ADAMTS1;CDK10;EEF1E1;FRK;CELF1;BTG1;GPNMB;MAP2K1;WNT5A;SFRP5;BMP5;TGFB1I1;TBX3;RERG;PTPRJ;KLF10;PTPN2;PDPN;TGFB2
prerank,negative regulation of inflammatory response (GO:0050728),0.5019286711267009,1.5147116283087443,0.0020554984583761563,0.3387520390324312,1.0,21/182,6.53%,RORA;MC5R;NR1H4;ADIPOQ;IAPP;GPR176;GPR39;TNFAIP3;ADCY7;TREM2;APOE;RXFP2;MDK;MYH9;ADCY2;PTGDR;ADM;MVK;ADCYAP1R1;PPARG;GLP2R
prerank,negative regulation of coagulation (GO:0050819),0.7086476413801963,1.513909375033902,0.040059347181008904,0.3399901201785457,1.0,5/14,11.22%,KNG1;SERPINE2;APOE;APOH;VTN
prerank,regulation of B cell differentiation (GO:0045577),0.6649882788175577,1.5132278778211656,0.04291845493562232,0.3407892610121376,1.0,4/17,5.95%,MMP14;ZFP36L1;ZFP36L2;SFRP1
prerank,camera-type eye morphogenesis (GO:0048593),0.7287262430656042,1.5126739910926643,0.05929487179487179,0.3411851497919691,1.0,4/10,6.00%,TENM3;TBX2;NF1;LRP6
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.5163639557599284,1.5117703584370812,0.01564129301355579,0.34252716162854185,1.0,30/124,16.12%,PSMA7;ROR2;CLTC;TCF7L2;SFRP4;PRICKLE2;FRZB;SMURF2;FZD1;SFRP1;CDC42;PRICKLE1;TNRC6B;ARHGEF19;PSMB8;PSMA6;WNT5A;SFRP5;PPP3CA;PLCB3;MOV10;RHOA;PSMF1;RAC1;AP2A2;PSMA8;SMURF1;PSMD2;PSMD12;PSMD11
prerank,positive regulation of T cell activation (GO:0050870),0.5488511133765702,1.5096171799848017,0.029345372460496615,0.34724765480789843,1.0,14/62,10.36%,IL23R;TNFSF11;CD276;ZMIZ1;FLOT2;MDK;NCK1;AIF1;LGALS9;NCK2;CCL5;ANXA1;IL7;CCL2
prerank,negative regulation of bone remodeling (GO:0046851),0.7243898273645144,1.5091088100853614,0.059748427672955975,0.34753239198424934,1.0,6/11,17.18%,TNFAIP3;SFRP1;TMEM119;UBASH3B;P2RX7;GPR137
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.7116578791415543,1.5088996754949657,0.060653188180404355,0.3470535042418436,1.0,5/12,12.30%,POU5F1;NCOR2;PPARG;TERT;TNF
prerank,regulation of neuroinflammatory response (GO:0150077),0.6587983789510683,1.5087555730992133,0.055873925501432664,0.34635340391302855,1.0,2/19,3.66%,MMP3;TREM2
prerank,cellular response to inorganic substance (GO:0071241),0.6418177699100495,1.5074037292107407,0.047683923705722074,0.34894726037685403,1.0,5/21,14.28%,MMP3;DDX11;TIMELESS;ATRX;FMR1
prerank,lipoprotein biosynthetic process (GO:0042158),0.7222115267631847,1.5064645359459914,0.05572755417956656,0.35051363009479347,1.0,6/11,16.47%,WIPI1;UGCG;APOE;ATG7;WDR45;PIK3C3
prerank,retinol metabolic process (GO:0042572),0.6867349158407796,1.5061817813656098,0.06144393241167435,0.3502073528862917,1.0,4/14,9.08%,CYP1B1;RDH12;RDH10;CYP1A1
prerank,endocrine system development (GO:0035270),0.6316629005797454,1.5053696340558054,0.047954866008462625,0.3513268530451748,1.0,6/21,9.20%,GLI2;MDK;NF1;FOXE1;TGFBR1;SALL1
prerank,vasodilation (GO:0042311),-0.5821590056029586,-1.5049354787264482,0.038338658146964855,0.4938553061998816,1.0,6/13,21.73%,NOS3;KLF2;SOD1;GPER1;SOD2;ADRB2
prerank,negative regulation of interferon-gamma production (GO:0032689),0.6352356470323984,1.504860977875409,0.03918918918918919,0.3517773276430999,1.0,3/23,5.04%,NR1H4;XCL1;LGALS9
prerank,positive regulation of cell death (GO:0010942),0.5552982544884032,1.5042977454811297,0.026869158878504672,0.3522281618202716,1.0,9/59,9.14%,MMP3;HP;HPR;LRP1;LRRK2;CD36;TRIM13;CELF1;WNT5A
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6007177756966187,1.504233272924318,0.04177897574123989,0.3513230339816581,1.0,7/29,13.32%,RUNX1;YAP1;DNAAF4;CARM1;CBFB;UBA5;DDRGK1
prerank,cellular protein catabolic process (GO:0044257),0.5412533088078479,1.5041845018612232,0.027586206896551724,0.350447604491233,1.0,18/59,15.12%,FAP;CLTC;MYLIP;CTSS;SIAH2;CTSK;CTSL;ADAMTS12;RAB7A;CAPN2;PSMA6;CTSB;CASP8;CTSC;ADAMTS7;CTSW;AP2A2;RIPK1
prerank,cardiac muscle cell action potential (GO:0086001),-0.4634349094793572,-1.5041244297077065,0.059574468085106386,0.49000012670368437,1.0,7/30,4.05%,DMD;ATP1A2;FGF12;KCND3;ATP1B1;ANK2;KCNJ2
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.5208033399458131,1.5038835976604485,0.011866235167206042,0.35021060238897506,1.0,16/95,10.36%,CXCL5;CXCL1;LBP;SBNO2;TLR2;TNFAIP3;CASP1;NUGGC;LY96;CD68;CXCL10;TIRAP;CD14;WNT5A;HMGB2;CCL2
prerank,defense response to tumor cell (GO:0002357),0.7321533557604143,1.5031502523963278,0.06918238993710692,0.3510534475569749,1.0,2/10,1.46%,RBMS3;DLEC1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6056897167185978,1.5026913905827408,0.05401844532279315,0.3513702540546094,1.0,7/27,9.14%,WNT2;PDGFRA;E2F1;DDR2;CDK6;S100A6;WNT5A
prerank,relaxation of muscle (GO:0090075),-0.563068936948892,-1.5023363497117277,0.05654761904761905,0.48906877854821335,1.0,4/13,4.05%,ATP1A2;ATP1B1;GSN;KCNJ2
prerank,regulation of cellular senescence (GO:2000772),0.6063386482540049,1.5020604457508444,0.03684210526315789,0.3520455671014102,1.0,14/28,21.87%,NEK6;NUAK1;AKT3;CDK6;EEF1E1;NEK4;TERT;YPEL3;CGAS;MAP3K3;FBXO5;HMGA2;YBX1;RSL1D1
prerank,acute-phase response (GO:0006953),0.7063913631682752,1.500862731712282,0.05855855855855856,0.3542829265567656,1.0,4/12,15.26%,LBP;CRP;IL22;IL6R
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6917116765551986,1.500716692810602,0.0625,0.35363214395774056,1.0,6/13,8.81%,SPRED1;SPRED2;PLA2R1;ATM;EEF1E1;ATR
prerank,cytoskeleton organization (GO:0007010),0.5083339741445025,1.5002658671944156,0.009503695881731784,0.353771036030914,1.0,29/114,14.73%,CCL11;CCL7;KRT25;PALLD;RND3;SH3KBP1;FMNL2;MAST4;TNFAIP3;SIPA1L3;MARK1;APOE;FMNL3;MDK;RHOD;FGD4;ABI2;MAST2;WDPCP;BRWD1;CCL2;PDZD8;ZMYM4;FGD6;RHOA;CFAP410;WTIP;RANBP9;RAC1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.720344795254009,1.4983729855728356,0.04503105590062112,0.3579666017665995,1.0,2/11,1.08%,RUNX1;ETV6
prerank,synaptic vesicle endocytosis (GO:0048488),0.5996824879737954,1.498066520227265,0.044213263979193757,0.35779616888794186,1.0,8/33,10.49%,CEL;STON2;ITSN1;OPHN1;DNAJC6;CANX;SYT2;GAK
prerank,regulation of endothelial cell proliferation (GO:0001936),0.5131008197411755,1.4966976970692096,0.01611170784103115,0.36047739460881445,1.0,25/88,12.48%,CCL11;SULF1;SPARC;THBS4;STAT1;EGR3;PRKCA;NRP1;APOE;NR2F2;AKT3;PRKD2;NF1;APOH;EGF;STAT5A;ARNT;AIMP1;ANGPT1;TGFBR1;WNT5A;HMGB2;PTPRM;VEGFC;FGF2
prerank,negative regulation of platelet activation (GO:0010544),0.6656661224903782,1.4966554233740217,0.06169296987087518,0.3595856800226601,1.0,4/16,8.25%,PDGFRA;SERPINE2;APOE;ADAMTS18
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6627309909456923,1.4961933652143202,0.058655221745350504,0.35878011703390494,1.0,10/16,19.84%,DLC1;APOD;PTEN;ARHGAP6;SRC;PHLDB2;ITGB1BP1;ACVRL1;BCAS3;CORO1C
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6627309909456923,1.4961933652143202,0.058655221745350504,0.35878011703390494,1.0,10/16,19.84%,DLC1;APOD;PTEN;ARHGAP6;SRC;PHLDB2;ITGB1BP1;ACVRL1;BCAS3;CORO1C
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.6716066763880619,1.4951550759849581,0.07164179104477612,0.36074524493058474,1.0,5/14,11.01%,IL34;CMKLR1;MDK;CCL5;PTK2
prerank,regulation of response to cytokine stimulus (GO:0060759),0.6364359576418442,1.4944138885272968,0.059854014598540145,0.3618003036162921,1.0,5/19,10.71%,RUNX1;IRAK2;WNT5A;LIFR;CBFB
prerank,heart process (GO:0003015),-0.5754855632470168,-1.4941408115388521,0.047021943573667714,0.5090092564440183,1.0,5/14,19.70%,SGCD;SGCZ;ACE;SOD1;PPCS
prerank,connective tissue development (GO:0061448),0.5896545381821777,1.4941064880809014,0.03911342894393742,0.36159046105864007,1.0,8/35,9.08%,SULF1;ITGB8;SH3PXD2B;COL11A2;SOX5;ARID5B;CREB3L2;TRIP11
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5362678391928845,1.4939830296852907,0.029082774049217,0.3609016542144365,1.0,15/68,13.14%,LBP;IL16;TLR2;TSLP;STAT3;AIF1;LGALS9;TLR7;RAB7B;TIRAP;TMEM106A;LPL;WNT5A;TNF;SPHK2
prerank,epithelial structure maintenance (GO:0010669),-0.5972944214611935,-1.4933879661575258,0.08333333333333333,0.5052726158050176,1.0,2/11,3.81%,RBP4;CXADR
prerank,hyaluronan catabolic process (GO:0030214),0.6773713248880446,1.4928307940776107,0.032904148783977114,0.36321931424364656,1.0,3/18,5.03%,CEMIP;SLC9A1;CEMIP2
prerank,positive regulation of inflammatory response (GO:0050729),0.5183751157221783,1.492158845378532,0.021691973969631236,0.36403117264803403,1.0,25/86,19.00%,ZBP1;LBP;OSMR;TNIP1;IL16;CREB3L3;TLR2;CCN4;TSLP;MDK;TLR7;PLA2G7;LPL;WNT5A;TNFRSF1A;NFKBIZ;TNF;ABCC1;CX3CL1;RIPK1;SNX4;ETS1;AGT;NFKBIA;IL17RA
prerank,regulation of response to interferon-gamma (GO:0060330),0.6863995298012677,1.4921137170510548,0.06616541353383458,0.36312333774332217,1.0,5/14,11.00%,JAK1;STAT1;JAK2;CDC37;PTPN2
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.6634888650952112,1.491679526273924,0.072992700729927,0.3633245797411755,1.0,9/16,14.77%,SEC16B;LRRK2;MIA3;VAPA;GBF1;SEC16A;TAPT1;DDRGK1;HSPA5
prerank,estrogen metabolic process (GO:0008210),0.6483829664391434,1.4910151961997062,0.08669656203288491,0.36411793246017815,1.0,3/15,9.08%,CYP1B1;HSD17B8;CYP1A1
prerank,positive regulation of protein processing (GO:0010954),0.6435712860583732,1.4908681404684392,0.06241331484049931,0.3635558957057436,1.0,4/19,6.24%,CCBE1;NKD2;MYH9;ENO1
prerank,sodium ion transmembrane transport (GO:0035725),-0.349653762342204,-1.4906422288667132,0.0,0.5075876523698599,1.0,17/84,10.98%,ATP1A2;ATP1B3;SLC12A2;SLC6A6;SLC24A2;ATP1B1;SLC9A2;SLC6A9;SCN2A;SLC6A1;SLC6A12;SLC8A3;SCN8A;SLC4A8;SCN9A;SLC9A6;SLC9A7
prerank,Notch signaling pathway (GO:0007219),0.5341641148498185,1.4898943027951317,0.04088785046728972,0.3651922360058927,1.0,20/59,15.59%,DTX4;SNAI1;STAT1;SNAI2;MAML3;JAG1;MDK;CREBBP;GMDS;MIB1;PLXND1;HEYL;MAML2;DTX2;GALNT11;MAML1;PSEN1;DTX3L;PSENEN;ITCH
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5831757120351561,1.4896385417901126,0.06200527704485488,0.364927318031821,1.0,10/29,14.20%,ZBP1;PTPN6;IFNAR2;PTPN1;ABCE1;WNT5A;CDC37;PTPN2;UBE2K;YTHDF3
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.5402555206449136,1.4895855323425304,0.029714285714285714,0.3640574397625314,1.0,19/59,18.36%,MAP3K14;BCL3;TLR2;BIRC3;REL;LY96;TLR7;IRAK2;CD14;TNFRSF1A;TNF;TANK;TRAF2;TIFA;RIPK1;RELB;RBCK1;AKT1;NFKBIA
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.7088943481802202,1.4892136720050635,0.056338028169014086,0.36405869853217365,1.0,5/13,10.04%,FBN2;FSTL1;FBN1;LTBP1;GREM2
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.6257383307754665,1.4885978894467777,0.05647382920110193,0.36493232987612145,1.0,8/24,18.91%,EPHA7;NF1;FBXW7;FOXO3;TGFB2;TNF;ATF4;PRNP
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.682813513625172,1.48854806115098,0.06446776611694154,0.3640500058049516,1.0,8/13,21.12%,PIK3AP1;TLR7;IRAK2;IRAK4;PIK3R4;PIK3C3;UNC93B1;TNIP2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.5044980893983672,1.488074173053186,0.006342494714587738,0.3643804651211292,1.0,35/128,15.51%,RUNX2;LTBP2;COL1A2;COL3A1;ITGB5;ZMIZ1;SMAD2;USP9X;SMURF2;ACVR1;HIVEP1;TGFB3;INHBB;RNF111;CBL;TGFBR1;SMAD5;BMP5;TGFB1I1;ACVR1B;PTK2;TGFB2;GCNT2;TGFBRAP1;ACVR2A;RHOA;ACVR1C;SMAD3;BMP7;SRC;ARHGEF18;SMAD4;LRRC32;SMAD1;SMURF1
prerank,B cell proliferation (GO:0042100),0.6550487746937722,1.4875394939236568,0.055232558139534885,0.3648899632507806,1.0,6/17,17.09%,CD40;BCL2;MS4A1;CTPS1;PTPRC;HSPD1
prerank,positive regulation of growth (GO:0045927),0.5309578039775085,1.4873956965542834,0.036954087346024636,0.36428130768669864,1.0,15/64,9.19%,RFTN1;MMP14;EIF4G2;KLHL22;EGFR;FXN;BCL2;PABIR1;INO80;SFRP1;CDC42;RPTOR;EXOSC4;TGFBR1;CSNK2A1
prerank,positive regulation of macrophage migration (GO:1905523),0.643677930414645,1.4869988105640772,0.07213578500707214,0.3643234453436633,1.0,8/19,17.06%,IL34;CMKLR1;TREM2;MDK;CCL5;PTK2;CX3CL1;MAPK1
prerank,cellular response to interleukin-1 (GO:0071347),0.5003397403974355,1.4861390991640049,0.008247422680412371,0.3655823348536739,1.0,36/143,17.74%,PSMA7;CCL11;CCL7;CD40;IL1R1;XCL1;IRAK3;CUL1;NOD1;CCL5;SFRP1;IRAK2;ADAMTS12;SKP1;MAPK11;PSMB8;PSMA6;IRAK4;PELI3;CCL2;FBXW11;PSMF1;ADAMTS7;TANK;CX3CL1;PSMA8;HIF1A;PSMD2;RBMX;PSMD12;SQSTM1;PSMD11;PELI2;PSMD14;MAP3K3;PSMB1
prerank,hyaluronan metabolic process (GO:0030212),0.6351201421665823,1.485922340072785,0.04289544235924933,0.36515012042419587,1.0,3/23,5.03%,CEMIP;SLC9A1;CEMIP2
prerank,relaxation of cardiac muscle (GO:0055119),-0.5478022030641712,-1.4852878004171242,0.0621301775147929,0.5181468677654334,1.0,4/13,4.05%,ATP1A2;ATP1B1;GSN;KCNJ2
prerank,protein processing (GO:0016485),0.5106842629042698,1.4851011904272968,0.014799154334038054,0.36656470473462405,1.0,15/102,9.03%,CASP4;HP;HPR;MMP14;ADAM19;STOML2;CASP1;FXN;KLK2;CTSS;CPXM1;OMA1;CTSL;MMP16;OGT
prerank,neuromuscular synaptic transmission (GO:0007274),-0.5057559859314027,-1.4835632488686674,0.06109324758842444,0.5169212584014314,1.0,6/18,19.28%,FCHSD2;KIF1B;DTNA;TBC1D24;CHRNB1;ERC1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5154323385977384,-1.4835540173808035,0.05228758169934641,0.5107785491350295,1.0,10/16,34.01%,PRKAG2;PPARGC1A;ACADL;ACADVL;TYSND1;MLYCD;NR4A3;SIRT4;SOX9;FABP3
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6458586936899049,1.4830066352699096,0.06741573033707865,0.37142082295484663,1.0,2/18,1.07%,LBP;SBNO2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.5263405481809821,1.4829692245847388,0.0362400906002265,0.3705369222158513,1.0,15/66,8.41%,RUNX3;SULF1;SPARC;STAT1;SNAI2;CDKN2B;APOE;NR2F2;CASK;NF1;APOH;CDK6;SFRP1;AIMP1;FBXW7
prerank,sulfate transport (GO:0008272),-0.5543748537131541,-1.4818752773099775,0.052307692307692305,0.5099650444533486,1.0,3/14,1.78%,SLC13A4;SLC26A7;SLC26A2
prerank,positive regulation of viral life cycle (GO:1903902),0.6309181685624584,1.4813643244726697,0.04748603351955307,0.37398153635773906,1.0,14/22,25.84%,LGALS9;VPS4A;FMR1;CHMP2B;DDB1;TYRO3;TMPRSS2;LGALS1;KPNA2;TRIM11;TSG101;P4HB;AXL;CHMP3
prerank,cellular response to organic cyclic compound (GO:0071407),0.5018838419286634,1.4813104032234425,0.004153686396677051,0.3731389756897633,1.0,26/141,12.90%,RORA;NR1H4;CYP1B1;PDE3A;SPP1;PDXP;ZFP36L1;NRIP1;LRRK2;EGFR;IGFBP5;ADCY2;PKD2;CCL5;SFRP1;AHR;MSN;CYP1A1;UBE2L3;HRH1;SSH1;CCL2;GNAI1;LCOR;TNF;P2RX7
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.489358230803603,1.4802893797202779,0.007238883143743537,0.3750173617899411,1.0,32/161,12.58%,PSMA7;RBMS3;BICC1;NKD2;TCF7L2;TNN;SFRP4;KREMEN1;TBX18;GLI3;IGFBP4;SNAI2;TLE1;APOE;FRZB;MDK;SFRP1;LRP6;PRICKLE1;SIAH2;DKK2;PSMB8;PSMA6;WNT5A;HDAC1;SFRP5;WWTR1;NPHP3;DRAXIN;GSK3B;CSNK1A1;PSMF1
prerank,lamellipodium assembly (GO:0030032),-0.47718378075687656,-1.4793287110740212,0.0502092050209205,0.5117869339003411,1.0,11/26,14.21%,ABLIM1;KIT;CDH13;ABLIM3;S1PR1;CCDC88A;PTPRO;ARHGEF6;VCL;PARVB;DMTN
prerank,regulation of erythrocyte differentiation (GO:0045646),0.5662312212340141,1.4789835619332898,0.0583756345177665,0.37768536067430464,1.0,19/35,19.61%,ZFP36L1;STAT1;MAFB;STAT3;CDK6;ARNT;MAPK11;FOXO3;HMGB2;ACVR1B;ACVR2A;SPI1;BRD1;HIF1A;STAT5B;PRKDC;ETS1;INHBA;MED1
prerank,regulation of angiogenesis (GO:0045765),0.4920484812034265,1.4787690487738117,0.006103763987792472,0.37731115719348923,1.0,45/192,12.48%,RUNX1;CYP1B1;COL4A2;DCN;SULF1;ITGB8;HSPG2;SPARC;THBS4;ADAM12;STAT1;RHOJ;THBS2;CD40;TNFAIP3;GATA6;PRKCA;SPRED1;HK2;PRKD2;CEMIP2;NF1;ANGPTL4;APOH;SFRP1;PPARG;CXCL10;EPHA1;EMILIN1;PLXND1;SERPINF1;SASH1;ADAMTS1;BTG1;GPNMB;SP100;WNT5A;RNH1;SEMA3E;BMPER;TGFB2;PTPRM;SPRY2;VEGFC;FGF2
prerank,cellular response to nitrogen compound (GO:1901699),0.6374224478990764,1.4785824877419926,0.04698972099853157,0.3768663750101119,1.0,5/20,14.28%,NR1H4;DDX11;TIMELESS;ATRX;FMR1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.7284346484579565,1.4782140253778147,0.06739811912225706,0.376828595222196,1.0,2/10,2.74%,CYP1B1;SNAI2
prerank,negative regulation of cell migration (GO:0030336),0.5000076255899054,1.4779743545611932,0.013415892672858616,0.3765076855943944,1.0,35/137,14.97%,CYP1B1;DLC1;COL3A1;ADIPOQ;SULF1;LRP1;TNN;TIMP1;DPYSL3;MITF;NAV3;IGFBP5;JAG1;SHH;PTEN;NF1;NF2;SFRP1;RAP2A;SRGAP1;EPHA1;MIA3;FOXO3;PTPRJ;PTPN23;LDLRAD4;CALR;FGF2;ACVR1C;DLG5;STK24;PHLDB2;RAC1;CX3CL1;TRIB1
prerank,response to molecule of bacterial origin (GO:0002237),0.5314187053731504,1.477780700464271,0.01694915254237288,0.3760631533348309,1.0,15/69,15.89%,IL23R;LBP;TNFAIP3;JAK2;IRAK3;LGALS9;CYP27B1;LY96;TIRAP;CD14;HMGB2;ERBIN;C4B;TRIB1;GGT7
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.5527554267628294,1.4770538545775587,0.04321728691476591,0.37707008093605815,1.0,17/43,20.71%,RUNX2;FBN2;YAP1;CCN4;NELL1;DDR2;ACVR1;TMEM119;WWTR1;ACVR2A;BMP7;IL6R;FBXO5;LRP5;CTNNBIP1;BMPR1A;IL6ST
prerank,regulation of steroid biosynthetic process (GO:0050810),0.7197407811653305,1.476948808340915,0.0641025641025641,0.3763399731269799,1.0,1/11,0.10%,NR1H4
prerank,lymphocyte proliferation (GO:0046651),0.6150221693142884,1.4765167816902924,0.06412005457025921,0.37662940651659593,1.0,9/22,17.09%,CD40;ELF4;BCL2;MSN;MS4A1;CTPS1;TNFRSF4;PTPRC;HSPD1
prerank,glycine metabolic process (GO:0006544),0.6947973235338711,1.476479659811434,0.05660377358490566,0.3757643770300799,1.0,4/12,10.40%,SDSL;AMT;GLDC;GCAT
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.5770492731516561,1.4751292913186833,0.05491698595146871,0.37842221384020186,1.0,12/30,15.85%,MGAT5;B4GALNT2;ST6GAL1;DDOST;ALG5;UGGT2;STT3A;LMAN1;UBE2J1;NUDT14;TUSC3;RPN1
prerank,DNA dealkylation (GO:0035510),0.7087049730634492,1.4749863221999935,0.08990536277602523,0.37687691620077535,1.0,6/10,12.96%,MPG;ASCC3;FTO;ALKBH5;ALKBH1;MGMT
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.7087049730634492,1.4749863221999935,0.08990536277602523,0.37687691620077535,1.0,6/10,12.96%,MPG;ASCC3;FTO;ALKBH5;ALKBH1;MGMT
prerank,proteolysis (GO:0006508),0.48159189496669924,1.474402173554223,0.0010070493454179255,0.37747725183682157,1.0,55/252,15.14%,MMP3;FAP;CASP4;MMP2;OLR1;MMP14;ADAM19;PRTN3;CASP1;ANPEP;SUFU;CPQ;XPNPEP1;CTSD;CTSS;BMP1;CPXM1;HTRA3;CAPN5;PLAT;CTSK;LACTB;CTSL;ADAMTS12;CAPN2;NPEPPS;CPA6;CAPN15;ADAMTS9;MMP16;HTRA4;PSMA6;OGT;ENPEP;TBL1X;NLN;PGPEP1L;CTSB;PAPPA2;SENP6;CASP8;CTSC;MMP15;ADAMTS7;SPG7;SPPL3;DPP7;CTSW;LVRN;FBXO2;PSEN1;HTRA1;XPNPEP3;DPP8;PSENEN
prerank,regulation of ossification (GO:0030278),0.5572081655949451,1.4740325515938166,0.049937578027465665,0.37746241628058613,1.0,12/36,11.67%,ENPP1;PTN;MDK;DDR2;ACVR1;CYP27B1;SFRP1;LRP6;WNT5A;CHSY1;TGFB2;NBR1
prerank,positive regulation of hormone secretion (GO:0046887),0.6474343229764532,1.473419663449768,0.06474820143884892,0.3782400731256569,1.0,2/17,1.15%,SPP1;EDN3
prerank,regulation of cholesterol metabolic process (GO:0090181),0.6276710482707367,1.4732782304171272,0.07402234636871509,0.3776998949796805,1.0,4/20,4.96%,NR1H4;APOE;ABCA2;EPHX2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5830183483451852,1.4731273268732323,0.047073791348600506,0.37715728204626975,1.0,14/32,16.81%,DLC1;APOD;MAP4K4;JAG1;CASK;PTEN;NF2;SEMA3E;ARHGAP6;SRC;PHLDB2;ITGB1BP1;RASA1;ACVRL1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.3668281240423142,-1.4729700322612167,0.024793388429752067,0.5256296574588529,1.0,19/63,9.76%,SLC12A2;SLC12A7;SLC20A2;SLC26A2;GABRA2;GABRB1;GLRA3;GABRG3;SLC1A1;SLC12A6;SLC6A1;GABRA5;SLC5A6;GLRA1;CLCN3;XPR1;GABRB2;ANO3;SLC4A8
prerank,cellular response to interleukin-6 (GO:0071354),0.6023579361528044,1.4724270103469246,0.055408970976253295,0.3780432679441859,1.0,12/26,15.26%,SBNO2;YAP1;JAK1;STAT1;JAK2;STAT3;PID1;CBL;SPI1;SRC;SMAD4;IL6R
prerank,actin filament depolymerization (GO:0030042),-0.609431925394406,-1.4717802650464142,0.0743801652892562,0.5236565632709181,1.0,7/11,25.66%,GSN;MICAL3;TWF2;MICAL1;CFL1;TWF1;WDR1
prerank,regulation of B cell apoptotic process (GO:0002902),0.6873351819546544,1.471775838040622,0.08163265306122448,0.37896594101296466,1.0,5/12,13.04%,BCL6;BLK;NOC2L;FNIP1;ORMDL3
prerank,peptidyl-asparagine modification (GO:0018196),0.5727041957434881,1.471747406863062,0.05590851334180432,0.37807790150440607,1.0,12/31,15.85%,MGAT5;B4GALNT2;ST6GAL1;DDOST;ALG5;UGGT2;STT3A;LMAN1;UBE2J1;NUDT14;TUSC3;RPN1
prerank,negative regulation of ossification (GO:0030279),0.6007327785135351,1.471274986096988,0.0625,0.37846870488762974,1.0,5/23,9.33%,ENPP1;MDK;CCR1;SFRP1;CHSY1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.5488261132704239,-1.4704392171677918,0.06748466257668712,0.521759280638566,1.0,4/14,8.04%,KIT;SEMA7A;MAVS;CAMK4
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.7039317279529359,1.4699136074241148,0.06327160493827161,0.3811676768568374,1.0,3/12,2.84%,DCN;BGN;VCAN
prerank,mitochondrial fission (GO:0000266),-0.5274579733015162,-1.4697196248767725,0.059006211180124224,0.5182650326898373,1.0,10/16,31.77%,DNM3;PRKN;GDAP1;DNM1L;DNM2;MTFR1L;MFF;MTFR2;OPA1;MTFP1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.5560505927868583,1.4693586914066559,0.02843601895734597,0.38166086118546966,1.0,10/47,11.22%,KNG1;SERPING1;FETUB;SERPINE2;TIMP1;SERPINH1;SERPINF1;SERPINA2;GAPDH;VTN
prerank,generation of neurons (GO:0048699),0.4850075779293263,1.4678181695523707,0.006097560975609756,0.38484390923416123,1.0,34/190,12.48%,RUNX1;RUNX2;WNT2;RUNX3;YAP1;DNAAF4;LRP12;MDGA1;AUTS2;NRP1;NAV1;WNT9A;ADGRL3;MARK1;BHLHE22;USP9X;SHH;ACSL4;ASTN2;OPHN1;FZD1;CDK6;BHLHE40;HEYL;SH3RF1;MAP2K1;WNT5A;HMGB2;DISC1;FGFR1;NEUROD6;TGFB2;NIF3L1;FGF13
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.6207468624253767,1.466995476635595,0.0638002773925104,0.386311101824244,1.0,1/21,0.03%,MMP3
prerank,positive regulation of macrophage differentiation (GO:0045651),0.7018436325249369,1.4667350314971452,0.07898894154818326,0.38611814537568906,1.0,4/11,15.12%,IL34;PRKCA;CASP8;RIPK1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5726790328837734,1.4665520950622726,0.04903225806451613,0.3856538621546811,1.0,7/36,5.75%,CYP1B1;BCL3;GHR;JAK2;NF2;CCL5;EGF
prerank,heart contraction (GO:0060047),-0.41870063311540645,-1.4665413444331168,0.05555555555555555,0.5221836387280956,1.0,5/41,1.45%,DMD;ATP1A2;SGCD;SGCZ;ATP1B1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.5013424041769631,1.46648642771858,0.011434511434511435,0.38485738458415275,1.0,35/129,17.00%,PSMA7;COL1A1;ZEB2;SFRP4;LYPD6;LRRK2;EGFR;SMURF2;UBR5;EGF;ATP6AP2;SFRP1;FAM53B;GSKIP;CCAR2;DKK2;LRRK1;PSMB8;PSMA6;TBL1X;WLS;CSNK1G2;RUVBL1;ZBED3;PSMF1;DACT1;TRPM4;PTK7;PSMA8;PSMD2;PSMD12;PSMD11;TNKS2;PSMD14;CSNK1D
prerank,regulation of cell aging (GO:0090342),0.6772714472881942,1.466477114328886,0.08372827804107424,0.3839268413590949,1.0,3/11,7.81%,NEK6;NUAK1;NEK4
prerank,ceramide biosynthetic process (GO:0046513),-0.4041357659827609,-1.4664422084619928,0.016853932584269662,0.5168121904887669,1.0,15/40,15.70%,ST6GALNAC3;ST8SIA4;ST3GAL5;CERS4;SGMS1;SPTLC2;SPTLC1;SGMS2;ST8SIA6;DEGS2;B4GALT6;ST8SIA2;ST6GALNAC5;ASAH2;SMPD2
prerank,negative regulation of wound healing (GO:0061045),0.5910255447084376,1.466422334509151,0.05150753768844221,0.38315351640602296,1.0,10/28,14.32%,KNG1;SERPINE2;APOE;CASK;PTEN;APOH;VTN;TNF;FGF2;PHLDB2
prerank,positive regulation of MAPK cascade (GO:0043410),0.48097794376706426,1.4663018255096611,0.00202020202020202,0.38250380266515377,1.0,46/245,12.55%,ROR2;CCL11;ROR1;CCL7;IL34;PDGFRA;EDN3;MID1;IAPP;TAOK1;TNFSF11;LRRK2;CD40;PDGFRB;XCL1;PRKCA;NRP1;EGFR;TREM2;APOE;CCR1;PRKD2;LGALS9;CD36;CCL5;EGF;EIF2AK2;ICAM1;TAOK3;PIK3R5;TIRAP;ANGPT1;TMEM106A;FBXW7;GPNMB;MAP2K1;CCL2;FGFR1;PTPRJ;BMPER;TGFB2;GCNT2;SPRY2;TNF;FGF2;NTRK3
prerank,regulation of mitochondrial depolarization (GO:0051900),0.7242000763602743,1.4662002789665751,0.06677018633540373,0.3818298642710523,1.0,3/10,4.98%,DCN;LRRK2;BCL2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.495946039202514,1.4660599380048673,0.019895287958115182,0.38126851472857104,1.0,24/113,10.06%,CCL11;LAMB1;YAP1;TCF7L2;THBS4;PTN;JAML;LAMC1;EGR3;FGF7;PRKCA;NRP1;EGFR;MDK;AKT3;PRKD2;EGF;SFRP1;STAT5A;ARNT;TGFBR1;WNT5A;BMP5;HMGB2
prerank,positive regulation of vasoconstriction (GO:0045907),-0.5438240661071145,-1.4648721161340423,0.06340057636887608,0.5160339055508569,1.0,4/13,16.39%,CAV1;ADRA1B;ADRA1A;TBXA2R
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6379874071501722,1.4643703147893594,0.06509695290858726,0.38492543333414814,1.0,5/20,12.48%,CREB3L1;SULF1;PRKD2;SPRY2;FGF2
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6139057939839633,1.4640834036863322,0.05319148936170213,0.3847548705139533,1.0,8/25,14.06%,GLMN;NRP1;EGFR;CCL5;EGF;DSCAM;PSEN1;SRC
prerank,actin filament bundle assembly (GO:0051017),0.5732871370805507,1.4638588516709088,0.05128205128205128,0.3844963448283644,1.0,11/33,8.76%,PDXP;MYO1B;DPYSL3;CALD1;FSCN1;LIMA1;BAIAP2;AIF1;RHOD;ADD2;LCP1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.625747068759724,1.4635180753001202,0.06147540983606557,0.38453430803695127,1.0,6/20,5.67%,LRP1;PDGFRB;CCN4;NRP1;IGFBP5;CCL5
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.5161283186076594,-1.4631746043988516,0.0782312925170068,0.5157986164760311,1.0,8/16,23.69%,RANBP3L;PLCB1;AKIRIN1;IGFBP3;RIPOR2;BOC;MEF2C;MAPK14
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6839866466281979,1.4631614722527622,0.06288343558282208,0.3845696342862079,1.0,4/13,5.75%,MGAT5;JAK2;TSLP;EGF
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5793714854027974,1.4626999403062924,0.0606826801517067,0.3849133094064451,1.0,5/32,10.28%,CXCL5;CXCL1;RNASE7;CXCL10;GAPDH
prerank,dermatan sulfate metabolic process (GO:0030205),0.6915477983684171,1.4620603491539874,0.05530642750373692,0.38593929619116496,1.0,3/13,2.84%,DCN;BGN;VCAN
prerank,regulation of autophagosome assembly (GO:2000785),0.5649469225658894,1.4619250731814986,0.06056701030927835,0.385376419955976,1.0,20/33,25.28%,LRRK2;CHMP4A;CHMP4B;TMEM39A;PIP4K2A;NPRL2;IFT88;RAB3GAP2;SMCR8;ADPRH;RAB3GAP1;SH3GLB1;MTMR3;SCFD1;MTM1;IFT20;RAB5A;TBC1D12;RALB;FEZ2
prerank,hexose metabolic process (GO:0019318),0.5631451407805338,1.4617173731466093,0.052311435523114354,0.3850812105228709,1.0,14/39,19.71%,ADIPOQ;APOD;AKR1A1;OMA1;GALK2;ADPGK;GALK1;KHK;CHST1;GAA;PMM2;SORD;CHST15;DCXR
prerank,positive regulation of response to external stimulus (GO:0032103),0.49731297903066823,1.4616778435824858,0.01564129301355579,0.3842562641809587,1.0,28/128,12.43%,ZBP1;TNIP1;PTN;IL16;TLR2;PDGFRB;CCN4;PRKCA;TSLP;TREM2;USF1;MDK;PUM1;AIF1;APOH;CCL5;LY96;TLR7;SASH1;PLA2G7;LPL;WNT5A;OASL;TNFRSF1A;ANKRD17;NFKBIZ;TNF;POLR3D
prerank,neuromuscular process controlling balance (GO:0050885),-0.5766561921885442,-1.4616441172795755,0.07428571428571429,0.5150375574735411,1.0,4/12,9.93%,PCDH15;NRXN1;SHANK1;CLN3
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.5064229591216703,-1.4613426280462858,0.07017543859649122,0.510713247109565,1.0,10/18,24.82%,DDX19B;NUP133;ZC3H11A;HHEX;POLDIP3;NUP93;SARNP;MCM3AP;ENY2;DDX25
prerank,Notch signaling involved in heart development (GO:0061314),0.7016749527040067,1.4599490418821184,0.08931419457735247,0.38814366521663857,1.0,5/11,11.10%,SNAI1;SNAI2;JAG1;HEYL;GALNT11
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.725193291763239,1.4590173787187215,0.07301587301587302,0.38974851672713623,1.0,3/10,4.35%,ENPP1;ADIPOQ;ERRFI1
prerank,response to cholesterol (GO:0070723),0.645385336682686,1.4589185241234106,0.05390070921985816,0.3891881104399862,1.0,7/17,15.46%,SMAD2;ABCA2;LRP6;GRAMD1A;TGFBR1;GRAMD1C;SMO
prerank,protein localization to kinetochore (GO:0034501),-0.5499676133086289,-1.4580405576650535,0.07668711656441718,0.5151892361491159,1.0,10/14,34.13%,RCC2;ZWILCH;IK;BUB3;CENPT;KNL1;TTK;ZW10;MTBP;SPDL1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.5432385958869549,1.4577507482337688,0.0378698224852071,0.39146285047693724,1.0,12/49,12.81%,RUNX1;KMT2A;RBBP5;CNOT4;RAB7B;TNRC6B;HDAC1;HMGB2;CBFB;KMT2E;MOV10;KMT2B
prerank,regulation of chondrocyte differentiation (GO:0032330),0.607402094017343,1.4573571653115376,0.0697350069735007,0.39174473435092755,1.0,7/24,9.03%,TRPS1;SOX5;SNAI2;WNT9A;MDK;ADAMTS12;TGFBR1
prerank,positive regulation of lymphocyte migration (GO:2000403),0.6920812653846301,1.4573199049279042,0.0804953560371517,0.3909086006746608,1.0,6/12,11.96%,CXCL12;SPN;AIF1;CCL5;CXCL10;RHOA
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5150213366067936,1.4573091443881998,0.024553571428571428,0.39002150472753994,1.0,22/72,14.06%,ROR2;ROR1;DCN;PDGFRA;PDGFRB;JAK2;TREM2;CCL5;EGF;PTPN6;PIK3AP1;PIK3R5;CBL;FGFR1;PTK2;TGFB2;UNC5B;TNF;FGF2;NTRK3;PIK3R1;SRC
prerank,secretory granule organization (GO:0033363),0.7004498672305852,1.4569157388116265,0.084375,0.3902024342928218,1.0,2/10,5.87%,ABCA1;DTNBP1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.6629848596879744,1.4560796731351913,0.07445255474452554,0.39167426761212626,1.0,5/15,12.30%,XCL1;IRAK3;TGFB3;TGFB2;TNF
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.5901597680317284,1.45602288377107,0.06535947712418301,0.3909029139112335,1.0,10/28,17.65%,CASP4;ERN2;BBC3;ITPR1;BCL2;BAG6;TRAF2;TRIB3;AIFM1;ATF4
prerank,cilium movement (GO:0003341),0.5321809321732286,1.4545586710239453,0.04196642685851319,0.3940184251705017,1.0,9/48,13.37%,TEKT4;CFAP251;DNAAF4;SPEF2;DNAH9;DNAH11;TTC29;ODAD1;DNAAF5
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6056849123311525,1.45423998925227,0.0925414364640884,0.39397622536283217,1.0,5/22,14.05%,ADIPOQ;FLOT2;GCNT2;TNF;BMP7
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.6887132348798526,1.4538869047804395,0.08540372670807453,0.3940118573651536,1.0,5/11,18.40%,TNFAIP3;TREM2;TIRAP;PJA2;MFHAS1
prerank,defense response to virus (GO:0051607),0.49670563637368376,1.4535437264006499,0.031453362255965296,0.3940027280143126,1.0,25/100,16.09%,ZBP1;MAP3K14;STAT1;TLR2;IRF7;CD40;BCL2;SHFL;EIF2AK2;CXCL10;TLR7;IRF1;IFNAR2;ABCE1;EXOSC4;MLKL;OASL;SETD2;MOV10;ATG7;AKAP1;RNASE1;TRIM56;RTP4;CGAS
prerank,glucose metabolic process (GO:0006006),0.5281299694507114,1.4532915519247804,0.03712035995500562,0.3937735061961797,1.0,8/58,10.28%,SLC39A14;ADIPOQ;APOD;AKR1A1;OMA1;ENO1;ADPGK;GAPDH
prerank,chloride transport (GO:0006821),-0.35892705905968325,-1.4523596030526005,0.009345794392523364,0.527367248466998,1.0,18/74,9.76%,SLC12A2;SLC4A10;SLC12A7;SLC26A7;GABRA2;GABRB1;GLRA3;GABRG3;SLC1A1;SLC12A6;SLC6A1;GABRA5;CLCN2;GLRA1;CLCN3;GABRB2;ANO3;SLC4A8
prerank,lipoprotein catabolic process (GO:0042159),0.6913513890281611,1.4521775595405988,0.08917197452229299,0.395956597112962,1.0,6/11,16.48%,APOE;ABHD17C;CTSD;LYPLAL1;ABHD17B;LYPLA2
prerank,endoderm development (GO:0007492),0.6908305305077026,1.4508736391657644,0.08370702541106129,0.39860294532885904,1.0,3/13,3.00%,LAMC1;DUSP2;DUSP5
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.6237971306092738,1.4503198982526015,0.07496463932107496,0.3991253644249735,1.0,5/19,11.01%,IL34;CMKLR1;MDK;CCL5;PTK2
prerank,oligosaccharide metabolic process (GO:0009311),-0.3992230390996983,-1.4499264229588311,0.035897435897435895,0.5292739689688344,1.0,8/46,3.39%,ST3GAL6;ST6GALNAC3;AMY1A;AMY1C;AMY1B;ST8SIA4;FUT9;ST3GAL4
prerank,intracellular sterol transport (GO:0032366),0.6729631430267022,1.449902638181801,0.07407407407407407,0.3992903624214861,1.0,5/13,11.20%,ABCA1;ABCG1;VPS4A;NPC2;RELCH
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.6600180787377321,1.449889331081196,0.0658682634730539,0.39842661755421915,1.0,4/15,5.97%,ADIPOQ;IRS1;ADM;PPARG
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.7013006102235924,1.4493172958834786,0.09838709677419355,0.39917689623610914,1.0,2/10,4.89%,GFPT2;HK2
prerank,copper ion transport (GO:0006825),0.7023789567124017,1.4491659145740574,0.09273570324574962,0.39865842486372066,1.0,4/11,5.77%,STEAP4;SLC11A2;STEAP2;STEAP3
prerank,defense response to symbiont (GO:0140546),0.4980215420250541,1.4490215570721348,0.03512623490669594,0.3981537872437334,1.0,24/92,17.01%,ZBP1;MAP3K14;STAT1;TLR2;IRF7;CD40;BCL2;SHFL;EIF2AK2;TLR7;IRF1;IFNAR2;ABCE1;EXOSC4;MLKL;OASL;SETD2;MOV10;ATG7;RNASE1;TRIM56;RTP4;CGAS;PTPRC
prerank,negative regulation of signal transduction (GO:0009968),0.4779792923125551,1.4486401188345526,0.003015075376884422,0.39832599812382236,1.0,64/249,15.60%,ENPP1;DCN;CREB3L1;ADIPOQ;SULF1;APOD;LRP1;MMP14;NKD2;ASXL1;SFRP4;GLI3;KCTD21;LRRK2;IRS1;TNFAIP3;SNAI2;SUFU;EGFR;TLE1;IRAK3;TAX1BP3;FRZB;IGFBP5;NCK1;PTEN;BCL2;ACVR1;PIP4K2A;CCL5;EGF;SFRP1;SIAH2;NXN;MDFI;EMILIN1;PTPN18;ADAMTS12;PTPN1;PID1;FBXW7;BRAP;CSNK2A1;CSNK2A2;SFRP5;BMP5;RPS6KB1;PTPRJ;PTPN2;SOCS5;CALR;SPRY2;TNF;NLRP2B;FGF2;UBASH3B;HERC4;DACT1;CX3CL1;TRIB1;SMPDL3B;EGFL7;MOSMO;NEDD4
prerank,negative regulation of immune response (GO:0050777),0.4852198411159945,1.448602784081181,0.007246376811594203,0.39757483000512417,1.0,18/154,6.53%,MC5R;COL3A1;IAPP;GPR176;GPR39;TNFAIP3;ADCY7;IRAK3;TREM2;RXFP2;MYH9;ADCY2;PTGDR;ADM;ILRUN;ADCYAP1R1;TRIM21;GLP2R
prerank,androgen metabolic process (GO:0008209),0.6138995523702925,1.4485931983276132,0.0915805022156573,0.3967082431072216,1.0,3/18,8.44%,SPP1;SHH;SRD5A3
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.7183227719176228,1.4485283274183351,0.07781456953642384,0.39514355902015064,1.0,2/10,2.06%,CLTC;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.7183227719176228,1.4485283274183351,0.07781456953642384,0.39514355902015064,1.0,2/10,2.06%,CLTC;MYLIP
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.7040623494178859,1.4485221163014566,0.07644305772230889,0.3942790762045183,1.0,1/10,0.26%,HP
prerank,L-amino acid transport (GO:0015807),0.5808273358496872,1.4484204752787162,0.0821566110397946,0.39369915879908585,1.0,3/28,1.81%,SLC7A2;SLC1A3;SLC38A3
prerank,regulation of cell killing (GO:0031341),0.6369227459234057,1.4482520930133267,0.10043041606886657,0.39324153213262886,1.0,5/16,14.73%,CFH;ICAM1;WNT5A;TGFB2;RAC1
prerank,regulation of B cell proliferation (GO:0030888),0.5515108916661725,1.4477770251411155,0.04790419161676647,0.3936582125001752,1.0,11/44,11.94%,TNFRSF21;CD40;VAV3;BLK;BCL2;ATM;AHR;SASH3;TIRAP;IL7;TNFRSF4
prerank,regulation of calcium ion import (GO:0090279),0.6204613045282014,1.4472625647046693,0.07232267037552156,0.39418550756481013,1.0,9/21,21.38%,CXCL12;PDGFRB;PKD2;EGF;CCL2;SPHK2;PRNP;PSEN2;TRIM27
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5202141917777412,1.4472160195400148,0.04152637485970819,0.3934627858218391,1.0,17/69,15.12%,LBP;SPN;TLR2;JAK2;STAT3;ARFGEF2;LGALS9;LY96;TIRAP;TMEM106A;CD14;LPL;WNT5A;PTPRJ;SPHK2;PSEN1;RIPK1
prerank,negative regulation of cell motility (GO:2000146),0.4997529359862599,1.4465915244211192,0.02328042328042328,0.39439124228146694,1.0,19/108,7.08%,CYP1B1;DLC1;ADIPOQ;SULF1;FBLN1;DPYSL3;MITF;NAV3;IGFBP5;JAG1;SHH;PTEN;NF1;NF2;SFRP1;RAP2A;SRGAP1;EPHA1;MIA3
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.5039325867352358,1.4459182408427032,0.02928416485900217,0.3953201039586206,1.0,24/87,15.51%,LTBP2;COL1A2;COL3A1;ITGB5;ZMIZ1;SMAD2;USP9X;ACVR1;TGFB3;CBL;TGFBR1;SMAD5;PTK2;TGFB2;GCNT2;TGFBRAP1;RHOA;SMAD3;SRC;ARHGEF18;SMAD4;LRRC32;SMAD1;SMURF1
prerank,regulation of cholesterol storage (GO:0010885),0.6551235810932001,1.4455310233013845,0.09267563527653214,0.3955426598440759,1.0,5/15,8.76%,ABCA1;TREM2;ABCG1;PPARG;LPL
prerank,Golgi localization (GO:0051645),0.6848681852175758,1.4445332816708567,0.08490566037735849,0.3974415241850541,1.0,5/11,14.53%,ARCN1;CDC42;COPG1;YWHAZ;PDCD10
prerank,diol metabolic process (GO:0034311),-0.48062208674154766,-1.4445002237841298,0.07971014492753623,0.5421973265407928,1.0,8/19,16.84%,NOS3;CALM1;HSP90AA1;DEGS2;PTS;SGPP1;ASAH2;NAAA
prerank,regulation of keratinocyte proliferation (GO:0010837),0.6040517542275016,1.4437195055931002,0.06188466947960619,0.39881938859097327,1.0,5/22,4.28%,ZFP36L1;FGF7;SNAI2;MDK;CASK
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3514728309152071,-1.4435583437042043,0.0,0.5395838544666394,1.0,48/87,29.53%,IMMP2L;COX16;NDUFS1;NDUFAF5;NDUFAF4;ECSIT;NDUFV2;NDUFA13;NDUFAF2;NDUFA6;DMAC2;PET100;COX18;NDUFA12;UQCC2;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;COX14;NDUFB7;NDUFS3;NDUFA1;COX17;NDUFC2;FOXRED1;TIMM21;SAMM50;BCS1L;SDHAF4;NDUFA10;SCO1;NDUFS2;UQCRFS1;LYRM7;TMEM126B;NDUFB11;SLC25A33;COA3;NUBPL;UQCC3;CHCHD4;SDHAF2;NDUFS5;NDUFAF8;TIMMDC1;NDUFV1;NDUFAF6
prerank,cellular response to peptide (GO:1901653),0.5322953047218246,1.4433934500229029,0.05439814814814815,0.3989354518657639,1.0,16/56,14.06%,CASP4;CACNA1A;LRP1;ZFP36L1;CACNA2D1;TREM2;CACNB1;NOD1;CD36;DDX11;ICAM1;TIMELESS;GSK3B;ABCC1;PSEN1;SRC
prerank,positive regulation of biosynthetic process (GO:0009891),0.5435123180464554,1.442867473945309,0.056372549019607844,0.3994289333116364,1.0,6/40,6.17%,RUNX1;CREB3L1;APOE;CD36;CCL5;TGFB3
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.7007045802590135,1.4428404620775683,0.1053484602917342,0.3977908772396941,1.0,1/10,0.48%,ADIPOQ
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.7007045802590135,1.4428404620775683,0.1053484602917342,0.3977908772396941,1.0,1/10,0.48%,ADIPOQ
prerank,regulation of glucose metabolic process (GO:0010906),0.5608142500261609,1.4428259402030217,0.06823821339950373,0.396979329059147,1.0,4/34,5.70%,RORA;ADIPOQ;IRS1;FOXK2
prerank,protein mono-ADP-ribosylation (GO:0140289),0.6919351306710154,1.4426864504776657,0.07575757575757576,0.3965415583906642,1.0,3/11,6.77%,PARP8;PARP3;PARP11
prerank,intracellular cholesterol transport (GO:0032367),0.6448127360817671,1.4418767364573108,0.08957415565345081,0.39784166391225306,1.0,6/15,11.20%,ABCA1;ABCG1;LRP6;VPS4A;NPC2;RELCH
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.51920277304285,1.4418205331174685,0.047126436781609195,0.39718138521541296,1.0,3/61,1.11%,PSMA7;NR1H4;NCOR2
prerank,regulation of monocyte chemotaxis (GO:0090025),0.6044359469147201,1.4405273861066534,0.06854838709677419,0.39995281697403406,1.0,6/24,8.59%,CXCL12;CCR1;AIF1;CCL5;CXCL10;PLA2G7
prerank,positive regulation of histone methylation (GO:0031062),0.604492802711538,1.4398348325118637,0.06105834464043419,0.40099187978453765,1.0,8/24,15.02%,KMT2A;AUTS2;PHF1;OGT;DNMT3B;RIF1;SMAD4;PAXIP1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.5292645113361001,1.4392931038869385,0.056451612903225805,0.4016666703999478,1.0,15/53,18.32%,MC5R;HTR1D;CCR1;HRH4;ANXA1;HRH1;CCL2;LPAR3;CALCRL;MC1R;HRH3;NPY;MC2R;AGT;HTR1B
prerank,renal absorption (GO:0070293),-0.5877556199719768,-1.4392570571334102,0.09114583333333333,0.5477314860379067,1.0,4/10,12.33%,KLHL3;GSN;WNK4;KCNQ1
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5550315787844153,-1.439198759588934,0.09009009009009009,0.542649390839628,1.0,3/13,1.45%,ATP1A2;ATP1B3;ATP1B1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.650830067641937,1.4388753998224433,0.09251101321585903,0.40201627916746313,1.0,3/15,2.84%,DCN;BGN;VCAN
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.650965349331228,1.4385016566615738,0.10355029585798817,0.4021744471316161,1.0,8/14,16.92%,SEC31A;SEC24D;SEC23A;SEC24A;MIA3;RAB1A;SEC13;TBC1D20
prerank,response to axon injury (GO:0048678),0.6373618431529802,1.4380594086857312,0.08495821727019498,0.4025322800532552,1.0,4/18,4.38%,APOD;DPYSL3;TREM2;NREP
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.646303946355695,1.4378748181964205,0.09267563527653214,0.4021985923705311,1.0,5/15,11.51%,GLI2;ANKRD11;LRP6;HDAC1;EDA
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.689459458710133,1.437816061463786,0.08689248895434462,0.4014995014394377,1.0,6/11,21.12%,RFTN1;COLEC12;CASP8;RIPK1;UNC93B1;TNIP2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.47285044685944005,1.4375187764623238,0.0060790273556231,0.4014776191270145,1.0,49/248,12.58%,PSMA7;RBMS3;COL1A1;ZEB2;BICC1;NKD2;TCF7L2;SFRP4;KREMEN1;GLI3;LYPD6;LRRK2;IGFBP4;SNAI2;EGFR;TLE1;APOE;FRZB;MDK;SMURF2;UBR5;EGF;ATP6AP2;SFRP1;LRP6;CDK14;PRICKLE1;SIAH2;FAM53B;GSKIP;CCAR2;DKK2;LRRK1;PSMB8;PSMA6;WNT5A;HDAC1;SFRP5;TBL1X;WLS;WWTR1;NPHP3;DRAXIN;CSNK1G2;RUVBL1;ZBED3;GSK3B;CSNK1A1;PSMF1
prerank,regulation of endopeptidase activity (GO:0052548),0.530656109211656,1.437396249888263,0.045662100456621,0.4009175349343194,1.0,19/59,18.42%,KNG1;SERPING1;FETUB;SERPINE2;TIMP1;BIRC3;SERPINH1;SERPINF1;PSMB8;SERPINA2;HDAC1;GAPDH;VTN;SERPINB8;PSENEN;AKT1;PICALM;AGT;TIMP2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.5586094874744819,1.4368820848962371,0.055762081784386616,0.40145331323255,1.0,9/39,12.48%,COL4A1;GLI2;NRP1;SHH;PKD2;LRP6;SALL1;SEMA3E;FGF2
prerank,regulation of fibroblast proliferation (GO:0048145),0.5393634016623063,1.4365548928294658,0.046172539489671933,0.4015146241139819,1.0,10/45,9.14%,WNT2;PDGFRA;E2F1;DDR2;NF1;MORC3;CDK6;SFRP1;S100A6;WNT5A
prerank,regulation of cell differentiation (GO:0045595),0.48147848648106595,1.4356754255610091,0.0125,0.4030977006305808,1.0,25/148,11.01%,RUNX1;RUNX2;TRPS1;RUNX3;EDN3;ZFP36L1;BCL6;ST7;MAFB;SNAI2;FLOT2;MDK;NREP;SHH;CEBPD;NF1;CREBBP;CDK6;EIF2AK2;DDX17;FADS1;TGFBR1;FGFR1;CBFB;PTK2
prerank,negative regulation of cell adhesion (GO:0007162),0.5069969346897959,1.4354562326705576,0.057971014492753624,0.40291385268029684,1.0,26/72,17.01%,CYP1B1;KNG1;FBLN1;SPN;B4GALNT2;SNAI2;PLXNC1;JAG1;MDK;NF2;PLXND1;MIA3;ARHGDIG;ANGPT1;PLXNA3;PTK2;DSCAM;GCNT2;RHOA;TGFBI;CX3CL1;ITGB1BP1;RASA1;ARHGDIA;ACVRL1;PTPRC
prerank,regulation of signal transduction (GO:0009966),0.47687711690224355,1.4350587476524186,0.007106598984771574,0.4032064097928704,1.0,37/190,11.29%,RORA;RUNX1;ADIPOQ;SULF1;MDFIC;IGFBP7;RGS16;LRRK2;TIMP1;IGFBP4;UGCG;TREM2;IGFBP5;NCK1;ACVR1;CD36;NCK2;CREBBP;DTNBP1;IRAK2;LLGL1;PTPN1;GSKIP;GAS1;ITGA3;BRAP;SP100;OGT;ZIC1;LIFR;TSPEAR;WWTR1;CBFB;PTPN2;SOCS5;GALNT11;IFT81
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.698444171768153,1.4347874540362033,0.07827476038338659,0.4030800562654654,1.0,4/10,7.08%,TREM2;CD36;CD68;MIA3
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5325790024542371,1.4346375357718026,0.04880952380952381,0.4026531723216993,1.0,25/51,22.90%,GAS7;MAP4K4;TAOK1;LRRK2;MAP1S;DTNBP1;TAOK3;DCLK1;TRIO;DICER1;DBN1;NRK;DBNL;SNX2;ANKRD27;BMP7;ALS2;CTTN;ATP7A;EPB41L3;NYAP1;PAK1;CNTNAP1;SNX1;PLXNB1
prerank,cellular response to amyloid-beta (GO:1904646),0.5718792941436397,1.4342352604910045,0.06734434561626429,0.40292345067373425,1.0,8/35,6.91%,CASP4;CACNA1A;LRP1;CACNA2D1;TREM2;CACNB1;CD36;ICAM1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.48088937176481805,-1.4338675190981711,0.06015037593984962,0.5537350978793459,1.0,5/20,4.05%,ATP1A2;ATP1B3;SLC12A2;ATP1B1;KCNJ2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.4710065135391833,1.4335763625334939,0.0020161290322580645,0.40380273232062985,1.0,41/291,10.36%,RORA;MMP3;NR1H4;PDE3A;CXCL5;WNT2;CXCL1;LBP;PDGFRA;SBNO2;PDXP;ZFP36L1;NRIP1;TLR2;IRS1;TNFAIP3;WNT9A;CASP1;EGFR;IGFBP5;PKD2;NUGGC;CPEB1;ATM;SFRP1;LY96;CD68;CXCL10;AHR;PID1;CAPN2;RPTOR;TIRAP;CD14;RRAGC;LPL;WNT5A;IP6K2;SSH1;HMGB2;CCL2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5882253481488935,1.4335705263468477,0.07190412782956059,0.4029961908335848,1.0,7/27,8.43%,ADIPOQ;PDGFRB;PRKD2;ATM;TOM1L1;PINX1;SMG6
prerank,regulation of cellular component biogenesis (GO:0044087),-0.4030399323561487,-1.4334038982502044,0.03571428571428571,0.5499108573648466,1.0,12/39,12.72%,TJP1;SNCAIP;EZR;HSP90AA1;TIE1;RAPGEF2;VPS11;RAP1A;ANKRA2;GFAP;RDX;PINK1
prerank,mesoderm formation (GO:0001707),0.6336449648427701,1.4324525027726305,0.08744710860366714,0.40528950262277574,1.0,4/17,8.66%,SNAI1;ITGA8;SMAD2;ITGA3
prerank,regulation of osteoblast proliferation (GO:0033688),0.6240320947428358,1.4322965649470931,0.09063893016344725,0.4049103923374578,1.0,7/17,11.96%,TNN;NELL1;SFRP1;EIF2AK2;HPSE;TMEM119;RHOA
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6001040232650788,1.4322688957964922,0.07569721115537849,0.40331422238474934,1.0,7/23,14.44%,ZEB2;CDKN2B;CREBBP;RNF111;TGFB1I1;GIPC1;SMAD4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6001040232650788,1.4322688957964922,0.07569721115537849,0.40331422238474934,1.0,7/23,14.44%,ZEB2;CDKN2B;CREBBP;RNF111;TGFB1I1;GIPC1;SMAD4
prerank,placenta development (GO:0001890),0.6699029732772845,1.4318921208963493,0.10869565217391304,0.4035482558514065,1.0,4/12,11.01%,ADAM19;PPARG;E2F8;PTK2
prerank,integrin-mediated signaling pathway (GO:0007229),0.5049036851598276,1.4318165926346689,0.033707865168539325,0.40292151136003196,1.0,28/73,21.28%,COL3A1;ITGB8;FBLN1;TEC;ITGB5;PTN;NRP1;DOCK1;MYH9;CCM2;CDC42;ADAMTS1;ITGA11;ITGBL1;PTK2;ERBIN;ITGA5;ADAM11;SRC;ITGB1BP1;PLEK;PTPRA;FERMT3;COL16A1;DST;ISG15;ADAM9;NME2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.37253204438933535,-1.4318107659375117,0.022556390977443608,0.5493649942998,1.0,23/57,22.90%,DLGAP1;LRRC7;ACTN2;DLG2;MINK1;SHISA6;DLGAP2;GRIA2;GRIA1;CACNG2;SHANK1;APP;GRIN2B;CAMK2B;LYNX1;CACNG7;SHISA7;RELN;NLGN1;NPTXR;MEF2C;SHISA9;CACNG8
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.517678201158577,1.4314083193448577,0.04971751412429379,0.40318220801199584,1.0,13/63,9.53%,IL23R;CD276;CD40;VAV3;NCK1;BCL2;AIF1;NCK2;CCL5;SASH3;TIRAP;ANXA1;IL7
prerank,regulation of vasculature development (GO:1901342),0.5806704884903641,1.4297713629172488,0.06768837803320563,0.4069434739877726,1.0,8/26,12.48%,NF1;SFRP1;PLXND1;GPNMB;SP100;RNH1;BMPER;FGF2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.6028673158490375,1.4294871222263825,0.09490084985835694,0.40694233494227916,1.0,3/21,4.80%,CREB3L1;LRRK2;NCK1
prerank,sterol metabolic process (GO:0016125),0.5166112695714736,1.4292509950498857,0.051194539249146756,0.40676897539536544,1.0,6/60,4.34%,CYP1B1;CYP7B1;ABCA1;INSIG2;APOE;ABCG1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.5881620700279698,1.4286934498480948,0.07529722589167767,0.40752937318311866,1.0,5/25,4.84%,CMKLR1;LRRK2;P2RX5;TREM2;ITPR1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5816071709603944,1.4277924968723008,0.08278580814717477,0.4092220099561878,1.0,9/27,9.78%,TNIP1;TLR2;IRAK3;CD36;LY96;IRAK2;TIRAP;CD14;IRAK4
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.34358794660688724,-1.4274613821415705,0.011111111111111112,0.558218490408496,1.0,17/75,5.75%,ATP1A2;ATP1B3;SLC12A2;SLC24A2;SLC12A7;ATP1B1;SLC9A2;SLC39A10;SLC12A6;KCNJ2;KCNJ3;SLC6A1;ATP2B4;SLC8A3;KCNJ13;SLC39A8;ABCC9
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5700366136993791,1.4270973510857508,0.07863695937090433,0.41028221716144136,1.0,9/29,15.12%,IRF7;CD40;BIRC3;IKBKE;LY96;CD14;CASP8;TANK;RIPK1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5626006419270198,1.4269789671324011,0.060991105463786534,0.409778151976452,1.0,9/33,13.41%,RUNX1;DNAAF4;KLK2;CARM1;CBFB;UBA5;CALR;DDRGK1;SAFB2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6248531411434547,1.4268241912229864,0.0958904109589041,0.4093836766713357,1.0,4/17,6.17%,ADIPOQ;PTEN;PPARG;TGFB3
prerank,mammary gland development (GO:0030879),0.5926259879349054,1.4265159682465123,0.07901907356948229,0.409367582322893,1.0,5/21,10.21%,WNT2;GLI2;JAK2;TGFB3;TBX3
prerank,regulation of bone mineralization (GO:0030500),0.5209968356397034,1.4264410635901381,0.0535077288941736,0.40875711942277293,1.0,17/55,14.55%,ENPP1;GPM6B;FBN2;PTN;NELL1;CCR1;DDR2;ACVR1;CYP27B1;TGFB3;TMEM119;NBR1;ATP2B1;ACVR2A;P2RX7;BMP7;TRPM4
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.564901465315518,1.4262101550340085,0.08072916666666667,0.40862932551058834,1.0,9/30,15.12%,IRF7;CD40;BIRC3;IKBKE;LY96;CD14;CASP8;TANK;RIPK1
prerank,cellular response to UV (GO:0034644),0.5029372301515909,1.426063662214977,0.05512679162072767,0.4082482839773523,1.0,20/76,21.00%,MMP3;MMP2;TIMP1;PPID;INO80;CREBBP;NOC2L;ATR;TMEM161A;MC1R;MFAP4;FMR1;NEDD4;USP28;DDB1;ATF4;RHBDD1;KDM1A;PRKCD;YY1
prerank,response to lipopolysaccharide (GO:0032496),0.4812576301398461,1.425679790237835,0.014675052410901468,0.40845564459575395,1.0,22/138,11.96%,CXCL5;IL23R;CXCL1;LBP;SBNO2;TNFAIP3;JAK2;CASP1;IRAK3;LGALS9;NUGGC;CYP27B1;LY96;CD68;CXCL10;TIRAP;CD14;WNT5A;HMGB2;CCL2;ERBIN;RHOA
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6590759263171314,1.4251050015258822,0.09938837920489296,0.40929808911461785,1.0,2/12,5.36%,IL23R;PAEP
prerank,regulation of catabolic process (GO:0009894),0.6261708557990272,1.4250035374426846,0.09490084985835694,0.40883188928419023,1.0,1/18,0.09%,FAP
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6325278677600916,1.423881867465966,0.09232954545454546,0.4110709952119069,1.0,6/17,14.53%,MID1;TAOK1;EIF2AK2;TAOK3;TGFB2;PDCD10
prerank,body fluid secretion (GO:0007589),-0.5362294921785545,-1.4236505131222421,0.08012820512820513,0.5649369306133741,1.0,6/15,21.76%,NPR1;ERBB4;SLC22A4;GPAT4;SLC22A2;PRLR
prerank,response to endoplasmic reticulum stress (GO:0034976),0.48941342354332423,1.4233489092256844,0.023404255319148935,0.41169998338716174,1.0,25/107,14.77%,CASP4;CREB3L1;THBS4;GORASP2;CREB3L3;ERN2;PDIA3;BBC3;NCK1;ITPR1;BCL2;BAG6;ERLEC1;CREB3L2;NIBAN1;ATP2A2;SEC16A;UBA5;RCN3;GSK3B;TRAF2;PIK3R1;DDRGK1;TRIB3;HSPA5
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5603451459426554,-1.4232522626164377,0.10140845070422536,0.560807625221604,1.0,6/11,15.49%,MLLT3;RSPO3;CSNK1E;WNT5B;DAB2;PLEKHA4
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.48711974397485097,1.42257463494742,0.028846153846153848,0.41304702544178007,1.0,26/100,13.29%,ROR2;ROR1;DCN;PDGFRA;PDGFRB;JAK2;EGFR;PIP5K1B;TREM2;PTPN13;PTEN;PIP4K2A;CCL5;EGF;PTPN6;PIK3AP1;PIK3R5;CBL;FGFR1;PTK2;TGFB2;UNC5B;TNF;FGF2;NTRK3;PIK3R1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.6277820866554222,1.4218571891501612,0.09852941176470588,0.41417031372756885,1.0,7/17,12.42%,STAT1;MAML3;CREBBP;PLXND1;HEYL;MAML2;MAML1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.5857185538575561,1.4213071302274716,0.06048387096774194,0.4148808202630467,1.0,5/26,5.86%,ADIPOQ;LRRC17;MAFB;FBN1;CDK6
prerank,regulation of establishment of protein localization (GO:0070201),0.6529285141652132,1.4206755883195012,0.10207336523125997,0.4157725991099696,1.0,6/14,18.88%,TREM2;CTSD;CEP120;SCFD1;CENPJ;GAPVD1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5914316910000512,1.4203879428436261,0.08179419525065963,0.41573270207701146,1.0,12/25,22.90%,ADIPOQ;ATXN2;ABCA2;DLG4;PSEN1;ANKRD13B;NEU3;RAC1;PICALM;MTMR2;SDCBP;ITGB3
prerank,endothelial cell differentiation (GO:0045446),0.6730714818524333,1.4189855245809466,0.0973724884080371,0.41879552780779716,1.0,3/12,4.21%,SCUBE1;FSTL1;JAG1
prerank,cellular response to superoxide (GO:0071451),-0.5753659575842376,-1.4183355732339147,0.11229946524064172,0.5708689424674115,1.0,6/10,22.70%,NOS3;SOD1;PRDX2;SOD3;SOD2;ADPRS
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.5489814990347901,1.4181587087941445,0.07840616966580977,0.4201172602296221,1.0,17/33,19.61%,STAT1;STAT3;ARNT;RAB7B;MAPK11;FOXO3;HMGB2;ACVR1B;ACVR2A;BRD1;FES;HIF1A;STAT5B;PRKDC;ETS1;INHBA;MED1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.507200090345424,1.4179947467832796,0.052338530066815145,0.41977274143065474,1.0,17/73,15.12%,LBP;SPN;TLR2;JAK2;STAT3;ARFGEF2;LGALS9;LY96;TIRAP;TMEM106A;CD14;LPL;WNT5A;PTPRJ;SPHK2;PSEN1;RIPK1
prerank,response to insulin (GO:0032868),0.49759337730335984,1.417948605699863,0.05136612021857923,0.4190532661903419,1.0,21/80,14.12%,SLC39A14;ENPP1;ADIPOQ;ZFP36L1;IRS1;INSIG2;USF1;CPEB1;PPARG;MYO5A;INHBB;RAB8B;DENND4C;OGT;RPS6KB1;GCK;KHK;ZBED3;PIK3R1;RAB10;TRIB3
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.39638394299127994,-1.4175143580275695,0.05917159763313609,0.5683335538626172,1.0,15/44,16.50%,ATP1B3;ATP1B1;ACTN2;AKAP6;ANK2;WNK4;KCNJ2;WNK3;KCNJ3;KCNJ10;KCNQ1;KCNJ12;KCNN2;KCNN3;WNK2
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5658298746049081,1.4174525330080137,0.07853403141361257,0.4195473313210268,1.0,10/30,15.22%,DCN;CHSY3;BGN;CHST13;VCAN;CHSY1;CHST11;UGDH;IDS;CHPF2
prerank,outflow tract septum morphogenesis (GO:0003148),0.5804598307962484,1.4168890243089964,0.09694555112881806,0.4202737821294371,1.0,7/24,5.19%,ROBO2;GATA6;ZFPM2;NRP1;TBX2;PARVA;ACVR1
prerank,regulation of oxidoreductase activity (GO:0051341),0.6763395043091209,1.416872467367643,0.10015408320493066,0.41952239564688265,1.0,1/13,0.26%,HP
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.5893885024090332,1.4168506229521316,0.08539944903581267,0.4188049892626012,1.0,6/23,11.00%,JAK1;STAT1;JAK2;PPARG;CDC37;PTPN2
prerank,regulation of T cell chemotaxis (GO:0010819),0.6816694167384699,1.4162710187272645,0.09516616314199396,0.41957335472673646,1.0,4/11,9.14%,XCL1;CCL5;CXCL10;WNT5A
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5811671303657456,1.4161392282622727,0.09446693657219973,0.41912013320652436,1.0,5/23,8.09%,ENPP1;GLI3;KCTD21;SUFU;GPR161
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.552652129784029,-1.4159186266843522,0.10510510510510511,0.5686778258404539,1.0,4/12,11.13%,MAP2;EML2;CDH5;STMN2
prerank,regulation of sensory perception of pain (GO:0051930),-0.5790030307082176,-1.4153690052654857,0.09831460674157304,0.5652730217592237,1.0,8/11,33.84%,MGLL;ZFHX2;CCN3;TMEM100;ATPSCKMT;ACP3;SPX;F2R
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.5424865198416643,-1.4148779211248004,0.07878787878787878,0.5617068163404808,1.0,7/13,20.11%,SHANK3;ADCY1;APP;ZDHHC2;SHISA7;RELN;LGMN
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6532211172826832,1.4146896722043043,0.10333863275039745,0.42229451147520924,1.0,7/12,19.34%,APOBEC1;SETDB1;SETDB2;PPHLN1;RESF1;ATF7IP;TASOR
prerank,aorta morphogenesis (GO:0035909),0.62223982996177,1.4144438467650058,0.10364145658263306,0.4221737053687477,1.0,6/17,9.18%,LRP1;PDGFRB;TBX2;JAG1;ADAMTS9;MYLK
prerank,regulation of cell adhesion (GO:0030155),0.47465558111221634,1.414298098686996,0.01888772298006296,0.4218452923877057,1.0,39/129,17.09%,IBSP;EPHA7;KNG1;FBLN1;CXCL12;SPN;PRKCA;PLXNC1;EPHB3;NUAK1;MDK;PRKD2;RHOD;CCL5;ATM;PLXND1;RSU1;MIA3;ARHGDIG;ANGPT1;PLXNA3;EFNA5;CXCR4;PPP3CA;PTPRJ;PTK2;DSCAM;PPP1CB;TNF;DUSP26;TGFBI;SRC;FES;ITGB1BP1;RASA1;ARHGDIA;CHRD;ACVRL1;ZFHX3
prerank,extracellular matrix assembly (GO:0085029),0.5911469562571534,1.414281251082597,0.07336956521739131,0.4210989287798317,1.0,5/23,8.73%,LTBP3;GPM6B;LAMB1;EMILIN1;PXDN
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5246217867841947,1.4141638805261387,0.06459627329192547,0.4206298258603142,1.0,17/48,20.64%,ADIPOQ;SLIT3;IRAK3;TREM2;PADI2;PPARG;PYDC1;PELI3;PTPN2;NLRP2B;YTHDF3;CCDC3;TRAIP;PTPRC;STAT2;ISG15;PARP14
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.6005760947805066,1.4140802237362005,0.09724238026124818,0.42004945902831536,1.0,9/20,18.24%,RUNX2;SMAD5;NFE2L2;SMAD4;SMAD1;CREB3;HIF1A;ATF4;RBPJ
prerank,regulation of interleukin-4 production (GO:0032673),-0.4516237397968559,-1.4135027758016205,0.053763440860215055,0.5611822890045334,1.0,8/21,20.15%,PRKCZ;LEF1;SLC7A5;PRKCQ;SYK;ZFPM1;HAVCR2;FCER1G
prerank,macrophage activation (GO:0042116),0.5564806917730796,1.4128972979017702,0.07160493827160494,0.42236997329873227,1.0,9/34,14.74%,LBP;SBNO2;JAK2;TREM2;AIF1;TMEM106A;CRTC3;TNF;CX3CL1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.6816307706269704,1.4124872251971645,0.11645962732919254,0.42268361097096874,1.0,3/11,7.94%,JAK2;TAF7;TMEM106A
prerank,regulation of interleukin-10 production (GO:0032653),0.538962820377383,1.4111347642365375,0.07237635705669482,0.4257334793432139,1.0,6/44,5.04%,IL23R;TNFRSF21;XCL1;TSLP;STAT3;LGALS9
prerank,regulation of programmed necrotic cell death (GO:0062098),0.602133239790186,1.4108823078080284,0.09577464788732394,0.4256156744949289,1.0,8/20,15.12%,BIRC3;FLOT2;CFLAR;OGT;CDC37;MLKL;CASP8;RIPK1
prerank,positive regulation of immune effector process (GO:0002699),0.5742995745494904,1.4107972837031324,0.08409986859395532,0.4250447190498728,1.0,5/27,11.83%,IL23R;LBP;LGALS9;PTPRJ;ANKRD17
prerank,innate immune response (GO:0045087),0.4622284670640487,1.4105450651001556,0.013171225937183385,0.4249968253739504,1.0,41/217,16.15%,C3;IL23R;TRIML2;LBP;COLEC12;MASP1;CRP;TLR2;IRF7;ALPK1;CD40;REL;TREM2;BLK;CYP27B1;TRIM21;SHFL;RNASE7;PPARG;CXCL10;STYK1;PYDC1;TRIM13;FRK;TRIM8;SP100;IRAK4;SETD2;PTK2;POLR3A;ANKRD17;PJA2;MFAP4;COLEC11;SRC;AKAP1;FES;TIFA;TRIM56;RELB;YES1
prerank,primary neural tube formation (GO:0014020),0.5695259857611716,1.4105178328764767,0.08461538461538462,0.4242684099725027,1.0,6/30,6.41%,DLC1;DEAF1;MTHFR;MTHFD1L;LRP6;PRICKLE1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.6350247520729544,1.410110430560402,0.1044776119402985,0.4245656234191782,1.0,2/14,5.36%,IL23R;PAEP
prerank,retinal metabolic process (GO:0042574),0.6556114539461173,1.4100348402382836,0.11728395061728394,0.423965025812194,1.0,2/12,8.12%,CYP1B1;RDH10
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.522388703625672,-1.4099863817223253,0.09294871794871795,0.567452083346336,1.0,6/15,17.80%,PIK3CB;HIP1R;BMP2K;WASL;DAB2;SNAP91
prerank,negative regulation of innate immune response (GO:0045824),0.5491092453054959,1.4098836856326828,0.0782051282051282,0.42358288454333953,1.0,5/34,5.54%,VSIG4;SERPING1;TNFAIP3;IRAK3;TRIM21
prerank,neural tube closure (GO:0001843),0.5589077394118915,1.4097117837617859,0.08406524466750313,0.4232884868794371,1.0,6/34,6.41%,DLC1;DEAF1;MTHFR;MTHFD1L;LRP6;PRICKLE1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6379919036061128,1.4096844013104455,0.12878787878787878,0.4225923705595911,1.0,5/14,12.65%,SNAI2;WNT9A;ADAMTS12;TGFBR1;ADAMTS7
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.6832357622588852,1.4093314061498876,0.11424100156494522,0.42275715821325693,1.0,3/11,8.59%,LIPC;ABCG1;PLA2G7
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.5030935920991916,1.4090716812012059,0.05630630630630631,0.42269921393574383,1.0,28/71,21.55%,FAP;TNFAIP3;USP9X;CHMP4B;CTSS;OMA1;VPS4A;CTSK;BAG6;CTSL;ADAMTS12;CAPN2;PSMA6;CTSB;CASP8;CTSC;ADAMTS7;CTSW;UBE2W;PSMA8;ZYG11B;DDB1;MDM2;RHBDD1;ISG15;NR1D1;HM13;RPS27A
prerank,neuron differentiation (GO:0030182),0.4679390402168906,1.4089691727112799,0.024415055951169887,0.42217381103382273,1.0,24/165,12.13%,RUNX1;RUNX2;WNT2;RUNX3;GLI2;UGCG;WNT9A;TENM3;BHLHE22;SHH;ACSL4;PBX3;OPHN1;FZD1;LRP6;TENM4;MYO7A;TGFBR1;MAP2K1;WNT5A;NEUROD6;TGFB2;TDP2;NIF3L1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.5344546484598914,1.4088290458350745,0.06172839506172839,0.4217544728513966,1.0,6/42,10.06%,IL23R;LBP;TREM2;RNASE7;MPEG1;HMGB2
prerank,tube closure (GO:0060606),0.5666196339105333,1.4073284623087472,0.08354430379746836,0.4250012960137419,1.0,6/31,6.41%,DLC1;DEAF1;MTHFR;MTHFD1L;LRP6;PRICKLE1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6401489259720355,1.4066790476365416,0.10349854227405247,0.42601634068949135,1.0,6/16,10.88%,PDGFRA;PDGFRB;NRP1;PLAT;PTPN1;PTPRJ
prerank,positive regulation of DNA replication (GO:0045740),0.628218866680319,1.4064447656742003,0.08456973293768547,0.42598631201862325,1.0,5/16,5.80%,GLI2;DNA2;EGFR;EGF;BRPF3
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5162384780603274,-1.406062294858531,0.0955223880597015,0.5754661014215231,1.0,7/13,26.51%,NAMPT;PARP16;NUDT12;NNMT;PARP10;NAXE;NAPRT
prerank,histone H3 deacetylation (GO:0070932),-0.5193543436421717,-1.405525957230152,0.1044776119402985,0.5723854172177075,1.0,8/15,17.77%,SFPQ;HDAC4;HDAC9;PER1;SMARCAD1;PER2;SIRT7;HDAC3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.3662035126790485,-1.4048961910713877,0.046153846153846156,0.5648997563161356,1.0,31/56,29.53%,NDUFS1;NDUFAF5;NDUFAF4;ECSIT;NDUFV2;NDUFA13;NDUFAF2;NDUFA6;DMAC2;NDUFA12;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;NDUFB7;NDUFS3;NDUFA1;NDUFC2;FOXRED1;TIMM21;BCS1L;NDUFA10;NDUFS2;TMEM126B;NDUFB11;NUBPL;NDUFS5;NDUFAF8;TIMMDC1;NDUFV1;NDUFAF6
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.3662035126790485,-1.4048961910713877,0.046153846153846156,0.5648997563161356,1.0,31/56,29.53%,NDUFS1;NDUFAF5;NDUFAF4;ECSIT;NDUFV2;NDUFA13;NDUFAF2;NDUFA6;DMAC2;NDUFA12;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;NDUFB7;NDUFS3;NDUFA1;NDUFC2;FOXRED1;TIMM21;BCS1L;NDUFA10;NDUFS2;TMEM126B;NDUFB11;NUBPL;NDUFS5;NDUFAF8;TIMMDC1;NDUFV1;NDUFAF6
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.48449931181792033,1.4048111367557372,0.04103671706263499,0.4296713104179963,1.0,28/95,15.52%,DCN;CEMIP;LUM;CHSY3;HSPG2;BGN;B4GALT5;CHST13;GPC6;VCAN;EXT1;ST3GAL3;EXT2;PRELP;ANGPT1;SDC1;HS2ST1;SDC2;CHSY1;CHST11;ST3GAL1;GCNT2;CHST1;UGDH;SLC35D2;CHPF2;B4GALT2;B4GALT7
prerank,phasic smooth muscle contraction (GO:0014821),0.6745952411093683,1.4041679470475608,0.11969696969696969,0.4306945454106043,1.0,2/10,3.32%,EDN3;HTR1D
prerank,positive regulation of signal transduction (GO:0009967),0.4631873504477785,1.4037861949313557,0.0030425963488843813,0.4309432473215685,1.0,73/238,17.73%,SLC39A14;C3;ADIPOQ;SULF1;MGAT5;CCBE1;YAP1;ASXL1;TNFSF11;ZMIZ1;TLR2;LRRK2;IRS1;TNFAIP3;JAK2;PRKCA;NRP1;TSLP;MAML3;TREM2;STAT3;STK36;JAG1;SHH;PTEN;PRKD2;PKD2;ASXL2;LIMS1;CYP27B1;CREBBP;ATP6AP2;SFRP1;LY96;DLG4;ARNT;SASH1;MAML2;TERT;TGFBR1;CSNK2A1;SALL1;IL7;DRD3;WLS;DISC1;LOXL3;TRIM44;NEPRO;PDE6H;VTN;TGFB2;MAML1;NTRK3;SNX5;PIK3R1;ITGA5;DACT1;RAB34;DLG5;SRC;PDCD10;CD63;SMO;HIF1A;DEPDC1B;ITGB1BP1;TSPAN14;SMARCA4;PTPRC;ING5;STX1B;GLI1
prerank,triglyceride catabolic process (GO:0019433),0.6100298804723102,1.4036740353290527,0.09550561797752809,0.43047485142158765,1.0,3/19,12.67%,LIPC;LPL;FABP5
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.6285487770227757,1.403387092283214,0.10879284649776454,0.43044625340771,1.0,1/14,0.33%,ENPP1
prerank,regulation of actin filament-based process (GO:0032970),0.5017201723131174,1.4032189862862947,0.05191873589164785,0.4301926880288199,1.0,13/70,8.60%,DLC1;GPM6B;LRP1;RND3;TAOK1;PDGFRB;RICTOR;FSCN1;BAIAP2;RHOD;CDK10;ARHGEF19;EFNA5
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5098403418486299,1.4032101845431362,0.06164383561643835,0.4294377250615306,1.0,14/55,17.74%,PSMA7;FBXL7;CUL1;PINX1;SKP1;PSMB8;PSMA6;PSMF1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1
prerank,central nervous system myelination (GO:0022010),0.6771923758044072,1.4028578393510016,0.09888357256778309,0.42964269151330176,1.0,4/11,7.14%,B4GALT5;ABCA2;PTEN;TENM4
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.6602608488358287,1.4027102994642011,0.11384615384615385,0.4293300327359197,1.0,5/12,11.30%,NEK6;PRKCA;PLK1;NEK9;CCNB2
prerank,positive regulation of cell adhesion (GO:0045785),0.49544649776491234,1.4026172321429304,0.049217002237136466,0.4288168204279708,1.0,17/74,12.57%,IBSP;FBLN2;CXCL12;JAK2;PRKCA;MDK;PRKD2;RHOD;LIMS1;CCL5;ATM;RSU1;PPP3CA;PTPRJ;TGFB2;TNF;DUSP26
prerank,diacylglycerol metabolic process (GO:0046339),-0.4536998776989655,-1.4024780545268172,0.06968641114982578,0.5676928871141941,1.0,9/23,19.59%,PLCE1;DGKB;DGKI;DGKA;LIPE;DGAT1;DGKG;DGKQ;PNPLA2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5350882793839828,1.4024585013529232,0.08138101109741061,0.42847046753931844,1.0,7/37,7.62%,MMP2;ADIPOQ;IGFBP5;PTEN;PPARG;TGFB3;ADAMTS1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.4772752582542206,-1.4022840567374328,0.07241379310344828,0.5636059972341678,1.0,4/20,1.98%,PLCE1;CHRM2;CAV1;KCNB2
prerank,regulation of feeding behavior (GO:0060259),0.6689056386026973,1.402101086305389,0.0974124809741248,0.42860509089500587,1.0,2/11,3.79%,QRFP;STAT3
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.6360513761133387,1.402087276277297,0.11287758346581876,0.42788083396354754,1.0,7/14,16.30%,ADIPOQ;PYDC1;PELI3;PTPN2;NLRP2B;CCDC3;TRAIP
prerank,chloride transmembrane transport (GO:1902476),-0.37539458797535863,-1.4018341564027996,0.038461538461538464,0.5605420135552919,1.0,15/48,9.76%,SLC12A2;SLC12A7;GABRA2;GABRB1;GLRA3;GABRG3;SLC1A1;SLC12A6;SLC6A1;GABRA5;GLRA1;CLCN3;GABRB2;ANO3;SLC4A8
prerank,cellular response to lipopolysaccharide (GO:0071222),0.4829933086294122,1.4014155034087157,0.055853920515574654,0.42887110653076516,1.0,17/101,12.30%,CXCL5;CXCL1;LBP;SBNO2;TNFAIP3;CASP1;NUGGC;CCL5;LY96;CD68;CXCL10;CD14;WNT5A;HMGB2;CCL2;RHOA;TNF
prerank,Golgi organization (GO:0007030),0.4766224786964556,1.4013503180265798,0.034371643394199784,0.42827138894215894,1.0,36/112,19.07%,SEC16B;VMP1;GORASP2;LRRK2;ATP8B1;STX6;RAB2A;PI4K2B;STX17;ATL2;CDC42;COG4;LMAN2L;GBF1;GOLGA8B;GOLGA5;TRIP11;SEC16A;GAK;LMAN1;SEC23IP;YWHAZ;CSNK1A1;TMED1;RAB1A;DYNC2H1;VCPIP1;PDCD10;LYSMD3;COG7;OBSL1;TBC1D20;CSNK1D;TMED5;BCAS3;TJAP1
prerank,negative regulation of bone mineralization (GO:0030502),0.6426865748245514,1.4008732159106057,0.10015649452269171,0.42880628419451106,1.0,2/13,4.31%,ENPP1;CCR1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.6172832338503185,1.4006546102045363,0.09654178674351585,0.4286394592894499,1.0,6/17,14.73%,THBS4;XCL1;MDK;TIRAP;DAPK2;RAC1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.45612370456329154,1.4006229359128317,0.0,0.42796806934313847,1.0,126/476,18.64%,RORA;RUNX1;NR1H4;RUNX2;COL1A1;KMT2A;RUNX3;CXXC1;SPP1;MDFIC;BCL3;GLI2;YAP1;DEAF1;TCF4;SNAI1;GLI3;STAT1;ZMIZ1;IRF7;GATA6;FGF7;MAFB;MITF;ZNF496;SMAD2;EGFR;APOE;STAT3;ELF4;ILF3;NR2F2;SHH;E2F1;MYBL1;SMARCC1;ACVR1;FOXK2;EGF;CREBBP;FZD1;SFRP1;PPARG;LRP6;YAF2;ZBTB48;TGFB3;AHR;FOXE1;GTF2H1;RNF111;IRF1;NEK4;CREB3L2;SP100;TGFBR1;MAP2K1;WNT5A;HDAC1;SALL1;FOXO3;TBL1X;ARID1B;SMAD5;TGFB1I1;HMGB2;ZIC1;TRIM44;TEAD1;KMT2E;RSF1;SP3;MED13;NIF3L1;MAP3K2;FBXW11;TNF;KLF6;FGF2;KMT2B;ELK1;NSD3;SNX5;BRPF1;CTCF;SMAD3;PSEN1;BMP7;EGR2;USP22;SMAD4;DTX3L;MMS19;NAA15;HIF1A;TRIM56;NPAS2;NSD1;POU3F3;ATF7IP;CLOCK;TCF3;SMARCA4;ACVRL1;ZFHX3;AKT1;ING5;CALCOCO1;THRAP3;PCBD2;BRD4;ATF4;PICALM;GLI1;ETS1;MAP3K12;RLF;RAI1;INHBA;BICRA;PAX8;AGT;SOX2;SETD3;HINFP;KAT6B
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.4253807510252902,-1.400014950435696,0.07203389830508475,0.5615332374566252,1.0,8/29,9.15%,TJP1;PRKN;KANK3;SHANK3;HIP1R;TWF2;KANK4;SHANK1
prerank,nuclear membrane disassembly (GO:0051081),0.6432053235351187,1.3997945280885868,0.10879284649776454,0.42930357665170255,1.0,5/14,11.30%,NEK6;PRKCA;PLK1;NEK9;CCNB2
prerank,response to glucocorticoid (GO:0051384),0.5719366820818771,1.3996328474975948,0.10719131614654002,0.42899216825092895,1.0,6/26,12.30%,ZFP36L1;ZFP36L2;SLIT3;ANXA1;UBE2L3;TNF
prerank,visual system development (GO:0150063),0.5443293012064196,1.3993784996764833,0.07985257985257985,0.4290328879542772,1.0,7/37,8.25%,C3;SH3PXD2B;MEIS2;SIPA1L3;MEIS1;PBX3;ADAMTS18
prerank,bile acid and bile salt transport (GO:0015721),0.579253139911604,1.3993233727776777,0.09959072305593451,0.4284295291630772,1.0,3/24,2.99%,NR1H4;ATP8B1;SLC10A6
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6510083776905677,1.3983230839093264,0.1094224924012158,0.430353366751299,1.0,6/14,15.02%,KMT2A;AUTS2;KMT2E;DNMT3B;SMAD4;PAXIP1
prerank,presynapse assembly (GO:0099054),0.6312379545842,1.3976370697689435,0.11259259259259259,0.431497647233972,1.0,4/16,9.14%,CEL;PTEN;FZD1;WNT5A
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5752709094929974,1.3974767719806762,0.09336941813261164,0.431188673961015,1.0,4/26,3.52%,ZFP36L1;ZFP36L2;SNAI2;EGFR
prerank,B cell receptor signaling pathway (GO:0050853),0.5534448772832044,1.3970417306025746,0.09102402022756005,0.43167570388090437,1.0,8/32,9.76%,RFTN1;TEC;VAV3;BLK;BCL2;SH2B2;LAT2;MS4A1
prerank,negative regulation of phagocytosis (GO:0050765),0.6290324977081169,1.3970184918302286,0.11532846715328467,0.43098305406405985,1.0,3/17,2.72%,ADIPOQ;TLR2;PRTN3
prerank,regulation of interleukin-6 production (GO:0032675),0.48488627703639897,1.396876946580599,0.04394426580921758,0.43060790943779675,1.0,17/96,9.14%,LBP;IL16;TLR2;TNFAIP3;TSLP;IRAK3;TREM2;STAT3;AIF1;LGALS9;PTPN6;TLR7;RAB7B;TIRAP;TMEM106A;LPL;WNT5A
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6537104880657922,1.3968195689618677,0.1187214611872146,0.4300337127315444,1.0,5/13,11.57%,CBLB;ERRFI1;CBL;SOCS5;ZGPAT
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.6315091459826828,1.3962393793491796,0.1228878648233487,0.4309527114858383,1.0,2/14,2.43%,CREB3L1;LRRK2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.6080736496778566,1.395518650121422,0.09557774607703282,0.4321312630739764,1.0,6/19,14.73%,THBS4;XCL1;MDK;TIRAP;DAPK2;RAC1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.46414416157766797,1.395277798693587,0.013238289205702648,0.4319770165661937,1.0,56/170,21.38%,IGF2BP1;TRIML2;POU5F1;C1D;EDN3;AFF1;ZFP36L1;IGF2BP2;AFF2;NELL1;TREM2;APOE;CGGBP1;SHH;PRDM5;PRDM2;AIF1;TBC1D16;TRIM21;CDK6;AHR;HMG20B;FUBP1;PRDM1;TRIM44;MARF1;NFKBIZ;PRDM10;CTCF;YBX3;KIF16B;ARF1;PSEN1;MKLN1;MTMR9;TCF19;HIF1A;ADNP2;RASA1;PTPRC;ZNF445;MTMR3;STX1B;PRDM4;SOX2;HINFP;MTMR2;MTMR1;PIN1;HNRNPDL;GDNF;TRIM6;FOXP1;ZC3H12A;SIRPA;TRIM27
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6702340203527347,1.3952591142732302,0.12111801242236025,0.4312892104032834,1.0,3/11,7.98%,CXCL12;IRF7;MERTK
prerank,renal system development (GO:0072001),0.5176956502191435,1.395164348747924,0.07692307692307693,0.4308180673769439,1.0,12/52,11.44%,SULF1;GLI2;TBX18;STAT1;ITGA8;IFT88;BAG6;TGFBR1;GREB1L;SALL1;NPHP3;TGFB2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5778283645931532,1.3950994877562788,0.10810810810810811,0.4302546000885641,1.0,9/26,13.23%,CBLB;ERRFI1;NCK2;EGF;CBL;FBXW7;SOCS5;ZGPAT;BTC
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.5654223281276145,-1.3950045678196314,0.11267605633802817,0.57245789610768,1.0,2/11,1.56%,CAV1;ACTN2
prerank,membrane raft organization (GO:0031579),0.6398818534261734,1.3946194563477656,0.11127596439169139,0.4308599621147471,1.0,2/15,3.15%,RFTN1;FLOT2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.49556356663741624,1.3940588253925057,0.06140350877192982,0.43157421444731486,1.0,14/72,14.73%,ABCA1;DLC1;COL3A1;P2RY10;NRP1;APOE;OPHN1;ITGA3;KCTD10;AKAP13;ARHGEF18;ARHGAP35;PDCD10;RAC1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4804030172028832,1.3933221071567585,0.04777415852334419,0.43294020896704727,1.0,14/87,8.91%,PSMA7;ZFP36L1;ZFP36L2;CDKN2B;FBXL7;CUL1;PTEN;PKD2;CDK6;PINX1;SKP1;GPNMB;PSMB8;PSMA6
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5509146625747259,-1.3929024641013197,0.09117647058823529,0.5745318513856367,1.0,7/11,29.63%,P3H2;P4HTM;EGLN2;EGLN3;CRTAP;P4HA3;P4HA1
prerank,neuron maturation (GO:0042551),0.6175543555572963,1.3925576898288095,0.10540915395284327,0.434194465743592,1.0,3/18,2.07%,C3;FARP2;B4GALT5
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5669483575073937,1.3924211078459998,0.09126466753585398,0.43379562955292283,1.0,11/29,17.65%,CXCL12;CCR1;AIF1;LGALS9;CCL5;CXCL10;PLA2G7;CALR;TNF;CREB3;ANO6
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.3297169035609861,-1.392012238263188,0.0,0.5725222979738791,1.0,38/91,20.27%,ARL6IP1;RPL34;SRP19;RPL36;RPL8;RPS4X;RPL18A;RPL19;RPL38;RPS21;RPL5;RPS10;RPLP0;RPL7;RPL13;RPS8;RPS23;RPL30;RPS12;RPL13A;RPL35A;RPL29;RPL32;RPL10;RPL15;RPS27;RPL35;SRP9;RPS16;RPL7A;RPS15;RPS29;RPL27;RPS13;RPS19;RPL41;RPLP1;RPL28
prerank,steroid metabolic process (GO:0008202),0.48874473886181785,1.3917843631397195,0.06285072951739619,0.43478938188351435,1.0,8/72,9.08%,CYP1B1;CYP7B1;DHRS4;SHH;CYP27B1;CYP2A6;HSD11B1;CYP1A1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4945873344572499,1.39053759439363,0.0782122905027933,0.43757092075198994,1.0,9/65,8.91%,PSMA7;FBXL7;CUL1;PABIR1;VPS4A;PINX1;SKP1;PSMB8;PSMA6
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4738010838175842,1.390414772659511,0.03536977491961415,0.4371306677259423,1.0,13/116,6.53%,MC5R;IAPP;GPR176;GPR39;ADCY7;TREM2;RXFP2;MYH9;ADCY2;PTGDR;ADM;ADCYAP1R1;GLP2R
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.550782011421193,1.389879366529481,0.08891752577319588,0.43787397859988636,1.0,2/30,0.65%,COL3A1;P2RY10
prerank,regulation of mRNA stability (GO:0043488),0.4645777306858842,1.3897340759877415,0.018769551616266946,0.43755270347340064,1.0,52/145,22.93%,PSMA7;IGF2BP1;ZFP36L1;IGF2BP2;ZFP36L2;PRKCA;E2F1;PUM1;TENT5A;METTL16;CARHSP1;GIGYF2;SAMD4A;CELF1;PSMB8;EXOSC4;PSMA6;DCP2;FTO;XRN1;YWHAZ;TNPO1;PSMF1;ANP32A;YTHDF3;FMR1;DCP1A;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;AKT1;RC3H2;THRAP3;PSMB1;AXIN2;PARN;NUP214;PSMC6;GDNF;EIF4G1;PRKCD;XPO1;RPS27A;YBX1;EXOSC5;ROCK2;PSMB4;YTHDF2;PSMB5;ROCK1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6847518713024782,1.3891304225836705,0.115625,0.4383235565186849,1.0,6/10,24.23%,CCL2;NFE2L2;HSPA5;EIF2AK3;ATF4;EIF2S1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.4989217477774755,1.3886218062989844,0.06077981651376147,0.43897080996254434,1.0,18/67,20.27%,PSMA7;ITGB5;PDIA3;CD36;PSMB8;PSMA6;CALR;PSMF1;PSMA8;FCGR1A;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1;CYBB;PSMC6;TAP1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5474531330867979,-1.388573974735501,0.09393939393939393,0.57861901716382,1.0,3/13,3.36%,NR3C2;BMP4;ESR1
prerank,carbohydrate derivative transport (GO:1901264),0.6054816022720477,1.3885093361559957,0.1111111111111111,0.43851998032861306,1.0,9/18,21.66%,LBP;SLC15A3;PLTP;ABCG1;NPC2;SLC29A1;CPTP;SLC15A2;SLC25A19
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.535527434849092,1.3880459187451881,0.07133592736705577,0.4389625819892027,1.0,15/40,22.19%,GLMN;PTEN;FBXW7;RAD23A;CSNK2A1;CSNK2A2;RAD23B;PTK2;RPL11;SMURF1;GNA12;XPO1;AXIN1;CLU;LATS1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6808448612791084,1.3872106075516004,0.10662358642972536,0.4404637720415607,1.0,3/10,10.46%,FAP;EMILIN1;TNFRSF1A
prerank,kinetochore organization (GO:0051383),-0.5298830172462252,-1.387130496304293,0.125,0.5787730472258631,1.0,10/13,41.57%,CENPC;POGZ;CENPT;CENPE;CENPH;NDC80;CENPF;DLGAP5;NUF2;CENPW
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.5015224277032009,-1.3871154232716936,0.07958477508650519,0.5743784040948126,1.0,8/17,20.66%,ALK;SORL1;GPLD1;BSCL2;PDE3B;MFSD2A;ADRA2A;PRKAA1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.4964964250113928,1.3870693254524262,0.06201550387596899,0.4400889071119655,1.0,27/65,22.28%,PMEPA1;FBN2;SPRED1;SMAD2;FBN1;SMURF2;SPRED2;HTRA3;EMILIN1;WFIKKN1;HTRA4;TGFBR1;LTBP1;TGFB1I1;LDLRAD4;SPRY2;SKOR2;SMAD3;SNX25;SMURF1;NRROS;ZBTB7A;PIN1;ASPN;RPS27A;SNX6;IL17RD
prerank,receptor catabolic process (GO:0032801),0.5820407336649647,1.3868950717602364,0.1115702479338843,0.43983530738936055,1.0,9/24,16.91%,CLTC;MYLIP;KIF16B;AP2A2;PIK3R4;SNX25;SMURF1;NEDD4;SH3GLB1
prerank,embryonic limb morphogenesis (GO:0030326),0.5546921475591069,1.3860188301404879,0.07575757575757576,0.4414491242322472,1.0,11/34,11.44%,GLI3;CACNA1C;TBX2;SHH;CREBBP;LRP6;HDAC1;SALL1;WDPCP;TBX3;TGFB2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5312501361612362,1.385925538252774,0.08543922984356198,0.4409767649463331,1.0,17/46,17.21%,ADIPOQ;FBLN1;TNIP1;SPRED1;SPRED2;PTEN;EMILIN1;PTPN1;CNKSR3;PTPN2;SPRY2;DUSP26;RANBP9;SMAD4;ITGB1BP1;PTPRC;DUSP6
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.6758434054340289,1.3859025113660135,0.12419354838709677,0.4403125178880654,1.0,3/10,5.97%,RARB;RXRG;PPARG
prerank,regulation of establishment of cell polarity (GO:2000114),-0.512722579511093,-1.3858604155351162,0.0914826498422713,0.5737356835476963,1.0,6/16,14.77%,KRIT1;CDH5;GSN;SHTN1;RACK1;RIPOR2
prerank,regulation of mast cell degranulation (GO:0043304),0.6371912024625218,1.3858517255766627,0.09170305676855896,0.4397159507508879,1.0,6/14,14.81%,GAB2;BLK;LGALS9;UNC13D;SPHK2;FES
prerank,regulation of nervous system development (GO:0051960),0.5377514535203188,1.3840500013730952,0.08578745198463508,0.44375043204771786,1.0,8/37,11.12%,YAP1;PTN;PTPRZ1;TENM4;BHLHE40;HEYL;HMGB2;NPHP3
prerank,regulation of lymphocyte activation (GO:0051249),0.6431396656993744,1.3840059752029807,0.12556732223903178,0.4431150340878602,1.0,2/12,5.67%,DCAF15;CCL5
prerank,lamellipodium organization (GO:0097581),-0.4360772036242087,-1.3835684667297576,0.05726872246696035,0.5761442346011021,1.0,12/29,14.21%,ABLIM1;KIT;CDH13;ABLIM3;S1PR1;CCDC88A;PTPRO;ARHGEF6;WASF1;VCL;PARVB;DMTN
prerank,negative regulation of cell communication (GO:0010648),0.578049726729316,1.3833605846286892,0.11596180081855388,0.44416118228758733,1.0,6/21,12.89%,ADIPOQ;ACVR1;PTPN1;BRAP;SOCS5;UBASH3B
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5114027110936437,1.3830621933460048,0.08198614318706697,0.4442329144431938,1.0,13/51,12.90%,IL16;JAK2;CASP1;STAT3;LGALS9;CD36;PYDC1;TMEM106A;LPL;WNT5A;CASP8;TNF;P2RX7
prerank,thyroid hormone generation (GO:0006590),0.6581936722167325,1.381639221814615,0.13106796116504854,0.4474908172846536,1.0,3/10,6.69%,CPQ;CTSK;FOXE1
prerank,negative regulation of cytokine production (GO:0001818),0.45844574200051663,1.3814901694261335,0.0205761316872428,0.44712951587995975,1.0,18/163,6.47%,NR1H4;IL23R;VSIG4;APOD;BCL3;TNFRSF21;CMKLR1;TNFAIP3;XCL1;ADCY7;NAV3;IRAK3;TREM2;IKBKE;LGALS9;ILRUN;PTPN6;INHBB
prerank,genitalia development (GO:0048806),0.6434421500147759,1.3807358024086607,0.1368421052631579,0.44850434204756906,1.0,4/12,10.21%,CHD7;SHH;WNT5A;TBX3
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.4796672314893149,1.3801280354993124,0.057297297297297295,0.449420536743841,1.0,15/87,8.60%,DLC1;GPM6B;PDGFRA;LRP1;RND3;TAOK1;PDGFRB;RICTOR;FSCN1;MDK;BAIAP2;RHOD;CDK10;ARHGEF19;EFNA5
prerank,regulation of amyloid-beta clearance (GO:1900221),0.6130422103063208,1.3801265458415575,0.11320754716981132,0.44869710499221854,1.0,5/16,12.30%,LRP1;TREM2;APOE;HDAC1;TNF
prerank,negative regulation of autophagosome assembly (GO:1902902),0.646561002336274,1.3789103840382633,0.11282843894899536,0.4511696828385377,1.0,4/13,4.23%,LRRK2;CHMP4A;CHMP4B;TMEM39A
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.5963382319693684,1.3782149132289743,0.11416184971098266,0.45236579609921446,1.0,4/18,8.41%,LRRC17;MAFB;FBN1;FBXW7
prerank,regulation of actomyosin structure organization (GO:0110020),0.6398470868110135,1.3782093708093655,0.13109756097560976,0.45164770181623165,1.0,6/13,14.73%,SLC9A1;ASAP3;ALMS1;CDC42;AKAP13;RAC1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.551823492926641,1.3781281910501675,0.09259259259259259,0.45112593592447137,1.0,7/29,8.68%,COPA;COPZ2;COPZ1;COPB2;GOSR1;GOLGA5;COPG1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.6092212407328638,1.3772195589755787,0.12354651162790697,0.4528777630924002,1.0,6/17,11.10%,SNAI1;SNAI2;JAG1;ACVR1;HEYL;GALNT11
prerank,cholesterol metabolic process (GO:0008203),0.49020921297568637,1.3771714014551353,0.06292134831460675,0.4522721127522128,1.0,7/68,7.56%,CEL;ABCA1;INSIG2;APOE;ABCG1;MVK;SOAT1
prerank,negative regulation of cartilage development (GO:0061037),0.6421931893879222,1.3770601542299705,0.13771517996870108,0.4518467598560722,1.0,5/13,12.65%,SNAI2;WNT9A;ADAMTS12;TGFBR1;ADAMTS7
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.5072717370289155,1.3769521071391224,0.09942196531791908,0.45144400590141615,1.0,13/53,17.05%,GLMN;DNAAF4;TREM2;APOE;OPHN1;FBXW7;RAD23A;RAD23B;PSMF1;DDRGK1;FMR1;PSMD14;GNA12
prerank,sterol biosynthetic process (GO:0016126),-0.408099367446631,-1.376618736429646,0.08296943231441048,0.5931886814992213,1.0,17/33,26.49%,PRKAG2;LBR;MSMO1;INSIG1;ACAT2;SQLE;CYP51A1;DHCR24;IDI1;ACLY;LSS;HSD17B7;FDPS;EBP;FDFT1;NSDHL;TM7SF2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.5739365779479142,1.3763635984656855,0.11624649859943978,0.45239958740455216,1.0,4/21,5.67%,IL34;CMKLR1;MDK;CCL5
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5765941162740876,1.3761988983587767,0.10810810810810811,0.45215356925871625,1.0,4/24,5.67%,CYP1B1;GHR;JAK2;CCL5
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6630484487856191,1.375375076582442,0.14401294498381878,0.4537276872460084,1.0,2/10,7.40%,ENPP1;PID1
prerank,positive regulation of proteolysis (GO:0045862),0.502919467879506,1.3752704856033209,0.0755813953488372,0.45325794933776536,1.0,15/55,13.06%,CCBE1;NKD2;TNIP1;APOE;PLK1;OGT;SNX33;SNX9;RCN3;CASP8;CLN6;CTSC;FBXW11;TNF;TANK
prerank,adherens junction organization (GO:0034332),-0.3785082712096499,-1.37474461839801,0.06172839506172839,0.5948795947774009,1.0,13/48,10.31%,TJP1;CADM2;CDH13;CADM1;ACTB;CDH5;CTNND1;CDH10;RAMP2;CDH1;CDH4;VCL;CDH12
prerank,chordate embryonic development (GO:0043009),0.5073271257204623,1.3747141797574363,0.06979405034324943,0.45408951381770823,1.0,11/55,10.51%,COL1A1;SULF1;DEAF1;CHD7;ALDH1A2;PKD2;TGFB3;TGFBR1;WNT5A;BMP5;FGFR1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.45208433818318783,1.3743272222833156,0.014271151885830785,0.45445727164428273,1.0,35/186,12.58%,PSMA7;RBMS3;BICC1;LRP1;NKD2;TCF7L2;SFRP4;KREMEN1;GLI3;IGFBP4;SNAI2;TLE1;TAX1BP3;APOE;FRZB;MDK;SFRP1;LRP6;PRICKLE1;SIAH2;NXN;MDFI;DKK2;PSMB8;PSMA6;WNT5A;HDAC1;SFRP5;WWTR1;NPHP3;DRAXIN;RNF213;GSK3B;CSNK1A1;PSMF1
prerank,ethanol metabolic process (GO:0006067),-0.5401247937648543,-1.3741422392946057,0.12302839116719243,0.5923681039011491,1.0,5/12,20.01%,ALDH1A1;SULT1A1;ALDH2;ACSS1;ACSS2
prerank,protein auto-ADP-ribosylation (GO:0070213),0.6464926869226661,1.3738087498224243,0.13682678311499272,0.45512597976288954,1.0,3/12,6.77%,PARP8;PARP3;PARP11
prerank,neuron migration (GO:0001764),0.5046356474787571,1.3737699476533967,0.09188544152744631,0.4544973111142891,1.0,14/48,12.48%,DNAAF4;LRP12;MDGA1;AUTS2;NRP1;NAV1;ADGRL3;MARK1;USP9X;ASTN2;SH3RF1;DISC1;FGFR1;FGF13
prerank,membrane lipid catabolic process (GO:0046466),0.668733505072926,1.3732598813859362,0.14705882352941177,0.45517834097149407,1.0,1/10,0.18%,CYP1B1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.5806781752015379,1.373076680329491,0.1309192200557103,0.45497285299395834,1.0,6/22,8.81%,SPRED1;SPRED2;PLA2R1;ATM;EEF1E1;ATR
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5768550308640196,1.3728405409877575,0.13655172413793104,0.45486754739557284,1.0,2/21,7.20%,CEL;ACOX1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.624256266595281,1.3727774137909865,0.13049853372434017,0.4543185685337576,1.0,4/14,11.83%,TLR2;PUM1;OASL;ANKRD17
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5129194013963394,1.3727451561621054,0.08364083640836409,0.4537072950185773,1.0,10/46,5.97%,APOD;TCF7L2;STAT1;TNFAIP3;PDGFRB;CCN4;IGFBP5;AIF1;CCL5;PPARG
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.32627271860200474,-1.3724264982998684,0.0,0.5933536550372368,1.0,37/87,20.27%,RPL34;SRP19;RPL36;RPL8;RPS4X;RPL18A;RPL19;RPL38;RPS21;RPL5;RPS10;RPLP0;RPL7;RPL13;RPS8;RPS23;RPL30;RPS12;RPL13A;RPL35A;RPL29;RPL32;RPL10;RPL15;RPS27;RPL35;SRP9;RPS16;RPL7A;RPS15;RPS29;RPL27;RPS13;RPS19;RPL41;RPLP1;RPL28
prerank,tyrosine metabolic process (GO:0006570),-0.5422042184196321,-1.3722227309861785,0.10393258426966293,0.5897109399084238,1.0,6/11,37.44%,GSTZ1;FAH;THAP4;TYR;HGD;IL4I1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5295926441810064,-1.3715087077929413,0.1111111111111111,0.5876568537334437,1.0,4/12,11.13%,UNC13C;UNC13B;SYT7;RIMS1
prerank,positive regulation of neutrophil migration (GO:1902624),0.5985562036017037,1.370489279916541,0.11847672778561354,0.4590180995129946,1.0,6/18,14.73%,THBS4;XCL1;MDK;TIRAP;DAPK2;RAC1
prerank,cytoplasmic translation (GO:0002181),-0.3262187978409847,-1.3698313090424066,0.010869565217391304,0.5884266457037397,1.0,41/91,21.75%,RPL34;RPL36;RPL8;RPS4X;RPL18A;RPL19;RPL38;RPS21;RPL5;RPS10;RPLP0;RPL7;RPL13;RPS8;RPS23;RPL30;RPS12;RPL13A;RPL35A;RPL29;RPL22L1;EIF4A2;RPL32;RPL10;RPL15;RPS27;RPL35;DRG2;RPS16;RPL7A;RPS15;RPS29;RPL27;RPS13;EIF3M;RPS19;RPL41;RPLP1;RPL28;GSPT2;RPS17
prerank,actin cytoskeleton reorganization (GO:0031532),0.48639193154480703,1.369466123410582,0.08154020385050963,0.46109759983946946,1.0,23/63,14.62%,ANTXR1;SYDE1;FARP2;FGF7;AUTS2;NRP1;RICTOR;MYH9;PARVA;RALA;DTNBP1;RAP2A;PTPN1;PDLIM4;GRB2;S1PR2;ANXA1;CDC42BPA;NRK;RHOA;MICALL2;MKLN1;PTK7
prerank,defense response to bacterium (GO:0042742),0.4616811450190459,1.369339856642091,0.06060606060606061,0.4607223251306424,1.0,13/105,10.16%,IL23R;LBP;SPN;COLEC12;CRP;TLR2;TREM2;NOD1;RNASE7;MPEG1;TIRAP;HMGB2;GBP7
prerank,regulation of mRNA catabolic process (GO:0061013),0.4620898215549792,1.369070464533681,0.044257112750263436,0.4607601378882675,1.0,50/121,25.24%,PSMA7;IGF2BP1;ZFP36L1;IGF2BP2;ZFP36L2;PRKCA;PUM1;CARHSP1;SAMD4A;PSMB8;EXOSC4;PSMA6;DCP2;MOV10;XRN1;YWHAZ;TNPO1;PSMF1;ANP32A;YTHDF3;FMR1;DCP1A;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;AKT1;RC3H2;PSMB1;PARN;NUP214;PSMC6;EIF4G1;PRKCD;XPO1;ZC3H12A;RPS27A;EXOSC5;PSMB4;YTHDF2;PSMB5;PCID2;FXR2;PSMD4;ZC3H14;PSMD7;PSMD9;PSMA4;CNOT1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5848983482399844,1.368642323630628,0.1379800853485064,0.4612853321613111,1.0,4/18,7.78%,CMKLR1;BLK;BAG6;SH2B2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.4888320546147011,-1.368067459347986,0.10526315789473684,0.5896656189437717,1.0,14/16,49.62%,CADM1;AP1G1;LAMP1;PVR;RAET1E;NECTIN2;RASGRP1;SLAMF6;CD226;IL12A;CRTAM;KLRD1;CD160;KLRK1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.65168370981097,1.3679667143764547,0.12878787878787878,0.4623638131485578,1.0,6/12,14.79%,CHMP4A;CHMP4B;SEC63;SEC61A1;HSPA5;SEC61A2
prerank,cobalamin metabolic process (GO:0009235),0.619660218549424,1.3663174899240018,0.10653409090909091,0.4661190048747603,1.0,3/17,7.43%,TCN1;MMAB;TCN2
prerank,regulation of protein import into nucleus (GO:0042306),0.5355307756318557,1.3661335900554732,0.0986093552465234,0.46586372678046234,1.0,9/36,13.92%,MDFIC;APOD;SUFU;UBR5;BAG3;ZIC1;PIK3R1;SMAD3;PSEN1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.37871770201597355,-1.3657863219169941,0.047058823529411764,0.592800731051593,1.0,25/39,33.61%,ERCC5;ERCC3;UBC;POLD3;CHD1L;PCNA;DDB2;GTF2H2;ERCC1;OGG1;GTF2H4;RFC3;UBA52;GTF2H3;FAN1;POLD2;RBX1;RPA2;PARP1;RFC4;NTHL1;POLD4;RFC2;RPA3;POLK
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5142608853786402,-1.3657305445624472,0.09597523219814241,0.5888101839361771,1.0,4/13,7.68%,SORBS1;PRKCZ;GKAP1;SORL1
prerank,renal filtration (GO:0097205),0.6717820559506965,1.3652691930173233,0.13814756671899528,0.46754402243976195,1.0,5/10,14.50%,SULF1;TBC1D8B;ITGA3;MYO1E;XPNPEP3
prerank,receptor signaling pathway via STAT (GO:0097696),0.5685164809014851,1.3650298081124503,0.11294765840220386,0.46747641622561115,1.0,8/25,10.36%,GHR;STAT1;JAK2;STAT3;PKD2;STAT5A;IFNAR2;CCL2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.555996836599278,-1.3648119875416176,0.13054830287206268,0.5875459041208215,1.0,5/11,15.71%,LDLR;SCARB1;SLC27A1;GPLD1;MFSD2A
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.45916721154457674,-1.3646666438288089,0.09868421052631579,0.5838936609086054,1.0,5/20,10.35%,CHRM2;PLCB1;AGRN;GNA11;GRK2
prerank,negative regulation of macrophage activation (GO:0043031),-0.48912163225616045,-1.3645067629875347,0.10289389067524116,0.5804205769163732,1.0,4/16,5.87%,LRFN5;IL31RA;LDLR;CD200
prerank,mRNA 3'-end processing (GO:0031124),-0.3311847367511799,-1.3639158416101624,0.0196078431372549,0.5781781571184008,1.0,29/78,25.42%,CDC40;SRSF5;WDR33;CSTF2;PABPC1;RPRD2;U2AF2;RPRD1A;LEO1;APP;TUT1;SRSF7;SRSF9;RBM8A;CHTOP;CPSF2;MAGOH;ZC3H11A;EIF4A3;LSM11;SRSF3;CLP1;POLDIP3;CPSF4;SARNP;PAPOLB;DDX39B;DDX39A;THOC1
prerank,response to hexose (GO:0009746),0.5572615260841985,1.3634085469105326,0.11378848728246319,0.4710794444431383,1.0,5/25,11.73%,ADIPOQ;TCF7L2;LPL;KHK;ZBED3
prerank,negative regulation of response to external stimulus (GO:0032102),0.4622199331724516,1.3629973071864037,0.05938494167550371,0.4714464434850171,1.0,12/105,5.97%,RORA;NR1H4;ADIPOQ;TNFAIP3;IRAK3;APOE;CASK;PTEN;ILRUN;MVK;TRIM21;PPARG
prerank,regulation of cellular amine metabolic process (GO:0033238),0.5007253572172367,1.3627642755529454,0.10760233918128655,0.4714186388205758,1.0,11/50,17.74%,PSMA7;OAZ3;PSMB8;PSMA6;PSMF1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.5307471308779702,-1.3619585805310634,0.13432835820895522,0.5799867869433811,1.0,4/12,7.68%,SORBS1;PRKCZ;GKAP1;SORL1
prerank,positive regulation of bone mineralization (GO:0030501),0.5289996959274464,1.3617702890945182,0.1059850374064838,0.47341109241722495,1.0,11/35,14.05%,GPM6B;FBN2;PTN;NELL1;ACVR1;TGFB3;TMEM119;ATP2B1;ACVR2A;P2RX7;BMP7
prerank,tetrapyrrole metabolic process (GO:0033013),0.6093708440085442,1.3614156164011855,0.10829817158931083,0.4737306167898312,1.0,3/18,7.43%,TCN1;MMAB;TCN2
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5213722035161145,-1.3605966127634959,0.12457912457912458,0.5799730109143502,1.0,5/14,8.96%,DMD;ATP1B1;WNK4;WNK3;ANK3
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5000281941801815,1.360582397169723,0.09905660377358491,0.47533250041821856,1.0,8/52,7.13%,CXXC1;SEC31A;ERN2;WIPI1;KDELR3;ARFGAP1;DDX11;YIF1A
prerank,actin filament bundle organization (GO:0061572),0.5333495957196339,1.3603682584031074,0.1073738680465718,0.4752100780253215,1.0,10/33,8.76%,MYO1B;DPYSL3;CALD1;FSCN1;LIMA1;BAIAP2;AIF1;RHOD;ADD2;LCP1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.464311340150577,1.359946704942995,0.046236559139784944,0.4756623687450763,1.0,13/117,6.53%,MC5R;IAPP;GPR176;GPR39;ADCY7;TREM2;RXFP2;MYH9;ADCY2;PTGDR;ADM;ADCYAP1R1;GLP2R
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4775265014499325,1.3596750310456909,0.06986899563318777,0.47570610644888445,1.0,17/86,11.22%,EPHA7;IL23R;THBS4;TEC;GHR;FGF7;JAK2;NRP1;EGFR;TREM2;ACVR1;SFRP1;PTPN6;ANGPT1;EFNA5;PTPRJ;VTN
prerank,membrane repolarization during action potential (GO:0086011),-0.5221847473227581,-1.3594206069106733,0.13218390804597702,0.5797839631497188,1.0,4/13,12.33%,KCND3;ATP1B1;KCNJ2;KCNQ1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.5952258730949277,1.358539313240533,0.12322946175637393,0.4782449182814628,1.0,9/18,15.68%,ITGB8;XCL1;LGALS9;LTBP1;TGFB2;SMAD3;SMAD4;LRRC32;HIF1A
prerank,regulation of innate immune response (GO:0045088),0.4907185426759433,1.3581921567752113,0.10520231213872833,0.4785170130030186,1.0,15/57,12.43%,TNFAIP3;BIRC3;IRAK3;TREM2;TRIM21;CCL5;PTPN6;IRF1;IFNAR2;PTPN1;ABCE1;TIRAP;CDC37;CASP8;POLR3D
prerank,glucose import (GO:0046323),-0.5192906322430513,-1.3570944664178939,0.11730205278592376,0.5828590915712752,1.0,3/13,10.23%,SLC2A1;SORT1;SLC27A1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.4924040427709859,1.3566739515304245,0.09392898052691867,0.4819380636200303,1.0,17/62,17.55%,CREB3L1;CXCL12;SNAI1;LRRK2;SNAI2;BCL2;ENO1;BCL2L2;NOC2L;CCAR2;TMEM161A;NFE2L2;YBX3;SRC;CREB3;AKT1;MDM2
prerank,protein targeting to ER (GO:0045047),-0.3108616324535134,-1.3564212450735411,0.0,0.5809344740602485,1.0,48/99,24.62%,RPL34;SRP19;SPCS2;RPL36;RPL8;SRPRB;RPS4X;RPL18A;RPL19;RPL38;RPS21;RPL5;RPS10;RPLP0;RPL7;RPL13;RPS8;RPS23;RPL30;RPS12;RPL13A;RPL35A;RPL29;SPCS3;RPL32;RPL10;RPL15;RPS27;RPL35;SRP9;RPS16;RPL7A;RPS15;RPS29;RPL27;SEC61G;RPS13;RPS19;RPL41;RPLP1;RPL28;SGTA;RPS17;SPCS1;RPL23A;ZFAND2A;UBA52;ZFAND2B
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5877179368337941,1.3562132107037006,0.1407103825136612,0.48239065690980765,1.0,3/19,3.88%,RUNX1;ZFPM2;TBX2
prerank,regulation of myeloid cell differentiation (GO:0045637),0.49551586165462924,1.3558718090626156,0.0798611111111111,0.48260435793240014,1.0,16/62,13.10%,RUNX1;KMT2A;MEIS2;MAFB;MEIS1;RBBP5;CNOT4;CREBBP;CDK6;TNRC6B;HDAC1;CBFB;KMT2E;MOV10;KMT2B;SPI1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.49532500470209984,1.3558128715155828,0.11020881670533643,0.4820535528622012,1.0,12/53,17.74%,PSMA7;OAZ3;PSMB8;PSMA6;PSMF1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PPM1K;PSMB1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6463903921031594,1.3554568159898353,0.13015873015873017,0.4822502029310218,1.0,2/11,1.41%,IGF2BP1;IGF2BP2
prerank,positive regulation of vasculogenesis (GO:2001214),-0.5657371237131699,-1.3551115588740725,0.13054830287206268,0.5811298178853453,1.0,5/10,14.13%,CD34;RAPGEF2;KDR;RAP1A;TMEM100
prerank,positive regulation of rRNA processing (GO:2000234),-0.5655973021428762,-1.3550756467944394,0.15267175572519084,0.5774475309740006,1.0,6/10,27.82%,RIOK1;WDR43;DIMT1;SIRT7;UTP15;TRMT112
prerank,sensory perception of mechanical stimulus (GO:0050954),0.46970745222921456,1.3549850897112128,0.06717226435536294,0.4829022787940516,1.0,15/85,11.96%,ROR1;COL1A1;CEMIP;COL11A2;SNAI2;CRYM;COL11A1;PIEZO2;MYO7A;HOXA1;TPRN;TBL1X;TSPEAR;ALDH7A1;MYO3A
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5434103001571637,1.3546894343152014,0.12840466926070038,0.483032673502559,1.0,8/28,11.00%,ENPP1;IRS1;NCK1;PIP4K2A;PTPN1;PID1;RPS6KB1;PTPN2
prerank,amino sugar metabolic process (GO:0006040),0.6489562089046701,1.3546766982498297,0.1566068515497553,0.48234369516039344,1.0,4/10,10.96%,B4GALNT2;ST6GAL1;GFPT2;ST3GAL1
prerank,nitric oxide metabolic process (GO:0046209),0.6238852497163866,1.354350516946128,0.1426470588235294,0.4825494329508853,1.0,1/14,0.18%,CYP1B1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5479231718636675,1.3542514391551832,0.12890625,0.48211048611970175,1.0,8/27,11.00%,ENPP1;IRS1;NCK1;PIP4K2A;PTPN1;PID1;RPS6KB1;PTPN2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.46976384317921616,1.3541279015457939,0.0706401766004415,0.4816591339984942,1.0,28/87,18.41%,ZFP36L1;FLRT2;EGR3;ZFP36L2;FGF7;SPRED1;GALNT3;SPRED2;CCL5;SFRP1;CBL;GRB2;GTF2F2;FRS2;NCBP2;CCL2;FGFR1;FGF2;GTF2F1;KIF16B;SETX;FGF18;ITGB1BP1;MAPK1;RBFOX2;POLR2L;POLR2K;DSTYK
prerank,regulation of lymphocyte differentiation (GO:0045619),0.583538053658482,1.353727111412302,0.13285714285714287,0.48191366598428703,1.0,4/18,15.88%,ZFP36L1;ZFP36L2;PRDM1;PRKDC
prerank,regulation of proteolysis (GO:0030162),0.5084203266425436,1.3537111356361362,0.08899297423887588,0.481237556829452,1.0,13/48,12.26%,KNG1;SERPINE2;DNAJC1;GSAP;SHH;PLK1;PLAT;BAG6;SPOP;OGT;CASP8;CLN6;FBXW11
prerank,T cell activation involved in immune response (GO:0002286),0.6443314146794441,1.3533881110012622,0.14241960183767227,0.4813751375017961,1.0,3/12,8.76%,MDK;ICAM1;LCP1
prerank,vasculature development (GO:0001944),0.6005202779812653,1.3531640198966604,0.12816691505216096,0.48131234193522676,1.0,4/16,8.41%,PDGFRA;PDGFRB;ERRFI1;FBXW7
prerank,response to growth factor (GO:0070848),0.5135796894668994,1.3531018837297282,0.08869987849331713,0.4807717303882504,1.0,16/41,21.50%,IBSP;GATA6;ACVR1;SFRP1;TGFBR1;RPS6KB1;ACVR1B;ACVR2A;ACVR1C;STAT5B;ACVRL1;AKT1;SOX2;CPNE3;BMPR1A;EPHA2
prerank,potassium ion transport (GO:0006813),-0.30610853079637906,-1.353005148193508,0.045454545454545456,0.5793787689687885,1.0,32/120,15.85%,ATP1A2;ATP1B3;KCNC2;SLC24A2;KCND3;SLC9A2;KCNB2;KCNK5;KCND2;KCNQ5;KCNH5;TMEM175;KCNH7;KCNJ2;KCNJ3;KCNK10;KCNJ13;ABCC9;KCNQ3;KCNQ4;KCNJ10;SLC9A6;KCNK2;SLC9A7;KCNQ1;LRRC38;KCNJ12;CCDC51;KCNN2;NALCN;KCNN3;KCNC1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.5141502462311751,-1.3529426280123535,0.11452513966480447,0.5757673400109055,1.0,2/13,1.56%,CAV1;ACTN2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.48163056139696847,1.3526335912610299,0.0867579908675799,0.48132626744485685,1.0,18/70,20.27%,PSMA7;ITGB5;PDIA3;CD36;PSMB8;PSMA6;CALR;PSMF1;PSMA8;FCGR1A;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1;CYBB;PSMC6;TAP1
prerank,wound healing (GO:0042060),0.4916505798706108,1.3523137446976616,0.09016393442622951,0.48150815007676256,1.0,15/62,15.01%,COL3A1;PDGFRA;JAML;CFLAR;MYH9;NF1;HPSE;MIA3;TGFBR1;WNT5A;PPP3CA;TGFB2;FGF2;SMAD3;ANXA6
prerank,androgen receptor signaling pathway (GO:0030521),0.6568645185905291,1.3518703205941942,0.14937106918238993,0.4820208099075982,1.0,3/11,7.03%,PMEPA1;ZMIZ1;DDX17
prerank,regulation of interferon-gamma production (GO:0032649),0.48220498372692683,1.3517617543028344,0.08609271523178808,0.48161467002582203,1.0,8/71,8.14%,NR1H4;IL23R;CD276;IL1R1;XCL1;LGALS9;TLR7;CD14
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.42927957064342087,-1.3512470895417839,0.09623430962343096,0.5770202397515076,1.0,10/24,13.41%,TEK;KRIT1;CDH5;GAS6;NDNF;RAMP2;KDR;SCG2;GATA2;SEMA5A
prerank,replicative senescence (GO:0090399),0.6504206963873167,1.351033991104944,0.1575037147102526,0.48276832542826764,1.0,4/12,8.81%,PLA2R1;ATM;TERT;ATR
prerank,negative regulation of viral life cycle (GO:1903901),-0.4894284299413831,-1.3506686466083522,0.12536443148688048,0.5750517424715045,1.0,5/15,20.07%,GSN;LY6E;PPIA;BST2;MID2
prerank,regulation of MAP kinase activity (GO:0043405),0.4740361240115952,1.3502431470393514,0.058759521218716,0.4842289555189629,1.0,24/92,15.70%,IL34;ADIPOQ;EDN3;TNFSF11;LRRK2;CD40;PDGFRB;EGFR;IRAK3;APOE;NF1;EGF;PTPN1;PIK3R5;FGFR1;PTPRJ;SPRY2;TNF;FGF2;BMP7;TRIB3;PDCD10;TRIB1;FGF18
prerank,Wnt signaling pathway (GO:0016055),0.46880672660064276,1.3500032162701852,0.06566200215285253,0.48417319204501114,1.0,21/92,12.56%,WNT2;TCF7L2;SFRP4;LRRK2;WNT9A;FRZB;CUL1;PTEN;STRN;FZD1;SFRP1;LRP6;NXN;SKP1;WNT5A;SFRP5;WLS;TCF7;CSNK1G2;GSK3B;CSNK1A1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.44325498307650524,1.349333435507459,0.03278688524590164,0.4853299937155206,1.0,42/173,13.45%,COL7A1;SEC16B;SEC31A;DYNLL1;SEC24D;SEC23A;COPA;PROS1;COPZ2;ARCN1;RAB2A;KDELR3;DYNC1H1;SEC24A;ARFGAP3;COPZ1;STX17;ARFGAP1;ATL2;COPB2;DCTN4;COG4;MIA3;YIF1A;LMAN2L;VAPA;DCTN3;GOSR1;GBF1;ERGIC1;COPG1;TRIP11;TRAPPC4;SEC16A;LMAN1;ARF4;ERGIC2;CTSC;KDELR2;TMED1;ACTR1A;RAB1A
prerank,positive regulation of cell motility (GO:2000147),0.4475927095528517,1.3488495537588412,0.027466937945066123,0.48599528001094855,1.0,28/205,6.61%,ROR2;CCL11;COL1A1;CCL7;CEMIP;MGAT5;PDGFRA;MMP14;LAMB1;CXCL12;MAP4K4;SNAI1;CCAR1;PDGFRB;SNAI2;PRKCA;EGFR;STAT3;MDK;CCR1;AIF1;ACVR1;RHOD;CARMIL1;CCL5;EGF;ATM;EPHA1
prerank,cell-matrix adhesion (GO:0007160),0.46676196697071565,1.34865065359057,0.07692307692307693,0.4858537095891589,1.0,29/95,17.86%,DLC1;COL3A1;ITGB8;TNN;COL13A1;ITGB5;PEAK1;ITGA8;RHOD;HPSE;EMILIN1;ADAMTS12;L1CAM;ITGA11;ADAMTS9;TMEM8B;ITGBL1;ITGA3;VTN;NID2;MKLN1;SRC;RAC1;CD63;ITGA1;ITGB1BP1;CTTN;TESK2;FERMT3
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5871272454354899,1.3485820335056515,0.13389121338912133,0.48532258871664924,1.0,1/18,0.16%,RAD51B
prerank,regulation of RNA export from nucleus (GO:0046831),0.6363526784898784,1.3484778395055799,0.1529790660225443,0.48489705102935593,1.0,5/11,18.74%,KHDRBS1;SETD2;NCBP2;NUP153;IWS1
prerank,negative regulation of cellular protein localization (GO:1903828),0.5337531800377765,1.348371610522552,0.11435832274459974,0.4844994638527186,1.0,13/34,18.70%,ADIPOQ;GPM6B;TAX1BP3;ILRUN;SNX33;GSK3B;SPI1;CTNNA1;LATS2;LEPROT;PICALM;MFHAS1;LEPROTL1
prerank,protein localization to cell periphery (GO:1990778),-0.29671798893402607,-1.3473632319868827,0.03125,0.5806898810454154,1.0,34/133,9.26%,KCNIP4;ATP1B3;TSPAN5;CACNB2;CAV1;BSG;ATP1B1;ACTN2;ANK2;KCNB2;CD81;LIN7A;EFR3B;TTC7B;DPP10;DPP6;C2CD5;EZR;GAS6;EHD4;SLMAP;RAMP1;RAPGEF2;WNK3;RAMP2;CDH1;RAB3C;ARL3;ZFYVE27;PACSIN1;MAP7;RAPGEF6;ANK3;INPP5K
prerank,regulation of epithelial cell proliferation (GO:0050678),0.46723763002737523,1.346226197012843,0.0671067106710671,0.4895846839089844,1.0,13/85,5.95%,RUNX3;LAMB1;YAP1;DEAF1;ZFP36L1;TCF7L2;LAMC1;FGF7;CDKN2B;EGFR;LIMS1;CDK6;SFRP1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5830032025991284,1.345785217878533,0.13760217983651227,0.49006192498845064,1.0,2/21,2.96%,EPHA7;BIRC3
prerank,endomembrane system organization (GO:0010256),0.4454426820884112,1.3454701622632679,0.0411522633744856,0.4901668973314631,1.0,59/178,20.02%,SEC16B;SEC31A;VMP1;GORASP2;LRRK2;ATP8B1;RAB2A;ARFGEF2;TLCD2;HOOK2;PI4K2B;DNAJC13;STX17;WASHC4;ATL2;CDC42;VPS4A;COG4;MIA3;LMAN2L;VAPA;LEMD2;GBF1;AP3D1;GOLGA8B;GOLGA5;TRIP11;SEC16A;GAK;LMAN1;SNX33;SEC23IP;PLEKHF1;SNX10;CSNK1A1;TMED1;RAB1A;SEC61A1;DYNC2H1;TMCC1;LYSMD3;CHMP2B;SUN1;SQSTM1;ALS2;COG7;TOR1AIP2;OBSL1;TBC1D20;CSNK1D;EIF2AK3;SPTSSB;TMED5;SPTBN1;BCAS3;TJAP1;HOOK1;UBXN2A;WASHC5
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.6277287500240032,1.3447793108142236,0.14586466165413534,0.49137524316607156,1.0,3/13,12.90%,ENPP1;TPST1;SULT4A1
prerank,metanephric mesenchyme development (GO:0072075),0.6666531005528166,1.3446207668248416,0.15210355987055016,0.4910993601417251,1.0,3/10,5.01%,STAT1;SHH;PKD2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.6311891437903662,1.3443338322660676,0.14774494556765164,0.4912244526256334,1.0,5/12,11.46%,SDK2;STAT3;MYO7A;DSCAM;AGTPBP1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.46801755915526955,-1.3440758208090715,0.11692307692307692,0.5867503645554256,1.0,3/19,3.02%,TJP1;BMP6;NEXMIF
prerank,gland development (GO:0048732),0.48422215090823695,1.3439478191166518,0.09813084112149532,0.4916694565107532,1.0,16/59,10.21%,GLI2;PRKCSH;ARID5B;EPHB3;MDK;SHH;PHF2;PKD2;NF1;TGFB3;FOXE1;MSN;ANXA1;TGFBR1;SALL1;TBX3
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.45930217702457876,1.343921548585427,0.07112526539278131,0.49102905095526644,1.0,26/108,17.60%,CASP4;DLC1;DAP;CASP8AP2;JAK2;CFLAR;CASP1;BBC3;CTSD;CASP12;IFT57;LGALS9;NOD1;PPARG;HSPE1;CASP8;TNF;ACVR1C;TRAF2;SMAD3;BCL2L13;RIPK1;CYCS;AIFM1;HSPD1;EIF2AK3
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.47927049134737304,-1.3439073789145557,0.13157894736842105,0.5835908632898205,1.0,8/16,29.16%,LDLR;SCARB1;SLC27A1;GPLD1;MFSD2A;PNPLA2;ABHD5;NR1H2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.4737624960450022,1.3438238273844616,0.07599118942731277,0.4905677382254425,1.0,26/79,20.69%,CREB3L1;SULF1;CASK;SMURF2;PPARG;HTRA3;EMILIN1;ADAMTS12;PTPN1;LEMD2;SMAD5;BMPER;ACVR2A;SPRY2;FGF2;SKOR2;SMAD4;SMAD1;SMURF1;NEDD4;CHRD;TRIM33;AGT;VWC2;SPRY4;BMPR1A
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.4492984192894144,1.3431722691585515,0.04526748971193416,0.4917095356859195,1.0,38/146,18.90%,PSMA7;RAD51B;DYNLL1;FBXL7;DYNC1H1;CUL1;TUBG1;ALMS1;PLK1;PCM1;HAUS3;PINX1;SKP1;CEP41;CNTRL;DCTN3;PSMB8;PSMA6;TPX2;PCNT;CEP72;PSMF1;ACTR1A;AKAP9;PSMA8;PSMD2;PSMD12;CEP192;PSMD11;PSMD14;CSNK1D;YWHAE;BRD4;CKAP5;PSMB1;CENPJ;FBXO5;HAUS6
prerank,positive regulation of multicellular organismal process (GO:0051240),0.4383913389353937,1.3429552429728455,0.012036108324974924,0.4915801545548327,1.0,58/308,12.67%,GLMN;ABCA1;COL1A1;ADIPOQ;LBP;LRP1;PLAC8;SNAI1;GHR;SYDE1;SOX5;PTN;B4GALT5;CMKLR1;JAK2;BATF;NKX6-1;SMAD2;TREM2;APOE;DYNC1H1;MDK;SHH;SMURF2;PLA2R1;BMP1;ACVR1;CYP27B1;CD36;EGF;ALMS1;OMA1;TGFB3;EIF2AK2;ENO1;EHMT1;INHBB;TMEM119;SHLD3;TERT;CXCR4;TGFBR1;OGT;WNT5A;HCRT;TGFB1I1;ACVR1B;GAPDH;WWTR1;PDPN;TGFB2;GCNT2;ZBED3;TNF;FGF2;TAPT1;ELOVL6;FABP5
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.5858513055866343,1.3423409954370613,0.1504297994269341,0.49257867253765897,1.0,5/18,11.83%,BIRC3;PUM1;SEC14L1;OASL;ANKRD17
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.442929652697361,-1.3420349420646132,0.10580204778156997,0.5853593822880558,1.0,5/21,2.77%,DMD;ATP1A2;AKAP6;ANK2;CALM1
prerank,regulation of translational initiation (GO:0006446),0.48464345968467715,1.341558162410227,0.10158013544018059,0.49408559429393945,1.0,30/63,23.22%,EIF4G2;CTIF;EIF4G3;KHDRBS1;NCK1;NCK2;CCL5;EIF3H;EIF5B;EIF5;RPS6KB1;NCBP2;ALKBH1;EIF4EBP1;MTIF2;YTHDF3;FMR1;EIF1;KLHL25;DNAJC3;DDX1;EIF2AK3;ATF4;AGO2;EIF4G1;CSDE1;HABP4;EIF3E;YTHDF2;POLR2D
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6227670824393438,1.3405783770423958,0.14954682779456194,0.49606238502605743,1.0,7/12,22.60%,NCOR2;STAT3;TERT;TNF;BCDIN3D;ZC3H12A;NCOR1
prerank,T cell receptor signaling pathway (GO:0050852),0.45353745927800265,1.3400365734952333,0.05578947368421053,0.49691809616269894,1.0,30/138,17.74%,PSMA7;RFTN1;TNFRSF21;TEC;CD276;STOML2;CUL1;LCP2;KHDRBS1;NCK1;PRKD2;SKP1;PSMB8;PSMA6;PTPRJ;NFKBIZ;FBXW11;PSMF1;SPPL3;PIK3R1;PSMA8;PSMD2;PSMD12;PSMD11;RBCK1;EIF2B3;PSMD14;PTPRC;RC3H2;PSMB1
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.5176009055078957,1.340016605669827,0.11210191082802548,0.4962804131954515,1.0,15/39,16.53%,YAP1;ROBO2;ZMIZ1;MAML3;STAT3;JAG1;CREBBP;MAML2;NEPRO;TGFB2;MAML1;SRC;PDCD10;ITGB1BP1;TSPAN14
prerank,glycogen metabolic process (GO:0005977),-0.4120681318788523,-1.3397941114448264,0.09274193548387097,0.5883509744166279,1.0,6/27,6.91%,PRKAG2;CALM1;GBE1;PGM2L1;PYGM;PYGB
prerank,digestive tract morphogenesis (GO:0048546),0.6037080843510952,1.3396074509260778,0.1617873651771957,0.4967090368014939,1.0,2/14,3.57%,PDGFRA;EPHB3
prerank,cellular response to BMP stimulus (GO:0071773),0.47583543790318705,1.339217848070124,0.09670079635949944,0.49713789242092477,1.0,21/66,17.85%,RUNX2;SMAD2;USP9X;ACVR1;HIVEP1;SFRP1;TGFB3;VSTM2A;ADAMTS12;SMAD5;BMP5;TGFB2;ACVR2A;ADAMTS7;SMAD3;BMP7;SMAD4;SMAD1;SMURF1;ACVRL1;ZFYVE16
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5337963147796153,1.3385807145380657,0.13578680203045684,0.4981071094800452,1.0,15/33,18.89%,STAT3;PPARG;TERT;FOXO3;TEAD1;TGFB2;TNF;FGF2;GNL3;SPI1;SMAD3;HIF1A;SMARCA4;ETS1;NR3C1
prerank,cell-cell junction organization (GO:0045216),-0.3338537228542146,-1.3384882360351833,0.02857142857142857,0.5887282156562116,1.0,15/79,4.71%,TJP1;PKP4;TJP2;OCLN;CADM2;CDH13;LIMS2;CADM1;CLDN5;CDH5;CXADR;CTNND1;CDH10;CDH1;ARVCF
prerank,negative regulation of DNA metabolic process (GO:0051053),0.5487025562557246,1.3381017279623992,0.157543391188251,0.4987144910144195,1.0,2/24,0.48%,KMT2A;ADIPOQ
prerank,serine family amino acid catabolic process (GO:0009071),0.6313952939340153,1.3371534899075537,0.16176470588235295,0.5006061908761845,1.0,3/10,11.98%,AMT;GLDC;THNSL2
prerank,RNA 3'-end processing (GO:0031123),-0.3335034300785123,-1.3370473621355519,0.008849557522123894,0.5891919471268895,1.0,26/69,25.42%,CDC40;SRSF5;WDR33;CSTF2;RPRD2;U2AF2;RPRD1A;TUT1;SRSF7;SRSF9;RBM8A;CHTOP;CPSF2;MAGOH;ZC3H11A;SUPV3L1;EIF4A3;SRSF3;CLP1;POLDIP3;TUT4;CPSF4;SARNP;DDX39B;DDX39A;THOC1
prerank,response to hydrogen peroxide (GO:0042542),0.5045219858306436,1.3364030711854518,0.09333333333333334,0.502006485317886,1.0,10/45,15.17%,CYP1B1;HP;TNFAIP3;FXN;ANXA1;NFE2L2;STK24;PDCD10;RIPK1;SETX
prerank,secondary alcohol metabolic process (GO:1902652),0.5146011657298066,1.3363587943893604,0.1070154577883472,0.501412442154025,1.0,8/42,13.26%,ABCA1;APOE;ABCG1;SOAT1;IDH2;OSBPL5;CLN6;IDH3B
prerank,calcium ion homeostasis (GO:0055074),0.46654907699185844,1.3362902814176132,0.0668103448275862,0.5008960726777115,1.0,18/95,12.14%,CCL11;CCL7;EDN3;CXCL12;CD40;STOML2;CCR1;FAM20A;CYP27B1;SLC24A5;CCL5;ATP2A2;DRD3;SELENON;TMEM203;ATP2B1;CALR;TPCN2
prerank,negative regulation of cell activation (GO:0050866),0.6162592779952277,1.3353759982553939,0.14497041420118342,0.5027024979050816,1.0,4/14,6.74%,PDGFRA;TREM2;APOE;EMILIN1
prerank,nitric oxide biosynthetic process (GO:0006809),0.6276342931035163,1.3353647126665906,0.15671641791044777,0.50203275374547,1.0,1/13,0.18%,CYP1B1
prerank,monosaccharide transmembrane transport (GO:0015749),-0.4629292539336878,-1.3350669184652204,0.11006289308176101,0.5916758603280502,1.0,5/16,20.89%,SLC5A3;SLC2A12;SLC45A3;SLC2A8;SLC2A9
prerank,positive regulation of organelle assembly (GO:1902117),0.4978033630534616,1.3350366104610574,0.1180722891566265,0.5022288472504731,1.0,22/44,25.24%,ASAP1;FSCN1;DYNC1H1;PIP4K2A;GPSM2;SDC1;LCP1;RAB3GAP2;ENTR1;CEP120;TNF;TAPT1;RAB3GAP1;ARHGAP35;SH3GLB1;CAPG;CNOT2;SDC4;SDCBP;PDCD6IP;RALB;CNOT1
prerank,detection of visible light (GO:0009584),-0.48229617640023814,-1.3343696866658776,0.15060240963855423,0.5901195224251544,1.0,5/16,25.14%,ABCA4;GNA11;RP1;CACNA2D4;TULP1
prerank,positive regulation of apoptotic process (GO:0043065),0.4388201377506336,1.3335674004624956,0.009054325955734407,0.5057085760722261,1.0,89/293,22.27%,FAP;CYP1B1;DLC1;ZBP1;EPHA7;ADIPOQ;KNG1;IAPP;SFRP4;BCL6;CCAR1;VAV2;VAV3;KALRN;ITSN1;FRZB;E2F1;CTSD;NF1;PPID;FGD4;TNFRSF12A;ATM;OMA1;SFRP1;TGFB3;RASSF2;RRP1B;PHLDA1;AIFM2;EEF1E1;CCAR2;BTG1;ARHGEF19;SAP18;TRIO;TGFBR1;FOXO3;IP6K2;ARHGEF12;PREX1;TGFB2;CASP8;ATG7;VAV1;TNF;NLRP2B;AKAP13;ACVR1C;CALHM2;SPHK2;PSEN1;ARHGEF18;DAPK2;RIPK1;PSENEN;PAWR;SQSTM1;STK4;OLFM1;AIFM1;HSPD1;PTPA;DUSP6;LATS2;ING5;ANO6;ATF4;CLIP3;DDX20;PLEKHG2;PRNP;TLE5;GADD45A;HMGA2;NCSTN;UTP11;ARHGEF26;TIAM2;UBE2Z;MAP3K20;ZC3H12A;PSEN2;RPS27A;RARG;ARHGEF17;CLU;LATS1;ARHGEF1
prerank,positive regulation of calcium ion transport (GO:0051928),0.5194581725116794,1.3331393499463233,0.11529126213592233,0.5061795350967879,1.0,11/36,13.14%,CXCL12;PDGFRB;P2RX5;CCR1;TRPC6;CCL5;MYLK;CCL2;ATP2B1;P2RX7;SPHK2
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.4485022852638083,-1.3330037636816805,0.13186813186813187,0.5903932743634102,1.0,10/22,19.40%,KANK3;GSN;HIP1R;TWF2;TMSB4X;KANK4;TMSB10;PFN1;SLIT2;TWF1
prerank,chemical synaptic transmission (GO:0007268),-0.2703218310196972,-1.332929442460731,0.0,0.5871402367845334,1.0,62/284,11.28%,UNC13C;FCHSD2;SNAP25;SYN3;SLC12A7;CACNB2;DLGAP1;CHRM2;UNC13B;CACNB4;KIF1B;SYNJ2BP;NRXN1;GRM7;GRM1;GRID2;HTR2C;RIT2;DLG2;GRIK4;GABRA2;MINK1;GABRB1;LIN7A;KCND2;GLRA3;GABRG3;CALM1;DTNA;SLC1A2;SLC1A1;ATXN3;PTCHD1;SLC12A6;SHISA6;SLC6A1;DLGAP2;GRIA2;PRKAR1A;GRM3;NOVA1;GABRA5;NRXN2;KCNQ3;GRIA1;HTR1F;CAMKK2;GLRA1;PRKAR2A;CAMK4;GABRB2;BSN;CACNA1E;CACNA1B;CPLX1;TBC1D24;GRIN2D;RPS6KA2;HTR7;GRIN2B;RIMS1;SNAPIN
prerank,organelle organization (GO:0006996),0.4321378155866945,1.3324865836792525,0.008008008008008008,0.507401459059159,1.0,107/388,19.44%,CCL11;CCL7;KRT25;SEC16B;PALLD;SEC31A;VMP1;SH3KBP1;FMNL2;GORASP2;MAST4;PEX10;LRRK2;ATP8B1;TNFAIP3;STOML2;SIPA1L3;MARK1;RAB2A;APOE;CHMP4A;CHMP4B;FMNL3;MDK;PPRC1;IQCG;PKD2;PPID;VPS13C;FGD4;PI4K2B;STX17;ATL2;CDC42;VPS4A;ADCK1;COG4;MIA3;LMAN2L;RAB7A;VAPA;ABI2;TTC17;GBF1;MTX2;GOLGA8B;GOLGA5;MAST2;TERT;TRIP11;FAM161A;WDPCP;RAB32;SEC16A;BRWD1;CCL2;GAK;LMAN1;TTC29;PDZD8;ZMYM4;SEC23IP;FGD6;AGTPBP1;PEX19;PLEKHF1;EPS15;CSNK1A1;CFAP410;TMED1;CHMP7;RAB1A;RAB3GAP1;SEC61A1;DYNC2H1;RAB34;TMCC1;YTHDF3;WTIP;RANBP9;GABPB1;MTX1;SIRT3;PEX11A;LYSMD3;CYCS;CHMP2B;COG7;TOR1AIP2;OBSL1;TBC1D20;POLRMT;CSNK1D;PEX6;PITPNB;KIF9;EIF2AK3;ZFYVE16;SPTSSB;ATP7A;TMED5;BCAS3;TJAP1;CAMSAP1;GABPA;PEX12;TPM1
prerank,ketone body metabolic process (GO:1902224),-0.5684113736509282,-1.3316722335875097,0.13402061855670103,0.5873620811575829,1.0,4/10,18.08%,BDH1;HMGCS2;HMGCLL1;HMGCL
prerank,cellular response to growth factor stimulus (GO:0071363),0.4455408456760713,1.3313103684702312,0.034518828451882845,0.5100414996627052,1.0,36/151,14.44%,RUNX2;IBSP;PDE3A;WNT2;ZFP36L1;SOX5;EGR3;ZFP36L2;SNAI2;XCL1;NRP1;EGFR;PRKD2;ACVR1;LIMS1;CCL5;SFRP1;VSTM2A;ADAMTS12;GAS1;ANXA1;TGFBR1;WNT5A;RPS6KB1;ACVR1B;CCL2;ACVR2A;SPRY2;NTRK3;ADAMTS7;ACVR1C;GAREM1;SMAD3;ACAP2;BMP7;SMAD4
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.46884168385669744,-1.331223217708825,0.1353135313531353,0.585126286358144,1.0,15/17,51.65%,CADM1;AP1G1;LAMP1;PVR;RAET1E;NECTIN2;RASGRP1;SLAMF6;CD226;IL12A;CRTAM;KLRD1;CD160;KLRK1;IL12B
prerank,negative regulation of cholesterol transport (GO:0032375),0.6530788064111782,1.3311813876641447,0.1642512077294686,0.5096777126151408,1.0,2/10,4.42%,ABCA2;SHH
prerank,angiogenesis involved in wound healing (GO:0060055),-0.5443321057905601,-1.330781479441816,0.125,0.5829657822593594,1.0,5/11,11.11%,ADIPOR2;CD34;NDNF;KDR;GATA2
prerank,zinc ion transport (GO:0006829),0.5675981571343108,1.3306742324362366,0.14783821478382148,0.510474766663455,1.0,1/21,0.13%,SLC39A14
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6033316496562405,1.3304020707132054,0.16903633491311215,0.5105314031067233,1.0,2/13,2.74%,SNAI1;SNAI2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.5402469077037364,-1.3293663984802837,0.13150684931506848,0.583712865955703,1.0,4/10,20.66%,PRKAA2;DIP2B;MYOCD;PRKAA1
prerank,regulation of cell-cell adhesion (GO:0022407),0.5119441059282726,1.3287983832914245,0.11864406779661017,0.514385393056662,1.0,10/39,11.01%,EPHA7;B4GALNT2;MDGA1;FLOT2;TENM3;EPHB3;JAG1;NF2;EFNA5;PTK2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5467693060130928,1.3287236518085142,0.15446071904127828,0.5138737666320827,1.0,11/24,22.90%,PRKD2;EMILIN1;ARNT;PTPN1;VTN;ITGA5;NEDD4;HIF1A;GRB10;TMEM204;ITGB3
prerank,regulation of type I interferon production (GO:0032479),0.4627683729790569,1.3286114036396408,0.08498896247240618,0.513480444058515,1.0,27/84,20.63%,ZBP1;DTX4;IRF7;TNFAIP3;IKBKE;ILRUN;TRIM21;CREBBP;IRF1;TIRAP;CD14;CRCP;GAPDH;POLR3A;POLR3D;NFKB2;ITCH;TRIM56;PRKDC;CGAS;POLR2L;POLR2K;POLR3GL;PIN1;RNF135;POLR3K;ISG15
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5483196936642921,1.3284909663952635,0.14681440443213298,0.5131163330805841,1.0,6/24,7.58%,SEC31A;SEC24D;SEC23A;PDIA3;SEC24A;CANX
prerank,negative regulation of epithelial cell migration (GO:0010633),0.5150810649539299,1.3282140266629592,0.1295143212951432,0.5132068671377474,1.0,9/33,11.84%,DCN;APOE;NR2F2;PTEN;APOH;ADAMTS9;SP100;PTPN23;PTPRM
prerank,negative regulation of synaptic transmission (GO:0050805),0.5564491824881956,1.3281501603393777,0.1320754716981132,0.5126870478472877,1.0,5/23,9.77%,ADIPOQ;LRRK2;PTEN;STXBP1;DRD3
prerank,histone lysine methylation (GO:0034968),0.5272855254370963,1.3281467658254709,0.12097812097812098,0.5119977795877478,1.0,10/33,15.80%,KMT2A;CXXC1;RBBP5;PRDM5;SETMAR;SETDB1;SETDB2;KMT2B;PAXIP1;WDR5B
prerank,response to estradiol (GO:0032355),0.5267139153495982,1.3279173730424128,0.13513513513513514,0.5119286237201589,1.0,8/31,15.89%,NRIP1;EGFR;STAT3;SFRP1;ANXA1;LCOR;STAT5B;GGT7
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.6551573797678267,1.3277061878901362,0.1597444089456869,0.5118261342599474,1.0,3/10,5.04%,CXCL12;BLK;LGALS9
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.4379853500719229,1.3272553793120778,0.03955375253549696,0.5124018341846446,1.0,52/185,20.91%,PSMA7;NEK6;PPP1R9B;ZFP36L1;DYNLL1;ZFP36L2;DYNC1H1;MAD2L1;CUL1;E2F1;TUBG1;INO80;ALMS1;PLK1;PTPN6;ANAPC11;PCM1;CDC27;HAUS3;SKP1;CEP41;CNTRL;DCTN3;PSMB8;PSMA6;TPX2;PCNT;CEP72;PSMF1;ACTR1A;AKAP9;CDC14A;PSMA8;PSMD2;PSMD12;CEP192;PSMD11;PSMD14;CSNK1D;YWHAE;DDB1;CKAP5;PSMB1;CENPJ;FBXO5;HAUS6;CDC14B;PSMC6;ERCC2;UBE2E1;HAUS5;RIOK2
prerank,regulation of NMDA receptor activity (GO:2000310),-0.38474283360617345,-1.3266604989289483,0.08585858585858586,0.5883047668167983,1.0,9/32,11.80%,LRRC7;ACTN2;DLG2;SLC6A9;GRIA2;GRIA1;APP;GRIN2B;CAMK2B
prerank,positive regulation of innate immune response (GO:0045089),0.5281911142579228,1.326572177671824,0.13133940182054615,0.5136334462098654,1.0,7/30,13.10%,ZBP1;LBP;CCL5;WNT5A;POLR3D;UBE2K;SPI1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.5555830567383371,1.3263322020710617,0.13934426229508196,0.5135930424232875,1.0,2/21,3.81%,RUNX1;BLK
prerank,arachidonic acid metabolic process (GO:0019369),0.5113291877121467,1.3263248811547503,0.13584905660377358,0.5129206708344409,1.0,6/35,9.08%,CYP1B1;PTGES;EPHX2;CYP2A6;PTGES2;CYP1A1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4714146210313435,1.3261851470296204,0.10437710437710437,0.512623308530737,1.0,18/64,12.44%,GPM6B;MAP4K4;SLC9A1;PEAK1;JAG1;CASK;NF1;CD36;NF2;CDK6;SFRP1;EPHA1;EFNA5;SEMA3E;PTK2;UTRN;RHOA;GSK3B
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6102803652919486,1.3258746895976117,0.17065868263473055,0.512821345274184,1.0,5/13,17.56%,B4GALNT2;GFPT2;UAP1L1;AMDHD2;GNPDA2
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5733367607958858,1.3257795533961456,0.14929577464788732,0.5124142406358275,1.0,8/18,20.32%,EDN3;FXN;POR;TNF;SIRT3;ATP7A;AGT;GDNF
prerank,negative regulation of autophagy (GO:0010507),0.49315156773620017,1.3245299595276605,0.11379310344827587,0.5151971150589065,1.0,17/54,18.15%,DAP;EIF4G2;LRRK2;EIF4G3;KLHL22;TREM2;STAT3;BCL2;FOXK2;ATG7;SMCR8;WASHC1;MTMR9;AKT1;CTSA;CPTP;USP36
prerank,regulation of platelet aggregation (GO:0090330),0.5826029598779161,1.3244490589929014,0.14368650217706821,0.51474650633888,1.0,5/17,11.38%,SERPINE2;PRKCA;BLK;ADAMTS18;PDPN
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5604550008591864,-1.3237590548968208,0.13881748071979436,0.5935468302145462,1.0,2/10,3.04%,IL15;IL18
prerank,endothelial cell development (GO:0001885),0.5485988441714531,1.322901497388279,0.13096862210095497,0.5183992216282427,1.0,2/25,0.19%,COL15A1;COL18A1
prerank,negative regulation of cellular process (GO:0048523),0.428438276030707,1.322144323662973,0.004,0.5198610102822429,1.0,81/521,11.44%,ROR2;GLMN;CYP1B1;COL18A1;DLC1;ENPP1;ADIPOQ;RUNX3;KNG1;CXCL1;IGFBP7;FBLN1;TNFRSF21;PPP1R9B;SPN;SFRP4;BCL6;TLR2;SLIT3;PRTN3;JAK2;CCN4;WNT9A;PLXNC1;CDKN2B;TREM2;SERTAD2;CHMP4B;FRZB;MDK;CASK;MYH9;SHH;MYBL1;NCK1;ALDH1A2;PTEN;BCL2;PKD2;VPS13C;CYP27B1;NCK2;NF2;STRN;CDK6;SFRP1;TGFB3;EIF2AK2;ENO1;PTPN6;PDS5B;EMILIN1;PLXND1;PINX1;MIA3;IRF1;ARHGDIG;ADAMTS1;CDK10;EEF1E1;ANGPT1;CCAR2;FRK;CELF1;BTG1;GPNMB;PLXNA3;SP100;MAP2K1;SFRP5;IP6K2;BMP5;TGFB1I1;ACVR1B;RERG;PTPRJ;KLF10;PTPN2;DSCAM;PDPN;TGFB2
prerank,membrane lipid biosynthetic process (GO:0046467),-0.3481751660348306,-1.3220176804799515,0.051470588235294115,0.5952770358859807,1.0,18/58,10.49%,CERT1;PPM1L;ACER2;ST3GAL4;CERS4;SGMS1;SPTLC2;SPTLC1;ELOVL7;SGMS2;ST8SIA6;ELOVL5;DEGS2;SPNS2;GBGT1;HACD1;HACD3;HACD4
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5567776014442742,1.3218416692082173,0.15384615384615385,0.5200504550675689,1.0,5/21,9.11%,ZFP36L1;ZFP36L2;LGALS9;EGF;MAP2K1
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.5129766952245812,-1.3207955601598063,0.15835777126099707,0.5954756550910143,1.0,5/12,14.27%,ACTB;LAMA3;AHI1;LAMA5;SCRIB
prerank,cell cycle G1/S phase transition (GO:0044843),0.4709788781616614,1.32003490434905,0.11425206124852769,0.5245486551166344,1.0,30/61,25.10%,CCNE2;CUL1;E2F1;KHDRBS1;ACVR1;CACUL1;CDK6;DBF4;RPS6KB1;ACVR1B;EIF4EBP1;CDK7;E2F3;CDKN1B;GSPT1;PPP6C;MAX;RCC1;LATS2;INHBA;HINFP;PLK2;CDC7;LATS1;CCNH;MNAT1;CDKN1A;NASP;CDC25A;BCAT1
prerank,muscle tissue morphogenesis (GO:0060415),-0.4823077394509165,-1.3197443410729774,0.13694267515923567,0.5953819034502202,1.0,6/16,18.68%,TGFBR3;BMP4;PROX1;TBX1;HEY2;ZFPM1
prerank,negative regulation of signaling (GO:0023057),0.5442965600989225,1.3197242514568404,0.14323962516733602,0.5246819599203248,1.0,6/25,12.89%,ADIPOQ;ACVR1;PTPN1;BRAP;SOCS5;UBASH3B
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4658120267999588,1.3195147470245936,0.12013348164627363,0.523849905663948,1.0,15/78,7.74%,CLTC;SEC31A;DYNLL1;SEC24D;SEC23A;DYNC1H1;CTSD;SEC24A;KIF2A;CTSS;DCTN4;CTSL;RAB7A;CANX;DCTN3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4658120267999588,1.3195147470245936,0.12013348164627363,0.523849905663948,1.0,15/78,7.74%,CLTC;SEC31A;DYNLL1;SEC24D;SEC23A;DYNC1H1;CTSD;SEC24A;KIF2A;CTSS;DCTN4;CTSL;RAB7A;CANX;DCTN3
prerank,regulation of keratinocyte migration (GO:0051547),0.6320501876795607,1.3194962218228488,0.1746268656716418,0.5231932527917454,1.0,4/12,10.79%,MAP4K4;FGF7;PTEN;MAPRE2
prerank,regulation of viral life cycle (GO:1903900),0.5710414557455553,1.319346133082257,0.15664335664335666,0.5229009687452292,1.0,11/21,25.14%,TRIML2;TRIM21;VPS4A;TYRO3;KPNA2;TRIM6;TRIM27;TRIM62;HS3ST5;TSG101;AXL
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.41254877746278784,-1.3192982826325175,0.14112903225806453,0.5933064464967146,1.0,9/26,10.80%,PRKAG2;PRKAA2;ADIPOR2;ERLIN1;LPGAT1;ELOVL5;ADIPOR1;ACADL;ERLIN2
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.45825640571749165,1.3189771293180876,0.0881057268722467,0.5232547668786525,1.0,13/94,7.46%,CYP1B1;CASP4;ERN2;BBC3;IKBKE;CUL1;E2F1;ITPR1;BCL2;ATM;BAG6;BCL2L2;GSKIP
prerank,histone H3-K4 methylation (GO:0051568),0.5415600967524449,1.3188420580010194,0.15013054830287206,0.522946864283581,1.0,9/26,15.80%,KMT2A;CXXC1;RBBP5;OGT;SETMAR;TET2;KMT2B;PAXIP1;WDR5B
prerank,lipid oxidation (GO:0034440),0.6222247997674272,1.318612161853317,0.17018072289156627,0.5229371338463074,1.0,3/12,8.59%,ADIPOQ;ACOX1;PLA2G7
prerank,fatty acid elongation (GO:0030497),-0.5011815557416887,-1.317700575899696,0.1519756838905775,0.5943368879113168,1.0,6/13,10.49%,TECR;ELOVL7;ELOVL5;HACD1;HACD3;HACD4
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.45563835811146014,1.317603670263055,0.07928118393234672,0.5250780045277579,1.0,36/95,22.30%,ZEB2;PMEPA1;SPRED1;SMAD2;CDKN2B;NREP;SMURF2;SPRED2;CREBBP;HTRA3;EMILIN1;RNF111;WFIKKN1;ITGA3;HTRA4;TGFBR1;TGFB1I1;LDLRAD4;SPRY2;SKOR2;GIPC1;SMAD3;SMAD4;SNX25;SMURF1;LATS2;TRIM33;ZBTB7A;PIN1;DKK3;ASPN;RPS27A;LATS1;SNX6;IL17RD;SDCBP
prerank,regulation of protein kinase A signaling (GO:0010738),0.5581362263292239,1.3175845923905913,0.14616497829232997,0.5244344274632731,1.0,6/20,12.75%,ADIPOQ;IAPP;LRRK2;PRKAR1B;PJA2;MC1R
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.6523853540349454,1.3174123176046197,0.1968503937007874,0.5242388414098302,1.0,5/10,11.96%,OPHN1;RAP2A;CDC42;MSN;RHOA
prerank,ameboidal-type cell migration (GO:0001667),-0.3477128052069553,-1.3173746916761928,0.05161290322580645,0.5919012638893181,1.0,25/51,26.72%,SEMA6A;SEMA3C;SEMA3D;GPC3;SEMA6D;SEMA7A;CCN3;ERBB4;TBX1;CENPV;ITGA4;SEMA4D;SEMA5A;AMOTL2;SEMA5B;SEMA3G;FAT2;RADIL;PKN3;SEMA6C;SEMA4B;SOX8;SEMA3B;SEMA4A;SEMA6B
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5725033867952735,1.3171371345424057,0.15469613259668508,0.5243665646194379,1.0,5/19,14.90%,ENPP1;PAPSS2;TPST1;SULT4A1;SLC35B3
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.4640614027603005,1.3169542333411983,0.12442922374429223,0.524189119474299,1.0,25/59,23.25%,LRRK2;PRKCA;CAMK2D;PRKD2;ACVR1;CDK10;HIPK4;TGFBR1;MAP2K1;CSNK2A1;CSNK2A2;HIPK3;ACVR1B;CDC42BPA;GSK3B;PRKDC;MAPK1;AKT1;MAP3K12;PRKCD;DYRK1A;MARK2;ROCK2;ROCK1;NLK
prerank,homologous chromosome segregation (GO:0045143),-0.44713826887716507,-1.3164717741505716,0.12982456140350876,0.591138099400978,1.0,15/20,51.41%,CENPC;SIRT7;PTTG1;FMN2;PRDM9;MEI4;SGO1;MEIOB;ZCWPW1;IHO1;FANCD2;RNF212B;MEIKIN;ANKRD31;TERB2
prerank,sensory perception of smell (GO:0007608),-0.533310546390309,-1.3162652966243893,0.13089005235602094,0.5884595300780412,1.0,4/11,19.93%,UBR3;BBS4;MKKS;DRD2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5443003950146652,1.3160666678789956,0.14624505928853754,0.5259734180566805,1.0,7/29,11.91%,SPRED1;SPRED2;PTEN;SFRP1;BMP5;LDLRAD4;SPRY2
prerank,regulation of myelination (GO:0031641),0.5450070887732706,1.315376992568017,0.1519674355495251,0.5271718647021352,1.0,9/25,17.61%,TNFRSF21;PTN;PTPRZ1;TENM4;DICER1;EGR2;TPPP;EIF2AK3;NCMAP
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5723797479741738,1.3153470069934554,0.16690442225392296,0.5265521091913884,1.0,4/18,9.70%,ZFP36L1;ZFP36L2;ANXA1;UBE2L3
prerank,artery development (GO:0060840),0.5525970933133818,1.315341611901938,0.1507607192254495,0.5258762885274986,1.0,6/23,9.03%,ROBO2;NRP1;PKD2;NF1;HOXA1;TGFBR1
prerank,regulation of receptor binding (GO:1900120),0.6391690397850952,1.3152941287368471,0.16049382716049382,0.5253121182990386,1.0,3/10,10.04%,ADIPOQ;ATP2A2;GREM2
prerank,positive regulation of cell communication (GO:0010647),0.5316498553769664,1.3151941470631632,0.1460823373173971,0.5248966291892234,1.0,7/28,12.30%,ADIPOQ;EDN3;DLG4;HCRT;WLS;PTPN23;TNF
prerank,positive regulation of endocytosis (GO:0045807),0.4890389403241669,1.315149515992165,0.13167259786476868,0.5243539284386362,1.0,9/45,11.22%,C3;LRP1;TREM2;APOE;RAB21;CDC42;CBL;ANKFY1;VTN
prerank,glucose transmembrane transport (GO:1904659),-0.4424847593308088,-1.3150230869517927,0.15140845070422534,0.5885857644246019,1.0,8/18,32.75%,SLC2A1;SORT1;SLC5A3;SLC2A8;SLC2A9;SLC45A1;SLC2A4;RAB4B
prerank,positive regulation of synaptic transmission (GO:0050806),-0.32553280539906926,-1.3149819244652334,0.03773584905660377,0.5855188617952031,1.0,26/72,20.84%,SLC24A2;NRXN1;PRKCZ;SHANK3;ADCY1;SLC8A3;CACNG2;CLSTN3;ADRA1A;KCTD13;GRIN2D;APP;GRIN2B;RIMS1;CACNG7;CLSTN1;GRIK2;ZDHHC2;LGI1;SHISA7;GPER1;RELN;SLC8A2;NLGN1;LGMN;RIMS2
prerank,protein localization to condensed chromosome (GO:1903083),-0.5197152419271966,-1.3149482518406839,0.16714697406340057,0.5824396925984844,1.0,9/12,39.44%,ZWILCH;IK;BUB3;KNL1;TTK;ZW10;MTBP;SPDL1;CDK1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.6501378252983754,1.3149195195525956,0.17896389324960754,0.5242731194405623,1.0,5/10,14.11%,STOML2;INO80;E2F8;DBF4;ATRX
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.6303726662159348,1.3148980908367351,0.17990275526742303,0.5236660015594746,1.0,1/11,0.45%,IL23R
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6138501484441414,1.314665906727578,0.18421052631578946,0.523646205253405,1.0,8/12,22.93%,FLOT2;APOE;ABCA2;RANBP9;PICALM;PRNP;ROCK2;ROCK1
prerank,organophosphate catabolic process (GO:0046434),0.6459214997131907,1.3146604318715231,0.15709969788519637,0.5229789986519122,1.0,1/11,1.24%,PDXP
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.45655621223615694,1.314361622133815,0.11135371179039301,0.523168605773423,1.0,24/80,17.88%,COPA;COPZ2;ARCN1;KDELR3;KIF1C;ARFGAP3;KIF2A;COPZ1;ARFGAP1;COPB2;COG4;GBF1;ERGIC1;COPG1;ARF4;ERGIC2;KDELR2;RINT1;RAB1A;ERGIC3;COG7;KIF5A;PITPNB;SCFD1
prerank,positive regulation of ossification (GO:0045778),0.5036160125283746,1.3140369574403523,0.13708690330477355,0.5233577204089038,1.0,13/39,14.05%,GPM6B;FBN2;PTN;NELL1;ACVR1;TGFB3;TMEM119;WNT5A;TGFB2;ATP2B1;ACVR2A;P2RX7;BMP7
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5952783518785896,1.313494466698178,0.17378497790868924,0.5241303684187946,1.0,4/15,9.03%,PDGFRA;MTHFD1L;HOXA1;TGFBR1
prerank,cellular response to hypoxia (GO:0071456),0.4423883731362926,1.313308246200923,0.07708333333333334,0.5239844516354786,1.0,13/126,8.91%,PSMA7;RORA;ZFP36L1;BACH1;GATA6;CPEB1;CREBBP;SFRP1;ARNT;NPEPPS;TERT;PSMB8;PSMA6
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5579440636226671,1.3131695638837426,0.14758620689655172,0.5236434205329588,1.0,1/21,0.16%,RAD51B
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.44870836584098567,1.3130893128900711,0.0913978494623656,0.5231779481372862,1.0,23/101,14.53%,CEMIP;IL34;ADIPOQ;EDN3;TNFSF11;LRRK2;CD40;PDGFRB;EGFR;PKD2;EGF;CCND3;PIK3R5;RPTOR;MAP2K1;WNT5A;FGFR1;RHOA;TNF;FGF2;CALM2;SRC;PDCD10
prerank,establishment of epithelial cell polarity (GO:0090162),0.5724521287341596,1.3125878961432216,0.16551724137931034,0.5237992822501889,1.0,7/19,11.96%,CYTH3;SIPA1L3;OPHN1;RAP2A;CDC42;MSN;RHOA
prerank,positive regulation of cell migration (GO:0030335),0.43275171979942706,1.312310763203788,0.02920443101711984,0.5238900696733232,1.0,49/253,12.59%,ROR2;CCL11;COL1A1;CCL7;CEMIP;MGAT5;PDGFRA;MMP14;LAMB1;CXCL12;MAP4K4;SNAI1;SYDE1;CCAR1;PDGFRB;SNAI2;CCN4;PRKCA;NRP1;EGFR;STAT3;DOCK1;MDK;CCR1;SMURF2;AIF1;DDR2;ACVR1;RHOD;CARMIL1;CCL5;EGF;ATM;EPHA1;MIA3;GPNMB;TGFBR1;MYLK;PPP3CA;ACVR1B;SEMA3E;PTK2;VTN;PDPN;TGFB2;GCNT2;SPRY2;NTRK3;NUMB
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.4495285044827034,-1.312181789968724,0.12585034013605442,0.5869986071342467,1.0,9/20,21.73%,ADRA1B;ADCY9;RAPGEF2;ADRA1A;PDE4D;ZDHHC21;ADRA2A;DRD2;ADRB2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.5012325731491787,1.3120902656462037,0.1329268292682927,0.5237821956767016,1.0,16/40,20.69%,GPM6B;FBN2;PTN;NELL1;ACVR1;TGFB3;TMEM119;ATP2B1;ACVR2A;P2RX7;BMP7;ANO6;FBXO5;ADGRV1;ISG15;BMPR1A
prerank,regulation of lipase activity (GO:0060191),0.6171628941462884,1.3120760950812205,0.1708029197080292,0.5231535754439358,1.0,3/13,11.96%,LIPC;LPL;RHOA
prerank,regulation of protein localization to cell periphery (GO:1904375),0.5745140175016594,1.311616081099196,0.17841726618705037,0.5237206324558572,1.0,4/18,6.56%,MMP14;ABCA2;PLK1;VPS4A
prerank,negative regulation of receptor binding (GO:1900121),0.6350017503661457,1.3113403924180738,0.1901081916537867,0.5238319997235171,1.0,2/10,9.67%,ADIPOQ;ATP2A2
prerank,cellular iron ion homeostasis (GO:0006879),0.48066356646328784,1.3112450695781228,0.1357733175914994,0.5233769946401371,1.0,8/55,7.29%,SLC39A14;HEPH;CP;SLC11A2;FXN;CUL1;ACO1;SKP1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.439363945459502,1.3111696406048026,0.06846473029045644,0.5229205418749646,1.0,36/163,17.74%,PSMA7;RFTN1;TNFRSF21;TEC;CD276;STOML2;VAV3;BLK;CUL1;LCP2;KHDRBS1;NCK1;BCL2;PRKD2;SKP1;SH2B2;PSMB8;PSMA6;LAT2;MS4A1;PTPRJ;NFKBIZ;FBXW11;PSMF1;SPPL3;PIK3R1;PSMA8;PSMD2;PSMD12;PSMD11;RBCK1;EIF2B3;PSMD14;PTPRC;RC3H2;PSMB1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.49416140338952036,1.3104899776854373,0.14521841794569068,0.5240757213012326,1.0,14/44,20.54%,ADIPOQ;IRAK3;APOE;AIDA;NF1;PTPN1;HIPK3;PTPRJ;SPRY2;BMP7;MAPK8IP1;AGT;SPRY4;PRKCD
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.49087613659273777,-1.3099875457600123,0.14545454545454545,0.5903504008434789,1.0,3/14,20.33%,MOXD1;ALDH9A1;SLC22A2
prerank,limb morphogenesis (GO:0035108),0.5580424727124333,1.3097436013116908,0.15883977900552487,0.5254089816018376,1.0,8/20,17.75%,GLI3;SHH;LRP6;TBX3;TGFB2;IQCE;NIPBL;FBXW4
prerank,regulation of macrophage cytokine production (GO:0010935),0.6074548549661654,1.309682266199711,0.17220543806646527,0.5249061602609766,1.0,4/13,11.44%,IRAK3;TGFB3;WNT5A;TGFB2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.6342639494695879,1.309063190635295,0.1705790297339593,0.5260024426093367,1.0,4/11,9.47%,ZMIZ1;SERTAD2;PADI2;ARID1B
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.6127892617651962,1.308823627851745,0.18222222222222223,0.525962017083155,1.0,5/13,13.10%,ZMIZ1;SERTAD2;PADI2;ARID1B;SPI1
prerank,actomyosin structure organization (GO:0031032),-0.31933271087725923,-1.307850944098277,0.00980392156862745,0.5932096299272038,1.0,10/75,3.95%,SORBS1;TJP1;PHACTR1;PGM5;ACTN2;FRMD5;EPB41;CIT;EPB41L5;TMOD3
prerank,RNA destabilization (GO:0050779),0.5624221507872658,1.3077973603422934,0.1563845050215208,0.5282812495121502,1.0,10/18,22.93%,PUM1;METTL16;GIGYF2;CELF1;FTO;YTHDF3;DXO;ROCK2;YTHDF2;ROCK1
prerank,zinc ion transmembrane transport (GO:0071577),0.5505669985206267,1.3076390366134356,0.16923076923076924,0.5280141581117374,1.0,1/22,0.13%,SLC39A14
prerank,neuron remodeling (GO:0016322),0.6549921300900166,1.3072627292791237,0.17111459968602827,0.5283500323573352,1.0,2/10,1.83%,C3;FARP2
prerank,synaptic membrane adhesion (GO:0099560),-0.4888256116443144,-1.307155548026185,0.1511627906976744,0.5921606194514464,1.0,6/14,13.91%,LRRC4C;LRFN5;NTNG1;SLITRK1;LRRC4B;PTPRD
prerank,regulation of myoblast fusion (GO:1901739),0.634698414542622,1.3071539632114966,0.19207317073170732,0.5279660635504845,1.0,3/11,7.85%,CFLAR;CD53;EHD2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.5297574069202398,-1.3070495506473347,0.16164383561643836,0.5893683155678162,1.0,5/11,16.83%,NOS3;CALM1;HSP90AA1;PTS;DHFR
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.5837186339320534,1.3066376344581347,0.18263473053892215,0.528731744109131,1.0,4/15,9.70%,ZFP36L1;ZFP36L2;ANXA1;UBE2L3
prerank,response to organonitrogen compound (GO:0010243),0.5015132975789929,1.30636404024303,0.15460122699386503,0.5288040646503406,1.0,7/38,11.52%,NR1H4;IRAK3;GLRB;ERLEC1;RRAGC;DRD3;RCN3
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5706901723376525,1.3061753473761177,0.1657142857142857,0.5286833096994565,1.0,6/18,14.92%,KMT2A;EHMT1;SETMAR;SETD2;KMT2B;ASH1L
prerank,ERBB2 signaling pathway (GO:0038128),0.5137755111667307,1.3060171831883989,0.1559748427672956,0.5284151596712282,1.0,10/31,14.06%,PRKCA;EGFR;EGF;PTPN18;GRB2;CDC37;ERBIN;BTC;PIK3R1;SRC
prerank,diterpenoid metabolic process (GO:0016101),0.46983533946375206,1.3052790546129418,0.12264150943396226,0.5297754607171318,1.0,10/55,11.18%,LRP1;HSPG2;GPC6;APOE;RDH12;SDC1;RDH10;SDC2;LPL;OPN1MW
prerank,canonical Wnt signaling pathway (GO:0060070),0.46391238590392825,1.3051812529165046,0.12751677852348994,0.5293925940238082,1.0,15/68,12.56%,WNT2;TCF7L2;SFRP4;LRRK2;WNT9A;FRZB;PTEN;FZD1;SFRP1;LRP6;WNT5A;SFRP5;TCF7;GSK3B;CSNK1A1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.6128307621384632,1.3050314591312009,0.18608414239482202,0.5291347993277534,1.0,3/12,6.07%,B4GALNT2;GFPT2;GMDS
prerank,endoplasmic reticulum organization (GO:0007029),0.46380223159191225,1.3050043195955248,0.10896708286038592,0.5285415600643524,1.0,23/72,18.91%,SEC16B;SEC31A;LRRK2;TRAM2;ATL2;WDR83OS;MIA3;LMAN2L;VAPA;SEC16A;GAK;LMAN1;ZBED3;RAB10;SEC61A1;TMCC1;VCPIP1;ALDH3A2;TOR1AIP2;LPCAT3;EIF2AK3;SPTSSB;PRNP
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5780340883222115,1.304974961332734,0.17985611510791366,0.5279523565207705,1.0,4/18,3.61%,VSIG4;TNFAIP3;XCL1;NAV3
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.45373446113094806,1.3047265886614852,0.0915032679738562,0.528001982863855,1.0,19/86,14.44%,ZEB2;SULF1;JAK2;SMAD2;CDKN2B;ACVR1;CREBBP;TGFB3;INHBB;RNF111;TGFBR1;BMP5;TGFB1I1;ACVR1B;TGFB2;ACVR2A;GIPC1;BMP7;SMAD4
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.34633600036527445,-1.3044713723946528,0.0625,0.5933365457174316,1.0,35/69,28.94%,COX5A;COX8A;NDUFS1;COX4I1;UQCRC2;NDUFV2;COX6C;COX6B1;NDUFA13;NDUFA6;COX6A1;NDUFA12;COX10;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;NDUFB7;NDUFS3;COX5B;UQCRB;NDUFA1;NDUFC2;NDUFA10;UQCRH;NDUFS2;UQCRFS1;NDUFB11;UQCC3;COA6;UQCR10;SDHAF2;UQCR11;NDUFS5;NDUFV1
prerank,potassium ion transmembrane transport (GO:0071805),-0.29889250289550606,-1.3044244911844811,0.0,0.5903726870450242,1.0,25/135,7.30%,ATP1A2;ATP1B3;SLC12A2;KCNC2;SLC24A2;SLC12A7;KCND3;ATP1B1;SLC9A2;KCNB2;KCNK5;KCND2;KCNQ5;KCNH5;TMEM175;KCNH7;SLC12A6;KCNJ2;KCNJ3;KCNK10;KCNJ13;ABCC9;KCNQ3;KCNQ4;KCNJ10
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.26940858006818047,-1.3040299918889915,0.0,0.5884844895252376,1.0,48/224,9.64%,UNC13C;SNAP25;SLC12A7;CACNB2;DLGAP1;CHRM2;UNC13B;CACNB4;SYNJ2BP;NRXN1;GRM7;GRM1;HTR2C;RIT2;DLG2;GRIK4;GABRA2;MINK1;GABRB1;KCND2;GLRA3;GABRG3;CALM1;DTNA;SLC1A2;SLC1A1;ATXN3;PTCHD1;SLC12A6;SLC6A1;GRIA2;PRKAR1A;GRM3;NOVA1;GABRA5;NRXN2;KCNQ3;GRIA1;HTR1F;CAMKK2;GLRA1;PRKAR2A;CAMK4;GABRB2;BSN;CACNA1E;CACNA1B;CPLX1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4589935427642178,1.3026718511068738,0.12791991101223582,0.5329352044980058,1.0,15/79,7.74%,CLTC;SEC31A;DYNLL1;SEC24D;SEC23A;DYNC1H1;CTSD;SEC24A;KIF2A;CTSS;DCTN4;CTSL;RAB7A;CANX;DCTN3
prerank,mammary gland epithelium development (GO:0061180),0.5999078866158649,1.3024834219971089,0.16152716593245228,0.5327966713645605,1.0,2/14,2.75%,WNT2;JAK2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6338241738434246,1.3023981100590805,0.1815431164901664,0.5323651218440776,1.0,3/10,9.14%,XCL1;CCL5;WNT5A
prerank,myofibril assembly (GO:0030239),0.49697093552000043,1.3023273740513097,0.13608748481166463,0.5319219606619776,1.0,6/42,7.35%,PDGFRA;CSRP1;PDGFRB;CFLAR;FHOD3;TMOD1
prerank,thymus development (GO:0048538),0.6038563071289856,1.3017834712891514,0.1634182908545727,0.532711238219369,1.0,4/13,9.03%,EPHB3;SHH;FOXE1;TGFBR1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3639855825149204,-1.3017409968692397,0.09090909090909091,0.5919483222181167,1.0,24/37,35.17%,ERCC5;ERCC3;UBC;POLD3;CHD1L;PCNA;DDB2;GTF2H2;ERCC1;GTF2H4;RFC3;UBA52;GTF2H3;POLD2;RBX1;RPA2;PARP1;RFC4;NTHL1;POLD4;RFC2;RPA3;POLK;RFC5
prerank,negative regulation of dephosphorylation (GO:0035305),-0.44598586111985306,-1.3010994199201409,0.13157894736842105,0.5905214922987952,1.0,7/18,9.86%,PPP1R16B;YWHAB;ARPP19;PPP1R8;SH3RF2;INPP5K;URI1
prerank,regulation of pH (GO:0006885),0.6235082449084753,1.300267460153624,0.19142419601837674,0.5362770266957337,1.0,2/11,2.41%,SLC9A1;LACC1
prerank,respiratory system development (GO:0060541),0.5065792943171821,1.300241086952785,0.14609571788413098,0.5356828195791975,1.0,11/32,12.48%,GLI2;CHD7;FGF7;SHH;SPEF2;BAG6;ITGA3;LOXL3;NPHP3;PDPN;FGF2
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5357846709479838,1.2999203356397753,0.17254901960784313,0.5358864741701824,1.0,7/25,12.30%,CBLB;ERRFI1;PPARG;CBL;SOCS5;ZGPAT;TNF
prerank,peptidyl-threonine modification (GO:0018210),0.45511183641493436,1.2999030631914477,0.1191827468785471,0.5352790897484456,1.0,28/66,23.25%,LRRK2;PRKCA;GALNT3;CAMK2D;PRKD2;ACVR1;CDK10;HIPK4;TGFBR1;MAP2K1;CSNK2A1;CSNK2A2;HIPK3;ACVR1B;CDC42BPA;GALNTL6;GALNT11;GSK3B;PRKDC;MAPK1;AKT1;MAP3K12;PRKCD;DYRK1A;MARK2;ROCK2;ROCK1;NLK
prerank,myelin assembly (GO:0032288),0.6429271229833546,1.299154585183004,0.18351477449455678,0.5366611635384453,1.0,8/10,22.05%,ABCA2;PMP22;TENM4;DICER1;TPPP;NCMAP;EPB41L3;CNTNAP1
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5824060756517271,1.2991364235814191,0.18262150220913106,0.5360555785355995,1.0,5/16,15.02%,KMT2A;AUTS2;DNMT3B;SMAD4;PAXIP1
prerank,protein localization to synapse (GO:0035418),-0.5105629076573468,-1.2989817604617042,0.18126888217522658,0.593320309322106,1.0,7/12,19.82%,NRXN1;PCLO;NRXN2;BSN;SHANK1;ZDHHC15;NLGN1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5818000198820581,1.2982501158253539,0.1791044776119403,0.537821371145883,1.0,8/15,22.93%,SLC9A1;PRKCA;CAMK2D;AGT;IL6ST;PDE9A;ROCK2;ROCK1
prerank,regulation of actin filament depolymerization (GO:0030834),0.6237865905891962,1.2978038458003345,0.17257318952234207,0.5383686051662042,1.0,4/12,16.76%,PDXP;LIMA1;PLEKHH2;PLEK
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.480333437097219,1.297596332021722,0.13620071684587814,0.5382567655463049,1.0,7/49,5.67%,IL23R;GHR;CD40;JAK2;TSLP;STAT3;CCL5
prerank,sulfur compound catabolic process (GO:0044273),0.4956409050596467,1.297414409548029,0.15143929912390489,0.5380876409272431,1.0,5/38,6.55%,DCN;LUM;BGN;VCAN;PRELP
prerank,defense response to protozoan (GO:0042832),0.6122117711658599,1.2970886970693336,0.20214395099540583,0.5382951061456134,1.0,3/12,10.16%,CD40;BATF;GBP7
prerank,response to reactive oxygen species (GO:0000302),0.47486039717501477,1.2968789439962718,0.15052508751458576,0.5382062346110894,1.0,6/54,5.01%,HP;PDGFRA;APOD;EGFR;APOE;PKD2
prerank,protein-containing complex assembly (GO:0065003),0.4230002350281821,1.295566489835575,0.034170854271356785,0.5411632722705444,1.0,70/259,17.95%,COL7A1;KMT2A;SEC16B;SH3PXD2B;SEC31A;YAP1;CXCL12;TCF7L2;FARP2;SEC24D;SLC9A1;LAMC1;SEC23A;SKAP2;LRRK2;CD40;STOML2;MITF;TLE1;FBXL7;RBBP5;WIPF1;CUL1;SEC24A;PPID;CREBBP;LLGL1;DLG4;KPNA3;ADD2;SKP1;TERT;HDAC1;TRAPPC4;SEC16A;TCF7;TNFRSF1A;LMAN1;TEAD1;SEC23IP;SNX9;RUVBL1;CASP8;DBNL;CTSC;TSPAN4;TNF;GSK3B;CSNK1A1;SPG7;P2RX7;TRAF2;RAB1A;RANBP9;CX3CL1;TUBGCP4;RIPK1;PPP6C;ITGB1BP1;TCF7L1;SMARCA4;SEC13;TBC1D20;CSNK1D;MDM2;ANO6;PICALM;FERMT3;SCFD1;CAPZA1
prerank,"wound healing, spreading of cells (GO:0044319)",0.5391002812474525,1.2949410442730995,0.1643646408839779,0.5422129509824536,1.0,10/24,16.81%,COL5A1;MRTFA;ARHGAP24;LCP1;PDPN;RHOA;ITGA5;ARHGAP35;PDCD10;ACVRL1
prerank,autophagosome assembly (GO:0000045),0.47262004310904143,1.2949329272785808,0.12573443008225618,0.5415873436884425,1.0,18/52,21.19%,VMP1;WIPI1;AMBRA1;STX17;ATG3;RAB7A;ATP2A2;ATG7;PACS2;RAB1A;ATG16L1;ATG16L2;SMURF1;WDR45;PIK3C3;IRGM;UBXN2A;BECN1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5540131062410497,1.2949290794309378,0.15961800818553887,0.5409346890651249,1.0,5/20,12.30%,LBP;CCL5;CD14;CCL2;TNF
prerank,negative regulation of protein metabolic process (GO:0051248),0.48697631626349547,1.2947305098368043,0.1276849642004773,0.5408245405497857,1.0,8/48,6.47%,IAPP;FLOT2;EGFR;IRAK3;TREM2;APOE;MAD2L1;INHBB
prerank,cell-cell junction assembly (GO:0007043),-0.32948093999876543,-1.294716385005148,0.05,0.6024890268423566,1.0,17/63,10.53%,TJP1;PKP4;CLDN5;ACTB;CDH5;GJB6;CTNND1;CDH10;RAMP2;ARVCF;GJB2;CLDN12;CD9;VCL;PATJ;CDH12;CLDN11
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.4512531465276943,-1.2946554201627074,0.13504823151125403,0.5996300596407429,1.0,6/16,13.78%,PPP1R16B;AGTR1;GATA2;JCAD;FGFBP1;THBS1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.5980750210717185,1.2943421597912854,0.18061674008810572,0.5412536838620995,1.0,2/14,3.64%,CMKLR1;IRAK3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.48472541442642736,1.2941206500371543,0.15635939323220538,0.5412461393969029,1.0,12/45,12.90%,JAK2;CASP1;STAT3;LGALS9;CD36;PYDC1;TMEM106A;LPL;WNT5A;CASP8;TNF;P2RX7
prerank,response to peptide hormone (GO:0043434),0.4909051615172095,1.2936021070172161,0.1346153846153846,0.5420124345839588,1.0,15/43,17.14%,ZFP36L1;STAT1;IRS1;STAT3;IGFBP5;STAT5A;ANXA1;OGT;GNAI1;KHK;ZBED3;SRC;STAT5B;EIF2B3;AKT1
prerank,glycogen biosynthetic process (GO:0005978),-0.5029106177825349,-1.2919583641028116,0.1787709497206704,0.6011685568352882,1.0,5/12,17.60%,GBE1;PGM2L1;PER2;PPP1R3C;UGP2
prerank,glucan biosynthetic process (GO:0009250),-0.5029106177825349,-1.2919583641028116,0.1787709497206704,0.6011685568352882,1.0,5/12,17.60%,GBE1;PGM2L1;PER2;PPP1R3C;UGP2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.42082376896068363,-1.2914466779111908,0.11654135338345864,0.5996734146003821,1.0,8/22,14.90%,KIDINS220;NTRK2;RAPGEF2;SH3GL2;WASF1;STMN2;RAP1A;BDNF
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.4418919177351205,1.2913779447719491,0.09188034188034189,0.5474561685221523,1.0,25/109,17.06%,PSMA7;TEC;VAV2;GAB2;VAV3;MAP2K4;CUL1;LCP2;SKP1;GRB2;PSMB8;PSMA6;LAT2;PPP3CA;VAV1;FBXW11;PSMF1;PIK3R1;RAC1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;MAPK1
prerank,histone ubiquitination (GO:0016574),-0.4336092896886257,-1.2908586759166076,0.13978494623655913,0.598507383880718,1.0,7/21,15.86%,HUWE1;CTR9;UBE2A;LEO1;UBE2B;UBE2N;PHC1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5342381038647539,1.290308049456089,0.16802168021680217,0.5499025289876428,1.0,9/26,11.83%,EGFR;AIF1;CCND3;ADAMTS1;CDK10;RPTOR;ANXA1;KMT2E;ANKRD17
prerank,positive regulation of cell cycle (GO:0045787),0.4610825999938632,1.2902283932364391,0.1473922902494331,0.5494411893639417,1.0,17/62,14.32%,MEIS2;PRKCA;EGFR;PKD2;TRIM21;CCND3;LRP6;ASNS;RAD23A;RPS6KB1;TBX3;EIF4EBP1;TGFB2;CALR;ANKRD17;CDKN1B;USP22
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5927752003114152,1.2895330916814358,0.2,0.5506699973249195,1.0,6/14,11.96%,FSCN1;OPHN1;RAP2A;CDC42;MSN;RHOA
prerank,protein N-linked glycosylation (GO:0006487),0.4558241573778942,1.2893162069340336,0.12599318955732122,0.5506118576684738,1.0,19/66,15.85%,MGAT5;B4GALNT2;ST6GAL1;GFPT2;DDOST;ALG5;SRD5A3;MAN1C1;MGAT4A;UGGT2;STT3A;LMAN1;ST3GAL1;UBE2J1;NUDT14;TUSC3;PMM2;B4GALT7;RPN1
prerank,positive regulation of phosphorylation (GO:0042327),0.4234851692982501,1.2883629376523604,0.046464646464646465,0.5526646795286735,1.0,43/240,12.90%,ROR2;GLMN;ROR1;C3;EPHA7;IL34;ADIPOQ;PDGFRA;LRRK2;CD40;PDGFRB;FGF7;NRP1;EGFR;EPHB3;TREM2;DDR2;FAM20A;CCL5;EGF;CCND3;RAP2A;EPHA1;TMEM119;ARNT;PFKFB4;ANGPT1;MERTK;GPNMB;EFNA5;NIBAN1;FBH1;FGFR1;FNIP1;PTK2;DSCAM;ACVR2A;TNF;VEGFC;FGF2;NTRK3;ZBTB20;P2RX7
prerank,lung development (GO:0030324),0.5022877208091902,1.2879540168719088,0.17440401505646172,0.5530516831610224,1.0,11/33,12.48%,GLI2;FGF7;ERRFI1;SHH;BAG6;ITGA3;LOXL3;NPHP3;PDPN;RCN3;FGF2
prerank,midbody abscission (GO:0061952),0.5800869337287532,1.2878044117004985,0.18168812589413447,0.552766853849388,1.0,6/17,17.50%,CHMP4A;CHMP4B;VPS4A;CHMP7;CHMP2B;KIF20A
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.44961238142974685,1.2877600381519183,0.11318681318681319,0.5522295845199336,1.0,23/88,20.15%,PSMA7;FBXL7;CUL1;SKP1;FBXL18;FBXW7;PSMB8;PSMA6;FBXW11;PSMF1;FBXO2;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1;FBXW4;FBXO31;AMN1;FBXO38;FBXL22;PSMC6
prerank,positive regulation of defense response (GO:0031349),0.44925041419395045,1.287492223025689,0.11123110151187905,0.5522957261117014,1.0,24/89,19.00%,ZBP1;TNIP1;IL16;TLR2;CCN4;TSLP;MDK;CCL5;TLR7;PLA2G7;LPL;WNT5A;TNFRSF1A;NFKBIZ;TNF;POLR3D;ABCC1;CX3CL1;RIPK1;NPAS2;ETS1;AGT;NFKBIA;IL17RA
prerank,negative regulation of translation (GO:0017148),0.45131061991889215,1.287278554748801,0.1419141914191419,0.5522031238450008,1.0,20/87,14.52%,IGF2BP1;IGF2BP2;SYNCRIP;ILF3;IGFBP5;PUM1;CPEB1;METTL16;EIF2AK2;CAPRIN1;GIGYF2;SAMD4A;CELF1;FTO;GAPDH;EIF4EBP1;CALR;YTHDF3;FMR1;CPEB4
prerank,female gamete generation (GO:0007292),0.5164862273124194,1.287119814034759,0.17310252996005326,0.5520266705600414,1.0,10/29,23.15%,PTN;USP9X;MDK;DIAPH2;MCM9;MARF1;PARN;GDF9;KMT2D;DMC1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5523558227686927,1.2865798349143784,0.17982456140350878,0.552889941310663,1.0,11/20,23.44%,FMNL2;FMNL3;FHOD3;LLGL1;LCP1;TNF;PLEK;DLG1;ROCK2;ROCK1;STRIP1
prerank,spinal cord development (GO:0021510),0.603621642645501,1.2863642968502078,0.19656786271450857,0.5528832652901099,1.0,4/12,10.24%,GLI2;PKD2;NF1;LOXL3
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.4162089103451154,1.2852431389123027,0.008,0.5553788421222224,1.0,129/497,18.98%,RUNX2;IGF2BP1;ENPP1;CREB3L1;ADIPOQ;MDFIC;BCL3;ZEB1;SBNO2;NCOR2;DAP;DEAF1;IGF2BP2;TCF7L2;ATXN1;GLI3;BCL6;ERN2;SYNCRIP;ATP8B1;GATA6;ZFPM2;XCL1;RCOR1;PHC2;ARID5B;SMAD2;TLE1;TBX2;ILF3;IGFBP5;NR2F2;ARID5A;KMT5A;SMURF2;MBD2;E2F1;PRDM5;KHDRBS1;LIMS1;TAF7;SCMH1;FOXK2;SFRP1;PPARG;RUNX1T1;YAF2;EIF2AK2;ENO1;ZHX2;SFMBT1;MBD1;EHMT1;AHR;PRICKLE1;TSHZ3;FOXE1;IRF1;CAPRIN1;GIGYF2;BHLHE40;SAMD4A;HEYL;CCAR2;PDS5A;ZMYND15;POU2F1;SAP18;ATR;BAHD1;WNT5A;HDAC1;SALL1;NONO;ZBTB38;HMGB2;TBX3;LOXL3;GAPDH;EID1;KLF10;RSF1;ZGPAT;CALR;TIMELESS;SP3;TNFRSF4;SETDB2;FBXW11;TNF;GSK3B;COMMD7;SPI1;GATAD2A;CTCF;BMP7;TRIB3;CDKN1B;FMR1;SMAD4;NIPBL;TSC22D4;PHC3;PATZ1;PHF12;L3MBTL3;POU3F3;ATF7IP;CLOCK;SMARCA4;ACVRL1;MTA3;TRIM33;RBFOX2;MDM2;EIF2AK3;RCOR2;RBPJ;HDAC5;RBM15;SPEN;HINFP;SPINDOC;KAT6B;ZBTB7A;ARID4A;NR3C1;TLE5;WAPL
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.4459227627010828,1.2838579809734314,0.12540192926045016,0.5584263087784413,1.0,23/94,18.36%,PSMA7;IL1R1;IRAK3;CUL1;NOD1;IRAK2;SKP1;PSMB8;PSMA6;IRAK4;PELI3;FBXW11;PSMF1;PSMA8;PSMD2;PSMD12;SQSTM1;PSMD11;PELI2;PSMD14;MAP3K3;PSMB1;NFKBIA
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5957558933151875,1.2836504067707046,0.2118380062305296,0.5583161923871324,1.0,1/12,0.41%,IL34
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.47009559182625127,-1.2835305061634774,0.15282392026578073,0.6166197653805596,1.0,8/17,16.35%,COX5A;COX8A;COX4I1;COX6C;COX6B1;COX6A1;COX10;COX5B
prerank,COPII vesicle coating (GO:0048208),0.46492240564548615,1.283456003070584,0.14913294797687862,0.5568758379849637,1.0,17/61,17.88%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;SEC24A;TRAPPC4;SEC16A;LMAN1;SEC23IP;CTSC;RAB1A;PPP6C;SEC13;TBC1D20;CSNK1D;SCFD1
prerank,vesicle coating (GO:0006901),0.46492240564548615,1.283456003070584,0.14913294797687862,0.5568758379849637,1.0,17/61,17.88%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;SEC24A;TRAPPC4;SEC16A;LMAN1;SEC23IP;CTSC;RAB1A;PPP6C;SEC13;TBC1D20;CSNK1D;SCFD1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.46492240564548615,1.283456003070584,0.14913294797687862,0.5568758379849637,1.0,17/61,17.88%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;SEC24A;TRAPPC4;SEC16A;LMAN1;SEC23IP;CTSC;RAB1A;PPP6C;SEC13;TBC1D20;CSNK1D;SCFD1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.41654268817555085,1.2831198652934765,0.009,0.5571887876151271,1.0,116/417,19.45%,RUNX2;CREB3L1;ADIPOQ;MDFIC;BCL3;ZEB1;SBNO2;NCOR2;DAP;DEAF1;TCF7L2;ATXN1;GLI3;BCL6;ERN2;ATP8B1;GATA6;ZFPM2;XCL1;RCOR1;PHC2;ARID5B;SMAD2;TLE1;TBX2;ILF3;NR2F2;ARID5A;KMT5A;SMURF2;MBD2;E2F1;PRDM5;KHDRBS1;LIMS1;TAF7;SCMH1;FOXK2;SFRP1;PPARG;RUNX1T1;YAF2;ENO1;ZHX2;SFMBT1;MBD1;EHMT1;AHR;PRICKLE1;TSHZ3;FOXE1;IRF1;BHLHE40;HEYL;CCAR2;ZMYND15;POU2F1;SAP18;BAHD1;WNT5A;HDAC1;SALL1;NONO;ZBTB38;HMGB2;TBX3;LOXL3;EID1;KLF10;RSF1;ZGPAT;CALR;TIMELESS;SP3;TNFRSF4;NIF3L1;SETDB2;FBXW11;TNF;COMMD7;SPI1;GATAD2A;CTCF;BMP7;TRIB3;CDKN1B;SMAD4;NIPBL;TSC22D4;PHC3;PATZ1;PHF12;L3MBTL3;POU3F3;ATF7IP;CLOCK;SMARCA4;MTA3;TRIM33;RBFOX2;MDM2;RCOR2;RBPJ;HDAC5;RBM15;SPEN;HINFP;SPINDOC;KAT6B;ZBTB7A;ARID4A;NR3C1;TLE5;THAP7;KDM1A;KAT7
prerank,muscle cell migration (GO:0014812),0.6294265877124806,1.2829878469861968,0.2183206106870229,0.556872476275943,1.0,8/10,25.24%,THBS4;PLAT;ITGB1BP1;DDR1;MEGF10;ITGB3;ROCK1;AAMP
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.538771582771314,1.2824762052290481,0.17744154057771663,0.5576429017642146,1.0,6/21,11.96%,GPM6B;SLC9A1;PEAK1;EFNA5;PTK2;RHOA
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.41403416106287433,1.281685647095921,0.001,0.5592860126367315,1.0,160/807,14.46%,RUNX1;NR1H4;RUNX2;CREB3L1;ADIPOQ;TRPS1;RUNX3;ZEB2;POU5F1;MDFIC;BCL3;GLI2;ZEB1;SBNO2;ETV6;NCOR2;DAP;YAP1;DEAF1;TCF7L2;NRIP1;SNAI1;ATXN1;GLI3;BCL6;MEIS2;STAT1;ERN2;RARB;IRF7;ATP8B1;BACH1;GATA6;SNAI2;ZFPM2;XCL1;RCOR1;FHL2;DNAJB1;NKX6-1;PHC2;MITF;CRYM;ARID5B;SMAD2;NFIX;MIER2;SUFU;TLE1;MLIP;GLIS1;STAT3;CGGBP1;TBX2;USP9X;ILF3;NR2F2;ARID5A;SHH;KMT5A;SMURF2;MBD2;E2F1;PRDM5;KHDRBS1;PRDM2;PPID;LIMS1;TAF7;SCMH1;HIVEP1;RNF2;FOXK2;CREBBP;CBX8;SFRP1;PPARG;RUNX1T1;YAF2;PLK1;ETV5;ENO1;ZHX2;SFMBT1;MBD1;EHMT1;AHR;PRICKLE1;MDFI;TSHZ3;FOXE1;E2F8;NOC2L;IRF1;BHLHE40;HEYL;CCAR2;FRK;ZMYND15;POU2F1;SAP18;SP100;BAHD1;WNT5A;HDAC1;ZBTB5;SALL1;NONO;FOXO3;TBL1X;ZBTB38;DICER1;FOXP4;PRDM1;NR2F1;MTA2;HMGB2;CXXC5;TGIF2;TBX3;LOXL3;EID1;FNIP1;CBFB;GATAD2B;KLF10;ELK4;RSF1;ZGPAT;PHF21A;DNMT3B;CALR;TIMELESS;SP3;LCOR;TNFRSF4;SETDB2;FBXW11;TNF;KDM2A;NAB2;DUSP26;SKOR2;COMMD7;GLIS3;SPI1;RIF1;GATAD2A;CTCF;SMAD3;DACT1;PSEN1;KCNIP3;BMP7;TRIB3;DRAP1;CDKN1B;TFAP2C;SMAD4;MAFK
prerank,aerobic electron transport chain (GO:0019646),-0.3420581221733524,-1.2816460803058576,0.06451612903225806,0.6189474721564439,1.0,35/68,29.95%,COX5A;COX8A;NDUFS1;COX4I1;UQCRC2;NDUFV2;COX6C;COX6B1;NDUFA13;NDUFA6;COX6A1;NDUFA12;COX10;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;NDUFB7;NDUFS3;COX5B;UQCRB;NDUFA1;NDUFC2;NDUFA10;UQCRH;NDUFS2;UQCRFS1;NDUFB11;UQCC3;UQCR10;SDHAF2;UQCR11;NDUFS5;NDUFV1;SDHA
prerank,regulation of mitotic cell cycle (GO:0007346),0.42710638126891515,1.281447819375445,0.06822810590631365,0.5592671076740433,1.0,47/171,20.36%,PSMA7;NEK6;PDXP;MEIS2;PRKCA;MAD2L1;CUL1;PTPN3;PLK1;CKS1B;ANAPC11;CDC27;ASNS;SKP1;CDK10;GBF1;BORA;TMEM8B;BTG1;GAS1;PSMB8;TTC28;PSMA6;RPS6KB1;EIF4EBP1;PSMF1;MAEA;SMAD3;CDKN1B;USP22;PSMA8;PSMD2;PSMD12;PSMD11;RCC1;OBSL1;PSMD14;DDB1;MDM2;PSMB1;CDK9;FBXO5;PIN1;CDK13;PSMC6;ERCC2;UBE2E1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.5506219540757189,1.2814172312913399,0.18208092485549132,0.5587017703393133,1.0,3/19,2.74%,RUNX1;SNAI1;SNAI2
prerank,T cell activation (GO:0042110),0.460813369691311,1.2811716065882668,0.11299435028248588,0.5587326719973258,1.0,15/69,11.94%,JAML;CD276;CHD7;MDK;KIF13B;NCK1;NCK2;DDOST;MSN;LCP1;PPP3CA;CTPS1;PTPN2;CASP8;TNFRSF4
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.45381490609341624,1.2807498840648532,0.13693901035673187,0.5592704387962428,1.0,21/76,18.77%,CCL11;PDXP;SYNPO;NRP1;DYNC1H1;NCK1;BAIAP2;NCK2;CARMIL1;CDC42;GPSM2;SNX9;NTRK3;P2RX7;CX3CL1;FES;CDC42EP1;PLEK;CTTN;CDC42EP4;BCAS3
prerank,cardiac muscle cell development (GO:0055013),0.5484641464637177,1.2807129447241696,0.1712707182320442,0.558720217503839,1.0,3/20,4.03%,PDGFRA;PDGFRB;FHOD3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.44291138284322873,1.2806651263999693,0.1102863202545069,0.558193945238545,1.0,16/107,12.14%,CCL11;SLC39A14;CCL7;EDN3;CXCL12;CD40;STOML2;CCR1;SLC24A5;CCL5;ATP2A2;DRD3;TMEM203;ATP2B1;CALR;TPCN2
prerank,regulation of viral release from host cell (GO:1902186),0.5538832448058998,1.2806224448737367,0.18208092485549132,0.557645072706326,1.0,13/21,28.11%,TRIM21;VPS4A;TRIM13;TRIM8;CHMP2B;DDB1;TRIM62;TRIM35;TRIM11;TSG101;CHMP3;TRIM26;PML
prerank,brain development (GO:0007420),0.4332506404396882,1.2805943516990381,0.10062893081761007,0.5570712988622777,1.0,17/136,7.04%,COL4A1;EPHA7;APOD;HSPG2;ROBO2;ATXN1;MEIS2;MDGA1;AFF2;ADGRL3;MEIS1;MAP1S;PTEN;NF1;PBX3;SPEF2;BAG6
prerank,cellular response to estradiol stimulus (GO:0071392),0.559239280493004,1.2799944983694833,0.21074964639321075,0.5580322168978457,1.0,4/18,11.91%,NRIP1;EGFR;SFRP1;LCOR
prerank,cation transport (GO:0006812),-0.2870167704360145,-1.2799536310058897,0.0,0.6209655337857793,1.0,29/167,11.47%,TRPM3;ATP1A2;SLC12A2;SLC47A1;SLC6A6;KCND3;ATP1B1;TRPM6;KCNB2;SLC6A9;KCNK5;SCN2A;SLC1A1;KCNJ2;KCNJ3;SLC8A3;KCNJ13;ABCC9;SLC9B2;SLC5A6;KCNQ4;KCNJ10;SCN8A;SLC22A4;SLC22A18;CLN3;SCN9A;SLC38A5;SLC5A5
prerank,negative regulation of T cell differentiation (GO:0045581),0.6269366483272619,1.2791644579591674,0.1987179487179487,0.5596688290627441,1.0,3/10,7.18%,GLI3;MDK;IRF1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.4311542717660492,1.2786999110670345,0.07692307692307693,0.560275847361302,1.0,21/140,13.03%,P2RY10;KNG1;PDGFRA;CACNA1A;IAPP;CMKLR1;CACNA2D1;EDNRA;CACNA1C;P2RX5;CCR1;PTGDR;CD36;S1PR3;DLG4;CXCR4;DRD3;LPAR3;LPAR2;P2RX7;SPPL3
prerank,regulation of cell migration (GO:0030334),0.4161791800434685,1.2786377955773316,0.02702702702702703,0.5598201352192813,1.0,59/382,9.23%,ROR2;CCL11;CYP1B1;DLC1;COL1A1;CCL7;CEMIP;ADIPOQ;SULF1;MGAT5;PDGFRA;MMP14;LAMB1;CXCL12;SERPINE2;MAP4K4;SNAI1;CCAR1;PDGFRB;FGF7;SNAI2;PRKCA;DPYSL3;MITF;PLXNC1;AMOTL1;EGFR;NAV3;STAT3;IGFBP5;JAG1;MDK;CCR1;SHH;KIF2A;PTEN;AIF1;NF1;ACVR1;RHOD;CARMIL1;NF2;CCL5;EGF;ATM;SFRP1;RAP2A;SRGAP1;EPHA1;PLXND1;MIA3;SASH1;IGSF10;GPNMB;PLXNA3;ANXA1;TGFBR1;MYLK;FOXO3
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.49312034003746175,1.2780812492024676,0.15527950310559005,0.5607178066781171,1.0,7/35,11.45%,CDH11;PCDHB6;PCDHB16;DCHS1;CDH6;CDH18;CDH24
prerank,negative regulation of developmental growth (GO:0048640),-0.38097860439470166,-1.277989761291799,0.11059907834101383,0.6234852317231852,1.0,9/30,15.97%,MAP2;DCC;DIP2B;WWC2;ULK2;DUSP10;CDKL3;MAG;WWC1
prerank,positive regulation of neuron projection development (GO:0010976),0.44112757666142044,1.2779362426647216,0.1210762331838565,0.5604458121378654,1.0,20/85,15.17%,ROR2;ROR1;PTN;DPYSL3;TENM3;APOE;MDK;FZD1;CAPRIN1;WNT5A;BMP5;DBN1;DBNL;NTRK3;BMP7;ARHGAP35;PTK7;CX3CL1;FES;SETX
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.41311155715825154,1.2771239183967547,0.001,0.5620453853686433,1.0,204/834,18.64%,RORA;RUNX1;NR1H4;RUNX2;DCN;KMT2A;WNT2;ZEB2;POU5F1;PLAC8;GLI2;SBNO2;YAP1;TCF7L2;TCF4;NRIP1;ASXL1;TNFSF11;TNIP1;MRTFA;GLI3;CREB3L3;SATB2;MEIS2;SLC9A1;STAT1;ZMIZ1;RARB;TLR2;IRF7;CD40;GATA6;ZFPM2;AUTS2;NPAS4;NKX6-1;RXRG;MITF;SMAD2;NFIX;CDKN2B;EGFR;REL;MAML3;MLIP;UBP1;GLIS1;USF1;STAT3;LITAF;MEIS1;HOXB3;ELF4;NR2F2;JAG1;PPRC1;SHH;E2F1;MYBL1;NCK1;PRDM2;PRKD2;PKD2;ACVR1;ASXL2;TAF7;TCF12;NCK2;HIVEP1;INO80;FOXK2;CREBBP;ATM;MACC1;PPARG;LRP6;TGFB3;EAPP;ETV5;CXCL10;AHR;MLXIP;E2F8;PLXND1;BCL11B;SUB1;DDX17;ARNT;RNF111;IRF1;PID1;RRP1B;HEYL;ACTR2;CRTC1;MAML2;TERT;HOXA1;POU2F1;OGT;WNT5A;HDAC1;SALL1;FOXO3;TBL1X;ZBTB38;SMAD5;BMP5;NR2F1;JUNB;HMGB2;PPP3CA;PELP1;TBX3;TNFRSF1A;WWTR1;TEAD1;KLF10;ARF4;ELK4;CRTC3;RSF1;TGFB2;NFE2L2;ZBED3;SP3;CDK7;ACVR2A;TET2;E2F3;MED13;TNF;ZSCAN21;HOXB2;KLF6;MAML1;GLYR1;FGF2;GNL3;MC1R;NKX2-8;ELK1;GLIS3;FOXJ3;NFKB2;SPI1;PIK3R1;DDRGK1;GTF2F1;PRDM10;SMAD3;ATRX;EGR2;DRAP1;MYSM1;TFAP2C;SMAD4;GABPB1;CX3CL1;PAXIP1;RIPK1;SETX;SMAD1;RTRAF;CREB3L4;CREB3;CCNT1;HIF1A;STAT5B;PRKDC;RBMX;PTOV1;SQSTM1;SLC30A9;NPAS2;MAX;ITGB1BP1;CLOCK;TCF3;SMARCA4;SREBF1;ACVRL1;ZFHX3;TCERG1;CALCOCO1;THRAP3;BRD4;MZF1;ATF4;GLI1;ETS1;RLF;PRDM4;INHBA;PAX8;RBPJ;HDAC5;NR2C2;NFKBIA;SOX2;CDK9;SETD3;HINFP;KAT6B
prerank,response to exogenous dsRNA (GO:0043330),0.5644381841492246,1.27684523837785,0.1871508379888268,0.5621662853598635,1.0,3/18,3.64%,RFTN1;COLEC12;IRAK3
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.5234565901493581,1.2758762310918643,0.18614130434782608,0.5642077027345138,1.0,6/25,11.60%,HK2;FOXK2;ENO1;ADPGK;GAPDH;GCK
prerank,chromatin assembly (GO:0031497),0.48535055673113003,1.2753405713626675,0.168141592920354,0.5649622239354333,1.0,15/38,20.05%,POLE3;NOC2L;BAHD1;GRWD1;HMGB2;LIN54;RSF1;SPTY2D1;NAP1L3;CTCF;ATRX;ASF1A;KAT6B;NAP1L1;HMGA2
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.49318865081597574,-1.2752596009986354,0.20555555555555555,0.6281321082857696,1.0,4/12,14.43%,MAOA;HNMT;DDC;SMS
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6056419242652067,1.2748816401887746,0.2057057057057057,0.5655411130941053,1.0,5/12,14.77%,KDELR3;INSIG2;KDELR2;TAPT1;HSPA5
prerank,protein localization to cell-cell junction (GO:0150105),-0.456417041485142,-1.273514209663558,0.16,0.6304360140539303,1.0,5/15,6.66%,TJP1;TJP2;ACTB;CDH5;LSR
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.47063834589458653,1.273476275059916,0.14575866188769415,0.5688086065748215,1.0,13/49,14.77%,PMEPA1;IAPP;TREM2;AIDA;CDC42;PYDC1;LDLRAD4;GSK3B;NLRP2B;ANKRD27;DACT1;SRC;HSPA5
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.5619678615775482,1.2733346918682458,0.19197707736389685,0.5685330257060712,1.0,7/16,16.86%,PARP3;SHLD3;SETMAR;RIF1;DTX3L;PRKDC;PNKP
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.4413846461996127,1.273262418734016,0.1337719298245614,0.5680765831616059,1.0,40/83,26.65%,BACH1;CCNE2;CUL1;E2F1;KHDRBS1;ACVR1;CACUL1;CDK6;CDK14;DBF4;RPS6KB1;ACVR1B;EIF4EBP1;CDK7;E2F3;CDKN1B;GSPT1;PPP6C;MAX;RCC1;LATS2;BRD4;INHBA;CDK16;FBXO5;HINFP;PLK2;CDC7;LATS1;CCNH;MNAT1;CDC6;CDKN1A;TYMS;NASP;CDC25A;BCAT1;TFDP1;CDK18;CDC34
prerank,integrated stress response signaling (GO:0140467),0.5990206313543133,1.273136326382437,0.2087745839636914,0.5678293726301166,1.0,6/14,17.65%,OMA1;CCL2;NFE2L2;HSPA5;EIF2AK3;ATF4
prerank,regulation of cellular amide metabolic process (GO:0034248),0.5036034597960308,1.2730479625349587,0.17786069651741293,0.5673958081338454,1.0,12/32,24.24%,NR1H4;ATXN2;FOXO3;NOLC1;PICALM;RBM4B;PRKCD;SAMD8;ROCK1;PCIF1;METAP1;EIF2A
prerank,post-translational protein modification (GO:0043687),0.4142217341464802,1.272974423598672,0.02002002002002002,0.5669293941721214,1.0,84/332,20.15%,PSMA7;C3;ENAM;KNG1;SPP1;IGFBP7;LAMB1;LAMC1;FBXO40;CP;TIMP1;IGFBP4;VCAN;SPSB1;FSTL1;PRKCSH;KLHL22;RAB2A;APOE;FBXL7;RBBP5;CALU;IGFBP5;WSB2;DCAF10;CUL1;FBN1;FN3KRP;MIA3;KLHL13;SKP1;CKAP4;DCUN1D1;SDC2;FBXL18;FBXW7;FBXO30;CHML;PSMB8;UBE2F;PSMA6;MGAT4A;TNC;LTBP1;STT3A;SOCS5;DCAF11;NEURL2;FBXO7;FBXW11;PSMF1;KCTD7;RAB1A;FBXO2;COPS6;RABGGTB;PSMA8;HIF1A;FBXL19;PSMD2;PSMD12;KLHL25;PSMD11;OBSL1;PSMD14;DNAJC3;DDB1;PSMB1;FBXW4;ASB3;RHBDD1;FBXO31;HSP90B1;DCAF8;EVA1A;FAM20C;PDIA6;FBXO32;FBXL22;LGALS1;ASB6;SHISA5;RAB8A;PSMC6
prerank,neuron projection regeneration (GO:0031102),0.6219916626937442,1.272725571757083,0.22,0.5669454298979145,1.0,3/10,13.48%,PTN;NREP;RTN4RL1
prerank,regulation of actin filament-based movement (GO:1903115),-0.5304647908837122,-1.272568767325706,0.1989247311827957,0.6301312664955999,1.0,3/10,10.43%,PDE4B;ANK2;PDE4D
prerank,regulation of vasculogenesis (GO:2001212),-0.4856547258223154,-1.2725373473493113,0.14411764705882352,0.627215117228714,1.0,6/14,14.26%,CD34;RAPGEF2;KDR;RAP1A;TMEM100;HEY2
prerank,Fc receptor signaling pathway (GO:0038093),0.4343149405510341,1.2717817549460368,0.11217948717948718,0.5689336712859809,1.0,25/110,17.06%,PSMA7;TEC;VAV2;GAB2;VAV3;MAP2K4;CUL1;LCP2;SKP1;GRB2;PSMB8;PSMA6;LAT2;PPP3CA;VAV1;FBXW11;PSMF1;PIK3R1;RAC1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;MAPK1
prerank,sensory perception of sound (GO:0007605),0.43969527494784383,1.2717190013023953,0.1272923408845739,0.568479891622708,1.0,14/88,11.96%,ROR1;COL1A1;CEMIP;COL11A2;SNAI2;CRYM;COL11A1;MYO7A;HOXA1;TPRN;TBL1X;TSPEAR;ALDH7A1;MYO3A
prerank,response to interferon-beta (GO:0035456),0.5353143737895227,1.2715437179134483,0.18467852257181944,0.5682954746451822,1.0,9/22,20.38%,STAT1;IKBKE;SHFL;IRF1;IFNAR2;UBE2K;IRGM;PLSCR1;TRIM6
prerank,lipid phosphorylation (GO:0046834),-0.5251444324908631,-1.271394844151018,0.18032786885245902,0.6275436014961225,1.0,5/10,16.74%,DGKB;DGKI;DGKA;DGKG;DGKQ
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5106371417300122,1.2712784829524906,0.18170103092783504,0.5683829829192395,1.0,8/29,10.36%,GHR;STAT1;JAK2;STAT3;PKD2;STAT5A;IFNAR2;CCL2
prerank,response to glucose (GO:0009749),0.47350912681307333,1.2699039537918482,0.16625615763546797,0.5715797971520656,1.0,9/46,12.61%,SLC39A14;ADIPOQ;TCF7L2;NKX6-1;LPL;GCK;KHK;ZBED3;ZBTB20
prerank,early endosome to late endosome transport (GO:0045022),0.5335062054085782,1.2698988872942756,0.2017167381974249,0.5709502699201793,1.0,10/20,21.89%,HOOK2;RAB7A;PTPN23;EEA1;ANKRD27;KIF16B;PIK3C3;HOOK1;BECN1;RAB5A
prerank,positive regulation of actin nucleation (GO:0051127),-0.5025789088074025,-1.2694982075286607,0.17534246575342466,0.6299389378512025,1.0,4/11,8.61%,FCHSD2;GSN;NCKAP1;WASF1
prerank,sensory organ development (GO:0007423),0.4690017746363406,1.2692180234346242,0.1511627906976744,0.5721919711646015,1.0,9/51,8.25%,SH3PXD2B;MEIS2;CHD7;MAFB;SIPA1L3;MEIS1;PBX3;MYO7A;ADAMTS18
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.44700501387843183,1.2690770912000442,0.13236929922135707,0.571929320976859,1.0,17/75,12.48%,CCL11;THBS4;EGR3;PRKCA;NRP1;MDK;AKT3;PRKD2;EGF;STAT5A;ARNT;TGFBR1;WNT5A;HMGB2;FGFR1;VEGFC;FGF2
prerank,maturation of 5.8S rRNA (GO:0000460),0.5555608695599982,1.268645965161188,0.22284908321579688,0.572484103280275,1.0,8/17,17.10%,C1D;MAK16;PES1;EXOSC4;MPHOSPH6;PRKDC;RPF1;MTREX
prerank,pinocytosis (GO:0006907),0.6250064728151284,1.2685084066876333,0.20634920634920634,0.5722366977888027,1.0,5/10,16.49%,CARMIL1;SNX33;SNX5;RAB34;DOCK2
prerank,negative regulation of chemokine production (GO:0032682),0.5800018234472019,1.2683898554232789,0.2085235920852359,0.5718943066962582,1.0,2/14,5.04%,APOD;LGALS9
prerank,regulation of cell junction assembly (GO:1901888),0.5095498009681717,1.2681772057027152,0.1959731543624161,0.5718769386955016,1.0,3/27,2.74%,RUNX1;SNAI1;SNAI2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.4324018545985384,-1.2680420198652524,0.16319444444444445,0.6309923570239704,1.0,11/19,21.07%,IL1RAPL1;CDKL5;CUX1;CUX2;CAMK2B;LRP8;CDKL3;PTPRD;RELN;DHX36;CUL7
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.49996830422677596,1.2679107007885888,0.1933497536945813,0.5719848002115128,1.0,4/32,6.32%,CEMIP;XCL1;P2RX5;CXCL10
prerank,cellular response to ATP (GO:0071318),0.584205893317404,1.2677544523631665,0.21547799696509864,0.5717688960574625,1.0,5/14,21.69%,PDXP;SSH1;P2RX7;HSP90B1;P2RY12
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.45095186274663374,1.2676921056815758,0.1378132118451025,0.5712738627611308,1.0,18/67,14.74%,FBLN2;JAK2;NRP1;DOCK1;MDK;LIMS1;CD36;CARMIL1;CDK6;SFRP1;CDC42;EPHA1;RSU1;CALR;UTRN;GSK3B;RAC1;CX3CL1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6163467262382908,1.2675850354361835,0.22308892355694226,0.5709264575989007,1.0,7/10,22.90%,PRKD2;ARNT;VTN;ITGA5;HIF1A;GRB10;ITGB3
prerank,negative regulation of glycolytic process (GO:0045820),-0.5200917021391973,-1.2674717297263016,0.2,0.6266512902996966,1.0,3/10,11.09%,HDAC4;CBFA2T3;GIT1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.5200917021391973,-1.2674717297263016,0.2,0.6266512902996966,1.0,3/10,11.09%,HDAC4;CBFA2T3;GIT1
prerank,postsynaptic membrane organization (GO:0001941),0.5502542392375933,1.2672455474879993,0.20457796852646637,0.5712075524669126,1.0,3/17,7.01%,CEL;APOE;DLG4
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4774399126925842,1.2665563148232513,0.15925925925925927,0.5725775939076011,1.0,13/42,14.74%,MAP4K4;NRP1;LIMS1;CD36;CDK6;SFRP1;EPHA1;PTPRJ;UTRN;RIN2;GSK3B;RAC1;CX3CL1
prerank,catecholamine metabolic process (GO:0006584),-0.46895938292359823,-1.2664408471324375,0.1762917933130699,0.6267500062539639,1.0,5/14,19.93%,SNCAIP;PRKN;DDC;RNF180;DRD2
prerank,regulation of protein polymerization (GO:0032271),-0.36258986243923647,-1.2661674566498982,0.11707317073170732,0.6246491465215962,1.0,9/35,12.55%,FCHSD2;MAP2;ARHGAP18;ESAM;HSP90AA1;ARHGAP28;TTBK1;PRUNE1;PAK3
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4365912407495896,1.265853558555752,0.11771058315334773,0.5738795461228767,1.0,22/102,14.12%,SLC39A14;ENPP1;ADIPOQ;ZFP36L1;IRS1;ADCY7;INSIG2;USF1;ADCY2;CPEB1;PPARG;MYO5A;INHBB;RAB8B;DENND4C;PRKAR1B;RPS6KB1;GCK;PIK3R1;RAB10;SRC;TRIB3
prerank,positive regulation of exosomal secretion (GO:1903543),0.5726551189313247,1.2658312510790934,0.21897810218978103,0.5733085689157308,1.0,8/15,24.73%,VPS4A;RAB7A;SDC1;SMPD3;SDC4;SDCBP;PDCD6IP;TSG101
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.46507594270452374,-1.265575259681474,0.1715210355987055,0.6235098066271659,1.0,6/15,14.90%,SORT1;NTRK2;ZFYVE27;CASP3;DDIT4;BDNF
prerank,regulation of hormone secretion (GO:0046883),0.5573957307640642,1.2651395517658248,0.20381231671554254,0.5745339525758765,1.0,2/15,8.96%,EDN3;ANXA1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.43407337683299096,-1.265001612526257,0.13513513513513514,0.6222231266364497,1.0,8/19,15.91%,SYNJ2BP;LRRC7;DLG2;PARD3;PATJ;SCRIB;CLIC4;MTCL1
prerank,oogenesis (GO:0048477),0.5687601078755441,1.26476578789191,0.215007215007215,0.5748936049403678,1.0,3/15,12.09%,PTN;MDK;MARF1
prerank,secondary palate development (GO:0062009),0.5877685273380324,1.2646038816534664,0.21238938053097345,0.5746698120662641,1.0,7/14,14.65%,CHD7;SMAD2;TGFB3;WNT5A;TGFB2;SMAD4;LRRC32
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4930730116161498,1.2643761553414539,0.17581047381546136,0.5746575332336065,1.0,10/36,12.48%,DCN;APOE;NR2F2;APOH;PPARG;ADAMTS9;SP100;PTPRM;TNF;FGF2
prerank,fatty acid catabolic process (GO:0009062),0.4533038867020629,1.263823841241496,0.1392978482446206,0.5754589475181605,1.0,6/67,7.20%,CEL;ADIPOQ;EHHADH;AIG1;SLC27A2;ACOX1
prerank,regulation of mast cell activation (GO:0033003),0.61996647397835,1.2635496298570947,0.22650231124807396,0.5755216638991605,1.0,6/10,25.11%,MILR1;TSLP;CD300LF;PLSCR1;CRLF2;CD84
prerank,negative regulation of protein phosphorylation (GO:0001933),0.42427574557170483,1.2634977583652303,0.10144927536231885,0.5750437527117432,1.0,46/150,17.28%,ENPP1;ADIPOQ;FBLN1;PMEPA1;LRRK2;SPRED1;ERRFI1;SPRED2;PTPN13;NCK1;PTEN;NF1;TAF7;NCK2;DTNBP1;SFRP1;LRP6;PTPN6;EPHA1;EMILIN1;PID1;RASSF2;GSKIP;PYDC1;NIBAN1;CNKSR3;MVP;WWTR1;IBTK;LDLRAD4;ZBED3;SPRY2;NLRP2B;NTRK3;UBASH3B;SMCR8;CALM2;TRIB3;TRIB1;RTRAF;SNX25;PRKDC;ITGB1BP1;PTPRC;AKT1;DNAJC3
prerank,positive regulation of type I interferon production (GO:0032481),0.45369814041237483,1.263159913615089,0.12514220705346984,0.5753507570059354,1.0,24/73,20.63%,ZBP1;STAT1;TLR2;IRF7;CREBBP;TLR7;IRF1;CD14;CRCP;SETD2;GAPDH;POLR3A;POLR3D;NFKB2;TRIM56;PRKDC;CGAS;HSPD1;POLR2L;POLR2K;POLR3GL;RNF135;POLR3K;ISG15
prerank,sulfur compound biosynthetic process (GO:0044272),0.4297545873315281,1.2628533200090848,0.12931034482758622,0.5755476444724786,1.0,27/104,16.06%,DCN;LUM;CHSY3;BGN;PAPSS2;B4GALT5;CHST13;VCAN;MGST1;AKR1A1;ST3GAL3;METTL16;PRELP;ANGPT1;CHSY1;CHST11;GSTK1;ST3GAL1;CHST1;GGCT;UGDH;SLC35D2;SLC35B3;CHPF2;B4GALT2;GGT7;CNDP2
prerank,negative regulation of immune system process (GO:0002683),0.5689808900127394,1.262357744850798,0.19377652050919378,0.5763008280374922,1.0,1/16,0.36%,COL3A1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.47843028447664204,-1.2619108148862737,0.17320261437908496,0.6277809839097215,1.0,6/14,17.08%,CHKA;PCYT2;LPIN1;SLC27A1;SELENOI;CHKB
prerank,mitotic cytokinetic process (GO:1902410),0.5453554384897293,1.2618349589149023,0.20883534136546184,0.5771063864302397,1.0,7/20,17.50%,CHMP4A;CHMP4B;VPS4A;RHOA;CHMP7;CHMP2B;KIF20A
prerank,cellular glucan metabolic process (GO:0006073),-0.5081055263633361,-1.261732691764548,0.17777777777777778,0.625464220737886,1.0,3/11,5.04%,PRKAG2;GBE1;PYGM
prerank,cytoplasmic sequestering of protein (GO:0051220),0.5981261060065481,1.2611924258625573,0.20239880059970014,0.5781182035081233,1.0,5/13,9.91%,SUFU;NFKBIE;PKD2;MDFI;DBN1
prerank,regulation of endothelial cell migration (GO:0010594),0.4399070169008161,1.2609678406590483,0.13333333333333333,0.5781235946894074,1.0,23/85,12.48%,DCN;SPARC;PTN;RHOJ;PRKCA;NRP1;APOE;NR2F2;PRKD2;NF1;APOH;EGF;SASH1;ANGPT1;ADAMTS9;SP100;WNT5A;PTK2;BMPER;CALR;PTPRM;RIN2;FGF2
prerank,negative regulation of catalytic activity (GO:0043086),0.5257951730880706,1.260821224024147,0.20218579234972678,0.5779348625725812,1.0,3/24,7.96%,HP;TIMP1;CCAR2
prerank,ion homeostasis (GO:0050801),-0.36650325800000205,-1.2604851096546648,0.15023474178403756,0.6261712461391964,1.0,7/30,10.82%,SLC4A10;FHL1;KLHL3;WNK4;WNK3;SLC4A8;SLC4A3
prerank,positive regulation of macrophage activation (GO:0043032),0.5555527842151121,1.2601535207079697,0.22028985507246376,0.5791867726048378,1.0,3/17,9.14%,LBP;TREM2;WNT5A
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5045302242714927,1.259826928181926,0.17503217503217502,0.5794451169704944,1.0,15/31,22.46%,ARRDC4;PTEN;PLK1;SKP1;ARRDC3;DCUN1D1;FBXW7;UBE2L3;RAB1A;TRIB3;DCUN1D5;PIN1;CDC14B;AXIN1;FZR1
prerank,heart morphogenesis (GO:0003007),0.46678085567483785,1.2595480730177233,0.17406542056074767,0.5795217235789304,1.0,10/50,11.44%,DLC1;FLRT2;CHD7;TBX2;ACVR1;HEYL;TGFBR1;TBX3;PTK2;TGFB2
prerank,regulation of cell cycle phase transition (GO:1901987),0.4361643257179834,1.2595409913620434,0.13759479956663057,0.5789066646114398,1.0,34/91,25.19%,PSMA7;MAD2L1;CUL1;PLK1;ANAPC11;CDC27;SKP1;FBXW7;PSMB8;PSMA6;DBF4;PSMF1;CDKN1B;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;DDB1;PSMB1;FBXO5;PSMC6;ERCC2;UBE2E1;FZR1;PSMB4;PSMB5;ANAPC2;CDKN1A;PSMD4;PSMD7;PSMD9;PSMA4;CDC16
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.4071249514761035,1.259404644051466,0.0,0.5786913263992254,1.0,259/1082,18.48%,RORA;RUNX1;NR1H4;RUNX2;COL1A1;DCN;KMT2A;WNT2;RUNX3;ZEB2;POU5F1;CXXC1;SPP1;MDFIC;BCL3;PLAC8;GLI2;SBNO2;YAP1;DEAF1;TCF7L2;TCF4;NRIP1;ASXL1;SNAI1;TNFSF11;TNIP1;MRTFA;GLI3;CREB3L3;SATB2;MEIS2;SLC9A1;STAT1;ZMIZ1;RARB;TLR2;IRF7;CD40;GATA6;FGF7;MAFB;ZFPM2;AUTS2;NPAS4;NKX6-1;RXRG;MITF;ZNF496;SMAD2;NFIX;CDKN2B;EGFR;REL;MAML3;MLIP;UBP1;GLIS1;APOE;USF1;STAT3;LITAF;MEIS1;SERTAD2;HOXB3;ELF4;ILF3;PADI2;NR2F2;JAG1;PPRC1;SHH;E2F1;MYBL1;NCK1;PRDM2;PRKD2;PKD2;SMARCC1;ACVR1;ASXL2;TAF7;TCF12;NCK2;HIVEP1;INO80;FOXK2;EGF;CREBBP;FZD1;ATM;MACC1;SFRP1;PPARG;LRP6;YAF2;ZBTB48;TGFB3;ETV5;CXCL10;AHR;FOXE1;MLXIP;E2F8;BCL11B;GTF2H1;DDX17;ARNT;RNF111;IRF1;PID1;RRP1B;RPTOR;NEK4;HEYL;CREB3L2;ACTR2;CRTC1;MAML2;HOXA1;POU2F1;SP100;TGFBR1;OGT;MAP2K1;WNT5A;HDAC1;SALL1;FOXO3;TBL1X;ZBTB38;ARID1B;SMAD5;BMP5;NR2F1;TGFB1I1;JUNB;HMGB2;PPP3CA;PELP1;ZIC1;TBX3;TNFRSF1A;WWTR1;TRIM44;TEAD1;KLF10;ARF4;KMT2E;ELK4;CRTC3;RSF1;NFE2L2;ZBED3;SP3;CDK7;ACVR2A;TET2;E2F3;MED13;NIF3L1;MAP3K2;FBXW11;TNF;ZSCAN21;HOXB2;KLF6;MAML1;GLYR1;FGF2;MC1R;NKX2-8;KMT2B;ELK1;NSD3;GLIS3;SNX5;FOXJ3;NFKB2;SPI1;BRPF1;PIK3R1;DDRGK1;GTF2F1;PRDM10;CTCF;SMAD3;PSEN1;BMP7;ATRX;EGR2;DRAP1;MYSM1;USP22;TFAP2C;SMAD4;ASF1A;DTX3L;GABPB1;MMS19;CX3CL1;NAA15;RIPK1;SETX;SMAD1;RTRAF;CREB3L4;CREB3;CCNT1;HIF1A;TRIM56;STAT5B;PRKDC;RBMX;PTOV1;SQSTM1;SLC30A9;NPAS2;NSD1;POU3F3;MAX;ITGB1BP1;ATF7IP;CLOCK;TCF3;SMARCA4;SREBF1;HMGN1;ACVRL1;ZFHX3;AKT1;ING5;TCERG1;CALCOCO1;THRAP3;PCBD2;BRD4;MZF1;EIF2AK3;ATF4;PICALM;ICE1;GLI1;ETS1;MAP3K12;RLF;PRDM4;RAI1;INHBA;BICRA;PAX8;AGT;RBPJ;HDAC5;NR2C2;NFKBIA;SOX2;CDK9;SETD3
prerank,vesicle transport along actin filament (GO:0030050),0.5494578099378393,1.2593247298435641,0.18707015130674004,0.578266898151577,1.0,5/19,7.53%,MYO1B;MYO5A;MYO1D;MYO1H;MYO7A
prerank,polarized epithelial cell differentiation (GO:0030859),0.5901928590816015,1.2589104275630238,0.23308270676691728,0.578822132534664,1.0,6/13,13.50%,OPHN1;RAP2A;CDC42;MSN;RHOA;RAB10
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5798454663914141,1.2575465663395753,0.22306525037936267,0.5820555758103967,1.0,3/14,13.11%,EHHADH;ACOX1;ACOX3
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.45661644425646153,1.2572191525565122,0.1611804767309875,0.5822854988096607,1.0,10/62,12.60%,COL3A1;P2RY10;MAP4K4;JAK2;AUTS2;GRB2;MAPRE2;ERBIN;VAV1;AKAP13
prerank,embryonic organ morphogenesis (GO:0048562),0.4751535375451601,1.2566734395337078,0.17682926829268292,0.5831885921276317,1.0,6/42,6.69%,PDGFRA;FBN2;HOXB3;FBN1;ACVR1;FOXE1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.42098784260496236,1.2564703118064597,0.09926854754440961,0.5830908482760709,1.0,23/138,11.01%,ROR2;ROR1;EPHA7;PDGFRA;PTN;PDGFRB;JAK2;EGFR;EPHB3;BLK;LCP2;DDR2;NPR2;EPHA1;STYK1;MERTK;FRK;TRIO;FRS2;ACVR1B;LIFR;FGFR1;PTK2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.4768974554017694,1.2563461612758746,0.17683686176836863,0.582813913105738,1.0,7/44,11.14%,CCL11;NCK1;BAIAP2;NCK2;CARMIL1;SPIRE1;SNX9
prerank,COPII-coated vesicle budding (GO:0090114),0.45049867672892446,1.2562634233943324,0.14793577981651376,0.5824059368512157,1.0,19/68,17.88%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;SEC24A;MIA3;VAPA;TRAPPC4;SEC16A;LMAN1;SEC23IP;CTSC;RAB1A;PPP6C;SEC13;TBC1D20;CSNK1D;SCFD1
prerank,pre-replicative complex assembly (GO:0036388),0.4507346829667255,1.2561925004260641,0.15188470066518847,0.5819734279486748,1.0,12/64,17.74%,PSMA7;MCM2;MCM7;PSMB8;PSMA6;PSMF1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1
prerank,fat cell differentiation (GO:0045444),0.45219333245401827,1.255994973759824,0.1581986143187067,0.5818685897730826,1.0,10/57,8.71%,ADIPOQ;STEAP4;TCF7L2;MAFB;TMEM120B;OSBPL11;PPARG;INHBB;PID1;PSMB8
prerank,hemopoiesis (GO:0030097),0.4403753566226162,1.2559723101044387,0.14814814814814814,0.5812843277393868,1.0,9/87,5.95%,RUNX1;RUNX2;KMT2A;RUNX3;ETV6;ZFP36L2;MEIS1;JAG1;SFRP1
prerank,positive regulation of leukocyte activation (GO:0002696),0.5562034862316596,1.2557307536178803,0.20675105485232068,0.5813478802580003,1.0,7/18,22.65%,LBP;TSLP;WNT5A;HSPD1;TNIP2;CRLF2;IL33
prerank,regulation of DNA binding (GO:0051101),0.4702454132162561,1.2550868173342213,0.17703349282296652,0.5825236667146904,1.0,15/44,20.05%,BCL3;JAK2;E2F1;ILRUN;EGF;PPARG;MDFI;SP100;HMGB2;RSF1;SMO;NFKBIA;ZBTB7A;KDM1A;HMGA2
prerank,dendritic cell chemotaxis (GO:0002407),0.582588629312322,1.254957639816822,0.21771771771771772,0.5822681131967216,1.0,4/14,14.55%,CCR1;CCL5;CXCR4;TRPM4
prerank,organic cation transport (GO:0015695),-0.41697215437098956,-1.2544260429816891,0.17028985507246377,0.6403328330888068,1.0,5/20,8.94%,SLC47A1;SLC25A42;SLC25A26;SLC22A4;SLC22A18
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5274553912850748,1.2541028864445565,0.2180349932705249,0.5840047031024226,1.0,5/23,6.94%,NOS1AP;CACNA2D1;CACNB1;CAMK2D;CBARP
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4678840702646109,1.2538776254904325,0.17822966507177032,0.5840497064623497,1.0,16/43,20.69%,MMP2;STAT1;PDGFRB;CCN4;IGFBP5;AIF1;CCL5;ADAMTS1;TNF;FGF2;CX3CL1;IL6R;AKT1;HTR1B;FOXP1;BMPR1A
prerank,ephrin receptor signaling pathway (GO:0048013),0.4368143793691122,1.2537370023044552,0.15167930660888407,0.5838196312584889,1.0,24/82,16.40%,EPHA7;MMP2;VAV2;EFNA4;VAV3;KALRN;EPHB3;ITSN1;ANKS1B;NCK2;CDC42;EPHA1;ACTR2;SDC2;EFNA5;PTK2;RHOA;PSEN1;SRC;RAC1;AP2A2;PSENEN;YES1;RASA1
prerank,primary alcohol metabolic process (GO:0034308),0.5149519863141727,1.2534982545683013,0.19429347826086957,0.5838450378222395,1.0,9/25,19.58%,CYP1B1;RDH12;RDH10;CYP1A1;ALDH3A2;PECR;ADH1A;DHRS3;GDPD3
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.597319136764032,1.2533058919884785,0.22981366459627328,0.5837184352024136,1.0,4/11,14.28%,STAT3;PUM1;WTIP;FMR1
prerank,regulation of translation (GO:0006417),0.4137799712198103,1.2531544884562462,0.10277492291880781,0.5834927286005467,1.0,37/173,16.04%,IGF2BP1;PRR16;BCL3;IGF2BP2;EIF4G2;SYNCRIP;CTIF;ATXN2;EIF4G3;PLD1;ILF3;IGFBP5;SHFL;EIF2AK2;EIF3H;CAPRIN1;GIGYF2;SAMD4A;EIF5B;NIBAN1;EIF5;FOXO3;RPS6KB1;NCBP2;GAPDH;ALKBH1;NAT10;MTIF2;TRAP1;CALR;YTHDF3;FMR1;NOLC1;GSPT1;EIF1;PRKDC;KLHL25
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.41404231249490625,1.2530887575578087,0.08624229979466119,0.5830427863024886,1.0,54/182,21.08%,RUNX1;RBMS3;CREB3L1;ITGB8;YAP1;APOBEC1;ATXN2;FLOT2;REL;APOE;CCR1;LGALS9;SFRP1;EMILIN1;SUB1;DLG4;CELF1;TERT;TNRC6B;FBXW7;MAP2K1;HDAC1;DICER1;SETDB1;MOV10;TGFB2;SETDB2;TNF;FGF2;SMCR8;SPI1;DDRGK1;MSR1;PSEN1;ANKRD13B;PDCD10;CCDC3;SMO;HIF1A;OLFM1;ACVRL1;PICALM;XDH;HINFP;TLE5;MTMR2;AGO2;TRIM6;FOXP1;PARP14;BMPR1A;YY1;VHL;ZC3H12A
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5587781097379068,1.2525289369856012,0.21294964028776978,0.5839352247838399,1.0,6/17,20.05%,LTBP3;TERT;PTPRC;KDM1A;KAT7;HMGA2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4054665343282,1.2523333130730003,0.031031031031031032,0.5838166856652587,1.0,83/390,15.17%,ROR2;ROR1;SLC39A14;COL4A2;COL1A1;EPHA7;MMP2;SULF1;PDGFRA;GHR;FLRT2;VAV2;EFNA4;IRS1;PDGFRB;FGF7;JAK2;VAV3;SPRED1;NRP1;EGFR;KALRN;EPHB3;STAT3;BLK;ITSN1;GALNT3;DOCK1;LCP2;SPRED2;NCK1;ANKS1B;BAIAP2;PRKD2;DDR2;AP3S1;NCK2;PLAT;CDC42;EPHA1;STYK1;GIGYF2;SH2B2;ANGPT1;MERTK;ACTR2;MAPK11;FRK;SDC2;CBL;GRB2;EFNA5;GTF2F2;FRS2;NCBP2;BRK1;FGFR1;MVP;PTPRJ;PTPN2;PTK2;ATP6V1F;RHOA;SHB;VAV1;GSK3B;VEGFC;FGF2;NTRK3;UBASH3B;ATP6V1H;ABI1;PIK3R1;ATP6V1G2;GTF2F1;KIF16B;PSEN1;SRC;RAC1;AP2A2;FES;PSENEN;SETX
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.28966969638735934,-1.2521319649024134,0.03333333333333333,0.6439974598921208,1.0,46/110,21.75%,RPL34;PPP2R1A;RPL36;RPL8;PABPC1;RPS4X;RPL18A;PYM1;RPL19;RPL38;RPS21;RPL5;UPF2;RPS10;RPLP0;RPL7;RPL13;RPS8;RPS23;RPL30;RPS12;UPF1;RPL13A;RPL35A;RPL29;RPL32;PNRC2;RPL10;RPL15;RPS27;RPL35;RPS16;RBM8A;RPL7A;RPS15;RPS29;MAGOH;RPL27;RPS13;RPS19;RPL41;RPLP1;RPL28;EIF4A3;GSPT2;RPS17
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5346398263182552,1.2519667926698659,0.1991643454038997,0.5841137777159923,1.0,6/21,17.16%,PLA1A;PLA2G12A;OSBPL5;PLA2G4A;PLA2G4E;LPCAT3
prerank,fatty acid metabolic process (GO:0006631),0.42338396306907633,1.2518043106373298,0.13473684210526315,0.5839355586492946,1.0,13/115,10.01%,CEL;ADIPOQ;LIPC;ACSL4;ACADSB;CD36;PPARG;SLC27A2;ACOX1;HSD17B8;LPL;CYP1A1;ACSF2
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.5880659103334717,1.2517503175553777,0.25150602409638556,0.583462579966713,1.0,3/12,3.78%,IAPP;TREM2;APOE
prerank,protein polymerization (GO:0051258),0.45126882305778593,1.2516079109708698,0.15240328253223914,0.5832225634619638,1.0,21/56,20.38%,GAS7;JAK2;CHMP4A;CHMP4B;AIF1;TTC17;SPIRE1;PREX1;ARHGAP6;FGF13;MICALL2;UBE2K;RAC1;TPPP;CKAP5;MSRB1;CENPJ;PIN1;RNF135;WASHC5;TRIM6
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6149855996375777,1.2512349310698847,0.22397476340694006,0.5836424607107107,1.0,3/10,7.08%,APOD;PADI2;MIA3
prerank,apoptotic process (GO:0006915),0.41419482938315494,1.250574617768923,0.06924643584521385,0.5848002143611479,1.0,29/203,9.31%,FAP;CASP4;DLC1;TNFRSF21;IAPP;DAP;KREMEN1;TLR2;JAK2;CFLAR;CASP1;BBC3;CASP12;IFT57;HK2;BCL2;MCM2;PAEP;AHR;YARS1;BAG6;IRF1;AIFM2;CD14;RRAGC;EFNA5;CXCR4;OGT;SFRP5
prerank,peptide catabolic process (GO:0043171),0.5211216547533859,1.2503430080831563,0.20410958904109588,0.5848026511522498,1.0,7/23,15.89%,ANPEP;CPQ;XPNPEP1;NPEPPS;ENPEP;LVRN;GGT7
prerank,regulation of defense response to virus by host (GO:0050691),0.49511555339422575,1.2501658899332904,0.18157894736842106,0.5847252121772442,1.0,7/30,16.40%,IL23R;STAT1;TNFAIP3;TRIM44;DTX3L;CGAS;TRAF3IP2
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.2560264156048978,-1.25013709374088,0.0,0.646571341541477,1.0,82/241,25.11%,ELAVL2;U2SURP;SRRM2;PSPC1;SFPQ;SNRNP70;DDX5;HNRNPU;YTHDC1;NOVA2;PRPF6;CDC40;SRSF5;SNRNP48;FRG1;WDR33;CSTF2;CWC22;SNRPN;PABPC1;NOVA1;AQR;HNRNPH3;ZCRB1;U2AF2;ISY1;PRPF38A;PRPF4;USP49;RALY;RBM5;CWF19L1;GCFC2;LSM6;SNRPC;PPIH;HNRNPA1;SNRPG;POLR2A;POLR2H;SRSF7;RBM19;POLR2G;PRPF40B;SRSF9;PPIL3;SNRNP27;POLR2F;RBM17;IK;PRPF19;CWC25;RBM8A;SART1;CPSF2;LSM5;HNRNPR;MAGOH;SNRPD3;HNRNPA3;POLR2E;HNRNPM;HNRNPA0;PRPF8;EIF4A3;SRSF3;CLP1;HNRNPL;CACTIN;DNAJC8;RAVER2;CPSF4;SF3B6;SF3B5;DDX39B;TXNL4A;PDCD7;DDX46;DDX39A;SF3A1;SF3A3;HNRNPD
prerank,inner ear morphogenesis (GO:0042472),0.5308680900267704,1.2499763762812512,0.20215633423180593,0.5846565622912185,1.0,7/22,18.17%,TBX18;CHD7;HOXA1;ZIC1;MYO3A;TTC39C;PAX8
prerank,inhibitory synapse assembly (GO:1904862),0.5990680025087386,1.2492659975696654,0.25990491283676703,0.5861250155103389,1.0,4/11,12.48%,LGI2;NPAS4;WNT5A;FGF13
prerank,amino acid transport (GO:0006865),0.4598780266978547,1.2488944632597778,0.1784431137724551,0.5864875553603234,1.0,8/49,11.38%,SLC7A2;SLC38A3;SLC25A47;SLC7A7;SLC38A4;SLC36A2;SLC7A8;PDPN
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.6149322036635781,1.2484516849665268,0.22345483359746435,0.587155646567798,1.0,3/10,4.80%,DNAJB1;BAG3;NCK1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.5613633582630759,1.2483588061755788,0.22518518518518518,0.5868130943190956,1.0,3/15,6.56%,NEK6;PLK1;CDC27
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.48190194151259225,-1.248092216892209,0.22327044025157233,0.6492629106134253,1.0,6/13,10.49%,TECR;ELOVL7;ELOVL5;HACD1;HACD3;HACD4
prerank,protein localization to phagophore assembly site (GO:0034497),0.6023216499726957,1.2479012688513926,0.21011058451816747,0.5874515542380779,1.0,4/11,15.93%,WIPI1;STX17;PACS2;WDR45
prerank,organic hydroxy compound transport (GO:0015850),0.48283116754104966,1.2476227708250054,0.19350811485642946,0.5875829712511095,1.0,6/36,11.69%,NR1H4;ATP8B1;SLC10A6;NPC2;SLC10A1;SLCO1B1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.46271271308443657,1.247229496419377,0.19308700834326578,0.5880469703402001,1.0,14/46,14.73%,ANTXR1;LAMB1;LAMC1;PEAK1;ITGA8;NRP1;EPHB3;PARVA;EPHA1;LAMC3;RHOA;MICALL2;PIK3R1;RAC1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.4990669814220206,1.2472269274987444,0.19240506329113924,0.5874376293157451,1.0,10/30,17.23%,SFRP4;FSTL1;SMAD2;NREP;SMURF2;ITGA3;SMAD3;SMAD4;LATS2;TRIM33
prerank,negative regulation of viral process (GO:0048525),0.4489998203425724,1.2468329920372285,0.18256772673733804,0.5879488716408703,1.0,12/57,12.30%,TNIP1;STAT1;UBP1;ILF3;TRIM21;SHFL;CCL5;EIF2AK2;TRIM13;TRIM8;OASL;TNF
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.5790450287817465,1.2466200016456281,0.23485967503692762,0.5879245153605127,1.0,4/14,6.54%,SUFU;NFKBIE;PKD2;MDFI
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.39547550294376826,-1.2462992202036565,0.13513513513513514,0.6518690685025594,1.0,11/25,22.56%,HNRNPU;LDB1;NELFB;WDR43;LEO1;EAF2;LARP7;NELFA;SUPT4H1;NELFE;ZMYND11
prerank,negative regulation of anoikis (GO:2000811),0.5751836353454894,1.246075691347037,0.22306525037936267,0.5887880319923614,1.0,6/14,14.06%,SNAI2;TLE1;BCL2;PTK2;ITGA5;SRC
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.41913152908684453,1.2456728220897584,0.12526315789473685,0.5892728434517246,1.0,30/136,16.25%,CYP1B1;DAP;TCF7L2;SFRP4;CMKLR1;TNFAIP3;XCL1;SUFU;IRAK3;NFKBIE;PKD2;TRIM21;RNF2;MDFI;IRAK2;BHLHE40;PYDC1;HEYL;SP100;SFRP5;ERBIN;TNFRSF4;NLRP2B;COMMD7;SPI1;BMP7;TRIB1;PAXIP1;ITCH;RBCK1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5888751753955248,1.245533621302089,0.23684210526315788,0.5890514831534559,1.0,3/12,7.62%,ADIPOQ;IGFBP5;ADAMTS1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4548908836431929,1.245409267809397,0.15625,0.5887742718056457,1.0,20/56,20.69%,PMEPA1;ACVR1;TGFB3;INHBB;EMILIN1;TGFBR1;BMP5;BMPER;TGFB2;LDLRAD4;ACVR2A;BMP7;SMAD4;SNX25;ACVRL1;INHBA;PIN1;GDF9;GDF11;BMPR1A
prerank,transition metal ion transport (GO:0000041),0.4903208917897618,1.24441246694932,0.21635220125786164,0.590947304470122,1.0,9/35,18.03%,HEPH;CP;SLC11A2;TRPC6;SLC31A1;IREB2;SLC30A9;TTYH1;ATP7A
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.6023865695284745,1.2439606154216856,0.24126984126984127,0.5915678167657965,1.0,4/11,5.87%,GATA6;XCL1;LGALS9;ATP6AP2
prerank,visual perception (GO:0007601),0.43406149855218,1.2439545646320511,0.17672886937431395,0.5909668673541839,1.0,8/84,9.31%,COL18A1;COL1A1;RGS16;COL11A1;RDH12;MYO7A;RDH10;SFRP5
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.48665644465585683,1.243771078634386,0.195,0.5908739844804015,1.0,11/34,12.89%,DUSP2;DUSP5;PTPN13;PTPRZ1;PTPN6;PTPN18;PTPN1;PTPRJ;PTPN9;PTPN2;UBASH3B
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.4349423887335287,1.2437041209393602,0.15848214285714285,0.5904398873697557,1.0,15/76,16.25%,CYP1B1;DAP;CMKLR1;TNFAIP3;IRAK3;TRIM21;IRAK2;PYDC1;ERBIN;NLRP2B;COMMD7;SPI1;BMP7;ITCH;RBCK1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.4387746087387196,-1.2432315038304382,0.1987179487179487,0.6576096780691725,1.0,4/16,2.77%,DMD;ATP1A2;ANK2;CALM1
prerank,regulation of neuroblast proliferation (GO:1902692),0.569501480336265,1.2431822219332747,0.21726190476190477,0.5911882325026818,1.0,9/15,25.00%,PTN;LRRK2;NF1;DISC1;CX3CL1;KDM1A;SMARCD3;FZD3;VEGFA
prerank,MAPK cascade (GO:0000165),0.4070237581078738,1.2430961185010103,0.05241935483870968,0.5908148313838357,1.0,72/295,17.44%,PSMA7;PDGFRA;ZFP36L1;MAP4K4;TAOK1;PTPN7;RASA3;JAK1;LRRK2;ZFP36L2;PLVAP;IRS1;PDGFRB;FGF7;JAK2;DUSP5;SPRED1;EGFR;CUL1;ABHD17C;PTPN3;LGALS9;NF1;CCM2;CCL5;EGF;IL3RA;DLG4;SKP1;TAOK3;ANGPT1;MAPK11;GRB2;PSMB8;BRAP;PSMA6;MAP2K1;FRS2;CCL2;RALGDS;FGFR1;PTK2;NRK;PDE6D;PPP1CB;FBXW11;TNF;FGF13;FGF2;PSMF1;BTC;PIK3R1;RANBP9;RASAL1;ABHD17B;ZDHHC9;SETX;PSMA8;FNTB;FGF18;PSMD2;PSMD12;PSMD11;RGL1;SYNGAP1;RASA1;PSMD14;MAPK1;PTPRA;DUSP6;YWHAE;MAP3K3
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5013182813609278,1.2424231800320829,0.20052770448548812,0.5919890528051125,1.0,12/26,22.60%,NCOR2;SFRP1;PIAS2;HEYL;HDAC1;CALR;CLOCK;SMARCA4;ZBTB7A;FOXP1;CNOT2;NCOR1
prerank,regulation of cell population proliferation (GO:0042127),0.4027471875536479,1.2420697212099396,0.005,0.5924261191640183,1.0,103/691,11.96%,ROR2;RUNX1;GLMN;CYP1B1;COL18A1;DLC1;CXCL5;IL34;WNT2;CXCL1;OSMR;IGFBP7;PDGFRA;EDN3;YAP1;PPP1R9B;ZFP36L1;TCF7L2;SFRP4;PTN;BCL6;MEIS2;STAT1;CCAR1;GAB2;TIMP1;IRS1;PDGFRB;PRTN3;FGF7;JAK2;WNT9A;TSLP;CDKN2B;EGFR;NUAK1;STAT3;MEIS1;TBX2;FRZB;FXN;JAG1;SHH;ALDH1A2;PTEN;BCL2;AIF1;PKD2;LIMS1;CYP27B1;NCK2;NF2;CACUL1;EGF;STRN;CDK6;SFRP1;STAT5A;TGFB3;EAPP;EIF2AK2;PTPN6;CXCL10;PDS5B;GLP2R;S1PR3;EPHA1;PINX1;IRF1;ADAMTS1;CDK10;EEF1E1;FRK;CELF1;BTG1;GPNMB;S1PR2;TGFBR1;MAP2K1;HDAC1;CSNK2A1;SFRP5;IL7;BMP5;TGFB1I1;JUNB;NOP2;HMGB2;LIFR;TBX3;RERG;FGFR1;WWTR1;PTPRJ;KLF10;PTPN2;PTK2;PDPN;TGFB2;GCNT2;CALR;TIMELESS;RHOA
prerank,ESCRT III complex disassembly (GO:1904903),0.6135863712016666,1.2417023440331767,0.2476038338658147,0.5921525508096054,1.0,3/10,15.31%,VPS4A;CHMP7;CHMP2B
prerank,ESCRT complex disassembly (GO:1904896),0.6135863712016666,1.2417023440331767,0.2476038338658147,0.5921525508096054,1.0,3/10,15.31%,VPS4A;CHMP7;CHMP2B
prerank,lipid droplet formation (GO:0140042),-0.5193195789139322,-1.2414569638049706,0.20604395604395603,0.6599079164618987,1.0,5/10,25.61%,CDS2;BSCL2;SQLE;PLA2G4C;FITM2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.4820015664099158,1.2412883961160073,0.18976279650436953,0.5926835953096901,1.0,11/35,11.84%,SULF1;SPARC;STAT1;APOE;NR2F2;NF1;APOH;PPARG;AIMP1;CCL2;PTPRM
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.40104350048707343,1.2412847964496276,0.018,0.5920887185512976,1.0,96/509,13.29%,ROR2;ROR1;DCN;ADIPOQ;MAP3K14;TRIML2;PDGFRA;NEK6;IAPP;TCF7L2;TNFSF11;NOS1AP;GAB2;TLR2;ALPK1;CD40;IRS1;PDGFRB;FGF7;JAK2;BIRC3;CFLAR;CASP1;EGFR;P2RX5;REL;TREM2;RICTOR;LITAF;BBC3;IKBKE;MIOS;SLC20A1;PUM1;UNC5CL;BCL2;PRKD2;LGALS9;NOD1;LIMS1;TRIM21;CCL5;EGF;STRN;EIF2AK2;PTPN6;PIK3AP1;HPSE;TLR7;SASH1;VAPA;PIK3R5;RPTOR;TIRAP;TRIM13;ANGPT1;TMEM106A;CD14;TRIM8;CBL;GRB2;RRAGC;TGFBR1;WNT5A;FRS2;IRAK4;OASL;WLS;EDA2R;CXXC5;GAPDH;TNFRSF1A;FGFR1;FNIP1;TRIM44;PTPRJ;PTK2;TGFB2;CASP8;GCNT2;ANKRD17;UNC5B;SPRY2;RHOA;VAV1;TNF;FGF2;NTRK3;AKAP13;MC1R;RASD2;TRAF2;SMCR8;SPHK2;BTC;PIK3R1
prerank,protein localization to plasma membrane (GO:0072659),-0.2769453509908663,-1.240990677598385,0.05405405405405406,0.6583134278139334,1.0,32/129,9.26%,KCNIP4;ATP1B3;TSPAN5;CACNB2;BSG;ATP1B1;ACTN2;ANK2;KCNB2;CD81;EFR3B;TTC7B;DPP10;DPP6;C2CD5;EZR;GAS6;EHD4;SLMAP;RAMP1;RAPGEF2;WNK3;RAMP2;CDH1;CCDC88A;RAB3C;ZFYVE27;PACSIN1;MAP7;RAPGEF6;ANK3;INPP5K
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.36711583174463813,-1.2404261774253595,0.14814814814814814,0.6568782528376036,1.0,18/31,20.52%,EPHA4;TANC2;SRCIN1;SHANK3;ARHGAP44;CUX2;NGEF;PDLIM5;CAMK2B;LRP8;ZDHHC15;ABI3;KIF1A;RELN;DHX36;CFL1;NLGN1;PPFIA2
prerank,BMP signaling pathway (GO:0030509),0.4439558358409129,1.240391420177224,0.1853546910755149,0.5938502809718275,1.0,21/62,20.88%,RUNX2;SMAD2;USP9X;ACVR1;HIVEP1;TGFB3;SMAD5;BMP5;TGFB2;ACVR2A;SMAD3;BMP7;SMAD4;SMAD1;SMURF1;CHRD;ACVRL1;ZFYVE16;GDF9;BMPR1A;RGMB
prerank,lytic vacuole organization (GO:0080171),0.4942256412527629,1.2398747317824128,0.2,0.5946342620078573,1.0,7/32,14.50%,ABCA1;LRRK2;HOOK2;MYO7A;CLN6;TPCN2;GAA
prerank,muscle contraction (GO:0006936),-0.27287857985838115,-1.2394792289019365,0.019230769230769232,0.6569968269949599,1.0,23/126,14.49%,SORBS1;DMD;ACTN2;MYOF;CALM1;DTNA;SNTA1;TMOD3;MYL6;SNTB1;SORBS3;GLRA1;BDKRB2;DYSF;ADRA1A;VCL;MYL9;MYOM1;LMOD1;KCNJ12;ACTA2;TPM2;ARHGEF11
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.48133458640243937,1.2393135437337972,0.2076923076923077,0.5955692206722502,1.0,11/34,19.09%,TNFAIP3;IRAK3;TREM2;LY96;RAB7B;CD14;NLRP2B;SMPDL3B;MFHAS1;CD300LF;TYRO3
prerank,cellular zinc ion homeostasis (GO:0006882),0.5163712913666418,1.2389861558786732,0.2119205298013245,0.5959082216604715,1.0,1/26,0.13%,SLC39A14
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3730159273448151,-1.2389161451707338,0.18376068376068377,0.6557920039157361,1.0,15/29,22.16%,SLC4A10;MCTP1;SHISA6;CLN3;APP;CAMK2B;GRIK2;ZDHHC2;SHISA7;SYP;NCDN;SYNGR1;SLC8A2;DRD2;SHISA9
prerank,amino acid import across plasma membrane (GO:0089718),0.5078061021502873,1.238906186842341,0.20713305898491083,0.5954830902439754,1.0,2/24,0.63%,SLC7A2;SLC1A3
prerank,aortic valve morphogenesis (GO:0003180),0.49202719570609377,1.2385579989266864,0.21298701298701297,0.5957902306898742,1.0,7/30,7.87%,SNAI1;ROBO2;SLIT3;SNAI2;JAG1;EMILIN1;HEYL
prerank,dendritic cell migration (GO:0036336),0.5553769430295207,1.2380147928812806,0.23444283646888567,0.5966161162964014,1.0,6/16,22.13%,CCR1;CCL5;CXCR4;TRPM4;EPS8;TRPM2
prerank,smooth muscle cell differentiation (GO:0051145),0.5707062798708087,1.237770350024987,0.23492063492063492,0.5966916894696457,1.0,3/12,2.70%,TBX18;MRTFA;GATA6
prerank,actin polymerization or depolymerization (GO:0008154),0.45714066989718893,1.2372189158068114,0.18203309692671396,0.5975087454505592,1.0,13/50,14.73%,GAS7;SVIL;JAK2;AIF1;ABI2;TTC17;SPIRE1;PREX1;VILL;ARHGAP6;MICALL2;ABI1;RAC1
prerank,regulation of vacuole organization (GO:0044088),0.522620733509743,1.2371467285678222,0.2441860465116279,0.5970945242169238,1.0,13/20,27.83%,NPRL2;IFT88;ENO1;ADPRH;MTMR3;MTM1;IFT20;RAB5A;TBC1D12;ENO3;ANXA2;SCARB2;ENO2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.45197726616470174,1.2370708441394986,0.17983963344788087,0.5966915100179178,1.0,12/56,13.21%,RAD51B;EGFR;AIF1;CCND3;ANAPC11;CDC27;ADAMTS1;RPTOR;ANXA1;KMT2E;ANKRD17;NSMCE2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4160190951383363,1.235667635832025,0.10961737331954498,0.5999447917755588,1.0,35/138,18.89%,RORA;NR1H4;NCOR2;YAP1;RARB;RXRG;MAML3;TEAD3;TAF7;CREBBP;PPARG;GTF2H1;MAML2;HDAC1;TBL1X;GTF2F2;NR2F1;WWTR1;TEAD1;CDK7;E2F3;MAML1;GTF2F1;TAF4;NR6A1;MED26;NRBF2;TAF2;POLR2L;POLR2K;RBPJ;HDAC5;NR2C2;CDK9;NR3C1
prerank,positive regulation of cell cycle process (GO:0090068),0.4323023900645327,1.2354229283903548,0.14639397201291712,0.6000217820733987,1.0,22/91,14.53%,SVIL;EDN3;PDGFRB;DYNC1H1;MAD2L1;INO80;EGF;XRCC3;DDX11;CDC42;E2F8;GPSM2;DRD3;DBF4;OPN1MW;CSPP1;RHOA;CEP120;BTC;GIPC1;ATRX;CDC14A
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5062311561103542,1.234747770979376,0.20451527224435592,0.6013356562482932,1.0,4/26,12.24%,LBP;TLR2;TIRAP;PJA2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.39927996770378715,1.234331052026504,0.017,0.6019345139149036,1.0,112/572,14.46%,RUNX1;NR1H4;TRPS1;RUNX3;ZEB2;POU5F1;GLI2;ZEB1;ETV6;NCOR2;YAP1;DEAF1;TCF7L2;NRIP1;SNAI1;ATXN1;GLI3;BCL6;MEIS2;STAT1;RARB;IRF7;BACH1;GATA6;SNAI2;ZFPM2;FHL2;DNAJB1;NKX6-1;MITF;CRYM;ARID5B;SMAD2;NFIX;MIER2;SUFU;MLIP;GLIS1;STAT3;CGGBP1;TBX2;USP9X;NR2F2;ARID5A;SHH;KMT5A;SMURF2;MBD2;E2F1;PRDM5;BAG3;PRDM2;PPID;TAF7;HIVEP1;RNF2;CREBBP;CBX8;PPARG;PLK1;ETV5;ENO1;ZHX2;MDFI;FOXE1;E2F8;NOC2L;BHLHE40;FRK;SP100;HDAC1;ZBTB5;SALL1;FOXO3;TBL1X;DICER1;FOXP4;PRDM1;NR2F1;MTA2;CXXC5;TGIF2;TBX3;EID1;FNIP1;CBFB;GATAD2B;KLF10;ELK4;ZGPAT;PHF21A;DNMT3B;CALR;LCOR;TNF;DUSP26;SKOR2;GLIS3;SPI1;RIF1;GATAD2A;CTCF;SMAD3;DACT1;PSEN1;KCNIP3;ATRX;TRIB3;DRAP1;TFAP2C;SMAD4;MAFK
prerank,regulation of cartilage development (GO:0061035),0.5432211637365791,1.2343268636276543,0.23209169054441262,0.6013368128772548,1.0,4/18,5.18%,TRPS1;SOX5;MDK;BMP1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5373705765764463,1.234259238312167,0.20084865629420084,0.6009165030844746,1.0,2/19,0.97%,DCN;CCBE1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4913796521731183,1.2339491365319604,0.1932555123216602,0.601101229769022,1.0,14/30,22.60%,NCOR2;KLK2;SFRP1;PIAS2;HEYL;HDAC1;SAFB2;SMARCA4;ZBTB7A;KDM1A;FOXP1;RNF14;PKN1;NCOR1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.48301861694937764,1.233894380335079,0.20986093552465235,0.6006449868954565,1.0,7/33,15.17%,CYP1B1;TNFAIP3;FXN;ANXA1;NFE2L2;RIPK1;SETX
prerank,regulation of osteoblast differentiation (GO:0045667),0.43077553733499907,1.2335829784127514,0.16539717083786726,0.6008850844961915,1.0,17/82,11.90%,RUNX2;FBN2;YAP1;TNN;SNAI2;CCN4;NELL1;SUFU;DDR2;ACVR1;CDK6;PPARG;TMEM119;WWTR1;PTK2;NBR1;ACVR2A
prerank,synapse assembly (GO:0007416),0.4462258501816286,1.2335065957095097,0.18959537572254334,0.6005079655718764,1.0,16/67,12.66%,LGI2;SLITRK6;PCDHB6;PCDHB16;FARP1;SDK2;NPAS4;ADGRL3;PTEN;FZD1;PLXND1;WNT5A;DSCAM;DBNL;FGF13;SDK1
prerank,protein localization to mitochondrion (GO:0070585),0.6036880735931556,1.2334333522181036,0.23565891472868217,0.6000793213021506,1.0,6/11,20.63%,LRRK2;HK2;RALA;AKT1;MAIP1;ISG15
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.5000599429098309,1.2332301659790217,0.22457067371202113,0.6000263651965779,1.0,2/27,0.63%,SLC7A2;SLC1A3
prerank,actin filament polymerization (GO:0030041),0.48787042643086986,1.2330288457017333,0.20969855832241152,0.5999632842669255,1.0,9/29,14.73%,GAS7;JAK2;AIF1;TTC17;SPIRE1;PREX1;ARHGAP6;MICALL2;RAC1
prerank,negative regulation of blood pressure (GO:0045776),0.583254153114575,1.2324253947462316,0.24127465857359637,0.6009714597557008,1.0,3/13,13.63%,ADIPOQ;DRD3;SCPEP1
prerank,mitotic sister chromatid segregation (GO:0000070),0.42132157255337016,1.2323980857784282,0.16648764769065522,0.6004307301671368,1.0,18/98,9.35%,KIFC1;EML4;SMC1A;KLHL22;CHMP4A;CHMP4B;NAA50;KMT5A;TUBG1;INO80;PLK1;PDS5B;VPS4A;PINX1;PDS5A;CSNK2A1;CSNK2A2;EML3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.4766410035948826,1.2321172944630887,0.1889168765743073,0.600595920744591,1.0,11/37,13.72%,DYNLL1;IFT57;IFT88;PCM1;DYNC2LI1;TRIP11;WDR35;TNPO1;IFT172;IFT81;DYNC2H1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.4098490957270894,1.2318193344655923,0.11746680286006128,0.600802561036696,1.0,56/166,23.36%,RORA;NR1H4;NCOR2;YAP1;RARB;RXRG;TAF1D;MAML3;TEAD3;TAF7;POLR1E;CREBBP;PPARG;GTF2H1;MAML2;HDAC1;TBL1X;GTF2F2;CRCP;NR2F1;WWTR1;TEAD1;RSF1;CDK7;E2F3;MAML1;GTF2F1;POLR1B;BRF1;TAF1A;TAF4;NR6A1;MED26;NRBF2;POLRMT;TAF2;POLR2L;POLR2K;RBPJ;HDAC5;NR2C2;CDK9;NR3C1;MED1;POLR1G;ERCC2;THRA;NR1D1;NR1D2;RARG;POLR1A;NCOR1;CCNH;THRB;POLR2D;MNAT1
prerank,positive regulation of transferase activity (GO:0051347),0.41258973079062283,1.2316394752419895,0.1462655601659751,0.6006932109334805,1.0,18/142,8.41%,ROR2;ROR1;EPHA7;ADIPOQ;PDGFRA;PARM1;PDGFRB;ARRDC4;EGFR;EPHB3;TREM2;DDR2;PLK1;EPHA1;ARRDC3;MERTK;DCUN1D1;FBXW7
prerank,proton transmembrane transport (GO:1902600),0.4788534171563826,1.2314875989360579,0.20998719590268886,0.6004823805850258,1.0,7/36,12.92%,HVCN1;SLC9A1;ATP5PO;DMAC2L;SLC36A2;ATP6V1F;ATP6V1H
prerank,regulation of ion transmembrane transport (GO:0034765),-0.3697528961537368,-1.2314629933975472,0.1715686274509804,0.6743005210202802,1.0,9/33,13.73%,AKAP6;WWP2;KCNJ2;WNK3;KCNJ3;KCNJ13;KCNJ10;KCNQ1;KCNJ12
prerank,respiratory tube development (GO:0030323),0.48970060421881506,1.2313401827532082,0.2300771208226221,0.6002811135188352,1.0,9/28,12.48%,GLI2;FGF7;SHH;BAG6;ITGA3;LOXL3;NPHP3;PDPN;FGF2
prerank,embryonic organ development (GO:0048568),0.45037938506094655,1.231288146542432,0.17573696145124718,0.5998122974335256,1.0,13/61,12.30%,KMT2A;GLI2;COL13A1;GLI3;RARB;TBX2;TEAD3;PBX3;FOXE1;SALL1;TEAD1;TGFB2;TNF
prerank,macrophage differentiation (GO:0030225),-0.4644243931422749,-1.2311700236747842,0.20786516853932585,0.6723608640182234,1.0,3/13,2.29%,IL15;BMP4;IL31RA
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.5210713129398118,1.2310619908774911,0.23224043715846995,0.5998138717789265,1.0,9/21,22.46%,MAD2L1;PTEN;PLK1;SKP1;RAB1A;RPL11;FBXO5;CDC14B;FZR1
prerank,positive regulation of vascular permeability (GO:0043117),-0.48879174798517777,-1.230817048859113,0.21944444444444444,0.6704455573299437,1.0,4/12,0.74%,TJP1;BMP6;TJP2;OCLN
prerank,negative regulation of cellular component organization (GO:0051129),0.43284873150023884,1.230603731051139,0.1662971175166297,0.6005001938905501,1.0,13/74,12.44%,FAP;NR1H4;IAPP;DNAJB1;IRAK3;AIDA;CARMIL1;CDC42;SNX33;DNAJB6;SPRY2;TNF;GSK3B
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4442157430642405,1.2305880398022202,0.18275862068965518,0.5999566589926185,1.0,11/57,12.30%,IL23R;GHR;CD40;JAK2;TSLP;STAT3;NF2;CCL5;TNFRSF1A;PTPN2;TNF
prerank,detection of mechanical stimulus (GO:0050982),0.5255006635963229,1.229207780554201,0.23504867872044508,0.6032244305158861,1.0,6/19,18.83%,PIEZO2;PKD2;PTK2;PKD1L3;LHFPL5;PIEZO1
prerank,regulation of heart contraction (GO:0008016),-0.2922009205951001,-1.228579983134274,0.060240963855421686,0.6742627414758844,1.0,20/90,14.38%,ATP1A2;ATP1B3;ATP1B1;ANK2;CELF2;CALM1;ITPR2;ATP2B4;ATP2B2;SLC8A3;ABCC9;NPR1;ITPR3;DMPK;FXYD6;PDE4D;KCNQ1;KCNJ12;ATP2A3;STIM1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.45827466081868384,1.228536216635192,0.1901913875598086,0.6044840378496187,1.0,11/47,11.67%,MID1;MAP4K4;TAOK1;EGFR;LGALS9;RAP2A;EIF2AK2;TAOK3;MAP2K1;TGFB2;NBR1
prerank,regulation of GTPase activity (GO:0043087),0.4048045737389908,1.2284424303917676,0.12284263959390863,0.6041218049453936,1.0,37/177,12.76%,CCL11;CCL7;RGS16;MAP4K4;VAV2;ARHGAP15;LRRK2;CD40;PRTN3;VAV3;XCL1;PLXNC1;EPHB3;ASAP3;NF1;LIMS1;FGD4;CCL5;SFRP1;EPHA1;PLXND1;RSU1;ZC3H15;RRP1B;PLXNA3;EFNA5;SNX18;RABGAP1;RAB3GAP2;CCL2;MAPRE2;PTK2;SNX9;FGD6;VAV1;GSK3B;RGS10
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.5188040086608597,1.2282336518527996,0.22134387351778656,0.6040989568555826,1.0,2/22,2.90%,IL23R;XCL1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.45418608167896674,-1.228201921928373,0.19745222929936307,0.6725516899855124,1.0,6/15,14.55%,KCND3;ATP1B1;KCNJ2;KCNJ3;KCNQ1;KCNN2
prerank,epithelial to mesenchymal transition (GO:0001837),0.4662300154972144,1.2280491904506619,0.1901840490797546,0.6040409105339475,1.0,19/47,20.05%,SNAI1;SNAI2;LIMS1;DDX17;HEYL;TGFBR1;WNT5A;TBX3;LOXL3;FGFR1;TGFB2;GSK3B;DLG5;BMP7;HIF1A;OLFM1;RBPJ;TASOR;HMGA2
prerank,regulation of kinase activity (GO:0043549),0.425103701259836,1.2276126808433305,0.16337719298245615,0.6045463157833781,1.0,11/89,6.61%,ROR2;ROR1;EPHA7;PDGFRA;PDGFRB;EGFR;EPHB3;TREM2;DDR2;NPRL2;EPHA1
prerank,regulation of phospholipase activity (GO:0010517),0.6064551738717684,1.227608658994834,0.2533532041728763,0.6039693793268559,1.0,2/10,10.51%,LRP1;FGFR1
prerank,regulation of mitochondrial fission (GO:0090140),0.501188232341649,1.2270854190486964,0.21363040629095675,0.6047278681876606,1.0,5/24,8.71%,DCN;LRRK2;RALA;SPIRE1;INF2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.48267822344206035,1.226853436401658,0.22509702457956016,0.6047607046778158,1.0,4/32,6.32%,CEMIP;XCL1;PKD2;CXCL10
prerank,positive regulation of kinase activity (GO:0033674),0.418630074888729,1.226814876282509,0.1491891891891892,0.604267421225165,1.0,15/107,7.98%,ROR2;ROR1;EPHA7;PDGFRA;JTB;PDGFRB;EGFR;EPHB3;TREM2;LCP2;DDR2;CACUL1;EPHA1;RASSF2;MERTK
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.43775164715412374,1.2267208628977477,0.18202247191011237,0.6039212550978945,1.0,21/67,14.73%,SULF1;VAV2;VAV3;NRP1;DOCK1;NCK1;BAIAP2;PRKD2;NCK2;CDC42;MAPK11;BRK1;PTK2;RHOA;SHB;VAV1;VEGFC;ABI1;PIK3R1;SRC;RAC1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.49076046420447417,1.2262805592937367,0.21166032953105196,0.6045748146786117,1.0,2/29,2.90%,IL23R;XCL1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.32360602869668353,-1.2261618941139463,0.15602836879432624,0.675656181809205,1.0,9/54,4.59%,KCNIP4;CAV1;FHL1;AKAP6;WWP2;DPP10;DPP6;KCNJ2;KCNJ3
prerank,positive regulation of cell differentiation (GO:0045597),0.40194633913771455,1.2260664423960517,0.09929078014184398,0.6045547217444444,1.0,62/237,19.37%,RUNX2;COL1A1;ZEB1;EDN3;FBN2;YAP1;ZFP36L1;TCF4;SNAI1;SOX5;PTN;CMKLR1;CCN4;NELL1;SMAD2;FRZB;MDK;DDR2;ACVR1;ASXL2;CD36;SFRP1;PPARG;TGFB3;CDC42;TMEM119;CARM1;HEYL;MAPK11;BTG1;LPL;TGFBR1;TGFB1I1;FGFR1;WWTR1;PDPN;TGFB2;GCNT2;ACVR2A;RHOA;RIN2;WDFY2;MSR1;SMAD3;BMP7;SMAD4;TRPM4;FES;IL6R;CTNNA1;TCF3;OLFM1;ACVRL1;AKT1;AAMDC;PAX8;AGT;FBXO5;AXIN2;LRP5;CTNNBIP1;VWC2
prerank,positive regulation of MAP kinase activity (GO:0043406),0.44543477131355724,1.22573417350977,0.1935483870967742,0.604923924181667,1.0,15/66,13.07%,IL34;EDN3;TNFSF11;LRRK2;CD40;PDGFRB;EGFR;EGF;SASH1;TAOK3;PIK3R5;FGFR1;TNF;FGF2;TRAF2
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.3670089409919622,-1.2257158973067301,0.1650943396226415,0.6740274994150705,1.0,15/31,30.82%,GPHN;MOCS2;CYP51A1;DHRS11;LIAS;NFS1;LSS;PRLR;NOXRED1;FDFT1;PYCR2;STAR;MOCS3;PYCR3;GCH1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.3954734513800836,-1.2254190947613788,0.20869565217391303,0.6721915041721372,1.0,16/24,29.80%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;SEMA4D;SEMA5A;SEMA5B;SEMA3G;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA6B;SEMA4G;SEMA3F
prerank,acylglycerol biosynthetic process (GO:0046463),-0.3890759549550219,-1.2245879279451366,0.1801470588235294,0.6717480533876059,1.0,6/23,14.31%,PLCE1;AGMO;LPGAT1;LPIN1;DGAT1;GPAT4
prerank,positive regulation of B cell activation (GO:0050871),0.4657378008513157,1.2237570107371407,0.17464114832535885,0.6096667614677732,1.0,12/50,15.02%,MMP14;SH3KBP1;CD40;VAV3;BCL2;SASH3;TIRAP;SHLD3;IL7;TNFRSF4;RIF1;PAXIP1
prerank,regulation of centrosome duplication (GO:0010824),0.48539974568974054,1.223709090071705,0.2131578947368421,0.6091954866120669,1.0,10/30,20.16%,CEP295NL;CHMP4B;ALMS1;XRCC3;NAT10;CEP120;CENATAC;CHMP2B;CENPJ;PLK2
prerank,cellular response to virus (GO:0098586),0.49350857435367235,1.2236441340803847,0.24302788844621515,0.6087908119138197,1.0,11/30,21.08%,LGALS9;CCL5;CXCL10;RRP1B;MAPK11;GBF1;ARF1;FMR1;HIF1A;IRGM;ZC3H12A
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.5174604900529124,1.2234902135398322,0.23226703755215578,0.6086116156454852,1.0,11/21,21.40%,ADAM19;PRTN3;MYH9;SPPL3;PSEN1;PSENEN;RBMX;NCSTN;ADAM9;PSEN2;HM13
prerank,ncRNA transcription (GO:0098781),0.5619578605303586,1.2233615850448891,0.24143302180685358,0.6083751602040081,1.0,6/13,20.16%,SNAPC3;USPL1;GTF3A;BRF1;RPAP2;POLR1G
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.5606917816069894,1.2232905319543101,0.23583460949464014,0.6073802153772837,1.0,4/13,8.42%,JAK1;STAT3;STAT5A;GRB2
prerank,cellular response to interleukin-15 (GO:0071350),0.5606917816069894,1.2232905319543101,0.23583460949464014,0.6073802153772837,1.0,4/13,8.42%,JAK1;STAT3;STAT5A;GRB2
prerank,membrane fusion (GO:0061025),-0.3681454723535437,-1.2231943681341646,0.18095238095238095,0.6731832970603426,1.0,11/33,16.82%,DNM3;MYOF;HUWE1;NSF;DYSF;GCA;HACE1;RIMS1;DNM1L;NAPA;DNM2
prerank,positive regulation of cellular process (GO:0048522),0.3946784897337958,1.2226020889873177,0.023,0.6086687973870504,1.0,107/565,14.74%,IBSP;HP;HPR;CXCL5;IL34;WNT2;LBP;OSMR;PDGFRA;LRP1;MMP14;EDN3;CXCL12;ZFP36L1;COLEC12;EIF4G2;PTN;MEIS2;CCAR1;GAB2;TLR2;TIMP1;IRS1;PDGFRB;PRTN3;FGF7;PRKCA;KLHL22;TSLP;EGFR;P2RX5;TREM2;MEIS1;TBX2;DYNC1H1;FXN;MDK;SHH;PTEN;BCL2;AIF1;PRKD2;RHOD;PABIR1;TRIM21;CD36;INO80;CACUL1;CCL5;EGF;ATM;SFRP1;LRP6;TGFB3;EAPP;PTPN6;CDC42;GLP2R;S1PR3;EPHA1;TENM4;RPTOR;TRIM13;MERTK;CELF1;S1PR2;RAD23A;EXOSC4;TGFBR1;FKBP1B;WNT5A;HDAC1;CSNK2A1;IL7;DICER1;BMP5;NOP2;PPP3CA;LIFR;TBX3;FGFR1;WWTR1;PTPRJ;PTK2;CSPP1;PDPN;TGFB2;GCNT2;CALR;ANKRD17;TNF;VEGFC;FGF2;NTRK3;DUSP26;P2RX7;BTC;DDRGK1;POFUT2;GAREM1;EGR2;CDKN1B;FMR1;PDCD10;TRPM4;RAC1;CX3CL1
prerank,mitotic cell cycle phase transition (GO:0044772),0.4010400454101709,1.2225736088157138,0.125,0.608150237994066,1.0,59/204,18.90%,DYNLL1;CDKN2B;FBXL7;CHMP4B;DYNC1H1;CCNE2;CUL1;E2F1;KHDRBS1;TUBG1;ACVR1;CACUL1;ALMS1;CDK6;CCND3;CDK14;PLK1;PCM1;CDC27;HAUS3;SKP1;CEP41;CNTRL;PHLDA1;DCTN3;BORA;DBF4;RPS6KB1;PCNT;ACVR1B;PPP2R2A;EIF4EBP1;CCNB2;CDK7;CEP72;E2F3;PPP1CB;FBXW11;CCNI;CHMP7;PPME1;ACTR1A;AKAP9;CDKN1B;GSPT1;PPP6C;CEP192;MAX;RCC1;CSNK1D;LATS2;YWHAE;CKAP5;TAF2;INHBA;CENPJ;HINFP;EPS8;HAUS6
prerank,mitochondrion localization (GO:0051646),0.5221692335049432,1.2225204000461105,0.24615384615384617,0.6076998958595095,1.0,4/19,11.73%,LRRK2;MARK1;TRAK1;ZBED3
prerank,regulation of interleukin-1 beta production (GO:0032651),0.43922637528284636,1.222403331129997,0.19686800894854586,0.6074173079885214,1.0,21/66,21.82%,TNFAIP3;JAK2;CASP1;STAT3;LGALS9;CD36;PYDC1;TMEM106A;LPL;WNT5A;CASP8;TNF;NLRP2B;P2RX7;CX3CL1;CPTP;PANX1;FOXP1;ZC3H12A;SIRPA;NLRP12
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4316954305598917,1.2221922280647342,0.19655172413793104,0.6074233301520332,1.0,17/66,11.83%,CDKN2B;EGFR;E2F1;PTEN;AIF1;PKD2;INO80;CDK6;CCND3;PTPN6;ADAMTS1;RPTOR;GPNMB;ANXA1;CCL2;KMT2E;ANKRD17
prerank,stem cell development (GO:0048864),0.5419250116596672,1.2213103315953864,0.2444113263785395,0.6092151902840023,1.0,5/16,17.01%,SNAI2;SHH;TAPT1;NOLC1;PTPRC
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.40331548435721415,-1.2212027154284864,0.1918819188191882,0.6760264292635431,1.0,7/23,12.82%,HDAC7;CCN3;NMI;TMSB4X;ADIPOR1;C1QTNF3;CYLD
prerank,neuron development (GO:0048666),0.40885939850793984,1.2206706369692875,0.1409185803757829,0.6103311006011621,1.0,19/141,7.73%,RUNX1;RUNX3;GPM6B;GLI2;LAMB1;PPP1R9B;LRP12;B4GALT5;ATXN10;UGCG;TENM3;APOE;BLK;PBX3;OPHN1;DTNBP1;TENM4;VAPA;L1CAM
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.48137344524374426,-1.2205632817174745,0.21865889212827988,0.6750659008631552,1.0,8/12,35.85%,PSAT1;CBS;SEPHS1;PHGDH;SEPHS2;CTH;GGT1;SERINC3
prerank,synaptic vesicle localization (GO:0097479),-0.464592633812298,-1.2202622535535566,0.21316614420062696,0.6731719107185907,1.0,7/13,19.82%,RAB27A;SYNDIG1;SNAPIN;TOR1A;SYNJ1;DNM2;NLGN1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5946893503834422,1.2197705331686828,0.2492063492063492,0.6121767107117506,1.0,6/11,18.70%,GPM6B;TAX1BP3;SNX33;LEPROT;PICALM;LEPROTL1
prerank,cellular response to ketone (GO:1901655),0.4831110924191015,1.2197003415792471,0.23037974683544304,0.6117614546028606,1.0,14/35,22.98%,SPP1;ADCY2;SFRP1;AHR;MSN;GNAI1;SPHK2;SRC;GNB1;NR3C1;PTGFR;ROCK2;NDOR1;KLF9
prerank,organic acid transport (GO:0015849),0.42338777182785026,1.2189339839874362,0.16630669546436286,0.6132290646493688,1.0,15/94,11.76%,NR1H4;SLC7A2;SLC38A3;ATP8B1;SLC10A6;SLC25A47;SLC7A7;SLC38A4;SLC13A5;SLC36A2;SLC7A8;SLC10A1;PDPN;SLCO1B1;SFXN5
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.57082333045647,1.218531009231843,0.2621664050235479,0.6136963464426101,1.0,6/13,25.50%,CBLB;KPNA3;NUP35;KPNA2;KPNB1;RGPD1
prerank,cellular response to hydroxyurea (GO:0072711),0.6002845197857478,1.2182704082928184,0.25508607198748046,0.6138285877770213,1.0,4/10,14.28%,DDX11;TIMELESS;ATRX;FMR1
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.5025220326825939,-1.2181845452712994,0.23195876288659795,0.6762035818332414,1.0,3/10,7.68%,RB1;HSP90AA1;SORL1
prerank,protein localization to membrane (GO:0072657),-0.2660050612264332,-1.2176922540701403,0.0,0.6749565361375396,1.0,44/187,9.26%,KCNIP4;ATP1B3;TSPAN5;CACNB2;CAV1;SYNJ2BP;NRXN1;BSG;ATP1B1;LRRC7;ACTN2;DLG2;ANK2;KCNB2;CD81;LIN7A;EFR3B;TTC7B;DPP10;DPP6;C2CD5;SHANK3;EZR;GAS6;EHD4;SLMAP;RAMP1;CPE;AGRN;RAPGEF2;WNK3;RAMP2;CDH1;RAB3C;NRXN2;ARL3;ZFYVE27;PACSIN1;MAP7;RAPGEF6;FRMPD1;TM9SF1;ANK3;INPP5K
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.429576877037686,1.2176396201853386,0.1997780244173141,0.6149610661701194,1.0,17/70,13.29%,ANTXR1;LAMB1;LAMC1;PEAK1;ITGA8;NRP1;SIPA1L3;EPHB3;PARVA;OPHN1;EPHA1;ABI2;LAMC3;RHOA;MICALL2;SPI1;PIK3R1
prerank,regulation of potassium ion transport (GO:0043266),-0.3711245416947558,-1.21706869666028,0.19130434782608696,0.6739932363579773,1.0,6/31,2.68%,KCNIP4;FHL1;ACTN2;ANK2;DPP10;DPP6
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5192075597578818,1.2165664486495713,0.2370266479663394,0.617278686442175,1.0,9/20,18.24%,SNAI1;SNAI2;HEYL;TGFBR1;TBX3;TGFB2;OLFM1;ACVRL1;RBPJ
prerank,stress fiber assembly (GO:0043149),-0.42904365720982157,-1.216525761815075,0.22429906542056074,0.6703078601747221,1.0,2/15,0.40%,SORBS1;PHACTR1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.42904365720982157,-1.216525761815075,0.22429906542056074,0.6703078601747221,1.0,2/15,0.40%,SORBS1;PHACTR1
prerank,prostanoid metabolic process (GO:0006692),0.5544023242755297,1.2162660756109192,0.25914634146341464,0.617479423984388,1.0,2/13,7.20%,PTGES;ACOX1
prerank,epithelium development (GO:0060429),0.41561024041949834,1.2160971620002707,0.1682743837084673,0.6173615541273324,1.0,18/107,11.81%,WNT2;STAT1;GATA6;SNAI2;JAK2;TBX2;ERRFI1;SHH;ALDH1A2;PKD2;PPARG;SALL1;CTSB;LOXL3;CNN3;GSTK1;RCN3;TIMELESS
prerank,heart development (GO:0007507),0.4124900210570071,1.2160084714677444,0.14018691588785046,0.6170127837987233,1.0,26/150,12.60%,SCUBE1;DLC1;COL3A1;SH3PXD2B;GLI2;FLRT2;DNAAF4;CHD7;ZFPM2;CACNA1C;TBX2;SHH;FBN1;PTEN;PKD2;NF1;ACVR1;PDLIM4;TGFBR1;SALL1;BMP5;PTK2;TGFB2;CASP8;NTRK3;AKAP13
prerank,sphingolipid biosynthetic process (GO:0030148),-0.3034136072962612,-1.215794505827618,0.10101010101010101,0.6696338309386433,1.0,22/71,16.44%,CERT1;PPM1L;ACER2;ST3GAL5;CERS4;SGMS1;SPTLC2;SPTLC1;ELOVL7;SGMS2;ELOVL5;DEGS2;SPNS2;B4GALT6;HACD1;HACD3;HACD4;ST6GALNAC5;SGPP1;ASAH2;SMPD2;PRKD1
prerank,cochlea morphogenesis (GO:0090103),0.5945623412036125,1.2153542633333272,0.25796661608497723,0.618224506267963,1.0,3/10,11.96%,TBX18;HOXA1;MYO3A
prerank,kidney development (GO:0001822),0.4405698628603473,1.2150269525996877,0.20670391061452514,0.6185335657635291,1.0,13/65,11.44%,SULF1;GLI2;ROBO2;ITGA8;SHH;NF1;IFT88;BAG6;TGFBR1;GREB1L;SALL1;NPHP3;TGFB2
prerank,protein transport (GO:0015031),0.3936028624790718,1.2148593873991396,0.0802407221664995,0.618405416716956,1.0,83/332,18.76%,LTBP2;ABCA1;CLTC;LRP1;SEC31A;VMP1;COPA;AP4M1;COPZ2;STX6;AP3B1;ARRDC4;ARCN1;APOE;MYH9;ABCG1;ARFGAP3;TBC1D16;CD36;STEAP3;COPZ1;PPARG;STX17;RAB21;SNX8;STXBP1;LAMP2;TBC1D2B;COPB2;RABGAP1L;RAB8B;MIA3;LMAN2L;RAB7A;CANX;ARRDC3;AP3D1;TBC1D8B;COPG1;RABGAP1;RAB3GAP2;STXBP3;RAB32;WLS;TMEM167A;SNX33;ARF4;SEC23IP;SNX9;ATP6V1F;RCN3;CALCRL;ATP6V1H;TMED1;TBC1D1;ATP6V1G2;ADPRH;RAB1A;RAB10;ARF1;RAB34;TBC1D10B;NDC1;SNX15;STX11;CHMP2B;COG7;SNX4;ATP6V1G1;SEC13;CTSA;ATP6V1D;CTTN;RUFY1;STX1B;SCFD2;SCFD1;REP15;TVP23B;ARL5A;TMED5;SPTBN1;HSP90B1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.41861491525862704,1.2148246981068307,0.1824175824175824,0.6179063977449251,1.0,19/86,17.45%,CCL11;PDXP;SYNPO;NAV3;APOE;NCK1;BAIAP2;NCK2;CARMIL1;SNX9;PSEN1;AKAP9;RAC1;CX3CL1;FES;CDC42EP1;TOGARAM1;PLEK;CTTN
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.43345741488568607,-1.2141762858033254,0.22151898734177214,0.6715447439753389,1.0,5/15,10.39%,ARL6IP1;REEP1;ZFYVE27;RAB18;TMEM170A
prerank,cellular protein modification process (GO:0006464),0.3888654133548202,1.214095058991433,0.011,0.6192271917337088,1.0,269/983,21.18%,PSMA7;CCL11;CEL;C3;COL3A1;ENAM;RUNX3;KNG1;SPP1;PARP8;IGFBP7;NEK6;LAMB1;PARP3;PDXP;PLOD2;MAP4K4;TEC;TAOK1;PTPN7;JAK1;B4GALT5;LAMC1;PEAK1;ERN2;DUSP2;FBXO40;CP;LRRK2;WIPI1;TIMP1;IGFBP4;JAK2;VCAN;SPSB1;UGCG;DUSP5;PRKCA;FSTL1;PRKCSH;KLHL22;MARK1;NUAK1;IRAK3;RAB2A;APOE;FBXL7;STK36;RBBP5;CALU;ILF3;IGFBP5;WSB2;IKBKE;DCAF10;CUL1;AKT3;FBN1;CAMK2D;PTPN3;PTPN13;PTEN;PRKD2;ST3GAL3;ACVR1;MORC3;FAM20A;DDOST;CDK6;ATM;PTPRZ1;CDK14;EIF2AK2;PLK1;PLAT;PTPN6;ALG5;PPP4R1;DAPP1;ATG3;FN3KRP;PTPN18;MIA3;LOXL1;KLHL13;SKP1;TAOK3;PTPN1;DCLK1;CDK10;NEK4;MERTK;PXK;CKAP4;FRK;DCUN1D1;SDC2;MAST2;PRKAR1B;MAN2A1;FBXL18;FBXW7;FBXO30;CHML;PSMB8;UBE2F;PSMA6;ANXA1;TGFBR1;MAP2K1;CSNK2A1;MGAT4A;MAP4K5;TNC;HIPK3;UBE2L3;LTBP1;SSH1;PPP3CA;ACVR1B;CDC42BPA;CCL2;STT3A;PPP2R2A;FGFR1;PPP2R5A;PTPRJ;PTPN9;ST3GAL1;ARF4;SOCS5;DCAF11;YWHAZ;NEURL2;FBXO7;NRK;CSNK1G2;TGFB2;GMFB;GCNT2;PPP4R2;PTPRM;CDK7;ACVR2A;PHKA2;COQ8B;ATG7;PPP1CB;FBXW11;MMP15;MAML1;GSK3B;CSNK1A1;DUSP26;PSMF1;ACVR1C;ILKAP;KCTD7;SSH2;ADPRH;RAB1A;MAP3K6;FBXO2;MKNK1;CTTNBP2NL;STK24;DAPK2;ZDHHC6;SIRT3;COPS6;TRIB1;RABGGTB;PMM2;PIK3R4;PSMA8;TIMM50;B4GALT7;CCNT1;FNTB;HIF1A;PPP6C;PRKAB1;FBXL19;PSMD2;RPN1;PRKDC;GRK4;PSMD12;WDR45;COG7;KLHL25;PSMD11;PIGH;PIGT;YES1;STK4;FAM20B;TNKS2;PIK3C3;B3GNT9;OBSL1;PSMD14;ACVRL1;PTAR1;CSNK1D;PTPRC;PTPN5;MAPK1;PTPRA;AKT1;DUSP6;LATS2;DNAJC3;CDKL1;DDB1;MTMR3;TYK2;EIF2AK3;TESK2;PSMB1;FBXW4;MAP3K12;SIK3;FCGR3A;CDK16;FUT4;ASB3;RHBDD1;CDK9;SETD3;FBXO31;AGA;HSP90B1;DCAF8;PHEX;MTMR2;EVA1A;MTMR6;FAM20C;PDIA6;FBXO32;FBXL22;LGALS1;MAN2A2;MTM1;ASB6;UBL5;SHISA5;CDK13;CDC14B;DUSP11;RAB8A;PSMC6;PLK2;UBE2E1;PRKCD;COPS3;ISG15;PARP14;PARP4;BMPR1A;PDK4;DCAF4;USP25;MAP3K20;VHL;CDK12;DYRK1A;PIGK
prerank,regulation of cellular component organization (GO:0051128),-0.2842815570997791,-1.213949406005859,0.08333333333333333,0.6695478264170286,1.0,41/135,18.86%,TJP1;SNCAIP;MLLT3;PLCE1;LTBP4;RIT2;CHPT1;CDH13;NRG3;HNRNPU;SPOCK1;HSP90AA1;PAK5;TFRC;HIP1R;RAPGEF2;RASGRP2;LAMTOR1;AGTR1;PACSIN1;URI1;FAM107A;RAP1A;ANKRA2;GFAP;HIP1;PINK1;SEMA4D;SSRP1;PACSIN3;ARHGEF11;TSC2;METTL4;WFDC1;STON1;EGLN2;PRKCQ;TAOK2;LAMTOR2;SOCS2;OGFR
prerank,regulation of dendritic spine development (GO:0060998),-0.4092477549412254,-1.2138833384229728,0.2226027397260274,0.6671198691419725,1.0,11/19,22.06%,TANC2;CPEB3;SHANK3;GRIN3A;SHANK1;CAMK2B;LLPH;KIF1A;NLGN1;PPFIA2;MEF2C
prerank,P-body assembly (GO:0033962),0.5775528454728954,1.213756975981963,0.25766871165644173,0.6195700022996735,1.0,2/12,4.12%,ATXN2;DYNC1H1
prerank,granulocyte differentiation (GO:0030851),-0.4233586325284836,-1.2136237354033192,0.19281045751633988,0.6652543112344,1.0,8/18,18.96%,LEF1;LBR;CBFA2T3;EP300;CDK4;TAL1;RXRA;DEK
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5948953584665677,1.2135253654066154,0.2618296529968454,0.6196118539405394,1.0,4/10,18.48%,KMT5A;EHMT1;SETD2;SETD3
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.3912453382510341,-1.2133931773783977,0.1992619926199262,0.6633269783669763,1.0,4/21,4.77%,PRKCH;CD81;SLC39A10;PRKCB
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.42363176585979584,1.2132660226579683,0.20044543429844097,0.6196933068060055,1.0,20/80,15.88%,PRR16;BCL3;SLC2A13;PLD1;GSAP;ABCA2;ABCG1;SAMD4A;NIBAN1;RPS6KB1;NSMAF;TNFRSF1A;NAT10;TNF;SPHK2;SMPD3;YTHDF3;FMR1;SIRT3;PRKDC
prerank,transcription preinitiation complex assembly (GO:0070897),0.571984340695143,1.2132330953414063,0.2672672672672673,0.6191876958031572,1.0,3/12,7.00%,TAF7;POLR1E;BDP1
prerank,negative regulation of MAPK cascade (GO:0043409),0.4255603467093998,1.2123479752176012,0.18892508143322476,0.6209231662330778,1.0,29/87,21.21%,ADIPOQ;FBLN1;TNIP1;SPRED1;IRAK3;APOE;SPRED2;PTEN;NF1;EMILIN1;PTPN1;CNKSR3;PTPRJ;PTPN2;SPRY2;DUSP26;P2RX7;BMP7;RANBP9;SMAD4;ITGB1BP1;PTPRC;DUSP6;AGT;PIN1;SPRY4;DLG1;PRKCD;SIRPA
prerank,neurogenesis (GO:0022008),0.4551640093003832,1.2122170518403523,0.21660649819494585,0.6206914296945301,1.0,7/43,11.44%,WNT2;TRAK1;DCHS1;CDK6;ANXA1;CXCR4;TGFB2
prerank,positive regulation of cell projection organization (GO:0031346),0.4085536421421209,1.2121324100830848,0.16381156316916487,0.6203058647204721,1.0,16/115,9.14%,ROR2;ROR1;ROBO2;PTN;DPYSL3;PLXNC1;TENM3;APOE;MDK;CARMIL1;FZD1;PLXND1;DLG4;CAPRIN1;PLXNA3;WNT5A
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.5987604884046319,1.211945643402373,0.2655007949125596,0.6202167460387514,1.0,7/10,25.76%,ST6GAL1;ST3GAL1;AMDHD2;GNPDA2;NPL;GNE;GNPDA1
prerank,smoothened signaling pathway (GO:0007224),0.4763670481374549,1.2119209945305118,0.23106060606060605,0.6196870410696887,1.0,4/32,4.42%,GLI2;GLI3;STK36;SHH
prerank,polyol metabolic process (GO:0019751),-0.33502190732847514,-1.2118179333300554,0.17532467532467533,0.6651022602663994,1.0,23/46,25.34%,PLCE1;INPP4B;CALM1;PLCB4;ITPK1;INPP5D;PLCB1;IPPK;NUDT3;ISYNA1;SLC5A3;PPIP5K1;IP6K1;SYNJ1;INPP5A;IMPA2;ITPKB;NUDT11;OCRL;PLCD4;PLCH1;INPPL1;PPIP5K2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.5733198415750507,1.211484389405091,0.27342549923195086,0.6196718408981462,1.0,2/11,6.10%,JAK1;STAT5A
prerank,cellular response to interleukin-2 (GO:0071352),0.5733198415750507,1.211484389405091,0.27342549923195086,0.6196718408981462,1.0,2/11,6.10%,JAK1;STAT5A
prerank,regulation of receptor internalization (GO:0002090),0.47689891842201243,1.2112260117197986,0.22693266832917705,0.6197448713462618,1.0,10/35,14.82%,SFRP4;ATXN2;EGF;DLG4;ANGPT1;ARF1;ANKRD13B;MKLN1;FMR1;CD63
prerank,negative regulation of protein catabolic process (GO:0042177),0.46359534038481814,1.2107965358681172,0.21680876979293545,0.6203661588601647,1.0,6/40,4.72%,TIMP1;NELL1;EGFR;IRAK3;MAD2L1;PTPN3
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.4382736214338038,-1.210749579362204,0.22151898734177214,0.6657571161771618,1.0,4/15,11.90%,ALDH4A1;GGACT;PRODH;CHAC2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.4458980894439115,1.210715430420297,0.2162485065710872,0.6200025875061237,1.0,22/54,21.92%,CD40;PRKCA;APOE;AKT3;PRKD2;NF1;PPARG;STAT5A;ANGPT1;FGFR1;TNF;FGF2;HIF1A;FGF18;ACVRL1;AKT1;ANGPT2;ETS1;GADD45A;ATP5F1A;EPHA2;RGCC
prerank,cellular response to nutrient levels (GO:0031669),0.43887275331292364,1.2098937478096772,0.2069767441860465,0.6215229439065175,1.0,25/62,24.69%,LRRK2;WIPI1;CDKN2B;SFRP1;CD68;INHBB;LAMP2;RPTOR;RRAGC;FADS1;LPL;FNIP1;KLF10;ATG7;STK24;WDR45;SREBF1;EIF4G1;ZFYVE1;PDK4;CLEC16A;VPS41;BMPR2;RALB;XBP1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.343375497608744,-1.2097501911450703,0.1693121693121693,0.6660586002643983,1.0,12/38,16.48%,FHL1;ACTN2;AKAP6;ANK2;KCNJ2;KCNJ3;KCNJ10;KCNQ1;KCNJ12;KCNN2;KCNN3;ADRA2A
prerank,regulation of cholesterol esterification (GO:0010872),0.5973669657785998,1.2095873143088527,0.2751235584843493,0.6217918674713953,1.0,3/10,4.34%,APOE;ABCA2;ABCG1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.5880663382560194,1.2090611313439137,0.25925925925925924,0.6227136062273185,1.0,2/11,3.66%,P2RX5;TREM2
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5848501738888323,1.2089757344985006,0.26058631921824105,0.6223845074327419,1.0,7/11,23.73%,SETDB1;SETDB2;PPHLN1;RESF1;ATF7IP;TASOR;MPHOSPH8
prerank,sister chromatid segregation (GO:0000819),0.48121354982129744,1.2089634690014086,0.23490813648293962,0.6218348436591546,1.0,6/31,6.21%,KIFC1;SMC1A;KLHL22;TUBG1;INO80;PLK1
prerank,cellular component assembly (GO:0022607),0.394610747351689,1.2087754531500632,0.09182643794147326,0.6217367240513738,1.0,52/253,15.18%,KMT2A;GPM6B;YAP1;MYO1B;VMP1;GORASP2;FLNC;LAMC1;SKAP2;RHOJ;CD40;DPYSL3;CALD1;MITF;FSCN1;WIPF1;PARVA;LIMA1;TLCD2;BAIAP2;AIF1;PPID;RHOD;OPHN1;LIMS1;CREBBP;FZD1;CDC42;LLGL1;DLG4;BAG6;KPNA3;NOC2L;ADD2;LCP1;WNT5A;TEAD1;SNX9;YWHAZ;FBLIM1;RHOA;TSPAN4;SPG7;TRAF2;AIF1L;YTHDF3;RANBP9;VCPIP1;PDCD10;RAC1;TUBGCP4;PAWR
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5251587337966821,1.208760652333987,0.25316455696202533,0.6212001075237323,1.0,4/19,9.84%,STAT1;IRF7;TLR7;SETD2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.40890042569506413,1.208434669632098,0.17450365726227796,0.6214868432564674,1.0,28/122,14.28%,PRR16;BCL3;GLI2;TLR2;IRS1;PDGFRB;JAK2;DNA2;PLD1;EGFR;PRKD2;EGF;BRPF3;SAMD4A;NMD3;TMEM106A;NIBAN1;RPS6KB1;CCL2;SLC25A37;NAT10;TGFB2;GCK;FGF2;HSPH1;CTC1;YTHDF3;FMR1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.547485039868276,1.2081716393112103,0.2547864506627393,0.6215925811122949,1.0,4/17,8.76%,LIPC;ANGPTL4;APOH;LPL
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3886296667185637,1.2077691806523012,0.001,0.6220786433534928,1.0,376/1645,18.68%,RORA;RUNX1;NR1H4;RUNX2;COL1A1;KMT2A;CREB3L1;ADIPOQ;SOHLH2;TRPS1;RUNX3;ZEB2;POU5F1;CXXC1;SPP1;MDFIC;PAX1;BCL3;GLI2;ZEB1;SBNO2;ETV6;NCOR2;DAP;YAP1;MED13L;DEAF1;TCF7L2;TCF4;SNAI1;TBX18;SOX5;ATXN1;PRRX1;GLI3;BCL6;CREB3L3;SATB2;MEIS2;BAZ1A;STAT1;EGR3;CCAR1;ERN2;CHD7;ZMIZ1;IRF7;ATP8B1;BRIP1;BACH1;GON4L;GATA6;FGF7;MAFB;SNAI2;ZFPM2;XCL1;RCOR1;NPAS4;BATF;NKX6-1;RXRG;PHC2;MITF;ZNF496;ARID5B;SMAD2;NFIX;SUFU;EGFR;ZIC4;REL;TLE1;PRRX2;BHLHE22;UBP1;GLIS1;APOE;USF1;STAT3;LITAF;MEIS1;TBX2;PKNOX2;TEAD3;ZBTB10;SOX21;HOXB3;ELF4;ILF3;NR2F2;ABCA2;ARID5A;TRAK1;SHH;KMT5A;SMURF2;MBD2;E2F1;PRDM5;CAMK2D;PHF1;PHF2;MYBL1;KHDRBS1;VGLL3;SP110;PRDM2;CEBPD;SMARCC1;CCNL1;BAZ2B;ACVR1;HIVEP2;PBX3;LIMS1;TAF7;SCMH1;SP140;TCF12;HIVEP1;FOXK2;EGF;CREBBP;FZD1;SFRP1;PPARG;LRP6;RUNX1T1;YAF2;CDK14;ZNF292;STAT5A;ZBTB48;TGFB3;ETV5;ENO1;ZHX2;SFMBT1;ZNF250;MBD1;EHMT1;AHR;PRICKLE1;PIAS2;TSHZ3;FOXE1;ZNF260;MLXIP;E2F8;BCL11B;ZKSCAN1;SUB1;ZBTB12;GTF2H1;DDX17;ARNT;RNF111;IRF1;NFE2L3;BHLHE40;TADA2B;CARM1;NEK4;HEYL;CREB3L2;CCAR2;EPC2;BTG1;ZMYND15;HOXA1;POU2F1;FADS1;ZFHX4;SAP18;SP100;BAHD1;TGFBR1;OGT;ZNF182;AHRR;MAP2K1;WNT5A;HDAC1;ZBTB5;SALL1;NONO;FOXO3;TBL1X;ZSCAN22;ZBTB38;ARID1B;SMAD5;FOXP4;UBE2L3;PRDM1;NR2F1;TGFB1I1;JUNB;NOP2;HMGB2;TGIF2;ZIC1;ACVR1B;TBX3;LOXL3;TCF7;BRWD1;NEUROD6;EID1;WWTR1;CBFB;TRIM44;TEAD1;FOXN2;KLF10;BBX;LIN54;CHD2;KMT2E;ELK4;RSF1;RUVBL1;NFE2L2;ZGPAT;SAFB;TGFBRAP1;CALR;TIMELESS;SP3;LCOR;TNFRSF4;SPTY2D1;ARID4B;E2F3;MED13;NIF3L1;SETDB2;MAP3K2;FBXW11;TNF;KDM2A;ZSCAN21;HOXB2;KLF6;NAB2;FGF2;ZBTB20;NKX2-8;SKOR2;KMT2B;ELK1;COMMD7;NSD3;GLIS3;SNX5;FOXJ3;NFKB2;SPI1;BRPF1;TFCP2L1;SAFB2;GATAD2A;CTCF;SMAD3;PSEN1;IRF9;BMP7;ATRX;EGR2;TRIB3;DRAP1;WTIP;CDKN1B;USP22;ZFP62;LCORL;HOXB5;TFAP2C;SMAD4;MAFK;DTX3L;NIPBL;MMS19;BAZ2A;NAA15;SMAD1;BNC2;TSC22D4;PHC3;SRCAP;CREB3L4;CREB3;PATZ1;NR6A1;CCNT1;HIF1A;MED26;TRIM56;PHF12;FBXL19;STAT5B;RELB;L3MBTL3;NPAS2;NUP35;NSD1;POU3F3;MAX;LIN9;NFXL1;ZKSCAN8;ATF7IP;CLOCK;TCF7L1;TCF3;SMARCA4;SREBF1;ACVRL1;ZNF18;MTA3;ZFHX3;HSPD1;BACH2;AKT1;HCFC2;TRIM33;NUCKS1;PHF20;ING5;CALCOCO1;THRAP3;RBFOX2;PCBD2;BRD4;ZNF445;MZF1;ZNF25;MDM2;NFE2L1;ATF4;RCOR2;PICALM;GLI1;ETS1;ZNF3;MAP3K12;RLF;RAI1;SALL3;POLR2L;LHX6;INHBA;ZSCAN29;POLR2K;BICRA;PAX8;ZBTB40;AGT;RBPJ;CDK16;ZBTB9;HDAC5;NR2C2;MXD4;SOX2;RBM15;SPEN;RBBP8;SETD3;FBXO5;HINFP;SPINDOC;KAT6B;ZBTB25;ZBTB7A
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.42081517257903694,1.2075020639880654,0.18878101402373246,0.6222300897596826,1.0,19/86,17.74%,PSMA7;BACH1;DNAJB1;BAG3;INO80;CREBBP;ARNT;PSMB8;PSMA6;NFE2L2;PSMF1;PSMA8;HIF1A;PSMD2;PSMD12;PSMD11;PSMD14;ATF4;PSMB1
prerank,autophagosome organization (GO:1905037),0.4395627579960615,1.2074472795962101,0.2202797202797203,0.6217930629624208,1.0,16/50,21.19%,VMP1;WIPI1;AMBRA1;ATG3;RAB7A;ATP2A2;ATG7;PACS2;RAB1A;ATG16L1;ATG16L2;WDR45;PIK3C3;IRGM;UBXN2A;BECN1
prerank,T cell differentiation (GO:0030217),0.46620180279047757,1.2072130366411107,0.22071516646115907,0.6218016032882347,1.0,9/40,13.10%,ZFP36L1;GLI3;CHD7;ZFP36L2;SHH;ANXA1;TCF7;PTPN2;SPI1
prerank,actin crosslink formation (GO:0051764),0.5658697773408705,1.2071035670617687,0.25225225225225223,0.621519885261659,1.0,4/12,8.76%,DPYSL3;BAIAP2;AIF1;LCP1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.42911326735822414,1.2064103528271755,0.21064552661381652,0.6227471201979738,1.0,7/65,8.34%,RORA;ZFP36L1;GATA6;CPEB1;SFRP1;NPEPPS;TERT
prerank,cardiac myofibril assembly (GO:0055003),0.5427025652370437,1.2062547637314667,0.2597968069666183,0.6225801765301632,1.0,3/15,4.03%,PDGFRA;PDGFRB;FHOD3
prerank,negative regulation of gluconeogenesis (GO:0045721),0.5717805230836359,1.2059163275316782,0.28794992175273865,0.6229207657051137,1.0,1/11,0.48%,ADIPOQ
prerank,positive regulation of defense response to virus by host (GO:0002230),0.4906051302820008,1.204474912957357,0.25,0.6262635891635766,1.0,8/24,21.08%,IL23R;STAT1;TRIM44;DTX3L;CGAS;TRAF3IP2;TRIM6;ZC3H12A
prerank,regulation of endocytic recycling (GO:2001135),-0.4873863847971136,-1.2040439483630687,0.24866310160427807,0.6798049128603367,1.0,5/11,10.54%,INPP5F;ACTN2;ATP9A;SORL1;RAB11B
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.409602724939005,1.203873026718701,0.18843683083511778,0.6272937159187852,1.0,27/100,17.55%,GLMN;NKD2;LRRK2;PABIR1;RNF144A;PLK1;PRICKLE1;BAG6;EIF3H;CCAR2;RAD23A;ARIH1;OGT;RAD23B;SOCS5;RNF19B;GSK3B;CSNK1A1;GIPC1;DDRGK1;TRIB3;RPL11;TRIB1;ZYG11B;CSNK1D;GNA12;MDM2
prerank,regulation of Golgi organization (GO:1903358),0.5329945927579516,1.2036414462942755,0.28165007112375534,0.627338504592657,1.0,8/17,17.54%,MYO5A;MAP2K1;CAMSAP2;AKAP9;PDCD10;ARMH3;MAPK1;RAB33B
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.40907539201904325,1.2031472448009595,0.17708333333333334,0.6280501331692708,1.0,21/121,11.22%,IL34;IL23R;THBS4;TEC;GHR;CD40;FGF7;JAK2;NRP1;TSLP;TREM2;STAT3;ACVR1;CCL5;DLG4;PTPN1;ANGPT1;EFNA5;TNFRSF1A;PTPRJ;VTN
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.44831825873802855,1.202799980049051,0.21875,0.6284226066206193,1.0,12/50,12.30%,TLR2;EGFR;LGALS9;NOD1;LIMS1;EIF2AK2;TLR7;SASH1;CD14;TRIM44;RHOA;TNF
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.4936772492212082,-1.2020312149419132,0.2519893899204244,0.6829762463161568,1.0,5/10,29.16%,LPGAT1;ELOVL5;SLC45A3;MLXIPL;NR1H2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.44894386793602664,1.2019643714754098,0.21708185053380782,0.6300826612637012,1.0,11/47,11.80%,FBLN1;NRP1;DOCK1;MDK;LIMS1;CARMIL1;CDC42;EFNA5;PTK2;PDPN;CALR
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5947369391496722,1.201893082464832,0.3048048048048048,0.629693825638855,1.0,3/10,10.79%,MAP4K4;FGF7;MAPRE2
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5510282088292738,1.201003783377833,0.26346433770014555,0.630909896759707,1.0,4/15,8.24%,AP3B1;AP3S1;DTNBP1;AP3D1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5510282088292738,1.201003783377833,0.26346433770014555,0.630909896759707,1.0,4/15,8.24%,AP3B1;AP3S1;DTNBP1;AP3D1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5826154234818782,1.2008896094925487,0.26356589147286824,0.6294825625389567,1.0,5/11,15.35%,DCAKD;SLC25A16;PANK2;COASY;PANK1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5826154234818782,1.2008896094925487,0.26356589147286824,0.6294825625389567,1.0,5/11,15.35%,DCAKD;SLC25A16;PANK2;COASY;PANK1
prerank,coenzyme A biosynthetic process (GO:0015937),0.5826154234818782,1.2008896094925487,0.26356589147286824,0.6294825625389567,1.0,5/11,15.35%,DCAKD;SLC25A16;PANK2;COASY;PANK1
prerank,regulation of ion transport (GO:0043269),-0.29716568773529595,-1.2004845921552412,0.12844036697247707,0.6847673195592372,1.0,16/76,10.54%,WWP2;PRKN;NKAIN2;KCNJ2;KCNJ3;PER1;NKAIN3;NKAIN4;KCNJ13;CA2;SIK1;KCNJ10;NKAIN1;SYT7;ANK3;RAB11B
prerank,lipid transport (GO:0006869),0.41545966492244485,1.2002128131421306,0.17475728155339806,0.6307453594398619,1.0,19/97,13.37%,NR1H4;ABCA1;LBP;ATP8B1;UGCG;SLC10A6;APOE;ABCA2;PLTP;ABCG1;CD36;NPC2;OSBPL5;SLC10A1;PEX19;SLCO1B1;FABP5;ABCA9;ABCG4
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.3403998685688592,-1.2000152908072632,0.13106796116504854,0.683570487323583,1.0,7/33,5.63%,GLUL;MTHFS;GCLC;ALDH4A1;GLUD1;SLC39A8;PRODH
prerank,long-term synaptic potentiation (GO:0060291),-0.39858011314263964,-1.1995481844912956,0.23024054982817868,0.6822276616669105,1.0,5/21,11.07%,SLC24A2;PRKCZ;SLC8A3;GRIN2D;GRIN2B
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.4114592418092433,1.1991185831170121,0.1997828447339848,0.6330427257283602,1.0,21/88,18.04%,MMP3;SYNPO;PRKCA;VPS4A;EMILIN1;RAB7A;TIRAP;SDC1;BRK1;FNIP1;TNF;GSK3B;SMPD3;SMAD3;BMP7;CX3CL1;PLEK;SH3GLB1;TPPP;ICE1;SLF2
prerank,miRNA metabolic process (GO:0010586),0.5077195883920984,1.198747874575804,0.24929971988795518,0.6334695643285547,1.0,7/20,19.62%,DDX17;DICER1;SND1;TUT7;PARN;BCDIN3D;AGO2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.5641396740190624,1.1985366486789608,0.2785388127853881,0.6334450268783682,1.0,6/12,22.46%,PTEN;PLK1;SKP1;RAB1A;CDC14B;FZR1
prerank,establishment of spindle orientation (GO:0051294),0.4887469286223348,1.1983605018576122,0.24129032258064517,0.6333258549837683,1.0,8/28,15.92%,MAD2L1;PLK1;GPSM2;LLGL1;INSC;FBXW11;NDEL1;MAP4
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.5713768537241672,1.19815690006994,0.2727272727272727,0.6332996378668393,1.0,2/12,5.41%,CLTC;TAF7
prerank,microtubule anchoring at centrosome (GO:0034454),0.592054648170185,1.1979645034280537,0.27903225806451615,0.6332076838888133,1.0,5/10,22.50%,CEP19;PCM1;NIN;CCDC120;NINL
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.505391221752555,1.197952657696202,0.25655172413793104,0.632665080054449,1.0,4/22,4.56%,SLC9A1;PRKCA;MLIP;CAMK2D
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.4298816682918399,-1.1973778772206196,0.24838709677419354,0.685851158734765,1.0,6/18,14.77%,TEK;KRIT1;CDH5;SHTN1;RACK1;RIPOR2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.41374500522683755,1.197341898993295,0.19181034482758622,0.6337142234213573,1.0,24/88,13.81%,CLTC;MYO1B;AP4M1;STEAP2;ARFGEF2;PUM1;RABIF;VPS13C;DNAJC6;TXNDC5;DTNBP1;MYO5A;LLGL1;EXOC4;GBF1;ACBD3;EXOC1;OSBPL5;CLINT1;EPS15;CCDC93;RAB10;KIF16B;ARF1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.48958653932693624,1.1965910514298883,0.2583547557840617,0.6351162938474004,1.0,10/26,20.32%,NOS1AP;APOE;POR;CYP27B1;TERT;TNF;HIF1A;AKT1;ATP7A;GDNF
prerank,positive regulation of interferon-gamma production (GO:0032729),0.4430290848421771,1.1959720449309355,0.24333719582850522,0.6362120992179323,1.0,6/48,8.14%,IL23R;CD276;IL1R1;LGALS9;TLR7;CD14
prerank,adipose tissue development (GO:0060612),0.5635138504944484,1.1957371752085963,0.27929373996789725,0.6362544383843058,1.0,2/11,3.37%,SH3PXD2B;ARID5B
prerank,regulation of melanin biosynthetic process (GO:0048021),0.5884675206819263,1.1951720512394517,0.28751974723538704,0.6372412632930431,1.0,1/10,0.58%,ZEB2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.4248369512696203,1.195037165211392,0.21666666666666667,0.6370312488726247,1.0,23/73,18.08%,MYO10;VAV2;VAV3;BLK;DOCK1;WIPF1;NCK1;BAIAP2;CDC42;ACTR2;GRB2;BRK1;PTK2;VAV1;ABI1;PIK3R1;SRC;RAC1;FCGR1A;WIPF2;YES1;MAPK1;FCGR3A
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4023903850572174,1.1949757369278413,0.15010351966873706,0.6366247620330063,1.0,34/149,16.63%,ROR1;TRIML2;TNFSF11;TLR2;CD40;FLOT2;CFLAR;IRAK3;STAT3;PRKD2;LGALS9;NOD1;TRIM21;CD36;EIF2AK2;IRAK2;RAB7B;TIRAP;TRIM13;TRIM8;PSMA6;WNT5A;EDA2R;EDA;TNF;NFKB2;TRAF2;DDRGK1;CX3CL1;RIPK1;RBCK1;CLOCK;LAMTOR5;TRAF5
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4625704717762113,1.1946640117598692,0.24516129032258063,0.6368917410763055,1.0,10/37,21.21%,APOD;ADCY7;TREM2;STAT3;PLD4;TNF;HIF1A;IL17RA;ZC3H12A;SIRPA
prerank,positive regulation of vasculature development (GO:1904018),0.4150131470591263,1.1943400183246429,0.19567567567567568,0.6372041504029919,1.0,14/94,9.14%,RUNX1;CYP1B1;ITGB8;ADAM12;CD40;GATA6;PRKCA;HK2;PRKD2;ANGPTL4;EPHA1;SASH1;BTG1;WNT5A
prerank,type I interferon signaling pathway (GO:0060337),0.45428615854016496,1.1942301964720428,0.22125,0.6363534567510699,1.0,9/41,9.83%,JAK1;STAT1;IRF7;IRF1;IFNAR2;PSMB8;SP100;IP6K2;OASL
prerank,cellular response to type I interferon (GO:0071357),0.45428615854016496,1.1942301964720428,0.22125,0.6363534567510699,1.0,9/41,9.83%,JAK1;STAT1;IRF7;IRF1;IFNAR2;PSMB8;SP100;IP6K2;OASL
prerank,negative regulation of protein transport (GO:0051224),0.49569569477856334,1.1941063841107264,0.26768377253814146,0.6361105706210752,1.0,4/25,12.15%,ADIPOQ;APOE;DRD3;DPH3
prerank,lysine catabolic process (GO:0006554),0.5547423621472198,1.1940799442419179,0.27341389728096677,0.635052048813746,1.0,6/12,21.44%,CRYM;DLST;ALDH7A1;HYKK;PIPOX;SLC25A21
prerank,lysine metabolic process (GO:0006553),0.5547423621472198,1.1940799442419179,0.27341389728096677,0.635052048813746,1.0,6/12,21.44%,CRYM;DLST;ALDH7A1;HYKK;PIPOX;SLC25A21
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.332624364307033,-1.1940610565560277,0.1610738255033557,0.6927660990547528,1.0,9/46,6.60%,ATP1A2;NRXN1;GRM7;GRM1;DGKI;SHANK3;GRM8;GRM3;CACNG2
prerank,negative regulation of centrosome duplication (GO:0010826),-0.49408758465250113,-1.1937351658761708,0.24719101123595505,0.6910939276635018,1.0,8/11,30.67%,TRIM37;MDM1;CDK5RAP2;KAT2A;CCNF;BRCA1;TMEM67;NPM1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.49511393079071614,1.193697143432926,0.2562326869806094,0.6355023325452682,1.0,7/24,18.24%,CREB3L1;CREB3L3;NFE2L2;HSPA5;HIF1A;ATF4;RBPJ
prerank,aortic valve development (GO:0003176),0.4671082660129733,1.193668825440919,0.24780976220275344,0.6350174470188186,1.0,8/34,10.46%,SNAI1;ROBO2;SLIT3;SNAI2;JAG1;EMILIN1;HEYL;TNFRSF1A
prerank,positive regulation of double-strand break repair (GO:2000781),0.4526690918597754,1.1936535897229439,0.241635687732342,0.6344841982273535,1.0,14/39,18.04%,PARP3;DDX11;ACTR2;SHLD3;SPIRE1;SETMAR;TIMELESS;MGMT;RIF1;DTX3L;MMS19;PRKDC;PNKP;SLF2
prerank,DNA geometric change (GO:0032392),0.49133640306216153,1.1936162368850662,0.24413793103448275,0.6340156594306087,1.0,6/24,10.37%,DNA2;ASCC3;DDX11;ANXA1;HMGB2;MCM9
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.407272456568107,1.1930634415027324,0.1799787007454739,0.6348957036546928,1.0,17/110,12.75%,MC5R;ABCA1;IAPP;ADCY7;ADGRL3;RXFP2;ADCY2;ADM;CXCL10;S1PR3;GPR161;S1PR2;DRD3;LPAR3;LPAR2;CALCRL;MC1R
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5694098627159615,1.1927258911238183,0.2966360856269113,0.63464351646819,1.0,6/12,23.22%,FBLN1;EFNA5;ITGB1BP1;CORO1C;SPRY4;AP1AR
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5694098627159615,1.1927258911238183,0.2966360856269113,0.63464351646819,1.0,6/12,23.22%,FBLN1;EFNA5;ITGB1BP1;CORO1C;SPRY4;AP1AR
prerank,cell chemotaxis (GO:0060326),0.4333038142219705,1.1926958275809358,0.22786304604486424,0.6341656107852006,1.0,7/60,4.50%,PDGFRA;CXCL12;EGR3;PDGFRB;NRP1;CCR1;PARVA
prerank,neuromuscular junction development (GO:0007528),-0.37369908897054327,-1.1922242478791314,0.2198581560283688,0.6929224728765735,1.0,6/24,4.28%,UNC13C;GPHN;CACNB2;UNC13B;CACNB4;AGRN
prerank,ERBB signaling pathway (GO:0038127),0.42872971871156695,1.1920679423588558,0.21970554926387317,0.6353298488799075,1.0,17/64,14.06%,FAM83A;PRKCA;EGFR;NCK2;EGF;PTPN18;CBL;GRB2;CDC37;MVP;PTK2;ERBIN;BTC;PIK3R1;GAREM1;KIF16B;SRC
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.45662770666791525,-1.191732234284456,0.23636363636363636,0.6917773618278644,1.0,4/13,14.26%,TMSB4X;SIN3A;PER2;HEY2
prerank,histone mRNA catabolic process (GO:0071044),0.5303718737386197,1.1912690575108205,0.2793053545586107,0.6369794425249119,1.0,5/15,11.16%,ATM;ERI1;EXOSC4;DCP2;XRN1
prerank,endodermal cell fate commitment (GO:0001711),0.5893954015051225,1.1911371309776198,0.2709677419354839,0.636786775466834,1.0,1/10,0.60%,POU5F1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.4638493808831459,1.1907415058289237,0.2701298701298701,0.6372673108359743,1.0,2/33,0.87%,CEL;CACNA1A
prerank,regulation of insulin secretion (GO:0050796),0.41244164887244633,1.1904477977878867,0.19957310565635006,0.6375003175714132,1.0,14/101,6.47%,NR1H4;CACNA1A;TCF7L2;IRS1;RAPGEF4;PRKCA;CACNA1C;BLK;ACSL4;ITPR1;KCNA5;CCL5;SFRP1;INHBB
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4440120058654901,1.1901490465043885,0.22344322344322345,0.6377148565908873,1.0,7/48,7.06%,BCL3;IKBKE;E2F1;BCL2;ATM;BAG6;BCL2L2
prerank,positive regulation of lyase activity (GO:0051349),0.542530694912422,1.1901333461853618,0.2886002886002886,0.6371830737699142,1.0,3/14,5.10%,CACNA1C;FXN;NF1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3824582501724387,1.1900779032677467,0.003,0.6367711867912401,1.0,408/1667,20.09%,RORA;RUNX1;NR1H4;RUNX2;DCN;KMT2A;CREB3L1;SOHLH2;WNT2;TRPS1;RUNX3;ZEB2;POU5F1;PAX1;PLAC8;GLI2;ZEB1;SBNO2;ETV6;NCOR2;YAP1;MED13L;DEAF1;TCF7L2;TCF4;NRIP1;ASXL1;SNAI1;TBX18;TNFSF11;SOX5;TNIP1;ATXN1;PRRX1;MRTFA;GLI3;BCL6;CREB3L3;SATB2;MEIS2;SLC9A1;BAZ1A;STAT1;EGR3;ZMIZ1;RARB;TLR2;IRF7;BRIP1;BACH1;CD40;GATA6;MAFB;SNAI2;ZFPM2;RCOR1;AUTS2;FHL2;NPAS4;BATF;DNAJB1;NKX6-1;RXRG;MITF;CRYM;ZNF496;ARID5B;SMAD2;NFIX;MIER2;SUFU;CDKN2B;EGFR;ZIC4;REL;MAML3;MLIP;PRRX2;BHLHE22;UBP1;GLIS1;APOE;USF1;STAT3;LITAF;CGGBP1;MEIS1;TBX2;PKNOX2;TEAD3;USP9X;ZBTB10;SOX21;HOXB3;ELF4;NR2F2;JAG1;PPRC1;ABCA2;ARID5A;TRAK1;SHH;KMT5A;SMURF2;MBD2;E2F1;PRDM5;CAMK2D;PHF2;MYBL1;VGLL3;NCK1;SP110;PRDM2;PTEN;CEBPD;PRKD2;PKD2;SMARCC1;CCNL1;BAZ2B;ACVR1;PPID;ASXL2;HIVEP2;PBX3;TAF7;SP140;TCF12;NCK2;HIVEP1;INO80;RNF2;FOXK2;CREBBP;ATM;CBX8;MACC1;PPARG;LRP6;ZNF292;STAT5A;ZBTB48;TGFB3;PLK1;ETV5;ENO1;ZHX2;ZNF250;CXCL10;AHR;PIAS2;MDFI;TSHZ3;FOXE1;ZNF260;MLXIP;E2F8;BCL11B;ZKSCAN1;SUB1;ZBTB12;GTF2H1;DDX17;ARNT;NOC2L;RNF111;IRF1;NFE2L3;PID1;BHLHE40;RRP1B;TADA2B;HEYL;CREB3L2;ACTR2;FRK;CRTC1;MAML2;EPC2;TNRC6B;HOXA1;POU2F1;ZFHX4;SAP18;SP100;OGT;ZNF182;AHRR;WNT5A;HDAC1;ZBTB5;SALL1;FOXO3;TBL1X;ZSCAN22;ZBTB38;ARID1B;DICER1;SMAD5;FOXP4;PRDM1;BMP5;NR2F1;MTA2;JUNB;NOP2;HMGB2;PPP3CA;PELP1;CXXC5;TGIF2;ZIC1;TBX3;TCF7;BRWD1;TNFRSF1A;NEUROD6;EID1;FNIP1;WWTR1;CBFB;TEAD1;GATAD2B;KLF10;ARF4;BBX;CHD2;MOV10;ELK4;CRTC3;RSF1;RUVBL1;NFE2L2;ZGPAT;PHF21A;DNMT3B;SAFB;ZBED3;CALR;SP3;CDK7;ACVR2A;LCOR;TET2;ARID4B;E2F3;MED13;TNF;KDM2A;ZSCAN21;HOXB2;KLF6;MAML1;GLYR1;FGF2;DUSP26;ZBTB20;MC1R;NKX2-8;SKOR2;ELK1;GLIS3;FOXJ3;NFKB2;SPI1;PIK3R1;TFCP2L1;DDRGK1;RIF1;SAFB2;GATAD2A;GTF2F1;PRDM10;CTCF;SMAD3;DACT1;PSEN1;KCNIP3;MED15;IRF9;ATRX;EGR2;TRIB3;DRAP1;MYSM1;ZFP62;LCORL;HOXB5;TFAP2C;SMAD4;MAFK;GABPB1;NIPBL;CX3CL1;RIPK1;SETX;SMAD1;RTRAF;SRCAP;CREB3L4;CREB3;PATZ1;NR6A1;CCNT1;HIF1A;MED26;PHF12;FBXL19;STAT5B;PRKDC;RBMX;PTOV1;SQSTM1;RELB;SLC30A9;NPAS2;NSD1;POU3F3;MAX;LIN9;ITGB1BP1;ZKSCAN8;CLOCK;TCF7L1;TCF3;SMARCA4;SREBF1;ACVRL1;ZNF18;MTA3;ZFHX3;HSPD1;BACH2;HCFC2;TRIM33;NUCKS1;PHF20;TCERG1;CALCOCO1;THRAP3;BRD4;ZNF445;MZF1;ZNF25;MDM2;NFE2L1;ATF4;RCOR2;GLI1;ETS1;ZNF3;RLF;PRDM4;RAI1;SALL3;LHX6;INHBA;ZSCAN29;PAX8;ZBTB40;RBPJ;DDX20;ZBTB9;HDAC5;NR2C2;NFKBIA;MXD4;SOX2;SPEN;RBBP8;CDK9;SETD3;RPAP2;HINFP;KAT6B;ZBTB25;ZBTB7A;BCAS3;ARID4A;NR3C1;TLE5;DVL2;BRMS1L;LRP5;THAP7;GADD45A;MGA;GABPA;STAT2;KDM1A;KAT7;MED12;MED1;AGO2;CCNL2;PCGF3;ELF2;CC2D1B;TMF1;RBAK;LAGE3;PIN1;CDK13;YEATS2;HMGA2;MXI1;ZNF367
prerank,regulation of lipid catabolic process (GO:0050994),-0.41062863621744355,-1.1896978506147489,0.2578397212543554,0.6949680158412105,1.0,6/19,22.92%,ALK;BSCL2;PDE3B;ADRA2A;PRKAA1;TYSND1
prerank,epithelial cell differentiation (GO:0030855),0.41313680369328154,1.1885012227700513,0.20304017372421282,0.640539662840323,1.0,12/88,10.94%,SCUBE1;GATA6;FSTL1;JAG1;PPARG;E2F8;DEUP1;ANXA1;HDAC1;CTSB;CNN3;GSTK1
prerank,mRNA processing (GO:0006397),-0.25071710509567996,-1.188438856227573,0.0,0.6959692088142718,1.0,100/287,25.11%,ELAVL2;U2SURP;SRRM2;PSPC1;SFPQ;SNRNP70;DDX5;HNRNPU;RNGTT;YTHDC1;NOVA2;PRPF6;CDC40;SRSF5;SNRNP48;FRG1;WDR33;CSTF2;PPARGC1A;CWC22;SNRPN;PABPC1;NOVA1;RPRD2;AQR;HNRNPH3;ZCRB1;U2AF2;ISY1;PRPF38A;PRPF4;GEMIN2;USP49;RPRD1A;ERCC3;RALY;RBM5;CWF19L1;GCFC2;LSM6;SNRPC;PPIH;HNRNPA1;SNRPG;POLR2A;POLR2H;SRSF7;RBM19;POLR2G;PRPF40B;SRSF9;PPIL3;SNRNP27;POLR2F;ERN1;RBM17;IK;PRPF19;CWC25;RBM8A;SART1;CHTOP;SRRM4;CPSF2;LSM5;HNRNPR;MAGOH;GTF2H2;ZC3H11A;SNRPD3;HNRNPA3;SUPT4H1;CMTR1;POLR2E;HNRNPM;HNRNPA0;PRPF8;EIF4A3;SRSF3;CLP1;HNRNPL;CACTIN;POLDIP3;GTF2H4;DNAJC8;RAVER2;CPSF4;SARNP;SF3B6;SF3B5;DDX39B;TXNL4A;PDCD7;DDX46;TBRG4;DDX39A;GTF2H3;SF3A1;SF3A3;HNRNPD
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.49710019786100634,1.188230383221531,0.26944444444444443,0.640685996568895,1.0,4/20,10.36%,SFRP4;CD40;PLA2R1;CCL2
prerank,cellular response to insulin stimulus (GO:0032869),0.4010711707167651,1.188104237311931,0.18124341412012646,0.6404617627647783,1.0,27/124,14.12%,SLC39A14;ENPP1;ADIPOQ;ZFP36L1;IRS1;INSIG2;USF1;BAIAP2;AP3S1;CPEB1;PPARG;MYO5A;INHBB;RAB8B;DENND4C;SH2B2;GRB2;RPS6KB1;PTPN2;ATP6V1F;GCK;GSK3B;ATP6V1H;PIK3R1;ATP6V1G2;RAB10;TRIB3
prerank,positive regulation of programmed cell death (GO:0043068),0.39317643361659294,1.1879049608921093,0.12701612903225806,0.6403959748995524,1.0,80/272,22.27%,CYP1B1;ZBP1;KNG1;IAPP;SFRP4;BCL6;CCAR1;VAV2;LRRK2;VAV3;KALRN;ITSN1;FRZB;E2F1;CTSD;NF1;PPID;FGD4;TNFRSF12A;ATM;OMA1;SFRP1;TGFB3;RASSF2;RRP1B;PHLDA1;AIFM2;EEF1E1;CCAR2;ARHGEF19;SAP18;TRIO;FOXO3;IP6K2;ARHGEF12;PREX1;CASP8;ATG7;VAV1;TNF;NLRP2B;AKAP13;ACVR1C;CALHM2;SPHK2;PSEN1;ARHGEF18;DAPK2;RIPK1;PSENEN;PAWR;SQSTM1;STK4;OLFM1;AIFM1;HSPD1;PTPA;DUSP6;LATS2;ING5;ANO6;ATF4;CLIP3;DDX20;PLEKHG2;GADD45A;HMGA2;NCSTN;UTP11;ARHGEF26;TIAM2;UBE2Z;MAP3K20;PSEN2;RPS27A;RARG;ARHGEF17;CLU;LATS1;ARHGEF1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.4920784099388479,1.18749424979277,0.28324468085106386,0.6409224749905175,1.0,8/24,14.73%,MAP4K4;NRP1;LIMS1;SFRP1;MAPRE2;PTPRJ;PIK3R1;RAC1
prerank,microtubule nucleation (GO:0007020),0.5103671155949099,1.1874760787237753,0.2765957446808511,0.6404099695034309,1.0,10/20,18.53%,TUBG1;TPX2;AKAP9;RANBP9;TUBGCP4;NDEL1;TUBG2;CSNK1D;TPPP;CENPJ
prerank,cellular response to reactive oxygen species (GO:0034614),0.43346323417816124,1.1869108876447396,0.23376623376623376,0.641374405428347,1.0,6/59,5.01%,CYP1B1;PDGFRA;TNFAIP3;EGFR;FXN;PKD2
prerank,protein-DNA complex assembly (GO:0065004),0.40553164245997225,1.1866911867690249,0.196875,0.6414288560192766,1.0,42/116,25.09%,PSMA7;TCF4;MCM2;GTF2H1;MCM7;PSMB8;PSMA6;RAD23B;GRWD1;HMGB2;RSF1;CDK7;SPTY2D1;PSMF1;NAP1L3;ATRX;ASF1A;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;DDB1;PSMB1;KAT6B;NAP1L1;PSMC6;ERCC2;RPS27A;RPA1;CCNH;PSMB4;PSMB5;DMC1;RAD51;MNAT1;CDC6;PSMD4;ORC4;PSMD7;PSMD9;PSMA4
prerank,response to hydroxyurea (GO:0072710),0.5709418813664539,1.1859776704898848,0.2962962962962963,0.6427072179238635,1.0,5/11,19.45%,DDX11;TIMELESS;ATRX;FMR1;KAT7
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.4656761881851332,1.1859374283462856,0.246558197747184,0.6422485428819833,1.0,9/35,16.39%,DLC1;ARHGAP24;MAPKAP1;ITGA3;TGFB2;KCTD10;SPRY2;ARHGAP35;SYNGAP1
prerank,mRNA destabilization (GO:0061157),0.4482921100817735,1.185183868655145,0.2699228791773779,0.6436658648625724,1.0,18/38,25.24%,ZFP36L1;ZFP36L2;PUM1;METTL16;GIGYF2;CELF1;FTO;MOV10;YTHDF3;RC3H2;TUT7;ZC3H12A;ROCK2;YTHDF2;ROCK1;POLR2D;PLEKHN1;CNOT1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3867550608274775,1.1848022670020233,0.13232323232323231,0.644132785643096,1.0,52/234,16.63%,ROR1;WNT2;TRIML2;TNFSF11;TLR2;CD40;FLOT2;NKX6-1;CFLAR;ARID5B;IRAK3;STAT3;STK36;IKBKE;PPRC1;SHH;PTEN;PRKD2;LGALS9;DDR2;NOD1;TRIM21;CD36;FZD1;PPARG;LRP6;EIF2AK2;IRAK2;RAB7B;TIRAP;TRIM13;CRTC1;TRIM8;PSMA6;WNT5A;EDA2R;CRTC3;EDA;TNF;NFKB2;TRAF2;DDRGK1;SMAD3;CX3CL1;RIPK1;SMO;RBCK1;CLOCK;TCF3;SMARCA4;LAMTOR5;TRAF5
prerank,regulation of cell death (GO:0010941),0.4090000375317735,1.184779503335889,0.22807017543859648,0.6436215002925025,1.0,11/94,8.29%,HP;HPR;LRP1;LRRK2;CCN4;CHMP4B;NCK1;CD36;CCL5;TRIM13;CELF1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.44095244641937265,1.1839918990608314,0.24327628361858192,0.6450695258678766,1.0,11/45,14.25%,ZFP36L1;BCL6;ZFP36L2;MAD2L1;PTPN3;TOM1L1;BTG1;GAS1;SMAD3;BMP7;CDKN1B
prerank,hexose transmembrane transport (GO:0008645),-0.38726488528495234,-1.18379361396272,0.22900763358778625,0.7068299786456441,1.0,7/21,24.99%,SLC2A1;SLC5A3;SLC2A12;SLC45A3;SLC2A8;SLC2A9;SLC45A1
prerank,protein palmitoylation (GO:0018345),-0.3561947931087197,-1.1835318968126152,0.21171171171171171,0.7051158353878504,1.0,10/30,16.77%,GLUL;ZDHHC13;ZDHHC21;ZDHHC17;ZDHHC14;SELENOK;ZDHHC5;ZDHHC15;PORCN;ZDHHC2
prerank,regulation of BMP signaling pathway (GO:0030510),0.419073123153676,1.183444382713314,0.23128491620111732,0.6459982785119887,1.0,20/73,18.24%,SULF1;SFRP4;FSTL1;SMAD2;SMURF2;PPARG;HTRA3;LEMD2;ITGA3;SMAD5;BMPER;ACVR2A;SKOR2;SMAD4;SMAD1;SMURF1;CHRD;ACVRL1;TRIM33;RBPJ
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3605435348792927,-1.1834396220932306,0.2264957264957265,0.7028267890115915,1.0,16/30,26.49%,LBR;MSMO1;INSIG1;ACAT2;SQLE;CYP51A1;DHCR24;IDI1;ACLY;LSS;HSD17B7;FDPS;EBP;FDFT1;NSDHL;TM7SF2
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5502337589399025,1.1832402800842257,0.2998477929984779,0.6459594616144606,1.0,3/12,4.97%,B4GALT5;MYCBP2;PTEN
prerank,regulation of nervous system process (GO:0031644),-0.4248992453853343,-1.1827574115647643,0.26262626262626265,0.7021476751856851,1.0,5/18,5.11%,DLGAP1;HTR2C;NOS3;DLGAP2;SLC8A3
prerank,regulation of cellular component size (GO:0032535),0.4731053687947754,1.182695871174377,0.2720105124835742,0.6467828324445817,1.0,11/30,18.74%,VAV2;VAV3;PTEN;RPTOR;MSN;VAV1;RAC1;PEX11A;LAMTOR5;PICALM;EPS8
prerank,positive chemotaxis (GO:0050918),0.5212504279095178,1.1826138106138955,0.26912181303116145,0.6464071915992743,1.0,6/17,14.74%,FGF7;NRP1;ANGPT1;GPNMB;PTPRJ;CX3CL1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3959390286692035,-1.182429150153758,0.23484848484848486,0.7004521468488843,1.0,5/20,3.68%,PRKCZ;CD81;MALT1;IL18;CD55
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.41805477116323064,1.1823883127059798,0.20953436807095344,0.6464416859662767,1.0,16/74,18.24%,PSMA7;BACH1;CREBBP;ARNT;PSMB8;PSMA6;NFE2L2;PSMF1;PSMA8;HIF1A;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1;RBPJ
prerank,I-kappaB phosphorylation (GO:0007252),0.5710103731396547,1.1820403368043138,0.28307692307692306,0.6468082048435703,1.0,2/10,6.73%,TLR2;TLR7
prerank,regulation of cellular localization (GO:0060341),0.44223608564970396,1.1817626351795918,0.2433734939759036,0.6469643930699231,1.0,8/46,8.60%,NR1H4;LRRK2;BLK;DYNC1H1;CAMK2D;UNC13D;GOSR1;EFNA5
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.5030721910387604,1.1812347096218827,0.2728512960436562,0.6477912856769898,1.0,6/19,21.08%,TNFAIP3;PYDC1;NLRP2B;CX3CL1;CPTP;ZC3H12A
prerank,cellular calcium ion homeostasis (GO:0006874),0.4017000278835716,1.1812168122584346,0.19162303664921465,0.6472794918974549,1.0,22/133,12.64%,CCL11;CCL7;EDN3;CXCL12;CD40;STOML2;CCR1;CAMK2D;BCL2;TRPC6;SLC24A5;CCL5;FKBP1B;ATP2A2;DRD3;PDZD8;TMEM203;ATP2B1;CALR;TPCN2;MICU2;PACS2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.5457141444668167,1.1810713970106768,0.2948905109489051,0.6471251114696246,1.0,3/14,4.55%,ZEB1;SPRED1;SPRED2
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4967424355945041,1.181070777547994,0.2618384401114206,0.6465662814942622,1.0,5/24,8.23%,OLR1;TNIP1;CCL5;ICAM1;MSN
prerank,atrioventricular valve development (GO:0003171),0.5347435913034854,1.181059439886611,0.29420505200594355,0.6460401309079112,1.0,4/14,11.44%,SLIT3;ACVR1;HEYL;TGFB2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3975846117203404,1.1801907391968594,0.21991701244813278,0.6477506319667382,1.0,36/129,18.90%,DYNLL1;BACH1;CDKN2B;FBXL7;DYNC1H1;CUL1;KHDRBS1;TUBG1;ALMS1;CDK14;PLK1;PCM1;HAUS3;SKP1;CEP41;CNTRL;PHLDA1;DCTN3;BORA;PCNT;PPP2R2A;CCNB2;CDK7;CEP72;PPP1CB;FBXW11;PPME1;ACTR1A;AKAP9;CEP192;CSNK1D;YWHAE;CKAP5;TAF2;CENPJ;HAUS6
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.2379021824344581,-1.1801583944198906,0.0,0.7046026374249418,1.0,86/264,25.11%,ELAVL2;U2SURP;SRRM2;PSPC1;SFPQ;SNRNP70;DDX5;HNRNPU;YTHDC1;NOVA2;PRPF6;CDC40;SRSF5;SNRNP48;FRG1;WDR33;CSTF2;CWC22;SNRPN;PABPC1;NOVA1;AQR;HNRNPH3;ZCRB1;U2AF2;ISY1;PRPF38A;PRPF4;GEMIN2;USP49;RALY;RBM5;CWF19L1;GCFC2;LSM6;SNRPC;PPIH;DCPS;HNRNPA1;SNRPG;POLR2A;POLR2H;SRSF7;RBM19;POLR2G;PRPF40B;SRSF9;PPIL3;SNRNP27;POLR2F;RBM17;IK;SCNM1;PRPF19;CWC25;RBM8A;SART1;CPSF2;LSM5;HNRNPR;MAGOH;SNRPD3;HNRNPA3;POLR2E;HNRNPM;HNRNPA0;PRPF8;EIF4A3;SRSF3;CLP1;HNRNPL;CACTIN;DNAJC8;RAVER2;CPSF4;SNUPN;SF3B6;SF3B5;DDX39B;TXNL4A;PDCD7;DDX46;DDX39A;SF3A1;SF3A3;HNRNPD
prerank,regulation of hippo signaling (GO:0035330),-0.41163879027447814,-1.180154128389228,0.22433460076045628,0.7020939125600434,1.0,9/17,23.69%,SCHIP1;CIT;MOB3B;WWC2;MARK3;WWC1;NEK8;MAP2K3;MAPK14
prerank,negative regulation of gene expression (GO:0010629),0.38245781445026633,1.1800844488211162,0.12951807228915663,0.647460061908142,1.0,58/302,15.68%,RUNX1;RBMS3;IGF2BP1;CREB3L1;ITGB8;NCOR2;YAP1;IGF2BP2;SYNCRIP;ZFP36L2;FLOT2;REL;APOE;ILF3;IGFBP5;CCR1;PHF1;LGALS9;METTL16;SFRP1;EIF2AK2;PTBP3;EMILIN1;CAPRIN1;GIGYF2;SAMD4A;CELF1;TERT;TNRC6B;FBXW7;GPNMB;MAP2K1;DCP2;HDAC1;RNH1;DICER1;GAPDH;SETDB1;MOV10;TGFB2;ATP2B1;DNMT3B;CALR;SETDB2;TNF;FGF2;SMCR8;SPI1;DDRGK1;MSR1;PSEN1;FMR1;PPHLN1;PDCD10;DXO;CCDC3;SMO;HIF1A
prerank,sensory perception of light stimulus (GO:0050953),0.41118278031457045,1.180046365390976,0.23555070883315157,0.6470135834828316,1.0,8/87,9.31%,COL18A1;COL1A1;RGS16;COL11A1;RDH12;MYO7A;RDH10;SFRP5
prerank,receptor clustering (GO:0043113),-0.36320884024956857,-1.1799846704408372,0.2066115702479339,0.7001266348860192,1.0,6/27,6.07%,SYNJ2BP;NRXN1;LRRC7;DLG2;AGRN;NRXN2
prerank,regulation of cell communication (GO:0010646),0.45582199372889237,1.1798064067369103,0.26243781094527363,0.6471025406494285,1.0,6/35,8.96%,IGFBP7;TBX18;UGCG;CAMK2D;PTPN1;ANXA1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.40699792064880513,1.1794837313159068,0.21911922663802363,0.6473588881773151,1.0,34/93,26.27%,SH3RF3;MID1;TAOK1;UNC5CL;EIF2AK2;SASH1;TAOK3;RASSF2;TIRAP;SH3RF1;EDA2R;TGFB2;PJA2;TRAF2;SPI1;PDCD10;RIPK1;TRAF5;MAPK8IP1;MFHAS1;XDH;GADD45A;DUSP15;ZC3H12A;WNT16;AXIN1;SDCBP;RELL1;TRAF3;SEMA3A;VEGFA;LTBR;MBIP;PYCARD
prerank,regulation of protein-containing complex assembly (GO:0043254),0.39746672961495344,1.1790009692869223,0.20490928495197439,0.6480836892162114,1.0,26/110,18.04%,MMP3;ABCA1;IAPP;FARP2;APOE;AIDA;CD36;EIF2AK2;CDC42;STXBP1;TIRAP;BRK1;FNIP1;FBLIM1;TNF;GSK3B;TRAF2;SRC;HSPA5;ATF7IP;SH3GLB1;KIF9;TPPP;STX1B;ICE1;SLF2
prerank,regulation of integrin activation (GO:0033623),0.530760608288003,1.1784137500075904,0.2786885245901639,0.6491347532039561,1.0,6/15,21.94%,FARP2;FBLIM1;SRC;PLEK;PIEZO1;RAP1B
prerank,cellular response to ionizing radiation (GO:0071479),0.43297141968414093,1.1782783717191083,0.2729498164014688,0.6489284847485166,1.0,16/47,21.02%,YAP1;TNKS1BP1;INO80;ATM;GRB2;ATR;TANK;NIPBL;CLOCK;NUCKS1;MDM2;RAD9A;SWI5;GADD45A;KDM1A;MAP3K20
prerank,organophosphate ester transport (GO:0015748),-0.3789759798566806,-1.178259176369646,0.21982758620689655,0.702695560299369,1.0,6/24,9.97%,PITPNC1;LDLR;PITPNA;SCARB1;ABCA3;TNFAIP8L3
prerank,epidermal cell differentiation (GO:0009913),0.4531056121002114,1.1780821838458764,0.26841448189762795,0.6488834196245289,1.0,13/41,21.50%,GATA6;UGCG;JAG1;ANXA1;WNT5A;HDAC1;GLI1;PIP5K1A;MED1;ERCC2;ADAM9;WNT16;EPHA2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5796193909630395,1.1778381933852902,0.28365384615384615,0.6489965238234497,1.0,4/10,18.30%,KMT2A;SPHK2;SMAD4;HDAC5
prerank,regulation of response to biotic stimulus (GO:0002831),0.4763822413746227,1.1777449734233245,0.27440633245382584,0.6486844340839987,1.0,8/28,14.74%,GATA6;BIRC3;TREM2;CD36;IRF1;TIRAP;CASP8;CX3CL1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.46847361978503,1.177645102903427,0.25371120107962214,0.6484051393744851,1.0,11/30,23.74%,CXCL12;SNAI1;SNAI2;CCAR2;TMEM161A;MDM2;FBXO5;KDM1A;DYRK1A;CLU;THOC5
prerank,positive regulation of protein polymerization (GO:0032273),0.41627875381358104,1.1773119218772765,0.24626006904487918,0.6487622986874395,1.0,15/65,18.41%,CCL11;NAV3;NCK1;BAIAP2;NCK2;CARMIL1;SNX9;AKAP9;RAC1;FES;CDC42EP1;TOGARAM1;CTTN;TPPP;CDC42EP4
prerank,myeloid cell differentiation (GO:0030099),0.4392989892902968,1.1772010569819213,0.2630952380952381,0.6485008229873895,1.0,9/47,13.10%,RUNX1;JAK2;CDKN2B;TIRAP;UBA5;PTPN2;KMT2E;TET2;SPI1
prerank,translesion synthesis (GO:0019985),-0.33131585495856747,-1.1771329710445617,0.2088607594936709,0.7035643179721265,1.0,27/42,35.17%,RCHY1;UBC;POLD3;PCNA;UFD1;FAAP20;RFC3;NPLOC4;UBA52;POLH;PARP10;USP10;POLD2;RPA2;PRIMPOL;PCLAF;POLE2;RFC4;ZBTB1;POLD4;RFC2;DTL;RPA3;POLK;USP43;SPRTN;RFC5
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5482411136865398,1.1768238922634247,0.3044117647058823,0.6488877324715625,1.0,1/13,0.45%,IL23R
prerank,negative regulation of cellular senescence (GO:2000773),0.5501889747421214,1.1754966441040051,0.28810975609756095,0.6519182821824508,1.0,7/13,21.73%,AKT3;CDK6;TERT;MAP3K3;FBXO5;HMGA2;YBX1
prerank,platelet aggregation (GO:0070527),0.4552859170118146,1.1754722484981657,0.258974358974359,0.6514333889944905,1.0,15/33,24.04%,PDGFRA;CSRP1;MYH9;STXBP1;STXBP3;UBASH3B;GNAS;PLEK;FERMT3;TYRO3;ACTN1;FIBP;P2RY12;ITGB3;METAP1
prerank,regulation of spindle assembly (GO:0090169),0.48766018521702004,1.1753507844289874,0.27956989247311825,0.6512034975440031,1.0,6/25,10.58%,CHMP4B;DYNC1H1;PLK1;GPSM2;EML3;SENP6
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.41324278548549026,-1.1744343877759114,0.23103448275862068,0.7087588154177559,1.0,4/17,1.15%,PRKAG2;PRKAA2;ADIPOR2;CAV1
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4931045144588602,1.1742322907879637,0.28493894165535955,0.6535248845331028,1.0,6/23,14.73%,THBS4;XCL1;MDK;TIRAP;DAPK2;RAC1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.42337883205208104,1.1741754449638664,0.23542600896860988,0.6531117429281343,1.0,20/65,18.20%,SH3KBP1;EGFR;ERRFI1;PTPN3;EGF;CDC42;EPS15L1;CBL;GRB2;MVP;PTPRJ;PTPN2;PDE6H;SPRY2;EPS15;BTC;NEU3;ITGA1;AKT1;AGT
prerank,ruffle organization (GO:0031529),0.5167804854568008,1.1733901759168166,0.2968299711815562,0.6547154400273588,1.0,9/16,22.70%,LIMA1;AIF1;CARMIL1;AIF1L;RAC1;PLEK;PIP5K1A;TPM1;ARFIP2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4461497417090194,1.1733704338926036,0.2819593787335723,0.6542034298195025,1.0,16/43,18.89%,POU5F1;STAT3;PPARG;TERT;FOXO3;TEAD1;TGFB2;TNF;FGF2;GNL3;SPI1;SMAD3;HIF1A;SMARCA4;ETS1;NR3C1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.4191605912003352,1.1722466793300066,0.24272930648769575,0.6565982146429523,1.0,22/70,18.08%,MYO10;VAV2;VAV3;DOCK1;WIPF1;NCK1;BAIAP2;CDC42;ACTR2;GRB2;BRK1;PTK2;VAV1;ABI1;PIK3R1;SRC;RAC1;FCGR1A;WIPF2;YES1;MAPK1;FCGR3A
prerank,mitotic metaphase plate congression (GO:0007080),0.432787859732213,1.1719403436317395,0.26785714285714285,0.6568208407053867,1.0,10/51,15.31%,KIFC1;EML4;CHMP4A;CHMP4B;VPS4A;PINX1;EML3;CHMP7;MAD1L1;CHMP2B
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.5026100491815918,1.171919403318087,0.2796610169491525,0.6563350831483225,1.0,4/20,12.59%,CLTC;PID1;PPP2R5A;NUMB
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5237293687891669,1.171087462376793,0.2966226138032305,0.6580008099635113,1.0,5/15,12.46%,TREM2;CD36;EIF2AK2;PYDC1;NLRP2B
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4394218249969746,-1.170856448032496,0.2550335570469799,0.7164449006919237,1.0,3/14,3.04%,PRKCZ;CD81;IL18
prerank,DNA replication (GO:0006260),0.40235652987647713,1.1708019545728872,0.2217438105489774,0.6582010282338293,1.0,26/105,19.97%,RBMS1;BAZ1A;POLE3;BRIP1;DNA2;MCM2;NT5M;ATM;MCM7;ATR;DBF4;GRWD1;RNASEH2A;MCM9;TIMELESS;POLA2;REV1;RMI1;POLG;ATRIP;PNKP;ING5;RAD9A;RBBP8;KAT7;NAP1L1
prerank,liver development (GO:0001889),0.459209284856124,1.1701658791713194,0.2835249042145594,0.6593583035612546,1.0,9/32,12.77%,PRKCSH;ARID5B;PHF2;PKD2;NF1;E2F8;ANXA1;NPHP3;NKX2-8
prerank,neural crest cell migration (GO:0001755),-0.3447244585720178,-1.1700490470997622,0.22580645161290322,0.7161194738677634,1.0,19/36,26.72%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;FN1;ERBB4;TBX1;SEMA4D;SEMA5A;SEMA5B;SEMA3G;RADIL;SEMA6C;SEMA4B;SOX8;SEMA3B;SEMA4A;SEMA6B
prerank,cell junction assembly (GO:0034329),0.4064689805466269,1.1700213843632383,0.2174863387978142,0.6591891895433201,1.0,25/100,12.66%,CDH11;VMP1;SLITRK6;PCDHB6;FLNC;PCDHB16;FARP1;SDK2;ADGRL3;FSCN1;PTEN;DCHS1;OPHN1;LIMS1;CDC42;CDH6;PLXND1;GJC1;DSCAM;CDH18;CDH24;DBNL;FBLIM1;RHOA;SDK1
prerank,positive regulation of behavior (GO:0048520),-0.4871241337302945,-1.1696811464828583,0.2967914438502674,0.7147157350359674,1.0,5/10,26.29%,SGIP1;CFAP20;NLGN1;MEF2C;NR4A3
prerank,glycerolipid catabolic process (GO:0046503),-0.3974507838390306,-1.1696770649183317,0.2638888888888889,0.712241702510122,1.0,6/19,17.01%,GPCPD1;MGLL;ABHD6;GDE1;GDPD1;ENPP6
prerank,immunoglobulin mediated immune response (GO:0016064),-0.4833065666188816,-1.1695677572836038,0.28610354223433243,0.7101284968855259,1.0,2/10,20.15%,CD81;FCER1G
prerank,positive regulation of B cell proliferation (GO:0030890),0.46931476434206515,1.1695132314804573,0.2708860759493671,0.6599409354043831,1.0,7/29,11.94%,CD40;VAV3;BCL2;SASH3;TIRAP;IL7;TNFRSF4
prerank,glucose catabolic process to pyruvate (GO:0061718),0.48414066675865525,1.1694624095166442,0.2713498622589532,0.6589561739743625,1.0,5/24,11.60%,HK2;FOXK2;ENO1;GAPDH;GCK
prerank,canonical glycolysis (GO:0061621),0.48414066675865525,1.1694624095166442,0.2713498622589532,0.6589561739743625,1.0,5/24,11.60%,HK2;FOXK2;ENO1;GAPDH;GCK
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.3307950100065574,-1.1685144371584317,0.20967741935483872,0.7104464991119626,1.0,16/38,23.59%,NDUFS1;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;NDUFB7;NDUFS3;NDUFA1;NDUFC2;NDUFA10;NDUFS2;NDUFB11
prerank,DNA modification (GO:0006304),0.49083602991301817,1.168487407143302,0.3066485753052917,0.6610587701868187,1.0,2/22,1.20%,PARP3;MPG
prerank,negative regulation of protein depolymerization (GO:1901880),0.4822981916997388,1.1680590253985528,0.28337874659400547,0.6616968774953975,1.0,7/24,13.76%,TAOK1;NAV3;LIMA1;TPX2;CAMSAP2;FGF13;PLEKHH2
prerank,receptor-mediated endocytosis (GO:0006898),0.3941043397332123,1.1680150704184509,0.19896373056994818,0.6612760958489403,1.0,31/132,15.88%,HP;HPR;CLTC;LRP1;HSPG2;SPARC;COLEC12;MASP1;APOE;ADM;DNAJC6;CD36;DNAJC13;LRP6;CTSL;CANX;GPR107;GRB2;GAK;SNX9;CALR;CALCRL;TPCN2;EPS15;MSR1;HSPH1;COLEC11;AP2A2;NEDD4;FCGR1A;GRK4
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5407160933545104,1.167865976451521,0.30060422960725075,0.6611422538391539,1.0,1/13,0.33%,ENPP1
prerank,maintenance of protein localization in organelle (GO:0072595),0.509201804302953,1.1676995246402828,0.2762039660056657,0.661015465402389,1.0,7/19,17.14%,BCL3;HK2;MORC3;SKP1;TAPT1;HSPA5;AKT1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.4039025833525974,1.1676013957931948,0.24888888888888888,0.6607259645863416,1.0,17/80,14.70%,CLTC;HEATR5A;STX6;TMEM87B;SNX8;RAB7A;RAB7B;GOSR1;GBF1;RAB9A;ANKFY1;LMAN1;DENND5A;SNX2;SNX5;TBC1D10B;WASHC1
prerank,regulation of Notch signaling pathway (GO:0008593),0.415733322410464,1.1674229658782407,0.23509561304836896,0.660656839026565,1.0,25/76,18.68%,MMP14;YAP1;ZMIZ1;EGFR;MAML3;STAT3;JAG1;EGF;CREBBP;LLGL1;MAML2;FBXW7;TSPEAR;NEPRO;GALNT11;TGFB2;MAML1;SRC;PDCD10;EGFL7;ITGB1BP1;TSPAN14;AKT1;RBPJ;ZBTB7A
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.4459098843983574,1.1665143688416586,0.2683513838748496,0.6625013369861575,1.0,9/40,14.82%,C3;SFRP4;EGF;RAB21;ANGPT1;CBL;VTN;FMR1;CD63
prerank,negative regulation of macroautophagy (GO:0016242),0.477150483198529,1.1664560044338732,0.27066666666666667,0.6620990063427613,1.0,10/26,21.25%,LRRK2;CHMP4A;CHMP4B;TMEM39A;SMCR8;AKT1;SCFD1;USP36;MTM1;CLEC16A
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.4714265412499385,1.1660721697894598,0.28741721854304636,0.6625747164011206,1.0,8/26,21.00%,TNFAIP3;IRAK3;ILRUN;TRIM21;TRIB1;ITCH;TYRO3;LYAR
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4995781785696978,1.1660663059825804,0.2868965517241379,0.6620379303036925,1.0,5/21,8.07%,SULF1;EXT1;EXT2;HPSE;HS2ST1
prerank,lymphocyte differentiation (GO:0030098),-0.28574093113363636,-1.1655453731275738,0.15966386554621848,0.7164867326405312,1.0,19/68,17.48%,KIT;HDAC4;HDAC9;TOX;GPR89B;GPR89A;VCAM1;TPD52;MSH2;JAG2;ITGA4;DNAJB9;BLNK;CEBPG;PIK3CD;NHEJ1;GPS2;LFNG;IKZF1
prerank,regulation of phosphate metabolic process (GO:0019220),0.5179469752701829,1.1653995570510478,0.2883522727272727,0.6632895083451982,1.0,4/16,13.92%,SMG7;SMG6;MCM7;PSEN1
prerank,phosphorylation (GO:0016310),0.37504487220171756,1.1646027940377601,0.114,0.6648714418022428,1.0,97/385,18.46%,CCL11;EPHA7;RUNX3;NEK6;MAP4K4;TEC;TAOK1;JAK1;PEAK1;ERN2;LRRK2;JAK2;PRKCA;MARK1;NUAK1;IRAK3;STAT3;STK36;ILF3;IKBKE;AKT3;CAMK2D;PRKD2;ACVR1;MORC3;FAM20A;CDK6;ATM;CDK14;EIF2AK2;PLK1;PPP4R1;DGKH;TAOK3;DCLK1;CDK10;NEK4;MERTK;PXK;FRK;MAST2;PRKAR1B;TGFBR1;MAP2K1;CSNK2A1;PANK2;MAP4K5;HIPK3;ACVR1B;CDC42BPA;CCL2;FGFR1;YWHAZ;NRK;CSNK1G2;TGFB2;GMFB;GK;CDK7;ACVR2A;COQ8B;MAML1;GSK3B;CSNK1A1;ACVR1C;PI4KA;SPHK2;MAP3K6;MKNK1;STK24;DAPK2;TRIB1;NADK;PIK3R4;CCNT1;PRKAB1;PRKDC;GRK4;STK4;FAM20B;ACVRL1;PNKP;CSNK1D;GNPTG;MAPK1;AKT1;LATS2;CDKL1;TYK2;EIF2AK3;TESK2;MAP3K12;SIK3;CDK16;GNPTAB;CDK9;POMK
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.5477351381363843,1.1644575968663438,0.296583850931677,0.6646975963768985,1.0,3/11,10.14%,ZFP36L1;ZC3H3;NCBP2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.4129857627597417,-1.1642690541756866,0.25316455696202533,0.7177015456112397,1.0,7/17,21.73%,ADRA1B;ADCY9;RAPGEF2;ADRA1A;ADRA2A;DRD2;ADRB2
prerank,negative regulation of hormone secretion (GO:0046888),-0.4841849481396029,-1.1641326567072883,0.27348066298342544,0.7156529479996557,1.0,3/10,19.05%,RAB11FIP3;RAB11FIP1;GJA1
prerank,second-messenger-mediated signaling (GO:0019932),0.4037169343446897,1.1638851601931597,0.25,0.6656602310496424,1.0,16/82,14.55%,EDN3;PPP1R9B;TNFSF11;LRRK2;APOE;CCR1;RCAN2;CD36;CXCR4;SAMD14;LAT2;HRH1;RCAN3;TPCN2;NUDT4;TRPM4
prerank,positive regulation of GTPase activity (GO:0043547),0.3858539440408581,1.1637356361821236,0.18431771894093688,0.6655122442905744,1.0,40/188,14.96%,CCL11;CCL7;RGS16;MAP4K4;SYDE1;CD40;PRTN3;ARHGAP24;XCL1;ARHGAP42;SIPA1L3;TAX1BP3;ASAP3;TBC1D16;NF1;LIMS1;CCL5;SFRP1;EPHA1;TBC1D2B;RABGAP1L;RSU1;ZC3H15;ARHGEF19;TBC1D8B;SNX18;RABGAP1;CCL2;MAPRE2;SNX9;GSK3B;NTRK3;RGS10;TBC1D1;ADPRH;RAB3GAP1;ARHGAP22;TBC1D10B;CX3CL1;SIPA1L2
prerank,regulation of cell morphogenesis (GO:0022604),0.4653108966345492,1.1634833962934743,0.25526315789473686,0.6656670980905504,1.0,8/30,14.24%,SPARC;FMNL2;EFNA5;PDZD8;ZMYM4;MOV10;PDPN;WTIP
prerank,nervous system development (GO:0007399),0.3739903853722693,1.16328576171915,0.112,0.6656629222325593,1.0,71/429,12.77%,IGF2BP1;WNT2;ZEB2;GPM6B;CXCL1;YAP1;SLITRK6;IGF2BP2;ROBO2;RBFOX1;PCDHB6;PTN;ATXN1;MYLIP;NUMBL;CHD7;PCDHB16;FARP1;ATXN10;HPCAL4;VCAN;SDK2;NELL1;NAV1;ADGRL3;ZIC4;P2RX5;KALRN;NAV3;STAT3;JAG1;MDK;GLRB;TRAK1;SHH;MAP1S;SERF1A;PMP22;ALDH1A2;PTEN;PKD2;DCHS1;NF1;OPHN1;GDA;PTPRZ1;PLXND1;DLG4;DCLK1;L1CAM;MERTK;SCD5;EFNA5;CXCR4;TGFBR1;WDPCP;ZIC1;ACVR1B;TBX3;WWTR1;TEAD1;DSCAM;ESS2;GMFB;DBNL;NAB2;FGF13;FGF2;SDK1;ACVR1C;SPG7
prerank,response to iron ion (GO:0010039),0.5429193856345402,1.1628791927338673,0.2938530734632684,0.6662612563729167,1.0,4/12,6.95%,SLC11A2;FXN;BCL2;ACO1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.41336673452126904,1.1628602275759683,0.25806451612903225,0.6657650432087053,1.0,22/71,18.08%,MYO10;VAV2;VAV3;DOCK1;WIPF1;NCK1;BAIAP2;CDC42;ACTR2;GRB2;BRK1;PTK2;VAV1;ABI1;PIK3R1;SRC;RAC1;FCGR1A;WIPF2;YES1;MAPK1;FCGR3A
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.45205345006595676,-1.1627450719177619,0.2785515320334262,0.7169929658839125,1.0,2/12,5.03%,GSN;LY6E
prerank,zinc ion homeostasis (GO:0055069),0.476358568800459,1.1625618344410458,0.283289817232376,0.6660034222993648,1.0,1/28,0.13%,SLC39A14
prerank,cholesterol biosynthetic process (GO:0006695),-0.3513848609064929,-1.161975051368306,0.242152466367713,0.7167709104098724,1.0,16/31,26.49%,LBR;MSMO1;INSIG1;ACAT2;SQLE;CYP51A1;DHCR24;IDI1;ACLY;LSS;HSD17B7;FDPS;EBP;FDFT1;NSDHL;TM7SF2
prerank,neurotransmitter transport (GO:0006836),-0.2914406136663383,-1.1617461010907422,0.1891891891891892,0.7149741819160504,1.0,23/73,17.20%,ATP1A2;SNAP25;SYN3;UNC13B;NRXN1;GABRA2;GLUL;LIN7A;SLC1A2;SLC1A1;NRXN2;CPLX1;RIMS1;SNAPIN;DNAJC5;GAD1;SYN2;PTPRN2;LIN7C;SYNJ1;NAAA;SNPH;PPFIA1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.39359181897296924,-1.1610098052864748,0.25806451612903225,0.7146563543276018,1.0,5/18,4.77%,PRKAG2;OCLN;SLC2A1;C2CD5;PRKCB
prerank,protein ADP-ribosylation (GO:0006471),0.46966196026002904,1.1610033000139184,0.28442728442728443,0.669483848130806,1.0,8/28,20.64%,PARP8;PARP3;PARP11;ARF4;SIRT3;TNKS2;PARP14;PARP4
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.42800614621845484,1.1605402492342611,0.25586854460093894,0.670215838586768,1.0,16/51,17.23%,FSTL1;FBN1;SMURF2;PPARG;HTRA3;LEMD2;SMAD5;GREM2;BMPER;ACVR2A;SKOR2;SMAD4;SMAD1;SMURF1;CHRD;TRIM33
prerank,natural killer cell activation (GO:0030101),0.48892510903371966,1.160185851349237,0.29365079365079366,0.6706205608430206,1.0,7/23,21.97%,ULBP1;ELF4;BAG6;CASP8;PTPRC;KAT7;NFIL3
prerank,positive regulation of hydrolase activity (GO:0051345),0.3900621342810432,1.1599944904723563,0.21748178980228927,0.670598900601498,1.0,34/137,18.77%,CCL11;CCL7;RGS16;MAP4K4;CD40;PRTN3;XCL1;ASAP3;NF1;LIMS1;CCL5;SFRP1;RSU1;ZC3H15;SNX18;HMGB2;CCL2;MAPRE2;SNX9;RCN3;RHOA;GSK3B;RGS10;RAB3GAP1;CALM2;CX3CL1;MTMR9;NDEL1;ALS2;TBC1D20;DOCK10;PICALM;CCL15;BCAS3
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.49571875167357793,1.159990835286678,0.2937158469945355,0.6700545862947704,1.0,4/19,9.53%,MMP14;ZMIZ1;MDK;IL7
prerank,carboxylic acid transport (GO:0046942),-0.30105907714427027,-1.1596851657460003,0.20863309352517986,0.7160728477769132,1.0,13/55,12.99%,SLC6A6;SLC13A3;SLC6A9;SLC7A5;SLC1A1;SLC6A12;SLC16A11;SLC16A1;CLN3;SLC16A9;SLC38A5;SLC16A4;SLC6A17
prerank,vascular process in circulatory system (GO:0003018),-0.4471941339265267,-1.1594892820948972,0.26704545454545453,0.711820163056231,1.0,7/13,23.37%,NOS3;GCLC;NPR1;AGTR1;ACE;ACE2;GCLM
prerank,regulation of tube diameter (GO:0035296),-0.4471941339265267,-1.1594892820948972,0.26704545454545453,0.711820163056231,1.0,7/13,23.37%,NOS3;GCLC;NPR1;AGTR1;ACE;ACE2;GCLM
prerank,cGMP-mediated signaling (GO:0019934),0.5481768546049236,1.1586629707942935,0.30243161094224924,0.6730135806480704,1.0,3/13,5.55%,PDE3A;APOE;CD36
prerank,circulatory system development (GO:0072359),0.3968579017854275,1.1584005499659686,0.2510460251046025,0.673108951474017,1.0,22/118,12.60%,COL3A1;SH3PXD2B;GLI2;HSPG2;DNAAF4;ZFPM2;CACNA1C;SHH;FBN1;PTEN;PKD2;NF1;ACVR1;NXN;PDLIM4;FBXW7;TGFBR1;SALL1;TGFB2;CASP8;NTRK3;AKAP13
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5826014037627453,1.1579518650234164,0.3103448275862069,0.673779970446982,1.0,1/10,0.38%,PDE3A
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.4483962233943073,-1.157559004115342,0.25263157894736843,0.7151646631909342,1.0,6/12,27.88%,PPP3CB;GPLD1;PLA2G6;ANO1;CFTR;BAIAP3
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3879244041353796,1.157150162456841,0.19390862944162437,0.6753421580414254,1.0,32/190,14.24%,RORA;NR1H4;PDE3A;ADIPOQ;TNIP1;STAT1;TNFAIP3;SPRED1;TLE1;TREM2;ITPR1;PTEN;BCL2;NF1;NPRL2;CGNL1;BCL2L2;NOC2L;SFRP5;OTUD3;DRD3;FNIP1;PTPRJ;CASP8;P2RX7;TANK;SPI1;DLG5;BMP7;SRC;TRIB3;WTIP
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5076096190549765,1.1568397098230516,0.2982216142270862,0.6756258958113829,1.0,4/18,14.08%,DLC1;ITGA3;KCTD10;ARHGAP35
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5624290403865467,1.1563760877647549,0.3155487804878049,0.6763416333626563,1.0,6/11,25.13%,BIRC3;CASP8;YBX3;RIPK1;FZD9;ARHGEF2
prerank,positive regulation of cellular component organization (GO:0051130),0.39288557721730466,1.15548905619029,0.23978494623655913,0.6781690109817624,1.0,16/107,12.44%,MMP3;RUNX1;LRP1;TREM2;ASAP1;APOE;TGFB3;TIRAP;TGFBR1;BRK1;LMAN1;FNIP1;PTPN23;TGFB2;TNF;GSK3B
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.47017766315558884,1.1552252663278257,0.29041095890410956,0.678326386899833,1.0,2/24,2.43%,CREB3L1;LRRK2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.41161246183660594,1.1546456573290407,0.26072234762979685,0.6792338852442225,1.0,20/72,18.12%,FLRT2;FGF7;SPRED1;GALNT3;SPRED2;CBL;GRB2;GTF2F2;FRS2;NCBP2;FGFR1;FGF2;GTF2F1;KIF16B;SETX;FGF18;MAPK1;RBFOX2;POLR2L;POLR2K
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.3229354202258939,-1.1544473965205935,0.22674418604651161,0.7215268291825125,1.0,26/42,35.17%,UBC;POLD3;PCNA;FAAP20;RFC3;UBA52;POLH;PARP10;USP10;POLD2;RPA2;PRIMPOL;PCLAF;POLE;RFC4;ZBTB1;CDKN2D;POLD4;RFC2;WRN;DTL;RPA3;POLK;USP43;SPRTN;RFC5
prerank,cellular metal ion homeostasis (GO:0006875),0.39886605858049246,1.1543179646996005,0.2467948717948718,0.6795690491302786,1.0,16/102,12.14%,CCL11;CCL7;EDN3;CXCL12;SLC9A1;CD40;STOML2;CCR1;SLC24A5;CCL5;ATP2A2;DRD3;TMEM203;ATP2B1;CALR;TPCN2
prerank,spindle assembly (GO:0051225),0.410603560088344,1.1537657896479057,0.2600229095074456,0.6805064849656999,1.0,17/67,17.00%,NEK6;KIFC1;SMC1A;KIF2A;INO80;HAUS3;STAG2;GOLGA8B;TPX2;STAG1;MAPRE2;RHOA;TUBGCP4;TOGARAM1;CEP192;RCC1;CSNK1D
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.46453885979153203,1.1529821706189678,0.2972972972972973,0.6820156447284377,1.0,10/27,25.49%,DTYMK;GUK1;CTPS1;AK2;AK8;TXNRD1;CTPS2;NME2;TYMS;NUDT13
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.40241189667985183,1.1528248049004053,0.2532467532467532,0.6819052751273428,1.0,28/84,25.19%,PSMA7;MAD2L1;PLK1;ANAPC11;CDC27;PSMB8;PSMA6;PSMF1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1;FBXO5;FBXO31;PSMC6;UBE2E1;RPS27A;FZR1;PSMB4;PSMB5;ANAPC2;PSMD4;PSMD7;PSMD9;PSMA4;CDC16
prerank,axon extension (GO:0048675),0.4824930857863382,1.1523880170151042,0.30567081604426005,0.6824810371140217,1.0,5/23,3.93%,SLIT3;SLIT1;AUTS2;NRP1;USP9X
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.37888129855680325,1.152252009715828,0.14673366834170853,0.6822909066972185,1.0,94/327,21.97%,RORA;RUNX3;POU5F1;CXXC1;SBNO2;ATXN1;CCAR1;CHD7;ZMIZ1;BACH1;GON4L;MAFB;SNAI2;MITF;SUFU;PRRX2;STAT3;SOX21;E2F1;PHF1;MYBL1;PRDM2;FOXK2;CREBBP;YAF2;AHR;BHLHE40;CARM1;CCAR2;BTG1;FADS1;TGFBR1;NONO;ZBTB38;UBE2L3;TGIF2;ACVR1B;TCF7;WWTR1;FOXN2;LIN54;TGFBRAP1;CALR;SP3;SPTY2D1;NIF3L1;ZSCAN21;NAB2;SKOR2;NSD3;NFKB2;SPI1;ATRX;DRAP1;WTIP;BAZ2A;BNC2;PATZ1;HIF1A;PHF12;NUP35;NSD1;NFXL1;CLOCK;TCF7L1;TCF3;ACVRL1;ZFHX3;HCFC2;MZF1;ATF4;NR2C2;SOX2;HINFP;KAT6B;NR3C1;TULP3;DVL2;THAP7;RPL6;KAT7;RBAK;HMGA2;NUP107;VHL;HINT1;MAGED1;NR1D2;RNF14;YBX1;ZNF423;RPS6KA4;CREM;NFIL3
prerank,long-chain fatty acid metabolic process (GO:0001676),0.41411288150518827,1.151927440878845,0.27534562211981567,0.6825896643361736,1.0,8/64,9.08%,CYP1B1;ACSL4;EPHX2;AIG1;SLC27A2;ACOX1;FADS1;CYP1A1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.47043233756129765,-1.1517827268802072,0.2749326145552561,0.7269069982894009,1.0,4/10,24.58%,PCGF5;IGF2;KDM1B;ZFP57
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.40123481750181617,1.151712252361001,0.26216814159292035,0.6826099212729643,1.0,30/76,24.13%,NKD2;LRRK2;PTEN;PABIR1;RNF144A;PLK1;PRICKLE1;FBXW7;RAD23A;ARIH1;PTK2;SOCS5;RNF19B;GSK3B;CSNK1A1;DDRGK1;TRIB3;TRIB1;SMURF1;ZYG11B;CSNK1D;MDM2;ARIH2;FBXO22;RNF14;AXIN1;CLU;RNF144B;RNF217;PIAS1
prerank,microglial cell activation (GO:0001774),0.4970174686366993,1.151488004112764,0.28885832187070154,0.6826218778044786,1.0,5/21,14.74%,JAK2;TREM2;AIF1;TNF;CX3CL1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4081862102306424,1.1510059978130147,0.26718403547671843,0.6833021227310799,1.0,4/75,1.35%,SLC39A14;C3;RGS16;PPP1R9B
prerank,inner dynein arm assembly (GO:0036159),0.5454091856596034,1.150965124752048,0.3264659270998415,0.6828545649765372,1.0,2/11,13.37%,DNAAF4;DNAAF5
prerank,positive regulation of neuron death (GO:1901216),0.4347126289871053,1.1508354951348518,0.2804733727810651,0.682657631503724,1.0,10/46,18.91%,EPHA7;NF1;WNT5A;FOXO3;TGFB2;TNF;GSK3B;ATF4;PICALM;PRNP
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4623161099799921,1.1505928156004719,0.2971576227390181,0.6827337900202713,1.0,11/29,18.78%,TCF7L2;TLE1;RBBP5;CREBBP;TERT;HDAC1;TCF7;RUVBL1;TCF7L1;SMARCA4;AXIN2
prerank,regulation of gene expression (GO:0010468),0.372030198378116,1.150544625919909,0.055,0.6823132996161856,1.0,204/903,19.25%,RORA;RUNX1;GLMN;RBMS3;IGF2BP1;CREB3L1;TRIML2;RUNX3;POU5F1;CXXC1;ITGB8;SEC16B;C1D;SBNO2;EDN3;ADAM19;YAP1;AFF1;ZFP36L1;IGF2BP2;SFRP4;ATXN1;BCL6;NOS1AP;CD276;CCAR1;CRP;CHD7;TLR2;BACH1;GON4L;FGF7;MAFB;SNAI2;CCN4;AFF2;NELL1;FLOT2;MITF;SUFU;REL;TLE1;PRRX2;TREM2;APOE;STAT3;CGGBP1;SOX21;CCR1;SHH;E2F1;PRDM5;PHF1;MYBL1;UBR5;PUM1;PRDM2;EPHX2;AIF1;LGALS9;LIMS1;TRIM21;CD36;FOXK2;EGF;METTL16;CREBBP;CDK6;DTNBP1;ATM;SFRP1;YAF2;AHR;PTBP3;HMG20B;VSTM2A;EMILIN1;TMEM119;PID1;FUBP1;BHLHE40;RRP1B;CARM1;ANGPT1;CCAR2;MAPK11;MSN;CELF1;BTG1;TERT;TNRC6B;FBXW7;FADS1;TGFBR1;MAP2K1;WNT5A;HDAC1;NONO;ZBTB38;DICER1;UBE2L3;PRDM1;TGIF2;ACVR1B;TCF7;SETDB1;HNRNPH2;WWTR1;TRIM44;FOXN2;LIN54;MOV10;TGFB2;NFE2L2;CASP8;GCNT2;DNMT3B;TGFBRAP1;CALR;SP3;SPRY2;SPTY2D1;MARF1;SETDB2;NFKBIZ;TNF;ZSCAN21;NAB2;GSK3B;FGF2;NTRK3;SKOR2;NSD3;P2RX7;NFKB2;SMCR8;SPI1;DDRGK1;PRDM10;MSR1;CTCF;YBX3;SMAD3;PSEN1;BMP7;ATRX;DRAP1;WTIP;TFAP2C;RPL11;PDCD10;BAZ2A;SMAD1;BNC2;CCDC3;SMO;TCF19;PATZ1;HIF1A;FGF18;ADNP2;MED26;PRKAB1;PHF12;NUP35;NSD1;POU3F3;NFXL1;CLOCK;TCF7L1;TCF3;LAMTOR5;OLFM1;ACVRL1;PTPRC;MAPK1;ZFHX3;AKT1;HCFC2;CALCOCO1;MZF1;STX1B;EIF2AK3;ATF4;PICALM;ETS1;PRDM4;INHBA;USP36;RBPJ;HDAC5;NR2C2;SOX2;XDH;HINFP;KAT6B;NR3C1;TLE5;TULP3;DVL2;THAP7;MBNL2;SON;RPL6
prerank,positive regulation of angiogenesis (GO:0045766),0.3965488758965405,1.1502781747222532,0.240128068303095,0.6824546111217187,1.0,16/108,9.14%,RUNX1;CYP1B1;ITGB8;ADAM12;JAK1;CD40;GATA6;PRKCA;MDK;HK2;PRKD2;ANGPTL4;EPHA1;SASH1;BTG1;WNT5A
prerank,regulation of histone acetylation (GO:0035065),0.45353790164844054,1.1501301013055627,0.28903225806451616,0.6822874074323158,1.0,10/33,19.16%,KMT2A;TAF7;NOC2L;TADA2B;GLYR1;SPI1;PAXIP1;HDAC5;IWS1;THAP7
prerank,regulation of cellular component movement (GO:0051270),0.4215004195046016,1.1501296709789581,0.27718040621266427,0.6817385036451619,1.0,20/49,22.93%,MYCBP2;EGFR;ZSWIM6;EGF;CDK6;SP100;TGFBR1;PDPN;MEMO1;RHOA;ZSWIM8;BTC;ZSWIM4;FES;ETS1;ACTN1;PKN1;RAF1;ROCK2;ROCK1
prerank,regulation of interleukin-13 production (GO:0032656),0.5430590756870155,1.1496516912489458,0.30357142857142855,0.6825070113250945,1.0,3/13,5.04%,TNFRSF21;TSLP;LGALS9
prerank,cellular response to pH (GO:0071467),0.5094873681966747,1.1488859092185513,0.3,0.6840484771766788,1.0,2/17,2.09%,HVCN1;SLC9A1
prerank,histone H3 acetylation (GO:0043966),-0.3216407654692765,-1.1488513816502572,0.2300469483568075,0.7328124790335586,1.0,17/40,17.30%,LEF1;PHF14;LDB1;JADE1;PER1;BRCA2;DR1;TADA1;JADE2;WDR5;TAF6L;NAA60;JADE3;MAP3K7;KAT6A;TRIM16;SUPT7L
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.3528904788421487,-1.1487661519087835,0.21393034825870647,0.7306476169377015,1.0,5/30,4.39%,FLT1;MLLT3;KIT;BMP4;KDR
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.28502377308218196,-1.1484948757831561,0.18,0.7290602199190426,1.0,12/76,8.49%,PLCE1;CHRM2;GRM1;ACTN2;HTR2C;ADRA1B;ESR1;GPR4;GNA11;GNA14;AGTR1;ADRA1A
prerank,regulation of primary metabolic process (GO:0080090),0.38686587381145443,1.1483426511183614,0.2359081419624217,0.6849597614804863,1.0,37/126,22.92%,PSMA7;NCOR2;APOE;MVK;CREBBP;PPARG;OAZ3;LACTB;CARM1;PSMB8;PSMA6;TBL1X;CHD9;PSMF1;ELOVL6;PSMA8;PRKAB1;PSMD2;PSMD12;RUBCNL;PSMD11;TGS1;SREBF1;PSMD14;PSMB1;ACACA;FASN;MED1;PSMC6;CERS2;NR1D1;NR1D2;ROCK2;NCOR1;SMARCD3;PSMB4;PSMB5
prerank,transepithelial transport (GO:0070633),-0.4212812703230988,-1.1482417244378829,0.2753623188405797,0.7273672508518159,1.0,5/15,3.81%,SLC12A2;ABCG2;SLC1A2;SLC1A1;CXADR
prerank,phosphatidylserine metabolic process (GO:0006658),0.45602124420204865,1.148160901356994,0.2980891719745223,0.6849173150985292,1.0,9/32,20.29%,PLA1A;PLA2G12A;OSBPL5;ABHD16A;PLA2G4A;PLA2G4E;LPCAT3;PTDSS2;PLSCR1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.48927615973663624,1.148158198478205,0.290633608815427,0.6843742301831057,1.0,6/19,14.73%,MAP4K4;NRP1;LIMS1;SFRP1;PTPRJ;RAC1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.41891430974963434,1.1479674606150299,0.26242774566473986,0.6842726435862327,1.0,14/55,19.71%,CYP1B1;PDGFRB;DHRS4;PID1;GRB2;ARF4;SPHK2;RAC1;RIPK1;AGT;XDH;CCN6;GADD45A;DCXR
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.5292457498165846,1.1479145389037542,0.31846153846153846,0.6838502018278697,1.0,4/13,8.76%,ABCA1;CD36;PPARG;LPL
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.5669575020978067,1.1475092302212462,0.32909379968203495,0.6837894399721507,1.0,7/10,20.54%,NSMAF;TNFRSF1A;TNF;SPHK2;SMPD3;SIRT3;PRKCD
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5669575020978067,1.1475092302212462,0.32909379968203495,0.6837894399721507,1.0,7/10,20.54%,NSMAF;TNFRSF1A;TNF;SPHK2;SMPD3;SIRT3;PRKCD
prerank,regulation of interferon-alpha production (GO:0032647),0.47733797684466844,1.1471459110341362,0.3112033195020747,0.6841832784956349,1.0,4/23,9.84%,STAT1;IRF7;TLR7;SETD2
prerank,cardiac muscle contraction (GO:0060048),-0.341106022269814,-1.1470635489598398,0.2100456621004566,0.7284164010008201,1.0,4/34,3.22%,DMD;ATP1A2;ATP1B1;GSN
prerank,striated muscle tissue development (GO:0014706),-0.3467100909130594,-1.1470171556037145,0.22026431718061673,0.726190858403702,1.0,8/29,7.19%,SGCD;PGM5;CAV1;SGCZ;RBP4;IGSF8;MYL6;NDUFV2
prerank,mRNA stabilization (GO:0048255),0.43753579787641206,1.1469695934173736,0.2922318125770654,0.6840651503219853,1.0,5/40,7.77%,IGF2BP1;SYNCRIP;E2F1;TENT5A;TIRAP
prerank,mesenchyme morphogenesis (GO:0072132),0.5036537322665956,1.146669767361994,0.2985294117647059,0.6842702034838424,1.0,5/17,11.44%,SMAD2;TBX2;ACVR1;HEYL;TGFB2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.28668458092502547,-1.1463326051164224,0.21052631578947367,0.7259105346425526,1.0,33/84,23.77%,KHDRBS2;QKI;DDX5;CELF2;MBNL1;HNRNPU;YTHDC1;WTAP;NOVA2;TIA1;NCL;CWC22;NOVA1;RBFOX3;U2AF2;CIRBP;RBM5;LARP7;HNRNPA1;SRSF7;DAZAP1;SRSF9;RBM8A;SRRM4;MAGOH;NUP98;FXR1;SRSF3;HNRNPL;PCBP4;RBM3;ZC3H10;CELF6
prerank,endosome organization (GO:0007032),0.4293030805439957,1.1452334578804997,0.2822085889570552,0.6874242649638763,1.0,16/41,20.02%,ARFGEF2;HOOK2;PI4K2B;DNAJC13;WASHC4;SNX33;EEA1;PLEKHF1;SNX10;TMCC1;CHMP2B;SQSTM1;ALS2;HOOK1;CORO1C;WASHC5
prerank,heterocycle biosynthetic process (GO:0018130),-0.4280578697891664,-1.145221285403601,0.2786377708978328,0.7266289487373851,1.0,9/14,30.82%,GPHN;MOCS2;LIAS;NFS1;NOXRED1;PYCR2;MOCS3;PYCR3;GCH1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.4330560240142465,1.1447688929054614,0.2965686274509804,0.6880877003217055,1.0,10/41,14.74%,ADAM19;TNFSF11;JAK1;MDK;CCL5;PTPN23;GCNT2;TNF;BMP7;CX3CL1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.47516182214751196,1.1447332945879127,0.3004172461752434,0.6876194602740998,1.0,13/23,21.64%,CEMIP;TNKS1BP1;EGF;PLK1;RPTOR;S1PR2;UBE2K;CALM2;BMP7;MAPK1;IRGM;TRIM6;AXIN1
prerank,DNA alkylation (GO:0006305),0.49805489050262186,1.1442962440488964,0.3227665706051873,0.6877005860650869,1.0,8/19,18.44%,EHMT1;KMT2E;DNMT3B;GATAD2A;ATRX;BAZ2A;ATF7IP;MTRR
prerank,DNA methylation or demethylation (GO:0044728),0.49805489050262186,1.1442962440488964,0.3227665706051873,0.6877005860650869,1.0,8/19,18.44%,EHMT1;KMT2E;DNMT3B;GATAD2A;ATRX;BAZ2A;ATF7IP;MTRR
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.41075781312548054,1.1442846545263217,0.2647058823529412,0.6871900424540625,1.0,7/59,9.82%,CYP7B1;LIPC;ALDH1A2;SLC27A2;HSD17B8;LPL;OSBPL3
prerank,negative regulation of TOR signaling (GO:0032007),-0.33531898336967136,-1.1441622726962004,0.22580645161290322,0.7274147952835948,1.0,14/36,20.66%,PRKAA2;RNF152;NPRL3;DEPDC5;SESN2;SESN3;DDIT4;TSC1;SPAAR;TSC2;MINAR1;AKT1S1;TNFAIP8L1;PRKAA1
prerank,central nervous system development (GO:0007417),0.3732392648675076,1.1441272415857717,0.1905241935483871,0.6870791803634065,1.0,25/250,5.93%,COL4A1;C3;EPHA7;APOD;HSPG2;ROBO2;ATXN1;MEIS2;MDGA1;CHD7;HPCAL4;VCAN;AFF2;ADGRL3;ZIC4;STAT3;MEIS1;SHH;MAP1S;PTEN;PKD2;NF1;PBX3;ATP6AP2;PTPRZ1
prerank,nucleosome organization (GO:0034728),0.4211923298896424,1.144095472271881,0.2713270142180095,0.6866152093716398,1.0,18/55,20.23%,POLE3;SMARCC1;INO80;SETD2;GRWD1;HMGB2;LIN54;RSF1;SPTY2D1;NAP1L3;CTCF;ATRX;ASF1A;SRCAP;SMARCA4;KAT6B;NAP1L1;ARID2
prerank,positive regulation of signaling (GO:0023056),0.4478555429952348,1.1436859344378933,0.2993710691823899,0.6871455562588524,1.0,7/37,12.30%,ADIPOQ;EDN3;DLG4;HCRT;WLS;PTPN23;TNF
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2853127421453561,-1.143498826546134,0.18269230769230768,0.7271182812477185,1.0,21/75,12.55%,MAP2;DCC;CTNNA2;NTNG1;CNTN4;MINK1;ACTB;RB1;KLF7;SHTN1;DSCAML1;DCDC2;FGFR2;SLITRK1;PARD3;ANK3;MAP1A;APP;ZDHHC17;S100B;PAK3
prerank,positive regulation of cell growth (GO:0030307),0.3961071244114416,1.143430518861449,0.27478448275862066,0.6872593808094083,1.0,19/96,11.62%,MMP14;EIF4G2;KLHL22;EGFR;FXN;BCL2;PABIR1;INO80;SFRP1;CDC42;RPTOR;L1CAM;SYT2;EXOSC4;TGFBR1;CSNK2A1;DBN1;TGFB2;DBNL
prerank,signal transduction in response to DNA damage (GO:0042770),0.42259797912590996,1.1431335257119826,0.28418549346016647,0.6875222309158786,1.0,15/49,19.28%,BCL3;BRIP1;BATF;E2F1;ATM;GRB2;ATR;ATRX;PAXIP1;USP28;CLOCK;ATRIP;RAD9A;HINFP;GADD45A
prerank,regulation of dephosphorylation (GO:0035303),0.5131692294205074,1.1429590173224715,0.3136966126656848,0.687435720507874,1.0,8/15,19.50%,SMG7;SMG6;PPP1R16A;SRC;MTMR9;MTMR3;MTMR2;MTMR1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3890290131004073,1.142925516567608,0.2677248677248677,0.6864343615817428,1.0,15/104,16.79%,PSMA7;CUL1;CREBBP;SKP1;PSMB8;PSMA6;FBXW11;PSMF1;SRC;PSMA8;PSMD2;PSMD12;RELB;PSMD11;PSMD14
prerank,cellular response to lectin (GO:1990858),0.3890290131004073,1.142925516567608,0.2677248677248677,0.6864343615817428,1.0,15/104,16.79%,PSMA7;CUL1;CREBBP;SKP1;PSMB8;PSMA6;FBXW11;PSMF1;SRC;PSMA8;PSMD2;PSMD12;RELB;PSMD11;PSMD14
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3852641625533415,1.1427980446979704,0.22910216718266255,0.6862146482395852,1.0,34/150,14.74%,PDGFRA;IAPP;TCF7L2;GAB2;IRS1;PDGFRB;FGF7;EGFR;RICTOR;EGF;STRN;PIK3AP1;HPSE;PIK3R5;ANGPT1;GRB2;TGFBR1;FRS2;FGFR1;PTPRJ;PTK2;GCNT2;SPRY2;VAV1;TNF;FGF2;MC1R;RASD2;BTC;PIK3R1;SRC;TRIB3;RAC1;CX3CL1
prerank,regulation of protein localization (GO:0032880),0.4111410703879157,1.1427710882984419,0.28125,0.6857502610847476,1.0,11/58,10.97%,TRIML2;STX6;CTSD;TRIM21;VPS4A;RABGAP1L;BORA;FBXW7;RAB9A;WDPCP;DNAJB6
prerank,regulation of DNA replication (GO:0006275),0.42400419650693644,1.1425395871479083,0.2980997624703088,0.6858163934996621,1.0,18/49,21.84%,GLI2;DNA2;EGFR;EGF;BRPF3;PDS5A;ATR;ZBTB38;ANKRD17;CTC1;ACVRL1;NUCKS1;GLI1;FBXO5;WAPL;KAT7;TERF1;RBBP6
prerank,anterior/posterior axis specification (GO:0009948),0.5274728919536881,1.1419676515434656,0.31626506024096385,0.6867398462266502,1.0,3/15,10.21%,SHH;WLS;TBX3
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3818271714462047,1.1417279375947205,0.24109014675052412,0.6868539865839104,1.0,20/142,11.75%,KNG1;PDGFRA;CACNA1A;IAPP;CMKLR1;EDNRA;CACNA1C;CCR1;PTGDR;TRPC6;CD36;S1PR3;DLG4;CXCR4;FKBP1B;WNT5A;DRD3;LPAR3;ATP2B1;LPAR2
prerank,glial cell development (GO:0021782),0.47725871980552603,1.1416496069688487,0.32157394843962006,0.6865178856627144,1.0,7/25,17.89%,TLR2;MDK;NF1;CDK6;EIF2B3;TPPP;NRROS
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.3181580621549379,-1.141557724816439,0.22988505747126436,0.7302749966541704,1.0,13/39,13.78%,TEK;KRIT1;CDH5;GAS6;NDNF;RAMP2;KDR;SCG2;ITGA4;GATA2;SEMA5A;ECSCR;THBS1
prerank,rRNA methylation (GO:0031167),0.4739253021513208,1.140538849109523,0.3310344827586207,0.6888525618531919,1.0,6/22,12.25%,METTL15;METTL16;MTERF4;NOP2;MRM1;MRM2
prerank,regulation of MAPK cascade (GO:0043408),0.3796485675690217,1.140348590481212,0.257172131147541,0.6888024672726728,1.0,23/157,12.90%,ROR2;ROR1;EPHA7;IAPP;MAP4K4;TAOK1;SPRED1;EGFR;NF1;EGF;ATP6AP2;PTPN6;TAOK3;TMEM106A;MAP2K1;FGFR1;PTPRJ;YWHAZ;NRK;NBR1;FGF2;NTRK3;P2RX7
prerank,protein targeting to lysosome (GO:0006622),0.48893280461116223,1.140131752942987,0.3088023088023088,0.6888107738984545,1.0,7/20,18.32%,AP4M1;VPS4A;LAMP2;RAB7A;NEDD4;ZFYVE16;GNPTAB
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.3923383304478162,-1.1400786070889684,0.2743055555555556,0.7321746282368762,1.0,9/18,20.84%,NRXN1;PRKCZ;SHANK3;CUX2;SHANK1;RIMS1;RELN;NLGN1;RIMS2
prerank,regulation of protein localization to nucleus (GO:1900180),0.42527998510800713,1.1399265987544045,0.3047158403869408,0.6888230591247597,1.0,17/43,19.95%,YAP1;SHH;ILRUN;PLK1;WWTR1;GSK3B;ORMDL3;DTX3L;CTNNA1;BYSL;LAMTOR5;AKT1;LATS2;EIF2AK3;MFHAS1;KAT7;PIN1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5325341469302194,1.1396264710544235,0.3048048048048048,0.6891552005572509,1.0,3/13,10.24%,SEC16B;TM9SF4;SEC16A
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3925845310666541,1.1396173659431357,0.25053763440860216,0.6886371451443308,1.0,35/104,22.28%,PMEPA1;SPRED1;SMAD2;SMURF2;SPRED2;ACVR1;PPARG;HTRA3;EMILIN1;LEMD2;WFIKKN1;HTRA4;TGFBR1;SMAD5;TGFB1I1;BMPER;LDLRAD4;ACVR2A;SPRY2;SKOR2;SMAD3;SMAD4;SMAD1;SNX25;SMURF1;CHRD;TRIM33;ZBTB7A;VWC2;PIN1;BMPR1A;ASPN;RPS27A;SNX6;IL17RD
prerank,Golgi to endosome transport (GO:0006895),0.49963508205402385,1.1395519465210084,0.32503660322108346,0.6882393654026009,1.0,6/16,13.78%,WIPI1;AP4M1;VPS13C;GBF1;EPS15;KIF16B
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.4562782561271194,-1.1391454720554528,0.30346820809248554,0.7324793887218012,1.0,4/12,10.80%,ERLIN1;PIBF1;ACADL;ERLIN2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.4893141847276299,1.1391160925367665,0.31,0.6887948131048371,1.0,4/20,12.59%,CLTC;PID1;PPP2R5A;NUMB
prerank,cranial nerve development (GO:0021545),0.5473241717415728,1.1389897039294612,0.34603658536585363,0.6885883803809782,1.0,2/11,9.20%,CHD7;SALL1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3881859810323174,1.138908796039166,0.2725344644750795,0.6882622858027565,1.0,15/105,16.79%,PSMA7;CUL1;CREBBP;SKP1;PSMB8;PSMA6;FBXW11;PSMF1;SRC;PSMA8;PSMD2;PSMD12;RELB;PSMD11;PSMD14
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.46442376421088716,-1.1385525368888894,0.2900763358778626,0.7295104162165357,1.0,4/10,12.44%,NFATC1;NFATC2;PPP3CB;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),-0.46442376421088716,-1.1385525368888894,0.2900763358778626,0.7295104162165357,1.0,4/10,12.44%,NFATC1;NFATC2;PPP3CB;NFATC3
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.45575580710203345,1.1381586368409458,0.30128205128205127,0.6896961414804974,1.0,12/29,21.64%,ARRDC4;PLK1;ARRDC3;DCUN1D1;FBXW7;UBE2L3;TRIB3;DTX3L;FBXO5;DCUN1D5;PIN1;AXIN1
prerank,positive regulation of exocytosis (GO:0045921),0.44694504332744456,1.1380462737207666,0.29848866498740556,0.6894537886167038,1.0,17/35,27.57%,RAB2B;VPS4A;UNC13D;RAB7A;SDC1;RAB9A;RAB27B;SMPD3;RAB15;SDC4;RAB5A;SDCBP;PDCD6IP;TSG101;CLASP2;CLASP1;CADPS2
prerank,positive regulation of filopodium assembly (GO:0051491),0.4763380213553167,1.1379317310321262,0.31466666666666665,0.6892292523494485,1.0,6/24,6.39%,DPYSL3;NRP1;FSCN1;RALA;TGFB3;CDC42
prerank,negative regulation of viral genome replication (GO:0045071),0.4272399283209796,1.1378628902774297,0.31896551724137934,0.6888941670205466,1.0,14/40,20.63%,TNIP1;ILF3;SHFL;CCL5;EIF2AK2;OASL;SETDB1;TNF;RESF1;TASOR;HMGA2;PLSCR1;TRIM6;ISG15
prerank,nuclear membrane organization (GO:0071763),0.4993573089712109,1.137469695157013,0.32373113854595337,0.6894136411330399,1.0,6/19,19.94%,CHMP4B;PLK1;VPS4A;CHMP7;TOR1AIP1;UBXN2A
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.34044079683605843,-1.1371878325558484,0.23684210526315788,0.7311125639372369,1.0,15/32,23.99%,ADGRB3;IL1RAPL1;CDKL5;CUX1;RAPGEF2;HECW1;CUX2;SEMA4D;CDKL3;PTPRD;CUL7;SARM1;HECW2;LZTS1;NEDD4L
prerank,mitotic nuclear division (GO:0140014),0.4009282700956348,1.1371216504393302,0.2966292134831461,0.6897606857270434,1.0,18/71,16.66%,KIFC1;SMC1A;KLHL22;CHMP4B;KIF2A;TUBG1;INO80;PLK1;STAG2;TPX2;STAG1;RHOA;CHMP7;NDEL1;TOGARAM1;CEP192;TUBG2;NCAPG2
prerank,coenzyme A metabolic process (GO:0015936),0.5288566680849293,1.1368150615465233,0.3185840707964602,0.6900068268616429,1.0,6/14,17.85%,DCAKD;SLC25A16;PANK2;COASY;PANK1;NUDT7
prerank,negative regulation of response to stimulus (GO:0048585),0.404939957748319,1.136194399722113,0.28268156424581004,0.6911212288225554,1.0,20/60,22.13%,COL3A1;CASK;AKT3;ACVR1;VPS13C;CDK6;PTPN1;TERT;BRAP;SOCS5;UBASH3B;GGT7;LPCAT3;MAP3K3;FBXO5;TLE5;HMGA2;YBX1;NLRP12;CLU
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.4123776405599589,1.1360490493721256,0.2888127853881279,0.6909508904959741,1.0,11/59,15.73%,RUNX2;TCF7L2;MITF;PTEN;TNRC6B;CBFB;MOV10;MED13;MED15;SETX;MED26
prerank,blood circulation (GO:0008015),0.42314548189929535,1.1359273956398603,0.29020556227327693,0.6907074889654363,1.0,5/49,2.14%,OLR1;SERPING1;EDN3;CXCL12;STAT1
prerank,regulation of nuclear division (GO:0051783),0.48793530745972585,1.1357607456289243,0.33738191632928477,0.6905976090609185,1.0,10/20,26.03%,PDXP;BORA;RCC1;OBSL1;FBXO5;PIN1;CDK13;PRMT5;CUL9;L3MBTL1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.41603256188235194,-1.13550218035871,0.2826086956521739,0.7336676158345634,1.0,3/14,3.04%,PRKCZ;MALT1;IL18
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4097946851021138,1.1353523381496986,0.30227272727272725,0.691061795645266,1.0,17/69,13.29%,PDGFRA;ZFP36L1;GAB2;IRS1;PDGFRB;PTEN;NF1;PIK3R5;OGT;PLCL1;EXOC1;RPS6KB1;FGFR1;PLCB3;RHOA;PI4KA;PIK3R1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4007771661978361,1.134897425700291,0.28476084538375973,0.6917132721044911,1.0,20/74,15.12%,TCF7L2;TNFAIP3;SNAI2;CFLAR;BCL2;ACVR1;SIAH2;ICAM1;TERT;SH3RF1;TGFBR1;BMP5;PELI3;CASP8;UNC5B;TNF;GSK3B;TRAF2;SRC;RIPK1
prerank,telomere maintenance (GO:0000723),0.4207664717315977,1.134696934115521,0.2918149466192171,0.6917333521190205,1.0,14/50,17.03%,PARP3;DNA2;XRCC3;ATM;ZBTB48;TERT;ATR;SP100;LTO1;NSMCE2;RIF1;CTC1;PRKDC;TEP1
prerank,regulation of cell cycle (GO:0051726),0.37047038680358063,1.1345565507950068,0.22334004024144868,0.6915578311509109,1.0,48/271,14.53%,FAP;RUNX3;NEK6;PPP1R9B;TCF7L2;EIF4G2;GATA6;RASSF1;BIRC3;CDKN2B;STAT3;PUM1;PKD2;PES1;TRIM21;NF2;CDK6;ATM;SFRP1;LRP6;PLK1;CKS1B;IRF1;CDK10;GBF1;TMEM8B;RAD23A;TTC28;TGFBR1;MAP2K1;CSNK2A1;CSNK2A2;SND1;SETMAR;JUNB;TBX3;LIN54;CCNB2;TGFB2;CALR;ANKRD17;CDK7;NLRP2B;MAEA;SMAD3;BMP7;CDKN1B;CDC14A
prerank,sympathetic nervous system development (GO:0048485),0.4981188400279989,1.134061568866821,0.3242467718794835,0.6923016022871753,1.0,2/15,5.10%,NRP1;NF1
prerank,cellular response to organonitrogen compound (GO:0071417),0.3927174440006221,1.1338991647071768,0.2815533980582524,0.6922004149710419,1.0,14/99,9.92%,NR1H4;PDE3A;PDXP;ZFP36L1;IGFBP5;PKD2;CPEB1;SFRP1;AHR;CAPN2;RPTOR;RRAGC;HRH1;SSH1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.46391594777322126,1.133712670786473,0.32769830949284784,0.6921495342467315,1.0,10/27,20.36%,EGFR;STAT3;PUM1;TNRC6B;MAP2K1;WTIP;FMR1;RIPK1;AGO2;EIF4G1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5475454678646188,1.1334705083265166,0.3532934131736527,0.6922545511034315,1.0,4/11,14.53%,CYP1B1;GSKIP;STK24;PDCD10
prerank,positive regulation of protein deacetylation (GO:0090312),-0.4252408109322569,-1.133386152104686,0.2857142857142857,0.7374029761878484,1.0,6/14,25.17%,SAP30BP;AKAP8;NNMT;CTBP1;APLNR;BRMS1
prerank,proteoglycan metabolic process (GO:0006029),0.4653007949286763,1.133366218999994,0.31994818652849744,0.6920041916173805,1.0,7/26,16.27%,SULF1;CHST13;HPSE;ADAMTS12;CHST11;B4GALT7;FAM20B
prerank,triglyceride biosynthetic process (GO:0019432),-0.3894030232126373,-1.132832084565207,0.2791519434628975,0.7366793559903823,1.0,5/18,14.31%,AGMO;LPGAT1;LPIN1;DGAT1;GPAT4
prerank,positive regulation of sodium ion transport (GO:0010765),-0.4329685911714214,-1.1327871152533286,0.288,0.734530714018784,1.0,8/12,34.10%,WNK3;GPD1L;ANK3;SCN4B;SCN3B;PKP2;SCN5A;AHCYL1
prerank,positive regulation of catalytic activity (GO:0043085),-0.32484472154249483,-1.1326975539423176,0.24875621890547264,0.732511002340962,1.0,16/37,23.69%,CAV1;XRCC4;YWHAB;APH1A;MSH2;SLC5A3;IGF2;NHEJ1;FGFR4;SOD1;SSBP1;CHTOP;MAPK3;CIB1;MSH3;MAPK14
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.48376497181710243,1.132613119996736,0.32833787465940056,0.6934022787647469,1.0,15/22,27.15%,SLC2A13;GSAP;ABCA2;ABCG1;TNF;RANBP9;PICALM;IFNGR1;EFNA3;CLU;ROCK2;RELA;CHRNA7;EFNA1;GSK3A
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.4336334517539743,1.1324645536570668,0.30350665054413545,0.6932350143042407,1.0,13/45,14.06%,FAM83A;EGFR;NCK2;EGF;CBL;GRB2;PTK2;ERBIN;BTC;PIK3R1;GAREM1;KIF16B;SRC
prerank,positive regulation of protein binding (GO:0032092),0.41342192517923854,1.1321741656928745,0.30186480186480186,0.6934762689418476,1.0,16/56,14.58%,LRP1;TCF7L2;LRRK2;APOE;TRIM21;ADD2;NMD3;TERT;VTN;GSK3B;SPPL3;DACT1;PSEN1;TRIB3;RPL11;DTX3L
prerank,regulation of protein localization to cell surface (GO:2000008),0.443725903146391,1.1320666011217448,0.3165829145728643,0.6932507018754775,1.0,8/33,12.30%,GPM6B;TM9SF4;TAX1BP3;ABCA2;EGF;GBF1;SNX33;TNF
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3862868613507215,1.131674293404857,0.25571725571725573,0.6937558017805191,1.0,36/140,16.71%,DLC1;SYDE1;VAV2;ARHGAP15;RHOJ;ARHGAP24;VAV3;ARHGAP32;KALRN;ITSN1;RHOD;OPHN1;FGD4;SRGAP1;CDC42;CGNL1;ARHGDIG;ARHGEF19;TRIO;ARHGEF12;PREX1;FAM13B;RHOA;VAV1;ARHGAP6;AKAP13;ARHGAP22;SRC;ARHGEF18;ARHGAP35;RAC1;RHOF;DEPDC1B;SQSTM1;ARHGAP9;ARHGDIA
prerank,positive regulation of binding (GO:0051099),0.3956469873688105,1.1316605525919867,0.2836644591611479,0.6932484284478104,1.0,21/84,14.58%,LRP1;TCF7L2;LRRK2;APOE;TRIM21;EGF;PPARG;DDX11;ADD2;NMD3;TERT;HMGB2;VTN;DPH3;GSK3B;SPPL3;DACT1;PSEN1;TRIB3;RPL11;DTX3L
prerank,urogenital system development (GO:0001655),0.5493352381555279,1.1314713083531343,0.33437990580847726,0.693209549775078,1.0,3/11,8.96%,EPHB3;SHH;ANXA1
prerank,regulation of cytoskeleton organization (GO:0051493),0.3839851934014129,1.1312686433081496,0.27243928194297784,0.6931730632602573,1.0,22/108,14.73%,DLC1;GPM6B;LRP1;RND3;TAOK1;SYDE1;PDGFRB;RICTOR;FSCN1;BAIAP2;RHOD;CAPN2;CDK10;ARHGEF19;EFNA5;PTK2;RHOA;GSK3B;P2RX7;ARHGAP35;PHLDB2;RAC1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4819824463073277,1.1307971583236471,0.34274193548387094,0.6938802727459934,1.0,6/22,12.30%,TIMP1;APOE;PTPN3;SNX33;SNX9;TNF
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.3801408622151401,-1.1305051076556294,0.2624113475177305,0.7361836448297867,1.0,4/20,4.84%,PRKAA2;RPS6KA5;DIP2B;PPARGC1A
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.4534481077044705,-1.1299129100255914,0.29521276595744683,0.7356881471366977,1.0,4/11,15.49%,TPK1;DCK;NT5C3A;SLC19A3
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.45517617678058214,1.1292985787474121,0.33378196500672946,0.6972054158633606,1.0,13/27,26.27%,TNFSF11;MDK;CCL2;RHOA;TNF;HSPD1;ETS1;SIRPA;CCDC88B;CYRIB;RELA;THY1;PYCARD
prerank,regulation of aerobic respiration (GO:1903715),-0.41753175801667697,-1.128762126891693,0.2909090909090909,0.7367823725371513,1.0,6/15,16.52%,COX7A2;CBFA2T3;PINK1;UQCC2;IDE;NOP53
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3587287899843382,-1.1286843162606597,0.2742616033755274,0.7347462175196013,1.0,5/27,2.77%,DMD;CACNB2;CACNB4;ANK2;CALM1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4731271977271505,1.1286213508005243,0.3261455525606469,0.6984578044393133,1.0,7/23,13.46%,CBLB;ERRFI1;CBL;MVP;SOCS5;ZGPAT;SH3BP5L
prerank,import into cell (GO:0098657),0.43018056235571056,1.1281864492553615,0.3117359413202934,0.699089614722756,1.0,5/41,3.66%,SLC39A14;SLC1A3;SLC11A2;SLC12A4;TREM2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.43787348651780567,1.128133054078751,0.32196969696969696,0.6986924453415201,1.0,12/37,14.05%,CEMIP;SPRED1;TNKS1BP1;SPRED2;EGF;PLK1;RPTOR;S1PR2;SPRY2;UBE2K;CALM2;BMP7
prerank,neuron cell-cell adhesion (GO:0007158),0.5048734944032663,1.128036364152051,0.336734693877551,0.6984181872777339,1.0,2/14,5.08%,CEL;ASTN2
prerank,positive regulation of cell population proliferation (GO:0008284),0.36604091927991694,1.1276920873968743,0.147,0.6987654826938965,1.0,70/423,12.55%,CXCL5;IL34;WNT2;OSMR;PDGFRA;LAMB1;EDN3;YAP1;TCF7L2;PTN;MEIS2;LAMC1;STAT1;CCAR1;GAB2;TIMP1;IRS1;PDGFRB;PRTN3;FGF7;CCN4;ZFPM2;TSLP;EGFR;MEIS1;TBX2;FXN;MDK;SHH;E2F1;PTEN;BCL2;AIF1;DDR2;CACUL1;CCL5;EGF;CDK6;SFRP1;TGFB3;EAPP;PTPN6;GLP2R;S1PR3;EPHA1;HPSE;TMEM119;PID1;TERT;S1PR2;S100A6;TGFBR1;WNT5A;HDAC1;CSNK2A1;IL7;BMP5;NOP2;LIFR;TBX3;FGFR1;WWTR1;PTK2;TGFB2;GCNT2;CALR;TNF;VEGFC;FGF2;NTRK3
prerank,negative regulation of organelle assembly (GO:1902116),0.43544407394710666,1.1273575986353437,0.3122629582806574,0.6991168899201675,1.0,6/35,7.63%,YAP1;LRRK2;CHMP4A;CHMP4B;TMEM39A;CDK10
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.35351504434231446,-1.1273306732113515,0.2727272727272727,0.7363661074420591,1.0,11/27,27.89%,CHKA;PCYT2;LPIN1;SLC27A1;SELENOI;PLA2G6;NAAA;CHKB;PLAAT3;PNPLA8;ETNPPL
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.40502957511858617,1.1272456264520285,0.296,0.6988908189568331,1.0,22/66,21.08%,YAP1;UBR5;BAG3;PLK1;PINX1;NMD3;TERT;CCT8;ZIC1;WWTR1;ORMDL3;PIK3R1;SMAD3;PSEN1;CCT3;DTX3L;LAMTOR5;AKT1;EIF2AK3;KAT7;PRKCD;ZC3H12A
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5349303365080312,1.1272253601617053,0.3434190620272315,0.6984204393883245,1.0,4/11,17.56%,GFPT2;UAP1L1;AMDHD2;GNPDA2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.34364306480650725,-1.1271873473803942,0.25,0.7345337370345868,1.0,8/27,9.26%,TJP1;TMEFF2;PRKN;RHPN2;SHANK3;ARHGAP28;SHANK1;INPP5K
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4501151894325099,1.1271562247041667,0.3359375,0.6980695328208989,1.0,13/33,21.92%,EGFR;AIF1;CCND3;ADAMTS1;RPTOR;ANXA1;KMT2E;ANKRD17;DDRGK1;AKT1;GLI1;EIF4G1;RGCC
prerank,water-soluble vitamin metabolic process (GO:0006767),0.4014276159008733,1.1267637687560528,0.3129855715871254,0.6985845428294012,1.0,5/68,3.92%,ENPP1;TCN1;MMAB;MTHFR;MTHFD1L
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.41213395944312514,-1.126669836037061,0.29337539432176657,0.7336801039268338,1.0,7/15,30.06%,HNRNPA1;DHX36;MKNK2;PPIF;GSTO2;ATF3;HSF1
prerank,cytosolic transport (GO:0016482),0.377161704276482,1.1263669562504688,0.28817204301075267,0.699087995747921,1.0,36/108,22.68%,CLTC;HEATR5A;AP4M1;STX6;TMEM87B;HOOK2;VPS13C;MYO1D;RAB7A;GOSR1;GBF1;RAB9A;ANKFY1;GAK;PTPN23;EEA1;DENND5A;SNX2;EPS15;SNX5;ANKRD27;KIF16B;TBC1D10B;WASHC1;PIK3C3;HOOK1;SYS1;BECN1;VPS35;TRIM27;SPAG9;GOSR2;RAB5A;SNX6;CORO7;SNX1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.5330318837231176,1.1262509748330352,0.353125,0.6988658761362415,1.0,3/12,14.05%,GCNT2;TNF;BMP7
prerank,positive regulation of cellular respiration (GO:1901857),-0.4508670133050276,-1.1261630540256653,0.3342857142857143,0.732851374222045,1.0,8/11,47.29%,PINK1;IFNAR1;ISCU;IL10RB;IFNLR1;IL4;PRELID1;VCP
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.38013916885535654,-1.1260669303014668,0.3321678321678322,0.7309083457521721,1.0,5/20,2.77%,DMD;ATP1A2;ATP1B1;ANK2;CALM1
prerank,base conversion or substitution editing (GO:0016553),0.543948492351399,1.1260618368976332,0.3401898734177215,0.698830155632977,1.0,1/11,1.47%,APOBEC1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.4236517870774343,-1.1260017824834438,0.3168044077134986,0.726704966919725,1.0,4/14,16.98%,ABCG2;BLVRB;BLVRA;HMOX2
prerank,heme catabolic process (GO:0042167),-0.4236517870774343,-1.1260017824834438,0.3168044077134986,0.726704966919725,1.0,4/14,16.98%,ABCG2;BLVRB;BLVRA;HMOX2
prerank,regulation of intracellular protein transport (GO:0033157),0.44668908302205595,1.125970795419465,0.32642487046632124,0.6985355773728648,1.0,9/32,18.77%,ADIPOQ;PCM1;PTPN1;LCP1;PCNT;PDCD10;NDEL1;ICE1;BCAS3
prerank,muscle organ development (GO:0007517),0.41040520595908775,1.1254248665433964,0.3162193698949825,0.6994214058447042,1.0,9/54,11.95%,LAMA2;COL6A3;EGR3;TCF12;CXCL10;FHL3;ITGA11;CHD2;UTRN
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.454531319188242,1.125381715898032,0.3456953642384106,0.6989879756672942,1.0,11/28,22.13%,TREM2;PTEN;FBXW7;PTK2;CTSC;DDRGK1;FMR1;SMURF1;PSMC6;AXIN1;CLU
prerank,negative regulation of viral release from host cell (GO:1902187),0.5281700265256153,1.1253067823403327,0.3370253164556962,0.6986517819704038,1.0,8/13,28.11%,TRIM21;TRIM13;TRIM8;TRIM35;TRIM11;CHMP3;TRIM26;PML
prerank,inositol phosphate metabolic process (GO:0043647),-0.3094355584982264,-1.1252145186656664,0.25161290322580643,0.7266845559684526,1.0,22/46,25.34%,PLCE1;INPP4B;CALM1;PLCB4;ITPK1;INPP5D;PLCB1;IPPK;NUDT3;ISYNA1;PPIP5K1;IP6K1;SYNJ1;INPP5A;IMPA2;ITPKB;NUDT11;OCRL;PLCD4;PLCH1;INPPL1;PPIP5K2
prerank,heterochromatin organization (GO:0070828),0.5005157888522944,1.125176136442606,0.33187134502923976,0.6984731181786658,1.0,5/14,12.13%,SNAI1;POLE3;BAHD1;SETDB1;SETDB2
prerank,keratan sulfate metabolic process (GO:0042339),0.44182917354432955,1.125129430505525,0.32232496697490093,0.6980689281287757,1.0,10/31,15.44%,LUM;B4GALT5;ST3GAL3;PRELP;GALNS;ST3GAL1;CHST1;GNS;SLC35D2;B4GALT2
prerank,positive regulation of fat cell differentiation (GO:0045600),0.41576308734356104,1.1250613008043189,0.309552599758162,0.6977119982651179,1.0,15/47,19.13%,ZFP36L1;CMKLR1;FRZB;ASXL2;SFRP1;PPARG;VSTM2A;CARM1;LPL;WDFY2;BMP7;TRPM4;AKT1;AAMDC;LRP5
prerank,cellular response to hormone stimulus (GO:0032870),0.3975738942149342,1.1249456455306595,0.3064699205448354,0.6975084543240502,1.0,13/69,11.60%,ZFP36L1;ROBO2;GHR;SLIT3;STAT3;ARID5A;CTSS;SFRP1;CTSL;UBE2L3;CTSB;PELP1;GCK
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.33423759044857515,-1.1249363057910633,0.25193798449612403,0.7253276590961119,1.0,8/30,10.49%,ACSL1;TECR;ELOVL7;ELOVL5;ABCD3;HACD1;HACD3;HACD4
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.31937087855744795,-1.1247050742147207,0.23645320197044334,0.723898468672016,1.0,7/38,4.59%,CACNB2;KCND3;CAV1;CTNNA3;ANK2;KCNJ2;KCNJ3
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4968926365085857,1.1246663648945592,0.33925925925925926,0.697732115537213,1.0,3/16,4.56%,SLC9A1;PRKCA;CAMK2D
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.3529176509791387,-1.1246298468673686,0.28205128205128205,0.7219915584156232,1.0,8/23,12.06%,ACSL1;TECR;FAR2;ELOVL7;ELOVL5;HACD1;ACSL3;DGAT1
prerank,peptidyl-tyrosine modification (GO:0018212),0.4136964677713857,1.1243355427943524,0.3076923076923077,0.6980256490632952,1.0,16/56,14.81%,PDGFRA;TEC;PDGFRB;JAK2;EGFR;BLK;DDR2;PTPN6;EPHA1;ABI2;FGFR1;PTK2;TPST1;ABI1;SRC;FES
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.468475576944957,1.1236221461792593,0.34469200524246396,0.6993436055451058,1.0,10/23,22.19%,SMAD2;NREP;SMURF2;ITGA3;SMAD3;SMAD4;LATS2;TRIM33;DKK3;LATS1
prerank,regulation of viral entry into host cell (GO:0046596),0.45057822923920365,1.1236014948388813,0.3372859025032938,0.6988811415079921,1.0,3/30,5.54%,TRIML2;LGALS9;TRIM21
prerank,protein prenylation (GO:0018342),0.5479411716186492,1.1235380893406208,0.3630573248407643,0.6985274871937716,1.0,4/10,16.88%,CHML;RABGGTB;FNTB;PTAR1
prerank,cellular senescence (GO:0090398),0.4527648135893726,1.1233272433291093,0.3557312252964427,0.6985722797946323,1.0,10/27,20.54%,CDKN2B;TBX2;MAP2K1;TBX3;CALR;SPI1;NSMCE2;SMC5;HMGA2;PRKCD
prerank,fatty acid beta-oxidation (GO:0006635),0.41352413328578397,1.1233017454570682,0.3146853146853147,0.6981281491815512,1.0,5/51,7.20%,ADIPOQ;EHHADH;ETFA;SLC27A2;ACOX1
prerank,"phototransduction, visible light (GO:0007603)",-0.41837417718589875,-1.1232284858783053,0.3081570996978852,0.7236047725564526,1.0,5/14,26.72%,ABCA4;GNA11;RP1;SAG;PDE6A
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.46410101036563495,1.1228341868582208,0.3386243386243386,0.6988060097066259,1.0,4/22,12.44%,MGAT5;FKBP1B;TNF;GSK3B
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.46578007432158114,1.122544913459355,0.3411458333333333,0.6990266167236905,1.0,3/26,2.62%,C3;ADIPOQ;IRS1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5456925765582792,1.1224657052459694,0.3543913713405239,0.6987287858122802,1.0,3/10,14.60%,LIPC;PLA2G7;PLA2G4A
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.485735020119802,1.1224249446503731,0.3231622746185853,0.6983131464897322,1.0,7/19,17.56%,GFPT2;UAP1L1;GMPPB;UGDH;AMDHD2;PMM2;GNPDA2
prerank,protein polyubiquitination (GO:0000209),0.36501005888047416,1.1217739092261918,0.22233400402414488,0.6995016550165124,1.0,91/297,23.20%,PSMA7;TRIML2;DCAF15;MYLIP;FBXO40;TNFAIP3;SPSB1;HECTD2;FBXL7;CUL1;SMURF2;UBR5;BCL2;TRIM21;RNF144A;ANAPC11;SIAH2;CDC27;SKP1;SASH1;SPOP;NPEPPS;TPP2;FBXL18;FBXW7;FBXO30;AREL1;PSMB8;ARIH1;PSMA6;UBE2L3;PELI3;CBFB;UBE2R2;UBE2J1;FBXO7;RNF213;RNF19B;FBXW11;PSMF1;UBE2K;TRAF2;UBE2W;FBXO2;DTX3L;PSMA8;SMURF1;ITCH;NEDD4;TRIM56;FBXL19;PSMD2;PSMD12;PSMD11;PELI2;RBCK1;TNKS2;TRAF3IP2;TRAF5;PSMD14;RC3H2;MDM2;PSMB1;FBXW4;FBXO31;ARIH2;FBXO32;FBXO38;FBXL22;RNF135;UBE2Q1;PSMC6;UBE2E1;TRIM6;IFI27;TRIM27;FBXO22;TRIM62;RPS27A;RUSC1;RNF14;RBBP6;UBE2L6;ZNRF2;FZR1;CHFR;PSMB4;PSMB5;ANKRD39;UBE3D;RNF144B
prerank,B cell differentiation (GO:0030183),-0.30321568606219884,-1.1216636165246172,0.2717391304347826,0.7260817626362314,1.0,13/46,17.13%,KIT;HDAC4;HDAC9;VCAM1;TPD52;MSH2;ITGA4;DNAJB9;BLNK;CEBPG;NHEJ1;GPS2;IRF2BP2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.4298974460423673,1.1211854572905924,0.312807881773399,0.7005014489123608,1.0,4/41,8.61%,CYP1B1;ACOX1;SCD5;FADS1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.4006045532768456,-1.120709494635079,0.3087248322147651,0.7264605577653758,1.0,8/16,31.17%,ERLIN1;ACADL;ERLIN2;ACADVL;SIRT4;BRCA1;CEACAM1;SOX9
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5356504070297847,1.120513554290409,0.338006230529595,0.701719854344142,1.0,2/11,3.66%,NOS1AP;TREM2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.36841721405916955,1.1200111595741564,0.268762677484787,0.702480725241937,1.0,32/198,13.52%,ENPP1;EPHA7;LGALS13;PDXP;TAOK1;LRRK2;INPP1;PPA1;DUSP5;STAT3;GFPT2;SLC20A1;HK2;EPHX2;PTEN;PIP4K2A;ITPKC;PFKFB4;LPL;IP6K2;PANK2;PPP3CA;PLD4;PLCB3;GCK;GK;THNSL2;DUSP28;PI4KA;NUDT14;SPHK2;NUDT4
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.3535856382217438,-1.1197437093503233,0.29554655870445345,0.7270992233390033,1.0,9/25,22.10%,PRPSAP2;PAICS;PRPSAP1;ADK;GMPR;DCK;PRPS1;PRPS1L1;APRT
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3761796995376463,1.1197027739545349,0.29516806722689076,0.7027503370236791,1.0,40/132,21.38%,DCN;TRIML2;LRRK2;IRS1;APOE;TRIM21;NPRL2;ARNT;PFKFB4;PTPN1;MSN;TRIM8;FOXO3;SNX33;MOV10;SNX9;PLEKHF1;TNF;GSK3B;ZSWIM8;ZBTB20;P2RX7;ORMDL3;DACT1;PSEN1;DTX3L;DXO;ITCH;HIF1A;SH3GLB1;IRGM;PLK2;TRIM6;PRKCD;PHKG2;ADAM9;TPCN1;ZC3H12A;VPS35;TRIM27
prerank,regulation of ATP biosynthetic process (GO:2001169),0.5037705080763872,1.1196578472977194,0.35294117647058826,0.7023463977100124,1.0,5/16,13.14%,TREM2;ANTKMT;ENO1;PID1;SPHK2
prerank,positive regulation of response to wounding (GO:1903036),0.4627319874064653,1.11944204993146,0.32407407407407407,0.7023864646690304,1.0,6/24,11.22%,PTN;MDK;ANXA1;MYLK;PTK2;VTN
prerank,response to laminar fluid shear stress (GO:0034616),0.5480674951126417,1.1192759032029722,0.3611111111111111,0.7022712429499994,1.0,1/10,0.25%,ABCA1
prerank,cellular response to interferon-beta (GO:0035458),0.516046278943492,1.1187782529733366,0.3427299703264095,0.7030861285641581,1.0,5/14,20.38%,STAT1;IRF1;UBE2K;IRGM;TRIM6
prerank,cell cycle G2/M phase transition (GO:0044839),0.3756910840485401,1.1184105591656472,0.31016597510373445,0.7035145685723243,1.0,35/130,18.90%,DYNLL1;CDKN2B;FBXL7;DYNC1H1;CUL1;KHDRBS1;TUBG1;ALMS1;CDK14;PLK1;PCM1;HAUS3;SKP1;CEP41;CNTRL;PHLDA1;DCTN3;BORA;PCNT;PPP2R2A;CCNB2;CDK7;CEP72;PPP1CB;FBXW11;PPME1;ACTR1A;AKAP9;CEP192;CSNK1D;YWHAE;CKAP5;TAF2;CENPJ;HAUS6
prerank,actin filament network formation (GO:0051639),0.531624394723947,1.1180582736855296,0.3663522012578616,0.7039070393851762,1.0,4/11,8.76%,FHOD3;CARMIL1;SPIRE1;LCP1
prerank,positive regulation of T cell proliferation (GO:0042102),0.41344412633114774,1.1178135676482102,0.2966002344665885,0.7040570064367925,1.0,7/55,8.96%,IL23R;CD276;NCK1;AIF1;NCK2;CCL5;ANXA1
prerank,mitochondrial protein processing (GO:0034982),0.5365665823366459,1.1177803458372386,0.3592085235920852,0.7036354161592845,1.0,5/11,14.18%,STOML2;OMA1;PMPCB;SPG7;PMPCA
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.47592279110980307,1.1175356110114583,0.3441011235955056,0.7037741091177037,1.0,5/20,5.86%,ZFP36L1;MEIS2;MAFB;MEIS1;CDK6
prerank,peptidyl-lysine trimethylation (GO:0018023),0.46186344695641146,1.1174431209857472,0.33422818791946307,0.7034867866376356,1.0,6/26,12.02%,KMT2A;ANTKMT;OGT;SETD2;VCPKMT;TET2
prerank,nitrogen compound transport (GO:0071705),0.3787326158320742,1.1171050938391034,0.290491118077325,0.7038553645436222,1.0,21/141,11.88%,SLC7A2;TCN1;SLC15A3;SLC6A2;SLC38A3;ARRDC4;SLC25A47;SLC7A7;MYH9;SLC38A4;SEC14L1;MIA3;LMAN2L;RAB7A;TCN2;ARRDC3;SLC36A2;SLC7A8;PDPN;RCN3;CALCRL
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.5613997108831104,1.1167478815052925,0.3573667711598746,0.7042533447888745,1.0,1/10,0.34%,DCN
prerank,positive regulation of dephosphorylation (GO:0035306),0.45637185733202706,1.116367546460483,0.3441295546558704,0.7047330242228291,1.0,10/27,20.54%,DLC1;PPP2R5A;SPPL3;CALM2;SRC;MTMR9;PTPA;ANKLE2;PIN1;PRKCD
prerank,regulation of autophagy (GO:0010506),0.3664531375816966,1.1161586201893876,0.25862068965517243,0.7047650122511481,1.0,55/216,18.35%,DCN;TRIML2;DAP;EIF4G2;LRRK2;EIF4G3;KLHL22;DRAM1;TREM2;STAT3;RMC1;ITPR1;BCL2;PIP4K2A;TRIM21;FOXK2;ATM;NPRL2;EXOC4;RPTOR;TRIM8;FBXW7;RRAGC;CSNK2A2;FOXO3;EXOC1;EXOC7;GAPDH;PLEKHF1;TPCN2;GSK3B;DCAF12;ATP6V1H;SNX5;ORMDL3;SMCR8;ATP6V1G2;TRIB3;DAPK2;WASHC1;MTMR9;NEDD4;PRKAB1;LAMTOR5;ATP6V1G1;SREBF1;SH3GLB1;AKT1;CTSA;GPR137;ATP6V1D;MTMR3;CPTP;USP36;LAMTOR3
prerank,regulation of amyloid fibril formation (GO:1905906),0.5121099864371798,1.1160527418642618,0.34852941176470587,0.7045071459577467,1.0,3/15,3.78%,IAPP;TREM2;APOE
prerank,regulation of calcium ion transport (GO:0051924),0.41707756924416184,1.116016590623789,0.3415783274440518,0.7040914239741132,1.0,11/54,11.67%,IL16;CACNA2D1;CCR1;BCL2;PKD2;TRPC6;CCL5;EGF;EFHB;MYLK;ATP2B1
prerank,stabilization of membrane potential (GO:0030322),-0.39939417383519216,-1.1151003537623023,0.32710280373831774,0.7381979142181985,1.0,7/16,25.91%,KCNK5;KCNK10;KCNK2;KCNK13;KCNK6;CHCHD10;KCNK12
prerank,defense response to fungus (GO:0050832),0.47523671194219663,1.1147894921722308,0.3290960451977401,0.7067260302827718,1.0,2/17,10.28%,RNASE7;GAPDH
prerank,regulation of synapse maturation (GO:0090128),-0.4624458466113567,-1.1147223242511655,0.32602739726027397,0.7371132368200406,1.0,4/10,18.19%,NRXN1;ARHGEF15;CAMK2B;RELN
prerank,regulation of vasoconstriction (GO:0019229),-0.3443857706967135,-1.1146633515038744,0.2894736842105263,0.7351823569504123,1.0,11/27,20.39%,CAV1;ADRA1B;BDKRB2;AGTR1;ADRA1A;ZDHHC21;PER2;ACE;TBXA2R;CHRM3;ACE2
prerank,dendritic spine morphogenesis (GO:0060997),0.4998579454369335,1.1140877376523852,0.35398230088495575,0.7079996155474564,1.0,4/15,7.01%,EPHB3;PTEN;CDC42;DLG4
prerank,amyloid-beta metabolic process (GO:0050435),-0.3930929067655718,-1.1140238412939418,0.2926829268292683,0.7347926861361473,1.0,7/16,17.61%,BACE2;APH1A;APH1B;ABCA7;ACE;IDE;APEH
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.49348400106130014,1.1137352652444836,0.33760683760683763,0.7084178624169716,1.0,13/18,27.15%,SLC2A13;GSAP;ABCA2;ABCG1;TNF;PICALM;IFNGR1;CLU;ROCK2;RELA;CHRNA7;EFNA1;GSK3A
prerank,regulation of microtubule-based movement (GO:0060632),-0.43951576014687366,-1.1136651538042548,0.3342696629213483,0.7336976017639728,1.0,9/11,43.87%,MAP2;TTC21B;LAMP1;CFAP298;DRC1;CCDC65;IGBP1;HDAC6;HAP1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3928166913710878,1.1134881684967688,0.327796234772979,0.7085296315206325,1.0,21/78,18.76%,CLTC;LRP1;MMP14;NKD2;EGFR;TREM2;VPS4A;PID1;ITGA3;PPP2R5A;PTPN9;TNF;NUMB;KIF5B;PIK3R1;STAC3;SQSTM1;AKT1;PICALM;CLIP3;SPTBN1
prerank,lysosome organization (GO:0007040),0.4351786193918533,1.1132291098721239,0.33205619412515963,0.7086531364148404,1.0,7/36,14.50%,ABCA1;LRRK2;HOOK2;MYO7A;CLN6;TPCN2;GAA
prerank,engulfment of apoptotic cell (GO:0043652),-0.414561128332643,-1.1128848975893755,0.34036144578313254,0.733834936758344,1.0,5/15,20.76%,RHOBTB1;XKR4;THBS1;RHOG;RHOH
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.5435391012041463,1.1123210682941462,0.3677621283255086,0.7104469982140554,1.0,2/10,5.59%,PDXP;CARMIL1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.5238236792874795,1.1121134120864333,0.36336779911373707,0.7104664528594267,1.0,5/12,13.26%,ACO1;ACO2;IDH2;IREB2;IDH3B
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.40315669377545527,1.1119655981504182,0.3123569794050343,0.7103107575091167,1.0,12/60,16.44%,RUNX2;TCF7L2;PTEN;SUB1;TNRC6B;CBFB;MOV10;MED13;MED15;PAXIP1;MED26;ATF7IP
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.38436727485520295,-1.1114717702700367,0.3087248322147651,0.7356194701039676,1.0,6/17,20.15%,PRKCZ;SLC7A5;PRKCQ;SYK;HAVCR2;FCER1G
prerank,amyloid precursor protein metabolic process (GO:0042982),0.486225739490327,1.1113172370057351,0.3424460431654676,0.711459590837923,1.0,8/18,22.85%,ADAM19;APOE;ABCG1;PSEN1;PSENEN;NCSTN;PSEN2;TMCC2
prerank,regulation of macrophage migration (GO:1905521),-0.461661005859457,-1.1113096153482127,0.34770114942528735,0.7339712019151634,1.0,3/10,5.87%,CD81;MTUS1;CD200
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4301803088136632,1.1110114224357943,0.3353733170134639,0.7116805515274047,1.0,12/39,16.40%,FBLN1;MAP4K4;JAG1;CASK;NF2;EFNA5;SEMA3E;GCNT2;RHOA;CX3CL1;ITGB1BP1;RASA1
prerank,limb development (GO:0060173),0.4567220964090414,1.1108531071215866,0.32129032258064516,0.7115961358781947,1.0,3/28,2.22%,KREMEN1;GLI3;CHD7
prerank,DNA-dependent DNA replication (GO:0006261),0.3744584782987892,1.1108185942705815,0.3115942028985507,0.7111722329060864,1.0,37/128,25.09%,PSMA7;BAZ1A;POLE3;DNA2;MCM2;MCM7;PSMB8;PSMA6;DBF4;PSMF1;POLA2;LRWD1;PSMA8;POLG;PSMD2;PSMD12;PSMD11;PSMD14;PNKP;PSMB1;PSMC6;RFC1;RPS27A;TWNK;CDC7;RPA1;PSMB4;PSMB5;RAD51;CDC6;DDX21;TEFM;PSMD4;ORC4;PSMD7;PSMD9;PSMA4
prerank,establishment of spindle localization (GO:0051293),0.5082411010767472,1.110629829943965,0.3662613981762918,0.7111481953102616,1.0,7/14,27.10%,DYNC1H1;LLGL1;ZBED3;MAP4;KPNB1;CLASP2;CLASP1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4663867135735686,1.1105997277629913,0.34986945169712796,0.7107163640910774,1.0,4/21,12.48%,MMP2;IGFBP5;ADAMTS1;FGF2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.37448822132641263,1.1105161738915899,0.3012684989429176,0.7104114041546319,1.0,27/118,14.32%,SPARC;FMNL2;BCL6;LRRK2;TNFAIP3;EPHB3;KIF13B;NF1;SFRP1;RAP2A;PLXND1;PID1;ABI2;SDC2;GPNMB;EFNA5;INF2;SP100;RNH1;PDZD8;ZMYM4;BMPER;GSK3B;FGF2;ARHGAP35;WTIP;PHLDB2
prerank,activation of protein kinase A activity (GO:0034199),-0.3933140814551571,-1.1102887927739133,0.3065015479876161,0.7346891361119497,1.0,6/16,9.23%,ADCY5;ADCY9;ADCY1;PRKAR1A;PRKAR2A;ADCY4
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3606833336076174,1.1102455699285705,0.2371859296482412,0.710587161414942,1.0,76/341,17.75%,PSMA7;RNF150;MYLIP;KCTD21;TNFAIP3;SPSB1;KLHL22;FBXL7;USP9X;MAD2L1;SMURF2;UBR4;CNOT4;APPBP2;RNF144A;PLK1;ANAPC11;SIAH2;MIB1;CDC27;VPS4A;TOM1L1;BAG6;RNF111;SPOP;TRIM13;CBL;FBXW7;AREL1;PSMB8;RAD23A;ARIH1;NTAN1;PSMA6;TBL1X;RAD23B;UBE2L3;TGFB1I1;VPS37C;UBE2R2;PTPN23;DCAF11;FBXO7;NFE2L2;RNF213;KCTD10;RNF19B;FBXW11;ZSWIM8;PSMF1;RNF149;UBE2K;MAEA;UBE2W;RNF11;DTX3L;PSMA8;SMURF1;ITCH;NEDD4;FBXL19;PSMD2;PSMD12;SQSTM1;KLHL25;PSMD11;RBCK1;CLOCK;PCNP;PSMD14;KCTD2;RC3H2;DDB1;MDM2;PSMB1;FBXW4
prerank,microtubule polymerization (GO:0046785),0.4470533806025899,1.1100650161906247,0.356763925729443,0.7105422363177532,1.0,13/29,19.95%,TUBG1;TPX2;FGF13;AKAP9;RANBP9;TUBGCP4;NDEL1;TUBG2;CSNK1D;TPPP;CKAP5;CENPJ;PIN1
prerank,positive regulation of transmembrane transport (GO:0034764),0.5161838171594598,1.1098777632038965,0.35658914728682173,0.7105327370402461,1.0,6/13,17.93%,C3;P2RX7;AZIN2;ANO6;ACSL5;CLIP3
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5453794539925063,1.1097557783268945,0.380327868852459,0.7103289062206982,1.0,2/10,8.25%,SERPINE2;ADAMTS18
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5012151390642885,1.1097368640751022,0.36517719568567025,0.7098642219327242,1.0,4/13,8.57%,NRP1;PLXNC1;PLXND1;PLXNA3
prerank,negative regulation of cell aging (GO:0090344),0.4932933368672965,1.1093864378355922,0.34718100890207715,0.7102382164394505,1.0,7/16,21.73%,AKT3;CDK6;TERT;MAP3K3;FBXO5;HMGA2;YBX1
prerank,calcium-mediated signaling (GO:0019722),0.3846748702818702,1.1091648844343267,0.3107960741548528,0.7102847903385424,1.0,26/93,19.18%,PPP1R9B;TNFSF11;SLC9A1;LRRK2;CACNA1C;EGFR;CCR1;RCAN2;STIMATE;CXCR4;FKBP1B;SAMD14;ATP2A2;LAT2;PPP3CA;PTPRJ;RCAN3;TPCN2;P2RX7;NUDT4;TRPM4;MCTP2;PTPRC;EIF2AK3;PRNP;IRGM
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.43555810121424865,-1.1089915103296537,0.321875,0.7363260611605564,1.0,4/12,31.17%,RBP4;TLR4;NOD2;SOX9
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.5047814418594578,1.1086055996258,0.3680351906158358,0.7112862824004027,1.0,2/15,5.97%,ADIPOQ;PPARG
prerank,ventricular septum morphogenesis (GO:0060412),0.4540772246507172,1.1082326751102038,0.3367741935483871,0.7117288664385811,1.0,8/27,14.44%,ROBO2;SLIT3;ZFPM2;ACVR1;HEYL;TGFBR1;TGFB2;SMAD4
prerank,icosanoid metabolic process (GO:0006690),0.42158756656494184,1.1081271230877487,0.3238566131025958,0.7114730129344359,1.0,6/40,14.60%,CYP1B1;DPEP2;FADS1;ABCC1;TBXAS1;PLA2G4A
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.3901394327340728,1.1073813739777836,0.3247767857142857,0.7129153678311335,1.0,26/73,23.73%,GLMN;TAF1D;CGGBP1;PHF1;PHF2;POLR1E;DNMT3B;SPI1;SPHK2;CTCF;POLR1B;TAF1A;TFAP2C;PPHLN1;POLR2L;POLR2K;HDAC5;TASOR;POLR1G;TRIM27;SUZ12;POLR1A;PPM1D;DDX21;BAZ1B;MPHOSPH8
prerank,cortical cytoskeleton organization (GO:0030865),0.4211106683696302,1.1070833655990708,0.3333333333333333,0.7131472309324941,1.0,18/41,23.44%,RND3;FMNL2;FMNL3;FHOD3;RHOD;LLGL1;LCP1;RHOA;TNF;RAC1;RHOF;PLEK;EPB41L3;DLG1;RHOC;ROCK2;ROCK1;STRIP1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.44465537066846467,1.1070360630102052,0.35240572171651496,0.7127658400891148,1.0,8/30,15.12%,TNFAIP3;CFLAR;ICAM1;BMP5;CASP8;GSK3B;TRAF2;RIPK1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.36530549056448747,1.1067456523009829,0.28498985801217036,0.7130055180343167,1.0,32/199,13.10%,NR1H4;ADIPOQ;PARP3;TBX18;TIMP1;SPRED1;EGFR;MDK;SHH;LAMA4;SPRED2;PTEN;ADM;PAEP;ADAMTS5;SFRP1;SFMBT1;ARRDC3;GPNMB;PLCL1;CHSY1;BMP5;ACOT13;PTPN23;LDLRAD4;ATP2B1;CALR;SPRY2;TNF;GSK3B;ACVR1C;SPI1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3479782302363561,-1.106363369803959,0.3155737704918033,0.7415085728995444,1.0,7/27,9.96%,FGF12;SLMAP;FXYD5;SNTA1;ATP2B4;GPD1L;FXYD6
prerank,calcium ion transmembrane transport (GO:0070588),0.38529240060279246,1.1062124268708837,0.32247557003257327,0.7137918956173184,1.0,22/86,18.80%,MCOLN2;CACNA1A;STOML2;CACNA2D1;CACNA1C;PKD2;TRPC6;SLC24A5;PMPCB;ATP2A2;ATP2B1;MICU2;SPG7;P2RX7;PMPCA;TRPM4;MCUR1;ORAI1;MAIP1;ANO6;TRPC4AP;MICU3
prerank,neuron projection development (GO:0031175),0.3692895118264876,1.1059271804693198,0.29519918283963226,0.7140575016462651,1.0,33/168,12.49%,GAS7;GPM6B;LAMB1;PPP1R9B;MAP4K4;TAOK1;LRP12;ATXN10;LRRK2;EPHB3;APOE;BLK;MAP1S;PTEN;OPHN1;DTNBP1;IFT88;CDC42;DLG4;TAOK3;VAPA;DCLK1;L1CAM;TRIO;DICER1;SAMD14;DBN1;NRK;DBNL;PTPRM;CAMSAP2;GSK3B;MICALL2
prerank,potassium ion export across plasma membrane (GO:0097623),0.5147275436560468,1.1056444355985502,0.38176197836166925,0.7142782396890848,1.0,2/13,4.90%,KCNT2;KCNA5
prerank,determination of bilateral symmetry (GO:0009855),0.45405496440367654,1.105035799120411,0.35497237569060774,0.7152923257114184,1.0,5/25,11.12%,DNAAF4;PKD2;DNAH11;GALNT11;NPHP3
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.37562067904720237,-1.1049024196693968,0.32081911262798635,0.7434967878818307,1.0,9/20,28.61%,HSP90AA1;NDUFAF1;MKKS;PSMG3;HSP90AB1;HOPX;TMEM35A;HSPA1A;PTGES3L
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.4843983294518448,1.1048267289057818,0.3540090771558245,0.7153028517237139,1.0,6/16,16.13%,PIGW;PIGN;PIGL;PIGC;PIGP;PIGH
prerank,peptide cross-linking (GO:0018149),0.45357585213059315,1.1048264224253044,0.355281207133059,0.7147937413865368,1.0,1/25,0.36%,COL3A1
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.4697027291649052,1.104812576946189,0.3729508196721312,0.7143202639244017,1.0,1/20,0.48%,ADIPOQ
prerank,response to alcohol (GO:0097305),0.45109536410272205,1.1042563095508724,0.35667963683527887,0.7151882681280984,1.0,5/27,9.77%,SLIT3;SMAD2;ABCA2;TGFBR1;DRD3
prerank,chromatin organization (GO:0006325),0.3747128593145317,1.1041118294799392,0.31224066390041494,0.7150463344917726,1.0,36/132,18.68%,SNAI1;SATB2;BAZ1A;PADI2;PHF1;SMARCC1;BAZ2B;INO80;DDX11;EHMT1;PWWP3A;TADA2B;HDAC1;SETD2;MTA2;HMGB2;BRWD1;SETDB1;RSF1;RUVBL1;SAFB;SETDB2;SPI1;LRWD1;ATRX;HMGN3;MYSM1;BAZ2A;TCF7L1;SMARCA4;HMGN1;HCFC2;NUCKS1;HDAC5;SOX2;ZBTB7A
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.38025040416588135,-1.104009335740833,0.30303030303030304,0.7438720801475683,1.0,3/18,5.98%,ATP1A2;CAV1;SLC43A2
prerank,calcium ion import across plasma membrane (GO:0098703),-0.41191500220283556,-1.103555401145111,0.3238993710691824,0.7429522745588203,1.0,6/14,19.38%,SLC24A2;ATP2B4;SLC8A3;TRPV2;TRPV4;SLC8A2
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.3313154861491627,-1.1023117020784015,0.31063829787234043,0.7441586709598969,1.0,6/30,8.96%,KIF13A;GGA1;VAMP4;PREPL;NSF;ANK3
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.5047223114019955,1.1021075951322414,0.37369207772795215,0.7195983785581759,1.0,9/15,21.42%,NSMAF;TNFRSF1A;TNF;ORMDL3;SPHK2;SMPD3;SIRT3;PRKCD;SAMD8
prerank,modulation by symbiont of host process (GO:0044003),0.5336602966075185,1.1019378046972255,0.37116564417177916,0.7195354593081458,1.0,2/10,6.24%,TLR2;ENO1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5384127903787256,1.1015559212088601,0.3785488958990536,0.7199784433981847,1.0,3/10,15.12%,LRRK2;NFE2L2;RIPK1
prerank,dendrite self-avoidance (GO:0070593),0.49941655040296695,1.1014026018331653,0.3795620437956204,0.7198595844506452,1.0,2/16,1.57%,PALLD;TNN
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.42932625694330356,1.101249242121239,0.3479899497487437,0.7197351048996905,1.0,16/35,21.63%,PMEPA1;YAP1;ZMIZ1;PADI2;UBR5;DDX17;SAFB;SRC;NEDD4;CALCOCO1;RBFOX2;NR3C1;MED1;TMF1;TADA3;RNF14
prerank,positive regulation of myelination (GO:0031643),0.5346164312582766,1.1008808945293656,0.39490445859872614,0.7201719445573557,1.0,5/11,17.61%,TENM4;DICER1;EGR2;TPPP;NCMAP
prerank,DNA integrity checkpoint signaling (GO:0031570),0.42872853161800695,1.1006834285357827,0.3320610687022901,0.7201854387458699,1.0,12/36,18.59%,BRIP1;DNA2;E2F1;ATM;ATR;SETMAR;TIMELESS;USP28;CLOCK;ATRIP;RAD9A;HINFP
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.4583512201685047,1.1004676601086374,0.36351531291611183,0.7201960254499188,1.0,3/25,6.32%,CEMIP;XCL1;CXCL10
prerank,calcium ion import (GO:0070509),0.4403707660201774,1.1003483589656822,0.34914361001317523,0.7199987795117652,1.0,8/28,18.80%,CACNA1A;CACNA1C;ATP2A2;MS4A1;MICU2;MCUR1;MAIP1;MICU3
prerank,keratan sulfate catabolic process (GO:0042340),0.5272593400275168,1.0999819996193894,0.3613861386138614,0.7204320357095184,1.0,4/11,14.06%,LUM;PRELP;GALNS;GNS
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.5463134775272461,1.099604611193566,0.37423312883435583,0.7208776506677241,1.0,3/10,10.36%,TLR2;JAK2;CCL2
prerank,regulation of intracellular signal transduction (GO:1902531),0.35843887320199874,1.0995623831324155,0.22122122122122123,0.7204693630186869,1.0,104/420,17.67%,DLC1;BCL3;MAP4K4;TAOK1;SYDE1;TNFSF11;VAV2;ARHGAP15;CMKLR1;RHOJ;LRRK2;BRIP1;ARHGAP24;VAV3;BIRC3;DNA2;SPRED1;ARHGAP32;EGFR;KALRN;PIP5K1B;NUAK1;TREM2;RICTOR;ITSN1;KMT5A;PTPN13;PTEN;PRKD2;RHOD;PIP4K2A;OPHN1;TAF7;FGD4;NF2;ATP6AP2;ATM;SRGAP1;CDC42;EHMT1;NOC2L;ARHGDIG;TAOK3;RASSF2;MAPKAP1;MAPK11;PRKAR1B;ARHGEF19;RRAGC;ATR;TRIO;WNT5A;HDAC1;CSNK2A1;CSNK2A2;TPX2;PRDM1;ARHGEF12;MTA2;NOP2;TTI1;PREX1;FAM13B;GNAI1;NRK;RCN3;RHOA;VAV1;PJA2;TNF;ARHGAP6;NTRK3;AKAP13;RASD2;TRAF2;BRPF1;SPHK2;GPAT3;ARHGAP22;RMI1;ARHGEF18;ARHGAP35;DAPK2;TAF4;RPL11;RAC1;BANP;RHOF;PRKAB1;DEPDC1B;SQSTM1;STK4;ARHGAP9;ATRIP;TRAF5;ARHGDIA;GNA12;MAPK1;AKT1;PHF20;ING5;MDM2;RAD9A;TAF2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3081674646918794,-1.0987569720767596,0.2961165048543689,0.7521131636416512,1.0,18/39,27.43%,FGF12;FHL1;ANK2;WWP2;FXYD5;WNK3;GPD1L;FXYD6;CHRM3;SCN4B;FXYD1;NEDD4L;TCAF2;SCN3B;PPIF;CACNA1D;YWHAH;PHB2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3942350982242599,1.0983697352087365,0.34966592427616927,0.722913967181098,1.0,17/70,15.26%,CASP8AP2;JAK2;SIVA1;BAG3;BCL2;BCL2L2;ACVR1B;TNFRSF1A;TGFB2;CASP8;TNF;GSK3B;P2RX7;TRAF2;SMAD3;RIPK1;IL6R
prerank,response to retinoic acid (GO:0032526),0.39921562707814634,1.0979145314371495,0.3465458663646659,0.7235819549953382,1.0,11/59,15.71%,WNT2;ASXL1;GATA6;WNT9A;RXRG;ATM;WNT5A;TMEM161A;PTK7;SETX;ADNP2
prerank,establishment of mitotic spindle orientation (GO:0000132),0.4602077112542574,1.0978657078725125,0.391644908616188,0.7231927454048646,1.0,6/23,15.66%,MAD2L1;PLK1;GPSM2;INSC;FBXW11;NDEL1
prerank,maintenance of protein location in nucleus (GO:0051457),0.47053570254409055,1.097861047594507,0.3473389355742297,0.7226992498187498,1.0,4/20,8.93%,BCL3;MORC3;SKP1;SP100
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.42655164716961125,1.0977086892001389,0.36228287841191065,0.7225802822335164,1.0,10/38,15.12%,TNFAIP3;CFLAR;SFRP1;ICAM1;SP100;BMP5;CASP8;GSK3B;TRAF2;RIPK1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3567365419023494,1.0975028300721363,0.251,0.7225439400215703,1.0,102/348,22.52%,C3;CEMIP;IL34;ADIPOQ;THBS4;TEC;GHR;JTB;LRRK2;CD40;FGF7;JAK2;NRP1;TNKS1BP1;EGFR;TREM2;LCP2;PRKD2;DDR2;ACVR1;FAM20A;CACUL1;EGF;CCND3;RAP2A;TGFB3;PLK1;INHBB;TOM1L1;TMEM119;RASSF2;RPTOR;ANGPT1;GPNMB;S1PR2;EFNA5;NIBAN1;TGFBR1;BMP5;FBH1;FNIP1;PTPRJ;PTK2;SNX9;VTN;TGFB2;ACVR2A;SPRY2;TNF;VEGFC;FGF2;NTRK3;UBE2K;DDRGK1;ITGA5;WDFY2;CALM2;BMP7;SRC;AKAP9;FMR1;SMAD4;PDCD10;RAC1;CX3CL1;RIPK1;IL6R;FGF18;ALS2;STK4;PELI2;ACVRL1;CSNK1D;PTPRC;MAPK1;AKT1;CLIP3;INHBA;AGT;CDK9;AXIN2;PRNP;DVL2;IRGM;PIN1;GDF9;GDF11;EIF4G1;TRIM6;BMPR1A;MMD2;NPTN;AXIN1;VEGFB;PAK1;RPS6KA4;RAF1;LATS1;CSF1;SDCBP;ROCK2;CD80
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.36037614714308797,1.0974889010895048,0.2296890672016048,0.7220770170637999,1.0,101/366,21.97%,RORA;RUNX3;POU5F1;CXXC1;SBNO2;ATXN1;CCAR1;CHD7;BACH1;GON4L;MAFB;SNAI2;ATXN2;MITF;SUFU;PRRX2;STAT3;SOX21;E2F1;PHF1;MYBL1;PRDM2;FOXK2;CREBBP;YAF2;AHR;TOM1L1;BHLHE40;CARM1;CCAR2;BTG1;FADS1;TGFBR1;NONO;FOXO3;ZBTB38;UBE2L3;TGIF2;ACVR1B;TCF7;WWTR1;FOXN2;LIN54;TGFBRAP1;CALR;SP3;ANKRD17;SPTY2D1;ZSCAN21;NAB2;SKOR2;NSD3;NFKB2;SPI1;ATRX;DRAP1;WTIP;BAZ2A;NOLC1;BNC2;PATZ1;HIF1A;PHF12;NUP35;NSD1;NFXL1;CLOCK;TCF7L1;TCF3;ACVRL1;ZFHX3;HCFC2;NUCKS1;MZF1;ATF4;NR2C2;SOX2;FBXO5;HINFP;KAT6B;NR3C1;TULP3;DVL2;THAP7;RPL6;KAT7;RBAK;HMGA2;RBM4B;NUP107;VHL;HINT1;MAGED1;NR1D2;RNF14;YBX1;ZNF423;RBBP6;RPS6KA4;CREM;NFIL3
prerank,mitochondrion distribution (GO:0048311),0.5280209494816951,1.097473522477196,0.4015625,0.7216057368165946,1.0,2/12,4.41%,LRRK2;TRAK1
prerank,gluconeogenesis (GO:0006094),0.42062914353829656,1.096793869723819,0.35006119951040393,0.7228137296786118,1.0,3/39,10.28%,SLC39A14;ENO1;GAPDH
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.36435162955039513,1.0967354963267815,0.32139201637666326,0.7224469865132428,1.0,40/166,18.10%,PRR16;ZEB2;BCL3;GLI2;NOS1AP;IRS1;PDGFRB;DNA2;PLD1;EGFR;PRKD2;PKD2;CD36;CCL5;EGF;BRPF3;ARNT;SAMD4A;NMD3;NIBAN1;RPS6KB1;SLC25A37;NAT10;PTPN2;GCK;TNF;FGF2;GIPC1;SMAD3;CTC1;YTHDF3;FMR1;HIF1A;PRKDC;SREBF1;AKT1;DDB1;GLI1;ATP7A;PLXNB2
prerank,positive regulation of developmental growth (GO:0048639),-0.2955461784656472,-1.0964947611822835,0.24675324675324675,0.7564576722069594,1.0,14/49,15.45%,CDKL5;SEMA7A;INSR;PLCB1;AGRN;ITSN2;SHTN1;TWF2;ZFYVE27;RIMS1;SEMA4D;BDNF;RNF157;PPIB
prerank,negative regulation of hippo signaling (GO:0035331),-0.4235875559217209,-1.0964857388310216,0.35785953177257523,0.7543771493402436,1.0,6/12,23.69%,CIT;WWC2;MARK3;WWC1;MAP2K3;MAPK14
prerank,O-glycan processing (GO:0016266),0.40396012833457323,1.0959988306735111,0.3474178403755869,0.723772024785695,1.0,7/54,11.10%,B4GALT5;ST6GAL1;GALNT3;ST3GAL3;GXYLT2;ST3GAL1;GALNT11
prerank,response to glucagon (GO:0033762),-0.3730021241853936,-1.0958590525768641,0.3217993079584775,0.754028089801696,1.0,6/19,9.23%,ADCY5;ADCY9;ADCY1;PRKAR1A;PRKAR2A;ADCY4
prerank,cation transmembrane transport (GO:0098655),-0.29651335613491975,-1.0957257696383573,0.2926829268292683,0.7522778595068084,1.0,7/44,5.75%,TRPM3;ATP1A2;ATP1B1;TRPM6;SLC6A9;SLC7A5;ABCC9
prerank,C4-dicarboxylate transport (GO:0015740),-0.3956557802711642,-1.0953848838957567,0.338368580060423,0.7512651826755191,1.0,4/14,11.25%,LRRC8D;SLC1A2;SLC1A1;SLC25A12
prerank,macrophage chemotaxis (GO:0048246),0.5414672258158325,1.0953824434670978,0.3990461049284579,0.7248288803810032,1.0,2/10,10.36%,CCL5;CCL2
prerank,modulation by symbiont of entry into host (GO:0052372),0.4859229267460008,1.0951977218400843,0.34699853587115664,0.7247504738947546,1.0,7/16,21.59%,TRIML2;TRIM21;EXOC7;TRIM6;TRIM27;TRIM62;HS3ST5
prerank,autophagy of peroxisome (GO:0030242),0.5073516130490836,1.0950831456831125,0.38073394495412843,0.724555241173892,1.0,5/12,16.47%,ATM;NBR1;PIK3R4;SQSTM1;PIK3C3
prerank,positive regulation of gene expression (GO:0010628),0.3549239272497948,1.0950624566733664,0.227,0.7241080470003372,1.0,98/442,18.24%,GLMN;RBMS3;PRR16;ITGB8;SEC16B;BCL3;ADAM19;YAP1;SFRP4;NOS1AP;CRP;TLR2;FGF7;BATF;MITF;PLD1;EGFR;TAF1D;TLE1;TREM2;STAT3;E2F1;PHF2;UBR5;EPHX2;LGALS9;PLA2R1;LIMS1;CD36;POLR1E;EGF;DTNBP1;ATM;EIF2AK2;VSTM2A;EMILIN1;TMEM119;PID1;FUBP1;SAMD4A;ANGPT1;MAPK11;MSN;CELF1;TNRC6B;NIBAN1;TGFBR1;MAP2K1;WNT5A;RPS6KB1;GAPDH;NAT10;MOV10;NFE2L2;DNMT3B;SPRY2;TNF;GSK3B;FGF2;NTRK3;P2RX7;SPHK2;PIK3R1;DDRGK1;CTCF;SMAD3;PSEN1;POLR1B;BMP7;YTHDF3;FMR1;TAF1A;RPL11;PDCD10;RIPK1;SETX;SMAD1;SMO;HIF1A;FGF18;MED26;PRKAB1;PRKDC;POU3F3;LAMTOR5;OLFM1;MAPK1;AKT1;CALCOCO1;EIF2AK3;ATF4;ETS1;POLR2L;INHBA;PLXNB2;POLR2K;AGT;RBPJ
prerank,L-glutamate transmembrane transport (GO:0015813),0.531590254446575,1.0950160733699457,0.36089030206677264,0.7237077583717784,1.0,1/10,0.63%,SLC1A3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.47899492013592315,1.0949165434540118,0.35624123422159887,0.7234659877785673,1.0,6/18,15.12%,NCOR2;EGFR;TERT;MAP2K1;TNF;RIPK1
prerank,regulation of cell cycle process (GO:0010564),0.37526777152509777,1.0947115088723902,0.32800851970181044,0.723484793335988,1.0,39/104,24.43%,PDXP;CDKN2B;DYNC1H1;NUGGC;SFRP1;PLK1;CDC42;KLHL13;ZFYVE26;BORA;CSNK2A1;CSNK2A2;SND1;DBF4;SETD2;ENTR1;CALM2;MAD1L1;PIK3R4;FSD1;RCC1;PIK3C3;OBSL1;SH3GLB1;KIF20A;FBXO5;PIN1;CDK13;HMGA2;PLK2;MYO19;E4F1;BECN1;KIF11;YTHDF2;PRMT5;CALM3;TTL;CUL9
prerank,regulation of protein neddylation (GO:2000434),-0.45066886689420815,-1.0946748049862745,0.3492063492063492,0.7510968429909333,1.0,4/10,8.10%,EPAS1;DCUN1D4;DCUN1D3;RPL5
prerank,positive regulation of viral process (GO:0048524),0.39513932244522953,1.094595604019999,0.3352402745995423,0.7232833047409822,1.0,19/60,19.93%,MDFIC;TMEM39A;PPID;CCL5;VPS4A;RAB7A;RAD23A;GTF2F2;RSF1;STAU1;GTF2F1;CCNT1;TBC1D20;DDB1;POLR2L;POLR2K;CDK9;TYRO3;KPNA2
prerank,positive regulation of signaling receptor activity (GO:2000273),0.4232602674371716,1.094084026095109,0.34545454545454546,0.7241017249492274,1.0,8/36,15.68%,JAK2;NRP1;EGF;FBXW7;HDAC1;CCL2;BTC;HIF1A
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4731169488595257,1.093954228714427,0.3463855421686747,0.7239355653874323,1.0,2/17,2.74%,SNAI1;SNAI2
prerank,cell junction organization (GO:0034330),0.39228639161288353,1.093785342688667,0.3539325842696629,0.7238816683312465,1.0,20/71,14.48%,VMP1;FLNC;SDK2;PPFIBP2;OPHN1;LIMS1;TGFB3;CDC42;RAB8B;L1CAM;PPFIBP1;SEMA3E;TGFB2;FBLIM1;RHOA;SDK1;ELFN1;SMAD3;PSEN1;PPFIA4
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.38476590033159247,-1.0937364607571076,0.34782608695652173,0.7516456734049625,1.0,9/17,34.13%,RB1;ZWILCH;IK;BUB3;KNL1;TTK;ZW10;MTBP;SPDL1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5181668219846662,1.093620480472219,0.37925925925925924,0.7238080061338483,1.0,4/13,12.48%,MDK;AKT3;FGFR1;FGF2
prerank,pancreas development (GO:0031016),0.5134847485805242,1.0935888046832953,0.3913764510779436,0.7233945686004913,1.0,3/12,11.12%,TCF7L2;NKX6-1;NPHP3
prerank,polyamine metabolic process (GO:0006595),-0.41328435106932254,-1.0930205109188909,0.3382352941176471,0.7516583377376437,1.0,8/13,35.66%,DHPS;SMS;OAZ2;PAOX;SAT2;HDAC10;SRM;SAT1
prerank,regulation of synapse assembly (GO:0051963),0.41023534792217536,1.0922551221390306,0.36524822695035464,0.7262061800194027,1.0,6/46,3.57%,ROBO2;MDGA1;TLR2;SLIT1;GPC6;EPHB3
prerank,neural crest cell differentiation (GO:0014033),0.47291665094632124,1.092097793648037,0.36337625178826893,0.7261013629958307,1.0,4/18,14.87%,SNAI2;LRP6;TAPT1;NOLC1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.35867704075933987,-1.0920216145233328,0.3253968253968254,0.7526554948237086,1.0,9/21,21.95%,PPP1R16B;YWHAB;ARPP19;TIPRL;PPP1R8;FKBP1A;CRY2;MASTL;STYXL1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3611346412071348,-1.0918196412618095,0.32608695652173914,0.7512191570814672,1.0,4/22,1.14%,DMD;PDE4B;CACNB2;CACNB4
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.32058765721140825,-1.0916865346849483,0.28205128205128205,0.7495274533582601,1.0,11/32,20.16%,CHPT1;CHKA;LPIN1;ABHD3;SLC27A1;PCYT1B;GPAT4;MFSD2A;CHKB;PCTP;PCYT1A
prerank,plasma membrane organization (GO:0007009),0.39947224853237395,1.090981208501226,0.3506944444444444,0.7284472078419602,1.0,17/61,18.76%,PLSCR5;COL5A1;UGCG;CHMP4A;MYH9;TLCD2;EHD2;CXCR4;SNX33;SNX9;BIN3;P2RX7;PLSCR4;ANXA6;ANO6;EPB41L3;SPTBN1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.4699300957774703,1.0909358818041746,0.37177747625508817,0.7280761912036752,1.0,2/20,3.24%,C3;CASP1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.353911256248316,1.0908539950059415,0.2755511022044088,0.7277790730411056,1.0,106/336,24.75%,RAD51B;BCL3;PARP3;YAP1;TAOK1;BCL6;POLE3;SUSD6;IRF7;BACH1;VAV3;SMC1A;BATF;RAD52;BLK;RBBP5;IKBKE;E2F1;PHF1;UBR5;BABAM2;BCL2;GNL1;INO80;XRCC3;ATM;DDX11;PDS5B;PWWP3A;GTF2H1;BCL2L2;LIG1;TAOK3;NEK4;GRB2;PDS5A;MCM7;ATR;RNF169;ZBTB38;FBH1;MCM9;ALKBH1;USP3;TIMELESS;POLI;MGMT;TANK;RIF1;PSEN1;FMR1;VCPIP1;ASF1A;DTX3L;NIPBL;MMS19;SETX;CHCHD6;PRKDC;USP28;CGAS;TRAIP;ATRIP;PNKP;MTREX;DDB1;RAD9A;SLF2;ZBTB40;RBBP8;FBXO31;HINFP;HMCES;EID3;GADD45A;MBD4;DCUN1D5;SMC5;FANCC;FOXP1;PARP4;YY1;ZC3H12A;EPHA2;PAK1;RBBP6;CDKN2AIP;ZRANB3;RPA1;SLX4;ENDOV;CBX5;RAD51;MNAT1;MSH6;DOT1L;BAZ1B;ETAA1;MACROD1;TRRAP;CDKN1A;TNFRSF1B;OARD1;TRIP12;BRAT1;FAM111A
prerank,sphingolipid catabolic process (GO:0030149),-0.3845494303617357,-1.0907241330280744,0.32628398791540786,0.7502245163100792,1.0,7/15,27.40%,ACER2;ENPP2;ASAH2;SMPD2;SMPDL3A;SPHK1;ASAH1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5314609264604128,1.0903929727531627,0.3790446841294299,0.7284737978745869,1.0,2/11,6.40%,XCL1;AHR
prerank,regulation of cellular respiration (GO:0043457),-0.3881499632011846,-1.0903901936397395,0.3490566037735849,0.7491133779064556,1.0,5/17,16.84%,PRDM16;CBFA2T3;IDE;NOP53;IFNAR1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.4388733453593146,1.0902625137988418,0.3841145833333333,0.7283205655347671,1.0,4/30,5.04%,XCL1;TSLP;STAT3;LGALS9
prerank,regulation of cellular response to stress (GO:0080135),0.3665379038705508,1.0900072910959369,0.3528161530286929,0.7284520298329077,1.0,28/115,17.65%,NEK6;DNAJB1;NUAK1;NUP37;CAMK2D;BAG3;RAE1;CREBBP;ATM;RPTOR;AIFM2;NEK4;CCAR2;ATR;NUP153;DNAJB6;DNAJC7;GSK3B;HSPH1;NDC1;NPAS2;NUP35;NUP188;BAG4;SEC13;MAPK1;YWHAE;ATF4
prerank,amino sugar biosynthetic process (GO:0046349),0.5086009310743499,1.0896107256201641,0.39317507418397624,0.7289745624485777,1.0,4/12,17.56%,GFPT2;UAP1L1;AMDHD2;GNPDA2
prerank,cellular response to glucagon stimulus (GO:0071377),-0.381532472411163,-1.0894638444687292,0.34726688102893893,0.7496572127618458,1.0,6/17,9.23%,ADCY5;ADCY9;ADCY1;PRKAR1A;PRKAR2A;ADCY4
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.534445029093225,1.0894196762665473,0.3783783783783784,0.7289359236795021,1.0,6/10,25.00%,DISC1;CX3CL1;KDM1A;SMARCD3;FZD3;VEGFA
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3799274555341413,1.088999404377652,0.3365591397849462,0.7295129187076973,1.0,27/98,21.08%,ADIPOQ;SFRP4;PDGFRB;DHRS4;APOE;CCL5;EGF;PPARG;PID1;ANGPT1;GRB2;RAB1A;FMR1;CD63;RIPK1;AKT1;INHBA;PAX8;AGT;NFKBIA;XDH;ACACA;FASN;GADD45A;DCXR;EIF4G1;ZC3H12A
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.37203611514732143,-1.088979888268444,0.33134328358208953,0.748939040320687,1.0,5/18,10.35%,CHRM2;PLCB1;AGRN;GNA11;GRK2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.43042204555212277,1.0888752617260313,0.35751295336787564,0.7293054265973943,1.0,15/30,25.73%,ADIPOQ;PINX1;DCP2;NAT10;XRN1;CTC1;SRC;ACVRL1;HNRNPC;TERF1;BMPR2;CDKN1A;CERS1;NIBAN2;TERF2
prerank,cell-cell junction maintenance (GO:0045217),-0.4288062253427933,-1.0887492501359615,0.3453038674033149,0.7476205624762023,1.0,1/11,0.05%,TJP1
prerank,regulation of membrane depolarization (GO:0003254),0.47977778456320375,1.0875410238771723,0.3854748603351955,0.7321585586857724,1.0,3/18,4.72%,LRRK2;CAMK2D;PTPN3
prerank,protein ubiquitination (GO:0016567),0.3517696027495322,1.087433265435713,0.24549098196392785,0.7319467294529319,1.0,99/471,17.75%,PSMA7;TRIML2;SH3RF3;DTX4;DCAF15;PDZRN3;MYLIP;PEX10;FBXO40;MYCBP2;SPSB1;ARRDC4;KLHL22;HECTD2;FBXL7;USP9X;CUL1;SMURF2;UBR5;BCL2;TRIM21;CNOT4;RNF144A;PLK1;ANAPC11;SIAH2;MIB1;CDC27;ATG3;RNF111;KLHL13;SKP1;SASH1;SPOP;NPEPPS;TRIM13;TPP2;CBL;FBXL18;FBXW7;FBXO30;AREL1;PSMB8;ARIH1;BRAP;PSMA6;SH3RF1;DTX2;UBE2L3;PELI3;FBH1;CBFB;TRIM44;UBE2R2;EIPR1;UBE2J1;FBXO7;NFE2L2;RNF213;KCTD10;RNF19B;PJA2;FBXW11;RNF181;ZSWIM8;PSMF1;UBE2K;TRAF2;UBE2W;FBXO2;RNF11;USP22;VCPIP1;DTX3L;RNF141;PSMA8;SMURF1;ITCH;NEDD4;HIF1A;FBXL19;PSMD2;PRKDC;PSMD12;KLHL25;PSMD11;PELI2;RBCK1;TRAIP;TNKS2;PCNP;PSMD14;KLHL7;TRIM33;RC3H2;DDB1;MDM2;PSMB1;FBXW4
prerank,Rho protein signal transduction (GO:0007266),0.39350443552283537,1.0871716837068912,0.36565420560747663,0.7320813804524955,1.0,15/53,18.74%,COL1A2;RHOJ;TAX1BP3;RHOD;CDC42;ARHGDIG;PDPN;RHOA;ARHGAP6;RTKN;CDC42EP1;ARHGDIA;GNA12;CDC42EP4;EPS8
prerank,carbohydrate homeostasis (GO:0033500),0.3817534046420794,1.08710941905824,0.35451505016722407,0.7317382368765941,1.0,7/67,5.97%,ADIPOQ;TCF7L2;IRS1;USF1;STAT3;PYGL;PPARG
prerank,positive regulation of protein modification process (GO:0031401),0.3596634801106208,1.087097445243999,0.3125638406537283,0.731264695896261,1.0,46/203,17.93%,DLC1;C3;IL34;ADIPOQ;TAOK1;NOS1AP;LRRK2;CD40;FGF7;EGFR;TREM2;FAM20A;CCND3;RAP2A;TMEM119;ANGPT1;GPNMB;EFNA5;NIBAN1;FAM161A;RAB3GAP2;FBH1;PPP2R5A;FNIP1;PTK2;ACVR2A;ATG7;TNF;VEGFC;FGF2;NTRK3;SPPL3;RAB3GAP1;WDFY2;CALM2;FMR1;RAC1;RIPK1;FGF18;STK4;PELI2;CSNK1D;PTPA;AKT1;ANKLE2;CLIP3
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3920201353838855,1.08695946369545,0.35689455388180763,0.7311274908342895,1.0,19/62,20.96%,POU5F1;STAT3;NUP37;PUM1;RAE1;PPARG;NUP153;WTIP;FMR1;NDC1;NUP35;NUP188;SEC13;POLR2L;POLR2K;NUP214;AGO2;EIF4G1;NUP107
prerank,cellular transition metal ion homeostasis (GO:0046916),0.378739410393383,1.0866104113400272,0.34371643394199786,0.7315167224966956,1.0,17/91,16.67%,SLC39A14;HEPH;CP;SLC11A2;FXN;CUL1;ACO1;SKP1;SLC22A17;SLC31A1;IREB2;ARF1;SMAD4;FRRS1;SLC39A6;SLC30A9;ATP6V1G1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.45328696995240286,1.0865276540750815,0.36962750716332377,0.7312377592299893,1.0,2/21,4.31%,ENPP1;CCR1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.4666585121432223,1.0860568441433311,0.3788300835654596,0.7319041533234665,1.0,3/18,8.45%,DCN;RALA;SPIRE1
prerank,protein trimerization (GO:0070206),0.4929659895835923,1.0856603360802812,0.37808641975308643,0.7319483181997518,1.0,2/14,9.64%,STEAP4;MLKL
prerank,protein homotrimerization (GO:0070207),0.4929659895835923,1.0856603360802812,0.37808641975308643,0.7319483181997518,1.0,2/14,9.64%,STEAP4;MLKL
prerank,protein phosphorylation (GO:0006468),0.34868940836561885,1.085645742829538,0.249,0.7314761985406157,1.0,110/479,17.81%,CCL11;RUNX3;PDGFRA;NEK6;MAP4K4;TEC;TAOK1;JAK1;MAST4;PEAK1;ERN2;TLR2;LRRK2;PDGFRB;JAK2;PRKCA;SMAD2;MARK1;EGFR;EPHB3;NUAK1;IRAK3;RICTOR;BLK;STK36;ILF3;IKBKE;AKT3;CAMK2D;PRKD2;DDR2;ACVR1;MORC3;FAM20A;CDK6;ATM;CDK14;EIF2AK2;PLK1;PTPN6;PPP4R1;EPHA1;TLR7;GTF2H1;TAOK3;DCLK1;CDK10;ABI2;HIPK4;NEK4;MERTK;PXK;FRK;MAST2;PRKAR1B;ATR;TGFBR1;MAP2K1;CSNK2A1;CSNK2A2;MAP4K5;HIPK3;RPS6KB1;ACVR1B;CDC42BPA;CCL2;FGFR1;PTK2;YWHAZ;NRK;CSNK1G2;TGFB2;GMFB;CDK7;ACVR2A;MYO3A;COQ8B;MAML1;GSK3B;CSNK1A1;ACVR1C;ABI1;MAP3K6;SRC;MKNK1;STK24;DAPK2;FES;TRIB1;VRK3;RIPK1;PIK3R4;CCNT1;PRKAB1;PRKDC;GRK4;STK4;FAM20B;ACVRL1;CSNK1D;MAPK1;AKT1;LATS2;CDKL1;MAP3K3;TYK2;EIF2AK3;TESK2;DCLK3;MAP3K12
prerank,regulation of lymphocyte migration (GO:2000401),0.5366308898357304,1.0856139820499595,0.39490445859872614,0.731056227375327,1.0,3/10,8.23%,SPN;MIA3;MSN
prerank,regulation of isotype switching (GO:0045191),0.5032489040603273,1.0851571638592667,0.38622754491017963,0.7316550948931545,1.0,5/14,18.69%,PARP3;SHLD3;RIF1;PAXIP1;HMCES
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.4340714824369226,1.0850270928465493,0.36855345911949683,0.73146077438355,1.0,11/32,20.54%,DLC1;PDGFRB;PPP2R5A;DUSP26;SPPL3;CALM2;ITGA1;PTPA;ANKLE2;PIN1;PRKCD
prerank,hepaticobiliary system development (GO:0061008),0.46734280929267147,1.0849870596352948,0.3769338959212377,0.7310486167041764,1.0,5/20,5.10%,PRKCSH;ARID5B;PHF2;PKD2;NF1
prerank,L-serine metabolic process (GO:0006563),-0.45357660894847474,-1.0849667810402022,0.38857142857142857,0.7563082071136265,1.0,5/10,36.08%,PSAT1;CBS;PHGDH;SERINC3;SHMT1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5042008838067192,1.0849310921400628,0.38591117917304746,0.7306738076954794,1.0,2/13,5.97%,POU5F1;PPARG
prerank,hexose biosynthetic process (GO:0019319),0.4115355438223412,1.0847281330644696,0.3542168674698795,0.7306796265984905,1.0,7/42,18.57%,SLC39A14;ENO1;GAPDH;SLC25A10;ATF4;SORD;CHST15
prerank,negative regulation of transport (GO:0051051),0.4022453149055631,1.084649121905009,0.363855421686747,0.7303901445043647,1.0,8/51,10.82%,ADIPOQ;TLR2;PRTN3;PTEN;EGF;RAB7A;PXK;SNX33
prerank,regulation of microtubule depolymerization (GO:0031114),0.43766566677631374,1.084493935738955,0.37753721244925575,0.7302749244040778,1.0,6/25,12.48%,TAOK1;NAV3;MAP1S;TPX2;CAMSAP2;FGF13
prerank,positive regulation of phospholipase C activity (GO:0010863),0.40985918392891,1.0842761784758368,0.36788874841972186,0.7303156137205098,1.0,9/40,12.55%,PDGFRA;PDGFRB;EDNRA;EGFR;FGFR1;LPAR2;ARHGAP6;FGF2;NTRK3
prerank,dephosphorylation (GO:0016311),0.3612743318562681,1.0841561937626707,0.3398357289527721,0.7301106704797284,1.0,44/147,20.59%,PDXP;PTPN7;DUSP2;DUSP5;PTPN3;PTPN13;EPHX2;PTEN;PTPRZ1;PTPN6;PPP4R1;DAPP1;PTPN18;PTPN1;SSH1;PPP3CA;PPP2R2A;PPP2R5A;PTPRJ;PTPN9;PPP4R2;PTPRM;THNSL2;PPP1CB;FBXW11;DUSP28;DUSP26;ILKAP;SSH2;CTTNBP2NL;TIMM50;PPP6C;PNKP;PTPRC;PTPN5;PTPRA;DUSP6;MTMR3;MTMR2;MTMR6;MTM1;CDC14B;DUSP11;DUSP15
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5347589515120987,1.084017705920254,0.39297658862876256,0.7299405697031953,1.0,4/10,21.05%,PCBD1;KYAT1;ATP7A;QDPR
prerank,microtubule bundle formation (GO:0001578),0.40975683192725665,1.0839768676974124,0.352059925093633,0.7295378889548731,1.0,9/42,17.61%,NAV1;MAP1S;NCKAP5;PLK1;NCKAP5L;TOGARAM1;TPPP;KIF20A;CFAP74
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5122943547258989,1.0833387616194092,0.4088145896656535,0.7306607672740685,1.0,2/12,2.50%,GLI2;MYCBP2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3521338611963381,-1.0831355499212343,0.31092436974789917,0.7572887973350468,1.0,11/21,27.25%,ERCC5;ERCC3;CHD1L;DDB2;GTF2H2;ERCC1;GTF2H4;GTF2H3;RBX1;RPA2;PARP1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3521338611963381,-1.0831355499212343,0.31092436974789917,0.7572887973350468,1.0,11/21,27.25%,ERCC5;ERCC3;CHD1L;DDB2;GTF2H2;ERCC1;GTF2H4;GTF2H3;RBX1;RPA2;PARP1
prerank,mitotic spindle organization (GO:0007052),0.3571274222517822,1.082950721090223,0.3340227507755946,0.7311087879899117,1.0,33/153,17.55%,NEK6;KIFC1;DYNLL1;TAOK1;EML4;SMC1A;CENPQ;DYNC1H1;MAD2L1;NUP37;CENPN;KIF2A;TUBG1;PLK1;GPSM2;NEK9;STAG2;TPX2;PCNT;STAG1;SPC25;CENPL;RHOA;MAD1L1;NDEL1;TOGARAM1;MAP4;CEP192;RCC1;TUBG2;SEC13;PTPA;CKAP5
prerank,ganglioside biosynthetic process (GO:0001574),-0.3972442104128871,-1.082735879666701,0.3475783475783476,0.7564759533511051,1.0,7/15,12.49%,ST6GALNAC3;ST8SIA4;ST3GAL5;ST8SIA6;B4GALT6;ST8SIA2;ST6GALNAC5
prerank,cilium-dependent cell motility (GO:0060285),0.4579794263322261,1.082567774596139,0.37907608695652173,0.7315775760704817,1.0,1/22,0.46%,TEKT4
prerank,regulation of interferon-beta production (GO:0032648),0.40884440206027595,1.0825059147585996,0.35444579780755175,0.7312444632248025,1.0,20/46,26.98%,TLR2;IRF7;REL;TLR7;IRF1;TIRAP;POLR3A;POLR3D;TRIM56;RELB;RNF135;ISG15;YY1;SIRPA;TRAF3;TLR3;NLRC3;PYCARD;PTPRS;DHX58
prerank,negative regulation of interferon-beta production (GO:0032688),0.5284780342620125,1.081322085102058,0.3795986622073579,0.7336837092112358,1.0,7/10,26.89%,REL;RELB;YY1;SIRPA;NLRC3;PYCARD;PTPRS
prerank,DNA recombination (GO:0006310),0.4222979875020185,1.0810845555754725,0.38143036386449186,0.7337500643002958,1.0,4/37,10.03%,RAD51B;RAD52;XRCC3;FBH1
prerank,protein modification by small protein removal (GO:0070646),0.3521285922135896,1.0809967143692027,0.30885311871227367,0.7334787307669095,1.0,50/252,16.12%,PSMA7;ASXL1;TNIP1;TNFAIP3;BIRC3;SMAD2;USP9X;SMURF2;BABAM2;OTULINL;PTEN;ASXL2;INO80;FOXK2;SIAH2;TADA2B;USP42;USP24;PSMB8;RAD23A;PSMA6;TGFBR1;OGT;RAD23B;USP12;OTUD3;USPL1;USP40;USP38;SENP6;USP3;RUVBL1;RHOA;PSMF1;TRAF2;SMAD3;MYSM1;USP22;VCPIP1;SMAD4;COPS6;RIPK1;SMAD1;PSMA8;STAMBPL1;HIF1A;PSMD2;PSMD12;USP28;PSMD11
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.36117207533499307,1.0809548642568831,0.3446502057613169,0.7330909533534035,1.0,20/152,12.75%,MC5R;ABCA1;IAPP;ADCY7;HTR1D;ADGRL3;RXFP2;ADCY2;ADM;ADCYAP1R1;CXCL10;GLP2R;S1PR3;GPR161;S1PR2;GNAI1;LPAR3;LPAR2;CALCRL;MC1R
prerank,negative regulation of hydrolase activity (GO:0051346),0.4032423374156193,1.0808882401006916,0.39176470588235296,0.7327627494032154,1.0,4/49,7.54%,SLC39A14;LRRK2;PPP1R36;RRP1B
prerank,homeostasis of number of cells (GO:0048872),-0.42249153148775753,-1.0808364912754933,0.34173669467787116,0.7597051337649207,1.0,3/12,6.10%,NOS3;CCN3;OCIAD1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.3247135516771778,-1.080311598299827,0.3317972350230415,0.7591236291330473,1.0,4/29,5.90%,TGFBR3;S1PR1;PROX1;FGFR2
prerank,negative regulation of vascular permeability (GO:0043116),0.5174560157335109,1.0797906230207885,0.3952451708766716,0.7349656502122411,1.0,3/12,10.88%,PDE3A;ANGPT1;PTPRJ
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.44713360360186194,-1.0792016907037159,0.375,0.760326765935468,1.0,8/10,42.16%,WWP2;NDFIP2;CORO2B;NDFIP1;MAPT;SNX12;PPM1F;DNAJA1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5149032700652342,1.078615278609917,0.40923076923076923,0.7372849087552926,1.0,3/12,11.91%,DCN;ADAMTS12;SPRY2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.4873444909780399,1.0782033389201051,0.4032258064516129,0.7378412871057808,1.0,5/16,18.70%,CHMP4A;CHMP4B;CHMP7;LEPROT;LEPROTL1
prerank,regulation of postsynapse organization (GO:0099175),-0.3392022458645506,-1.07808692140659,0.3422222222222222,0.7614576105016485,1.0,13/28,20.52%,EPHA4;TANC2;IL1RAPL1;SRCIN1;SHANK3;CDKL5;ARHGAP44;PDLIM5;ZDHHC15;ABI3;KIF1A;CFL1;PPFIA2
prerank,regulation of RNA metabolic process (GO:0051252),0.38839036844135466,1.0778210422496315,0.3513203214695752,0.7382715992843969,1.0,9/59,10.49%,IGF2BP1;IGF2BP2;AFF2;MITF;PTBP3;RRP1B;CELF1;OASL;HNRNPH2
prerank,oxoacid metabolic process (GO:0043436),0.43960200443537417,1.0777487889949018,0.3848202396804261,0.7379499194672217,1.0,2/27,2.97%,ENPP1;PPA1
prerank,multivesicular body assembly (GO:0036258),0.4325034750427322,1.0774172805311415,0.3834394904458599,0.7382496432312838,1.0,6/30,15.31%,CHMP4A;CHMP4B;VPS4A;VPS37C;CHMP7;CHMP2B
prerank,protein deubiquitination (GO:0016579),0.3516053366530794,1.0773664479516833,0.33131313131313134,0.7378764678432942,1.0,47/242,16.12%,PSMA7;ASXL1;TNIP1;TNFAIP3;BIRC3;SMAD2;USP9X;SMURF2;BABAM2;OTULINL;PTEN;ASXL2;INO80;FOXK2;SIAH2;TADA2B;USP42;USP24;PSMB8;RAD23A;PSMA6;TGFBR1;OGT;RAD23B;USP12;OTUD3;USP40;USP38;USP3;RUVBL1;RHOA;PSMF1;TRAF2;SMAD3;MYSM1;USP22;VCPIP1;SMAD4;RIPK1;SMAD1;PSMA8;STAMBPL1;HIF1A;PSMD2;PSMD12;USP28;PSMD11
prerank,negative regulation of developmental process (GO:0051093),-0.2679606960759093,-1.0770977398340074,0.2767857142857143,0.7622631971768836,1.0,15/69,9.72%,NFIB;DCC;BMP4;RAPGEF3;PRKN;HUWE1;NOS3;GAS6;CST3;TFRC;GRIN3A;KLF7;TBX1;ARHGEF15;IL17D
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.43672630901048176,1.0769406105010308,0.3767313019390582,0.7384271748264504,1.0,1/26,0.10%,NR1H4
prerank,protein kinase B signaling (GO:0043491),0.4415240923770046,1.0766509965256528,0.37101063829787234,0.7386693294288911,1.0,10/23,22.06%,ZFP36L1;PTEN;CCL5;CCL2;TNF;SETX;AKT1;TYRO3;EPHA2;THEM4
prerank,protein localization to cell junction (GO:1902414),-0.3452636972008308,-1.076387064738748,0.3169811320754717,0.7622208720251366,1.0,5/22,9.15%,TJP1;TJP2;PCLO;BSN;SHANK1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.4044952473151524,1.0761529392787517,0.375750300120048,0.7394152052428796,1.0,11/46,17.95%,JAK1;JAK2;RALA;CDC42;MSN;LMNB1;LCP1;TALDO1;ARF1;TYK2;CAPZA1
prerank,peroxisome organization (GO:0007031),0.44126973828591504,1.076111700646082,0.38409703504043125,0.7390115758826928,1.0,2/25,2.13%,SEC16B;PEX10
prerank,nucleic acid metabolic process (GO:0090304),0.38716505194624334,1.0756905849370952,0.36727688787185353,0.7395355345750646,1.0,23/69,23.27%,ENPP1;ATXN2;DNA2;WDR74;GTF2F2;SETMAR;NCBP2;HNRNPH2;GTF2F1;MMS19;DXO;POLG;RBMX;RBFOX2;DDX1;POLR2L;POLR2K;KPNA2;DUSP11;DDX24;HNRNPC;POLR2D;PCBP1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.2995482553595463,-1.0753062175268493,0.3548387096774194,0.7631973267701206,1.0,12/47,10.97%,EXOC6;STXBP6;KIF13A;EXOC6B;GOPC;GGA1;VAMP4;PREPL;ARL3;NSF;ANK3;EXOC2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.41833376033310177,1.0752917417506944,0.375,0.7400329280896851,1.0,5/32,7.31%,TAOK1;BABAM2;ATM;PLK1;TAOK3
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.4599481551960641,1.0751259194257092,0.3922413793103448,0.7399473686105413,1.0,3/21,4.90%,NOS1AP;CACNA2D1;KCNA5
prerank,phospholipid translocation (GO:0045332),0.43351228571822287,1.0751146727783811,0.38026315789473686,0.7394819189287571,1.0,3/28,2.43%,ABCA1;PLSCR5;ATP8B1
prerank,regulation of cytokinesis (GO:0032465),0.3786183109675588,1.0745908260759935,0.3786724700761698,0.7402487328049744,1.0,26/78,20.31%,SVIL;PDXP;PLK1;CDC42;VPS4A;E2F8;KLHL13;ZFYVE26;DRD3;SETD2;OPN1MW;CSPP1;RHOA;ENTR1;GIPC1;CALM2;CDC14A;PIK3R4;FSD1;PIK3C3;SH3GLB1;KIF20A;PIN1;CDC14B;PLK2;MYO19
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.4992923591076928,1.0745217090970378,0.3896296296296296,0.7399255894436693,1.0,3/13,10.36%,TLR2;JAK2;CCL2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3727226532521787,1.0742469429447095,0.3690078037904125,0.740130021563332,1.0,28/78,26.05%,CDKN2B;EGFR;NR2F2;CCNE2;PTEN;PKD2;CCND3;PLK1;GTF2H1;CDC37;CCNB2;CDK7;CCNI;CDKN1B;CCNT1;AKT1;LATS2;SERTAD1;GADD45A;RGCC;LATS1;CCNH;MNAT1;CDC6;CDKN1A;CDC25A;BCCIP;CCNY
prerank,negative regulation of histone modification (GO:0031057),0.4844218686946746,1.073889925326741,0.3994252873563218,0.740466389689165,1.0,4/14,19.16%,TAF7;NOC2L;SPHK2;THAP7
prerank,chromosome organization (GO:0051276),0.3713351220629767,1.0726177250943723,0.3688172043010753,0.7430801917055141,1.0,35/99,23.70%,TCF7L2;POLE3;MTHFR;PADI2;PHF1;RAE1;EHMT1;PWWP3A;BAHD1;HDAC1;RAD23B;HMGB2;BRWD1;TOP2B;SAFB;LRWD1;HMGN3;COPS6;TCF7L1;SMARCA4;HMGN1;NUCKS1;DDB1;HDAC5;SOX2;ZBTB7A;AXIN2;HMGA2;COPS3;RPS27A;LATS1;ACTL6B;MSH6;DOT1L;HDAC8
prerank,atrioventricular valve morphogenesis (GO:0003181),0.46316831730756264,1.0710383764276459,0.3914835164835165,0.7464637616068487,1.0,6/19,16.65%,SLIT3;ACVR1;HEYL;TGFB2;SMAD4;OLFM1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4415784076125077,1.0710210600782688,0.3925233644859813,0.746003595748844,1.0,4/26,6.56%,NEK6;PLK1;ANAPC11;CDC27
prerank,regulation of cholesterol transport (GO:0032374),0.4654026328954819,1.0708393461718482,0.39198855507868385,0.7459693636269574,1.0,2/20,4.25%,LRP1;ABCA2
prerank,renal water homeostasis (GO:0003091),-0.3444265909532167,-1.0708258897284098,0.29844961240310075,0.7736530728707758,1.0,6/23,9.23%,ADCY5;ADCY9;ADCY1;PRKAR1A;PRKAR2A;ADCY4
prerank,positive regulation of lipid metabolic process (GO:0045834),0.4429556389610783,1.0706254379242703,0.38292011019283745,0.7460196447726269,1.0,3/22,5.97%,ADIPOQ;APOE;PPARG
prerank,positive regulation of cellular senescence (GO:2000774),0.5198534458076626,1.070388680694776,0.41294298921417566,0.7460853912337637,1.0,4/10,20.05%,EEF1E1;YPEL3;CGAS;HMGA2
prerank,synaptic vesicle membrane organization (GO:0048499),-0.3768117624554177,-1.0703439124622594,0.35172413793103446,0.7729037012412826,1.0,7/17,19.45%,SNAP25;STX3;STX2;TOR1A;SYP;SYNGR1;SYNGR2
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.41419241813784896,-1.0702390921916707,0.36033519553072624,0.771157133357706,1.0,6/13,20.51%,CPEB3;PABPC1;TOB1;TNRC6C;POLR2G;ZFP36
prerank,negative regulation of kinase activity (GO:0033673),0.3832683184306145,1.0699621316459975,0.37755102040816324,0.7466409921809115,1.0,20/62,17.14%,SPRED1;NF1;TAF7;DTNBP1;LRP6;NPRL2;EPHA1;GSKIP;PYDC1;PPP2R5A;WWTR1;UBASH3B;SMCR8;TRIB3;CDKN1B;TRIB1;RTRAF;ITGB1BP1;PTPRC;AKT1
prerank,actin filament organization (GO:0007015),0.35955144428138897,1.0695632254857603,0.35802469135802467,0.7471473020410567,1.0,31/151,14.73%,SVIL;MYO1B;PPP1R9B;RND3;DPYSL3;FHOD3;BAIAP2;AIF1;RHOD;CARMIL1;MYO5A;CDC42;FAT1;MYO1D;CGNL1;MYO1H;TMOD1;MYO7A;ABI2;SPIRE1;LCP1;SAMD14;DBN1;VILL;ZBED3;RHOA;BIN3;ABI1;TPM4;MYO1E;RAC1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.41061460311738507,1.0689456798572645,0.3923566878980892,0.7481813277646105,1.0,7/33,14.25%,E2F1;PTEN;INO80;PTPN6;FBXW7;DDRGK1;CDKN1B
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4379338164425278,1.0688440601807174,0.3926218708827404,0.7479666396506535,1.0,2/26,4.25%,CYP1B1;ABCA2
prerank,negative regulation of DNA binding (GO:0043392),0.4286374616634702,1.0685117199201486,0.38461538461538464,0.7482684800150876,1.0,10/28,20.05%,JAK2;E2F1;ILRUN;MDFI;SP100;RSF1;SMO;NFKBIA;KDM1A;HMGA2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.501093134018549,1.0684402049736696,0.4036979969183359,0.747953123208336,1.0,3/13,15.60%,EMILIN1;PTPN1;NEDD4
prerank,positive regulation of nuclear division (GO:0051785),0.4360485862002797,1.0680395033055192,0.39789196310935443,0.748495217198524,1.0,5/25,13.23%,EDN3;PDGFRB;EGF;DRD3;BTC
prerank,neutrophil mediated immunity (GO:0002446),0.34673436253724393,1.067680203818304,0.3053053053053053,0.7488968754583519,1.0,103/432,20.68%,HP;C3;OLR1;TCN1;CXCL1;PLAC8;DYNLL1;HVCN1;TLR2;PRTN3;PLD1;ANPEP;MGST1;PADI2;DYNC1H1;CTSD;CD53;CTSS;PYGL;CD36;UBR4;DDOST;TXNDC5;ATP6AP2;DNAJC13;CD68;PTPN6;LAMP2;HPSE;SLC27A2;PDAP1;UNC13D;RAB7A;VAPA;ACTR2;PTGES2;CKAP4;FRK;CD14;CCT8;STXBP3;IRAK4;CTSB;NPC2;GALNS;MVP;PTPRJ;KMT2E;DBNL;RHOA;ATG7;CTSC;RAB37;FABP5;ORMDL3;KCMF1;DPP7;RAB10;PSEN1;GNS;GAA;RAC1;AP2A2;CD63;SLCO4C1;NEU1;RHOF;PSMD2;PSMD12;FGL2;PSMD11;SRP14;GGH;ARHGAP9;DOCK2;TSPAN14;PSMD14;PTPRC;MAPK1;CTSA;DNAJC3;ATP6V1D;ANO6;LAIR1;PSMB1;FCGR3B;LAMTOR3;TIMP2;AGA;IMPDH2;ATP11A;CPNE3;ADGRG3;CYBB;MGAM;HGSNAT;CYB5R3;AMPD3;CDK13;NCSTN;PRKCD;LCN2;TOM1
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3715010474599874,-1.0675695644384824,0.33641975308641975,0.7764161449207669,1.0,7/18,23.40%,STT3B;OGA;SAMHD1;DERA;MANBA;FBXO44;FUCA1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.4139938376859167,1.0675363927882195,0.4079110012360939,0.7487495527351263,1.0,8/34,13.23%,EDN3;PDGFRB;EGF;ANAPC11;CDC27;DRD3;NSMCE2;BTC
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4169397776821616,-1.067478359198882,0.3586206896551724,0.7746599513243518,1.0,5/12,16.23%,SORBS1;INSR;IGF1;IGF2;DYRK2
prerank,regulation of RNA splicing (GO:0043484),-0.26143760092109997,-1.06735997078753,0.3103448275862069,0.7730393010231974,1.0,24/69,21.42%,KHDRBS2;QKI;SNRNP70;MBNL1;YTHDC1;TIA1;CWC22;HNRNPH3;U2AF2;AHNAK;CLK1;LARP7;POLR2A;METTL4;ERN1;HNRNPLL;SRRM4;PRX;RPS13;FAM50A;TMBIM6;PTBP2;SRSF3;HNRNPL
prerank,regulation of coagulation (GO:0050818),-0.4313961870783127,-1.0673593204988063,0.3597560975609756,0.771067261989975,1.0,1/11,1.15%,CAV1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.39683895945731407,-1.067009857195659,0.363013698630137,0.7700389388024665,1.0,5/13,16.23%,SORBS1;INSR;IGF1;IGF2;DYRK2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3781763970798231,1.0662495279839523,0.40484048404840484,0.7514220474766532,1.0,22/75,20.54%,ADIPOQ;IRAK3;APOE;NR2F2;PTEN;NF1;LRP6;PLK1;PTPN1;PRKAR1B;PTPRJ;SPRY2;BMP7;CDKN1B;AKT1;LATS2;AGT;LRP5;GADD45A;PKIB;SPRY4;PRKCD
prerank,cellular protein metabolic process (GO:0044267),0.3451863705792982,1.0659379289074928,0.3246492985971944,0.7516667963485371,1.0,99/396,21.71%,C3;MMP2;ENAM;KNG1;SPP1;RPSA;RRBP1;IGFBP7;LAMB1;PLOD2;ASMT;TNIP1;LAMC1;CP;TIMP1;IGFBP4;GATA6;STOML2;VCAN;FSTL1;PRKCSH;RPL3L;APOE;CALU;IGFBP5;FBN1;OMA1;PLAT;SIAH2;ATG3;MIA3;PABPC4;CKAP4;SDC2;MGAT4A;MSRB3;TNC;UBE2L3;LTBP1;PAPPA2;CCDC59;ST3GAL1;GALNT11;RPL12;PPP4R2;MRPS18A;PHKA2;MMP15;SPG7;SPPL3;RPL22;RPL14;ADPRH;FBXO2;PCMT1;PSEN1;MRPS14;RPL11;RABGGTB;RIPK1;PSENEN;GSPT1;B4GALT7;RPN1;PRKDC;PIGH;YES1;SEC11A;MRPL55;L2HGDH;FDXR;DNAJC3;RPL36A;MSRB1;MRPL52;RPS9;HSP90B1;PHEX;EVA1A;RPL6;CSF2RA;FAM20C;PDIA6;RPLP2;AGO2;LGALS1;MRPS33;UBL5;SHISA5;NCSTN;EIF4G1;PARP4;ADORA2B;USP25;PSEN2;HM13;FBXO22;RPS27A;MXRA8
prerank,regulation of filopodium assembly (GO:0051489),0.4144217316288852,1.0655093890864509,0.39655172413793105,0.7521986452067899,1.0,7/38,6.39%,MYO10;DPYSL3;NRP1;FSCN1;RALA;TGFB3;CDC42
prerank,cellular response to gamma radiation (GO:0071480),0.4684415727777643,1.0650290343760662,0.4146341463414634,0.752932667210981,1.0,6/17,21.02%,YAP1;ATM;ATR;MDM2;KDM1A;MAP3K20
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3111523412527034,-1.0642892191474658,0.3378995433789954,0.7757530241267507,1.0,12/34,16.62%,FLT1;GAB1;SEMA6A;VEGFD;RAMP2;KDR;HSPB1;NR4A1;ERN1;FLT4;PRKD1;PGF
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.46774943628578836,1.0642084524883617,0.4166666666666667,0.754429171837661,1.0,2/16,2.45%,ZFP36L1;ZFP36L2
prerank,regulation of protein acetylation (GO:1901983),0.5005858787716051,1.0640693767880558,0.413290113452188,0.7542801423281149,1.0,3/12,12.44%,TAOK1;FAM161A;GSK3B
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4284550615173047,1.0636903713576524,0.39707835325365204,0.7547400613736504,1.0,5/26,6.39%,SLC9A1;SYNPO;ASAP3;ALMS1;CDC42
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.4366159181541312,1.0635745334815554,0.3933588761174968,0.7545542951034429,1.0,7/28,13.10%,CASP8AP2;BAG3;BCL2;TNFRSF1A;CASP8;TNF;SPI1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.4829883316108827,1.0635612974431752,0.41812865497076024,0.7540984940773614,1.0,3/13,10.24%,SEC16B;TM9SF4;SEC16A
prerank,histone H3-K4 trimethylation (GO:0080182),0.5217228047817115,1.0632807640975854,0.4098883572567783,0.7543022016615649,1.0,3/11,12.02%,KMT2A;OGT;TET2
prerank,muscle tissue development (GO:0060537),0.4973868061986554,1.0630779290336365,0.4069069069069069,0.7543310253259211,1.0,3/13,5.10%,CSRP1;SHH;NF1
prerank,histone H4-K16 acetylation (GO:0043984),0.4614264013648487,1.0623245846938765,0.4008438818565401,0.7556952338073178,1.0,3/19,9.03%,KMT2A;KANSL1;OGT
prerank,proteasomal protein catabolic process (GO:0010498),0.350647112402062,1.0613996928944598,0.40061162079510704,0.7575335761726694,1.0,43/201,17.74%,PSMA7;SPSB1;KLHL22;SMURF2;APPBP2;SIAH2;BAG6;ERLEC1;SPOP;TRIM13;FBXW7;AREL1;PSMB8;RAD23A;PSMA6;TBL1X;RAD23B;DCAF11;RCN3;NFE2L2;KCTD10;FBXW11;ZSWIM8;PSMF1;UBE2K;MAEA;UBE2W;PSMA8;SMURF1;ITCH;NEDD4;FBXL19;PSMD2;PSMD12;PSMD11;RBCK1;CLOCK;PCNP;PSMD14;KCTD2;DDB1;MDM2;PSMB1
prerank,cardiac conduction system development (GO:0003161),0.4354021040338617,1.0606243904053805,0.4203480589022758,0.7589597734813971,1.0,6/24,15.19%,TBX18;GATA6;SMAD5;MAML1;SMAD4;SMAD1
prerank,glutamate metabolic process (GO:0006536),-0.3558735874796928,-1.0604922871872435,0.38515901060070673,0.784459045905697,1.0,5/19,5.63%,GLUL;MTHFS;GCLC;GLUD1;PRODH
prerank,neutrophil degranulation (GO:0043312),0.34467107462226393,1.060464811970467,0.3283283283283283,0.7588618471991186,1.0,101/425,20.68%,HP;C3;OLR1;TCN1;CXCL1;PLAC8;DYNLL1;HVCN1;TLR2;PRTN3;PLD1;ANPEP;MGST1;PADI2;DYNC1H1;CTSD;CD53;CTSS;PYGL;CD36;UBR4;DDOST;TXNDC5;ATP6AP2;DNAJC13;CD68;PTPN6;LAMP2;HPSE;SLC27A2;PDAP1;UNC13D;RAB7A;VAPA;ACTR2;PTGES2;CKAP4;FRK;CD14;CCT8;STXBP3;CTSB;NPC2;GALNS;MVP;PTPRJ;DBNL;RHOA;ATG7;CTSC;RAB37;FABP5;ORMDL3;KCMF1;DPP7;RAB10;PSEN1;GNS;GAA;RAC1;AP2A2;CD63;SLCO4C1;NEU1;RHOF;PSMD2;PSMD12;FGL2;PSMD11;SRP14;GGH;ARHGAP9;DOCK2;TSPAN14;PSMD14;PTPRC;MAPK1;CTSA;DNAJC3;ATP6V1D;ANO6;LAIR1;PSMB1;FCGR3B;LAMTOR3;TIMP2;AGA;IMPDH2;ATP11A;CPNE3;ADGRG3;CYBB;MGAM;HGSNAT;CYB5R3;AMPD3;CDK13;NCSTN;PRKCD;LCN2;TOM1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3807759783415874,-1.0600461095299951,0.36462093862815886,0.783680555416207,1.0,4/16,11.13%,SNCAIP;MCTP1;CPLX1;RIMS1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.35265666422403236,1.059963972031672,0.3862212943632568,0.7595984251295157,1.0,26/125,17.55%,NEK6;DYNLL1;TAOK1;EML4;CENPQ;DYNC1H1;MAD2L1;NUP37;CENPN;KIF2A;TUBG1;PLK1;GPSM2;NEK9;SETD2;PCNT;SPC25;CENPL;MAD1L1;NDEL1;MAP4;RCC1;TUBG2;SEC13;PTPA;CKAP5
prerank,natural killer cell mediated immunity (GO:0002228),0.476193584999781,1.0599523811529024,0.4,0.7591344126228592,1.0,2/15,13.14%,ULBP1;KIF5B
prerank,neuron projection morphogenesis (GO:0048812),0.3566433129292117,1.0583027140631174,0.3834745762711864,0.76267359349926,1.0,24/137,11.62%,GAS7;SLITRK6;MAP4K4;TNN;TAOK1;FARP1;LRRK2;EPHB3;MAP1S;BAIAP2;PTEN;DTNBP1;CDC42;LLGL1;DLG4;TAOK3;DCLK1;SDC2;S100A6;TRIO;DICER1;DBN1;NRK;DBNL
prerank,rRNA pseudouridine synthesis (GO:0031118),0.5186547257017717,1.0579899088907287,0.4326923076923077,0.7629335291064671,1.0,1/10,1.03%,RPUSD3
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.36633214883776327,1.0577922445319485,0.4013230429988975,0.7629214661260276,1.0,22/85,17.55%,NKD2;LRRK2;TREM2;PABIR1;RNF144A;PLK1;PRICKLE1;BAG6;FBXW7;RAD23A;ARIH1;SOCS5;RNF19B;GSK3B;CSNK1A1;DDRGK1;TRIB3;FMR1;TRIB1;ZYG11B;CSNK1D;MDM2
prerank,negative regulation of protein localization to membrane (GO:1905476),0.4356863693253472,1.0573598638422506,0.39037433155080214,0.763476888768958,1.0,6/24,17.72%,CLTC;PID1;PPP2R5A;NUMB;ITGB1BP1;PICALM
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.37213708950084307,1.0573055056615523,0.39558011049723757,0.7631091405218873,1.0,16/76,14.05%,BCL3;TLR2;EGFR;LGALS9;NOD1;LIMS1;EIF2AK2;TLR7;SASH1;RASSF2;CD14;TRIM44;RHOA;TNF;SPI1;BMP7
prerank,neutrophil activation involved in immune response (GO:0002283),0.343344154857354,1.0570543779387274,0.332,0.7631935371803783,1.0,101/428,20.68%,HP;C3;OLR1;TCN1;CXCL1;PLAC8;DYNLL1;HVCN1;TLR2;PRTN3;PLD1;ANPEP;MGST1;PADI2;DYNC1H1;CTSD;CD53;CTSS;PYGL;CD36;UBR4;DDOST;TXNDC5;ATP6AP2;DNAJC13;CD68;PTPN6;LAMP2;HPSE;SLC27A2;PDAP1;UNC13D;RAB7A;VAPA;ACTR2;PTGES2;CKAP4;FRK;CD14;CCT8;STXBP3;CTSB;NPC2;GALNS;MVP;PTPRJ;DBNL;RHOA;ATG7;CTSC;RAB37;FABP5;ORMDL3;KCMF1;DPP7;RAB10;PSEN1;GNS;GAA;RAC1;AP2A2;CD63;SLCO4C1;NEU1;RHOF;PSMD2;PSMD12;FGL2;PSMD11;SRP14;GGH;ARHGAP9;DOCK2;TSPAN14;PSMD14;PTPRC;MAPK1;CTSA;DNAJC3;ATP6V1D;ANO6;LAIR1;PSMB1;FCGR3B;LAMTOR3;TIMP2;AGA;IMPDH2;ATP11A;CPNE3;ADGRG3;CYBB;MGAM;HGSNAT;CYB5R3;AMPD3;CDK13;NCSTN;PRKCD;LCN2;TOM1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4347881470134676,1.0570499254640175,0.38903394255874674,0.7627127782393459,1.0,8/25,14.55%,TBX18;NOS1AP;CACNA1C;CAMK2D;ATP2A2;FGF13;AKAP9;TRPM4
prerank,regulation of hydrolase activity (GO:0051336),0.3731527762342509,1.0564150916228223,0.3813364055299539,0.7637992178426338,1.0,21/71,16.35%,VAV2;ARHGAP15;VAV3;PLXNC1;EPHB3;NF1;FGD4;EPHA1;PLXND1;PLXNA3;EFNA5;RABGAP1;RAB3GAP2;PTK2;FGD6;VAV1;FBXW11;RAB3GAP1;TBC1D10B;ARHGAP9;ITGB1BP1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5170979417782638,1.0562145221155579,0.4209726443768997,0.7638163428900149,1.0,2/10,4.42%,STAT1;SHH
prerank,regulation of anoikis (GO:2000209),0.4581826323553392,1.0561296472521309,0.41134751773049644,0.763540586892804,1.0,6/19,14.06%,SNAI2;TLE1;BCL2;PTK2;ITGA5;SRC
prerank,ceramide metabolic process (GO:0006672),-0.2747721746328391,-1.0560055979651568,0.3357142857142857,0.792936579490691,1.0,9/49,7.25%,ST6GALNAC3;ACER2;CERS4;SGMS1;PPP2R1A;SPTLC2;SPTLC1;SGMS2;DEGS2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.46907781460235193,1.055361227211533,0.4005722460658083,0.7649711094334322,1.0,4/17,12.48%,SFRP4;NKX6-1;BTG1;FGF2
prerank,positive regulation of neuron migration (GO:2001224),-0.42908554300492496,-1.0553423543627545,0.4110787172011662,0.7926966860187936,1.0,3/11,5.43%,SEMA6A;RAPGEF2;SHTN1
prerank,early endosome to Golgi transport (GO:0034498),0.5009958972469941,1.055321700826908,0.4169278996865204,0.7645777083286158,1.0,7/11,27.51%,SNX8;LMAN1;SNX2;SNX1;TRAPPC10;RBSN;RAB6A
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.48834900754774796,1.0550816613403187,0.41448382126348227,0.7646983012665698,1.0,4/13,10.83%,TSLP;WNT5A;IL7;TRIM44
prerank,positive regulation of blood coagulation (GO:0030194),0.4663701204876102,1.0542828617546665,0.42141863699582754,0.7661147863970021,1.0,3/17,6.67%,USF1;APOH;HPSE
prerank,heterochromatin assembly (GO:0031507),0.4412462999792151,1.0541588016089596,0.40308988764044945,0.7659311412807575,1.0,7/20,20.05%,POLE3;MBD2;BAHD1;HDAC1;BAZ2A;ZNFX1;HMGA2
prerank,neuropeptide signaling pathway (GO:0007218),-0.27321577147927323,-1.0535450097763441,0.3673469387755102,0.7958229871859183,1.0,9/58,7.68%,SORCS1;GLRA3;SORT1;SORCS3;CPE;RAPGEF2;SORCS2;GLRA1;SORL1
prerank,cellular response to estrogen stimulus (GO:0071391),0.47839339745977205,1.053360982497509,0.4261119081779053,0.7673936314246265,1.0,3/14,10.09%,ARID5A;SFRP1;PELP1
prerank,positive regulation of phagocytosis (GO:0050766),0.3891037368599299,1.0532619508653067,0.41854934601664684,0.7671358583307657,1.0,15/47,21.54%,C3;TREM2;MERTK;CCL2;PTPRJ;CALR;TNF;C4B;DOCK2;PTPRC;ANO6;CD300LF;LYAR;SIRPA;C2
prerank,apoptotic mitochondrial changes (GO:0008637),0.41055024012085234,1.053195450945283,0.4108040201005025,0.7667963914471586,1.0,13/32,22.87%,BBC3;HK2;BCL2;ATG3;AIFM2;CCAR2;GGCT;TIMM50;HSPD1;VPS35;THEM4;CLU;FZD9
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3563105485367,1.0529421814663997,0.4017278617710583,0.7669078811249629,1.0,43/104,26.79%,CDKN2B;CCNE2;CCND3;LRP6;GTF2H1;RPTOR;MAP2K1;CDC37;CCNB2;CDK7;RHOA;CCNI;CALM2;SRC;TRIB3;CDKN1B;PDCD10;TRIB1;CCNT1;AKT1;LRP5;IRGM;SERTAD1;GADD45A;TELO2;HMGA2;CDK12;CCNH;MNAT1;CDC6;ETAA1;CALM3;RALB;CDKN1A;TSG101;CDC25A;CAB39;MAP2K2;THY1;BCCIP;PYCARD;PIH1D1;PPP2CA
prerank,regulation of viral genome replication (GO:0045069),0.3800502713107657,1.052739392175818,0.4004739336492891,0.7668986417054753,1.0,11/56,12.30%,TNIP1;ILF3;TMEM39A;PPID;SHFL;CCL5;EIF2AK2;RAD23A;OASL;STAU1;TNF
prerank,keratan sulfate biosynthetic process (GO:0018146),0.43003688442607857,1.0522450340606775,0.42445054945054944,0.7676052615989326,1.0,9/26,17.68%,LUM;B4GALT5;ST3GAL3;PRELP;ST3GAL1;CHST1;SLC35D2;B4GALT2;B4GALT4
prerank,regulation of G0 to G1 transition (GO:0070316),0.40101783831111076,1.0521670286996894,0.403680981595092,0.7673089079380455,1.0,16/38,26.01%,CDKN2B;E2F1;RNF2;YAF2;EHMT1;PHC3;MAX;RBBP8;MGA;SUZ12;CDC7;CBX5;RAD51;RYBP;TFDP1;RBBP7
prerank,regulation of protein kinase B signaling (GO:0051896),0.3495579945308861,1.0521262970209448,0.38686868686868686,0.7669213601031192,1.0,40/193,14.74%,PDGFRA;IAPP;TCF7L2;GAB2;IRS1;PDGFRB;FGF7;EGFR;RICTOR;PTEN;EGF;STRN;PIK3AP1;HPSE;PIK3R5;ANGPT1;GRB2;TGFBR1;SFRP5;FRS2;OTUD3;DRD3;FGFR1;PTPRJ;PTK2;RCN3;GCNT2;SPRY2;VAV1;TNF;FGF2;NTRK3;MC1R;RASD2;BTC;PIK3R1;SRC;TRIB3;RAC1;CX3CL1
prerank,positive regulation of mitochondrial translation (GO:0070131),0.4774916682828092,1.0519953037852088,0.44072948328267475,0.7667591745192668,1.0,2/14,6.91%,RPUSD3;TRUB2
prerank,phospholipid catabolic process (GO:0009395),-0.3410034791498484,-1.0516762686078418,0.36771300448430494,0.7992207634544837,1.0,7/24,22.77%,GPCPD1;ENPP2;GDE1;GDPD1;ENPP6;SMPDL3A;PLA2G4C
prerank,bile acid biosynthetic process (GO:0006699),0.4316999354756382,1.0513106526877745,0.3958041958041958,0.767989951266432,1.0,3/24,9.82%,CYP7B1;SLC27A2;OSBPL3
prerank,regulation of peptidase activity (GO:0052547),-0.35448292911867485,-1.0511276962126601,0.37809187279151946,0.7988296190475634,1.0,6/19,12.83%,CAV1;CST3;NDUFA13;PSMA3;PINK1;MAPK12
prerank,regulation of stem cell population maintenance (GO:2000036),0.45929746731807314,1.0508163577072847,0.41201716738197425,0.7687386606412232,1.0,2/18,4.42%,PTN;ZC3H13
prerank,ncRNA catabolic process (GO:0034661),0.42302677241485626,1.0507366667395375,0.40463215258855584,0.7684307858897964,1.0,8/28,18.91%,ERN2;POP1;EXOSC4;SND1;XRN1;ZCCHC8;MTREX;PARN
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5098053513024955,1.0506011056759275,0.4117647058823529,0.7682947831359462,1.0,2/10,7.11%,TAF7;NOC2L
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.35896975247055346,-1.050346175360934,0.38489208633093525,0.7990071318908606,1.0,11/20,28.49%,ACTN2;OSR1;GOPC;HECW1;ADRA2A;HECW2;NEDD4L;TCAF2;CASQ2;PLN;PRKCE
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.5012826972851712,1.0502455005532687,0.4246987951807229,0.7686782748242957,1.0,5/11,19.26%,STAT1;WNT5A;CHRD;LRP5;CTNNBIP1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.253536068955442,-1.050067372626968,0.32222222222222224,0.7977612339147655,1.0,28/72,26.50%,ERCC5;COPS5;AQR;ISY1;ERCC6;ERCC3;UBC;COPS7B;EP300;UVSSA;POLD3;USP7;POLR2A;POLR2H;PCNA;POLR2G;POLR2F;PRPF19;GTF2H2;ERCC1;POLR2E;GTF2H4;RFC3;UBA52;GTF2H3;POLD2;RBX1;RPA2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.40434579328694636,1.0497453646996877,0.39950980392156865,0.7693197954261253,1.0,6/35,6.40%,PDE3A;PDE7B;APOE;ADCY2;CD36;AHR
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.45953935767169357,1.0497094547072683,0.42105263157894735,0.768929037395664,1.0,1/18,0.45%,IL23R
prerank,regulation of viral transcription (GO:0046782),0.40435830359117,1.0496712592581325,0.44139650872817954,0.768523168758909,1.0,15/39,23.95%,MDFIC;UBP1;TRIM21;TRIM13;GTF2F2;RSF1;GTF2F1;CCNT1;POLR2L;POLR2K;CDK9;TRIM27;TRIM62;POLR2D;TRIM11
prerank,axonogenesis (GO:0007409),0.34403500557287187,1.0496376989226381,0.3780241935483871,0.7681236662426199,1.0,37/237,11.29%,EPHA7;LAMA2;PALLD;GLI2;CXCL12;LAMA1;SLITRK6;ROBO2;SH3KBP1;B4GALT5;GAB2;SLIT3;SLIT1;EFNA4;AUTS2;PRKCA;NRP1;EPHB3;USP9X;SHH;MAP1S;BAIAP2;PTEN;OPHN1;EPHA1;LLGL1;L1CAM;GRB2;EFNA5;S100A6;CXCR4;WNT5A;FRS2;SEMA3E;PTK2;DSCAM;DRAXIN
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3920915294937745,1.0494284067659696,0.41676942046855736,0.7681449127662874,1.0,12/46,17.37%,TCF7L2;KHDRBS1;UBR5;BAG3;NCBP2;ZIC1;GSK3B;PIK3R1;SMAD3;PSEN1;NEDD4;YWHAE
prerank,ventricular septum development (GO:0003281),0.4097986172953161,1.0490409340622775,0.4211822660098522,0.7685783165746093,1.0,8/37,11.44%,ROBO2;SLIT3;ZFPM2;ACVR1;HEYL;TGFBR1;SALL1;TGFB2
prerank,RNA biosynthetic process (GO:0032774),0.41593043695744086,1.0488301450588728,0.4191461836998706,0.7685849759229317,1.0,9/31,15.17%,TAF7;TTF2;TERT;RSF1;POLA2;SMN1;BRF1;TAF4;SETX
prerank,muscle filament sliding (GO:0030049),-0.2970241225603221,-1.0485614043892106,0.4,0.7980681873363852,1.0,3/38,4.34%,DMD;ACTN2;MYL6
prerank,actin-myosin filament sliding (GO:0033275),-0.2970241225603221,-1.0485614043892106,0.4,0.7980681873363852,1.0,3/38,4.34%,DMD;ACTN2;MYL6
prerank,negative regulation of calcium ion transport (GO:0051926),-0.3856753162911283,-1.048037853837482,0.37942122186495175,0.7975122209993618,1.0,5/15,19.44%,ATP1A2;INPP5K;PACSIN3;ADRA2A;TMBIM6
prerank,DNA methylation (GO:0006306),0.4391425651927504,1.048007932064578,0.43134535367545074,0.7700573988974176,1.0,10/23,22.75%,EHMT1;KMT2E;DNMT3B;GATAD2A;ATRX;BAZ2A;ATF7IP;MTRR;N6AMT1;PPM1D
prerank,sodium ion import across plasma membrane (GO:0098719),-0.37544584836772893,-1.0473776963710784,0.3864406779661017,0.7974590904801082,1.0,5/17,10.98%,SLC12A2;SLC9A2;SLC6A1;SLC9A6;SLC9A7
prerank,positive regulation of cell junction assembly (GO:1901890),-0.2762063146764449,-1.0470998902867685,0.38028169014084506,0.796188774883527,1.0,16/56,14.90%,TEK;CAV1;NRXN1;GRID2;IL1RAPL1;CLDN5;CNTNAP2;KDR;CLSTN3;SYNDIG1;CUX2;LRRC4B;CLSTN1;TSC1;PTPRD;BDNF
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.42618040661441015,-1.046206828002369,0.4084507042253521,0.7966870206792692,1.0,3/10,21.32%,VSIR;TLR4;NCKAP1L
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.42841585971126644,1.0461730409619974,0.4353099730458221,0.7741155601454605,1.0,2/26,2.07%,TNIP1;B4GALT5
prerank,intracellular protein transport (GO:0006886),0.33889617959645557,1.0460280116977472,0.38755020080321284,0.7739697791549139,1.0,70/304,18.47%,LTBP2;CLTC;SEC31A;COPA;AP4M1;COPZ2;STX6;AP3B1;ARCN1;STAT3;TRAK1;KIF13B;BAG3;ARFGAP3;TBC1D16;COPZ1;STX17;RAB21;SNX8;PRICKLE1;FAM53B;STXBP1;LAMP2;TBC1D2B;COPB2;RABGAP1L;RAB7A;AP3D1;TBC1D8B;RABGAP1;CDC37;RAB3GAP2;STXBP3;RAB32;WLS;SEC16A;XPO7;LMAN1;NUP153;ARF4;SEC23IP;SNX9;TNPO1;CALR;E2F3;TMED1;TBC1D1;GIPC1;ADPRH;RAB1A;ARF1;EGR2;TBC1D10B;RPL11;SNX15;STX11;SMURF1;COG7;NUP188;SEC13;AKT1;CTSA;CTTN;STX1B;MAIP1;SCFD2;SCFD1;CLIP3;ARL5A;TMED5
prerank,aminoglycan catabolic process (GO:0006026),0.42122605543462305,1.0457842403693733,0.41644562334217505,0.7740726510471675,1.0,7/28,15.16%,HSPG2;GPC6;HPSE;SDC1;SDC2;GNS;IDS
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.4032040047739899,-1.0455628254249618,0.4012345679012346,0.796531537259502,1.0,3/12,6.19%,PODXL;PTPRO;PROM1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.4392624745640087,1.0454715973051536,0.4180790960451977,0.7743409331447837,1.0,5/21,12.48%,TAOK1;NAV3;TPX2;CAMSAP2;FGF13
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3949392623045678,1.045154634006765,0.41536614645858344,0.7746127530447987,1.0,15/42,21.22%,PPA1;YARS1;CARS2;AIMP1;EEF1E1;IARS2;TARS1;RARS2;RARS1;EARS2;GARS1;LARS2;NARS2;FARS2;NARS1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.3581687230228642,-1.0449038896680525,0.41830065359477125,0.7963858973602558,1.0,4/17,8.61%,FCHSD2;CTNNA2;NCKAP1;WASF1
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.39652134320048504,-1.044701613286054,0.38181818181818183,0.794994546943496,1.0,8/13,35.63%,OGA;EXTL2;CHST3;RENBP;CHST7;NAGK;CHST2;CHST5
prerank,amyloid precursor protein catabolic process (GO:0042987),0.47840618650427763,1.0445841639164606,0.4432515337423313,0.7754770960529704,1.0,7/14,21.31%,ADAM19;ABCG1;PSEN1;PSENEN;NCSTN;DYRK1A;PSEN2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.38097758008357807,-1.0444464180013022,0.3888888888888889,0.7937636636997206,1.0,4/17,4.05%,ATP1A2;CACNB2;ANK2;KCNJ2
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3945517928279786,1.0442174212741329,0.4162621359223301,0.7758407940850626,1.0,11/42,14.74%,FBLN2;JAK2;NF1;LIMS1;RSU1;PTK2;PDPN;GCNT2;RHOA;RAC1;CX3CL1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.2741715904049054,-1.0440820677128808,0.36496350364963503,0.7929446745881837,1.0,10/52,6.01%,KHDRBS2;DDX5;CELF2;MBNL1;HNRNPU;YTHDC1;WTAP;NOVA2;NOVA1;RBFOX3
prerank,positive regulation of JNK cascade (GO:0046330),0.3709863999975867,1.0435826777636057,0.4324022346368715,0.7768587163737339,1.0,19/70,22.30%,SH3RF3;TAOK1;UNC5CL;TAOK3;RASSF2;TIRAP;SH3RF1;EDA2R;PJA2;TRAF2;RIPK1;TRAF5;MAPK8IP1;MFHAS1;GADD45A;DUSP15;WNT16;AXIN1;SDCBP
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.3975919915313763,1.0433882627191686,0.4119897959183674,0.7768246530769701,1.0,5/39,7.08%,ADIPOQ;B4GALNT2;JAG1;NF2;MIA3
prerank,cellular biogenic amine catabolic process (GO:0042402),0.5078642411114763,1.0433565969720509,0.4212121212121212,0.7764169998125846,1.0,4/10,15.46%,DMGDH;ALDH7A1;COMT;SMOX
prerank,platelet degranulation (GO:0002576),0.35379611883657847,1.0432995360725046,0.40760295670538543,0.7760517068695775,1.0,14/118,6.60%,KNG1;SERPING1;SPARC;LHFPL2;TIMP1;PROS1;BLK;CD36;APOH;EGF;BRPF3;TGFB3;STXBP1;LAMP2
prerank,regulation of double-strand break repair (GO:2000779),0.40251629692370205,1.0432748578618731,0.4111111111111111,0.7756180323127136,1.0,10/39,13.88%,UBR5;DDX11;ACTR2;SPIRE1;RNF169;SETD2;PPP4R2;TIMELESS;MGMT;PPP4C
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3866143765039195,1.0432416722808042,0.40892193308550184,0.7752016213669234,1.0,9/44,11.12%,ZFP36L1;ZFP36L2;PUM1;METTL16;GIGYF2;CELF1;TNRC6B;FTO;MOV10
prerank,mesenchymal cell differentiation (GO:0048762),0.38696160976880745,1.0432285565197312,0.4092009685230024,0.7747446098593826,1.0,15/51,15.68%,SNAI1;SNAI2;LIMS1;LRP6;DDX17;HEYL;TGFBR1;WNT5A;LOXL3;FGFR1;TGFB2;GSK3B;DLG5;BMP7;HIF1A
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.47487025923154663,1.0431393800748636,0.4338781575037147,0.7744641275072028,1.0,3/16,10.87%,KLK2;ADM;PLCB3
prerank,heart trabecula morphogenesis (GO:0061384),-0.36641459978439433,-1.0430010444712423,0.3741258741258741,0.7941004847030347,1.0,5/18,8.80%,TEK;TGFBR3;RBP4;S1PR1;ADGRG6
prerank,negative regulation of chemotaxis (GO:0050922),-0.30901099912016905,-1.0428789486126993,0.3842364532019704,0.7925147862383817,1.0,20/31,29.80%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;SEMA4D;SEMA5A;THBS1;SEMA5B;SLIT2;SEMA3G;SEMA6C;SEMA4B;SEMA3B;SEMA4A;CORO1B;SEMA6B;NOTCH1;SEMA4G;SEMA3F
prerank,protein dephosphorylation (GO:0006470),0.35174372561621425,1.0427876712687325,0.43912591050988553,0.7748212707290768,1.0,43/135,20.10%,PDXP;PTPN7;DUSP2;DUSP5;PTPN3;PTPN13;NCK1;PTEN;PTPRZ1;PTPN6;PPP4R1;DAPP1;PTPN18;PTPN1;SSH1;PPP3CA;PPP2R2A;PPP2R5A;PTPRJ;PTPN9;PTPN2;PPP4R2;PTPRM;PPP1CB;FBXW11;DUSP26;ILKAP;UBASH3B;SSH2;CTTNBP2NL;TIMM50;PPP6C;PTPRC;PTPN5;PTPRA;DUSP6;MTMR3;RPAP2;MTMR2;MTMR6;MTM1;CDC14B;DUSP11
prerank,ureteric bud morphogenesis (GO:0060675),0.4684024609615992,1.0427538713769045,0.42653352353780316,0.7744217992137572,1.0,6/16,20.32%,SHH;PKD2;SALL1;FGF2;PAX8;GDNF
prerank,transcription by RNA polymerase II (GO:0006366),0.3420033647294946,1.0427248054118259,0.38368580060422963,0.7739978318071156,1.0,96/305,24.31%,RORA;NR1H4;PAX1;NCOR2;YAP1;DEAF1;SOX5;PRRX1;RARB;RXRG;NFIX;MAML3;TEAD3;CEBPD;TAF7;CSTF1;CREBBP;PPARG;MBD1;TTF2;GTF2H1;NFE2L3;MAML2;SNAPC3;POU2F1;TRIP11;HDAC1;TBL1X;GTF2F2;NR2F1;SETD2;NCBP2;WWTR1;CBFB;ELL2;TEAD1;INTS1;CDK7;E2F3;MAML1;NKX2-8;GLIS3;GTF2F1;IRF9;DRAP1;TAF1A;TAF4;INTS4;SETX;NR6A1;CCNT1;MED26;RBMX;NRBF2;INTS14;MLLT1;ATF4;TAF2;ICE1;POLR2L;POLR2K;RBPJ;HDAC5;NR2C2;CDK9;RPAP2;IWS1;NR3C1;MED1;SNRPB;PMF1;CDK13;ERCC2;INTS8;THRA;CDK12;NR1D1;SNAPC5;NR1D2;RARG;PCF11;NFIC;NCOR1;CCNH;THRB;TCEA1;POLR2D;MNAT1;DDX21;CDC73;PCID2;TAF5;FIP1L1;CPSF3;TAF3;PPARD
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.4785281471106135,1.0426419035289047,0.43859649122807015,0.7737198029083794,1.0,5/14,16.35%,TIMP1;LIMS1;LOXL3;CD63;ITGB1BP1
prerank,skeletal muscle organ development (GO:0060538),0.42261212202169035,1.0425191036006416,0.4198675496688742,0.7735618317889632,1.0,2/26,3.22%,SVIL;CFLAR
prerank,modified amino acid transport (GO:0072337),0.4727576041676232,1.0424924951739671,0.42212518195050946,0.7731283243086075,1.0,3/15,11.38%,MGST1;SLC16A12;PDPN
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.38322286250015286,1.0424593618037126,0.41263940520446096,0.7727241306697374,1.0,18/50,25.83%,CDKN2B;CCNE2;CCND3;GTF2H1;CDC37;CCNB2;CDK7;CCNI;CDKN1B;CCNT1;SERTAD1;GADD45A;CCNH;MNAT1;CDC6;CDKN1A;CDC25A;BCCIP
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.39685548620374067,1.0415588847520774,0.4148418491484185,0.7743152576298121,1.0,12/39,16.42%,MYO1B;TRAK1;MYO5A;MYO1D;MYO1H;MYO7A;FBXW11;KIF5B;RAB1A;MYO1E;NDEL1;CCDC186
prerank,negative regulation of interleukin-8 production (GO:0032717),0.45637491274698505,1.0414506209998136,0.4367816091954023,0.7741119719228996,1.0,2/17,8.96%,BCL3;ANXA1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.40246793816030263,1.0412375114090127,0.4157441574415744,0.7741520775362989,1.0,6/34,6.39%,NRP1;DOCK1;MDK;LIMS1;CARMIL1;CDC42
prerank,regulation of apoptotic process (GO:0042981),0.33492615746535076,1.0410416725058615,0.349,0.7741334594218161,1.0,145/676,18.41%,NR1H4;CYP1B1;ZBP1;KNG1;BCL3;IAPP;MAP4K4;SFRP4;BCL6;STAT1;EGR3;CCAR1;VAV2;GATA6;JAK2;VAV3;BIRC3;FHL2;FSTL1;CFLAR;CASP1;TSLP;EGFR;KALRN;ITSN1;FRZB;FXN;MAD2L1;SHH;E2F1;CTSD;BAG3;IFT57;BABAM2;BCL2;NF1;NUGGC;PPID;FGD4;ANGPTL4;NF2;TXNDC5;STEAP3;TNFRSF12A;CREBBP;ATM;OMA1;SFRP1;TGFB3;PLK1;PTPN6;CXCL10;SIAH2;ASNS;BCL2L2;RASSF2;RRP1B;PHLDA1;AIFM2;EEF1E1;ANGPT1;CCAR2;USP42;GAS1;CBL;ARHGEF19;AREL1;SAP18;TRIO;SH3RF1;ANXA1;WNT5A;HDAC1;FOXO3;IP6K2;IL7;HIPK3;CTSB;RPS6KB1;ARHGEF12;PREX1;TBX3;ARF4;PTK2;YWHAZ;PDPN;CASP8;CALR;SPRY2;ATG7;VAV1;TNF;GSK3B;NLRP2B;AKAP13;ANP32A;ACVR1C;CALHM2;MGMT;TRAF2;SPHK2;PIK3R1;DDRGK1;PSEN1;SRC;ARHGEF18;DAPK2;PDCD10;RTKN;CX3CL1;HSPA5;RABGGTB;NAA15;RIPK1;PSENEN;SETX;PAWR;ITCH;PRKDC;SQSTM1;POU3F3;STK4;RASA1;OLFM1;BAG4;ARHGDIA;AIFM1;HSPD1;PTPA;AKT1;DUSP6;LATS2;DNAJC3;ING5;ANO6;ATF4;ANKLE2;CLIP3;USP36;PAX8;AGT;DDX20;NFKBIA;RHBDD1;DSTYK
prerank,bile acid metabolic process (GO:0008206),0.4172800069877683,1.0406439491316561,0.4156545209176788,0.7745495431957589,1.0,3/27,9.82%,CYP7B1;SLC27A2;OSBPL3
prerank,negative regulation of histone acetylation (GO:0035067),0.4948647462484854,1.0404909768636825,0.42,0.7744319713867087,1.0,4/11,19.16%,TAF7;NOC2L;SPI1;THAP7
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.48710754978592063,1.0404033313258498,0.4255639097744361,0.7741751386587956,1.0,6/12,25.91%,MDK;MIA3;AKT1;FUT4;ASS1;PPARA
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.4250883832692183,1.040241040309495,0.42416107382550333,0.7741101123566766,1.0,7/26,17.55%,MEIS2;PRKCA;ASNS;RPS6KB1;EIF4EBP1;USP22;MDM2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.5056564746710952,1.0400619804024225,0.4376899696048632,0.7735812866327464,1.0,2/11,4.97%,INPP1;PTEN
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5056564746710952,1.0400619804024225,0.4376899696048632,0.7735812866327464,1.0,2/11,4.97%,INPP1;PTEN
prerank,regulation of neuron projection development (GO:0010975),0.3421263114561782,1.0389441957984262,0.411522633744856,0.775859829050821,1.0,33/163,15.66%,ROR2;ROR1;PTN;MYLIP;LRRK2;DPYSL3;MARK1;TENM3;EPHB3;APOE;MDK;KIF13B;PTEN;FZD1;ABI2;WNT5A;DBN1;DISC1;GAK;PTPN9;DENND5A;FBXO7;CAMSAP2;GSK3B;NTRK3;RTN4RL1;PSEN1;ARHGAP35;PTK7;CX3CL1;FES;SETX;NDEL1
prerank,extracellular transport (GO:0006858),0.4764770930680443,1.0388932858818303,0.4331306990881459,0.7755153341664794,1.0,2/13,6.77%,DNAAF4;SPEF2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.44587728270244675,1.038778691248505,0.43232044198895025,0.7753063500618009,1.0,8/21,20.28%,STK36;SHH;SFRP1;RAB34;DLG5;SMO;GLI1;KIF7
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.44361606936978015,1.03825060435032,0.43319268635724334,0.7750797501766203,1.0,4/20,6.21%,KLHL22;MAD2L1;ATM;PLK1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.44361606936978015,1.03825060435032,0.43319268635724334,0.7750797501766203,1.0,4/20,6.21%,KLHL22;MAD2L1;ATM;PLK1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.44361606936978015,1.03825060435032,0.43319268635724334,0.7750797501766203,1.0,4/20,6.21%,KLHL22;MAD2L1;ATM;PLK1
prerank,endothelial cell proliferation (GO:0001935),-0.3694075388093762,-1.0382313856690701,0.3957597173144876,0.8035939908209488,1.0,3/17,3.63%,TEK;BMP4;CD34
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.29665375739724215,-1.0376108291594783,0.39195979899497485,0.8035187740476177,1.0,8/36,5.32%,CAV1;NPR3;NOS3;CALM1;HSP90AA1;PIK3CB;ATP2B4;SCARB1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.40393830876742515,1.0374971094252634,0.42375,0.7763512520360837,1.0,6/33,7.94%,YAP1;TCF7L2;TNFAIP3;MDK;ICAM1;ANGPT1
prerank,axonal transport (GO:0098930),0.3980446658989749,1.037469284375348,0.43719806763285024,0.7759413487533354,1.0,7/36,12.26%,AP3B1;DYNC1H1;AP3S1;DTNBP1;RAB21;AP3D1;FBXW11
prerank,sulfation (GO:0051923),-0.41085096994421594,-1.0374212615911726,0.41348973607038125,0.8021447863429063,1.0,2/11,6.17%,UST;SULT1A1
prerank,positive regulation of developmental process (GO:0051094),0.3456456674291156,1.0374144887776873,0.41649484536082476,0.7755843952513417,1.0,34/164,15.02%,DCN;EDN3;SYDE1;SOX5;PTN;B4GALT5;APOE;MDK;SHH;SMURF2;BMP1;ACVR1;RALA;DLG4;TMEM119;SHLD3;SPIRE1;WNT5A;BMP5;ACVR1B;FGFR1;ZBED3;TNF;TAPT1;RIF1;PSEN1;DLG5;BMP7;SRC;FMR1;PHLDB2;TRPM4;ZDHHC6;PAXIP1
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.30879318629006397,-1.0371745082340313,0.34951456310679613,0.8009707465845474,1.0,7/34,12.33%,PDE4B;ATP1B1;ANK2;CALM1;ADRA1A;PDE4D;KCNQ1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.4556334340014623,1.0370758194009797,0.43714285714285717,0.7759471005839815,1.0,4/18,12.30%,NCOR2;PTBP3;TERT;TNF
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.2944925078293552,-1.0368834413503358,0.38095238095238093,0.7998821238341898,1.0,8/38,5.08%,CAV1;CD47;KLF2;HSP90AA1;INSR;CD34;KLF4;ATP2B4
prerank,neural tube development (GO:0021915),0.46512382001524644,1.036781054013998,0.4470588235294118,0.7761604283545496,1.0,3/15,13.84%,ALDH1A2;PKD2;DACT1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.4144903375561486,1.0366884419886546,0.42857142857142855,0.7758790502521561,1.0,6/34,13.14%,LACC1;XCL1;SASH3;WNT5A;TNFRSF4;SPHK2
prerank,substrate-dependent cell migration (GO:0006929),0.47349786178257275,1.0364635170459833,0.4411764705882353,0.7759251332688726,1.0,9/14,24.13%,NRP1;OPHN1;ITGA11;VEGFC;ITGB1BP1;PTPRC;P2RY12;SDCBP;ITGA2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.36088687207137976,1.036356301067486,0.42572062084257206,0.7757066064120389,1.0,10/84,7.60%,IGF2BP1;IGF2BP2;SYNCRIP;APOE;ILF3;IGFBP5;EIF2AK2;CAPRIN1;GIGYF2;SAMD4A
prerank,positive regulation of translation (GO:0045727),0.35813056216752465,1.0363510402683085,0.4280973451327434,0.7752422145897219,1.0,14/94,14.28%,PRR16;BCL3;RPUSD3;PLD1;KHDRBS1;CCL5;TRUB2;SAMD4A;NIBAN1;RPS6KB1;NAT10;YBX3;YTHDF3;FMR1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4299091362464208,1.0353559510434531,0.40829986613119146,0.7771646165857675,1.0,1/24,0.40%,CEMIP
prerank,heme biosynthetic process (GO:0006783),-0.3458577753914885,-1.0353406104742102,0.40714285714285714,0.8022767291470962,1.0,7/22,14.86%,ABCG2;CPOX;FLVCR1;SLC25A38;UROS;COX10;ABCB10
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.4810973339268352,1.035179132496594,0.4398216939078752,0.7770941091759905,1.0,5/14,16.31%,PINX1;TERT;ATR;ATRX;TNKS2
prerank,regulation of cellular catabolic process (GO:0031329),0.37193251967970475,1.0349179680865275,0.42709529276693453,0.7772228715763009,1.0,15/62,17.45%,LRRK2;DRAM1;RMC1;ITPR1;PIP4K2A;ATM;RPTOR;RRAGC;TPCN2;DCAF12;SMCR8;TRIB3;DAPK2;GPR137;MTMR3
prerank,cellular response to drug (GO:0035690),-0.3299020538062704,-1.0347533371719446,0.3865546218487395,0.8020156893560477,1.0,5/25,4.06%,PDE4B;PPM1E;GAS6;ACER2;TFRC
prerank,glucose homeostasis (GO:0042593),0.3586690808464079,1.0346890048235198,0.4293537787513691,0.7772566549648616,1.0,9/83,5.97%,ADIPOQ;TCF7L2;IRS1;USF1;STAT3;HK2;PYGL;FOXK2;PPARG
prerank,positive regulation of intracellular protein transport (GO:0090316),0.34652621052657884,1.0345656562266714,0.41631799163179917,0.7770851829877237,1.0,35/144,18.91%,CEMIP;SEC16B;TCF7L2;TM9SF4;BBC3;E2F1;UBR5;BAG3;BCL2;PCM1;NPEPPS;FBXW7;TOMM7;CSNK2A2;UBE2L3;PCNT;ZIC1;SEC16A;YWHAZ;CASP8;GSK3B;MICALL2;PIK3R1;SMAD3;PSEN1;PDCD10;ITGB1BP1;SH3GLB1;YWHAE;LEPROT;ICE1;USP36;BCAS3;ARIH2;PRNP
prerank,nucleotide catabolic process (GO:0009166),-0.3675173599478123,-1.0345040127869318,0.3950617283950617,0.8008618382206014,1.0,6/16,18.00%,NT5E;NUDT3;SAMHD1;ITPA;DERA;NT5C
prerank,regulation of chromosome segregation (GO:0051983),0.46272785494477064,1.0344947995213951,0.43833580980683506,0.7767608898004343,1.0,3/16,9.20%,PUM1;CSNK2A1;CSNK2A2
prerank,regulation of cellular response to heat (GO:1900034),0.36379960624628405,1.0344391353668099,0.4276094276094276,0.7764144301517951,1.0,22/77,17.37%,DNAJB1;NUP37;CAMK2D;BAG3;RAE1;CREBBP;ATM;RPTOR;CCAR2;ATR;NUP153;DNAJB6;DNAJC7;GSK3B;HSPH1;NDC1;NUP35;NUP188;BAG4;SEC13;MAPK1;YWHAE
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.4670070512415281,1.0337925249614301,0.44984802431610943,0.777461531944029,1.0,1/15,0.28%,C3
prerank,positive regulation by host of viral transcription (GO:0043923),-0.37164368277586785,-1.033791435588946,0.39759036144578314,0.8009239056623519,1.0,5/15,11.77%,LEF1;JUN;CHD1;EP300;SP1
prerank,cellular response to heat (GO:0034605),-0.3034289800152337,-1.0335846710423335,0.3684210526315789,0.7995895451464589,1.0,19/35,35.20%,HSP90AA1;FGF1;ATXN3;THBS1;TRPV4;HIKESHI;ANO1;DHX36;HTRA2;TCIM;HSP90AB1;IER5;HSPA1A;HSF1;HSBP1;HSPA1B;HMOX1;TPR;MAPT
prerank,peptidyl-serine phosphorylation (GO:0018105),0.33986733082855775,1.0335441150412936,0.4211618257261411,0.7776014898853884,1.0,49/153,23.25%,NEK6;MAST4;LRRK2;PRKCA;MARK1;RICTOR;IKBKE;AKT3;CAMK2D;PRKD2;MORC3;ATM;PLK1;HIPK4;MAST2;ATR;TGFBR1;CSNK2A1;CSNK2A2;HIPK3;RPS6KB1;CSNK1G2;GSK3B;CSNK1A1;MKNK1;VRK3;RIPK1;PRKDC;STK4;CSNK1D;MAPK1;AKT1;LATS2;EIF2AK3;DCLK3;MAP3K12;PLK2;PRKCD;DYRK1A;VRK2;PKN1;RPS6KA4;MARK2;CDC7;LATS1;ROCK2;ROCK1;RPS6KA3;NLK
prerank,ribosomal small subunit assembly (GO:0000028),0.4557859745958642,1.0332657261547304,0.4493865030674847,0.7778107226342544,1.0,1/16,0.80%,RPSA
prerank,protein localization to nucleus (GO:0034504),0.35369224593848236,1.0326811700066034,0.4284188034188034,0.7787331201476205,1.0,26/102,19.57%,COL1A1;BCL3;STAT3;MORC3;PLK1;PRICKLE1;FAM53B;PINX1;SKP1;NUP153;TNPO1;CALR;E2F3;BMP7;RPL11;BANP;TOR1AIP2;NUP188;SEC13;AKT1;YWHAE;MDM2;TOR1AIP1;ZBTB7A;HEATR3;NUP214
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.367865486531178,1.0326529063750347,0.4348314606741573,0.7783209015994392,1.0,16/67,14.81%,PDGFRA;TEC;GHR;PDGFRB;JAK2;EGFR;BLK;DDR2;PTPN6;EPHA1;ABI2;FGFR1;PTK2;ABI1;SRC;FES
prerank,positive regulation of response to stimulus (GO:0048584),0.3928793111772624,1.0318186337430955,0.43118148599269185,0.7798507409927237,1.0,12/40,22.52%,ADIPOQ;EEF1E1;WNT5A;SELENON;TGFB2;YPEL3;FMR1;CGAS;HMGA2;PRKCD;CDKN2AIP;CD80
prerank,positive regulation of vacuole organization (GO:0044090),0.49827648326443663,1.0315258496073567,0.41264559068219636,0.7800655766767172,1.0,7/10,26.81%,PIP4K2A;RAB3GAP2;RAB3GAP1;SH3GLB1;RALB;ANXA2;PIP4K2B
prerank,positive regulation of heart contraction (GO:0045823),0.44263943651537707,1.0311872228051,0.45314685314685316,0.7803699672393215,1.0,5/19,14.55%,EDN3;ADM;ATP2A2;TGFB2;TRPM4
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.5022578452154141,1.0311036907145732,0.4491392801251956,0.7800705825344447,1.0,4/10,19.43%,DNMT3B;RIF1;ATRX;KDM1A
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.5083807088247357,1.0310132291773388,0.4481658692185008,0.7798189089143113,1.0,6/10,27.69%,LRP6;BMP5;BMP7;PHACTR4;ARHGAP12;DLL4
prerank,cellular protein localization (GO:0034613),0.3338474414959729,1.0309705151050423,0.40562248995983935,0.7794380433582464,1.0,68/285,18.78%,CLTC;SH3PXD2B;SEC31A;LRRK2;WIPI1;COPA;FGF7;AP4M1;COPZ2;STX6;AP3B1;EGFR;ARCN1;TM9SF4;ITSN1;ARFGAP3;TBC1D16;COPZ1;ARMCX3;STX17;RAP2A;RAB21;SNX8;STXBP1;TBC1D2B;COPB2;RABGAP1L;MYO7A;ANGPT1;AP3D1;TBC1D8B;RRAGC;RABGAP1;WNT5A;RAB3GAP2;STXBP3;RAB32;WLS;ARF4;SEC23IP;SNX9;PACS2;TMED1;TBC1D1;ADPRH;RAB1A;ARF1;TBC1D10B;NIPBL;CD63;SNX15;STX11;SMURF1;RTP4;WDR45;COG7;TM9SF2;SEC13;CTSA;CTTN;STX1B;SCFD2;SCFD1;LAMTOR3;ARL5A;TMED5;EPB41L3;AXIN2
prerank,regulation of pseudopodium assembly (GO:0031272),0.4913267599759027,1.0308826331995822,0.43344155844155846,0.7786745947978926,1.0,4/10,18.41%,CDC42;WASHC1;CDC42EP1;CDC42EP4
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.4913267599759027,1.0308826331995822,0.43344155844155846,0.7786745947978926,1.0,4/10,18.41%,CDC42;WASHC1;CDC42EP1;CDC42EP4
prerank,monocyte differentiation (GO:0030224),-0.427142974743821,-1.0301620094387147,0.45408163265306123,0.8072811771800684,1.0,3/10,2.29%,PIR;BMP4;IL31RA
prerank,organelle assembly (GO:0070925),0.33408938221083206,1.0300755445729721,0.41164658634538154,0.7800656431525256,1.0,82/385,17.08%,TEKT4;NEK6;SH3PXD2B;VMP1;DYNLL1;FARP2;GORASP2;WIPI1;CEP19;SYNPO;ATXN2;ASAP1;STK36;CHMP4A;CHMP4B;DYNC1H1;PARVA;AMBRA1;INO80;IFT88;PCM1;VPS4A;HAUS3;ATG3;RAB8B;RAB7A;TMOD1;CEP41;EXOC4;EHD2;ACTR2;GBF1;GOLGA8B;FAM161A;EXOC1;EXOC7;WDPCP;ATP2A2;PCNT;RAB32;WDR35;DISC1;VPS37C;MAPRE2;PTPN23;ARF4;GALNT11;NPHP3;IFT172;IFT81;DBNL;ATG7;PDE6D;UBAP2L;SNX10;CFAP410;PACS2;CPLANE1;CHMP7;RAB1A;DYNC2H1;ATG16L1;DZIP1L;YTHDF3;KIF27;CDC14A;ATG16L2;TUBGCP4;PATL1;CHMP2B;TTC39C;EXOC5;WDR45;EXOC3;NUDCD3;POC1B;RCC1;PIK3C3;WDR90;DHX29;CSNK1D;PRRC2C
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4886083922657481,1.0300298451103693,0.4437596302003082,0.7797023232423984,1.0,4/11,26.69%,NRP1;RAC1;PAK1;BCAR1
prerank,regulation of glucose import (GO:0046324),0.4071046001095209,1.0299204932988812,0.44372574385511,0.7794666882052163,1.0,3/30,2.62%,ENPP1;ADIPOQ;IRS1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.4655506031994846,1.029701689084054,0.4455732946298984,0.7794763663469279,1.0,4/16,8.44%,SMC1A;NAA50;PDS5B;PDS5A
prerank,regulation of stress fiber assembly (GO:0051492),0.36221878606213437,1.029676909663136,0.4540420819490587,0.7790638505016038,1.0,19/74,14.73%,DLC1;SLC9A1;NRP1;ASAP3;CARMIL1;NF2;ALMS1;SFRP1;TGFB3;CDC42;EPHA1;CGNL1;TGFBR1;RHOA;ARHGAP6;PIK3R1;ARHGEF18;PHLDB2;RAC1
prerank,regulation of intracellular pH (GO:0051453),-0.30006986839380595,-1.0288839089210962,0.4009009009009009,0.8089028507802286,1.0,11/34,10.98%,SLC4A10;SLC9A2;TMEM165;GPR89B;GPR89A;CA2;SLC4A8;CLN3;SLC9A6;SLC4A3;SLC9A7
prerank,regulation of lipid metabolic process (GO:0019216),0.3552825403619353,1.0288563170666647,0.4366812227074236,0.7804448661284118,1.0,11/88,10.57%,RORA;NCOR2;MVK;CREBBP;PPARG;LACTB;CARM1;TBL1X;PANK2;NPC2;CHD9
prerank,monoacylglycerol metabolic process (GO:0046462),-0.39813072752334233,-1.0287649216351533,0.41055718475073316,0.8073872861024718,1.0,3/13,12.06%,MGLL;ABHD6;DGAT1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.44150312965094535,1.0284726259185686,0.4363143631436314,0.7808452632170411,1.0,8/20,18.80%,STOML2;PMPCB;MICU2;SPG7;PMPCA;MCUR1;MAIP1;MICU3
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.4666721574633803,1.0284271323996252,0.4264705882352941,0.7804747473473751,1.0,5/15,14.32%,RICTOR;CELF1;FGFR1;TGFB2;USP22
prerank,primary miRNA processing (GO:0031053),0.49782837023773224,1.028083596925213,0.4276629570747218,0.7808369163052252,1.0,3/10,15.19%,SMAD2;SMAD3;SMAD1
prerank,positive regulation of protein kinase activity (GO:0045860),0.3437838102482139,1.0278321457439825,0.44111570247933884,0.7809520375905831,1.0,45/148,22.25%,IL34;IL23R;MAP4K4;TAOK1;JTB;LCP2;DDR2;CACUL1;CCL5;TOM1L1;DLG4;TAOK3;PTPN1;RASSF2;RPTOR;BORA;MAP2K1;TPX2;PTK2;SNX9;NRK;TGFB2;RHOA;TNF;NAB2;CALM2;SRC;PDCD10;IL6R;FCGR1A;ALS2;STK4;PTPRC;AGT;PRNP;IRGM;TELO2;HMGA2;PRKCD;MMD2;AXIN1;PAK1;MARK2;CLU;CSF1
prerank,regulation of defense response to virus (GO:0050688),0.47556613255340713,1.0278275788544755,0.4376899696048632,0.7804894754254514,1.0,2/14,5.26%,TNFAIP3;ILRUN
prerank,negative regulation of response to wounding (GO:1903035),-0.34231145671684937,-1.0274599723541349,0.4119718309859155,0.8090011702697883,1.0,6/19,12.15%,EPHA4;INPP5F;CRK;AJAP1;GIT1;CD109
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.49350917790994375,1.027159598891334,0.44992050874403816,0.7815967021532417,1.0,6/11,17.60%,GHR;IRS1;GIGYF2;PIK3R1;AKT1;EIF2AK3
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.2901497356861487,-1.027069984580735,0.41089108910891087,0.8082181244268174,1.0,6/35,2.94%,SEMA6A;SEMA3C;SEMA3D;PLXNA4;SEMA6D;SEMA7A
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.4193172614216393,-1.0270553584402524,0.43515850144092216,0.8063667008059521,1.0,3/10,7.06%,ATP1A2;OSR1;HECW1
prerank,neural crest cell development (GO:0014032),-0.2823866259872389,-1.0270133506186196,0.3772455089820359,0.804618706211144,1.0,20/44,26.72%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;ERBB4;TBX1;SEMA4D;SEMA5A;SEMA5B;CDH2;SEMA3G;RADIL;SEMA6C;SEMA4B;SOX8;SEMA3B;SEMA4A;KBTBD8;SEMA6B
prerank,response to ATP (GO:0033198),0.44861640274633396,1.0262856701422876,0.43564356435643564,0.7831665356134014,1.0,5/18,21.69%,PDXP;SSH1;P2RX7;HSP90B1;P2RY12
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4363046602131564,1.0262752444834462,0.4604519774011299,0.7827250543007591,1.0,3/19,11.12%,DNAAF4;SPEF2;NPHP3
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.37404956528247224,-1.026218713981399,0.436950146627566,0.8049397472196952,1.0,5/15,14.46%,CPEB3;PABPC1;TOB1;TNRC6C;POLR2G
prerank,membrane depolarization (GO:0051899),-0.30578268044722634,-1.0259268212707886,0.4117647058823529,0.8038319622564017,1.0,8/32,10.06%,CACNB4;CAV1;SCN2A;CACNG2;SCN8A;CACNA1E;CACNA1B;SCN9A
prerank,actin filament-based transport (GO:0099515),0.4396151634711663,1.0259039354559567,0.4465753424657534,0.7831400120691605,1.0,5/21,7.53%,MYO1B;MYO5A;MYO1D;MYO1H;MYO7A
prerank,regulation of metal ion transport (GO:0010959),0.4621969125792411,1.025728979702748,0.432510885341074,0.7830796631815393,1.0,3/16,4.98%,IL16;CACNA2D1;BCL2
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3229776872537766,-1.025078474454877,0.38823529411764707,0.8042925304747596,1.0,5/25,14.26%,RB1;IGF1;SIN3A;PER2;HEY2
prerank,protein O-linked mannosylation (GO:0035269),-0.3484478163707779,-1.0250406845921074,0.42517006802721086,0.8025588725129936,1.0,1/18,0.12%,TMTC1
prerank,focal adhesion assembly (GO:0048041),0.4260472630062247,1.024654109582631,0.43356643356643354,0.7851574961850771,1.0,3/21,5.21%,DLC1;PEAK1;RHOD
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.38607965993224064,1.024589135153969,0.47002398081534774,0.7848407424890158,1.0,10/43,12.95%,ENPP1;IRS1;NCK1;PIP4K2A;PTPN1;PID1;OGT;RPS6KB1;PTPN2;SNX5
prerank,regulation of protein localization to centrosome (GO:1904779),-0.4179194066009432,-1.0240542716841594,0.42485549132947975,0.8033698413641991,1.0,2/10,4.50%,BICD1;APC
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.392338800237993,-1.0240450055267765,0.40869565217391307,0.8015568563956912,1.0,4/13,10.21%,NOS3;CALM1;HSP90AA1;PTS
prerank,glycerophospholipid metabolic process (GO:0006650),0.3589541546060005,1.023628756218295,0.45051194539249145,0.7866629784439905,1.0,19/75,19.58%,PLA1A;PDXP;PDGFRB;PIGW;CPNE7;PIGN;DGKH;PLA2G7;PIGL;PIGC;PLCB3;PLA2G4A;PIGP;PLA2G4E;PIGH;PLEK;PIP5K1A;CPNE3;GDPD3
prerank,mesenchymal cell development (GO:0014031),0.4400843120402605,1.0235121370760076,0.44329896907216493,0.7864685699693409,1.0,4/18,14.87%,SNAI2;HEYL;TAPT1;NOLC1
prerank,B cell mediated immunity (GO:0019724),-0.4304828712417855,-1.023323283024531,0.4255874673629243,0.8016385703157577,1.0,6/10,49.20%,MSH2;FCER1G;CD27;TLR8;CARD9;SLA2
prerank,regulation of neuron death (GO:1901214),-0.24269324222476452,-1.0233222933728319,0.3902439024390244,0.799827147344681,1.0,26/82,22.18%,DCC;GRID2;PRKN;MAP3K5;CD34;RILPL1;PPARGC1A;BTBD10;CD200;SORL1;GRIN2B;TRIM2;DDIT4;TSC1;DHCR24;EGLN2;EPHB1;EGLN3;INPP5A;AKT1S1;NAE1;HTRA2;CHGA;SARM1;MEF2C;IKBKG
prerank,regulation of lipid biosynthetic process (GO:0046890),0.40283147652783796,1.0232090069743611,0.4332909783989835,0.7867348802650751,1.0,3/32,3.78%,C3;ADIPOQ;APOE
prerank,positive regulation of peptidase activity (GO:0010952),-0.3476928587694694,-1.0230942476259592,0.4141791044776119,0.798689326304364,1.0,7/20,13.22%,APH1A;NDUFA13;VSIR;APH1B;PINK1;MAPK12;GRN
prerank,positive regulation of locomotion (GO:0040017),0.417550473966851,1.0229792452120174,0.45751633986928103,0.7867891746895576,1.0,3/27,4.99%,PDGFRB;TREM2;AIF1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.42270155121723796,1.0224834363308968,0.4470108695652174,0.7875149043684073,1.0,7/26,13.03%,SLC9A1;FHL2;EFHB;STIMATE;TNF;GSK3B;SPPL3
prerank,RNA catabolic process (GO:0006401),0.38669663902276263,1.0224467118223435,0.44660194174757284,0.7871224928862045,1.0,12/46,17.10%,ZFP36L2;DNA2;METTL16;PABPC4;DCP2;RNASEH1;RNH1;SND1;RNASEH2A;DXO;SIDT2;MTREX
prerank,neuron fate commitment (GO:0048663),0.46400470816913725,1.0223352512051989,0.4622356495468278,0.7869173667462726,1.0,2/14,9.03%,SHH;TGFBR1
prerank,negative regulation of nuclear division (GO:0051784),-0.41043506757982195,-1.0219662045559637,0.40896358543417366,0.8000078156694636,1.0,2/11,1.76%,TOM1L2;BMP4
prerank,synaptic vesicle transport (GO:0048489),-0.41792921499100577,-1.0218338797092428,0.4375,0.7985025027588035,1.0,5/11,16.82%,RAB27A;SNAPIN;TOR1A;SYNJ1;DNM2
prerank,sensory perception of pain (GO:0019233),0.4415271400073759,1.0217810938063383,0.4520743919885551,0.7877635300600715,1.0,3/21,12.90%,PTGES;CCL2;P2RX7
prerank,acylglycerol metabolic process (GO:0006639),-0.2886126423842729,-1.021208322137595,0.45,0.7984453894033727,1.0,8/37,12.43%,DGKB;CAV1;MGLL;DGKI;ABHD6;DGKA;DGAT1;DGKG
prerank,monocarboxylic acid transport (GO:0015718),0.37643254112560093,1.0211522150474872,0.45734597156398105,0.7887322574862455,1.0,5/51,6.46%,NR1H4;ATP8B1;SLC10A6;CD36;SLC16A12
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.4577251138843146,1.0209476936904431,0.4375,0.7887393053277412,1.0,2/14,8.35%,ADIPOQ;PRKAR1B
prerank,spliceosomal complex assembly (GO:0000245),-0.27512611803929654,-1.0207290917394949,0.4140127388535032,0.7979803088329126,1.0,15/46,25.10%,CELF2;YTHDC1;PRPF6;SRSF5;RBM5;GCFC2;SNRPG;SRSF9;PRPF19;LUC7L3;DDX39B;CELF6;TXNL4A;SF3A1;SF3A3
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.4819678194748942,1.0206484855428761,0.4714064914992272,0.7889614309873925,1.0,2/13,4.42%,GLI2;SHH
prerank,anterograde axonal transport (GO:0008089),0.39295835441539295,1.0206144680631992,0.44472049689440996,0.7885652878075968,1.0,8/37,9.93%,AP3B1;KIF1C;TRAK1;AP3S1;DTNBP1;RAB21;AP3D1;RAB27B
prerank,nucleotide biosynthetic process (GO:0009165),-0.3585583641665646,-1.0203035089636727,0.4270833333333333,0.7973146985059549,1.0,4/18,9.41%,PRPSAP2;ME1;NMNAT3;PRPSAP1
prerank,endochondral bone morphogenesis (GO:0060350),0.48777647084540565,1.0199819860256816,0.4420731707317073,0.789545256986207,1.0,2/11,7.02%,COL13A1;TMEM119
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.38182322967333876,-1.0199476167824493,0.4231974921630094,0.7964957516139958,1.0,6/13,22.43%,HNRNPU;NELFB;LARP7;NELFA;SUPT4H1;NELFE
prerank,regulation of biomineral tissue development (GO:0070167),0.41390122812855523,1.0197152170827366,0.4418604651162791,0.7896884301024515,1.0,3/26,5.42%,ENPP1;DDR2;CYP27B1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.4309198543080941,1.0189678743843218,0.4594972067039106,0.7909481851928459,1.0,4/22,15.23%,APOD;PPP2R5A;TNF;CCDC3
prerank,cAMP-mediated signaling (GO:0019933),0.42003423459944017,1.0189293056299005,0.44591029023746703,0.7905621587468248,1.0,4/24,6.40%,PDE3A;PDE7B;ADCY2;AHR
prerank,metanephros development (GO:0001656),0.41787700776535647,1.0186980725113903,0.45194805194805193,0.7906058349610295,1.0,4/26,5.10%,ROBO2;SHH;PKD2;NF1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.3790362888678978,1.0186955326167544,0.47455621301775147,0.7901407602600056,1.0,15/48,17.75%,RHOJ;CD40;PRKCA;AKT3;PRKD2;STAT5A;ANGPT1;ANXA1;FGFR1;FGF2;HIF1A;FGF18;AKT1;MAP3K3;ETS1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.3952355309146083,-1.0184382664421412,0.40406976744186046,0.7987684589067181,1.0,4/13,10.43%,CAV1;CALM1;ANK3;PDE4D
prerank,glycosaminoglycan metabolic process (GO:0030203),0.37205578741430617,1.018033170718173,0.4439306358381503,0.79125068564307,1.0,15/54,15.52%,HSPG2;GPC6;EXT1;EXT2;HPSE;SDC1;HS2ST1;SDC2;GCNT2;CLN6;UGDH;GNS;SLC35D2;IDS;B4GALT7
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.41434544379439386,-1.0178219715878627,0.44329896907216493,0.7987840086878595,1.0,6/10,19.93%,SHANK3;APP;CAMK2B;SYP;SYNGR1;DRD2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.3462381995637061,1.0176693950162388,0.4652631578947368,0.7916257148424831,1.0,32/113,22.34%,MMP3;ABCA1;ASAP1;FSCN1;CD36;ATM;GTF2H1;TIRAP;LCP1;ATR;BRK1;FNIP1;TNF;GSK3B;SRC;PLEK;SH3GLB1;DDB1;TPPP;ICE1;SLF2;PIEZO1;CAPG;PSMC6;ERCC2;EIF4G1;ISG15;TERF1;RHOC;RAP1B;CLU;RPA1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.46018426475026164,1.0176388634474713,0.4549689440993789,0.7907505917002239,1.0,3/15,8.36%,ZFP36L1;ZFP36L2;TNRC6B
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.46018426475026164,1.0176388634474713,0.4549689440993789,0.7907505917002239,1.0,3/15,8.36%,ZFP36L1;ZFP36L2;TNRC6B
prerank,retina homeostasis (GO:0001895),-0.3232036442928581,-1.0176336412146318,0.39919354838709675,0.7974828143567806,1.0,6/23,16.36%,ACTB;POTEF;HSPB1;WHRN;SOD1;BBS4
prerank,axon development (GO:0061564),-0.24598674019418865,-1.0174902865751396,0.43820224719101125,0.7960737660154379,1.0,24/78,17.87%,DCC;GRM7;CTNNA2;NTNG1;CNTN4;ACTB;KLF7;SHTN1;DSCAML1;FGFR2;SLITRK1;PARD3;ANK3;MAP1A;APP;ZDHHC17;S100B;PAK3;SEMA5A;PLP1;PLPPR4;DHFR;APBB1;TAOK2
prerank,positive regulation of receptor internalization (GO:0002092),0.42902716485676684,1.0172903835802178,0.4472295514511873,0.791082175000161,1.0,5/22,14.82%,SFRP4;EGF;ANGPT1;FMR1;CD63
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.33255066410233713,1.0171298643446518,0.46238716148445336,0.7909962139725359,1.0,79/348,18.24%,RBMS3;ITGB8;SEC16B;ADAM19;YAP1;SFRP4;NOS1AP;CRP;TLR2;FGF7;MITF;TLE1;TREM2;STAT3;E2F1;UBR5;EPHX2;LGALS9;LIMS1;CD36;EGF;DTNBP1;ATM;VSTM2A;EMILIN1;TMEM119;PTPN1;PID1;FUBP1;ANGPT1;MAPK11;MSN;CELF1;TNRC6B;TGFBR1;MAP2K1;WNT5A;SETDB1;MOV10;NFE2L2;DNMT3B;SPRY2;SETDB2;TNF;GSK3B;FGF2;NTRK3;P2RX7;DDRGK1;CTCF;SMAD3;PSEN1;BMP7;FMR1;PPHLN1;RPL11;PDCD10;RESF1;DTX3L;CD63;SMAD1;SMO;ITCH;HIF1A;FGF18;MED26;PRKAB1;POU3F3;ATF7IP;LAMTOR5;OLFM1;MAPK1;AKT1;CALCOCO1;EIF2AK3;ATF4;ETS1;INHBA;RBPJ
prerank,positive regulation of cytokinesis (GO:0032467),0.4013370704061532,1.0169709667271687,0.4408866995073892,0.7908958118494293,1.0,8/32,14.53%,SVIL;CDC42;DRD3;OPN1MW;CSPP1;RHOA;GIPC1;CDC14A
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.316053669865397,-1.0168942244346788,0.4413145539906103,0.7959096620248757,1.0,4/27,1.87%,PDE4B;CAV1;CTNNA3;ANK2
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5005284350326717,1.016312267890696,0.46730462519936206,0.7910042226143033,1.0,2/10,5.88%,DNA2;XRCC3
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5005284350326717,1.016312267890696,0.46730462519936206,0.7910042226143033,1.0,2/10,5.88%,DNA2;XRCC3
prerank,t-circle formation (GO:0090656),0.5005284350326717,1.016312267890696,0.46730462519936206,0.7910042226143033,1.0,2/10,5.88%,DNA2;XRCC3
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4209345961458569,-1.016284618558614,0.45429362880886426,0.7959005232540399,1.0,2/10,3.17%,PODXL;DPP4
prerank,negative regulation of receptor internalization (GO:0002091),0.48037251572671846,1.0161733934258206,0.4671875,0.7908617365322576,1.0,5/12,22.30%,ATXN2;DLG4;ANKRD13B;MTMR2;SDCBP
prerank,regulation of protein phosphorylation (GO:0001932),0.3326563733356694,1.0161117415192478,0.4501510574018127,0.7905321261225442,1.0,69/256,21.81%,C3;EPHA7;IL34;ADIPOQ;FBLN1;LRRK2;CD40;FGF7;EGFR;TREM2;PTPN13;PTEN;FAM20A;CCND3;LRP6;RAP2A;TMEM119;PID1;ANGPT1;GPNMB;EFNA5;NIBAN1;FBH1;PPP2R5A;FNIP1;WWTR1;IBTK;PTK2;BMPER;ZBED3;ACVR2A;TNF;VEGFC;FGF2;NTRK3;WDFY2;BMP7;FMR1;RAC1;RIPK1;FGF18;PRKDC;NSD1;STK4;PELI2;CSNK1D;AKT1;BRD4;EIF2AK3;ATF4;CLIP3;PLXNB2;XDH;AXIN2;PRNP;DVL2;IRGM;STAT2;CORO1C;PIN1;SPTBN4;NDUFS4;ZC3H12A;SIRPA;NPTN;PPP2R5C;AXIN1;VEGFB;PAK1
prerank,neuromuscular process (GO:0050905),0.44671653999055605,1.0159478506371458,0.4517543859649123,0.7904480538432336,1.0,4/16,11.46%,MYCBP2;HOXA1;UBA5;AGTPBP1
prerank,lymphocyte mediated immunity (GO:0002449),0.47341608601106144,1.0157811487495845,0.44461305007587254,0.7903441668704466,1.0,2/12,5.33%,JAG1;GNL1
prerank,negative regulation of viral transcription (GO:0032897),0.46485107392090924,1.0157217510407748,0.45440956651718983,0.7900003687373335,1.0,3/13,7.89%,UBP1;TRIM21;TRIM13
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.4413067893975151,1.015705011738556,0.44851904090267986,0.7895744005506562,1.0,3/18,6.47%,IRS1;SFRP1;INHBB
prerank,cellular response to radiation (GO:0071478),0.38640618679661354,1.015676144258635,0.4838709677419355,0.7891790544109325,1.0,14/40,24.47%,TNKS1BP1;INO80;GRB2;OPN1MW;OPN1MW3;TANK;CLOCK;GPR88;RAD9A;SWI5;GADD45A;RRH;RAD51;CDKN1A
prerank,embryonic hemopoiesis (GO:0035162),0.47620266202508515,1.0153746616011263,0.4583333333333333,0.7893603204551601,1.0,1/12,0.42%,KMT2A
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.4309896558493599,1.0150760058598345,0.4405594405594406,0.7895780752656997,1.0,7/21,18.54%,KLHL22;MAD2L1;ATM;PLK1;MAD1L1;TEX14;FBXO5
prerank,endothelial tube morphogenesis (GO:0061154),0.49612933079821997,1.0146964046509555,0.47420965058236275,0.7899615390996294,1.0,6/10,21.40%,PRKD2;CCM2;RHOA;ACVRL1;RBPJ;STARD13
prerank,glycerol metabolic process (GO:0006071),0.4875225443241201,1.014431669195202,0.4592476489028213,0.7901360148145666,1.0,2/10,11.61%,PDXP;GK
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.3878732091112037,-1.0141402163009563,0.4276923076923077,0.7999503677015453,1.0,6/14,16.62%,GAB1;VEGFD;KDR;PIK3CD;FLT4;PGF
prerank,sphingolipid metabolic process (GO:0006665),-0.2371954605862057,-1.0140589155947912,0.46153846153846156,0.798466366375716,1.0,22/108,10.49%,ST6GALNAC3;CERT1;PPM1L;TECR;ACER2;CERS4;SGMS1;ESYT2;PPP2R1A;SPTLC2;ESYT1;SPTLC1;ELOVL7;SGMS2;ENPP2;ELOVL5;DEGS2;SPNS2;HACD1;HACD3;GAL3ST1;HACD4
prerank,DNA damage checkpoint signaling (GO:0000077),0.4066201992611089,1.0140159416367376,0.4592496765847348,0.790617200480098,1.0,10/28,21.02%,BRIP1;E2F1;ATM;ATR;USP28;CLOCK;ATRIP;RAD9A;HINFP;MAP3K20
prerank,DNA strand elongation (GO:0022616),-0.35359712450896397,-1.0138501672363154,0.41935483870967744,0.7973280081277414,1.0,12/18,30.44%,MRE11;POLD3;GINS3;DCLRE1B;MCMDC2;RFC3;GINS4;RAD50;POLD2;GINS1;RFC4;MCM3
prerank,positive regulation of RNA splicing (GO:0033120),-0.3087869916056696,-1.0134746495166902,0.448559670781893,0.7965738009734284,1.0,13/29,27.78%,NCL;U2AF2;CIRBP;POLR2A;DAZAP1;ERN1;HNRNPLL;NUP98;RBM3;SLC38A2;ZPR1;SF3B4;HSPA1A
prerank,regulation of cytoplasmic transport (GO:1903649),0.4833762617325159,1.013412645096566,0.4525316455696203,0.7915840340273009,1.0,5/11,17.06%,LRRK2;DNAJC13;MAP2K1;SRC;MAPK1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.4130833129293211,1.0130347505981232,0.47736093143596375,0.7920158105954848,1.0,11/28,26.27%,SH3KBP1;TNFSF11;CCL2;PRKDC;HSPD1;TNIP2;SIRPA;CCDC88B;CYRIB;THY1;PYCARD
prerank,presynapse organization (GO:0099172),0.49903403365876364,1.0130309626897727,0.4712286158631415,0.7915591334790458,1.0,2/10,9.14%,FZD1;WNT5A
prerank,regulation of rRNA processing (GO:2000232),-0.36903058649156817,-1.012999918192574,0.42201834862385323,0.7960995260577358,1.0,7/16,27.82%,RIOK1;WDR43;DIMT1;SIRT7;UTP15;NUDT16;TRMT112
prerank,RNA metabolic process (GO:0016070),0.3459990994601407,1.012943754407376,0.4631578947368421,0.791301929080194,1.0,45/127,23.27%,RBMS1;APOBEC1;ATXN1;SYNCRIP;ATXN2;SNRNP40;DDX17;WDR74;PABPC4;FTO;RNASEH1;GTF2F2;DICER1;SND1;DHX8;RNASEH2A;NCBP2;ALKBH1;HNRNPH2;PAPOLG;GTF2F1;RBM6;RNASE1;SETX;RBMX;HNRNPUL1;SIDT2;MTREX;RBFOX2;POLR2L;POLR2K;DDX20;RBM39;PARN;AGO2;LAGE3;DUSP11;RBMS2;DDX24;ZC3H12A;HNRNPC;RNASE3;RNASEH2B;POLR2D;PCBP1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.4308378760231788,1.012891991640639,0.4556786703601108,0.7909617854698849,1.0,5/22,14.55%,LACC1;WNT5A;TNF;SPHK2;TRPM4
prerank,regulation of mitochondrion organization (GO:0010821),0.37944464359153607,1.0127138267790807,0.45872641509433965,0.7909105197865371,1.0,15/47,21.29%,IAPP;LRRK2;TREM2;OMA1;PID1;FBXW7;INF2;CSNK2A2;GSK3B;SQSTM1;SREBF1;USP36;STAT2;MYO19;VPS35
prerank,energy reserve metabolic process (GO:0006112),-0.33762022668646835,-1.0125134798945814,0.4337748344370861,0.7956983540782595,1.0,3/19,5.04%,PRKAG2;GBE1;PYGM
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.3106556897123436,-1.012508957749401,0.44129554655870445,0.7939844792974866,1.0,10/27,23.91%,SYT7;PPP3CB;RIMS1;VAMP7;SDF4;RIMS2;SYT12;SYT11;SYT13;SYT3
prerank,cellular response to alcohol (GO:0097306),0.38813345109109937,1.0120868706437,0.4628501827040195,0.7918995037566892,1.0,11/42,15.47%,ADCY7;ADCY2;SFRP1;LRP6;AHR;GRAMD1A;GNAI1;GRAMD1C;SPHK2;SMO;CTNNA1
prerank,regulation of urine volume (GO:0035809),-0.42553789846410406,-1.0119616642942653,0.456,0.7936603553516627,1.0,3/10,9.26%,NPR3;NPR1;INPP5K
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.484562834771663,1.011909651107753,0.4704918032786885,0.7918549227320364,1.0,7/12,24.11%,CTSS;CTSL;CTSB;MED1;KLF9;THRB;CTSH
prerank,iron ion homeostasis (GO:0055072),0.3703684837877175,1.0116554956130064,0.4657210401891253,0.7919782784169846,1.0,11/58,14.51%,HEPH;CP;SLC11A2;FXN;CUL1;ACO1;SKP1;SLC22A17;IREB2;SMAD4;FRRS1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.456562576312041,1.0115180075218861,0.4561664190193165,0.7918250304510995,1.0,3/17,5.97%,EGFR;PKD2;CCND3
prerank,regulation of multicellular organismal development (GO:2000026),0.4174845019362625,1.011382544403731,0.46264744429882043,0.7916827032168853,1.0,7/25,17.21%,PTN;EHMT1;HPSE;BAG6;MYSM1;NIPBL;DUSP6
prerank,tetrahydrofolate metabolic process (GO:0046653),0.49957607246139785,1.0112263144885614,0.47368421052631576,0.7915930260626498,1.0,3/10,11.59%,MTHFR;MTHFD1L;MTHFD2L
prerank,positive regulation of viral transcription (GO:0050434),0.42241710896034373,1.011012263552118,0.45652173913043476,0.7916256456570907,1.0,8/25,18.45%,MDFIC;GTF2F2;RSF1;GTF2F1;CCNT1;POLR2L;POLR2K;CDK9
prerank,triglyceride metabolic process (GO:0006641),0.3733044350164168,1.010828861889146,0.45680473372781066,0.7915998475104077,1.0,7/48,13.16%,LIPC;APOE;APOH;LPL;GK;FABP5;GPAT3
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3560160460691836,1.0107569175651383,0.47333333333333333,0.7912894956230682,1.0,17/77,15.12%,TCF7L2;CFLAR;FXN;BCL2;ACVR1;SIAH2;BCL2L2;NOC2L;SH3RF1;TGFBR1;CSNK2A1;CSNK2A2;PELI3;TNF;SRC;CX3CL1;RIPK1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.4000731219893153,1.0105505405615578,0.45534591194968554,0.7912817739369068,1.0,2/33,2.74%,CYP1B1;SNAI2
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3998545859134845,1.010347279847255,0.4854614412136536,0.7913020107426456,1.0,10/32,14.73%,AUTS2;FSCN1;CARMIL1;CDC42;ABI2;ACTR2;BRK1;PIK3R1;SRC;RAC1
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.2886992303439315,-1.0101698125642045,0.43023255813953487,0.7967517141875915,1.0,11/41,15.79%,ACTN2;AKAP6;ANK2;KCNJ2;KCNJ3;KCNJ10;ANK3;KCNQ1;KCNJ12;KCNN2;KCNN3
prerank,myoblast fusion (GO:0007520),0.4799657479527327,1.0101187263967595,0.4604651162790698,0.7913442139785163,1.0,4/12,9.87%,ADAM12;ADAMTS15;ADAMTS5;PTGFRN
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.37562475265088385,1.0100972513652666,0.46867749419953597,0.790932568705969,1.0,17/52,18.76%,LRP1;NKD2;EGFR;TREM2;GPSM2;ITGA3;PTPN9;GNAI1;TNF;KIF5B;PIK3R1;EPB41L2;STAC3;SQSTM1;AKT1;CLIP3;SPTBN1
prerank,magnesium ion transport (GO:0015693),0.4811718453043459,1.0100830831519914,0.4817629179331307,0.7905029994694409,1.0,7/12,22.98%,NIPAL2;NIPAL4;TUSC3;NIPA2;CNNM4;NIPA1;SLC41A1
prerank,regulation of mitotic nuclear division (GO:0007088),0.3695026433958693,1.009925591715045,0.4610169491525424,0.7903919318148529,1.0,20/55,24.43%,EDN3;PDXP;PDGFRB;EGF;TOM1L1;BORA;DRD3;BTC;BMP7;RCC1;OBSL1;FBXO5;LRP5;PIN1;CDK13;RGCC;IL1A;PRMT5;PHIP;CUL9
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3883826261181599,1.009568265445101,0.4551122194513716,0.7907636491475014,1.0,8/38,12.43%,PRKCA;PUM1;CCL5;LY96;SASH1;OASL;ANKRD17;POLR3D
prerank,positive regulation of nervous system development (GO:0051962),-0.27082087132339305,-1.0090839769695865,0.39655172413793105,0.7978839107378454,1.0,14/42,19.82%,NRXN1;GRID2;IL1RAPL1;CLSTN3;SYNDIG1;CUX2;LRRC4B;CLSTN1;PTPRD;BDNF;EPHB1;TRIM32;GPER1;NLGN1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.42546013690737744,1.0086953677780077,0.4735413839891452,0.7922958371119724,1.0,7/22,18.07%,DYNLL1;CDKN2B;BMP7;CDKN1B;PLEK;ANKLE2;INHBA
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.33992976695506916,1.008529354373145,0.47346514047866806,0.7922378180616589,1.0,23/124,12.49%,GPM6B;LAMB1;PPP1R9B;LRP12;ATXN10;APOE;BLK;IQCG;LIMA1;PKD2;OPHN1;CARMIL1;DTNBP1;VAPA;L1CAM;TTC17;FAM161A;WDPCP;SAMD14;TTC29;PTPRM;GSK3B;MICALL2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.41404843572747174,-1.0083841936416431,0.4591549295774648,0.7982301590680887,1.0,4/10,6.69%,PDE4B;CACNB2;CALM1;NIPSNAP2
prerank,regulation of phosphorylation (GO:0042325),0.3412984711176031,1.0082911591633827,0.47280334728033474,0.7923390906802084,1.0,34/120,20.96%,GLMN;DYNLL1;NRP1;CDKN2B;EGFR;NUP37;RAE1;CCL5;EGF;MCM7;OGT;FNIP1;NUP153;PTK2;DSCAM;GCK;PSEN1;BMP7;CDKN1B;NDC1;HIF1A;NUP35;NUP188;SEC13;ANKLE2;INHBA;PLXNB2;ZBTB7A;STAT2;NUP214;CORO1C;PIN1;NDUFS4;NUP107
prerank,telomere organization (GO:0032200),0.38388380575283626,1.00828902002183,0.4497549019607843,0.7918841707786843,1.0,10/43,15.88%,PARP3;DNA2;ATM;TERT;ATR;SP100;LTO1;RIF1;CTC1;PRKDC
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.3769297279930924,1.0082109904679186,0.48444976076555024,0.7915888177158925,1.0,13/47,21.08%,CRP;PDGFRB;DHRS4;CD36;PID1;GRB2;RIPK1;AGT;XDH;GADD45A;DCXR;PRKCD;ZC3H12A
prerank,mRNA polyadenylation (GO:0006378),-0.31289075144882494,-1.0077411180111424,0.46825396825396826,0.7964950375729865,1.0,8/26,23.17%,WDR33;PABPC1;LEO1;APP;TUT1;CPSF2;CLP1;PAPOLB
prerank,RNA polyadenylation (GO:0043631),-0.31289075144882494,-1.0077411180111424,0.46825396825396826,0.7964950375729865,1.0,8/26,23.17%,WDR33;PABPC1;LEO1;APP;TUT1;CPSF2;CLP1;PAPOLB
prerank,amino acid transmembrane transport (GO:0003333),-0.26802943819028185,-1.0072110055786003,0.4540229885057471,0.7961637194932489,1.0,6/45,3.48%,SLC47A1;SLC6A6;LRRC8D;SLC38A9;SLC7A5;SLC38A11
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.44177457318718955,1.0071963359517966,0.4704225352112676,0.7933873107894531,1.0,10/20,25.68%,CELF1;TNRC6B;MOV10;WTIP;HELZ;AGO2;AGO1;NRDE2;CNOT1;CNOT7
prerank,regulation of peptide hormone secretion (GO:0090276),0.36229701489078286,1.0069201097076197,0.4710467706013363,0.7935638643186377,1.0,12/67,13.20%,CACNA1A;CHD7;RAPGEF4;PRKCA;CACNA1C;ITPR1;KCNA5;CCL5;EIPR1;GCK;TNF;KCNS3
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.41900344931786726,-1.0068137800818469,0.44192634560906513,0.7938068099045129,1.0,4/11,12.55%,CCT4;CCT5;LARP7;DKC1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.41900344931786726,-1.0068137800818469,0.44192634560906513,0.7938068099045129,1.0,4/11,12.55%,CCT4;CCT5;LARP7;DKC1
prerank,protein methylation (GO:0006479),0.3813282714550618,1.006732265287404,0.44776119402985076,0.7935324627976026,1.0,20/40,27.82%,EHMT1;CARM1;CAMKMT;VCPKMT;NSD3;PCMT1;GSPT1;NSD1;ETFBKMT;PRMT3;SETD3;SNRPB;ETF1;N6AMT1;EEF2KMT;PRMT5;FAM98A;METTL21A;RAB6A;EEF1AKMT3
prerank,vitamin D metabolic process (GO:0042359),0.4614692246436056,1.0065355327565026,0.47569955817378495,0.793532950029261,1.0,3/13,12.52%,CYP27B1;CYP1A1;CYP2R1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.2941808989906519,-1.006268604475887,0.39555555555555555,0.7936993841909896,1.0,16/31,31.48%,CTNNA2;HDAC9;FGFR2;MAPK12;IGF2;BNIP2;BOC;MYOCD;CDH2;MEF2C;MAPK14;SRF;CAMK1;PTBP1;ID2;CDON
prerank,keratinocyte differentiation (GO:0030216),0.4086197764451696,1.0059216702805065,0.4732620320855615,0.7944395289598295,1.0,9/29,21.50%,UGCG;JAG1;ANXA1;WNT5A;PIP5K1A;MED1;ADAM9;WNT16;EPHA2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.406891064314885,1.0053838950196867,0.47516778523489933,0.79517773456177,1.0,8/28,16.86%,PARP3;ACTR2;SHLD3;SETMAR;RIF1;DTX3L;PRKDC;PNKP
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.390172263251201,-1.005231643533436,0.45294117647058824,0.7947456667512417,1.0,3/12,15.14%,SNAP25;STX3;STX2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.43746916467258873,1.0051043499496317,0.4579172610556348,0.7953238932951255,1.0,10/19,27.34%,MTHFR;MTHFD1L;MTHFD2L;GGH;MTRR;SLC19A1;ALDH1L2;MTHFD1;FOLR2;SLC25A32
prerank,membrane protein proteolysis (GO:0033619),0.38867788234318906,1.0050271751705402,0.4821648216482165,0.795033804548546,1.0,12/37,21.40%,ADAM19;PRTN3;MYH9;SPPL3;PSEN1;PSENEN;RBMX;RHBDD1;NCSTN;ADAM9;PSEN2;HM13
prerank,cellular response to interleukin-12 (GO:0071349),0.3766782782740064,1.0047833464219293,0.45758661887694146,0.7951269432546912,1.0,14/48,21.94%,JAK1;JAK2;RALA;CDC42;MSN;LMNB1;LCP1;TALDO1;ARF1;TYK2;CAPZA1;HNRNPDL;SIRPA;RAP1B
prerank,error-free translesion synthesis (GO:0070987),-0.3233421614774045,-1.0046551256461949,0.4092664092664093,0.7945676219970252,1.0,14/22,35.17%,RCHY1;UBC;PCNA;UFD1;RFC3;NPLOC4;UBA52;POLH;RPA2;RFC4;RFC2;RPA3;SPRTN;RFC5
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.4116409978580938,1.00441699700926,0.4786096256684492,0.7954868463915583,1.0,8/25,21.74%,SULF1;SMAD2;ACVR2A;SMAD4;ACVRL1;RBPJ;BMPR1A;ZNF423
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.35082823927700024,1.0037332061225854,0.4581497797356828,0.7966024283688372,1.0,21/83,18.90%,DYNLL1;DYNC1H1;TUBG1;ALMS1;PLK1;PCM1;HAUS3;CEP41;CNTRL;DCTN3;TPX2;PCNT;CEP72;ACTR1A;AKAP9;CEP192;CSNK1D;YWHAE;CKAP5;CENPJ;HAUS6
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.48268496025295715,1.0036960904693493,0.4578125,0.7962200895817879,1.0,3/11,11.44%,ACVR1;TGFBR1;TGFB2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.4695568851213315,1.003477048706673,0.4843517138599106,0.7962554118739724,1.0,2/13,5.88%,MAD2L1;XRCC3
prerank,protein-containing complex subunit organization (GO:0043933),0.34292403826835083,1.0032104501074823,0.5,0.7963927398083153,1.0,25/109,17.95%,KMT2A;YAP1;LAMC1;SKAP2;CD40;MITF;WIPF1;PPID;CREBBP;LLGL1;DLG4;KPNA3;ADD2;TEAD1;SNX9;TSPAN4;SPG7;TRAF2;RANBP9;NDC1;TUBGCP4;NUP35;MDM2;PICALM;CAPZA1
prerank,negative regulation of growth (GO:0045926),0.3434263336018608,1.0030284880563625,0.4968421052631579,0.796348794095628,1.0,20/121,14.44%,ENPP1;PPP1R9B;BCL6;SLIT3;SERTAD2;FRZB;CYP27B1;SFRP1;ENO1;CCAR2;BTG1;IP6K2;ACVR1B;RERG;PTPRJ;TGFB2;SPHK2;SMAD3;CDKN1B;SMAD4
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4017255454557453,1.0028440241391716,0.480719794344473,0.79631427160156,1.0,13/30,23.36%,TAF1D;POLR1E;GTF2H1;CDK7;POLR1B;TAF1A;POLR2L;POLR2K;POLR1G;ERCC2;POLR1A;CCNH;MNAT1
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.31368626619935425,-1.0026064907138243,0.4385245901639344,0.7983850607396337,1.0,5/25,10.64%,CTNNA3;CXADR;CD200;VCAM1;ITGA4
prerank,axon guidance (GO:0007411),0.3312698056870835,1.0025431575411927,0.4903553299492386,0.7965303671541054,1.0,33/201,11.84%,EPHA7;LAMA2;PALLD;GLI2;CXCL12;LAMA1;ROBO2;SH3KBP1;GAB2;SLIT3;SLIT1;EFNA4;PRKCA;NRP1;PLXNC1;EPHB3;SHH;OPHN1;EPHA1;PLXND1;L1CAM;GRB2;PLXNA3;EFNA5;CXCR4;WNT5A;FRS2;SEMA3E;PTK2;DSCAM;DRAXIN;PTPRM;UNC5B
prerank,response to gamma radiation (GO:0010332),0.4113265750559816,1.002057636073035,0.46338028169014084,0.7971130903979913,1.0,4/24,8.81%,YAP1;ATM;TRIM13;ATR
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.39390184920434695,1.0016441031861427,0.4688279301745636,0.79760859677544,1.0,7/35,14.73%,C3;RAB21;CBL;VTN;ARF1;MKLN1;RAC1
prerank,homotypic cell-cell adhesion (GO:0034109),0.37708054241239963,1.0015865948913925,0.4507897934386391,0.7972695138817606,1.0,16/39,24.04%,PDGFRA;CSRP1;MYH9;STXBP1;STXBP3;UBASH3B;GNAS;PLEK;FERMT3;TYRO3;ACTN1;FIBP;P2RY12;MEGF10;ITGB3;METAP1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.352534442211489,-1.0015370796701535,0.44336569579288027,0.7995465686416879,1.0,6/16,19.56%,SFPQ;DDX5;SRSF9;RBM17;SCNM1;HNRNPM
prerank,receptor metabolic process (GO:0043112),0.3676921768668671,1.0013168036318065,0.4842840512223516,0.7974279084360656,1.0,16/53,18.00%,CLTC;LRP1;ARFGEF2;ADM;CD36;GRB2;CALCRL;KIF16B;PIK3R4;SNX25;SMURF1;NEDD4;GRK4;SH3GLB1;PICALM;REP15
prerank,intermediate filament organization (GO:0045109),-0.35045674375919134,-1.0012602822424563,0.46204620462046203,0.7985553399014854,1.0,8/17,30.30%,GFAP;BFSP2;KLHL24;BFSP1;DSP;TCHH;PKP2;NEFL
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.4394682270958423,1.0004277388293126,0.48546511627906974,0.7989510228233858,1.0,6/17,14.97%,PRKCA;CD36;LY96;SASH1;CX3CL1;TRIB1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.40123443326548264,1.000410933052396,0.4806924101198402,0.7985300702209268,1.0,11/27,23.02%,CUL1;CCM2;SKP1;MAPK11;FBXW11;MAPK1;KAT7;MAP3K20;TNIP2;RPS27A;MAP2K7
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.31131317183767243,-1.0001246743732286,0.4541832669322709,0.8000326344469665,1.0,12/26,20.84%,NRXN1;PRKCZ;SHANK3;SLC8A3;CUX2;SHANK1;APP;RIMS1;RELN;SLC8A2;NLGN1;RIMS2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.37236461685221856,1.000058079218865,0.4672330097087379,0.7988851522436407,1.0,6/43,7.31%,TAOK1;BABAM2;PABIR1;ATM;PLK1;TAOK3
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3741935942606601,0.9999361571718978,0.4850657108721625,0.7987077413471082,1.0,9/48,14.74%,CEMIP;XCL1;CAMK2D;CXCL10;FKBP1B;SELENON;UBASH3B;CALM2;CX3CL1
prerank,protein import into mitochondrial matrix (GO:0030150),-0.34108112516238775,-0.9996005872983228,0.4602076124567474,0.7997438195982832,1.0,10/18,26.74%,DNAJC19;GRPEL2;DNAJC15;TIMM17B;TOMM20;TIMM21;TOMM70;ROMO1;TOMM40;DNLZ
prerank,positive regulation of TOR signaling (GO:0032008),0.377679820947955,0.9994481391612264,0.48267326732673266,0.7992568578357052,1.0,15/40,21.25%,KLHL22;TREM2;RICTOR;MIOS;RPTOR;RRAGC;FNIP1;SMCR8;LAMTOR5;SEC13;GPR137;SIK3;LAMTOR3;TELO2;CLEC16A
prerank,regulation of ERBB signaling pathway (GO:1901184),0.45295969388826,0.9994442630589644,0.4769452449567723,0.798810495190775,1.0,3/15,6.99%,EGFR;EGF;PTPN18
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.3568297354648614,-0.9991349879449333,0.449685534591195,0.7992573894412156,1.0,3/16,4.33%,KCNC2;NOS3;NDNF
prerank,positive regulation of autophagy (GO:0010508),0.3464883324817182,0.998942381045088,0.5071664829106945,0.7994717954138714,1.0,12/81,13.04%,DCN;TRIML2;LRRK2;TRIM21;NPRL2;TRIM13;TRIM8;FOXO3;FBXO7;PLEKHF1;GSK3B;ORMDL3
prerank,inositol lipid-mediated signaling (GO:0048017),0.37186206365267754,0.9988777297224801,0.4934445768772348,0.7991514147160897,1.0,13/50,13.29%,PDGFRA;GAB2;IRS1;PDGFRB;OGT;PLCL1;EXOC1;RPS6KB1;FGFR1;PLCB3;RHOA;PI4KA;PIK3R1
prerank,amino acid import (GO:0043090),-0.3369213713249556,-0.9984451076186918,0.4413793103448276,0.7993954394255771,1.0,7/21,11.55%,SLC47A1;SLC6A6;SLC7A5;SLC1A1;SLC6A1;SLC22A4;SLC25A38
prerank,regulation of protein secretion (GO:0050708),0.3403628011232532,0.9982198045025883,0.4963350785340314,0.8002028698800392,1.0,23/119,13.20%,CACNA1A;DNAJC1;RAPGEF4;PRKCA;CACNA1C;TREM2;APOE;ABCG1;ITPR1;KCNA5;PPID;CCL5;TGFB3;FRMD4A;LLGL1;EXOC1;DRD3;EIPR1;TGFB2;GCK;DPH3;TNF;KCNS3
prerank,cardiocyte differentiation (GO:0035051),0.4822489548069861,0.998027830692005,0.4627831715210356,0.8001873584858236,1.0,3/10,12.60%,GATA6;TGFB2;AKAP13
prerank,epithelial cell-cell adhesion (GO:0090136),0.49105695813350947,0.9979159803439108,0.49139280125195617,0.7999890163318265,1.0,2/11,1.76%,THBS4;ITGB5
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3247967255947274,0.997559071944561,0.4883955600403633,0.8003176678547961,1.0,61/260,16.55%,TEKT4;PPP1R9B;DYNLL1;MAP4K4;EMP1;CEP19;NRP1;ASAP1;FSCN1;STK36;PARVA;PMP22;AIF1;RHOD;OPHN1;FGD4;CARMIL1;RAP2A;IFT88;PCM1;RAB8B;CEP41;EXOC4;EHD2;ACTR2;GBF1;S1PR2;MYLK;FAM161A;EXOC1;EXOC7;WDPCP;PCNT;WDR35;DISC1;PTPN23;ARF4;GALNT11;NPHP3;FGD6;IFT172;IFT81;PDE6D;SNX10;CFAP410;CPLANE1;P2RX7;RAB1A;AIF1L;DYNC2H1;DZIP1L;KIF27;CDC14A;RAC1;TTC39C;EMP3;EXOC5;EXOC3;NUDCD3;POC1B;WDR90
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.32340329178899213,-0.9967228916204334,0.4559386973180077,0.8022368993329999,1.0,9/24,20.11%,ABCG2;CPOX;FLVCR1;SLC25A38;UROS;COX10;ABCB10;RSAD1;ALAS1
prerank,Ras protein signal transduction (GO:0007265),0.33400740561655357,0.9966688840255097,0.49737118822292326,0.8018728279924953,1.0,37/137,18.74%,COL1A2;FARP2;RASSF1;PLD1;TAX1BP3;AIF1;NF1;RHOD;RAB42;RALA;RAP2A;GPSM2;ARHGDIG;ABI2;MAPK11;GRB2;BRAP;RERG;BRK1;SETDB1;RALGDS;PDPN;RIT1;DBNL;RHOA;ARHGAP6;FGF2;RTKN;RAC1;CDC42EP1;USP28;ARHGDIA;GNA12;CDC42EP4;GNB1;SHC2;EPS8
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.4491875345084979,0.9960188659918228,0.47969924812030074,0.8028751347817317,1.0,10/16,27.70%,ATM;PINX1;SMG6;TNKS2;TERF1;SLX4;SMG5;TERF2;HNRNPA2B1;TINF2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3238842414703055,-0.9957533678755643,0.4628099173553719,0.8032108314759351,1.0,10/25,25.42%,LDB1;WDR43;ERCC6;EAF2;TSFM;SUPT4H1;CCNK;ZMYND11;DDX39B;THOC1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.28428252114665986,-0.9954042129768372,0.4444444444444444,0.8025182777293562,1.0,15/36,24.77%,MECOM;PRKN;EZR;PER1;SH3RF2;DUSP10;PINK1;CYLD;QARS1;GPS2;HDAC3;PPIA;ZMYND11;DUSP19;MEN1
prerank,regulation of axon extension (GO:0030516),-0.2898812178048314,-0.995367741131989,0.4473684210526316,0.8009894312083975,1.0,14/37,22.21%,MAP2;CDKL5;SEMA7A;DIP2B;SHTN1;TWF2;ZFYVE27;SIN3A;CDKL3;MAG;DNM2;SEMA3G;LIMK1;TRIM46
prerank,response to progesterone (GO:0032570),0.43286686776543554,0.9939494116155735,0.4933530280649926,0.8070825015776574,1.0,5/18,14.47%,YAP1;TGFB3;TGFB2;SRC;CATSPER3
prerank,determination of left/right symmetry (GO:0007368),0.3811002894243416,0.9938758975345087,0.48672566371681414,0.8067841489025415,1.0,6/37,11.12%,DNAAF4;SHH;PKD2;DNAH11;GALNT11;NPHP3
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.4208748108976999,0.9938283880569124,0.49449035812672176,0.8064300200149135,1.0,4/22,12.52%,ALDH1A2;CYP27B1;CYP1A1;CYP2R1
prerank,regulation of programmed cell death (GO:0043067),0.32487454940364263,0.9936906160550745,0.5201654601861427,0.8062948405343453,1.0,27/161,15.12%,BCL3;BCL6;STAT1;LRRK2;JAK2;BIRC3;CASP1;IFT57;NF2;STEAP3;CREBBP;ATM;OMA1;PTPN6;CXCL10;AIFM2;USP42;GAS1;CTSB;CALR;TNF;ANP32A;TRAF2;DAPK2;RTKN;RABGGTB;RIPK1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.43530071452238406,0.99333722446393,0.47413793103448276,0.8066226663390275,1.0,2/17,2.85%,NOS1AP;CACNA2D1
prerank,negative regulation of phosphorylation (GO:0042326),0.3441457053056667,0.9929980293519319,0.49782608695652175,0.806905652551652,1.0,24/85,21.21%,FBLN1;DYNLL1;LRRK2;CDKN2B;PTPN13;PTEN;LRP6;NPRL2;PID1;NIBAN1;WWTR1;IBTK;ZBED3;NTRK3;BMP7;CDKN1B;PRKDC;ANKLE2;INHBA;XDH;PRNP;CORO1C;ZC3H12A;SIRPA
prerank,negative regulation of type I interferon production (GO:0032480),0.37372641408573276,0.9925158327819312,0.4876847290640394,0.8074994240992761,1.0,12/40,22.02%,TNFAIP3;REL;IKBKE;ILRUN;ITCH;RELB;PIN1;RNF135;ISG15;YY1;SIRPA;UBE2L6
prerank,pulmonary valve development (GO:0003177),0.4319501009405061,0.9919214286697524,0.4895397489539749,0.8083751879081399,1.0,5/18,11.44%,ROBO2;JAG1;HEYL;TNFRSF1A;TGFB2
prerank,activation of protein kinase activity (GO:0032147),0.33846375536756274,0.9916143144787044,0.5064239828693791,0.8085754133404889,1.0,20/106,13.07%,MAP4K4;TAOK1;GHR;JAK2;ADCY7;RICTOR;ADCY2;TOM1L1;TAOK3;TIRAP;MAPKAP1;ANGPT1;BORA;PRKAR1B;WNT5A;TPX2;NRK;TGFB2;NTRK3;TRAF2
prerank,axonal fasciculation (GO:0007413),-0.3825219991211268,-0.9912628998558132,0.44086021505376344,0.810024211373634,1.0,2/12,1.91%,EPHA4;CNTN4
prerank,cellular response to hexose stimulus (GO:0071331),0.4132630771675253,0.9912003512108541,0.4868965517241379,0.8090548758785396,1.0,1/23,0.13%,SLC39A14
prerank,striated muscle contraction (GO:0006941),-0.26737673238575754,-0.990737673137206,0.47586206896551725,0.8097810687525638,1.0,4/53,3.33%,DMD;ATP1A2;ATP1B1;DTNA
prerank,cardiac muscle cell contraction (GO:0086003),0.4279473263350989,0.9906721357819906,0.4755043227665706,0.809756090170302,1.0,3/19,4.56%,CACNA2D1;CACNA1C;CAMK2D
prerank,cell-substrate junction assembly (GO:0007044),0.3822706075543713,0.9903727376939963,0.4884020618556701,0.8099655587240701,1.0,4/33,5.21%,DLC1;LAMC1;PEAK1;RHOD
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.42429555509686195,0.9903231045287979,0.4809590973201692,0.8096156592559941,1.0,8/18,19.20%,DNAJC13;RAB21;MSN;MAP2K1;PTPN23;SRC;MAPK1;MTMR2
prerank,myelin maintenance (GO:0043217),0.48346274744417106,0.99026972706594,0.49767441860465117,0.8092707531371579,1.0,4/10,22.13%,PTEN;CXCR4;EPB41L3;CLU
prerank,positive regulation of protein secretion (GO:0050714),0.3569572268541882,0.9900713194919905,0.49492671927846676,0.8092457079466108,1.0,14/69,11.60%,TCF7L2;TLR2;TREM2;BLK;ABCG1;ACSL4;PPID;TGFB3;FRMD4A;EXOC1;WLS;PTPN23;TGFB2;GCK
prerank,RNA export from nucleus (GO:0006405),-0.23894650361404474,-0.9900522435651937,0.4262295081967213,0.8097862444236797,1.0,38/100,25.42%,YTHDC1;CDC40;SRSF5;WDR33;DDX19B;U2AF2;NUP133;UPF2;UPF1;SEH1L;POM121;HNRNPA1;SRSF7;SRSF9;RBM8A;NUP43;CHTOP;CPSF2;MAGOH;NUP210;NUP50;ZC3H11A;NUP98;HHEX;EIF4A3;SRSF3;POLDIP3;XPO5;NUP93;CPSF4;SARNP;MCM3AP;DDX39B;NUP88;NUP85;DDX39A;DDX25;THOC1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.2916436595613338,-0.9890991614034056,0.4811320754716981,0.8106275016911031,1.0,5/31,3.09%,SYNJ2BP;LRRC7;DLG2;LIN7A;EZR
prerank,response to thyroid hormone (GO:0097066),0.46522028695877354,0.9889835622516777,0.4896988906497623,0.8112202924182413,1.0,7/13,24.11%,CTSS;CTSL;CTSB;MED1;KLF9;THRB;CTSH
prerank,peptidyl-lysine methylation (GO:0018022),0.3973590030492745,0.9888784714473536,0.48745046235138706,0.8109812458205314,1.0,13/26,27.82%,ANTKMT;KMT5A;EHMT1;SETD2;VCPKMT;ETFBKMT;SETD3;N6AMT1;EEF2KMT;SETD7;SETD4;METTL21A;EEF1AKMT3
prerank,sensory perception of taste (GO:0050909),0.4888034683047731,0.9882562223290351,0.4984375,0.8119052013215073,1.0,2/10,16.22%,CD36;PKD1L3
prerank,positive regulation of interferon-beta production (GO:0032728),0.39457130318500755,0.9881243983574409,0.4967741935483871,0.8117291016846966,1.0,9/33,20.63%,TLR2;IRF7;TLR7;IRF1;POLR3A;POLR3D;TRIM56;RNF135;ISG15
prerank,translational elongation (GO:0006414),-0.23004727843232373,-0.9879289319300553,0.49295774647887325,0.8120705872877005,1.0,48/101,31.25%,MRPS9;MRPS35;MRPS28;MRPS15;EEF1B2;MRPS24;MRPL13;MRPL10;MRPL21;MRPL39;GTPBP2;ERAL1;TSFM;RACK1;PTCD3;MRPL4;MRPS7;MRPS31;EEF1G;EEF1D;MRPL30;MRPL28;MRPS18C;MRPL22;MRPL40;GADD45GIP1;MRPL46;MRPS16;MRPS18B;MRPL58;MRPS22;MRPS6;MRPS25;MRPS12;MRPS34;MRPL44;EEF2;MRPL18;MRPL20;MRPL35;MRPL23;GFM1;MRPL42;MRPL43;MRPL54;MRPL34;MRPL2;MRPS10
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.40786869935298165,0.987790948340889,0.4933862433862434,0.811980642060689,1.0,8/24,14.73%,AUTS2;FSCN1;CDC42;ABI2;ACTR2;BRK1;PIK3R1;RAC1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.34320114949150893,0.987639749551123,0.4994547437295529,0.8118585274676109,1.0,24/91,17.88%,STON2;LRRK2;NRP1;PLD1;OPHN1;RALA;DNAJC13;ARFGAP1;RAB21;RAB8B;PTPN1;GAS1;MAP2K1;RINT1;RAB10;SRC;FES;PTPRC;MAPK1;RUFY1;RAB33B;PICALM;ZFYVE16;SCFD1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.4875002114501378,0.9865079631475124,0.4928909952606635,0.8139165802463781,1.0,2/10,7.04%,CD40;BAG6
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.45271422175617093,0.986011798974521,0.5014450867052023,0.8145891922544166,1.0,3/15,7.85%,TREM2;CD53;EHD2
prerank,insulin secretion (GO:0030073),-0.3482617836216182,-0.9857159434879025,0.4798657718120805,0.8160992211720268,1.0,7/19,23.68%,SELENOT;RAB11B;PTPRN2;ADCYAP1;PTPRN;RIMS2;CYB5R4
prerank,regulation of cell growth (GO:0001558),0.3286238764492469,0.9854716030216673,0.5369059656218402,0.8153062150241915,1.0,31/204,11.44%,ENPP1;MMP14;PPP1R9B;EIF4G2;BCL6;SLIT3;KLHL22;EGFR;SERTAD2;FRZB;FXN;CAMK2D;BCL2;PABIR1;CYP27B1;INO80;SFRP1;ENO1;CDC42;RPTOR;CCAR2;BTG1;EXOSC4;TGFBR1;CSNK2A1;IP6K2;PAPPA2;ACVR1B;RERG;PTPRJ;TGFB2
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.47136907618900126,0.9854396888281649,0.48829953198127923,0.8149253936524281,1.0,3/11,8.96%,BLK;LGALS9;ANXA1
prerank,cellular response to light stimulus (GO:0071482),0.3533583665080287,0.9853697779257604,0.5011389521640092,0.8146158092365442,1.0,20/66,24.87%,INO80;CREBBP;NOC2L;ATR;TMEM161A;OPN1MW;OPN1MW3;FMR1;NEDD4;USP28;GPR88;ATF4;RHBDD1;GNB1;KDM1A;PRKCD;YY1;RRH;EIF2S1;CDC25A
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.44916940599918975,0.9848956820861904,0.502865329512894,0.8152328772247597,1.0,6/16,17.14%,NOS1AP;APOE;TERT;TNF;HIF1A;AKT1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.4060671385086807,0.9841682581847369,0.4875816993464052,0.8163517942281938,1.0,7/26,15.59%,ALPK1;TNFAIP3;NOD1;IRAK2;CASP8;TIFA;ITCH
prerank,outer dynein arm assembly (GO:0036158),0.43747530760539044,0.9840840633437804,0.46636085626911317,0.816082979134755,1.0,3/15,13.37%,DNAAF4;ODAD1;DNAAF5
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.36228087412733595,-0.9840668839840507,0.4785276073619632,0.8190579650341994,1.0,7/15,20.11%,FGF1;TMSB4X;HSPB1;SEMA5A;THBS1;PRKD1;LGMN
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.3710918790998164,0.9838626730165551,0.5042321644498187,0.8161004944317445,1.0,13/48,19.83%,PAPSS2;DCAKD;ADCY7;ADCY2;SLC25A16;NPR2;PANK2;SLC35B3;COASY;PANK1;AMPD2;IMPDH2;AMPD3
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.42464084686125936,0.9834808184350103,0.47577092511013214,0.8164596684950282,1.0,6/17,18.77%,NRP1;BAIAP2;CDC42;NTRK3;FES;BCAS3
prerank,aspartate family amino acid catabolic process (GO:0009068),0.4247205306408632,0.9833367375873883,0.5013850415512465,0.8163306836656684,1.0,7/19,21.44%,SDSL;CRYM;DLST;ALDH7A1;HYKK;PIPOX;SLC25A21
prerank,regulation of cell division (GO:0051302),0.34755838272217227,0.9830189050522744,0.5198187995469988,0.8165840958680889,1.0,20/72,21.19%,POU5F1;PDXP;SHH;PLK1;KLHL13;ZFYVE26;SETD2;CSPP1;INSC;ENTR1;CALM2;PIK3R4;FSD1;PIK3C3;SH3GLB1;KIF20A;PIN1;PLK2;MYO19;BECN1
prerank,membrane lipid metabolic process (GO:0006643),0.41784502243076826,0.9829541587060899,0.4971671388101983,0.8162698502802299,1.0,1/22,0.18%,CYP1B1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.3263612601191576,-0.9828001115474843,0.45977011494252873,0.8206914567335704,1.0,6/22,8.92%,NCL;IPPK;WDR43;PHF8;PWP1;DHX33
prerank,embryonic heart tube development (GO:0035050),0.4479230602023197,0.9826696717782787,0.49544072948328266,0.8164230117559224,1.0,2/14,5.19%,TBX2;ACVR1
prerank,negative regulation of cation channel activity (GO:2001258),0.4030292596002516,0.9826583584446704,0.5118421052631579,0.8159927898605627,1.0,7/26,14.28%,PKD2;CBARP;FKBP1B;KCNAB1;DRD3;CALM2;FMR1
prerank,chromatin remodeling (GO:0006338),0.338979263927843,0.9825855857627502,0.5223880597014925,0.81571515356043,1.0,30/100,22.80%,SATB2;BAZ1A;POLE3;MBD2;SMARCC1;BAZ2B;INO80;TADA2B;BAHD1;HDAC1;ARID1B;MTA2;GATAD2B;RSF1;RUVBL1;ATRX;MYSM1;BAZ2A;SRCAP;SMARCA4;HCFC2;HDAC5;ZBTB7A;MBD3;HMGA2;HNRNPC;PAK1;ACTL6B;CHD8;SMARCD3
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.48121819905282043,0.982124448725539,0.5039494470774092,0.8163102551037644,1.0,3/11,11.44%,ZFPM2;JAG1;TGFB2
prerank,male meiosis I (GO:0007141),0.4422400782112349,0.9820850993790805,0.503586800573888,0.8159409074897762,1.0,3/16,12.98%,MYBL1;ZSCAN21;FOXJ3
prerank,regulation of cilium assembly (GO:1902017),0.3537046511655028,0.9816709498883935,0.4947856315179606,0.8164269989044254,1.0,17/62,17.41%,YAP1;TBC1D16;IFT88;TBC1D2B;ATG3;DYNC2LI1;CDK10;RABGAP1;ENTR1;CEP120;TAPT1;TBC1D1;ARHGAP35;TBC1D10B;TBC1D19;TBC1D20;CDKL1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.40812865038475604,0.9816126490737002,0.5086551264980027,0.8161016017610839,1.0,7/23,21.82%,TNFAIP3;PYDC1;NLRP2B;CX3CL1;CPTP;ZC3H12A;NLRP12
prerank,positive regulation of phospholipase activity (GO:0010518),0.41693552502579895,0.9815431042719334,0.5027777777777778,0.8158026009774114,1.0,7/22,12.55%,PDGFRA;PDGFRB;CCL5;FGFR1;ARF4;FGF2;NTRK3
prerank,organophosphate biosynthetic process (GO:0090407),-0.28462765355639635,-0.9815075856679055,0.48,0.8225550559776855,1.0,9/37,12.84%,GPHN;TPK1;MBOAT1;IPPK;PCYT2;PPIP5K1;AGPAT3;MOCS2;TPI1
prerank,negative regulation of leukocyte activation (GO:0002695),-0.36103774843222003,-0.9813701559040724,0.48214285714285715,0.8212415123105267,1.0,6/15,18.69%,LRFN5;IL31RA;CD200;GRN;GPER1;HAVCR2
prerank,microvillus assembly (GO:0030033),-0.3640807049228183,-0.9812251837259441,0.5014577259475219,0.8199955212254184,1.0,6/14,11.64%,MINK1;EZR;FXYD5;RAPGEF2;RAPGEF6;RAP1A
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.37621851432234055,0.9809049911485607,0.48198757763975153,0.8167156136233362,1.0,5/39,7.69%,TCF7L2;TNFSF11;BLK;ACSL4;AIMP1
prerank,multivesicular body organization (GO:0036257),0.392260486976553,0.9806807834160073,0.5119798234552333,0.8167710876470832,1.0,6/31,15.31%,CHMP4A;CHMP4B;VPS4A;VPS37C;CHMP7;CHMP2B
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3724594727649813,-0.9805366796750328,0.49318801089918257,0.8201042490095359,1.0,9/13,30.87%,GLRX3;NFU1;CIAO2A;YAE1;ISCA2;GLRX5;BOLA2;ISCA1;CIAO2B
prerank,alpha-amino acid metabolic process (GO:1901605),0.3696792191955405,0.9803809801590208,0.4797619047619048,0.8169666331266631,1.0,5/45,7.20%,ALDH18A1;ASPG;MTHFR;ASNS;KYAT1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4093774324046576,0.9802570630263386,0.49100968188105115,0.8168084354896561,1.0,8/21,22.53%,MITF;SUB1;MED13;PAXIP1;SETX;MED12;MED1;MED14
prerank,glycolipid biosynthetic process (GO:0009247),-0.27482043770101827,-0.9795334158332918,0.48130841121495327,0.8211349474899307,1.0,19/38,27.34%,ST3GAL4;ST3GAL5;ST8SIA6;B4GALT6;PGAP2;PIGB;GBGT1;ST6GALNAC5;PIGG;PIGF;DPM3;SCCPDH;ST8SIA3;PIGZ;PIGM;PIGU;PGAP3;PIGO;PIGA
prerank,cellular response to glucose starvation (GO:0042149),-0.2723935880320642,-0.9792959588123964,0.4607329842931937,0.8200691634334427,1.0,11/41,14.59%,PRKAG2;PRKAA2;NIM1K;SIK1;SIK2;SESN2;SESN3;IMPACT;HNRNPA1;MYBBP1A;PRKAG3
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.3330467366014624,-0.9789717483761764,0.46441947565543074,0.8193257384393504,1.0,7/20,23.25%,BICD1;YWHAB;GRK2;RNF157;MRAP2;RPGRIP1L;STMN1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.38055387534644514,-0.9787264355599491,0.46439628482972134,0.8183369282589407,1.0,4/12,12.90%,HNRNPU;NELFB;LARP7;NELFA
prerank,endocytic recycling (GO:0032456),0.3593813984853329,0.9783660068928766,0.4976190476190476,0.8204890816121523,1.0,14/50,16.56%,STX6;RAB7A;EHD2;VPS39;PTPN23;EIPR1;ENTR1;MICALL2;EPS15;CCDC93;ANKRD27;ACAP2;WASHC1;SNX4
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.38980239946958317,0.9780977885911014,0.5102040816326531,0.8206241449686252,1.0,5/33,7.60%,ZFP36L1;IRS1;PTEN;NF1;PIK3R5
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.38307690062762,-0.9780706928010364,0.453125,0.8185075177492518,1.0,2/12,3.58%,IGF1R;INSR
prerank,positive regulation of establishment of protein localization (GO:1904951),0.41672942195769686,0.9778008816154432,0.4957865168539326,0.8207866855519544,1.0,6/19,18.53%,TREM2;CCT8;CEP120;TNF;CCT3;CENPJ
prerank,neuron projection fasciculation (GO:0106030),-0.40444761544275776,-0.9776631137969037,0.4910025706940874,0.8180264554721083,1.0,2/10,1.91%,EPHA4;CNTN4
prerank,2-oxoglutarate metabolic process (GO:0006103),0.464400852206714,0.9774998730476216,0.5022156573116692,0.8209755308847613,1.0,3/13,16.99%,DLST;IDH2;L2HGDH
prerank,microvillus organization (GO:0032528),-0.3752668113956404,-0.9770977560743672,0.4764705882352941,0.8179166942869387,1.0,6/13,11.64%,MINK1;EZR;FXYD5;RAPGEF2;RAPGEF6;RAP1A
prerank,protein localization to chromosome (GO:0034502),0.3866711905453837,0.9770419773253092,0.5227848101265823,0.821557268813813,1.0,12/34,18.98%,PARP3;PLK1;PINX1;LEMD2;ATR;MCM9;CHMP7;CTCF;ATRX;TNKS2;SLF2;WAPL
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.36441083781657035,0.9767413506306903,0.5054282267792521,0.8217505469823699,1.0,15/48,20.16%,ZMIZ1;TAF1D;SERTAD2;PADI2;PHF2;POLR1E;ARID1B;SPHK2;POLR1B;TAF1A;ASF1A;POLR2L;POLR2K;SERTAD1;POLR1G
prerank,apical protein localization (GO:0045176),-0.41415415896827623,-0.976738696081034,0.5040431266846361,0.8172349338856162,1.0,4/10,6.86%,MAL;ACTB;GOPC;SHROOM3
prerank,negative regulation of heart contraction (GO:0045822),-0.39406654310003175,-0.9766180180863461,0.5052083333333334,0.8159032219445904,1.0,3/11,10.43%,ATP1A2;GRK2;PDE4D
prerank,cytosolic calcium ion transport (GO:0060401),0.389979577185868,0.9765977337153479,0.5012953367875648,0.8216128261586819,1.0,8/28,18.80%,CACNA2D1;CACNA1C;ATP2A2;ATP2B1;MICU2;MCUR1;MAIP1;MICU3
prerank,cellular response to acid chemical (GO:0071229),-0.30102684095154353,-0.9764849869510799,0.4829059829059829,0.8145933806440687,1.0,12/27,20.44%,CPEB3;SLC38A9;KLF2;LAMTOR1;GLRA1;SESN2;RRAGB;SPAAR;RRAGD;GLRA2;LAMTOR2;RRAGA
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.42466188416186773,0.9762846293486138,0.5,0.8218350979488578,1.0,3/17,5.33%,STAT3;JAG1;GNL1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.34278499199577545,0.9762649044476012,0.5126512651265126,0.8214243783578876,1.0,24/80,18.77%,AUTS2;DPYSL3;NRP1;FSCN1;RALA;TGFB3;CDC42;ABI2;ACTR2;BRK1;ENTR1;CEP120;TAPT1;P2RX7;PIK3R1;ARHGAP35;FMR1;WASHC1;RAC1;CDC42EP1;NDEL1;CDC42EP4;EPS8;BCAS3
prerank,DNA double-strand break processing (GO:0000729),0.4299206802031528,0.97589233770044,0.48567335243553006,0.8217689452597412,1.0,4/18,9.64%,DNA2;RAD52;ATM;SETMAR
prerank,regulation of centrosome cycle (GO:0046605),0.4155894752829083,0.9758678029319288,0.5194444444444445,0.8213660108389228,1.0,4/21,15.31%,CHMP4B;XRCC3;NAT10;CHMP2B
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3621016474384036,0.9758621120286457,0.5233532934131736,0.8209292972424569,1.0,18/45,26.07%,ACVR1;TGFB3;INHBB;TGFBR1;BMP5;TGFB2;ACVR2A;BMP7;SMAD4;ACVRL1;INHBA;GDF9;GDF11;BMPR1A;SDCBP;BMPR2;GDF1;INHA
prerank,positive regulation of cell division (GO:0051781),0.37525037078743256,0.9758106650383379,0.4994011976047904,0.8205906264218146,1.0,9/38,14.53%,SVIL;SHH;CDC42;DRD3;OPN1MW;CSPP1;RHOA;GIPC1;CDC14A
prerank,negative regulation by host of viral process (GO:0044793),0.46924877468477055,0.9758047878180803,0.4856175972927242,0.8201536969714968,1.0,2/10,7.36%,CRP;VAPA
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.40996962867631326,0.9748954447575691,0.5239398084815321,0.8216938133769617,1.0,4/23,12.65%,EPHX2;FADS1;CYP1A1;ELOVL6
prerank,cell projection assembly (GO:0030031),0.40472115076962484,0.9747900987899669,0.49519890260631,0.8214487646085452,1.0,3/22,6.39%,RHOJ;PARVA;CDC42
prerank,protein modification by small protein conjugation (GO:0032446),0.31562563799137405,0.974331512219879,0.5646940822467402,0.8219939683395695,1.0,95/361,21.72%,TRIML2;DTX4;DCAF15;PDZRN3;MYLIP;PEX10;MYCBP2;SPSB1;ARRDC4;FBXL7;USP9X;CUL1;SMURF2;NUP37;TRIM21;RAE1;CNOT4;RNF144A;PLK1;ANAPC11;PIAS2;MIB1;CDC27;ATG3;RNF111;KLHL13;SKP1;TRIM13;DCUN1D1;CBL;FBXW7;AREL1;ARIH1;UBE2F;BRAP;DTX2;UBE2L3;FBH1;NUP153;TRIM44;UBE2R2;UBA5;EIPR1;FBXO7;NFE2L2;RNF213;KCTD10;ATG7;PJA2;FBXW11;RNF181;ZSWIM8;UBE2K;NSMCE2;DDRGK1;UBE2W;FBXO2;EGR2;VCPIP1;TRPM4;DTX3L;NDC1;SMURF1;ITCH;NEDD4;HIF1A;PRKDC;KLHL25;NUP35;NUP188;TRAIP;PCNP;KLHL7;TRIM33;DDB1;MDM2;TRPC4AP;ARIH2;PEX12;UBR1;FBXO32;NUP214;DCUN1D5;RNF135;UBE2E1;TRIM6;ISG15;NUP107;UBE2Z;VHL;TRIM27;TRIM62;RPS27A;RNF14;TNFAIP1
prerank,regulation of organelle assembly (GO:1902115),0.3407887996461425,0.973831173508538,0.5227272727272727,0.8226034389038867,1.0,21/73,18.53%,CEP295NL;ATXN2;TBC1D16;ALMS1;NPRL2;IFT88;TBC1D2B;ATG3;DYNC2LI1;MSN;RABGAP1;SENP6;TBC1D1;ADPRH;TBC1D10B;TBC1D19;TBC1D20;KIF9;CDKL1;MTMR3;CENPJ
prerank,modification-dependent protein catabolic process (GO:0019941),0.32174208417455974,0.9732199399672362,0.5580448065173116,0.8235045293424684,1.0,55/193,22.68%,RNF150;MYLIP;KCTD21;SPSB1;FBXL7;MAD2L1;SMURF2;UBR4;CNOT4;RNF144A;PLK1;ANAPC11;SIAH2;MIB1;CDC27;BAG6;RNF111;CBL;AREL1;ARIH1;NTAN1;UBE2L3;UBE2R2;FBXO7;RNF213;KCTD10;RNF19B;PSMF1;RNF149;UBE2K;RNF11;DTX3L;SMURF1;ITCH;NEDD4;SQSTM1;KLHL25;PSMD11;PSMD14;RC3H2;DDB1;MDM2;FBXW4;TRPC4AP;ARIH2;UBE2E1;COPS3;ISG15;FBXO22;RPS27A;RNF14;RBBP6;UBE2L6;FZR1;CHFR
prerank,nuclear membrane reassembly (GO:0031468),0.3593266447392118,0.9731260771377811,0.5132336018411968,0.8232623776041909,1.0,18/54,20.96%,CHMP4A;CHMP4B;NUP37;VPS4A;LEMD2;PPP2R2A;CCNB2;CHMP7;NDC1;CHMP2B;NUP35;NUP188;RCC1;SEC13;ANKLE2;CC2D1B;UBXN2A;NUP107
prerank,T cell homeostasis (GO:0043029),-0.4059144949812616,-0.97301641950571,0.4973544973544973,0.8218815091127938,1.0,7/10,37.46%,PPP2R3C;NCKAP1L;ZC3H8;JAK3;FAS;FADD;PMAIP1
prerank,dendritic spine organization (GO:0097061),0.4018547578111034,0.9728566049554569,0.522972972972973,0.8233956381162483,1.0,10/26,19.20%,EPHB3;TREM2;PTEN;CDC42;DLG4;ITGA3;ARF1;DOCK10;PRNP;MTMR2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3990342548096692,0.9723270608416124,0.506578947368421,0.8240833553776257,1.0,6/27,12.48%,PDGFRA;IRS1;PDGFRB;AMBRA1;PTK2;FGF2
prerank,response to ketone (GO:1901654),0.4050128269090899,0.9722642611317801,0.5139275766016713,0.8237687903694545,1.0,5/24,14.47%,YAP1;SLIT3;TGFB3;TGFB2;CATSPER3
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3321727793146502,-0.9721422123655657,0.5173611111111112,0.8225408556486294,1.0,7/18,22.90%,NRXN1;SHANK3;CACNG2;CACNG7;RELN;NLGN1;CACNG8
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.34777429360689416,-0.9719946348670362,0.5161290322580645,0.8213485948034768,1.0,7/16,24.87%,COX7A2;PINK1;UQCC2;PDE12;SLC25A33;MLXIPL;PPIF
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.4761847805754297,0.9719611946908141,0.493730407523511,0.8239834853571372,1.0,2/10,17.01%,LGALS9;PTPRC
prerank,glycoprotein metabolic process (GO:0009100),0.3517485135662548,0.9718490912416042,0.5083532219570406,0.823785181735875,1.0,14/53,19.82%,TNIP1;B4GALT5;PRKCSH;HPSE;ADAMTS9;MAN2A1;MAN1C1;MGAT4A;FBXO2;B4GALT7;HIF1A;AGA;GANAB;MAN2A2
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3472955576483802,0.9718482035125346,0.5229050279329609,0.8233365644332187,1.0,14/68,22.06%,ENPP1;LRRK2;ACSF2;ACOT13;TPST1;SULT4A1;ENTPD7;ACOT9;AMPD2;AMPD3;PDE9A;HINT1;EPHA2;THEM4
prerank,protein targeting to mitochondrion (GO:0006626),-0.25702589485881583,-0.9716613759525429,0.4726027397260274,0.820563773422826,1.0,23/52,27.19%,IMMP2L;HSP90AA1;DNAJC19;BCAP31;GRPEL2;NDUFA13;DNAJC15;TIMM17B;GDAP1;TOMM20;TIMM21;SAMM50;IMMP1L;TIMM22;TOMM70;TIMM8B;ROMO1;TOMM5;TOMM40;DNLZ;CHCHD4;MFF;TIMM9
prerank,mitotic spindle assembly (GO:0090307),0.36972002391693076,0.9714343223199484,0.5169385194479298,0.8237742723120968,1.0,9/42,16.03%,KIFC1;SMC1A;KIF2A;STAG2;TPX2;STAG1;RHOA;TOGARAM1;CEP192
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3593050562250114,0.9714319824867428,0.5321428571428571,0.8233300425283289,1.0,22/56,23.85%,JTB;CHMP4B;PLK1;VPS4A;DCTN3;SPIRE1;SNX18;SNX33;SNX9;RHOA;BIN3;RTKN;RASA1;TTC19;KIF20A;SPTBN1;SON;RHOC;ROCK2;ROCK1;PDCD6IP;RAB35
prerank,regulation of amyloid-beta formation (GO:1902003),0.3809201893682383,0.9710904165419274,0.5135834411384217,0.8236199840545215,1.0,21/34,27.92%,SLC2A13;APOE;GSAP;ABCA2;ABCG1;TNF;PICALM;PRNP;PIN1;IFNGR1;CLU;RTN2;ROCK2;ROCK1;RELA;BIN1;CHRNA7;EFNA1;GGA3;GSK3A;TMED10
prerank,cyclooxygenase pathway (GO:0019371),0.4621392406260062,0.9707043985943392,0.496875,0.8239612735909013,1.0,3/10,13.69%,PTGES;PTGES2;TBXAS1
prerank,dendrite morphogenesis (GO:0048813),0.37658822078201737,0.9706511359440602,0.5101522842639594,0.8236364837757171,1.0,7/35,8.32%,PTN;FARP1;EPHB3;PTEN;CDC42;DLG4;SDC2
prerank,stress-activated MAPK cascade (GO:0051403),0.3496168947848815,0.9705490317109358,0.5103926096997691,0.8234113772706053,1.0,9/61,7.99%,ZFP36L1;MAP2K4;CUL1;LGALS9;NOD1;CCM2;IRAK2;SKP1;MAPK11
prerank,positive regulation of protein export from nucleus (GO:0046827),0.4350737523536549,0.9705131928734265,0.5,0.8230412058350065,1.0,4/15,17.37%,TCF7L2;BAG3;GSK3B;YWHAE
prerank,positive regulation of secretion by cell (GO:1903532),0.3464523754076896,0.9703714465958444,0.528555431131019,0.8228959339932721,1.0,13/70,11.44%,EDN3;TREM2;RAB2B;ABCG1;PPID;DTNBP1;TGFB3;FRMD4A;UNC13D;RAB9A;EXOC1;RAB27B;TGFB2
prerank,rRNA transcription (GO:0009303),0.43600103162821224,0.9703063081464174,0.5107692307692308,0.8225868315161936,1.0,5/17,20.16%,POLR1E;GTF3A;BRF1;GTF3C4;POLR1G
prerank,regulation of astrocyte differentiation (GO:0048710),0.4544135127947028,0.9700470454333969,0.5123456790123457,0.8227204817981727,1.0,1/12,1.44%,SERPINE2
prerank,exit from mitosis (GO:0010458),0.45561339460941364,0.9699961866969125,0.5037821482602118,0.8224024014510979,1.0,6/12,27.10%,CHMP4B;CHMP7;EPS8;CLASP2;CTDP1;CLASP1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.4540208400407375,0.9696169298593171,0.5053598774885145,0.8227539338041614,1.0,1/13,2.18%,CRP
prerank,regulation of multicellular organism growth (GO:0040014),0.44500066075836997,0.9693667779324235,0.4978165938864629,0.8228491323205918,1.0,2/15,6.10%,GHR;STAT5A
prerank,recombinational repair (GO:0000725),0.33914114711382715,0.9691866024867627,0.539647577092511,0.8228088615081385,1.0,17/77,18.69%,RAD51B;RAD52;INO80;XRCC3;MMS22L;ZFYVE26;FBH1;AP5Z1;MCM9;NSMCE2;RMI1;XRCC1;PSMD14;NUCKS1;HELQ;RBBP8;SWI5
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3434370204152824,0.9691747710223899,0.5286195286195287,0.822392574687713,1.0,18/67,17.41%,MYO10;ATP8B1;PLD1;FSCN1;TBC1D16;IFT88;CDC42;TBC1D2B;ATG3;DYNC2LI1;RABGAP1;TBC1D1;FMR1;TBC1D10B;RAC1;TBC1D19;TBC1D20;CDKL1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.42033229777474374,0.9691242873883567,0.5127118644067796,0.8220556622092504,1.0,4/17,9.04%,CACNA1C;GJD3;GJC1;FKBP1B
prerank,protein autophosphorylation (GO:0046777),0.320117199325731,0.968649370104342,0.5565843621399177,0.822629286803178,1.0,34/157,17.81%,PDGFRA;NEK6;TEC;TAOK1;PEAK1;LRRK2;PDGFRB;JAK2;EGFR;EPHB3;CAMK2D;PRKD2;DDR2;ATM;EIF2AK2;EPHA1;TAOK3;ATR;ACVR1B;FGFR1;PTK2;MYO3A;GSK3B;SRC;MKNK1;STK24;DAPK2;FES;RIPK1;STK4;AKT1;MAP3K3;EIF2AK3;MAP3K12
prerank,smooth muscle tissue development (GO:0048745),0.4756094083859194,0.9682010571759131,0.512,0.8231868549112594,1.0,4/10,15.46%,SHH;NF1;MYLK;SMO
prerank,plasma membrane tubulation (GO:0097320),0.4533256486806496,0.9681334388562272,0.5029850746268657,0.8228825697012281,1.0,5/13,12.50%,CHMP4A;EHD2;SNX33;SNX9;BIN3
prerank,mitotic nuclear membrane organization (GO:0101024),0.3594443942509182,0.9680772565202924,0.530373831775701,0.8221318715499264,1.0,15/51,17.78%,CHMP4A;CHMP4B;NUP37;VPS4A;LEMD2;PPP2R2A;CCNB2;CHMP7;NDC1;CHMP2B;NUP35;NUP188;RCC1;SEC13;ANKLE2
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3594443942509182,0.9680772565202924,0.530373831775701,0.8221318715499264,1.0,15/51,17.78%,CHMP4A;CHMP4B;NUP37;VPS4A;LEMD2;PPP2R2A;CCNB2;CHMP7;NDC1;CHMP2B;NUP35;NUP188;RCC1;SEC13;ANKLE2
prerank,cell differentiation in spinal cord (GO:0021515),-0.3938374486161367,-0.9680123776489752,0.5076923076923077,0.828356897235536,1.0,3/10,6.00%,MDGA2;SOX13;SOX6
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.35070258707071766,0.9678552961917152,0.5390713476783692,0.8221488245735123,1.0,15/63,15.12%,TCF7L2;CFLAR;ACVR1;TNFRSF12A;SIAH2;SH3RF1;SP100;TGFBR1;PELI3;FGFR1;CASP8;TNF;TRAF2;SRC;RIPK1
prerank,peptide biosynthetic process (GO:0043043),-0.21398961585357096,-0.9675833172417235,0.4722222222222222,0.8279170542629777,1.0,53/153,22.53%,DMD;RPL34;RPL36;RPL8;RPS4X;COPS5;RPL18A;RPL19;RPL38;RPS21;MRPS15;RPL5;RPS10;RPLP0;RPL7;RPL13;MRPL13;RPS8;MRPL10;RPS23;RPL30;RPS12;RPL13A;RPL35A;RPL29;RPL32;DHPS;EIF4EBP2;RPL10;RPL15;RPS27;RPL35;RPS16;RPL7A;RPS15;MRPS7;RPS29;RPL27;RPS13;RPS19;ABCF1;RPL41;SARS1;RPLP1;MRPL28;WARS1;MRPS18C;RPL28;GSPT2;RPS17;MRPS16;MRPS18B;RPS6KB2
prerank,mitotic DNA replication (GO:1902969),0.47224436140719334,0.9673534588772154,0.5292259083728278,0.8227496870076546,1.0,2/10,7.30%,MCM2;LIG1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.396916148222459,0.9673257621147376,0.5236167341430499,0.8223656732940208,1.0,9/27,22.97%,TNFAIP3;IRAK3;PTPN6;TNF;CX3CL1;ZC3H12A;SIRPA;NLRP12;CD200R1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.4410345516157454,0.9673105003903645,0.5331278890600925,0.8219546104110564,1.0,4/15,12.55%,CXCL12;IL16;VEGFC;NTRK3
prerank,peptidyl-serine modification (GO:0018209),0.3178126885704159,0.9670983011850177,0.5557851239669421,0.8219650348674775,1.0,37/166,17.81%,NEK6;MAST4;LRRK2;PRKCA;MARK1;RICTOR;GALNT3;IKBKE;AKT3;CAMK2D;PRKD2;MORC3;ATM;PLK1;HIPK4;MAST2;ATR;TGFBR1;CSNK2A1;CSNK2A2;HIPK3;RPS6KB1;CSNK1G2;GSK3B;CSNK1A1;MKNK1;POGLUT3;VRK3;PRKDC;STK4;CSNK1D;MAPK1;AKT1;LATS2;EIF2AK3;DCLK3;MAP3K12
prerank,negative regulation of stem cell differentiation (GO:2000737),0.45491533292090447,0.9670954598697998,0.5196850393700787,0.8215315854827901,1.0,2/12,4.21%,ZFP36L2;JAG1
prerank,calcium ion transport (GO:0006816),0.3290423959908482,0.9667712633300991,0.5482502651113468,0.8217900852196963,1.0,11/113,5.67%,MCOLN2;CACNA1A;CACNA2D1;CACNA1C;CCR1;ITPR1;PKD2;TRPC6;CYP27B1;SLC24A5;CCL5
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.35913667176473346,-0.9667226585578972,0.4967532467532468,0.8285527491069996,1.0,3/15,4.13%,TJP1;FGF1;KLF4
prerank,lipid translocation (GO:0034204),0.4025035598791637,0.9665644471415157,0.5167597765363129,0.8217879756624537,1.0,2/21,2.43%,ABCA1;ATP8B1
prerank,response to acidic pH (GO:0010447),0.4561169469154953,0.9659849531106646,0.52023988005997,0.822585069013085,1.0,2/13,5.02%,SLC9A1;CTSS
prerank,nucleosome disassembly (GO:0006337),0.4469352742225725,0.9653215035107172,0.50509461426492,0.8231178882301801,1.0,5/14,22.80%,SMARCC1;GRWD1;SMARCA4;ARID2;SMARCD3
prerank,chromatin disassembly (GO:0031498),0.4469352742225725,0.9653215035107172,0.50509461426492,0.8231178882301801,1.0,5/14,22.80%,SMARCC1;GRWD1;SMARCA4;ARID2;SMARCD3
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.45327070883308596,0.9650713221176662,0.5214180206794683,0.8232058561841781,1.0,2/13,12.95%,LRRK2;ENTPD7
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.327842138192217,0.9643746800805657,0.5433155080213904,0.8242322420293086,1.0,23/101,18.36%,PRR16;BCL3;PLD1;PLK1;SAMD4A;MSN;NIBAN1;OGT;RPS6KB1;NAT10;CASP8;CLN6;ATG7;FBXW11;DACT1;YTHDF3;FMR1;PRKDC;AKT1;INHBA;PLXNB2;AGT;NFKBIA
prerank,regulation of protein kinase activity (GO:0045859),0.3283570845194522,0.9643262985561151,0.5426439232409381,0.8238950387142636,1.0,26/106,17.14%,JTB;SPRED1;LCP2;DDR2;NF1;TAF7;CACUL1;DTNBP1;LRP6;EPHA1;RASSF2;GSKIP;PYDC1;WWTR1;PTK2;SNX9;TNF;UBASH3B;SMCR8;TRIB3;TRIB1;RTRAF;ALS2;ITGB1BP1;PTPRC;AKT1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.4358455049988061,0.9643090523596856,0.5159420289855072,0.8234899441284149,1.0,2/14,9.18%,EDN3;ENPEP
prerank,positive regulation of epithelial cell migration (GO:0010634),0.33361756643317547,0.9642705692821866,0.5386266094420601,0.8231283947235649,1.0,25/92,18.77%,SPARC;MAP4K4;FGF7;PRKCA;NRP1;DOCK1;PRKD2;EGF;SASH1;ANGPT1;WNT5A;MAPRE2;TGFB2;CALR;RIN2;FGF2;SRC;RAC1;HIF1A;ITGB1BP1;AKT1;ETS1;INSL3;AGT;BCAS3
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.3912309164787689,0.9639971640988093,0.5182767624020888,0.8232761196256431,1.0,4/28,8.41%,MMP14;EGFR;EGF;FBXW7
prerank,double-strand break repair (GO:0006302),0.32080310157809183,0.9639201590294865,0.5665983606557377,0.8229919352955255,1.0,34/158,17.50%,RAD51B;PARP3;BRIP1;DNA2;RAD52;TNKS1BP1;BABAM2;INO80;XRCC3;ATM;MMS22L;ZFYVE26;DCLRE1C;SETMAR;FBH1;HMGB2;AP5Z1;MCM9;TDP2;KDM2A;MDC1;NSMCE2;RIF1;EME2;RMI1;XRCC1;DTX3L;PAXIP1;SETX;PRKDC;PSMD14;NUCKS1;DDX1;HELQ
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3654827079813998,0.9636885668332148,0.5372005044136192,0.8230464060289987,1.0,15/38,19.96%,LRRK2;NPEPPS;FBXW7;TOMM7;CSNK2A2;UBE2L3;LMAN1;MICALL2;BAG4;SREBF1;SH3GLB1;LEPROT;USP36;ARIH2;UBL5
prerank,aspartate family amino acid metabolic process (GO:0009066),0.42379420141274887,0.9636774053865739,0.5308988764044944,0.822631408554438,1.0,3/18,6.93%,ASPG;MTHFR;ASNS
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3999391086212375,0.9633230462171931,0.5208613728129206,0.8229407312922556,1.0,3/25,7.63%,YAP1;ARHGAP24;CDK10
prerank,negative regulation of telomere maintenance (GO:0032205),0.43942899457874496,0.9633203039154655,0.5052473763118441,0.8225077370223304,1.0,8/15,25.73%,ATM;PINX1;SMG6;TNKS2;TERF1;SLX4;TERF2IP;TERF2
prerank,protein localization to chromatin (GO:0071168),0.4245229455368546,0.9632721600982593,0.523121387283237,0.8221676310705441,1.0,9/18,19.34%,PLK1;LEMD2;MCM9;CHMP7;LRWD1;PPHLN1;NIPBL;WAPL;TASOR
prerank,excitatory postsynaptic potential (GO:0060079),0.40529586342242035,0.9632477134978447,0.5200553250345782,0.8217773509229767,1.0,8/19,23.07%,LRRK2;NPAS4;GSK3B;RAB3GAP1;AKT1;GRIN2A;NPFF;MAPK8IP2
prerank,negative regulation of cellular metabolic process (GO:0031324),0.3758941118213735,0.9631657413190727,0.519159456118665,0.8215210912709964,1.0,11/37,23.22%,ATXN2;APOE;ABCA2;DLG4;TRAP1;ANKRD13B;MTMR2;SDCBP;NCOR1;ITGB3;AP1AR
prerank,positive regulation of heart rate (GO:0010460),0.41754850161344964,0.9630566290750489,0.52046783625731,0.8213052729377083,1.0,4/17,14.55%,EDN3;ADM;ATP2A2;TRPM4
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3801985972923618,0.9628909238168817,0.5297845373891001,0.8211954780508591,1.0,14/32,24.58%,TAF1D;POLR1E;GTF2H1;CDK7;POLR1B;TAF1A;POLR2L;POLR2K;POLR1G;ERCC2;POLR1A;CCNH;MNAT1;RRN3
prerank,protein kinase A signaling (GO:0010737),-0.3791576254991042,-0.9627583399853005,0.49586776859504134,0.8370913701636469,1.0,4/12,19.16%,EZR;RDX;MYOM1;RAB13
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.40605768335414083,0.9623712255294666,0.514018691588785,0.8218519929634684,1.0,7/24,17.01%,XCL1;ITPR1;PKD2;IBTK;FGF2;ANXA6;PTPRC
prerank,organic substance transport (GO:0071702),0.32878819875322274,0.9623152553341682,0.549163179916318,0.8215279510741582,1.0,31/121,21.26%,ABCA1;TCN1;SLC6A2;ARRDC4;ABCA2;PLTP;MYH9;ABCG1;MIA3;LMAN2L;RAB7A;TCN2;ARRDC3;RCN3;PEX19;SLCO1B1;CALCRL;ABCA9;ABCG4;NDC1;CHMP2B;SNX4;RUFY1;HSP90B1;SLCO2B1;SLC50A1;TAP1;SLC18A2;TOM1;SLC19A1;MFSD12
prerank,Rac protein signal transduction (GO:0016601),0.4196210270113855,0.9622383941735346,0.5299145299145299,0.821258961704142,1.0,6/18,14.73%,FARP2;AIF1;ABI2;BRK1;DBNL;RAC1
prerank,establishment of mitotic spindle localization (GO:0040001),0.39203620539377126,0.9620625121177341,0.5441558441558442,0.8211943590388809,1.0,6/28,15.66%,MAD2L1;PLK1;GPSM2;INSC;FBXW11;NDEL1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.39147521891919046,-0.9616972952802257,0.5192307692307693,0.8381563988722891,1.0,2/10,6.15%,CSGALNACT1;DSEL
prerank,"phagocytosis, engulfment (GO:0006911)",0.36932104176636904,0.9616378189028106,0.5229813664596273,0.8216665923462121,1.0,8/36,15.63%,DOCK1;MYH9;AIF1;CD36;CDC42;MSR1;RAC1;FCGR1A
prerank,substantia nigra development (GO:0021762),0.36867343909333566,0.9616332211591538,0.5237515225334958,0.8212394997284249,1.0,9/37,14.77%,DYNLL1;GNB4;PADI2;CDC42;MAPKAP1;SEC16A;RHOA;CALM2;HSPA5
prerank,chromosome condensation (GO:0030261),0.36502724996656777,0.960523871745855,0.5206508135168961,0.8231673791417519,1.0,11/36,21.09%,ERN2;KMT5A;PLK1;CSNK2A1;CSNK2A2;NCAPD2;NCAPG2;AIFM1;NCAPG;TENT4A;SMC4
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3350896293601861,0.9601654478964641,0.5309633027522935,0.8234557589464998,1.0,9/72,8.93%,BCL3;BATF;TNKS1BP1;E2F1;CNOT4;ATM;E2F8;CARM1;SP100
prerank,regulation of superoxide anion generation (GO:0032928),0.43885539128626494,0.9591436248249228,0.5128593040847201,0.8251617469124062,1.0,1/14,2.18%,CRP
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3533401878289602,0.9591141055092826,0.5333333333333333,0.8247892955358054,1.0,4/47,4.25%,ADIPOQ;SNAI1;SNAI2;ABCA2
prerank,regulation of developmental growth (GO:0048638),0.38462535523728775,0.9587735566825768,0.5356200527704486,0.8250504712244977,1.0,9/29,17.45%,GHR;APOE;STAT5A;GSK3B;NIPBL;STAT5B;OLFM1;LATS2;CTTN
prerank,DNA biosynthetic process (GO:0071897),-0.3394437587937259,-0.958738927162416,0.5152439024390244,0.8441317858887782,1.0,11/16,37.77%,POLD3;PPIA;RFC3;POLH;POLD2;POLE;CDKN2D;POLD4;WRN;POLL;SIRT1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.3498215886916016,0.9582494365390597,0.5380047505938242,0.825695746884808,1.0,20/51,24.18%,ATM;PINX1;SMG6;ATR;CCT8;DCP2;NAT10;XRN1;CTC1;SRC;CCT3;TNKS2;PNKP;MAPK1;PARN;PKIB;HNRNPC;TERF1;MAP2K7;SMG5
prerank,cilium organization (GO:0044782),0.31315275702830975,0.9581813316851262,0.6054766734279919,0.8253958041494569,1.0,46/210,16.55%,TEKT4;DYNLL1;CEP19;ASAP1;STK36;PARVA;IQCG;PKD2;IFT88;PCM1;RAB8B;CEP41;EXOC4;TTC17;EHD2;ACTR2;GBF1;FAM161A;EXOC1;EXOC7;WDPCP;PCNT;WDR35;DISC1;TTC29;PTPN23;ARF4;GALNT11;NPHP3;IFT172;IFT81;PDE6D;SNX10;CFAP410;CPLANE1;RAB1A;DYNC2H1;DZIP1L;KIF27;CDC14A;TTC39C;EXOC5;EXOC3;NUDCD3;POC1B;WDR90
prerank,SNARE complex assembly (GO:0035493),-0.4076426780630641,-0.9580616495128259,0.5054347826086957,0.8443049933119373,1.0,3/10,14.95%,STXBP6;VAMP4;VAMP8
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.2309705028248182,-0.9579430727359765,0.5217391304347826,0.8429670612086967,1.0,36/96,25.42%,YTHDC1;CDC40;SRSF5;WDR33;DDX19B;U2AF2;NUP133;UPF2;UPF1;SEH1L;POM121;SRSF7;SRSF9;RBM8A;NUP43;CHTOP;CPSF2;MAGOH;NUP210;NUP50;ZC3H11A;NUP98;HHEX;EIF4A3;SRSF3;POLDIP3;NUP93;CPSF4;SARNP;MCM3AP;DDX39B;NUP88;NUP85;DDX39A;DDX25;THOC1
prerank,acidic amino acid transport (GO:0015800),-0.3357606803025771,-0.9578311409862568,0.5147540983606558,0.8416324859150567,1.0,5/17,4.88%,SLC6A6;LRRC8D;SLC1A2;SLC1A1;SLC6A1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.42949383945847014,0.9572324560980928,0.5426829268292683,0.8269050926106974,1.0,5/16,18.25%,MDK;RHOA;TNF;ETS1;FUT4
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.41205252150264426,0.9569890444947913,0.5265306122448979,0.8269503811785638,1.0,6/20,18.25%,CAMK2D;BCL2;ATP2A2;PACS2;PSEN1;THADA
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.44339635594135507,0.9567624515693008,0.5277777777777778,0.8269628064452414,1.0,5/14,18.69%,XCL1;SHLD3;RIF1;PAXIP1;HMCES
prerank,response to zinc ion (GO:0010043),0.4009262747665902,0.9567050674473062,0.517555266579974,0.8266531500897875,1.0,2/25,2.51%,HVCN1;PAM
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4591944697262502,0.9563681205957812,0.5247678018575851,0.8269005599074332,1.0,2/11,5.62%,BCL3;NF2
prerank,regulation of protein targeting to membrane (GO:0090313),0.38758093906878716,0.9559045718498976,0.515625,0.827391557980703,1.0,1/28,0.40%,CEMIP
prerank,positive regulation of intracellular transport (GO:0032388),0.3670973487551365,0.9552337177163779,0.5344180225281602,0.8283136502337427,1.0,11/38,18.77%,DYNC1H1;PCM1;EHD2;PCNT;EIPR1;PDCD10;NEDD4;PLA2G4E;TBC1D20;ICE1;BCAS3
prerank,catecholamine biosynthetic process (GO:0042423),-0.3808776740468003,-0.9550219716311288,0.5263157894736842,0.8474061939371753,1.0,2/11,12.12%,MOXD1;DDC
prerank,mRNA modification (GO:0016556),0.40322970233924443,0.9545338675664145,0.53360768175583,0.8294048587464075,1.0,4/22,9.72%,ZC3H13;METTL16;TRUB2;PUS3
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.44355789554453484,0.9544836633548714,0.5384615384615384,0.8290706010461972,1.0,3/13,7.40%,TREM2;ENO1;PID1
prerank,histone mRNA metabolic process (GO:0008334),0.38473635083421154,0.9541479181531838,0.55,0.8293536113396718,1.0,6/27,11.16%,ATM;ERI1;EXOSC4;DCP2;NCBP2;XRN1
prerank,transferrin transport (GO:0033572),0.3753659553341311,0.9539069550468464,0.525065963060686,0.8294295435612716,1.0,8/33,18.00%,CLTC;STEAP3;ATP6V1F;ATP6V1H;ATP6V1G2;ATP6V1G1;ATP6V1D;REP15
prerank,glycogen catabolic process (GO:0005980),-0.35339745916077114,-0.9537124301571316,0.5369318181818182,0.849326244940803,1.0,4/15,6.91%,CALM1;PGM2L1;PYGM;PYGB
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.33455866764653075,-0.9535723879237322,0.5083612040133779,0.8480712242511114,1.0,8/17,27.78%,HDAC4;CBFA2T3;GIT1;PDE12;MLXIPL;PPIF;PARP1;TIGAR
prerank,response to cAMP (GO:0051591),0.37325236984969684,0.9534888411264826,0.5582278481012658,0.8298229010547468,1.0,5/37,6.40%,ZFP36L1;STAT1;IGFBP5;PKD2;AHR
prerank,positive regulation of cation channel activity (GO:2001259),-0.2677385369587093,-0.9530875890879391,0.5270935960591133,0.8476297161658142,1.0,7/40,8.96%,ACTN2;AKAP6;ANK2;SHANK3;CALM1;TMSB4X;ANK3
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.2304069500412892,-0.9528973183251809,0.5945945945945946,0.8464433055733719,1.0,25/69,30.55%,STT3B;ERLIN1;EDEM2;JKAMP;UBXN4;UBE4A;DNAJC18;DNAJB9;ERLIN2;DERL1;ANKZF1;WFS1;RNF185;UFD1;YOD1;SGTA;FBXO44;RNF5;NPLOC4;UBQLN2;DNAJB2;ECPAS;TMEM67;UBE2J2;TMEM129
prerank,autonomic nervous system development (GO:0048483),0.41589169238862267,0.9528254118203142,0.5319767441860465,0.8307504518923592,1.0,2/17,5.10%,NRP1;NF1
prerank,skeletal muscle tissue development (GO:0007519),0.381539717299564,0.9527729195341773,0.5556946182728411,0.8304243877098645,1.0,5/32,14.11%,SVIL;CFLAR;LEMD2;SELENON;EGR2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3968108678068285,0.9527602166491127,0.5208333333333334,0.8300136666638864,1.0,3/22,5.01%,VMP1;SLC9A1;PKD2
prerank,regulation of microtubule polymerization (GO:0031113),-0.26771824663960236,-0.9523346772482643,0.5473684210526316,0.8463124715812523,1.0,4/40,3.01%,MAP2;OCLN;EML2;CDH5
prerank,regulation of inclusion body assembly (GO:0090083),-0.38097159083373644,-0.9522833836683658,0.5244956772334294,0.8448313166195078,1.0,2/11,2.49%,SNCAIP;SACS
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.33814212743038746,-0.9521284507746758,0.49216300940438873,0.8436144493112323,1.0,2/17,1.76%,ATP1A2;BMP4
prerank,establishment of vesicle localization (GO:0051650),-0.34567930135113656,-0.952115329916789,0.5183823529411765,0.8420591346734607,1.0,8/18,23.09%,RAB27A;SNAPIN;TOR1A;SYNJ1;DNM2;TESK1;IKBKG;SYT11
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.443513640352493,0.9519597660752713,0.5327380952380952,0.8312511588689215,1.0,2/13,11.55%,LRRK2;NFE2L2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3776100585752906,0.9519307246493146,0.5288831835686778,0.8308698062055102,1.0,9/34,15.39%,PDGFRA;IRS1;PDGFRB;AMBRA1;PTK2;FGF2;PIK3R1;WASHC1;PIK3R4
prerank,response to metal ion (GO:0010038),0.340138281502101,0.9513785021168446,0.5544332210998878,0.8315707475033077,1.0,12/67,16.97%,SEC31A;HVCN1;PAM;SLC11A2;FXN;BCL2;PPP3CA;KHK;CALM2;NEDD4;HIF1A;TNNT2
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.4414290539331796,0.9511970935734562,0.525679758308157,0.8315075704514923,1.0,5/12,21.84%,DPYSL3;CTPS1;DPYD;CTPS2;UMPS
prerank,DNA metabolic process (GO:0006259),0.31336022962324267,0.9511660259558854,0.6277665995975855,0.8311416104820795,1.0,74/270,23.59%,RAD51B;PARP3;MPG;TCF7L2;POLE3;BACH1;SMC1A;DNA2;RAD52;MCM2;INO80;XRCC3;ATM;PDS5B;PWWP3A;GTF2H1;LIG1;TERT;PDS5A;MCM7;ATR;SP100;RNASEH1;SETMAR;DBF4;RNASEH2A;HMGB2;ALKBH1;USP3;TOP2B;TIMELESS;LTO1;POLI;POLA2;MGMT;RIF1;LRWD1;CTC1;XRCC1;ASF1A;MMS19;POLG;PRKDC;ATRIP;PNKP;DDB1;ZNF445;RAD9A;RBBP8;HINFP;AXIN2;EID3;GADD45A;MBD4;KPNA2;FANCC;NEIL1;PARP4;TOP3B;RFC1;RPS27A;TERF1;ZRANB3;CDC7;RPA1;SLX4;ENDOV;DMC1;RAD51;MNAT1;CDC6;MSH6;DDX21;DOT1L
prerank,negative regulation of cilium assembly (GO:1902018),0.44935474399514214,0.9508851597018663,0.5404984423676013,0.8312966820705611,1.0,2/12,7.63%,YAP1;CDK10
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.2822325858924617,-0.9506731669800921,0.5473251028806584,0.8441402858919245,1.0,9/32,16.23%,FHIT;DDX5;PPP1R13B;HIPK1;MSH2;EP300;DDIT4;MYBBP1A;DYRK2
prerank,glycine transport (GO:0015816),-0.4008350106601523,-0.950653780507294,0.5274725274725275,0.8426021798444557,1.0,4/10,12.99%,SLC6A9;SLC38A5;SLC25A38;SLC6A17
prerank,JNK cascade (GO:0007254),-0.26851017780522524,-0.9505703187936339,0.5297619047619048,0.8412369096055424,1.0,17/40,26.65%,MINK1;TAB3;MAP3K5;ARHGEF6;CRKL;UBC;UBE2N;MAPK9;GPS2;MAP3K7;MAPK10;IRAK1;IKBKG;UBA52;MAP3K11;NOD2;UBE2V1
prerank,rRNA catabolic process (GO:0016075),0.42314767187701496,0.950138278629809,0.5392749244712991,0.8323980725600456,1.0,3/16,11.16%,ERN2;EXOSC4;XRN1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3660320491339553,0.9501187850954178,0.5580808080808081,0.8320045384755431,1.0,16/40,24.75%,DDX11;MMS22L;ATR;SETMAR;FBH1;MCM9;TIMELESS;EME2;ATRX;TRAIP;NUCKS1;CDK9;ZRANB3;RAD51;ETAA1;FAM111A
prerank,regulation of sprouting angiogenesis (GO:1903670),0.37486848519007043,0.9499662161283116,0.543640897755611,0.8318811756995093,1.0,10/33,15.70%,CREB3L1;JAK1;RHOJ;CEMIP2;ADAMTS9;BMPER;FGF2;ITGA5;SMAD1;FGF18
prerank,erythrocyte differentiation (GO:0030218),-0.26206062347490766,-0.9498074142046325,0.5621621621621622,0.8415949538095668,1.0,15/44,21.32%,KIT;TGFBR3;FLVCR1;CASP3;SLC25A38;CEBPG;DMTN;ABCB10;TAL1;HSPA9;IKZF1;RPS19;ZFPM1;ALAS1;NCKAP1L
prerank,RNA transport (GO:0050658),0.33891258118452955,0.9497823058255482,0.5459704880817253,0.8318095256557596,1.0,24/71,26.82%,RFTN1;ZFP36L1;RBFOX1;ATXN2;RAE1;NCBP2;NUP153;FMR1;RTRAF;NUP188;SIDT2;CKAP5;SRSF2;NUP214;YBX1;SLU7;SRSF11;THOC5;RNPS1;THOC2;KIF5C;HNRNPA2B1;NUP155;SRSF1
prerank,inositol phosphate catabolic process (GO:0071545),0.45396107252543855,0.9497037996643017,0.5329341317365269,0.8315466032439477,1.0,2/12,4.97%,INPP1;PTEN
prerank,regulation of mitochondrial translation (GO:0070129),0.40152460953241964,0.9491920234747504,0.5365853658536586,0.832141911548895,1.0,3/21,10.43%,RPUSD3;TRUB2;ALKBH1
prerank,negative regulation of cell cycle (GO:0045786),0.3389206921918761,0.949064970777721,0.5730337078651685,0.8319635134202596,1.0,13/73,14.25%,RUNX3;MAD2L1;NR2F2;PTPN3;PTEN;CDK6;PLK1;BTG1;GAS1;NLRP2B;SMAD3;BMP7;CDKN1B
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.4386283899403422,0.9488264515916014,0.5194029850746269,0.8319890859170582,1.0,5/13,21.15%,APOE;CYP27B1;BMP5;PLEK;DKK3
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.433040056974942,0.9477829029236878,0.548621190130624,0.8337034728564684,1.0,4/15,12.30%,APOE;SNX33;SNX9;TNF
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.452761535917548,0.947707600378096,0.5438871473354232,0.8334275262997528,1.0,9/11,33.22%,TRAP1;COA8;SLC18A2;MPV17L;PPARA;ABCD2;PARK7;ABCB7;FYN
prerank,development of primary male sexual characteristics (GO:0046546),0.36374953448058556,0.9477058145169112,0.5363984674329502,0.8329987353367794,1.0,6/34,14.39%,LHFPL2;GATA6;WNT5A;TGFB2;ADAM21;TFAP2C
prerank,ATP synthesis coupled proton transport (GO:0015986),0.41907906749498625,0.9475939302390812,0.5298295454545454,0.832802349403305,1.0,3/17,8.50%,STOML2;ATP5PO;DMAC2L
prerank,lipid modification (GO:0030258),-0.27672301680757966,-0.9473758946636726,0.5363128491620112,0.8463152510164696,1.0,9/37,16.74%,DGKB;MBOAT1;DGKI;DGKA;DGKG;SGPP1;PORCN;PLPPR4;DGKQ
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.3392003341705288,-0.9471475965404259,0.5329341317365269,0.8452951450176426,1.0,6/16,25.95%,NCL;CIRBP;DAZAP1;NUP98;RBM3;SF3B4
prerank,pyruvate metabolic process (GO:0006090),-0.2550454868329126,-0.9464764116330783,0.5616438356164384,0.8454062493128032,1.0,12/52,17.23%,BSG;ME3;ME1;SLC16A1;VDAC1;HAGH;LDHB;PFKM;TPI1;ALDOC;PGK1;LDHA
prerank,branched-chain amino acid catabolic process (GO:0009083),0.39871002129150207,0.946424950697812,0.5125348189415042,0.8342718824923923,1.0,8/20,26.03%,ACADSB;HIBCH;ECHS1;BCKDHB;AUH;HIBADH;BCAT1;SLC25A44
prerank,branched-chain amino acid metabolic process (GO:0009081),0.39871002129150207,0.946424950697812,0.5125348189415042,0.8342718824923923,1.0,8/20,26.03%,ACADSB;HIBCH;ECHS1;BCKDHB;AUH;HIBADH;BCAT1;SLC25A44
prerank,autophagy of nucleus (GO:0044804),0.41851670590607415,0.9457762537336545,0.5375722543352601,0.8352357854396568,1.0,4/16,15.93%,WIPI1;ATG3;ATG7;WDR45
prerank,cellular response to copper ion (GO:0071280),-0.32725247453618717,-0.9456812929950511,0.5029940119760479,0.845849649645145,1.0,13/16,49.30%,MT2A;HSF1;AQP1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;SNCA;MT3
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.4098569008356984,0.9454112139350704,0.5305832147937412,0.8355560429512893,1.0,3/18,8.70%,POLE3;LIG1;MCM7
prerank,transport across blood-brain barrier (GO:0150104),0.33077515137036223,0.944801744093426,0.5684782608695652,0.8363957372816562,1.0,9/83,6.46%,SLC7A2;SLC1A3;LRP1;SLC38A3;SLC2A13;SLC28A2;ABCA2;CD36;SLC16A12
prerank,acylglycerol catabolic process (GO:0046464),0.37818449422986394,0.9446212251522212,0.5467349551856594,0.8363338864155924,1.0,5/30,16.48%,LIPC;LPL;ABHD16A;FABP5;LYPLA2
prerank,aminoglycan biosynthetic process (GO:0006023),0.35015824719493527,0.9444313246900128,0.5409836065573771,0.8363206454610761,1.0,12/49,16.66%,HSPG2;GPC6;EXT1;EXT2;SDC1;HS2ST1;SDC2;GCNT2;UGDH;SLC35D2;B4GALT7;B3GNT9
prerank,positive regulation of neuron differentiation (GO:0045666),0.3618719428981015,0.9444251785840356,0.5645161290322581,0.8359050110928586,1.0,5/40,11.96%,ZEB1;TCF4;HEYL;FGFR1;RHOA
prerank,positive regulation of ERAD pathway (GO:1904294),-0.35506765294171827,-0.9443506250055967,0.5663956639566395,0.8478510093453828,1.0,3/13,7.27%,CAV1;ATXN3;BCAP31
prerank,membrane depolarization during action potential (GO:0086010),-0.2948664411715865,-0.9439224339683323,0.5650557620817844,0.847352801697332,1.0,5/26,10.06%,ATP1A2;SCN2A;KCNJ2;SCN8A;SCN9A
prerank,peptidyl-proline modification (GO:0018208),-0.30328643021545615,-0.9438182262337343,0.5418326693227091,0.8460405553185788,1.0,8/25,15.45%,FKBP5;PPIG;P3H2;PPIH;PPIL2;PPIL3;FKBP1A;PPIB
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.3205118675882356,-0.9436911409733112,0.5264900662251656,0.8448006015577519,1.0,6/18,11.61%,ACSL1;TECR;ELOVL7;ELOVL5;HACD1;ACSL3
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3279212526266617,0.9436784047229693,0.5625,0.8369320305264822,1.0,18/86,16.71%,DLC1;JAK2;OPHN1;ARFGAP1;DENND4C;MAPKAP1;GRB2;OGT;ERBIN;TGFB2;SPRY2;VAV1;AKAP13;ARHGEF18;PDCD10;SQSTM1;SYNGAP1;ARHGDIA
prerank,positive regulation of interleukin-13 production (GO:0032736),0.46925980893693614,0.9435142152131315,0.5491419656786272,0.8368357848962504,1.0,3/10,13.14%,TSLP;LGALS9;SPHK2
prerank,positive regulation of protein depolymerization (GO:1901881),0.4529535713409828,0.9426185856357717,0.5454545454545454,0.8382351404510485,1.0,1/11,1.24%,PDXP
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.37594064648085634,-0.9424365383169931,0.5285714285714286,0.844697905687444,1.0,5/11,27.23%,NOTCH4;TNRC6C;ZFP36;AGO3;AGO4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.37594064648085634,-0.9424365383169931,0.5285714285714286,0.844697905687444,1.0,5/11,27.23%,NOTCH4;TNRC6C;ZFP36;AGO3;AGO4
prerank,regulation of actin filament polymerization (GO:0030833),0.33614093091438063,0.9412623255346815,0.5838084378563284,0.8405188394031914,1.0,17/69,20.54%,CCL11;NCK1;BAIAP2;NCK2;CARMIL1;DBN1;SSH1;SNX9;DBNL;SSH2;CDC42EP1;RASA1;CTTN;CDC42EP4;PLEKHG2;WASHC5;PRKCD
prerank,mesonephric tubule development (GO:0072164),0.428713539356502,0.940999706114657,0.5524079320113314,0.8406039574325053,1.0,4/15,14.05%,ROBO2;PKD2;SALL1;BMP7
prerank,ribosomal large subunit biogenesis (GO:0042273),0.3460404694832934,0.9409722592243212,0.5654205607476636,0.8402284117821305,1.0,19/54,24.01%,MAK16;RPL3L;PES1;NOC2L;WDR74;NOP2;NIP7;GTF3A;LTO1;RPL14;RPL11;NOP16;RPF1;HEATR3;RPL6;PAK1IP1;RSL1D1;MDN1;PPAN
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.4215264809801311,0.9408202948747214,0.5432276657060519,0.8400881516923463,1.0,3/16,8.50%,STOML2;ATP5PO;DMAC2L
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3418409213197585,0.9404400571466488,0.5842044134727061,0.8404149660792656,1.0,8/57,12.44%,DCN;TREM2;BBC3;RALA;ADCK1;SPIRE1;FBXO7;GSK3B
prerank,regulation of wound healing (GO:0061041),0.35575919081750845,0.9402775756432753,0.5631768953068592,0.8403062519461593,1.0,8/42,12.48%,TNFAIP3;CASK;TNFRSF12A;ANXA1;MYLK;PTK2;VTN;FGF2
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.36298884392547687,0.940025768417953,0.5625,0.8403828654629766,1.0,15/36,26.01%,E2F1;RNF2;YAF2;EHMT1;PHC3;MAX;RBBP8;MGA;SUZ12;CDC7;CBX5;RAD51;RYBP;TFDP1;RBBP7
prerank,neuronal action potential (GO:0019228),-0.3012153342849319,-0.9398860553197882,0.5431654676258992,0.8493908988740011,1.0,9/22,27.42%,SCN2A;SCN8A;ANK3;SCN9A;GPER1;MYH14;CACNA1I;SCN3A;KCNMB2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4586440840303874,0.9398680371983966,0.5648967551622419,0.8402601201100179,1.0,4/11,21.08%,ANXA1;SOCS5;RC3H2;ZC3H12A
prerank,negative regulation of apoptotic process (GO:0043066),0.3032528195366922,0.9396307617844891,0.6786786786786787,0.8403272439085836,1.0,88/444,17.37%,NR1H4;BCL3;YAP1;MAP4K4;EGR3;GATA6;SNAI2;BIRC3;PRKCA;FHL2;FSTL1;CFLAR;TSLP;EGFR;TLE1;TREM2;APOE;FXN;MAD2L1;MDK;SHH;BAG3;BABAM2;BCL2;NUGGC;ANGPTL4;APOH;TXNDC5;PTPRZ1;SFRP1;TGFB3;PLK1;SIAH2;ASNS;BCL2L2;ANGPT1;MERTK;CBL;AREL1;SH3RF1;ANXA1;WNT5A;HDAC1;CSNK2A1;CSNK2A2;IL7;HIPK3;RPS6KB1;TBX3;CCL2;FNIP1;DNAJB6;ARF4;PTK2;YWHAZ;PDPN;RNF213;UNC5B;SPRY2;TNF;GSK3B;MGMT;PIK3R1;DDRGK1;ITGA5;MAEA;PSEN1;SRC;CPEB4;PDCD10;CX3CL1;HSPA5;NAA15;RIPK1;SETX;ITCH;PRKDC;SQSTM1;POU3F3;RASA1;LAMTOR5;BAG4;ARHGDIA;MAPK1;HSPD1;AKT1;DNAJC3;YWHAE
prerank,fatty acid transport (GO:0015908),0.41898257854846355,0.9392802138297334,0.5449275362318841,0.8406117104203732,1.0,4/17,12.67%,APOE;CD36;PPARG;FABP5
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4034618898162475,0.9390966938161702,0.5510204081632653,0.8405738621313694,1.0,2/19,7.04%,BCL3;BAG6
prerank,epiboly involved in wound healing (GO:0090505),0.4170991114220801,0.9388891709534446,0.5537065052950075,0.8405575098402195,1.0,6/16,14.53%,MRTFA;LCP1;PDPN;RHOA;ARHGAP35;PDCD10
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.29564352936250626,-0.9387294442989971,0.5485232067510548,0.8506768993526433,1.0,9/26,21.38%,EPHA4;APH1A;VSIR;GRIN2B;APH1B;TTBK1;AIM2;USP50;PSME1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.4609490367938844,0.9387268935820028,0.5515548281505729,0.8404559125553746,1.0,3/10,13.23%,EGF;FBXW7;BTC
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.44439649547069254,0.9386667175806218,0.5515625,0.8401463407831727,1.0,3/12,9.95%,CEP19;PCM1;NIN
prerank,fatty acid oxidation (GO:0019395),0.3439463106407136,0.9385260361392452,0.5860091743119266,0.8399990741437583,1.0,12/57,20.43%,ADIPOQ;EHHADH;SLC27A2;ACOX1;ALDH3A2;ECHS1;DECR1;PECR;HACL1;AUH;ADH5;ECHDC2
prerank,protein insertion into membrane (GO:0051205),0.368385143359057,0.9384402660066524,0.55,0.8397605599427237,1.0,8/32,18.91%,EGFR;TRAM2;WDR83OS;VAPA;ALDH3A2;RTP4;MAIP1;PRNP
prerank,stem cell differentiation (GO:0048863),0.3588534158537263,0.9384397624249544,0.5520094562647754,0.8393312345030802,1.0,8/39,11.44%,BATF;SOX21;SHH;PUM1;SFRP1;LRP6;SETD2;TGFB2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.46243434888335394,0.9384045354508186,0.5562599049128367,0.8389623481269369,1.0,1/10,2.70%,GATA6
prerank,cellular response to retinoic acid (GO:0071300),0.35719483700667565,0.9383279692466014,0.5513905683192262,0.8387049127917745,1.0,7/42,15.71%,WNT2;WNT9A;ATM;WNT5A;PTK7;SETX;ADNP2
prerank,protein-DNA complex disassembly (GO:0032986),0.42179801199594397,0.9382835720784994,0.5278969957081545,0.8383570498931042,1.0,5/16,22.80%,SMARCC1;GRWD1;SMARCA4;ARID2;SMARCD3
prerank,activation of adenylate cyclase activity (GO:0007190),0.365303236233019,0.9381931678340436,0.5598991172761665,0.8381121677661982,1.0,4/35,4.40%,EDNRA;ADCY7;RXFP2;ADCY2
prerank,establishment of protein localization to membrane (GO:0090150),0.3371074061529271,0.9381806315821818,0.5690045248868778,0.8377144561935804,1.0,13/66,16.83%,RFTN1;GORASP2;EGFR;ATG3;SEC63;RAB3GAP2;VPS37C;RAB10;RAB3GAP1;ZDHHC6;ZDHHC9;RTP4;ZDHHC3
prerank,embryonic heart tube morphogenesis (GO:0003143),0.35280226595419717,0.93807575571947,0.5518925518925519,0.8374842023398082,1.0,7/44,12.13%,TBX2;SHH;PKD2;ACVR1;TBX3;NPHP3;SETDB2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.32833631992921797,0.9378602771580715,0.5739130434782609,0.8374752455772332,1.0,17/80,18.37%,EPHA7;CASP1;CTSD;NOD1;SIAH2;SH3RF1;CSNK2A1;FNIP1;DNAJB6;TNF;ACVR1C;SRC;CYCS;LAMTOR5;AKT1;YWHAE;SOX2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.41087234138526485,0.9377238908280505,0.5593451568894953,0.8373321683249151,1.0,6/18,25.91%,MIA3;GPNMB;AKT1;PAG1;ASS1;PPARA
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.326233484879759,0.9374599321796685,0.5637362637362637,0.8374615163421032,1.0,27/78,24.13%,NKD2;LRRK2;PABIR1;RNF144A;PLK1;PRICKLE1;RAD23A;ARIH1;SOCS5;NFE2L2;RNF19B;GSK3B;CSNK1A1;DDRGK1;TRIB3;TRIB1;ZYG11B;CSNK1D;MDM2;ARIH2;FBXO22;RNF14;CLU;FZR1;RNF144B;RNF217;PIAS1
prerank,transcription by RNA polymerase I (GO:0006360),0.3670777228533751,0.9373724839446941,0.5645569620253165,0.8372116048369372,1.0,14/34,24.58%,TAF1D;POLR1E;GTF2H1;CDK7;POLR1B;TAF1A;POLR2L;POLR2K;POLR1G;ERCC2;POLR1A;CCNH;MNAT1;RRN3
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.45329869582242216,0.9371605780348622,0.5419968304278923,0.8372297975177251,1.0,6/10,30.06%,PIH1D2;RUVBL1;PIH1D1;RUVBL2;ZNHIT6;NUFIP1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.40338410797653584,0.9371464598352858,0.5758426966292135,0.8368339489284696,1.0,3/18,5.95%,NF1;MORC3;SFRP1
prerank,response to muscle stretch (GO:0035994),-0.34321495263235774,-0.937108225940598,0.5391849529780565,0.8531693948327016,1.0,2/15,3.22%,DMD;GSN
prerank,electron transport chain (GO:0022900),0.4226403464783635,0.9370827903894082,0.5489913544668588,0.8365333992740742,1.0,3/15,10.07%,ETFA;POR;SDHB
prerank,alanine transport (GO:0032328),0.45793566771567884,0.9369495684200823,0.5516129032258065,0.8363694673344048,1.0,2/10,8.93%,SLC38A3;SLC36A2
prerank,response to estrogen (GO:0043627),0.3739683590696497,0.936561204678224,0.5749385749385749,0.8367175211604245,1.0,5/31,10.09%,RBBP5;ARID5A;CYP27B1;SFRP1;PELP1
prerank,positive regulation of cartilage development (GO:0061036),0.41287155187438446,0.9363522118480833,0.5356622998544396,0.8367043341007218,1.0,3/17,5.18%,SOX5;MDK;BMP1
prerank,carbohydrate biosynthetic process (GO:0016051),-0.3146573738108401,-0.9362886190532853,0.5652173913043478,0.8537101586317338,1.0,4/21,6.77%,ST3GAL6;FUT9;ST3GAL4;ST8SIA6
prerank,ganglioside metabolic process (GO:0001573),-0.3106722718335114,-0.9361418351773907,0.6020066889632107,0.8525198449324706,1.0,6/20,12.49%,ST6GALNAC3;ST8SIA4;ST3GAL5;ST8SIA6;ST8SIA2;ST6GALNAC5
prerank,sprouting angiogenesis (GO:0002040),0.3448587502953079,0.9360662384800761,0.5575539568345323,0.8368852269311451,1.0,12/51,12.48%,CCBE1;EGR3;NRP1;PARVA;E2F8;MIA3;ANGPT1;SEMA3E;BMPER;RNF213;VEGFC;FGF2
prerank,nucleic acid-templated transcription (GO:0097659),0.3443518508666435,0.9359515698687453,0.5696969696969697,0.8366893795319607,1.0,11/42,18.17%,BCL3;E2F1;TERT;RRAGC;POLR3A;NKX2-8;MMS19;BAZ2A;POLR2L;POLR2K;PAX8
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.4345475038335834,0.9359255189180983,0.5362537764350453,0.8358993676868217,1.0,4/12,13.03%,SLC9A1;STIMATE;TNF;SPPL3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.4345475038335834,0.9359255189180983,0.5362537764350453,0.8358993676868217,1.0,4/12,13.03%,SLC9A1;STIMATE;TNF;SPPL3
prerank,ceramide transport (GO:0035627),0.4420833587658061,0.9358527444654534,0.5565610859728507,0.8356268465910272,1.0,2/12,4.28%,ABCA2;PLTP
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3638834251453049,-0.9353647971438754,0.5718085106382979,0.8529695192808605,1.0,5/13,14.35%,RNF152;DEPDC5;SESN2;SESN3;SPAAR
prerank,positive regulation of immune system process (GO:0002684),0.41452183008324645,0.9346681350056623,0.5497076023391813,0.8375866609181217,1.0,4/16,11.44%,LGALS9;MIA3;ANXA1;TGFB2
prerank,positive regulation of isotype switching (GO:0045830),0.42023843623364365,0.9343103737221177,0.5386861313868613,0.8378970927218947,1.0,5/15,18.69%,CD40;SHLD3;RIF1;PAXIP1;HMCES
prerank,regulation of autophagosome maturation (GO:1901096),0.4287720038578645,0.9342380968366969,0.5383458646616541,0.8376229442225265,1.0,4/13,21.25%,TMEM39A;SMCR8;IRGM;CLEC16A
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.3270353561714793,-0.9339281388730075,0.5682539682539682,0.8550111040727381,1.0,7/18,18.19%,RPS6KA5;ADCY1;EPHA5;CD200;LRP8;PRKD1;RELN
prerank,synapse organization (GO:0050808),0.3173349699489322,0.933876414342462,0.6069182389937107,0.8379222204640271,1.0,25/125,14.74%,SLITRK6;PDZRN3;PCDHB6;PCDHB16;FARP1;LRRK2;GPC6;SDK2;ADGRL3;CACNB1;PPFIBP2;PTEN;C1QB;CDC42;PLXND1;L1CAM;PPFIBP1;SEMA3E;DSCAM;DBNL;SDK1;ELFN1;PSEN1;PPFIA4;CX3CL1
prerank,folic acid metabolic process (GO:0046655),0.40528970165638434,0.9337038895149838,0.5575842696629213,0.8378487334680171,1.0,9/18,27.34%,MTHFR;MTHFD1L;MTHFD2L;MTRR;SLC19A1;ALDH1L2;MTHFD1;FOLR2;SLC25A32
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.34053881397091146,0.9336795870619192,0.5525997581620314,0.8374643203907036,1.0,11/53,11.09%,SPRED1;EGFR;SPRED2;BABAM2;PLA2R1;ATM;EEF1E1;CCAR2;ATR;FBH1;TMEM161A
prerank,calcium ion import into cytosol (GO:1902656),-0.34354350028510205,-0.9329879231358993,0.5253164556962026,0.8558773160903187,1.0,6/15,19.38%,SLC24A2;ATP2B4;SLC8A3;TRPV2;TRPV4;SLC8A2
prerank,regulation of activated T cell proliferation (GO:0046006),0.3731646487452527,0.9328817094569127,0.5426751592356688,0.8385794454107486,1.0,2/30,5.04%,IL23R;LGALS9
prerank,negative regulation of axonogenesis (GO:0050771),-0.2975504056842226,-0.932866842765602,0.5690376569037657,0.8545951227830512,1.0,10/27,22.21%,MAP2;DCC;DIP2B;ULK2;CDKL3;MAG;LINGO1;SEMA3G;EFNB3;TRIM46
prerank,production of siRNA involved in RNA interference (GO:0030422),0.46121476454887755,0.9327076943813261,0.5576619273301737,0.8385165404086886,1.0,3/10,19.62%,TERT;DICER1;AGO2
prerank,neuron projection extension (GO:1990138),0.36905256072519843,0.9324213977205859,0.5687022900763359,0.8386531785545331,1.0,4/32,3.93%,TNN;AUTS2;NRP1;USP9X
prerank,regulation of embryonic development (GO:0045995),0.36226862390910125,0.9323668073783375,0.5440993788819876,0.8383390200446899,1.0,10/34,18.34%,B4GALT5;EHMT1;BAG6;WDPCP;NPHP3;ZBED3;PHLDB2;NIPBL;PHLDB1;NR2C2
prerank,protein O-linked glycosylation (GO:0006493),0.3225217728496791,0.9318786431980269,0.5956756756756757,0.8388582464696843,1.0,18/96,16.87%,PLOD2;B4GALT5;ST6GAL1;GALNT3;TRAK1;ST3GAL3;GXYLT2;OGT;SLC35C1;GALNTL6;ST3GAL1;GALNT11;TET2;POFUT2;POGLUT3;TMTC4;CRPPA;C1GALT1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.30868360497204417,0.9318228672473171,0.6208677685950413,0.8385453274502548,1.0,22/159,11.84%,PALLD;CDH11;ROBO2;PCDHB6;JAML;PCDHB16;MILR1;GPC6;SDK2;ADGRL3;TENM3;DCHS1;ACVR1;CDH6;ICAM1;TENM4;L1CAM;DSCAM;TGFB2;CDH18;CDH24;PTPRM
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2560781485395873,-0.9313649164871322,0.5864197530864198,0.8568070350472137,1.0,11/48,16.74%,DGKB;DDHD1;GPD1L;DGKA;SLC27A1;AGPAT3;ACP6;DGKG;GPAT4;PLA2G6;DGKQ
prerank,vascular transport (GO:0010232),0.32606923797030407,0.9312625183683565,0.5947995666305526,0.8392399181624792,1.0,7/81,4.25%,SLC7A2;SLC1A3;LRP1;SLC38A3;SLC2A13;SLC28A2;ABCA2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.4598813050215199,0.9305985945544374,0.5782945736434109,0.8401466364559419,1.0,2/10,5.04%,XCL1;LGALS9
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4180577427701593,0.930557409797858,0.5491679273827534,0.8397986868430896,1.0,5/15,21.08%,POP1;RNASEH1;DICER1;ZC3H12B;ZC3H12A
prerank,cytoplasmic translational initiation (GO:0002183),0.4143337272707619,0.9304344421905324,0.5736994219653179,0.8396278359198497,1.0,6/17,20.36%,EIF4A1;EIF5;EIF2B3;DHX29;MCTS1;EIF4G1
prerank,protein heterotetramerization (GO:0051290),0.43140814163691776,0.9302322940117463,0.5479876160990712,0.8396251122101128,1.0,2/13,8.54%,PKD2;HSD17B8
prerank,filopodium assembly (GO:0046847),0.41700336637671986,0.9300489998346713,0.56047197640118,0.839564045592954,1.0,4/16,11.23%,PPP1R9B;FGD4;S1PR2;FGD6
prerank,regulation of neuron migration (GO:2001222),0.37911218154091053,0.9299610321479119,0.5708712613784135,0.8393122329745244,1.0,4/26,8.12%,COL3A1;TNN;MDK;IGSF10
prerank,sphingosine metabolic process (GO:0006670),-0.31877967315890077,-0.929498149643834,0.5785714285714286,0.859846700995254,1.0,6/17,16.84%,ACER2;SPTLC2;SPTLC1;SGPP1;ASAH2;NAAA
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3897138709820666,0.9294831972962317,0.5574866310160428,0.8397928416442594,1.0,10/22,23.74%,EAPP;CCNT1;HMGN1;TCERG1;BRD4;KAT7;CDK13;CDK12;CDC73;THOC5
prerank,amide transport (GO:0042886),0.3783193764388068,0.9294247182675065,0.5633245382585752,0.8394829085460799,1.0,2/26,4.28%,SLC14A2;PLTP
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.41586372374977953,0.9289588245897633,0.553030303030303,0.8399844037345682,1.0,4/15,18.54%,MAD2L1;RPL11;DTX3L;FBXO5
prerank,negative regulation of programmed cell death (GO:0043069),0.3004217350475802,0.9287434076259303,0.6836836836836837,0.8399804888633889,1.0,66/355,17.28%,NR1H4;BCL3;MAP4K4;EGR3;GATA6;BIRC3;FHL2;FSTL1;CFLAR;TSLP;EGFR;TREM2;FXN;MAD2L1;SHH;BAG3;BABAM2;BCL2;NUGGC;ANGPTL4;TXNDC5;SFRP1;PLK1;SIAH2;ASNS;BCL2L2;RAB7A;AIFM2;ANGPT1;CBL;AREL1;SH3RF1;ANXA1;WNT5A;HDAC1;IL7;HIPK3;RPS6KB1;TBX3;ARF4;PTK2;YWHAZ;PDPN;SPRY2;GSK3B;MGMT;PIK3R1;DDRGK1;PSEN1;SRC;PDCD10;CX3CL1;HSPA5;NAA15;RIPK1;SETX;ITCH;PRKDC;SQSTM1;POU3F3;RASA1;BAG4;ARHGDIA;HSPD1;AKT1;DNAJC3
prerank,cellular amide metabolic process (GO:0043603),0.3197383462591121,0.9285681467315915,0.6095744680851064,0.8399051402174698,1.0,26/102,22.77%,DNPEP;ST6GAL1;MTHFR;MTHFD1L;ABCA2;CPXM1;NLN;PANK2;ACSF2;NSMAF;ACOT13;ST3GAL1;MTHFD2L;ORMDL3;SMPD3;ACOT9;SGPL1;PLA2G4E;ATF4;MTRR;PCCA;SLC19A1;ALDH1L2;THEM4;AEBP1;GNE
prerank,negative chemotaxis (GO:0050919),0.3693196913523469,0.9284290479330759,0.5723270440251572,0.8397610149120182,1.0,3/33,2.46%,EPHA7;SLIT3;SLIT1
prerank,neutral amino acid transport (GO:0015804),-0.2874245409389786,-0.9281210573001282,0.547085201793722,0.8619046358502881,1.0,8/28,15.87%,SLC6A6;SLC6A9;SLC7A5;SLC1A1;SLC43A2;SLC38A5;SLC6A17;SLC6A7
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3751962927314663,0.9280166195021957,0.5867875647668394,0.8401502421544607,1.0,4/29,5.21%,PDGFRA;IRS1;PDGFRB;AMBRA1
prerank,mitochondrial translational elongation (GO:0070125),-0.21973947661753057,-0.927833577996312,0.6575342465753424,0.8610279416767059,1.0,45/88,33.37%,MRPS9;MRPS35;MRPS28;MRPS15;MRPS24;MRPL13;MRPL10;MRPL21;MRPL39;ERAL1;TSFM;PTCD3;MRPL4;MRPS7;MRPS31;MRPL30;MRPL28;MRPS18C;MRPL22;MRPL40;GADD45GIP1;MRPL46;MRPS16;MRPS18B;MRPL58;MRPS22;MRPS6;MRPS25;MRPS12;MRPS34;MRPL44;MRPL18;MRPL20;MRPL35;MRPL23;GFM1;MRPL42;MRPL43;MRPL54;MRPL34;MRPL2;MRPS10;TUFM;MRPL16;MRPL11
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.38834081433909706,-0.9278323803156937,0.5691489361702128,0.8594810095514306,1.0,2/10,8.96%,CAV1;ANK3
prerank,negative regulation of cell growth (GO:0030308),0.3178162275516375,0.9271425384767594,0.620253164556962,0.8413945403813425,1.0,21/121,14.44%,ENPP1;PPP1R9B;BCL6;SLIT3;SERTAD2;FRZB;CYP27B1;SFRP1;ENO1;CCAR2;BTG1;IP6K2;ACVR1B;RERG;PTPRJ;TGFB2;FGF13;SPHK2;SMAD3;CDKN1B;SMAD4
prerank,protein oxidation (GO:0018158),0.4440136691624148,0.926770249354497,0.5545171339563862,0.8417214544967697,1.0,2/11,10.24%,LOXL1;LOXL3
prerank,protein K63-linked ubiquitination (GO:0070534),-0.2652132354904199,-0.9265044893930495,0.6166666666666667,0.8612586381283123,1.0,10/41,15.59%,RNF152;WWP2;PRKN;UBE2E3;HECTD1;UBE2V2;UBE2B;UBE2N;BFAR;PRPF19
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3220071840954969,0.926337983491548,0.608505997818975,0.8421116673434043,1.0,23/98,18.91%,CEMIP;LRP1;NKD2;EGFR;TREM2;BBC3;E2F1;BCL2;ITGA3;PTPN9;YWHAZ;CASP8;TNF;KIF5B;PIK3R1;STAC3;SQSTM1;ITGB1BP1;AKT1;YWHAE;CLIP3;SPTBN1;PRNP
prerank,protein homotetramerization (GO:0051289),-0.25174075417963204,-0.9256274366393209,0.6352201257861635,0.8618184538122099,1.0,20/49,28.76%,KCNJ2;SAMHD1;UPB1;ALDH9A1;GOLGA2;KCNJ12;GBP5;SSBP1;HCN1;SOD2;CBR4;GLS;USP16;APIP;CRYZ;PKD2L1;CTH;TRPA1;CBY1;HSD17B10
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.4098585977026582,0.9253319267284649,0.5670553935860059,0.8436273412106298,1.0,3/16,9.71%,IGFBP4;IGFBP5;BMP5
prerank,negative regulation of binding (GO:0051100),0.32237684317759224,0.9253253247498753,0.5953947368421053,0.8432199203318429,1.0,25/81,20.54%,LRRK2;JAK2;E2F1;ILRUN;DDX11;MDFI;EFHB;SP100;DISC1;RSF1;PEX19;GSK3B;GTF2F1;DACT1;SMO;ITGB1BP1;AKT1;NFKBIA;TLE5;WAPL;CTNNBIP1;KDM1A;PIN1;HMGA2;PRKCD
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.32328423974623666,0.9250885355003267,0.6323851203501094,0.8432738762476036,1.0,12/90,9.38%,ADIPOQ;PLAC8;CMKLR1;JAK2;DYNC1H1;CD36;ALMS1;OMA1;EHMT1;CXCR4;OGT;HCRT
prerank,regulation of membrane repolarization (GO:0060306),-0.35203400184974154,-0.9250626956085218,0.5804597701149425,0.8616814349322235,1.0,3/13,4.05%,CAV1;AKAP6;KCNJ2
prerank,myotube differentiation (GO:0014902),0.40410419634493233,0.9249848076029291,0.5563480741797432,0.8430539748788517,1.0,3/17,5.90%,ADAM12;ADAMTS15;ADAMTS5
prerank,positive regulation of protein sumoylation (GO:0033235),-0.3741388531978681,-0.9243016577331833,0.5512048192771084,0.8620134127029675,1.0,4/10,14.45%,HDAC4;PIAS3;UBA2;PIAS4
prerank,regulation of gluconeogenesis (GO:0006111),0.3752907335654977,0.9241620455197883,0.5947368421052631,0.84422649282395,1.0,6/27,17.41%,ADIPOQ;OGT;PTPN2;GCK;SDHAF3;DDB1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.41370700171025687,0.9237728041932829,0.565406976744186,0.8445777584443251,1.0,2/16,13.14%,ULBP1;KIF5B
prerank,protein localization to cell surface (GO:0034394),-0.28558383664257614,-0.9237283568131665,0.5793991416309013,0.8618715418422291,1.0,12/26,26.61%,ANK2;FBLN5;GGA1;VCL;PTPRK;FGF10;WNT11;PIGU;UNC50;RIC3;PRRT1;PTPRU
prerank,phospholipid metabolic process (GO:0006644),0.3323225536511549,0.9237282641809209,0.5955555555555555,0.8442439181392167,1.0,6/71,8.76%,LGALS13;PDXP;ABCA2;PIP4K2A;FADS1;LPL
prerank,methylguanosine-cap decapping (GO:0110156),0.4582868615943029,0.9237002485106632,0.5882352941176471,0.8438769489705374,1.0,4/10,15.07%,EDC4;DCP2;DCP1A;PATL1
prerank,non-motile cilium assembly (GO:1905515),0.36669593230443553,0.9235380308552228,0.5678073510773131,0.8437915758053345,1.0,6/30,17.00%,IFT57;IFT88;PCM1;DISC1;TOGARAM1;CSNK1D
prerank,mRNA export from nucleus (GO:0006406),-0.21874442195464205,-0.9232839301928953,0.5737704918032787,0.8614377778454714,1.0,37/102,25.42%,YTHDC1;CDC40;SRSF5;WDR33;DDX19B;U2AF2;NUP133;UPF2;UPF1;SEH1L;POM121;SRSF7;SRSF9;RBM8A;NUP43;CHTOP;CPSF2;MAGOH;NUP210;NUP50;ZC3H11A;NUP98;HHEX;EIF4A3;SRSF3;POLDIP3;NUP93;CPSF4;SARNP;MCM3AP;DDX39B;ENY2;NUP88;NUP85;DDX39A;DDX25;THOC1
prerank,pulmonary valve morphogenesis (GO:0003184),0.40468396623531466,0.923115652660956,0.5625920471281296,0.8441899686226233,1.0,4/17,11.44%,ROBO2;JAG1;HEYL;TGFB2
prerank,positive regulation of hemostasis (GO:1900048),0.45067528425683967,0.9221088342628122,0.5623052959501558,0.8452805505973214,1.0,2/10,6.67%,APOH;HPSE
prerank,positive regulation of coagulation (GO:0050820),0.45067528425683967,0.9221088342628122,0.5623052959501558,0.8452805505973214,1.0,2/10,6.67%,APOH;HPSE
prerank,regulation of neuron differentiation (GO:0045664),0.32133697256262034,0.9217038514674283,0.6104190260475651,0.8456381678083416,1.0,16/76,19.61%,ZEB1;TCF4;LRRK2;NREP;HEYL;FGFR1;NEPRO;CALR;RHOA;BMP7;MOSMO;TCF3;ZFHX3;SOX2;VWC2;MED1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.37738161184514685,0.9209561895637243,0.5751295336787565,0.846658101635416,1.0,7/26,17.14%,NOS1AP;PKD2;CD36;TMEM106A;TNF;SMAD3;AKT1
prerank,nucleosome assembly (GO:0006334),0.36479730210586686,0.9209246134308811,0.5755208333333334,0.8462901985248051,1.0,10/31,19.97%,GRWD1;HMGB2;RSF1;UBN1;SPTY2D1;NAP1L3;ATRX;ASF1A;KAT6B;NAP1L1
prerank,regulation of phagocytosis (GO:0050764),0.33991703619154,0.9204251037703814,0.5889281507656066,0.8468512985298248,1.0,7/53,12.30%,ADIPOQ;TLR2;PRTN3;TREM2;MERTK;CALR;TNF
prerank,blood vessel diameter maintenance (GO:0097746),0.3553725184723589,0.9203915591089996,0.5869017632241813,0.8464952722005311,1.0,3/34,2.89%,EDN3;CRP;EDNRA
prerank,cellular response to fluid shear stress (GO:0071498),-0.35233842961493045,-0.920344726244612,0.56,0.8671101305362684,1.0,7/12,24.48%,KLF2;SREBF2;KLF4;HDAC3;MAP2K5;MEF2C;MAPK7
prerank,regulation of T cell activation (GO:0050863),0.3516199267996386,0.9197223840722408,0.578443113772455,0.84737706426358,1.0,12/42,26.27%,TNFSF11;CCL5;GPNMB;CCL2;HSPD1;PAG1;SIRPA;CCDC88B;CYRIB;TNFRSF1B;THY1;PYCARD
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.30427133389126376,0.9197132041451185,0.6457905544147844,0.8469782710950085,1.0,35/148,18.96%,BRIP1;DNA2;NUAK1;RICTOR;KMT5A;PIP4K2A;TAF7;ATM;EHMT1;NOC2L;MAPKAP1;MAPK11;ATR;HDAC1;CSNK2A1;CSNK2A2;TPX2;PRDM1;MTA2;NOP2;BRPF1;RMI1;TAF4;RPL11;BANP;PRKAB1;ATRIP;AKT1;PHF20;ING5;MDM2;RAD9A;TAF2;RBBP8;MBD3
prerank,glucan catabolic process (GO:0009251),-0.3381565988735413,-0.9191230668950857,0.5764705882352941,0.8685972285374994,1.0,4/15,6.91%,CALM1;PGM2L1;PYGM;PYGB
prerank,purine nucleotide metabolic process (GO:0006163),-0.2933682478379086,-0.9189609477152929,0.5714285714285714,0.8674631058777403,1.0,5/24,9.41%,FHIT;PRPSAP2;NT5E;ITPA;PRPSAP1
prerank,nuclear body organization (GO:0030575),0.42120137154426507,0.9187786133722492,0.5628930817610063,0.8483765342316901,1.0,4/12,22.31%,AFF2;USPL1;ETS1;HABP4
prerank,cellular response to oxidative stress (GO:0034599),0.3111733551488748,0.9187475478183076,0.6246056782334385,0.8480184431145121,1.0,29/118,21.45%,PDGFRA;LRRK2;RAD52;EGFR;AIF1;PKD2;PLA2R1;ETV5;ARNT;FOXO3;TMEM161A;NFE2L2;GPX8;TXNRD1;TXNRD2;SETX;CYCS;HIF1A;ADNP2;MAPK1;AKT1;ATF4;CYBB;TPM1;FANCC;PRKCD;ZC3H12A;WNT16;VRK2
prerank,melanosome transport (GO:0032402),0.4035224367210382,0.9185720481767938,0.5804195804195804,0.8475282625063905,1.0,3/18,9.93%,MLPH;MYO5A;RAB27B
prerank,pigment granule transport (GO:0051904),0.4035224367210382,0.9185720481767938,0.5804195804195804,0.8475282625063905,1.0,3/18,9.93%,MLPH;MYO5A;RAB27B
prerank,positive regulation of endothelial cell migration (GO:0010595),0.32070330428590244,0.918481671598284,0.6266375545851528,0.8472847918538432,1.0,34/84,25.43%,SPARC;CD40;PRKCA;NRP1;AKT3;PRKD2;EGF;STAT5A;SASH1;ANGPT1;WNT5A;FGFR1;CALR;RIN2;FGF2;RAC1;HIF1A;FGF18;ITGB1BP1;AKT1;ETS1;AGT;BCAS3;ATP5F1A;FOXP1;ZC3H12A;ROCK2;ITGB3;GPI;BMPR2;VEGFA;AAMP;PLPP3;PDPK1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.44170758236239643,0.9177995852937565,0.5786163522012578,0.8482139319479094,1.0,2/11,8.15%,CREB3L1;ADAMTS9
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.3775786127990951,0.9175011257260047,0.5844504021447721,0.8483552666834975,1.0,1/23,0.48%,ADIPOQ
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.3805368865165919,0.9173920615694686,0.5653950953678474,0.8481549409364632,1.0,5/22,8.49%,TNKS1BP1;RAP2A;TOM1L1;RASSF2;GPNMB
prerank,positive regulation of immunoglobulin production (GO:0002639),0.36620757287719263,0.9173743215025115,0.5694087403598972,0.8477695776743747,1.0,8/31,18.69%,XCL1;SASH3;SHLD3;TNFRSF4;RIF1;PAXIP1;PTPRC;HMCES
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.33363800359499096,-0.9160478309291633,0.552870090634441,0.8731244406433102,1.0,4/16,6.91%,CALM1;PGM2L1;PYGM;PYGB
prerank,response to interleukin-6 (GO:0070741),0.44498289538009556,0.9158628226386608,0.5798722044728435,0.8502475433581446,1.0,2/10,7.40%,SBNO2;PID1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.3767137783590214,0.9158369506196767,0.5664893617021277,0.8498851012214603,1.0,6/25,14.77%,DNAJB1;HSPE1;GAK;DNAJC7;SDF2;HSPA5
prerank,apoptotic cell clearance (GO:0043277),0.3744288819770222,0.9157072843681933,0.5844327176781002,0.8497114853891635,1.0,4/30,8.96%,LRP1;TREM2;TXNDC5;ANXA1
prerank,vesicle transport along microtubule (GO:0047496),0.38096361799275147,0.9156525517596922,0.575136612021858,0.849404271538371,1.0,8/23,17.19%,DYNC1H1;KIF1C;TRAK1;FBXW11;KIF5B;RAB1A;NDEL1;KIF5A
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.29691666611993467,0.9154524814141486,0.7079556898288016,0.8494023215739145,1.0,62/306,19.97%,RPSA;RRBP1;RBMS1;BCL3;ASMT;EIF4G2;TNIP1;B4GALT5;POLE3;BRIP1;DNA2;EXT1;RPL3L;APOE;E2F1;MCM2;EXT2;NT5M;ATM;PABPC4;TERT;RRAGC;MCM7;ATR;DBF4;GRWD1;RNASEH2A;MCM9;POLR3A;RPL12;MRPS18A;TIMELESS;EEFSEC;POLA2;NKX2-8;RPL22;RPL14;REV1;RMI1;MRPS14;RPL11;MMS19;BAZ2A;GSPT1;ATRIP;MRPL55;ING5;RPL36A;RAD9A;MRPL52;POLR2L;RPS9;INHBA;POLR2K;PAX8;RBBP8;RPL6;KAT7;RPLP2;AGO2;MRPS33;NAP1L1
prerank,sarcomere organization (GO:0045214),0.3683747289677197,0.9147999495311827,0.5911458333333334,0.8502137088542423,1.0,2/27,4.03%,CSRP1;FHOD3
prerank,histone acetylation (GO:0016573),-0.23221579068343187,-0.914713817386222,0.6074766355140186,0.874998151839797,1.0,23/69,17.75%,LEF1;JADE1;PER1;ACTL6A;PHF20L1;BRCA2;DR1;TADA1;JADE2;WDR5;EP300;TAF6;TAF6L;HAT1;NAA60;JADE3;MAP3K7;KAT6A;KAT5;TRIM16;EPC1;SUPT7L;APBB1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3579510539289872,0.9144217029323879,0.5938271604938271,0.8505105249671222,1.0,4/33,6.70%,IAPP;FXN;OMA1;ADCK1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.45906401167545496,0.9142742476600101,0.563011456628478,0.8503740297306,1.0,3/10,17.77%,AIDA;HIPK3;MAPK8IP1
prerank,"transcription, DNA-templated (GO:0006351)",0.30184628596051993,0.9134934242674563,0.6863543788187373,0.8514416359246638,1.0,71/207,24.69%,PAX1;BCL3;DEAF1;SOX5;NFIX;E2F1;CEBPD;TAF7;MBD1;TTF2;GTF2H1;NFE2L3;SNAPC3;RRAGC;TRIP11;FOXO3;GTF2F2;CRCP;HIPK3;NCBP2;GTF3A;CBFB;POLR3A;RSF1;CDK7;NKX2-8;GLIS3;SMN1;GTF2F1;IRF9;DRAP1;BRF1;TAF1A;TAF4;MMS19;BAZ2A;SETX;CCNT1;GTF3C4;RBMX;MLLT1;POLRMT;ATF4;TAF2;POLR2L;POLR2K;PAX8;CDK9;IWS1;POLR3GL;PMF1;ERCC2;POLR3K;THRA;TWNK;NFIC;CCNH;THRB;TCEA1;FUBP3;POLR2D;MNAT1;DDX21;PRMT5;CDC73;TAF5;RNPS1;TAF3;TEFM;RNMT;XBP1
prerank,embryonic appendage morphogenesis (GO:0035113),0.429831907426211,0.9134879430242254,0.5843558282208589,0.8510325723698885,1.0,4/12,17.75%,SHH;LRP6;TGFB2;FBXW4
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.37022748351861673,0.9133611154049383,0.5760309278350515,0.8508650660923502,1.0,5/28,11.58%,LACC1;TNFAIP3;NOD1;IRAK2;CASP8
prerank,T cell migration (GO:0072678),-0.3462745399697462,-0.9130415440509808,0.5681818181818182,0.8775457998450924,1.0,2/13,4.04%,SLC12A2;S1PR1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3665842468552305,0.9127967684011533,0.5871313672922251,0.8515271384524288,1.0,6/31,15.09%,STXBP1;CBARP;SYT2;STXBP3;RAB3GAP1;DOC2B
prerank,microtubule-based transport (GO:0099111),0.41229814887184335,0.9125904177480003,0.5652173913043478,0.8514847536508079,1.0,2/13,6.77%,DNAAF4;SPEF2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.4096986455717422,0.9125105232381873,0.5832106038291606,0.8512175601685326,1.0,2/15,5.42%,SFRP4;CYP27B1
prerank,prostaglandin biosynthetic process (GO:0001516),0.39281802341922045,0.9123789761197663,0.5824964131994261,0.851061253553232,1.0,4/18,14.60%,PTGES;PTGES2;TBXAS1;PLA2G4A
prerank,smooth muscle contraction (GO:0006939),0.40695350222609367,0.9122919252916585,0.5806938159879337,0.8508024964932448,1.0,6/14,22.93%,EDNRA;MYLK;TPCN2;SMTN;ROCK2;ROCK1
prerank,fatty acid biosynthetic process (GO:0006633),0.32878324034579975,0.9120292392766425,0.608793686583991,0.8509168661829672,1.0,8/63,9.08%,LIPC;EPHX2;HACD2;SCD5;HSD17B8;FADS1;LPL;CYP1A1
prerank,positive regulation of protein metabolic process (GO:0051247),0.30904986935698475,0.9114688206162365,0.6312433581296493,0.8515690160221493,1.0,37/110,22.52%,IL23R;TNFAIP3;APOE;ABCA2;SMURF2;PAEP;OAZ3;RAB7A;AREL1;WNT5A;CSNK2A1;SLC25A37;ATG7;TNF;GSK3B;RAB1A;DACT1;PSEN1;CDKN1B;RANBP9;SMURF1;ITCH;NEDD4;AKT1;DDB1;INHBA;AGT;NFKBIA;TNFSF12;PLK2;EIF4G1;AXIN1;CLU;CSF1;FZR1;ROCK2;CD80
prerank,tRNA aminoacylation (GO:0043039),0.3494291431226287,0.9114663438986771,0.5738916256157636,0.8511572075837487,1.0,10/37,16.17%,PPA1;YARS1;AIMP1;EEF1E1;IARS2;TARS1;RARS2;RARS1;GARS1;LARS2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.3530333483634073,-0.91141459453907,0.5752212389380531,0.880002447328079,1.0,4/12,15.94%,RAB27A;SLC5A3;TLR4;ZNF205
prerank,positive regulation of ATP metabolic process (GO:1903580),0.36201429531564144,0.911153647125244,0.6051282051282051,0.8513627044078746,1.0,9/32,15.68%,TREM2;ENO1;ARNT;PFKFB4;PID1;ZBTB20;P2RX7;PSEN1;HIF1A
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3425375961960884,-0.9110596278030808,0.5755813953488372,0.8793840732334139,1.0,2/13,2.73%,SOX13;HNRNPU
prerank,regulation of protein kinase C signaling (GO:0090036),0.4096352813072446,0.9109616702839851,0.5933429811866859,0.8513235457884646,1.0,4/14,13.14%,CD40;WNT5A;MC1R;SPHK2
prerank,regulation of endocytosis (GO:0030100),0.3297349781342928,0.910825234472289,0.6113074204946997,0.851189074413072,1.0,6/61,7.37%,STON2;LRP1;APOE;OPHN1;ARFGAP1;PTPN1
prerank,positive regulation of viral genome replication (GO:0045070),0.3649787101831776,0.9108199481167388,0.5931307793923382,0.8507856971391471,1.0,6/29,11.48%,TMEM39A;PPID;CCL5;RAD23A;TOP2B;STAU1
prerank,mitotic recombination (GO:0006312),0.4173482044322563,0.9107856670838541,0.5875190258751902,0.8504323255119541,1.0,7/15,23.20%,RAD52;XRCC3;NSMCE2;TEP1;SMC5;DMC1;RAD51
prerank,intestinal absorption (GO:0050892),0.4234014576003827,0.9106894752205222,0.5681818181818182,0.8502112053116426,1.0,2/13,5.55%,UGCG;CD36
prerank,double-strand break repair via homologous recombination (GO:0000724),0.31247814764161885,0.9106211756780389,0.6389776357827476,0.8499347864657018,1.0,20/95,18.69%,RAD51B;RAD52;MCM2;INO80;XRCC3;MMS22L;ZFYVE26;MCM7;FBH1;AP5Z1;MCM9;NSMCE2;RMI1;XRCC1;NIPBL;PSMD14;NUCKS1;HELQ;RBBP8;SWI5
prerank,phagosome-lysosome fusion (GO:0090385),0.4453986552109014,0.9104778583928783,0.5851063829787234,0.849781993992926,1.0,3/10,13.84%,RAB7A;RAB7B;RAB34
prerank,B cell activation involved in immune response (GO:0002312),0.4232672159617522,0.9102001864214153,0.5780525502318392,0.8498972388200111,1.0,1/13,3.16%,BATF
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.2726636621682117,-0.910075878758316,0.6403508771929824,0.8801544861934858,1.0,6/30,7.73%,CAV1;INPP5F;PRKCZ;SRCIN1;PPP2R1A;PIBF1
prerank,myotube cell development (GO:0014904),-0.37732431934909844,-0.9097975234654156,0.5822102425876011,0.879281736129606,1.0,3/10,15.63%,CAV2;IGF1;SKI
prerank,regulation of Rac protein signal transduction (GO:0035020),0.405878390502171,0.9095922563633503,0.575801749271137,0.8506211406356526,1.0,3/16,9.03%,ARHGAP24;AUTS2;OGT
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.36812706092784014,-0.9092881538059835,0.6032171581769437,0.8790149321545263,1.0,7/11,33.01%,NDUFA13;TIMM22;TOMM70;TIMM8B;ROMO1;TIMM9;TIMM10
prerank,positive regulation of chromatin organization (GO:1905269),-0.35220436948559963,-0.9091232218204345,0.6144200626959248,0.8778902023178731,1.0,4/12,16.59%,UBE2N;SIN3A;H3-3A;TAL1
prerank,polyol biosynthetic process (GO:0046173),0.402988909579703,0.9085381480727938,0.5924308588064047,0.8521813634475662,1.0,5/16,12.52%,CYP27B1;ITPKC;IP6K2;FGF2;CYP2R1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.34901472939253597,0.9075846381288222,0.60546875,0.8535640493248056,1.0,9/35,16.71%,PDGFRA;NRP1;MDK;BAIAP2;CDC42;SEMA3E;NTRK3;FES;ARHGDIA
prerank,T cell mediated immunity (GO:0002456),0.41421258162036717,0.9073886184457352,0.5886627906976745,0.8534909212665722,1.0,2/13,5.33%,JAG1;GNL1
prerank,protein localization to organelle (GO:0033365),0.30657679288413425,0.907302240402258,0.6614906832298136,0.8532375626779369,1.0,37/133,21.74%,COL1A1;LRRK2;TRAM2;CD68;LAMP2;WDR83OS;VAPA;GBF1;WDR35;GAK;CALR;SNX10;DDRGK1;BMP7;RPL11;DCP1A;ALDH3A2;BANP;COG7;OBSL1;CSNK1D;YWHAE;ATP6V1D;DDX1;RAB33B;MDM2;TOR1AIP1;ZBTB7A;PRNP;TULP3;SYS1;LAMP5;ISG15;IFT20;VPS35;YBX1;ZNF423
prerank,selective autophagy (GO:0061912),0.329422070032618,0.906923964484873,0.6142191142191142,0.853519660312339,1.0,11/56,13.32%,DYNLL1;DYNC1H1;AMBRA1;ATM;IFT88;RAB7A;PCNT;WDFY3;UBA5;NBR1;DDRGK1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.33551694202185284,0.9064466385094382,0.6064209274673008,0.854003819694967,1.0,21/51,23.88%,SYNPO;NRP1;CARMIL1;NF2;SFRP1;TGFB3;CDC42;EPHA1;TGFBR1;RHOA;RAC1;CX3CL1;ITGB1BP1;PLEK;TPM1;PAK1;RHOC;RGCC;ROCK2;LPAR1;PXN
prerank,cellular response to leucine (GO:0071233),0.444126887453285,0.9063367965351973,0.5828025477707006,0.8533802466460197,1.0,2/10,7.66%,KLHL22;RPTOR
prerank,response to leucine (GO:0043201),0.444126887453285,0.9063367965351973,0.5828025477707006,0.8533802466460197,1.0,2/10,7.66%,KLHL22;RPTOR
prerank,cilium assembly (GO:0060271),0.2939008258957249,0.9055475527448112,0.7282828282828283,0.8544191399958992,1.0,64/297,17.61%,TEKT4;DYNLL1;CEP19;ASAP1;STK36;DYNC1H1;PARVA;IFT57;TUBG1;ALMS1;IFT88;PLK1;PCM1;HAUS3;RAB8B;CEP41;EXOC4;DYNC2LI1;CNTRL;DCTN3;EHD2;ACTR2;GBF1;TRIP11;FAM161A;EXOC1;EXOC7;WDPCP;PCNT;WDR35;DISC1;PTPN23;ARF4;GALNT11;NPHP3;TNPO1;IFT172;IFT81;CEP72;PDE6D;SNX10;CFAP410;CPLANE1;ACTR1A;RAB1A;DYNC2H1;DZIP1L;AKAP9;KIF27;CDC14A;TTC39C;EXOC5;TOGARAM1;CEP192;EXOC3;NUDCD3;POC1B;WDR90;CSNK1D;SPATA6;YWHAE;ATP6V1D;CKAP5;CFAP74
prerank,regulation of cellular pH (GO:0030641),0.35878973184446983,0.9055048001153827,0.5974025974025974,0.8540803638796328,1.0,5/29,10.23%,SLC9A1;LACC1;TM9SF4;SLC9A8;SLC4A7
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.3620434980915579,-0.905499939512049,0.5816023738872403,0.8850637107778093,1.0,7/11,28.08%,UQCRC2;UQCRB;UQCRH;UQCRFS1;UQCC3;UQCR10;UQCR11
prerank,positive regulation of immune response (GO:0050778),0.32374780368702993,0.9046334146958978,0.6042600896860987,0.8552754566840118,1.0,7/64,13.14%,IL23R;LGALS9;CCL5;SASH3;TGFB2;POLR3D;SPHK2
prerank,inner mitochondrial membrane organization (GO:0007007),-0.24290600603350945,-0.9043796493007353,0.6790123456790124,0.8862374074597282,1.0,23/47,27.19%,ATP5MG;TMEM11;ATP5PD;ATP5PF;LETM1;NDUFA13;MTX3;IMMT;HSPA9;ATP5F1D;MICOS13;ATP5ME;SAMM50;APOO;TIMM22;APOOL;TOMM70;TIMM8B;ROMO1;MICOS10;UQCC3;ATP5MC2;TIMM9
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.40524790957088,0.9043088180415408,0.5925373134328358,0.8554709842231364,1.0,2/15,3.52%,TEC;EGFR
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.2318239523749772,-0.9041234227388452,0.6493506493506493,0.8853163693341335,1.0,8/57,6.50%,CHRM2;ADCY5;GRM7;ADCY9;GRM8;AKAP12;ADCY1;HTR1F
prerank,negative regulation of lymphocyte activation (GO:0051250),0.39409815536510895,0.9040805465974403,0.6146272855133614,0.855481885411501,1.0,3/21,11.70%,TNFAIP3;GPNMB;LST1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.4067869349713687,0.9040701435274083,0.58,0.8550916322847876,1.0,6/15,17.00%,SFRP4;SFRP1;NPHP3;RNF213;DACT1;CSNK1D
prerank,protein acetylation (GO:0006473),0.36042482294024475,0.9038411253804983,0.5875486381322957,0.8551272735996078,1.0,8/30,18.30%,NAA50;CREBBP;NAT9;NAT10;NAA15;CLOCK;ING5;AANAT
prerank,blood vessel endothelial cell migration (GO:0043534),0.37394097633725876,0.9036563761887184,0.5831024930747922,0.8550504130256612,1.0,4/22,7.08%,EGR3;NRP1;MYH9;MIA3
prerank,response to amino acid (GO:0043200),-0.26547210129323207,-0.903568893916578,0.6405529953917051,0.8851658157889725,1.0,13/31,20.44%,CPEB3;SLC38A9;GLRA3;LAMTOR1;GLRA1;SESN2;RRAGB;SPAAR;RRAGD;GLRA2;LAMTOR2;TMBIM6;RRAGA
prerank,replication fork processing (GO:0031297),0.34854376526433556,0.9032564206628546,0.5942211055276382,0.8553481744959368,1.0,15/38,24.75%,DNA2;DDX11;MMS22L;ATR;SETMAR;FBH1;EME2;ATRX;TRAIP;NUCKS1;CDK9;ZRANB3;RAD51;ETAA1;FAM111A
prerank,regulation of protein transport (GO:0051223),0.36913505540395736,0.9032514591659077,0.5896414342629482,0.8549479413849891,1.0,8/27,18.88%,DNAJC1;LLGL1;PTPN1;LCP1;TNF;NDEL1;SCFD1;GAPVD1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.33763352060182683,0.9027259851393425,0.6007025761124122,0.8554509508567189,1.0,23/47,29.52%,ATXN2;APOE;FOXO3;SSH1;NOLC1;AKT1;INHBA;AGT;NFKBIA;RBM4B;EIF4G1;VPS35;CSF1;PCIF1;METAP1;EIF2A;NR1H3;PUM3;CYFIP1;WDR91;GEMIN5;NFKB1;EIF4E
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3398254567121166,-0.9022774365744048,0.6045197740112994,0.8867525238890174,1.0,5/14,19.13%,MALT1;CARD10;CARD14;MAP3K7;IRAK1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.4020880453568477,0.9022734091563054,0.5646551724137931,0.8558593624587977,1.0,4/16,18.30%,NAA50;CREBBP;NAA15;AANAT
prerank,central nervous system neuron differentiation (GO:0021953),0.3577247350882825,0.9021312079937098,0.6066584463625154,0.8557024737091005,1.0,6/33,11.46%,WNT2;MDGA1;OPHN1;LRP6;DRAXIN;AGTPBP1
prerank,NAD biosynthetic process (GO:0009435),-0.29917650480006786,-0.9020760971883054,0.6106870229007634,0.8856872606526826,1.0,9/20,28.02%,NAMPT;NMNAT3;PARP16;NUDT12;NNMT;PARP10;NAXE;NAPRT;KYNU
prerank,regulation of lysosomal lumen pH (GO:0035751),0.430220789001588,0.9018715141198294,0.5990639625585024,0.8557592497052633,1.0,3/12,11.74%,LRRK2;ATP6AP2;CLN6
prerank,cellular response to glucose stimulus (GO:0071333),0.35732543395166577,0.9014856859836029,0.6015625,0.8560793097998839,1.0,1/30,0.13%,SLC39A14
prerank,long-chain fatty acid transport (GO:0015909),-0.2752582828687075,-0.9013003674303066,0.6724890829694323,0.8859691351551668,1.0,6/30,11.61%,PRKAG2;PRKAA2;ACSL1;ABCD3;SLC27A1;ACSL3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.32945395640659136,0.9012045838270256,0.6248520710059171,0.8561769471758817,1.0,17/52,19.96%,BBC3;E2F1;BCL2;NPEPPS;FBXW7;TOMM7;CSNK2A2;UBE2L3;YWHAZ;CASP8;MICALL2;SH3GLB1;YWHAE;LEPROT;USP36;ARIH2;UBL5
prerank,regulation of glycolytic process (GO:0006110),-0.22389832579703975,-0.9005450323863673,0.6486486486486487,0.8862067259641052,1.0,12/68,11.30%,PRKAG2;PRKAA2;HDAC4;INSR;NUP133;CBFA2T3;IGF1;SEH1L;POM121;APP;GIT1;EP300
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.344489460858008,-0.9002672455979372,0.5909090909090909,0.8853384601727954,1.0,6/14,18.65%,KLF4;MEOX2;CARD10;THBS1;TBXA2R;MAP2K5
prerank,microtubule polymerization or depolymerization (GO:0031109),0.3723929300907319,0.8999377027071155,0.6096551724137931,0.8580686613116674,1.0,8/25,19.95%,NCKAP5;KIF2A;FGF13;NCKAP5L;TPPP;CKAP5;CENPJ;PIN1
prerank,negative regulation of insulin secretion (GO:0046676),0.3961047242186656,0.8996258955765897,0.59,0.8582454118301618,1.0,3/17,6.47%,IRS1;SFRP1;INHBB
prerank,linoleic acid metabolic process (GO:0043651),-0.31350606657388513,-0.898969163946269,0.5844594594594594,0.8869288742580738,1.0,2/17,7.04%,ACSL1;ELOVL5
prerank,mitotic chromosome condensation (GO:0007076),0.36270117205288754,0.8986232271938412,0.6,0.8596985483097511,1.0,9/26,21.09%,KMT5A;PLK1;CSNK2A1;CSNK2A2;NCAPD2;NCAPG2;NCAPG;TENT4A;SMC4
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3742052456641407,0.8983445690932845,0.6030013642564802,0.859393526052981,1.0,5/23,11.58%,BBC3;E2F1;BCL2;YWHAZ;CASP8
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3742052456641407,0.8983445690932845,0.6030013642564802,0.859393526052981,1.0,5/23,11.58%,BBC3;E2F1;BCL2;YWHAZ;CASP8
prerank,cAMP metabolic process (GO:0046058),-0.34640262080700596,-0.8981745539346343,0.5867768595041323,0.8873726865568753,1.0,5/13,10.43%,ADCY5;ADCY9;ADCY1;ADCY4;PDE4D
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2923900952579937,0.8978554341018792,0.7409274193548387,0.8599093301081109,1.0,67/314,20.36%,PSMA7;SPSB1;KLHL22;FBXL7;MAD2L1;CUL1;SMURF2;APPBP2;PLK1;ANAPC11;SIAH2;CDC27;BAG6;SKP1;SPOP;TRIM13;FBXL18;FBXW7;AREL1;PSMB8;RAD23A;PSMA6;TBL1X;RAD23B;DCAF11;UBE2J1;NFE2L2;KCTD10;FBXW11;DCAF12;ZSWIM8;PSMF1;UBE2K;MAEA;UBE2W;FBXO2;RHBDD2;HSPA5;PSMA8;SMURF1;ITCH;NEDD4;FBXL19;PSMD2;PSMD12;PSMD11;RBCK1;CLOCK;PCNP;PSMD14;KCTD2;FAM8A1;DDB1;MDM2;PSMB1;FBXW4;FBXO5;FBXO31;HSP90B1;LTN1;AMN1;UBR1;FBXO38;FBXL22;UBXN2A;PSMC6;UBE2E1
prerank,organonitrogen compound catabolic process (GO:1901565),0.33022524179615753,0.8974098684505997,0.6321303841676368,0.860332971433063,1.0,11/57,15.09%,LIPC;ANPEP;CPQ;NPEPPS;PLA2G7;ENPEP;CLN6;LVRN;AMDHD2;PLA2G4A;SGPL1
prerank,macrophage migration (GO:1905517),0.42462036370073863,0.8970953970149828,0.5997001499250375,0.8605144707913681,1.0,2/13,10.36%,CCL5;CCL2
prerank,long-term memory (GO:0007616),-0.3058727855786984,-0.8961848583885139,0.629757785467128,0.8904933392911348,1.0,5/19,9.15%,CPEB3;LDLR;RASGRF1;CAMK4;SHANK1
prerank,regulation of exit from mitosis (GO:0007096),0.3432711025063911,0.8960873333459811,0.6206060606060606,0.8619789277751301,1.0,4/38,6.56%,PPP1R9B;MAD2L1;ANAPC11;CDC27
prerank,cellular response to starvation (GO:0009267),0.29670787498855494,0.8959593211303881,0.696149843912591,0.861803051560092,1.0,45/147,21.25%,DAP;LRRK2;WIPI1;NUAK1;MIOS;SFRP1;NPRL2;EIF2AK2;INHBB;LAMP2;ASNS;RPTOR;RRAGC;FADS1;FOXO3;KPTN;FNIP1;KLF10;ATP6V1F;ATG7;ATP6V1H;ATP6V1G2;STK24;CPEB4;HSPA5;PIK3R4;WDR45;PIK3C3;LAMTOR5;ATP6V1G1;SREBF1;SEC13;SH3GLB1;MAPK1;ATP6V1D;MTMR3;EIF2AK3;ATF4;LAMTOR3;TBL2;ZFYVE1;PDK4;ZC3H12A;BECN1;CLEC16A
prerank,DNA catabolic process (GO:0006308),0.43659326884893723,0.8957707166254489,0.6003134796238244,0.8617718861199426,1.0,2/11,10.03%,SETMAR;FBH1
prerank,entry into host (GO:0044409),0.41799128158489035,0.8957347415302616,0.5945121951219512,0.8614260202725045,1.0,4/13,14.06%,CBL;GRB2;CXCR4;SRC
prerank,negative regulation of cell division (GO:0051782),0.4323109392778449,0.8956157065851129,0.5904761904761905,0.8612287789842549,1.0,2/11,6.83%,VPS4A;E2F8
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3735597645287267,0.895092951734053,0.613031914893617,0.8617709044265734,1.0,5/25,13.14%,LACC1;XCL1;WNT5A;TRAF2;SPHK2
prerank,receptor internalization (GO:0031623),0.336605938318392,0.895002977015217,0.633769322235434,0.8615421129172225,1.0,7/44,11.88%,CLTC;LRP1;ADM;CD36;GRB2;DRD3;CALCRL
prerank,gonad development (GO:0008406),0.3364903854289588,0.8945747568259036,0.615,0.861928692896527,1.0,10/41,21.01%,GATA6;NR2F2;WNT5A;SALL1;TGFB2;ADAM21;TFAP2C;INHBA;NUP107;CSDE1
prerank,myoblast differentiation (GO:0045445),0.41220108681768086,0.8942403688496504,0.5898203592814372,0.8621368042352691,1.0,4/14,8.05%,TCF7L2;JAG1;DDX17;SDC1
prerank,histone H4 deacetylation (GO:0070933),-0.3685313882053195,-0.8942274257172054,0.5915841584158416,0.8934920177372772,1.0,3/10,5.95%,HDAC4;HDAC9;SMARCAD1
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.30944888172860774,-0.8938104509472818,0.5878378378378378,0.8930141301144623,1.0,5/17,10.72%,CLDN5;CDH5;ADD1;VCL;ZDHHC21
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.260557331602044,-0.893642622682383,0.6735751295336787,0.8918847647420671,1.0,7/36,8.96%,KIF13A;RILPL1;GGA1;VAMP4;PREPL;NSF;ANK3
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.36904114588668135,-0.8936121278069261,0.6036745406824147,0.8904601336175914,1.0,3/10,7.73%,INPP5F;PPP2R1A;PIBF1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.39160194578044594,0.8934458767766651,0.6172661870503597,0.8632018166510081,1.0,3/20,5.97%,EGFR;PKD2;CCND3
prerank,protein mannosylation (GO:0035268),-0.2890727050507802,-0.8932564541738433,0.6551724137931034,0.8898160205199633,1.0,1/22,0.12%,TMTC1
prerank,plasma membrane repair (GO:0001778),-0.342883222394201,-0.8929816671257006,0.6168478260869565,0.888951703609597,1.0,3/13,8.42%,MYOF;DYSF;SYT7
prerank,protein destabilization (GO:0031648),0.34988819515061614,0.8928662969873267,0.6227154046997389,0.8638440169286932,1.0,13/32,24.11%,SERF1A;TRIM21;CREBBP;PLK1;RAD23A;FBXW11;MDM2;PRNP;IRGM;SERF2;NR1D1;CDC73;CTSH
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.3721005463653458,0.8927835066542389,0.6157965194109772,0.8635924929117429,1.0,2/24,2.62%,ENPP1;IRS1
prerank,regulation of epithelial cell migration (GO:0010632),0.3316632809694753,0.8927239643810565,0.6308962264150944,0.8632840520568661,1.0,10/51,15.68%,PTN;RHOJ;DOCK1;SASH1;PTPN23;PTK2;BMPER;TGFB2;SRC;HIF1A
prerank,leukotriene metabolic process (GO:0006691),0.38997046525505275,0.8920747931520457,0.6043795620437956,0.8640840973443378,1.0,3/19,14.60%,DPEP2;ABCC1;PLA2G4A
prerank,sodium-independent organic anion transport (GO:0043252),-0.37260121563445625,-0.8913323302659688,0.6072423398328691,0.8913164575294236,1.0,3/10,8.27%,SLCO1C1;SLCO3A1;SLCO2A1
prerank,V(D)J recombination (GO:0033151),0.42438424809995084,0.8912971696382989,0.5873261205564142,0.8651475987835221,1.0,4/11,16.54%,LIG1;HMGB2;PRKDC;TCF3
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.29913062581997146,-0.8912529952940778,0.6286764705882353,0.8899904003326172,1.0,7/20,15.45%,FKBP5;PPIG;PPIH;PPIL2;PPIL3;FKBP1A;PPIB
prerank,establishment of melanosome localization (GO:0032401),0.38659615142151427,0.8911474795997318,0.6192468619246861,0.8650216906675297,1.0,3/19,9.93%,MLPH;MYO5A;RAB27B
prerank,regulation of JNK cascade (GO:0046328),0.30589255936271953,0.8909200573500663,0.657725321888412,0.8650423874575527,1.0,29/101,23.07%,SH3RF3;MAP4K4;TAOK1;EGFR;UNC5CL;AIDA;RAP2A;TAOK3;RASSF2;TIRAP;SH3RF1;EDA2R;PJA2;TRAF2;DACT1;RIPK1;ITCH;TRAF5;MAPK8IP1;MFHAS1;GADD45A;DUSP15;WNT16;SIRPA;AXIN1;SDCBP;MAPK8IP3;NCOR1;MAPK8IP2
prerank,barbed-end actin filament capping (GO:0051016),0.3909502403478528,0.8908056331823803,0.6228813559322034,0.8644408576918666,1.0,7/18,19.06%,SVIL;ADD2;VILL;ADD3;CAPZA1;EPS8;CAPG
prerank,actin filament capping (GO:0051693),0.3909502403478528,0.8908056331823803,0.6228813559322034,0.8644408576918666,1.0,7/18,19.06%,SVIL;ADD2;VILL;ADD3;CAPZA1;EPS8;CAPG
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.27412854007696,-0.8905906456275667,0.6466165413533834,0.8900041982862817,1.0,14/25,37.46%,TNFSF10;PINK1;BNIP3;DNM1L;GPER1;BID;TP53;PPIF;MFF;BIK;PDCD5;BMF;HRK;PMAIP1
prerank,positive regulation of transport (GO:0051050),0.31012798064089264,0.8901746330060504,0.6542669584245077,0.8651787062592132,1.0,13/85,15.09%,KMT2A;LRP1;TREM2;APOE;DYNC1H1;MERTK;ANXA1;CALR;TNF;GSK3B;KCTD7;FMR1;DOC2B
prerank,macroautophagy (GO:0016236),0.3004767812799788,0.8901041123300302,0.6826411075612353,0.8649030118948834,1.0,29/118,18.27%,DYNLL1;WIPI1;CHMP4A;CHMP4B;AMBRA1;ILRUN;PIP4K2A;STX17;VPS4A;LAMP2;ATG3;VPS39;TOMM7;CSNK2A1;CSNK2A2;VPS37C;NBR1;ATG7;ATG16L1;SRC;CHMP2B;PIK3R4;PRKAB1;SQSTM1;RUBCNL;PIK3C3;MTMR3;LIX1L;TOMM22
prerank,regulation of lipid kinase activity (GO:0043550),-0.3583413932409212,-0.8900917474853286,0.580110497237569,0.8896388382506278,1.0,2/11,3.11%,PIK3R3;RB1
prerank,sulfur amino acid catabolic process (GO:0000098),-0.36815386931188265,-0.8895058453543522,0.6010928961748634,0.8895233707507089,1.0,5/10,33.30%,TXN2;CBS;CTH;ADO;MPST
prerank,regulation of neuron apoptotic process (GO:0043523),0.3070679472060497,0.8893775307954267,0.656989247311828,0.8658068240836273,1.0,13/96,12.30%,EPHA7;TREM2;APOE;MDK;BCL2;NF1;PTPRZ1;TGFB3;FOXO3;CCL2;TGFB2;UNC5B;TNF
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.2647592426718791,-0.8890958029722563,0.6842105263157895,0.8889867282150223,1.0,11/32,13.78%,HDAC7;HDAC9;KLF4;KDR;MEOX2;CARD10;GATA2;JCAD;FGFBP1;FOXC2;THBS1
prerank,regulation of response to stress (GO:0080134),-0.3780824778781105,-0.8880942068716802,0.6124031007751938,0.8898375895626529,1.0,8/10,44.04%,CORO2B;SLC38A2;MLC1;STOX1;OPRM1;DYRK3;ADCY8;CRHBP
prerank,ear morphogenesis (GO:0042471),0.3888750523964542,0.8879586557077153,0.6283309957924264,0.8679959763157524,1.0,5/20,18.17%,CHD7;HOXA1;ZIC1;NIPBL;PAX8
prerank,release of cytochrome c from mitochondria (GO:0001836),0.3897347868704406,0.8878567541145121,0.604551920341394,0.8677646370186608,1.0,6/17,22.87%,BBC3;BCL2;GGCT;TIMM50;CLU;FZD9
prerank,positive regulation of cyclase activity (GO:0031281),0.41279582095819356,0.8878083537188044,0.6142433234421365,0.8674579005698257,1.0,2/14,5.10%,CACNA1C;NF1
prerank,sphingoid metabolic process (GO:0046519),-0.33495057417000484,-0.8877677294462594,0.5965909090909091,0.8890687921314833,1.0,5/12,24.73%,DEGS2;SGPP1;ASAH2;NAAA;SPHK1
prerank,protein lipidation (GO:0006497),0.3218160369093609,0.8874004099739096,0.6549295774647887,0.867757535521843,1.0,15/59,16.83%,WIPI1;UGCG;PIGW;PIGN;PIGL;PIGC;ATG7;HHAT;PIGP;ZDHHC6;ZDHHC9;WDR45;PIGH;PIK3C3;ZDHHC3
prerank,protein localization to cilium (GO:0061512),-0.26069085703005285,-0.8873739419636247,0.6407766990291263,0.8885122815523215,1.0,12/32,25.14%,BBS9;INVS;TTC21B;ARL3;TCTN1;TCTN2;BBS4;TULP2;NPHP4;ARL6;IFT122;TULP1
prerank,transcription by RNA polymerase III (GO:0006383),0.36069102878217885,0.8872791195120696,0.6154891304347826,0.8675535813255446,1.0,11/27,21.37%,SNAPC3;CRCP;GTF3A;BRF1;GTF3C4;ICE1;POLR2L;POLR2K;POLR3GL;POLR3K;SNAPC5
prerank,cardiac muscle tissue development (GO:0048738),0.33082302836012917,0.8871010462506297,0.6248492159227985,0.8674772699952017,1.0,11/50,15.19%,TBX18;GATA6;TBX2;ADAMTS9;SMAD5;BMP5;MAML1;AKAP13;BMP7;SMAD4;SMAD1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.3707509671597573,0.8856540023116117,0.623448275862069,0.8696931020988874,1.0,6/21,21.64%,FZD1;LRP6;GSK3B;CSNK1A1;DVL2;AXIN1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.41618490327262125,0.8854873331500102,0.6224961479198767,0.8696014409529956,1.0,1/12,4.98%,BCL2
prerank,regulation of lamellipodium organization (GO:1902743),0.40648313455938173,0.8854560911602584,0.620384047267356,0.8692630085506883,1.0,4/14,14.73%,CARMIL1;CDC42;PDPN;RAC1
prerank,metal ion export (GO:0070839),0.349972081328247,0.8852395370764413,0.622568093385214,0.869236921468821,1.0,3/31,4.90%,KCNT2;SLC9A1;KCNA5
prerank,regulation of protein dephosphorylation (GO:0035304),0.3467995558397219,0.8851319646641445,0.6372670807453417,0.8690342865794888,1.0,13/37,20.54%,DLC1;PPP2R5A;PPP1R2;SPPL3;PPP1R16A;CALM2;PTPA;ANKLE2;MFHAS1;HSP90B1;PIN1;PPP6R2;PRKCD
prerank,rRNA modification (GO:0000154),-0.29281407221401345,-0.8845613430485031,0.6462093862815884,0.8935550470970047,1.0,12/21,31.05%,ZCCHC4;TFB1M;DKC1;DIMT1;GAR1;NOP10;TSR3;THUMPD1;TRMT112;FBL;NHP2;TFB2M
prerank,negative regulation of DNA replication (GO:0008156),0.4079105030314126,0.8843713160237653,0.6143497757847534,0.8700432882311205,1.0,5/13,23.37%,PDS5A;ATR;WAPL;TERF1;CDC6
prerank,mitochondrial membrane organization (GO:0007006),-0.26481550316135183,-0.8842991836644806,0.6860986547085202,0.892712683585687,1.0,13/32,20.64%,SLC25A4;RCC1L;BCL2L1;TMEM11;MFN1;MTX3;IMMT;BNIP3;HSPA9;MICOS13;SAMM50;APOO;APOOL
prerank,phospholipid transport (GO:0015914),0.3260632497809363,0.8840745635744894,0.6533490011750881,0.8702019066731838,1.0,5/52,4.34%,ABCA1;ATP8B1;APOE;PLTP;ABCG1
prerank,mitochondrion disassembly (GO:0061726),0.3454727384176334,0.8834792607538802,0.6392156862745098,0.870883597806234,1.0,12/34,23.32%,WIPI1;AMBRA1;CTSK;ATG3;FBXO7;ATG7;WDR45;SQSTM1;FUNDC2;BECN1;MARK2;ATG2B
prerank,positive regulation of chromosome organization (GO:2001252),-0.3206507596235573,-0.8833897009390591,0.6046511627906976,0.8933462833021386,1.0,4/15,8.31%,RAD21;MRE11;PPP1R10;RTEL1
prerank,chemical homeostasis (GO:0048878),0.3199234086946548,0.883243066450534,0.6640271493212669,0.8709214654222234,1.0,11/61,14.14%,TREM2;USF1;TLCD2;PPARG;ADCK1;ACOX1;FBXW7;SLC4A7;ZBTB20;ACOX3;ABHD8
prerank,regulated exocytosis (GO:0045055),0.29398935468501114,0.8829372743704176,0.7126673532440783,0.8710631735562216,1.0,16/173,6.60%,KNG1;SERPING1;SPARC;LHFPL2;TIMP1;PROS1;STEAP2;BLK;MYH9;CD36;APOH;EGF;BRPF3;TGFB3;STXBP1;LAMP2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3667559242420638,0.8827439772034885,0.6433378196500673,0.8709937449155204,1.0,14/24,30.93%,PHF1;DNMT3B;SPI1;PPHLN1;TASOR;TRIM27;SUZ12;PPM1D;MPHOSPH8;RBBP7;DNMT3A;EZH2;BMI1;JARID2
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.2803228066172355,-0.8827240602722453,0.6407407407407407,0.8934731382794655,1.0,5/24,11.39%,LPGAT1;SERAC1;ABCA3;SLC27A1;CDS2
prerank,GTP metabolic process (GO:0046039),0.39846623636431255,0.8823836723229095,0.5963172804532578,0.8712290220623687,1.0,4/15,23.82%,LRRK2;ENTPD7;IMPDH2;IMPDH1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.34037805610616056,0.8822821056913009,0.6317733990147784,0.8710137849788652,1.0,4/40,7.40%,LRRK2;STOML2;BCL2;PID1
prerank,regulation of neutrophil migration (GO:1902622),-0.3618975428790018,-0.8822689415199819,0.583547557840617,0.892975580518281,1.0,4/10,21.32%,RHOG;MPP1;RHOH;NCKAP1L
prerank,modulation of chemical synaptic transmission (GO:0050804),0.30465406732944095,0.8821453559872723,0.6687965921192758,0.8708427065061616,1.0,12/107,9.38%,CEL;ADIPOQ;CACNA1A;LRRK2;NPAS4;PTEN;OPHN1;DLGAP3;DLG4;PXK;KCNMB4;HCRT
prerank,Golgi inheritance (GO:0048313),0.42915839505167097,0.8821050475318926,0.6220839813374806,0.8705103687764064,1.0,4/11,14.53%,GBF1;YWHAZ;VCPIP1;PDCD10
prerank,regulation of phospholipase C activity (GO:1900274),0.4011703239431078,0.8820981970797646,0.6257575757575757,0.8701196279095569,1.0,5/15,12.55%,PDGFRA;PDGFRB;FGFR1;FGF2;NTRK3
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3391326362412665,0.8818856424641145,0.6468446601941747,0.8701052271497981,1.0,14/42,22.61%,MBD2;SMARCC1;INO80;HDAC1;ARID1B;MTA2;GATAD2B;SPTY2D1;SRCAP;SMARCA4;MBD3;HNRNPC;ACTL6B;CHD8
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.353053642413075,0.8817423980121382,0.6259640102827764,0.869971137266634,1.0,3/31,9.03%,PDGFRA;HOXB3;TGFBR1
prerank,clathrin coat assembly (GO:0048268),0.38878833249650174,0.8815856772442582,0.6092814371257484,0.8698562397860548,1.0,1/15,0.64%,CLTC
prerank,fibrinolysis (GO:0042730),0.40426865203747425,0.8815338001746131,0.6137339055793991,0.8695546781517516,1.0,1/13,6.23%,PLAT
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4151638185072971,0.8812352398164262,0.5933734939759037,0.8696862957894098,1.0,6/13,20.69%,ZFPM2;TBX2;FGF2;GLI1;RBPJ;BMPR1A
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3848586272246547,0.8808449229645607,0.6228323699421965,0.8700072440252509,1.0,5/18,14.28%,LRRK2;DTNBP1;GSK3B;RAB3GAP1;FMR1
prerank,negative regulation of JNK cascade (GO:0046329),-0.26427374522917085,-0.880826749988099,0.6711111111111111,0.8947869439284566,1.0,12/31,24.77%,MECOM;PRKN;PER1;SH3RF2;DUSP10;PINK1;CYLD;GPS2;HDAC3;ZMYND11;DUSP19;MEN1
prerank,metal ion transport (GO:0030001),0.31021642842431574,0.8806151950086585,0.6786492374727668,0.8700053064778472,1.0,13/86,13.92%,CACNA1A;CACNA2D1;CACNA1C;CCR1;ITPR1;PKD2;CYP27B1;CCL5;NIPAL2;CALCRL;NIPAL4;TUSC3;PSEN1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.41286206162705585,0.8805974822794171,0.6200607902735562,0.8696300483313036,1.0,2/13,13.14%,GAB2;SPHK2
prerank,positive regulation of protein ubiquitination (GO:0031398),0.30755327901222446,0.8798729026732924,0.672566371681416,0.8705395313426453,1.0,11/80,9.70%,LRRK2;MYCBP2;BIRC3;ARRDC4;PLK1;PRICKLE1;ARRDC3;ANGPT1;DCUN1D1;FBXW7;UBE2L3
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.35465015771236913,0.8797561744554993,0.6186666666666667,0.8699315623285184,1.0,5/29,11.47%,CENPQ;CENPN;RSF1;CENPL;RUVBL1
prerank,CENP-A containing chromatin organization (GO:0061641),0.35465015771236913,0.8797561744554993,0.6186666666666667,0.8699315623285184,1.0,5/29,11.47%,CENPQ;CENPN;RSF1;CENPL;RUVBL1
prerank,negative regulation of endocytosis (GO:0045806),-0.27547372273455945,-0.8796882313952787,0.6631578947368421,0.8958168416498662,1.0,14/24,39.35%,CAV1;MCTP1;ABCA7;PACSIN3;PRKD1;RUBCN;SYT11;LRSAM1;NR1H2;SCAMP5;ARF6;LILRB1;UNC119;EPHA3
prerank,positive regulation of lipid catabolic process (GO:0050996),0.37686527689190435,0.8793960398450319,0.6193820224719101,0.8701546654302525,1.0,1/19,2.62%,IRS1
prerank,protein autoubiquitination (GO:0051865),0.31542247423511227,0.8789970479915606,0.6486796785304249,0.870443986286073,1.0,13/61,15.59%,SH3RF3;TRIM21;CNOT4;TRIM13;SH3RF1;RNF213;RNF19B;RNF181;TRAF2;RNF11;DTX3L;RNF141;ITCH
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.24315282563426918,-0.8788825609867045,0.6547619047619048,0.8961856416281004,1.0,10/46,16.74%,DGKB;DDHD1;GPD1L;DGKA;SLC27A1;AGPAT3;ACP6;DGKG;GPAT4;DGKQ
prerank,positive regulation of cell aging (GO:0090343),0.4205002850746585,0.8786334913333377,0.6325301204819277,0.8706984185240564,1.0,4/11,20.05%,EEF1E1;YPEL3;CGAS;HMGA2
prerank,regulation of cell development (GO:0060284),0.3417181815408785,0.8777034579817912,0.6426735218508998,0.8719622865978842,1.0,7/36,17.14%,YAP1;BHLHE40;HEYL;HMGB2;CX3CL1;CLOCK;AKT1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.266667418062587,-0.8759071622674491,0.65,0.9012966330708791,1.0,13/31,21.49%,ATXN3;STAMBP;USP8;USP7;CYLD;SPATA2;OTUD1;BABAM1;OTUD7A;YOD1;OTUD4;USP50;USP16
prerank,positive regulation of mRNA processing (GO:0050685),-0.28584779156278156,-0.8758616282071844,0.6633986928104575,0.8999132029045106,1.0,8/21,25.95%,NCL;CIRBP;LEO1;DAZAP1;DHX36;NUP98;RBM3;SF3B4
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.3709512272845012,0.8758110230363283,0.6301939058171745,0.874908882846492,1.0,7/23,15.68%,EGF;ARNT;PFKFB4;ZBTB20;P2RX7;PSEN1;HIF1A
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.35485668212393345,0.8757017444857411,0.6245059288537549,0.8746849374866736,1.0,9/27,17.14%,MARK1;TREM2;PTEN;DISC1;FBXO7;GSK3B;PSEN1;NDEL1;AKT1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.2709090969254451,-0.8754540732226519,0.7016129032258065,0.8993688084134295,1.0,10/27,20.24%,PRKN;UBE2E3;UBE2A;CDC23;UBE2B;ANAPC1;ANAPC4;ANAPC5;ANAPC13;CDC26
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.3933782236877269,0.8745844857558629,0.6167664670658682,0.8762206980961612,1.0,1/15,1.62%,ASMT
prerank,glutathione derivative metabolic process (GO:1901685),0.3686179160719919,0.8742611096640188,0.6343178621659634,0.8759907066468114,1.0,3/20,10.94%,MGST1;AKR1A1;GSTK1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3686179160719919,0.8742611096640188,0.6343178621659634,0.8759907066468114,1.0,3/20,10.94%,MGST1;AKR1A1;GSTK1
prerank,regulation of DNA repair (GO:0006282),-0.2446666660066422,-0.8741999641830686,0.6795580110497238,0.9005808383534101,1.0,14/44,18.96%,EYA2;EYA1;EYA4;SMCHD1;ERCC6;UBE2V2;UBE2N;CEBPG;USP1;PCNA;SIRT7;FGF10;BABAM1;DEK
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.38860830091781867,0.8741870069091999,0.6150506512301013,0.8757283858313601,1.0,4/15,13.84%,ACVR1;ACVR1B;ACVR2A;DACT1
prerank,positive regulation of neurogenesis (GO:0050769),0.31284604618997247,0.874042952019455,0.6794582392776524,0.8755541907415844,1.0,22/68,22.90%,ROBO2;NUMBL;PLXNC1;PLXND1;SERPINF1;CAPRIN1;PLXNA3;DISC1;RHOA;NUMB;CX3CL1;ARHGDIA;OBSL1;PLXNB2;SPEN;KDM1A;NAP1L1;TIAM2;NPTN;SMARCD3;FZD3;PLXNB1
prerank,clathrin-dependent endocytosis (GO:0072583),0.3573334736604412,0.8740424868775327,0.6398362892223738,0.8751501610961574,1.0,6/26,10.49%,CLTC;ITSN1;DNAJC6;CANX;GPR107;GAK
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.36696881811210147,-0.8739375798616931,0.6124031007751938,0.8997299581762599,1.0,2/10,6.00%,ZBTB16;SOX6
prerank,icosanoid secretion (GO:0032309),-0.33403588129797457,-0.8734099812361049,0.6186666666666667,0.8994526803556155,1.0,4/12,19.93%,ABCC4;BDKRB2;ACE;DRD2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.22723154034973708,-0.8733152558771868,0.7421875,0.8981880570483052,1.0,20/62,22.43%,MLLT3;ELOC;CTR9;NELFB;ERCC3;LEO1;EAF2;POLR2A;POLR2H;NELFA;SSRP1;POLR2G;POLR2F;GTF2H2;SUPT4H1;POLR2E;ELOB;CCNK;GTF2H4;NELFE
prerank,cellular response to zinc ion (GO:0071294),0.4036108697664479,0.8729338456341083,0.6205882352941177,0.87667058934016,1.0,1/15,1.99%,HVCN1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.4197114008983372,0.8725391932161773,0.6391912908242613,0.8769335904119062,1.0,1/11,4.98%,BCL2
prerank,mitochondrial translational termination (GO:0070126),-0.2082410826005531,-0.8713302825984559,0.775,0.9012539368759452,1.0,41/88,31.25%,MRPS9;MRPS35;MRPS28;MRPS15;MRPS24;MRPL13;MRPL10;MRPL21;MRPL39;ERAL1;MTRF1;PTCD3;MRPL4;MRPS7;MRPS31;MRPL30;MRPL28;MRPS18C;MRPL22;MRPL40;GADD45GIP1;MRPL46;MRPS16;MRPS18B;MRPL58;MRPS22;MRPS6;MRPS25;MRPS12;MRPS34;MRPL44;MRPL18;MRPL20;MRPL35;MRPL23;MRPL42;MRPL43;MRPL54;MRPL34;MRPL2;MRPS10
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.3137982504612174,0.8704724330990572,0.6666666666666666,0.8801571538449061,1.0,13/57,20.09%,TAOK1;BABAM2;ATM;PLK1;TAOK3;MDC1;RINT1;EME2;PRKDC;RAD9A;FBXO31;HMGA2;CDC14B
prerank,positive regulation of organelle organization (GO:0010638),0.3461650679131583,0.8704616365854807,0.6358974358974359,0.8797696583660167,1.0,9/32,15.09%,TREM2;ANXA1;RAB3GAP2;LMAN1;GSK3B;P2RX7;SMCR8;RAB3GAP1;DOC2B
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.32347854210671034,0.8701778775004856,0.6709601873536299,0.8798640672368445,1.0,14/52,18.76%,LRP1;NKD2;EGFR;TREM2;ITGA3;PTPN9;TNF;KIF5B;PIK3R1;STAC3;SQSTM1;AKT1;CLIP3;SPTBN1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.3495244101466276,-0.8701501900332277,0.6350974930362117,0.9023745483055815,1.0,2/11,8.04%,MAVS;CAMK4
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3695917937951042,0.8701360736186342,0.6014084507042253,0.8795279284615098,1.0,6/19,14.06%,PINX1;DCP2;NAT10;XRN1;CTC1;SRC
prerank,negative regulation of locomotion (GO:0040013),0.41501964745617337,0.8696841776402685,0.6352583586626139,0.8798831551618284,1.0,1/12,1.00%,FBLN1
prerank,homocysteine metabolic process (GO:0050667),0.4102471774925599,0.8696559342976058,0.6081504702194357,0.8795237909286192,1.0,1/11,3.82%,MTHFR
prerank,activation of protein kinase B activity (GO:0032148),-0.26216072001708524,-0.8695871089010299,0.6611570247933884,0.902183783639298,1.0,5/29,4.70%,IL18;GAS6;INSR;FGF1;CCDC88A
prerank,protein localization to Golgi apparatus (GO:0034067),0.3528085615357288,0.8694893034987973,0.644474034620506,0.8794201374983407,1.0,16/27,28.61%,VPS13C;GBF1;GAK;COG7;OBSL1;CSNK1D;RAB33B;ARL5A;SYS1;IFT20;ARL5C;ARFRP1;RAB6A;TMED10;OPTN;RIPOR1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.33626282840796207,0.8694725138652706,0.6556776556776557,0.8790420434082692,1.0,9/36,14.52%,OPHN1;BAG6;EIF3H;CCAR2;OGT;PSMF1;GIPC1;DDRGK1;RPL11
prerank,Rap protein signal transduction (GO:0032486),-0.36642719672744894,-0.8689613045245137,0.6380208333333334,0.9021186269912349,1.0,3/10,11.64%,RAPGEF3;RAPGEF2;RAP1A
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.36079724165151045,0.8686306565719292,0.6266666666666667,0.8800786353134202,1.0,5/24,16.09%,PDE3A;PRKAR1B;GNAI1;RASD2;CGAS
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.34111023390914713,0.8684202948978599,0.6367137355584083,0.8800486068859916,1.0,13/33,21.92%,APOE;PPARG;RHOA;TNF;FGF2;PDCD10;ITGB1BP1;ACVRL1;ANGPT2;HDAC5;GADD45A;STARD13;RGCC
prerank,N-glycan processing (GO:0006491),0.3756568331454182,0.8673740415357467,0.6427525622254758,0.8814034766730169,1.0,7/18,19.82%,PRKCSH;MAN2A1;MAN1C1;MGAT4A;GNPTAB;GANAB;MAN2A2
prerank,cellular response to interleukin-4 (GO:0071353),0.4260361172870868,0.8670062935690303,0.629742033383915,0.8816675446503005,1.0,2/10,10.26%,XCL1;TCF7
prerank,calcium import into the mitochondrion (GO:0036444),0.4231291967054841,0.8665876862988897,0.637223974763407,0.8820284564206701,1.0,4/10,18.80%,MICU2;MCUR1;MAIP1;MICU3
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3495995097581521,0.8654225726626037,0.64,0.8836482363676587,1.0,10/29,25.80%,SMAD2;PUM1;DICER1;SMAD3;SMAD1;TUT7;AGO2;SNIP1;AGO1;HNRNPA2B1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.23249946966143123,-0.8654191048630816,0.7485380116959064,0.908440592813079,1.0,19/54,26.37%,RNF152;PRKN;KLHL3;UBE2E3;UBE2A;UBE3A;RFFL;HACE1;UBE2B;BFAR;SKP2;TRIM32;UBE2D1;KBTBD7;RNF5;NEDD4L;RNF126;RBX1;RNF115
prerank,retrograde axonal transport (GO:0008090),0.38481244413154936,0.86521016740956,0.6573116691285081,0.8836082041151385,1.0,6/16,20.40%,DYNC1H1;KIF1C;FBXW11;KIF5B;KIF5A;DST
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.33322164203366667,0.8651195081688076,0.6575682382133995,0.8833588467761868,1.0,8/38,14.54%,CENPQ;CENPN;RSF1;CENPL;RUVBL1;UBN1;ATRX;ASF1A
prerank,cell junction maintenance (GO:0034331),0.3985658726175857,0.8644414863294352,0.6408759124087591,0.8841312349210061,1.0,1/14,2.72%,PRTN3
prerank,photoreceptor cell development (GO:0042461),0.3920450527171115,0.864325055532521,0.6329866270430906,0.8839207055944311,1.0,2/14,7.53%,CDHR1;MYO7A
prerank,modulation by host of symbiont process (GO:0051851),-0.2656678044006401,-0.8640982040791421,0.7373271889400922,0.9098846928982447,1.0,7/31,11.77%,LEF1;SAP30BP;JUN;INPP5K;CHD1;EP300;SP1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.35619106278642376,0.8637608013828456,0.646112600536193,0.8844886673516812,1.0,6/24,14.32%,DLC1;CGNL1;ARHGAP6;PIK3R1;ARHGEF18;PHLDB2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.34633253625140986,0.8635747438798045,0.6333333333333333,0.8844310439497569,1.0,10/27,24.17%,POP1;RNASEH1;DICER1;XRN1;RNASE1;PARN;ZC3H12B;ZC3H12A;PCF11;CPSF3
prerank,neurotransmitter uptake (GO:0001504),0.40776214438703856,0.8635150693147403,0.6461538461538462,0.8841356180200033,1.0,1/12,0.63%,SLC1A3
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.33284656174113947,0.8632761293077952,0.6628056628056628,0.8841520083349543,1.0,9/37,14.52%,BAG6;EIF3H;CCAR2;OGT;CSNK2A1;CSNK2A2;GIPC1;DDRGK1;RPL11
prerank,positive regulation of protein import into nucleus (GO:0042307),0.35109308252157906,0.8631828282946212,0.6374501992031872,0.883879390006188,1.0,6/28,13.92%,UBR5;BAG3;ZIC1;PIK3R1;SMAD3;PSEN1
prerank,amyloid fibril formation (GO:1990000),0.3239226377204113,0.8630729635671845,0.6607773851590106,0.8836798195879714,1.0,6/51,6.45%,HSPG2;IAPP;USP9X;SERF1A;CD36;SIAH2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.3776965983900088,0.8624027782606504,0.6210995542347697,0.884416120691615,1.0,4/17,12.48%,EGR3;NRP1;MIA3;FGF2
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.23323959619344006,-0.8623815374696299,0.7241379310344828,0.9120749976249581,1.0,18/45,27.82%,BMP4;DDX5;RIOK1;U2AF2;WDR43;POLR2A;DIMT1;ERN1;HNRNPLL;SIRT7;ZC3H18;SUPV3L1;UTP15;TP53;SLC38A2;ZPR1;HSPA1A;TRMT112
prerank,anion transmembrane transport (GO:0098656),0.30769810661786773,0.862036339742102,0.6994413407821229,0.8846482185260288,1.0,2/67,0.63%,SLC7A2;SLC1A3
prerank,protein deacetylation (GO:0006476),0.32995788508194707,0.8618075361356675,0.6773006134969325,0.88464010446735,1.0,12/41,19.11%,RCOR1;MIER2;PRDM5;HDAC1;TBL1X;MTA2;SIRT3;BAZ2A;MTA3;RCOR2;HDAC5;BRMS1L
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.38216961838837893,0.8615103746572328,0.6177715091678421,0.8847479837232333,1.0,4/16,14.88%,NCBP2;SFSWAP;SRSF12;SNRNP200
prerank,regulation of transport (GO:0051049),-0.2471939711309673,-0.86091569466623,0.7128712871287128,0.9138408194413269,1.0,4/36,2.95%,ICA1;PRKN;EPB41;ACTB
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.33309600523538646,-0.8606115665351599,0.6394366197183099,0.9130315032027653,1.0,2/12,1.54%,CAV1;CTNNA3
prerank,heart looping (GO:0001947),0.3292076232867566,0.8601124260578968,0.6436498150431565,0.886749802882317,1.0,7/40,15.46%,TBX2;SHH;PKD2;TBX3;NPHP3;SETDB2;SMO
prerank,response to X-ray (GO:0010165),0.38702475880035025,0.8600229049249687,0.6270430906389302,0.8864973471219106,1.0,5/14,17.25%,ATM;ANXA1;IKBIP;NIPBL;NUCKS1
prerank,myeloid dendritic cell activation (GO:0001773),0.4136044663421523,0.8599815343189433,0.6604068857589984,0.8861613907473597,1.0,1/12,3.16%,BATF
prerank,glycolytic process (GO:0006096),0.3461234548156006,0.8599067309137148,0.6675603217158177,0.8858820003113904,1.0,4/28,11.60%,HK2;ENO1;GAPDH;GCK
prerank,striated muscle cell development (GO:0055002),-0.32015861599942375,-0.8594894241081886,0.6426332288401254,0.9139280675065347,1.0,2/14,3.95%,PGM5;TMOD3
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.36374017696785554,0.859459552775986,0.6704067321178121,0.8862581571660382,1.0,9/21,25.68%,TNKS1BP1;CNOT4;SAMD4A;TUT7;PARN;CNOT2;CNOT3;CNOT1;CNOT7
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.22111980421245625,-0.8592506200990625,0.7941176470588235,0.912993129102705,1.0,17/57,21.02%,CYFIP2;MALT1;MAP3K5;TNFSF10;BCAP31;NDUFA13;GRIN2B;PERP;TTBK1;GRAMD4;GPER1;SOX7;SYK;AIM2;LGMN;HTRA2;USP50
prerank,mRNA splice site selection (GO:0006376),-0.25499642826115365,-0.8590866117695468,0.6792452830188679,0.911903572536932,1.0,7/30,15.71%,CELF2;YTHDC1;SRSF5;ISY1;SNRPC;SRSF9;LUC7L3
prerank,protein targeting (GO:0006605),0.29220143223206296,0.8589764408192881,0.729758149316509,0.8866781026054886,1.0,26/118,19.53%,LTBP2;AP4M1;TRAK1;KIF13B;LAMP2;ATG3;TOMM7;SEC63;CDC37;VPS37C;FBXO7;PEX19;TIMM17A;GIPC1;SEC61A1;RPL11;ZDHHC6;ZDHHC9;RTP4;SRP14;ZDHHC3;PEX6;TOMM22;PEX12;HACL1;TIMM23
prerank,cellular glucose homeostasis (GO:0001678),0.3250759518917401,0.8588233154129558,0.6633906633906634,0.8865372269314113,1.0,8/41,17.25%,SLC39A14;HK2;FOXK2;GCK;ZBTB20;PIK3R1;HIF1A;NUCKS1
prerank,activation of GTPase activity (GO:0090630),0.3005729975687078,0.8587651313551444,0.7175572519083969,0.8862349679919632,1.0,18/89,14.96%,SYDE1;ARHGAP24;ARHGAP42;SIPA1L3;TAX1BP3;TBC1D16;EPHA1;TBC1D2B;RABGAP1L;ARHGEF19;TBC1D8B;RABGAP1;NTRK3;TBC1D1;ADPRH;ARHGAP22;TBC1D10B;SIPA1L2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.28270629280836057,-0.8585161846316864,0.6415094339622641,0.9116784253938227,1.0,3/24,2.77%,DMD;AKAP6;CALM1
prerank,mononuclear cell differentiation (GO:1903131),0.35161613708037076,0.8584657551181603,0.6535859269282814,0.8863518873631514,1.0,4/24,5.97%,TREM2;BLK;MYH9;PPARG
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.33839682136801785,-0.8580197031528289,0.6552706552706553,0.9112064936956891,1.0,5/13,24.29%,PRR5L;CNOT8;UPF1;RC3H1;ZC3HAV1
prerank,positive regulation of integrin activation (GO:0033625),0.40716270414496325,0.857972091330678,0.6191950464396285,0.8868030221059076,1.0,5/11,21.94%,SRC;PLEK;PIEZO1;P2RY12;RAP1B
prerank,peptide hormone secretion (GO:0030072),0.34554457806544253,0.8579461260491579,0.6455525606469003,0.8864408015937356,1.0,3/26,13.45%,EDN3;ANXA1;RAB1A
prerank,mitochondrion morphogenesis (GO:0070584),-0.34841317058717336,-0.8577737578735698,0.6705202312138728,0.9102625592334102,1.0,7/11,27.02%,WASF1;DNM1L;SUPV3L1;SLIRP;MYH14;NUBPL;MFF
prerank,protein import into nucleus (GO:0006606),0.3057594169502707,0.8576988259263814,0.6771300448430493,0.8864722266155861,1.0,16/66,20.96%,CBLB;STAT3;PRICKLE1;FAM53B;KPNA3;NUP153;TNPO1;E2F3;NUP35;NUP188;SEC13;AKT1;HEATR3;NUP214;KPNA2;NUP107
prerank,pseudouridine synthesis (GO:0001522),0.394787051474158,0.8574599734631373,0.646969696969697,0.8864730611331803,1.0,3/13,9.72%,PUS7L;TRUB2;PUS3
prerank,response to interleukin-4 (GO:0070670),0.426013832002582,0.8573374118786367,0.6409090909090909,0.8862882917598381,1.0,2/10,10.26%,XCL1;TCF7
prerank,microtubule depolymerization (GO:0007019),0.3774816795481326,0.8572730807140474,0.6455882352941177,0.8860009835261787,1.0,4/17,17.55%,NCKAP5;KIF2A;NCKAP5L;CKAP5
prerank,protein acylation (GO:0043543),-0.2418362504669745,-0.8571176761903563,0.7208121827411168,0.9101784701550691,1.0,12/38,16.77%,GLUL;ZDHHC13;ZDHHC21;EP300;ZDHHC17;ZDHHC14;SELENOK;ZDHHC5;KAT6A;ZDHHC15;PORCN;ZDHHC2
prerank,cellular component maintenance (GO:0043954),-0.3297908287756711,-0.8567202956860084,0.6335227272727273,0.9095415187849164,1.0,2/12,3.58%,IGF1R;INSR
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.3893895067824993,0.8566497040460542,0.6483679525222552,0.8866572957144252,1.0,7/15,25.49%,COL11A1;PIEZO2;TMEM120A;LHFPL5;ADGRV1;PDZD7;TMC1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3027132204428319,0.8565214520423684,0.7068004459308808,0.8864796272027865,1.0,15/72,14.83%,IAPP;TAOK1;NAV3;TREM2;APOE;LIMA1;EMILIN1;TPX2;SSH1;CAMSAP2;FGF13;SSH2;PLEKHH2;SMAD4;PFDN1
prerank,positive regulation of metabolic process (GO:0009893),0.29664293786832896,0.8563116403740626,0.728448275862069,0.8864351792125647,1.0,28/103,21.99%,ADIPOQ;PLAC8;CMKLR1;JAK2;DYNC1H1;CD36;ALMS1;OMA1;EHMT1;CXCR4;OGT;HCRT;TNF;ELOVL6;FABP5;GNAS;PRKAB1;DECR1;ACACA;FASN;KDM1A;IL4R;LCN2;THRA;GRB10;DIO2;FABP4;CNOT3
prerank,"base-excision repair, AP site formation (GO:0006285)",0.3759380052772263,0.8563064433586274,0.6506364922206507,0.8860453420297196,1.0,1/17,1.20%,MPG
prerank,cardiac ventricle development (GO:0003231),-0.2851457114902862,-0.8560916419681913,0.6989247311827957,0.9094809224809604,1.0,5/20,14.26%,MATR3;HECTD1;MDM4;PDE2A;HEY2
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.39240792809157443,0.8559977246382255,0.6216617210682492,0.8861354547729766,1.0,2/12,12.30%,TREM2;TNF
prerank,negative regulation of cyclase activity (GO:0031280),-0.31746959673926356,-0.8553033233118784,0.6477611940298508,0.90974987817371,1.0,2/14,5.48%,PALM;GRM3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.360653882566788,0.8545334568886194,0.6606896551724138,0.8882297496997315,1.0,5/22,15.60%,VPS4A;TOM1L1;VPS37C;PTPN23;NEDD4
prerank,regulation of presynapse organization (GO:0099174),0.3696473679382278,0.8541573841924415,0.6221910112359551,0.888062031172702,1.0,2/18,2.81%,MDGA1;GPC6
prerank,regulation of presynapse assembly (GO:1905606),0.3696473679382278,0.8541573841924415,0.6221910112359551,0.888062031172702,1.0,2/18,2.81%,MDGA1;GPC6
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.38859064128242543,0.8541229637979606,0.6363636363636364,0.8877193371747439,1.0,4/14,21.92%,CD40;CCL2;ANO6;RGCC
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.37774067532763517,0.8539505603544052,0.6523031203566122,0.8875901889230873,1.0,2/17,9.77%,NOS1AP;KCNAB1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.32239363887581357,-0.8539310173338418,0.6558823529411765,0.9111968325262318,1.0,2/13,5.48%,PALM;GRM3
prerank,regulation of protein catabolic process (GO:0042176),0.2948669543506533,0.8533974742129287,0.7188841201716738,0.8880499403730081,1.0,24/99,17.55%,TNFAIP3;EGFR;IRAK3;MAD2L1;SMURF2;OAZ3;RAB7A;AREL1;WNT5A;CSNK2A1;ATG7;TNF;GSK3B;DACT1;CENATAC;AZIN2;CDKN1B;BANP;SMURF1;ITCH;NEDD4;CTSA;DDB1;MDM2
prerank,mRNA methylation (GO:0080009),0.38840485761976173,0.8527683098599641,0.6323529411764706,0.8886947135033251,1.0,5/15,23.59%,ZC3H13;METTL16;TRMT61B;TRMT61A;PCIF1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3494926544429363,0.8525307667538148,0.6508795669824087,0.8886913217392519,1.0,10/24,22.66%,PINX1;DCP2;NAT10;XRN1;CTC1;SRC;TNKS2;HNRNPC;TERF1;SLX4
prerank,nuclear export (GO:0051168),-0.21038448986977415,-0.8521055069562977,0.85,0.9137532105981856,1.0,28/80,25.42%,RANBP3L;MALT1;CDC40;SRSF5;U2AF2;DESI1;STRADB;POM121;HNRNPA1;SRSF7;SRSF9;RBM8A;CHTOP;MAGOH;ZC3H11A;EIF4A3;SRSF3;CSE1L;POLDIP3;XPO5;PHAX;SARNP;XPO6;NUTF2;DDX39B;DDX39A;XPO4;THOC1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.39369909102460343,0.8517866332752949,0.6324237560192616,0.889551755830056,1.0,4/13,17.75%,MDK;RHOA;TNF;ETS1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3724771973253008,0.8514981845719222,0.6575539568345323,0.8896136924639085,1.0,3/18,13.29%,NCK1;BAG6;PIK3R1
prerank,sphingoid biosynthetic process (GO:0046520),-0.3381345754702381,-0.8513959791527057,0.6081871345029239,0.9123631881922508,1.0,3/11,5.15%,ACER2;SPTLC2;SPTLC1
prerank,sphingosine biosynthetic process (GO:0046512),-0.3381345754702381,-0.8513959791527057,0.6081871345029239,0.9123631881922508,1.0,3/11,5.15%,ACER2;SPTLC2;SPTLC1
prerank,DNA replication initiation (GO:0006270),0.3301004042465722,0.8503664801003473,0.6845310596833131,0.8911311303770186,1.0,6/37,14.00%,POLE3;MCM2;MCM7;DBF4;POLA2;LRWD1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3389754455214933,-0.8502910833084627,0.6744186046511628,0.9131974181429701,1.0,4/12,12.96%,CCT4;CCT5;DKC1;GNL3L
prerank,skeletal muscle contraction (GO:0003009),0.3734316207549876,0.8499905020746584,0.6623188405797101,0.8913800749496615,1.0,3/19,14.95%,CCDC78;TNNC1;STAC3
prerank,ncRNA metabolic process (GO:0034660),0.32740582629543064,0.8499545972504365,0.6798029556650246,0.8910482894326683,1.0,8/37,19.62%,DDX17;DICER1;DTD1;ZCCHC8;TUT7;PARN;BCDIN3D;AGO2
prerank,proteoglycan biosynthetic process (GO:0030166),0.33633256455512445,0.8499475433506778,0.6691729323308271,0.8906571720399696,1.0,7/31,16.27%,CHST13;EXT1;EXT2;CHST11;UGDH;B4GALT7;FAM20B
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3715271482943491,0.849781284568886,0.6770538243626062,0.8905341618114903,1.0,4/19,15.31%,CHMP4B;PLK1;EML3;CHMP2B
prerank,nucleus organization (GO:0006997),0.3186663886859268,0.8493578523337942,0.6920374707259953,0.89082875542215,1.0,11/47,18.15%,CHMP4A;CHMP4B;VPS4A;LEMD2;CHMP7;NDC1;CHMP2B;SUN1;NUP35;PITPNB;USP36
prerank,neutrophil activation (GO:0042119),0.40039069026870855,0.8489789869226437,0.6676829268292683,0.8910841483492372,1.0,3/12,11.07%,CCL5;PREX1;KMT2E
prerank,hippo signaling (GO:0035329),0.34691206182039336,0.8481696464962182,0.6564673157162726,0.8920467203796586,1.0,12/26,22.19%,YAP1;AMOTL1;TEAD3;DCHS1;WWTR1;TEAD1;STK4;LATS2;YWHAE;DVL2;LATS1;SAV1
prerank,regulation of protein localization to membrane (GO:1905475),0.33839304845003904,0.847815483318694,0.6692810457516339,0.8922120939251484,1.0,3/28,6.56%,MMP14;GPC6;VPS4A
prerank,positive regulation of translational initiation (GO:0045948),0.3717131739158621,0.8467157180698066,0.676056338028169,0.8936536301167891,1.0,7/18,23.22%,KHDRBS1;CCL5;RPS6KB1;YTHDF3;HABP4;YTHDF2;POLR2D
prerank,regulation of receptor recycling (GO:0001919),-0.3003747814332385,-0.8465020295504653,0.6742671009771987,0.9197796984423886,1.0,4/16,14.27%,INPP5F;LAMTOR1;NSF;SCRIB
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3096033133197257,0.8461781113075814,0.6926658905704307,0.8941148939113966,1.0,5/59,3.46%,PALLD;ROBO2;PCDHB6;SDK2;TENM3
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.38772217952561133,0.8454030620963053,0.6558823529411765,0.8950058283709482,1.0,2/14,5.04%,XCL1;LGALS9
prerank,anterior/posterior pattern specification (GO:0009952),0.3171304103428809,0.8452710785238488,0.7077464788732394,0.8948251208000938,1.0,7/53,9.97%,SMAD2;HOXB3;ATP6AP2;BHLHE40;HEYL;TGFBR1;WLS
prerank,aggrephagy (GO:0035973),0.34613696261132154,0.8452336024163432,0.6762028608582574,0.8944810974838616,1.0,5/27,10.21%,DYNLL1;DYNC1H1;IFT88;PCNT;WDFY3
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.21806847043788935,-0.8452149204200243,0.7155963302752294,0.9210215331231864,1.0,21/70,23.11%,CHPT1;MBOAT1;CHKA;ENPP2;LPCAT2;LPIN1;ABHD3;ABCA3;SLC27A1;GPLD1;PCYT1B;GPAT4;PLA2G6;MFSD2A;CHKB;DBI;PCTP;PCYT1A;PLA2G4C;PLAAT3;TMEM86B
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.37752019992910696,0.8447199124066865,0.6714082503556188,0.8949283863633396,1.0,6/16,20.32%,SHH;PKD2;SALL1;FGF2;PAX8;GDNF
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.27168257245723104,-0.8443970865790066,0.6976744186046512,0.9212619341405044,1.0,18/23,49.62%,CADM1;PIK3R6;AP1G1;LAMP1;PVR;RAET1E;NECTIN2;RASGRP1;LILRB1;ARRB2;SLAMF6;CD226;IL12A;CRTAM;NCR1;KLRD1;CD160;KLRK1
prerank,cellular response to osmotic stress (GO:0071470),0.3566925730669911,0.843920201409141,0.6639784946236559,0.895876218967395,1.0,4/21,13.71%,ZFP36L1;PKD2;MYLK;YBX3
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3591011409580196,-0.8437831227262443,0.6693766937669376,0.9210332987452798,1.0,3/10,12.55%,CCT4;CCT5;DKC1
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.2772966043253907,-0.8436477519282282,0.7047244094488189,0.9198514263503609,1.0,8/23,22.66%,HSP90AA1;NDUFA13;COX18;SAMM50;TIMM22;TOMM70;TIMM8B;ROMO1
prerank,cytoplasmic microtubule organization (GO:0031122),0.3111826724292502,0.8436237562976131,0.6860189573459715,0.8959489975497422,1.0,18/54,23.09%,DYNC1H1;HOOK2;PCM1;RHOA;CAMSAP2;FIGN;FIGNL2;TUBGCP4;FSD1;TPPP;CLIP3;CAMSAP1;HOOK1;DST;DLG1;CCDC88B;CLIP4;KPNB1
prerank,purine-containing compound salvage (GO:0043101),-0.32603891636822196,-0.8436026744652024,0.6722689075630253,0.9185330164670434,1.0,4/12,22.10%,ADK;GMPR;DCK;APRT
prerank,activation of phospholipase C activity (GO:0007202),0.3339429750088657,0.8435219526488044,0.6490765171503958,0.8957290713108294,1.0,4/29,12.45%,EDNRA;EGFR;LPAR2;ARHGAP6
prerank,carbohydrate catabolic process (GO:0016052),0.3211770135978252,0.8434213572308392,0.7001270648030495,0.8955079744813251,1.0,13/38,25.93%,HK2;ENO1;GAPDH;GCK;NEU3;NEU1;MAN2C1;GPI;PFKFB1;MAN2B1;ENO3;PFKFB2;PGM1
prerank,retinoic acid metabolic process (GO:0042573),0.3825280891927245,0.8431951507336571,0.6575342465753424,0.8954929241236795,1.0,3/14,18.23%,ALDH1A2;SCPEP1;ADH1A
prerank,regulation of exosomal secretion (GO:1903541),0.36308830884729587,0.8430702495082526,0.6748971193415638,0.8952876070513894,1.0,9/19,25.84%,VPS4A;RAB7A;SDC1;SMPD3;SDC4;SDCBP;PDCD6IP;TSG101;CHMP3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.3787568715770943,0.842820050241664,0.6496124031007752,0.8952963289747986,1.0,5/16,16.89%,DPYSL3;NT5M;TET2;DPYD;NT5C1A
prerank,DNA repair (GO:0006281),0.27603074203154415,0.8426808024662718,0.8279678068410463,0.8951062911164124,1.0,65/284,20.80%,RAD51B;PARP3;MPG;BRIP1;BACH1;SMC1A;DNA2;RAD52;TNKS1BP1;ASCC3;BABAM2;INO80;XRCC3;ATM;PDS5B;PWWP3A;GTF2H1;LIG1;DCLRE1C;PDS5A;RAD23A;ATR;FTO;RAD23B;SETD2;RNASEH2A;FBH1;ALKBH5;ALKBH1;USP3;TIMELESS;TDP2;POLI;MC1R;MGMT;MDC1;EME2;XRCC1;VCPIP1;ASF1A;DTX3L;MMS19;SETX;PRKDC;SLC30A9;TRAIP;ATRIP;PNKP;NUCKS1;DDB1;DDX1;RAD9A;RBBP8;HINFP;EID3;GADD45A;MBD4;KPNA2;HMGA2;ERCC2;TENT4A;FANCC;NEIL1;PARP4;FANCE
prerank,protein deneddylation (GO:0000338),-0.3451109252061822,-0.8424483221961165,0.6542553191489362,0.919555046735311,1.0,3/10,16.01%,COPS5;COPS7B;TOR1A
prerank,gastrulation (GO:0007369),0.3815648785734829,0.8424042000564684,0.6570605187319885,0.8951596375461378,1.0,5/15,19.34%,SMAD2;NPHP3;UGDH;LRP5;TASOR
prerank,nuclear migration (GO:0007097),0.39305968257922846,0.841744758345521,0.6449612403100775,0.8958336541060486,1.0,4/13,12.26%,DYNC1H1;PCM1;CEP120;FBXW11
prerank,determination of heart left/right asymmetry (GO:0061371),0.31986582728748075,0.8416761888411667,0.6825980392156863,0.8955418893293564,1.0,7/43,15.46%,TBX2;SHH;PKD2;TBX3;NPHP3;SETDB2;SMO
prerank,negative regulation of protein secretion (GO:0050709),0.3227815593969159,0.8411747952880707,0.6703567035670357,0.8959763319086954,1.0,6/38,12.15%,IRS1;APOE;SFRP1;INHBB;DRD3;DPH3
prerank,inorganic cation transmembrane transport (GO:0098662),0.2744684520182172,0.8410139354408418,0.8308308308308309,0.8958472232535845,1.0,16/268,5.83%,MCOLN2;SLC39A14;SLC1A3;CACNA1A;SLC6A2;HVCN1;SLC9A1;SLC11A2;CACNA1C;ATP5PO;KCNF1;KCNA5;PKD2;TRPC6;SLC24A5;SCN7A
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.33432695148219094,0.8409780586420424,0.6649145860709592,0.8955050383413017,1.0,9/29,19.15%,ACSL4;HACD2;SCD5;HSD17B8;HSD17B12;ELOVL6;ACSL5;ACACA;FASN
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.32602028757341667,-0.8409485652058651,0.6798780487804879,0.9211517091470232,1.0,2/13,1.76%,BMP6;BMP4
prerank,regulation of axonogenesis (GO:0050770),0.30513477062005634,0.8407721281096182,0.6883116883116883,0.89546647950638,1.0,10/51,14.08%,ROBO2;PLXNC1;EPHB3;KIF13B;PTEN;PLXND1;PLXNA3;RHOA;GSK3B;ARHGAP35
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3178263621741935,0.8406388532757855,0.6764705882352942,0.8952865580147426,1.0,14/41,20.96%,LACC1;NUP37;RAE1;OGT;NUP153;GCK;NDC1;HIF1A;NUP35;NUP188;SEC13;ZBTB7A;NUP214;NUP107
prerank,regulation of water loss via skin (GO:0033561),0.37859936368999747,0.8392578823316873,0.6489208633093525,0.8967641757675536,1.0,1/15,2.95%,UGCG
prerank,establishment of skin barrier (GO:0061436),0.37859936368999747,0.8392578823316873,0.6489208633093525,0.8967641757675536,1.0,1/15,2.95%,UGCG
prerank,TOR signaling (GO:0031929),0.34736775495736233,0.8388916988706098,0.6657929226736566,0.896975863412205,1.0,6/26,11.24%,RICTOR;RPTOR;MAPKAP1;RPS6KB1;FNIP1;EIF4EBP1
prerank,positive regulation of ATPase activity (GO:0032781),0.31756279403357784,0.838860224556657,0.7142857142857143,0.8966313737490711,1.0,3/41,3.17%,VMP1;DYNLL1;DNAJB1
prerank,cell projection organization (GO:0030030),0.3298428098661169,0.8382531696005708,0.6696542893725992,0.8972467398188412,1.0,8/30,23.39%,RHOJ;PARVA;CDC42;RAC1;PLEK;CAPG;P2RY12;ITGB1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.33691445867575825,0.8382522630086334,0.6796875,0.896851360206109,1.0,12/27,28.12%,NAA50;CREBBP;BAG6;RUVBL1;PHF20;KAT6B;KAT7;TRRAP;MORF4L2;MORF4L1;MRGBP;RUVBL2
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.36177947394437054,0.8381796444657678,0.6703755215577191,0.8965593389361548,1.0,3/20,9.55%,PUM1;TERT;DICER1
prerank,response to chemokine (GO:1990868),0.3939108503669522,0.8380286272485553,0.6710526315789473,0.8964147948475761,1.0,4/13,21.08%,CXCL12;RHOA;LRCH1;ZC3H12A
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3232998232892052,0.8378750345131771,0.6838235294117647,0.8962640590732671,1.0,10/38,18.91%,IL34;NCK2;DLG4;PTPN1;MVP;SH3BP5L;FCGR1A;PTPRC;AGT;PRNP
prerank,negative regulation of cell projection organization (GO:0031345),0.31399352288486737,0.8374349755449599,0.7049180327868853,0.8965921717763481,1.0,9/48,13.48%,MYLIP;DPYSL3;APOE;PTEN;GAK;PTPN9;DENND5A;SPRY2;RTN4RL1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.3430621220484155,0.8373147045384425,0.6757105943152455,0.8963887246066772,1.0,6/25,17.14%,NOS1AP;PKD2;CD36;TNF;SMAD3;AKT1
prerank,nucleotide metabolic process (GO:0009117),-0.26436597355931735,-0.8369844920158316,0.7076923076923077,0.9278161102931095,1.0,3/23,7.23%,FHIT;ME1;NMNAT3
prerank,leukocyte tethering or rolling (GO:0050901),0.37722831527304757,0.8361523551298826,0.6751117734724292,0.89787097626704,1.0,3/17,12.30%,SPN;ADD2;TNF
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.3476505958013266,0.835421172881012,0.6897001303780965,0.8986895447677425,1.0,5/26,12.48%,XCL1;ITPR1;PKD2;IBTK;FGF2
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2797304720433218,-0.8351732464181656,0.698170731707317,0.9300314894157462,1.0,6/19,15.74%,PRKN;SREBF2;CAMKK2;VDAC1;PINK1;DNM1L
prerank,cellular response to misfolded protein (GO:0071218),-0.277118206531334,-0.8348845620652331,0.7092198581560284,0.9292267571897512,1.0,9/20,24.84%,ATXN3;DNAJC18;DERL1;TOR1A;RNF185;UFD1;KLHL15;RNF5;RNF126
prerank,positive regulation of glucose import (GO:0046326),0.3577190234372005,0.834116874653857,0.6938775510204082,0.9003987256061511,1.0,2/21,2.62%,ADIPOQ;IRS1
prerank,nucleotide-excision repair (GO:0006289),-0.18974443743459288,-0.8338939088123211,0.875,0.9297605723970824,1.0,42/101,29.31%,ERCC5;ATXN3;COPS5;AQR;ISY1;BRCA2;ERCC6;ERCC3;UBC;COPS7B;HUS1;EP300;UVSSA;POLD3;USP7;POLR2A;POLR2H;CHD1L;PCNA;POLR2G;DDB2;POLR2F;PRPF19;GTF2H2;ERCC1;POLR2E;OGG1;GTF2H4;RFC3;TP53;UBA52;GTF2H3;FAN1;POLD2;CETN2;RBX1;RPA2;PARP1;LIG4;XPC;POLE;RFC4
prerank,neuron apoptotic process (GO:0051402),0.3722770909593591,0.8337848535158533,0.6723646723646723,0.9005478143645935,1.0,3/19,10.28%,TNFRSF21;BCL2;GAPDH
prerank,axonemal dynein complex assembly (GO:0070286),0.3316702574128293,0.8335043165478146,0.6881578947368421,0.9006108218218498,1.0,4/28,13.37%,DNAAF4;TTC12;ODAD1;DNAAF5
prerank,apoptotic nuclear changes (GO:0030262),0.34812645269294923,0.8333955837341679,0.7020408163265306,0.9003881500206377,1.0,4/24,12.75%,ERN2;DICER1;HMGB2;ACVR1C
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.2777703461418906,-0.8333187841992558,0.7116104868913857,0.9294548713344586,1.0,3/20,11.30%,RB1;IGF1;EP300
prerank,ERAD pathway (GO:0036503),-0.19467919768644457,-0.832701837118017,0.8674698795180723,0.9292357638552369,1.0,26/83,26.81%,PRKN;STT3B;ATXN3;ERLIN1;JKAMP;UBXN4;UBE4A;DNAJC18;DNAJB9;ERLIN2;DERL1;ANKZF1;TOR1A;WFS1;UBXN6;RNF185;UFD1;YOD1;SGTA;FBXO44;RNF5;NPLOC4;RNF139;UBQLN2;CCDC47;DNAJB2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.34281337407196794,-0.831688435900247,0.7044198895027625,0.9298469464351445,1.0,4/11,22.06%,GPER1;DHX36;MYOCD;MEF2C
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.24084305529218292,-0.8311884610048511,0.7830188679245284,0.9294144153832222,1.0,17/36,26.62%,RB1;SGMS1;MADD;TPD52L1;NR4A2;CYLD;QARS1;BDNF;ASAH2;CRADD;BCL2L12;TMBIM6;PPIA;STYXL1;TRAF1;MAZ;TRIM39
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.29394110060272566,-0.8311240545707813,0.7045454545454546,0.928119156184751,1.0,6/16,15.61%,IGF1R;INSR;CLN3;UPF1;MTRF1;BNIP3
prerank,DNA duplex unwinding (GO:0032508),0.3091141609529218,0.8308825232617438,0.7215041128084606,0.9040025872658554,1.0,8/50,10.37%,ASCC3;MCM2;DDX11;GTF2H1;MCM7;ANXA1;RAD23B;MCM9
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.3650637600841535,0.8307872919777611,0.6900420757363254,0.9037507555002833,1.0,6/18,12.48%,MDK;AKT3;PPARG;CCL2;FGFR1;FGF2
prerank,glutathione metabolic process (GO:0006749),-0.23572904285265112,-0.8303844462301334,0.7440758293838863,0.9282226781134177,1.0,11/38,23.37%,GCLC;HAGH;GSTZ1;CHAC2;ETHE1;GSTA3;GSR;SOD1;CTNS;GSTM5;GCLM
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3506615920835839,0.8302719606824532,0.6626344086021505,0.904178347071227,1.0,9/21,27.89%,CGNL1;MAPKAP1;TGFB2;SPRY2;SYNGAP1;SPRY4;CYRIB;ARHGAP12;SPRY1
prerank,striated muscle cell differentiation (GO:0051146),-0.2965939012637071,-0.8302166320533708,0.7203647416413373,0.9271300953625274,1.0,8/16,28.39%,SORT1;SIK1;SKI;MYOCD;MEF2C;MTLN;KDM6B;CBY1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3484919606053606,0.8300305107067383,0.6875852660300137,0.9041879833031606,1.0,6/25,18.70%,CHMP4A;CHMP4B;CHMP7;CHMP2B;LEPROT;LEPROTL1
prerank,regulation of protein export from nucleus (GO:0046825),0.35218468775300893,0.829923185918425,0.6796657381615598,0.9039826298284365,1.0,4/23,12.44%,TCF7L2;BAG3;SP100;GSK3B
prerank,regulation of cytoplasmic translation (GO:2000765),0.38966184409929805,0.8296940379453658,0.6919575113808801,0.90396228635223,1.0,4/14,14.52%,CPEB1;YBX3;FMR1;CPEB4
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2858048533647396,0.8292665433182557,0.7606093579978237,0.9042621314720876,1.0,27/95,22.62%,DYNLL1;DYNC1H1;TUBG1;ALMS1;PLK1;PCM1;HAUS3;CEP41;CNTRL;DCTN3;PCNT;CEP72;ACTR1A;AKAP9;CEP192;CSNK1D;YWHAE;CKAP5;CENPJ;IQCB1;HAUS6;CEP162;HAUS5;RAB3IP;CC2D2A;NINL;C2CD3
prerank,prostanoid biosynthetic process (GO:0046457),0.37203001179706063,0.8288251122737538,0.6691616766467066,0.9045621615605252,1.0,3/15,14.60%,PTGES;TBXAS1;PLA2G4A
prerank,endocardial cushion morphogenesis (GO:0003203),0.3608029169080341,0.8286610900400658,0.6812865497076024,0.9044403369524944,1.0,4/18,11.44%,TBX2;ACVR1;HEYL;TGFB2
prerank,RNA interference (GO:0016246),0.367728087882509,0.8284818218453265,0.6788321167883211,0.904339219312785,1.0,3/17,9.55%,CELF1;TERT;DICER1
prerank,positive regulation of phospholipid transport (GO:2001140),0.3980585996563508,0.8280654758870075,0.6725806451612903,0.9045918196389016,1.0,1/10,3.78%,APOE
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.30534316782170645,0.827876961906567,0.7300832342449465,0.9045028050081878,1.0,17/52,23.22%,TNKS1BP1;EDC4;CNOT4;SAMD4A;EXOSC4;DCP2;DCP1A;PATL1;LSM7;RC3H2;TUT7;PARN;CNOT2;CNOT3;EXOSC5;PATL2;POLR2D
prerank,protein heterooligomerization (GO:0051291),0.3668726378540039,0.8278105553980439,0.6602658788774003,0.9042099269689574,1.0,3/17,8.54%,TMEM120B;PKD2;HSD17B8
prerank,cellular respiration (GO:0045333),-0.23119068557363406,-0.8271160465081961,0.7759562841530054,0.9318183222815424,1.0,20/41,29.95%,ME3;NDUFS1;PPARGC1A;UQCRC2;COX10;ETFRF1;ATP5F1D;UQCRB;ETFB;SDHAF4;UQCRH;UQCRFS1;LYRM7;MTFR1L;MTLN;NR4A3;UQCR10;MTFR2;SLC25A14;SDHA
prerank,phosphatidylinositol metabolic process (GO:0046488),0.281320408525477,0.8269845167176091,0.762962962962963,0.9051591938270158,1.0,30/109,19.90%,PDGFRB;PIGW;PIP5K1B;PTPN13;PTEN;PIP4K2A;PI4K2B;PIK3R5;PLA2G12A;FIG4;PLCB3;FGF2;PI4KA;PIK3R1;SACM1L;ARF1;PLA2G4A;MTMR9;PIK3R4;PLA2G4E;PIK3C3;PLEK;MTMR3;RUFY1;PIP5K1A;PLEKHA2;MTMR2;MTMR6;MTMR1;MTM1
prerank,lysosome localization (GO:0032418),0.3211969370338876,0.8266271093916256,0.7192118226600985,0.905356477604835,1.0,6/37,15.66%,BORCS6;MILR1;MYH9;KIF5B;RAB34;NDEL1
prerank,regulation of synapse organization (GO:0050807),0.3390879492681209,0.8264940572428583,0.6903225806451613,0.9051672339713923,1.0,8/26,15.60%,MDGA1;ABHD17C;WNT5A;YWHAZ;TNF;ARHGAP22;ABHD17B;NEDD4
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.32694665114916993,0.8258524866136863,0.7058823529411765,0.905422489500133,1.0,10/32,20.96%,NUP37;XPOT;RAE1;NUP153;NDC1;NUP35;NUP188;SEC13;NUP214;NUP107
prerank,tRNA export from nucleus (GO:0006409),0.32694665114916993,0.8258524866136863,0.7058823529411765,0.905422489500133,1.0,10/32,20.96%,NUP37;XPOT;RAE1;NUP153;NDC1;NUP35;NUP188;SEC13;NUP214;NUP107
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.3227378173756408,-0.8257422193003816,0.71875,0.9331164255842332,1.0,2/12,3.11%,RAD21;RB1
prerank,UV protection (GO:0009650),-0.3374271737782316,-0.8255007728109451,0.6815476190476191,0.9322075735945289,1.0,2/10,6.43%,ERCC5;CAT
prerank,"DNA-templated transcription, termination (GO:0006353)",0.29857511021887895,0.8254413028794071,0.7400681044267877,0.9056723955410644,1.0,24/68,24.17%,TAF1D;POLR1E;CSTF1;TTF2;GTF2H1;NCBP2;CDK7;SMN1;POLR1B;TAF1A;SETX;POLR2L;POLR2K;SNRPB;POLR1G;ERCC2;POLR3K;PCF11;POLR1A;CCNH;MNAT1;PRMT5;FIP1L1;CPSF3
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.27870227183079205,0.8253831740139417,0.7899159663865546,0.9053642964767216,1.0,35/119,19.99%,PIGW;PIP5K1B;PTPN13;PTEN;PIP4K2A;PI4K2B;PIGN;ITPKC;PIK3R5;TTC7A;IP6K2;PIGL;FIG4;PIGC;SOCS5;FGF2;PI4KA;PIK3R1;SACM1L;ARF1;PIGP;EFR3A;MTMR9;PIK3R4;PIGH;PIK3C3;MTMR3;RUFY1;PIP5K1A;PLEKHA2;MTMR2;MTMR6;MTMR1;MTM1;MPPE1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.35043615540895473,0.8247724653205665,0.6836734693877551,0.905985259662251,1.0,11/19,26.61%,FLOT2;APOE;PICALM;PRNP;PIN1;CLU;RTN2;ROCK1;BIN1;CHRNA7;GGA3
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.36695267782481666,0.8242356053363831,0.6887052341597796,0.9064310513806063,1.0,5/17,17.13%,PDGFRB;CALM2;ITGA1;PTPRC;PTPA
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.37467806453968244,0.8239888796733846,0.6862170087976539,0.9064356177343479,1.0,1/14,2.62%,IRS1
prerank,morphogenesis of an epithelium (GO:0002009),-0.2577578435509568,-0.8239696790478084,0.7291666666666666,0.9337687443882867,1.0,6/25,9.23%,ACTB;LAMA3;FGFR2;AHI1;LAMA5;VCL
prerank,histone H4-K5 acetylation (GO:0043981),-0.3000140577659867,-0.8237804341540084,0.7183544303797469,0.9313366974071813,1.0,5/15,13.96%,JADE1;KANSL2;JADE2;WDR5;JADE3
prerank,histone H4-K8 acetylation (GO:0043982),-0.3000140577659867,-0.8237804341540084,0.7183544303797469,0.9313366974071813,1.0,5/15,13.96%,JADE1;KANSL2;JADE2;WDR5;JADE3
prerank,regulation of axon regeneration (GO:0048679),-0.32290364801542804,-0.82365265388225,0.6931818181818182,0.9302102668173663,1.0,2/12,1.20%,EPHA4;INPP5F
prerank,necroptotic process (GO:0070266),0.3641478119541421,0.8227090034199468,0.6883308714918759,0.9080723446456976,1.0,4/16,15.12%,LY96;CD14;MLKL;RIPK1
prerank,rRNA 3'-end processing (GO:0031125),-0.3386699795349093,-0.8223149923898895,0.7007874015748031,0.9315312997695209,1.0,5/10,22.00%,EXOSC7;RPS21;EXOSC8;EXOSC3;EXOSC10
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.27818516262113935,-0.8218276988806399,0.7167235494880546,0.9310495059906013,1.0,6/19,18.65%,SLCO1C1;KLF2;KLF4;APP;WFS1;MAP2K5
prerank,melanosome localization (GO:0032400),0.3471224561902351,0.8217664093093907,0.6870748299319728,0.9091137018748614,1.0,3/21,9.93%,MLPH;MYO5A;RAB27B
prerank,ncRNA export from nucleus (GO:0097064),0.3155926771462635,0.8213474224405087,0.6945137157107232,0.909355012429747,1.0,11/36,20.96%,NUP37;XPOT;RAE1;NCBP2;NUP153;NDC1;NUP35;NUP188;SEC13;NUP214;NUP107
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3076937172844575,0.8213085961526536,0.7146311970979444,0.9090302465498397,1.0,18/44,23.88%,NRP1;CARMIL1;NF2;SFRP1;TGFB3;CDC42;EPHA1;TGFBR1;RHOA;RAC1;ITGB1BP1;TPM1;PAK1;RHOC;RGCC;ROCK2;LPAR1;PXN
prerank,regulation of lymphocyte proliferation (GO:0050670),0.37281450304558006,0.821167665166557,0.690856313497823,0.9088559436726655,1.0,2/16,11.70%,AHR;LST1
prerank,prostaglandin metabolic process (GO:0006693),0.3316229376897725,0.8207978679587928,0.7195121951219512,0.90904153554269,1.0,4/26,14.60%,PTGES;ACOX1;TBXAS1;PLA2G4A
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3200268840561487,0.8207648754303003,0.7137404580152672,0.9087053433413007,1.0,7/31,13.84%,CDKN2B;PTEN;PKD2;CDK6;GPNMB;CCL2;DACT1
prerank,isotype switching (GO:0045190),0.39847104977137077,0.8202677795105789,0.6693290734824281,0.9090803168698356,1.0,4/10,25.96%,BATF;HSPD1;MSH6;RNF8
prerank,positive regulation of protein acetylation (GO:1901985),-0.3323253506133733,-0.8202558949364304,0.6927536231884058,0.9325928237540851,1.0,3/12,4.66%,PRKAA2;RAPGEF3;DIP2B
prerank,regulation of leukocyte activation (GO:0002694),-0.30643850168143627,-0.8198166879366009,0.7026143790849673,0.9320203029035765,1.0,5/14,22.86%,CD200;MYO18A;SHPK;GPER1;MIF
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.22606761140016063,-0.8196938558957144,0.791907514450867,0.9308581114593938,1.0,5/41,5.90%,TGFBR3;BMP4;CPE;PROX1;FGFR2
prerank,GPI anchor biosynthetic process (GO:0006506),0.3184695901024359,0.8191059675714976,0.6852589641434262,0.9105172632931828,1.0,9/30,21.18%,PIGW;PIGN;PIGL;PIGC;PIGP;PIGH;PIGT;MPPE1;PIGK
prerank,stress granule assembly (GO:0034063),0.35179299953295395,0.8190907843361748,0.6832641770401107,0.9101476165538143,1.0,8/20,24.23%,ATXN2;DYNC1H1;UBAP2L;YTHDF3;PRRC2C;CSDE1;YTHDF2;EIF2S1
prerank,positive regulation of phosphatase activity (GO:0010922),0.34978387543074047,0.8189658512301373,0.6979591836734694,0.9099657488415565,1.0,6/21,17.13%,PDGFRB;CALM2;MTMR9;ITGA1;PLEK;PTPA
prerank,histone exchange (GO:0043486),0.31628004622704126,0.8185210310658273,0.7043478260869566,0.9102668775629095,1.0,7/37,15.43%,CENPQ;CENPN;RSF1;CENPL;RUVBL1;SPTY2D1;SRCAP
prerank,positive regulation of DNA metabolic process (GO:0051054),0.29525136916978634,0.8182778535387866,0.735052754982415,0.9102529291560167,1.0,6/61,5.00%,PARP3;PDGFRB;EGFR;USP9X;BABAM2;PRKD2
prerank,ureteric bud development (GO:0001657),0.3651214641505676,0.8178601785321783,0.7009873060648801,0.9104974637646178,1.0,4/17,14.05%,ROBO2;PKD2;SALL1;BMP7
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.2634103522120877,-0.8175327924403089,0.756,0.9334771705616774,1.0,12/22,28.69%,ERCC3;UBC;CHD1L;DDB2;GTF2H2;GTF2H4;UBA52;GTF2H3;CETN2;RBX1;PARP1;XPC
prerank,vitamin transport (GO:0051180),0.3338469383625406,0.8173274448397905,0.7001321003963011,0.9109231685998792,1.0,3/29,11.38%,TCN1;TCN2;PDPN
prerank,mitochondrial transport (GO:0006839),-0.21213788657528082,-0.8172808289209167,0.8368794326241135,0.9325729261005671,1.0,22/53,27.19%,HSP90AA1;FLVCR1;DNAJC19;BCAP31;SLC25A4;BCL2L1;COX18;TIMM17B;GDAP1;ABCB10;BNIP3;TOMM20;STARD3;BCS1L;TIMM22;TOMM70;TIMM8B;TOMM5;TOMM40;PPIF;MFF;TIMM9
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.36466169056802555,0.8165579016166383,0.7011494252873564,0.9117389706897423,1.0,3/17,4.34%,APOE;ABCA2;ABCG1
prerank,cellular response to cAMP (GO:0071320),0.32746103233541307,0.8164492545847678,0.7041343669250646,0.9115131272347896,1.0,4/30,6.40%,ZFP36L1;IGFBP5;PKD2;AHR
prerank,amide biosynthetic process (GO:0043604),0.30342456493047687,0.8162366755422708,0.7381516587677726,0.9114562549077728,1.0,3/47,2.51%,ASMT;CERS6;PAM
prerank,establishment of protein localization to organelle (GO:0072594),0.28888536173765045,0.8155862728340326,0.7480490523968785,0.9120424451239323,1.0,18/72,20.96%,STAT3;HK2;RALA;CD68;PRICKLE1;FAM53B;LAMP2;NUP153;TNPO1;PEX19;E2F3;NUP188;SEC13;AKT1;HEATR3;NUP214;LAMP5;NUP107
prerank,negative regulation of cell cycle process (GO:0010948),0.2988868122278285,0.8154718666938152,0.7546082949308756,0.9118242678528203,1.0,23/61,26.01%,E2F1;RNF2;YAF2;EHMT1;VPS4A;TOM1L1;E2F8;BMP7;PHC3;MAX;RBBP8;FBXO5;WAPL;MGA;TERF1;SUZ12;CDC7;CBX5;RAD51;RYBP;TERF2;TFDP1;RBBP7
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.2986264028351817,-0.8153491933096016,0.7214076246334311,0.9348436604867985,1.0,4/14,14.60%,PAICS;ATIC;ADK;RFK
prerank,peptidyl-lysine acetylation (GO:0018394),0.39743116437631115,0.8153246053603225,0.6729559748427673,0.9116583464576484,1.0,2/10,7.04%,CREBBP;BAG6
prerank,somite development (GO:0061053),0.39787223276636097,0.8150518213902481,0.6740858505564388,0.9116791358304138,1.0,3/11,15.46%,SHH;LOXL3;SMO
prerank,Golgi to lysosome transport (GO:0090160),0.3940459484042298,0.8150437185751718,0.6957210776545166,0.9112965136718543,1.0,3/11,10.49%,AP4M1;ANKFY1;GAK
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.29220851797725833,0.8149402051820657,0.7734375,0.9110644926521949,1.0,17/72,22.34%,ENPP1;DNA2;EDC4;GTF2H1;DICER1;SETMAR;FBH1;DCP1A;RNASE1;DXO;DDB1;DDX1;ERCC2;ZC3H12A;RFC1;RPS27A;RPA1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.23252970996349256,-0.8143807075159023,0.8341232227488151,0.9352320073458325,1.0,7/34,11.07%,GRID2;GABRA2;GABRG3;GABRA5;GLRA1;GRIN2D;GRIN2B
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.31923952407328693,-0.8143582404396524,0.6837606837606838,0.9338968694663683,1.0,5/12,31.91%,LFNG;MFNG;DOCK11;DLL1;PTK2B
prerank,telomere maintenance via recombination (GO:0000722),0.39615852974836285,0.8140858305952082,0.6934189406099518,0.9119982001949535,1.0,5/11,23.20%,XRCC3;NSMCE2;TEP1;SMC5;RAD51
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.29393523653338127,-0.8138174150100913,0.6517571884984026,0.9335117681777333,1.0,3/15,7.43%,PRKCH;IL18;AGTR1
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.28223740324974866,-0.8136454567703105,0.7060931899641577,0.9324337398546608,1.0,5/18,12.69%,EZR;HSP90AA1;VPS11;RDX;FAF1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.32687512272385294,0.8133496416367243,0.710594315245478,0.9127492598233408,1.0,10/30,24.86%,DNAJB1;HSPE1;GAK;DNAJC7;SDF2;HSPA5;HSPA13;DNAJB14;ST13;UGGT1
prerank,covalent chromatin modification (GO:0016569),0.36625115300977296,0.8131992330098461,0.6819571865443425,0.9125983324760075,1.0,2/14,9.16%,MBD2;HDAC1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.3217704974653397,-0.8127416331539166,0.7222222222222222,0.9327738452591208,1.0,3/12,14.69%,ZWINT;NABP1;ZWILCH
prerank,indolalkylamine catabolic process (GO:0046218),0.39393208940300223,0.8127217622875728,0.6837060702875399,0.9129288049965764,1.0,1/10,7.20%,KYAT1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.31919063513832546,0.812034419219579,0.7260981912144703,0.9136054986206766,1.0,6/31,12.44%,BBC3;E2F1;BCL2;YWHAZ;CASP8;GSK3B
prerank,regulation of cell projection organization (GO:0031344),0.38244910339205146,0.8118016171802377,0.6833333333333333,0.9135765893843679,1.0,3/13,11.91%,TREM2;MOV10;SPRY2
prerank,regulation of intracellular transport (GO:0032386),0.31474924560038164,0.8112859147224827,0.7209876543209877,0.9139637691771179,1.0,6/38,8.76%,LRRK2;ANTKMT;DYNC1H1;PTPN1;GAS1;LCP1
prerank,response to interferon-alpha (GO:0035455),-0.289580796132065,-0.8110802251965203,0.7424242424242424,0.934418729327836,1.0,6/16,21.84%,GAS6;ADAR;IFNAR1;RO60;BST2;PDE12
prerank,protein insertion into ER membrane (GO:0045048),0.3147060184255478,0.8101957373707495,0.7329113924050633,0.9152566044687036,1.0,5/37,7.67%,TRAM2;WDR83OS;BAG6;VAPA;EMC7
prerank,positive regulation of macroautophagy (GO:0016239),0.2993578213341779,0.8100244217264472,0.7395459976105138,0.9151216694122907,1.0,7/48,13.51%,DCN;BAG3;PIP4K2A;TRIM13;RAB3GAP2;SMCR8;RAB3GAP1
prerank,positive regulation of protein import (GO:1904591),0.32624454676410203,0.8097403015914382,0.7126288659793815,0.9151518328379905,1.0,6/30,13.92%,UBR5;BAG3;ZIC1;PIK3R1;SMAD3;PSEN1
prerank,regulation of microtubule nucleation (GO:0010968),-0.3328439194517393,-0.8096073929761287,0.7342105263157894,0.9358339316167893,1.0,2/10,11.09%,EML2;GIT1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.33364771985094444,-0.809247417680129,0.6982097186700768,0.9337661464168012,1.0,3/10,33.75%,CACNA2D4;TULP1;CNGB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.33364771985094444,-0.809247417680129,0.6982097186700768,0.9337661464168012,1.0,3/10,33.75%,CACNA2D4;TULP1;CNGB1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.3839768770560783,0.8091342499005315,0.7222222222222222,0.9157117928528575,1.0,3/12,12.30%,TIRAP;LPL;TNF
prerank,meiosis I (GO:0007127),0.332568237600135,0.8091159840645745,0.7047872340425532,0.9153523720517822,1.0,3/23,12.98%,MYBL1;ZSCAN21;FOXJ3
prerank,ion transport (GO:0006811),0.2753279324662769,0.8089888360869258,0.7782515991471215,0.9151540858864954,1.0,14/111,10.09%,SLC1A3;SLC15A3;SLC9A1;SLC12A4;PIEZO2;GLRB;SLC20A1;TRPC6;VDAC2;SLC24A5;SLC9A8;SLC36A2;LASP1;SLC15A1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.29319292407362096,0.8089414157814977,0.7421236872812136,0.9148298171201886,1.0,13/60,19.69%,PARM1;PDGFRB;PRKD2;ATM;ATR;CCT8;FGF2;CCT3;TNKS2;PNKP;MAPK1;PARN;PKIB
prerank,response to UV (GO:0009411),0.2810002817353136,0.8088109820281989,0.7920258620689655,0.9146358656741302,1.0,22/95,21.00%,BCL3;EGFR;USF1;INO80;CREBBP;NOC2L;CCAR2;ATR;TMEM161A;MC1R;REV1;MFAP4;FMR1;NEDD4;USP28;AKT1;ATF4;RHBDD1;KDM1A;ERCC2;PRKCD;YY1
prerank,positive regulation of histone modification (GO:0031058),-0.23970943850855259,-0.808648017134817,0.813953488372093,0.9334779993294512,1.0,9/33,19.62%,RPS6KA5;PPARGC1A;SAP30BP;AKAP8;UBE2N;CHTOP;TET1;CTBP1;MAPK3
prerank,endocardial cushion development (GO:0003197),0.3428736653587158,0.8084548390902658,0.700139470013947,0.9147882654481002,1.0,4/21,11.44%,TBX2;ACVR1;HEYL;TGFB2
prerank,autophagosome maturation (GO:0097352),0.3192823866646297,0.8083543321129391,0.7157622739018088,0.914539814589673,1.0,4/32,9.67%,VMP1;STX17;LAMP2;ATP2A2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.4001947966756142,0.8080110612778272,0.6846275752773375,0.914677694725791,1.0,5/10,24.21%,CBARP;DRD3;FMR1;GNB5;CALM3
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.24897102292087664,-0.8079769604154889,0.7580645161290323,0.933339264529333,1.0,12/25,32.52%,PRPF6;PRPF4;GEMIN2;PRPF8;TXNL4A;SF3A3;SF3B4;LSM1;SRSF10;BCAS2;MPHOSPH10;WDR83
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.3867595333927403,0.8079275227373308,0.7054263565891473,0.9144163911329936,1.0,2/11,9.77%,ADM;DRD3
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3447203992496905,0.8078115516144485,0.6916666666666667,0.9142160410581758,1.0,2/22,3.00%,DUSP2;DUSP5
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.38337966254012,0.8076844470511306,0.7028231797919762,0.9140337678419485,1.0,1/12,2.62%,IRS1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3442955655648073,0.8075220480934294,0.6925207756232687,0.9138808981344593,1.0,3/21,6.15%,ADCY7;ADCY2;NPR2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.3281077916009857,0.8073775503921049,0.7179144385026738,0.9137006693131094,1.0,8/25,23.07%,LRRK2;NPAS4;GSK3B;RAB3GAP1;AKT1;GRIN2A;NPFF;MAPK8IP2
prerank,chromatin remodeling at centromere (GO:0031055),0.32503614330059893,0.8072791344952291,0.73342175066313,0.9134582237034864,1.0,5/31,11.47%,CENPQ;CENPN;RSF1;CENPL;RUVBL1
prerank,melanosome organization (GO:0032438),0.3308518652687837,0.8072649486259322,0.7208994708994709,0.9130895529779721,1.0,4/26,9.89%,AP3B1;DTNBP1;AP3D1;RAB32
prerank,cristae formation (GO:0042407),-0.24839248737322472,-0.8072422658418943,0.7662835249042146,0.933286680328473,1.0,11/27,20.64%,ATP5MG;ATP5PD;ATP5PF;LETM1;IMMT;ATP5F1D;MICOS13;ATP5ME;SAMM50;APOO;APOOL
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.33180377874902156,0.8071882047311493,0.7182910547396528,0.9128179416399602,1.0,11/26,24.21%,PKD2;CBARP;FKBP1B;DRD3;CALM2;FMR1;YWHAE;THADA;GSTM2;GNB5;CALM3
prerank,cAMP biosynthetic process (GO:0006171),0.400211475034854,0.8071186051567213,0.7018121911037891,0.9125195547923456,1.0,2/10,4.40%,ADCY7;ADCY2
prerank,signal transduction by p53 class mediator (GO:0072331),0.31858442567932205,0.807102178413617,0.71334214002642,0.9121565455663598,1.0,2/30,3.16%,BCL3;BATF
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2978198367897622,0.8070133899384032,0.7411225658648339,0.9119052645912284,1.0,6/52,11.59%,ALDH18A1;MTHFR;MTHFD1L;DLST;IDH2;MTHFD2L
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.31514589860853187,0.8070057697683648,0.705955334987593,0.911526294759964,1.0,9/31,20.69%,ZFPM2;TGFBR1;TNNC1;TGFB2;SMAD4;TNNT2;RBPJ;TPM1;BMPR1A
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.3126203611943927,0.8066974410400377,0.7453874538745388,0.9116068587145288,1.0,8/37,17.10%,PABPC4;RNASEH1;SND1;RNASEH2A;ENTPD7;ENTPD6;SIDT2;MTREX
prerank,atrial septum morphogenesis (GO:0060413),0.39235194205946367,0.8066605410441542,0.6972049689440993,0.911273544654496,1.0,2/10,11.44%,ACVR1;TGFB2
prerank,autophagy of mitochondrion (GO:0000422),0.3060577259666631,0.8065013595857674,0.7334167709637046,0.9111186546712584,1.0,12/38,23.32%,WIPI1;AMBRA1;CTSK;ATG3;FBXO7;ATG7;WDR45;SQSTM1;FUNDC2;BECN1;MARK2;ATG2B
prerank,"base-excision repair, gap-filling (GO:0006287)",0.31692858740397073,0.8062938380997638,0.7245657568238213,0.9110533630737311,1.0,9/35,22.34%,MPG;LIG1;XRCC1;POLG;PNKP;MBD4;NEIL1;RFC1;RPA1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.33521714823678156,0.806096406771681,0.7383419689119171,0.9109738010583782,1.0,1/27,0.65%,P2RY10
prerank,peptidyl-amino acid modification (GO:0018193),0.39292224440575746,0.8059693150148161,0.6957210776545166,0.9107888605044001,1.0,5/10,27.13%,FKBP10;ATP7A;METAP1;TTLL4;METAP1D
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3792882383467736,0.8058457695964492,0.693939393939394,0.9105958358197875,1.0,2/12,13.29%,PTPN1;PIK3R1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.37373693965118365,0.8052871109072252,0.7109144542772862,0.9110706671828768,1.0,4/13,14.77%,NCK1;PTPN1;DDRGK1;HSPA5
prerank,cell part morphogenesis (GO:0032990),-0.31133599034097587,-0.8051421294171691,0.7386018237082067,0.9356846496226118,1.0,7/13,27.02%,WASF1;DNM1L;SUPV3L1;SLIRP;MYH14;NUBPL;MFF
prerank,positive regulation of dendritic spine development (GO:0060999),0.3459286711298452,0.8049785011373924,0.7074175824175825,0.911163719052214,1.0,7/20,14.28%,APOE;CAPRIN1;DBN1;DBNL;PSEN1;DLG5;FMR1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3007917575391852,0.8048755777327327,0.7727272727272727,0.9109374247317755,1.0,7/48,7.26%,NRP1;DOCK1;MDK;LIMS1;CARMIL1;CDC42;CAPRIN1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3636358221090453,0.8046115366551755,0.7171717171717171,0.9109603058017494,1.0,4/15,19.00%,STAT3;TNF;HIF1A;IL17RA
prerank,regulation of JUN kinase activity (GO:0043506),0.31977106620576545,0.8045729986216368,0.7220812182741116,0.9106425293639167,1.0,8/33,19.10%,AIDA;SASH1;TAOK3;HIPK3;TNF;TRAF2;MAPK8IP1;DVL2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.33623299303741766,-0.8043688924986073,0.7060518731988472,0.9356640937123383,1.0,4/10,23.55%,ESR1;PSMC3;PSMC4;TP53
prerank,regulation of protein binding (GO:0043393),0.2735363620170967,0.8041788547732758,0.801058201058201,0.9108770807432353,1.0,29/114,20.54%,LRP1;TCF7L2;LRRK2;TRIM21;PLK1;DDX11;EFHB;ADD2;NMD3;TERT;DISC1;VTN;GSK3B;SPPL3;GTF2F1;DACT1;PSEN1;TRIB3;RPL11;DTX3L;STK4;ITGB1BP1;AKT1;HDAC5;TLE5;CTNNBIP1;KDM1A;PIN1;PRKCD
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2846006122304117,0.8037455802469216,0.7519553072625699,0.9111378137683659,1.0,12/76,13.06%,TNIP1;LRRK2;MYCBP2;BIRC3;PRICKLE1;ANGPT1;DCUN1D1;FBXW7;UBE2L3;GNL3;RASD2;TANK
prerank,icosanoid biosynthetic process (GO:0046456),0.3868502276420671,0.8035825529378214,0.6754658385093167,0.9109924137868092,1.0,2/10,14.60%,FADS1;PLA2G4A
prerank,response to muramyl dipeptide (GO:0032495),0.37770964414055724,0.8032934197323848,0.7019667170953101,0.9110307787152295,1.0,2/12,11.02%,NOD1;ERBIN
prerank,protein alkylation (GO:0008213),0.3359677626429216,0.8031628436709881,0.7172701949860725,0.9108367405509123,1.0,11/22,27.43%,CAMKMT;VCPKMT;PCMT1;GSPT1;ETFBKMT;PRMT3;SNRPB;ETF1;EEF2KMT;FAM98A;METTL21A
prerank,alpha-amino acid catabolic process (GO:1901606),-0.23995163812352432,-0.8031281149866529,0.8,0.9365908287285674,1.0,5/29,13.47%,DDO;ALDH4A1;PRODH;GSTZ1;FAH
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.28229323433849984,-0.8031182872866237,0.7344827586206897,0.9352564544266453,1.0,6/18,23.85%,WDR43;PHF8;DHX33;SIRT7;UTP15;MAF1
prerank,regulation of protein ubiquitination (GO:0031396),0.270114774357272,0.8028000222982844,0.7817796610169492,0.9110314262234523,1.0,14/108,9.70%,LRRK2;MYCBP2;TNFAIP3;BIRC3;PRICKLE1;NXN;PINX1;SASH1;ANGPT1;DCUN1D1;FBXW7;TGFBR1;OGT;UBE2L3
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.2766338994127962,0.80271833011665,0.8075675675675675,0.9107650513107092,1.0,27/93,22.19%,TNKS1BP1;EGFR;NCK1;PTEN;PRKD2;NCK2;RASSF2;RPTOR;CNKSR3;FNIP1;SPRY2;TNF;NLRP2B;NTRK3;AKAP9;PDCD10;NSD1;STK4;AKT1;IRGM;EIF4G1;SPTBN4;TRIM6;AXIN1;PAK1;RAF1;LATS1
prerank,protein depolymerization (GO:0051261),-0.2441681639897505,-0.8016736156785759,0.7777777777777778,0.9363810748448356,1.0,11/27,25.66%,GSN;MICAL3;TWF2;STMN2;STMN3;MICAL1;CFL1;TWF1;KIF18A;STMN1;WDR1
prerank,protein localization to lysosome (GO:0061462),0.32049268146689897,0.8016037481531242,0.7340425531914894,0.9120414743587761,1.0,7/28,17.85%,AP4M1;VPS4A;RAB7A;KPTN;NEDD4;LAMTOR5;ZFYVE16
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.38570013835116707,0.8014811696815817,0.7035256410256411,0.9118438876588592,1.0,1/10,3.36%,ETFA
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.34688114276046433,0.8012594614512588,0.700139470013947,0.9117960261847337,1.0,3/20,6.21%,NR2F2;PTEN;PLK1
prerank,regulation of regulated secretory pathway (GO:1903305),0.31307924957948474,0.8012436768576795,0.7297297297297297,0.9114397363896521,1.0,5/34,12.44%,LRRK2;DTNBP1;UNC13D;SYT2;GSK3B
prerank,regulation of secretion (GO:0051046),-0.31007131288870343,-0.8011543625886095,0.71875,0.9359413642973997,1.0,7/13,22.38%,GPLD1;ACSL3;KCNQ1;FGF10;OAS2;ERBB3;OPRK1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.33626378553612707,0.8003241116263194,0.717391304347826,0.9124092586435787,1.0,3/22,5.93%,LRRK2;MDK;PTPRZ1
prerank,protein homooligomerization (GO:0051260),-0.1877156692550606,-0.800183929287182,0.9607843137254902,0.936304567220633,1.0,32/114,23.54%,KCNC2;GLRA3;EHD4;SLC1A2;KCNJ2;ATL3;SAMHD1;UPB1;DISP1;LETM1;AQP11;GSDMD;ALDH9A1;GOLGA2;EHD3;PRMT1;KCNJ12;GBP5;SSBP1;POLQ;HCN1;SOD2;NACC2;PRMT8;CBR4;GLS;USP16;APIP;VSTM5;G3BP2;MIF;CRYZ
prerank,glycoprotein biosynthetic process (GO:0009101),0.2810991124375234,0.8000609371057948,0.7895902547065338,0.9124343973744965,1.0,16/79,18.25%,TNIP1;B4GALT5;CHST13;ST3GAL3;DDOST;ALG5;TMEM106A;CHST11;GCNT2;PMM2;B4GALT7;COG7;FAM20B;B3GNT9;ATP7A;FUT4
prerank,negative regulation of transposition (GO:0010529),0.36088476771474637,0.7999753045485501,0.7078488372093024,0.9121794042226083,1.0,3/16,17.80%,MYBL1;MOV10;TUT7
prerank,mRNA metabolic process (GO:0016071),-0.194120220749021,-0.799815912642678,0.918918918918919,0.9356281053252591,1.0,37/90,27.78%,SFPQ;DDX5;SRSF5;PPARGC1A;CNOT10;U2AF2;GEMIN2;RIDA;LSM6;PCBP3;SNRPG;SRSF7;SRSF9;NUDT12;ERN1;SRRM4;LSM5;HNRNPR;SNRPD3;RNASE4;SUPT4H1;HNRNPA0;PRPF8;ZFP36;LSM11;AGO3;TP53;TBRG4;SF3A1;SF3A3;LSM10;SF3B4;NUDT16;NUDT16L1;AGO4;U2AF1;HSPA1A
prerank,cellular response to catecholamine stimulus (GO:0071870),0.33527042870567514,0.7997122616260712,0.73342175066313,0.9122097797525699,1.0,2/23,2.43%,SLC9A1;LRRK2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.30031530637879367,-0.799549244813661,0.7556818181818182,0.9347870054455061,1.0,5/14,22.93%,CSTF2;TUT1;ERN1;CPSF2;CPSF4
prerank,calcium ion transport into cytosol (GO:0060402),0.3347577974692735,0.799211751956775,0.7222982216142271,0.9125617062929782,1.0,3/21,9.76%,CACNA2D1;CACNA1C;MS4A1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.3941498251020402,0.799199333014314,0.7001545595054096,0.9121952506065059,1.0,2/10,5.95%,BATF;SFRP1
prerank,histone deacetylation (GO:0016575),0.3032662905705662,0.7989139345978368,0.75453446191052,0.9122651000549105,1.0,12/43,19.11%,RCOR1;MIER2;PRDM5;HDAC1;TBL1X;MTA2;ELK4;BAZ2A;MTA3;RCOR2;HDAC5;BRMS1L
prerank,tRNA transport (GO:0051031),0.31113071961830796,0.7986148203306097,0.7277289836888331,0.9123310264011807,1.0,11/35,21.73%,NUP37;XPOT;RAE1;NUP153;NDC1;NUP35;NUP188;SEC13;NUP214;NUP107;YBX1
prerank,tRNA wobble uridine modification (GO:0002098),-0.2991655560089645,-0.7984333702942321,0.7539432176656151,0.9354440886492915,1.0,2/14,4.38%,ALKBH8;TRMT9B
prerank,positive regulation of embryonic development (GO:0040019),0.34897518519268467,0.7979804131260334,0.7405329593267882,0.9128724424773011,1.0,3/19,11.73%,B4GALT5;TENM4;ZBED3
prerank,regulation of cellular protein localization (GO:1903827),0.3003060794696233,0.7978369849903711,0.7537922987164527,0.9127046756855565,1.0,11/45,15.66%,GPC6;ABCA2;SHH;EGF;PTPN1;GBF1;LCP1;SETD2;CEP72;VCPIP1;NDEL1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.2482075693857676,-0.7973116334257551,0.8049792531120332,0.9361260777843045,1.0,15/24,35.17%,UBC;POLD3;PCNA;RFC3;UBA52;POLD2;RPA2;LIG4;POLE;RFC4;POLD4;RFC2;RPA3;POLK;RFC5
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.3132968004980821,0.7972973477473995,0.7435897435897436,0.9131434180684674,1.0,10/35,20.46%,PDGFRB;NUAK1;FKBP1B;PPP1R2;GSK3B;CALM2;ITGA1;PTPA;HSP90B1;PPP6R2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.29898412988757916,0.7965944248380912,0.7470023980815348,0.913793546074964,1.0,15/44,25.00%,SIAH2;SH3RF1;CSNK2A1;FNIP1;DNAJB6;TNF;SRC;LAMTOR5;AKT1;YWHAE;CAST;RAF1;RPS6KA3;PCID2;VEGFA
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.3838055529434507,0.7959402343728416,0.7016742770167428,0.9143625757159992,1.0,1/10,3.11%,NELL1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.314524666775083,-0.7959217935028493,0.7506849315068493,0.9370950452958805,1.0,5/11,13.07%,ITM2A;BACE2;NECAB1;ITM2C;ABCA7
prerank,response to steroid hormone (GO:0048545),0.31629107484783536,0.7957672724833299,0.7326343381389253,0.9142454321310398,1.0,6/31,14.47%,YAP1;ABCA2;TGFB3;UBE2L3;TGFB2;CATSPER3
prerank,organelle transport along microtubule (GO:0072384),0.31549549497792195,0.7956357565344955,0.7522816166883963,0.914062457431981,1.0,8/31,15.66%,TRAK1;MAP1S;CDC42;COPG1;FBXW11;KIF5B;RAB1A;NDEL1
prerank,positive regulation of cellular protein localization (GO:1903829),0.28020756904731614,0.7947630785284789,0.7602272727272728,0.9149700099525141,1.0,16/69,17.60%,YAP1;CENPQ;TM9SF4;PLK1;WWTR1;SNX33;ENTR1;TNF;GSK3B;GNL3;ORMDL3;DDRGK1;DTX3L;LAMTOR5;AKT1;EIF2AK3
prerank,regulation of transposition (GO:0010528),0.3761516745483373,0.7941432936682286,0.7129770992366412,0.9155162054856082,1.0,1/13,4.62%,MYBL1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.33391519036030864,0.7940530564627185,0.7186629526462396,0.9152636613841759,1.0,9/22,25.00%,SASH1;PJA2;SPI1;MFHAS1;XDH;GADD45A;ZC3H12A;RELL1;VEGFA
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.29256481777142823,0.7939381254331255,0.7466504263093788,0.9150450929766237,1.0,4/44,9.82%,CYP7B1;INSIG2;SLC27A2;OSBPL3
prerank,GPI anchor metabolic process (GO:0006505),0.3182820146524408,0.7936098691872847,0.7355371900826446,0.9151184966922968,1.0,6/26,16.13%,PIGW;PIGN;PIGL;PIGC;PIGP;PIGH
prerank,response to purine-containing compound (GO:0014074),0.34876412283207525,0.7934013764462926,0.7318840579710145,0.9150547597017128,1.0,4/17,22.13%,STAT1;P2RX7;NDUFS4;TRPM2
prerank,negative regulation of biosynthetic process (GO:0009890),0.352476417241327,0.7929127896872963,0.7271407837445574,0.9154051300181183,1.0,4/16,20.53%,EMILIN1;TRAP1;COA8;SLC18A2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3346958187304704,0.7916127513868145,0.7293447293447294,0.9169341282988913,1.0,6/20,15.68%,ZMIZ1;DCUN1D1;TGFBR1;WASHC1;ITCH;HIF1A
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.28482303006880316,-0.7914230242332736,0.7756410256410257,0.9435244038829281,1.0,3/16,3.36%,DDX5;PPARGC1B;ESR1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.3795474980757625,0.791357925768782,0.7101910828025477,0.9169307027278375,1.0,3/10,17.06%,MAP2K1;NBR1;MAPK1
prerank,protein hydroxylation (GO:0018126),0.3620062154224928,0.791180268002319,0.7204783258594918,0.9168262409637612,1.0,1/15,1.48%,PLOD2
prerank,double-strand break repair via break-induced replication (GO:0000727),0.37671969989256315,0.7910969539569486,0.7167721518987342,0.9165569474344335,1.0,2/12,8.70%,MCM2;MCM7
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.27619706159786866,-0.7910899088164834,0.7632398753894081,0.9427874053785771,1.0,8/17,24.48%,SFPQ;HSPB1;SOD1;SOD2;NME5;PPIA;HTRA2;MAPK7
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.30648255337781294,-0.7903726237798442,0.7353760445682451,0.9426971616937141,1.0,3/12,11.90%,GCLC;HAGH;CHAC2
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.25017402340441924,-0.7902661050128784,0.7601626016260162,0.9415085715527612,1.0,3/23,5.90%,TGFBR3;PROX1;FGFR2
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3738666411031734,0.7902248255453806,0.7127496159754224,0.917405622316491,1.0,6/12,23.09%,ABCA2;H6PD;SREBF1;LPCAT3;SEC14L2;KPNB1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.35183239493345597,0.790212056665451,0.7267355982274741,0.917042637585982,1.0,3/16,11.00%,BCL3;NF2;PTPN2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3317511575919803,0.7894454079190596,0.7449664429530202,0.9177559083755747,1.0,6/21,12.46%,NCK1;PTEN;NCK2;RASSF2;CNKSR3;NLRP2B
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.2969056399898691,0.7890823196539742,0.767639902676399,0.9178861615972681,1.0,6/46,10.88%,ADIPOQ;LAMA4;ADAMTS5;ARRDC3;PLCL1;ACOT13
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.32394652118602646,0.788915206709608,0.7383561643835617,0.9177407380005994,1.0,1/23,0.98%,MMP14
prerank,regulation of myotube differentiation (GO:0010830),0.3249343204980729,0.7888227547799225,0.7375690607734806,0.9174789628274047,1.0,7/24,18.88%,MMP14;TMEM119;HDAC1;MAML1;HDAC5;PIEZO1;ATP11A
prerank,atrial septum development (GO:0003283),-0.29575737088469634,-0.7884044226262344,0.7832817337461301,0.9432505759387402,1.0,4/13,18.68%,ANK2;MDM4;HEY2;ZFPM1
prerank,regulation of exocytosis (GO:0017157),0.2967506257471554,0.7883574795384102,0.7619047619047619,0.9177795559160367,1.0,8/46,9.93%,RAB2B;RALA;RAB21;UNC13D;RAB8B;ANXA1;RAB9A;RAB27B
prerank,phagolysosome assembly (GO:0001845),0.37343017258833483,0.7882170818415073,0.7227272727272728,0.9176016540037784,1.0,3/12,13.84%,RAB7A;RAB7B;RAB34
prerank,regulation of mitochondrial fusion (GO:0010635),0.38048949637215146,0.7874656436327814,0.7131782945736435,0.9183371123745385,1.0,4/11,14.64%,OMA1;ADCK1;PID1;ZDHHC6
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.31921269960821835,0.7870776560752448,0.7543391188251002,0.9185185730832274,1.0,11/30,19.96%,NPEPPS;FBXW7;TOMM7;CSNK2A2;UBE2L3;MICALL2;SH3GLB1;LEPROT;USP36;ARIH2;UBL5
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.2730713051272582,-0.7870428131248324,0.7623456790123457,0.944219732679162,1.0,2/16,2.73%,SOX13;HNRNPU
prerank,regulation of lamellipodium assembly (GO:0010591),0.31243281408830526,0.7861516516191583,0.7556962025316456,0.9194782894535318,1.0,8/34,14.73%,AUTS2;FSCN1;CDC42;ABI2;ACTR2;BRK1;PIK3R1;RAC1
prerank,positive regulation of wound healing (GO:0090303),0.30731615958866365,0.7860193899817894,0.7559153175591532,0.9192719920521832,1.0,6/36,11.22%,APOH;HPSE;ANXA1;MYLK;PTK2;VTN
prerank,myelination in peripheral nervous system (GO:0022011),-0.3009928003444299,-0.7846514247479883,0.7570621468926554,0.9468402767047938,1.0,6/13,17.70%,ARHGEF10;PARD3;ADGRG6;SOD1;SKI;PRX
prerank,regulation of histone modification (GO:0031056),-0.2978867713624024,-0.7846367289950557,0.771117166212534,0.9455295605062661,1.0,5/13,18.42%,AKAP8;UBE2N;IGF2;NNMT;MYOCD
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.37929155769847134,0.784329117474405,0.7152,0.9209689483014029,1.0,5/11,24.21%,PKD2;FKBP1B;CALM2;GSTM2;CALM3
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.37929155769847134,0.784329117474405,0.7152,0.9209689483014029,1.0,5/11,24.21%,PKD2;FKBP1B;CALM2;GSTM2;CALM3
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.2852675450690999,-0.7840672823915428,0.7304075235109718,0.9450981247717907,1.0,3/15,9.42%,PRKN;BCL2L1;IGF1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.33622063919087847,0.7838610757444873,0.7230989956958394,0.9212573560522243,1.0,2/20,5.13%,B4GALNT2;ST3GAL3
prerank,negative regulation of ion transport (GO:0043271),0.32678276183909316,0.7836263732799705,0.719626168224299,0.921214064831395,1.0,5/24,18.32%,GPM6B;PXK;HRH3;NEDD4;HTR1B
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.32305295734802675,-0.7834252669510197,0.7150997150997151,0.9448195648483182,1.0,6/10,31.06%,APC;RCC2;RACGAP1;ECT2;KNSTRN;SPAG5
prerank,carboxylic acid metabolic process (GO:0019752),-0.2342300375993385,-0.7832048666037189,0.8357487922705314,0.9438412014654081,1.0,7/33,15.75%,DDO;SLC2A1;GLUD1;CSGALNACT1;CARNMT1;CYB5A;LIAS
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.3223578775323161,-0.7829619592758842,0.7605633802816901,0.9429208258117371,1.0,3/11,12.55%,CCT4;CCT5;DKC1
prerank,insulin receptor signaling pathway (GO:0008286),0.2770060680484075,0.7827314926048894,0.7839643652561247,0.9221199235220405,1.0,12/69,13.35%,SLC39A14;IRS1;BAIAP2;AP3S1;SH2B2;GRB2;PTPN2;ATP6V1F;GSK3B;ATP6V1H;PIK3R1;ATP6V1G2
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3027577483155842,-0.7826640736609037,0.7514285714285714,0.9421277924274825,1.0,2/12,10.23%,CENPC;SEH1L
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.2851595847692181,0.7823723757517929,0.7704545454545455,0.9222658012393069,1.0,20/57,23.00%,PES1;NOC2L;WDR74;NOP14;NIP7;GTF3A;LTO1;DDX31;RPL14;RPL11;NOP16;BYSL;TGS1;HEATR3;PAK1IP1;RIOK2;XPO1;DHX37;NOM1;RRP36
prerank,positive regulation of axon extension (GO:0045773),0.3307448035203765,0.7822158720192852,0.7344173441734417,0.9221092600951305,1.0,5/22,11.62%,NRP1;L1CAM;DBN1;DSCAM;DBNL
prerank,mitotic cytokinesis (GO:0000281),0.2954818470221931,0.7817458029354853,0.7814407814407814,0.9224122359130174,1.0,17/47,23.85%,JTB;CHMP4B;PLK1;SNX18;SNX33;SNX9;RTKN;RASA1;TTC19;KIF20A;SPTBN1;SON;RHOC;ROCK2;ROCK1;PDCD6IP;RAB35
prerank,purine-containing compound catabolic process (GO:0072523),0.3621809154010567,0.7816645347117136,0.7170658682634731,0.9221433934460936,1.0,4/13,18.52%,GDA;DPYD;NT5C1A;XDH
prerank,myelination (GO:0042552),0.29036197429758426,0.7812552209637714,0.7686832740213523,0.9223464488463818,1.0,4/46,5.10%,TNFRSF21;B4GALT5;PMP22;NF1
prerank,phospholipid biosynthetic process (GO:0008654),-0.22724474594258404,-0.7807202176251943,0.8620689655172413,0.9439701741475566,1.0,7/36,11.79%,MBOAT1;SGMS1;PCYT2;SGMS2;CLN3;AGPAT3;HDHD5
prerank,tryptophan metabolic process (GO:0006568),0.3741540648602063,0.7805295804878584,0.7332268370607029,0.9229731200995522,1.0,2/11,18.03%,KYAT1;ATP7A
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3115363187342529,0.7804896554345012,0.7516425755584757,0.9226583897561036,1.0,4/30,7.90%,CACNA2D1;CACNA1C;KCNA5;GJC1
prerank,protein stabilization (GO:0050821),0.25808452525965836,0.7804160617520063,0.8640081799591002,0.9223894680522368,1.0,35/168,17.09%,FLOT2;USP9X;PARVA;BAG3;PTEN;MORC3;RAB21;LAMP2;BAG6;RASSF2;FBXW7;CCT8;TBL1X;CDC37;OTUD3;SEC16A;GAPDH;TRIM44;PEX19;ZBED3;CALR;CDK7;PIK3R1;CCT3;COA8;RPL11;PDCD10;NAA15;MTMR9;COG7;STK4;ATF7IP;BAG4;PEX6;HSPD1
prerank,response to copper ion (GO:0046688),-0.26251630241837964,-0.7799224427341876,0.8275862068965517,0.9439766941053308,1.0,14/20,45.66%,MT2A;ATP5F1D;HSF1;ATP7B;AQP1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;SNCA
prerank,lung epithelium development (GO:0060428),0.3707292690498759,0.7796879429711123,0.723338485316847,0.9230790027716905,1.0,2/10,11.52%,ERRFI1;RCN3
prerank,protein export from nucleus (GO:0006611),-0.24039945677087704,-0.7795791325075424,0.8257261410788381,0.9432012060882237,1.0,9/27,25.07%,RANBP3L;DESI1;STRADB;CSE1L;XPO5;DUSP16;XPO6;NUTF2;XPO4
prerank,cellular response to amino acid starvation (GO:0034198),0.2727838241127414,0.7795522078030249,0.8055865921787709,0.9228952519553903,1.0,19/71,18.35%,DAP;MIOS;NPRL2;EIF2AK2;RPTOR;RRAGC;KPTN;ATP6V1F;ATP6V1H;ATP6V1G2;LAMTOR5;ATP6V1G1;SEC13;SH3GLB1;MAPK1;ATP6V1D;EIF2AK3;ATF4;LAMTOR3
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.29063708063137517,-0.7790082600918705,0.7760252365930599,0.9428366171248792,1.0,7/15,19.93%,SYN3;ADRA1A;CNTNAP4;CLN3;USP46;NLGN1;DRD2
prerank,glycosphingolipid metabolic process (GO:0006687),0.29506686785429287,0.7789981065039866,0.797377830750894,0.9233093705929781,1.0,10/42,17.90%,UGCG;ABCA2;B4GALNT1;CLN6;SMPD3;NEU3;GALC;NEU1;CTSA;CPTP
prerank,negative regulation of RNA splicing (GO:0033119),0.33530072225904956,0.7783843969752868,0.7577464788732394,0.9238212525713904,1.0,5/19,15.90%,PTBP3;SAP18;SFSWAP;SRSF12;RBMX
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.30242369031540145,0.7778617844956998,0.7695167286245354,0.9241702538621009,1.0,5/37,7.14%,JAML;TENM3;DCHS1;ICAM1;TENM4
prerank,steroid biosynthetic process (GO:0006694),0.27982935342545584,0.7774956355095645,0.7768595041322314,0.9243136639905776,1.0,5/56,9.82%,CYP7B1;INSIG2;SLC27A2;HSD11B1;OSBPL3
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.21511749406673425,-0.7770192722583036,0.825,0.9445386180154557,1.0,16/40,31.73%,PRKN;TNFSF10;BCL2L1;IGF1;PINK1;BNIP3;DNM1L;GPER1;BID;TP53;PPIF;MFF;PSMD10;BIK;PDCD5;OPA1
prerank,vesicle organization (GO:0016050),0.2867793204693566,0.7768487008201804,0.8029020556227328,0.9248526754258153,1.0,15/46,20.02%,ARFGEF2;HOOK2;PI4K2B;DNAJC13;WASHC4;SNX33;PLEKHF1;SNX10;EPS15;CHMP2B;SQSTM1;ALS2;ZFYVE16;HOOK1;WASHC5
prerank,regulation of monooxygenase activity (GO:0032768),0.32551081157385153,0.7766470431211653,0.7560975609756098,0.92476280840245,1.0,4/23,9.94%,NOS1AP;EGFR;POR;CYGB
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.35623500576926276,0.7764010566472511,0.7368421052631579,0.9247377237775799,1.0,4/14,17.47%,TSEN2;TRPT1;RTRAF;DDX1
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.3643036993692136,0.7755568610120254,0.7630769230769231,0.9255657037378076,1.0,3/13,7.90%,CACNA1C;KCNA5;GJC1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.29002132262946023,-0.7753168658149368,0.7660256410256411,0.9459793372234067,1.0,2/14,7.23%,ME1;NMNAT3
prerank,response to organophosphorus (GO:0046683),0.34537639218336247,0.77527666100422,0.7328571428571429,0.9255898506163496,1.0,2/16,12.90%,STAT1;P2RX7
prerank,spermatid development (GO:0007286),0.3023811373582267,0.7746115940709503,0.7626262626262627,0.9261561868004702,1.0,3/32,8.47%,IQCG;ACRBP;ZMYND15
prerank,negative regulation of neuron death (GO:1901215),0.27099507703493303,0.7741826517158464,0.8496732026143791,0.9263629706719456,1.0,26/93,22.97%,LRRK2;APOE;CHMP4A;CHMP4B;MDK;BCL2;PTPRZ1;TGFB3;GPNMB;CCL2;FBXO7;UNC5B;GSK3B;TRAF2;CPEB4;RASA1;AKT1;ATF4;TYRO3;GDNF;EIF4G1;VPS35;CSF1;SNX6;FZD9;CD200R1
prerank,organelle fusion (GO:0048284),-0.2491512748867037,-0.7740668709671563,0.8127090301003345,0.9465720901726213,1.0,5/22,14.58%,MIGA1;VPS11;MFN1;USP30;GDAP1
prerank,embryonic axis specification (GO:0000578),0.3524564460828443,0.7735932425426403,0.7474150664697193,0.9268035662834279,1.0,2/15,10.21%,SMAD2;TBX3
prerank,positive regulation of dendrite extension (GO:1903861),-0.27311157065463176,-0.7733608481186667,0.7785234899328859,0.946347685179196,1.0,8/17,28.12%,ITSN2;RIMS1;RNF157;RIMS2;SYT3;NEDD4L;CPNE9;CPNE5
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.3153477376204,0.7732563858676421,0.7593085106382979,0.926916863393535,1.0,9/26,20.32%,SNAI2;BCL2;TERT;FGFR1;UNC5B;TNF;AKT1;INHBA;GDNF
prerank,tRNA wobble base modification (GO:0002097),-0.2877436341498266,-0.7732026914092662,0.7924528301886793,0.9452758108448149,1.0,2/14,4.38%,ALKBH8;TRMT9B
prerank,carboxylic acid transmembrane transport (GO:1905039),0.2947458896195408,0.7729614154509516,0.7756332931242461,0.9269479478928845,1.0,10/40,21.44%,SLC38A3;SLC7A7;SLC38A4;SLC36A2;SLC7A8;ABCC1;SLC25A10;SLC19A1;SLC36A4;SLC25A21
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3041289046904576,0.772701152697948,0.7890625,0.9269228869082267,1.0,9/32,19.69%,ATM;ATR;CCT8;CCT3;TNKS2;PNKP;MAPK1;PARN;PKIB
prerank,central nervous system neuron development (GO:0021954),0.3435061283068712,0.7720835023209075,0.7514619883040936,0.9273926720257133,1.0,6/15,18.03%,B4GALT5;PTEN;ARHGAP35;NPY;LHX6;ATP7A
prerank,regulation of dendrite extension (GO:1903859),-0.2675019078767144,-0.7720346469605452,0.7804878048780488,0.9458372886580888,1.0,8/18,28.12%,ITSN2;RIMS1;RNF157;RIMS2;SYT3;NEDD4L;CPNE9;CPNE5
prerank,response to amino acid starvation (GO:1990928),0.2696461544158704,0.7720038904688351,0.8182831661092531,0.9271184640913006,1.0,19/72,18.35%,DAP;MIOS;NPRL2;EIF2AK2;RPTOR;RRAGC;KPTN;ATP6V1F;ATP6V1H;ATP6V1G2;LAMTOR5;ATP6V1G1;SEC13;SH3GLB1;MAPK1;ATP6V1D;EIF2AK3;ATF4;LAMTOR3
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3501049495435689,0.7719785028582893,0.7375565610859729,0.9267762993701588,1.0,4/14,15.90%,SAP18;SFSWAP;SRSF12;RBMX
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.32772881257030656,0.7713409071546335,0.7611940298507462,0.927266055256169,1.0,4/23,10.06%,DICER1;SETMAR;FBH1;HMGB2
prerank,positive regulation of dendrite development (GO:1900006),0.3869198351567537,0.7712360778725781,0.7546218487394958,0.9270419717718673,1.0,3/10,14.05%,PTN;BMP5;BMP7
prerank,membrane organization (GO:0061024),0.2563728774876333,0.7711547573906888,0.9040816326530612,0.9267829783363257,1.0,47/227,19.10%,CLTC;STON2;SH3KBP1;EGFR;ITSN1;CHMP4A;CHMP4B;RABIF;TLCD2;DNAJC6;EGF;VPS4A;VAPA;EPS15L1;LEMD2;ACTR2;AP3D1;CBL;SYT2;GRB2;WNT5A;GAK;SNX9;AGFG1;EPS15;CHMP7;BTC;TMCC1;AZIN2;AP2A2;STX11;CHMP2B;TIMM50;SUN1;RTP4;TOR1AIP2;REPS1;SH3GLB1;LPCAT3;CTTN;KIF20A;PICALM;CPTP;TOR1AIP1;SPTBN1;GAPVD1;DVL2
prerank,negative regulation of histone methylation (GO:0031061),0.3761077824223645,0.7710809375672111,0.7408,0.9265099981246232,1.0,3/10,19.43%,PHF1;DNMT3B;KDM1A
prerank,glutathione biosynthetic process (GO:0006750),-0.3109410287758922,-0.770800524167177,0.7659574468085106,0.9464812681970018,1.0,3/11,11.90%,GCLC;HAGH;CHAC2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.37243681383953814,0.7705070997031037,0.7586750788643533,0.9269072260349847,1.0,3/11,15.12%,EGFR;MAP2K1;RIPK1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.35716449941524975,0.7703974152389913,0.7332317073170732,0.9266815691627943,1.0,2/13,7.77%,ABCE1;NMD3
prerank,long-chain fatty acid import into cell (GO:0044539),0.37441574604393607,0.769304925573861,0.7586776859504132,0.9278658778947546,1.0,3/10,9.84%,CD36;SLC27A2;RPS6KB1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.308938020181907,0.7691094329885596,0.7658227848101266,0.9277642574308272,1.0,7/32,18.59%,BACH1;E2F1;CDK14;BRD4;CDK16;FBXO5;HINFP
prerank,regulation of secretion by cell (GO:1903530),0.2830899196545242,0.7680387357149479,0.7956120092378753,0.9289008977107608,1.0,11/54,16.28%,DNAJC1;RALA;RAB21;LLGL1;RAB8B;KCNMB4;ANXA1;HCRT;RAB10;FMR1;MCTP2
prerank,negative regulation of neuron projection development (GO:0010977),0.27956949120713276,0.7679805140793512,0.8115606936416185,0.9286023099892154,1.0,9/56,13.48%,MYLIP;DPYSL3;APOE;PTEN;GAK;PTPN9;DENND5A;RHOA;RTN4RL1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.27804910948138734,0.76755151384474,0.7940119760479042,0.9288144901460683,1.0,6/54,7.75%,TNKS1BP1;E2F1;CNOT4;ATM;E2F8;CARM1
prerank,protein glycosylation (GO:0006486),0.2591321388157666,0.7673998102678995,0.8498435870698644,0.9286481307203158,1.0,21/125,16.66%,MGAT5;PLOD2;B4GALT5;GFPT2;TRAK1;ST3GAL3;DDOST;ALG5;OGT;MAN1C1;MGAT4A;STT3A;ST3GAL1;GCNT2;TET2;TUSC3;PMM2;B4GALT7;RPN1;COG7;B3GNT9
prerank,positive regulation of axonogenesis (GO:0050772),0.29114168295352133,0.7673616769774805,0.7852834740651388,0.9283233822064486,1.0,8/43,11.96%,ROBO2;PLXNC1;PLXND1;L1CAM;PLXNA3;DBN1;DBNL;RHOA
prerank,ganglion development (GO:0061548),0.3576265756313309,0.7669456444945071,0.7275590551181103,0.9285495574923838,1.0,1/11,3.11%,NRP1
prerank,positive regulation of DNA binding (GO:0043388),0.3043542339168719,0.7668886688482164,0.7692307692307693,0.9282529679079797,1.0,4/31,10.06%,EGF;PPARG;PINX1;HMGB2
prerank,positive regulation of DNA recombination (GO:0045911),0.3110130460369128,0.7666489510817269,0.7453580901856764,0.9282047133792268,1.0,9/27,20.29%,ACTR2;SHLD3;TIMELESS;RIF1;MMS19;PAXIP1;HMCES;ARID2;ERCC2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.2968978550607967,0.7666317124638021,0.7941176470588235,0.9278449494976908,1.0,6/33,10.36%,CDKN2B;PTEN;PKD2;CDK6;GPNMB;CCL2
prerank,protein maturation (GO:0051604),0.26582537337009393,0.7664222728721717,0.8387096774193549,0.9277508097008348,1.0,20/95,21.31%,MMP14;ADAM19;NAA50;CTSS;CPXM1;MMP16;OGT;LMF2;PSEN1;XPNPEP3;MMS19;NAA15;PSENEN;TSPAN14;HSPD1;AANAT;PHEX;NCSTN;PITRM1;PSEN2
prerank,peptide metabolic process (GO:0006518),0.26966125655423984,0.766054868008659,0.8233995584988962,0.9278808790740182,1.0,11/75,13.92%,DNPEP;ANPEP;CPQ;CPXM1;NPEPPS;ENPEP;NLN;GSTK1;SPPL3;LVRN;PSEN1
prerank,mitochondrial fusion (GO:0008053),0.3330865139578937,0.766006014602799,0.7510980966325037,0.927579770185959,1.0,3/18,12.77%,STOML2;MIGA2;SPG7
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.3246040020095007,0.7658059736589257,0.7664516129032258,0.9274841939163351,1.0,2/23,3.02%,SLC9A1;SLC12A4
prerank,negative regulation of protein kinase activity (GO:0006469),0.2653387780877477,0.7652169879396598,0.8300865800865801,0.9279500025610248,1.0,25/88,19.84%,SPRED1;NF1;TAF7;DTNBP1;LRP6;EPHA1;PTPN1;GSKIP;PYDC1;MVP;WWTR1;DUSP26;UBASH3B;SMCR8;SH3BP5L;TRIB3;CDKN1B;TRIB1;RTRAF;ITGB1BP1;PTPRC;AKT1;LRP5;GADD45A;CORO1C
prerank,C-terminal protein amino acid modification (GO:0018410),-0.31407140714324544,-0.7650445080898481,0.760752688172043,0.9540802219107279,1.0,3/11,10.52%,FOLH1;ATG12;GPLD1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.3654433558210296,0.7647308077517757,0.7539184952978056,0.9282314454491303,1.0,3/11,12.48%,ITPKC;IP6K2;FGF2
prerank,protein modification process (GO:0036211),0.26686313372382153,0.7640544872828512,0.8307349665924276,0.9287976423312473,1.0,22/76,22.02%,PLOD2;PLAT;ATG3;UBE2L3;ST3GAL1;PPP4R2;PHKA2;MMP15;ADPRH;FBXO2;RABGGTB;B4GALT7;RPN1;PRKDC;PIGH;YES1;PHEX;UBL5;PARP4;USP25;FBXO22;UBE2L6
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.36120846622971486,0.7638945287237743,0.7519872813990461,0.9286387915425499,1.0,2/12,11.80%,ASXL1;CALR
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.340682032716124,0.7636457570587637,0.7588757396449705,0.9286129258867292,1.0,3/18,12.30%,SPN;ADD2;TNF
prerank,pore complex assembly (GO:0046931),-0.25715733528475604,-0.763352585478736,0.8282828282828283,0.9553610023330599,1.0,7/19,22.48%,PLEKHA7;ADAM10;TMEM170A;GSDMD;AFDN;NUP98;NUP93
prerank,response to nutrient levels (GO:0031667),0.33700894512478907,0.7631962556439349,0.7644508670520231,0.9288444119328875,1.0,5/17,20.36%,CD68;RPTOR;RPS6KB1;ATF4;EIF4G1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.2918072705621245,0.7630446914196763,0.782716049382716,0.9286675391278016,1.0,10/39,16.47%,PIP4K2A;PI4K2B;ITPKC;TTC7A;IP6K2;SOCS5;PI4KA;PIK3R1;EFR3A;PIK3C3
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3059356052405771,0.7626078714216831,0.7914572864321608,0.9285088461917291,1.0,13/31,24.54%,GTF2H1;GTF2F2;NCBP2;RAMAC;CDK7;GTF2F1;POLR2L;POLR2K;ERCC2;CCNH;POLR2D;MNAT1;RNMT
prerank,7-methylguanosine RNA capping (GO:0009452),0.3059356052405771,0.7626078714216831,0.7914572864321608,0.9285088461917291,1.0,13/31,24.54%,GTF2H1;GTF2F2;NCBP2;RAMAC;CDK7;GTF2F1;POLR2L;POLR2K;ERCC2;CCNH;POLR2D;MNAT1;RNMT
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3222773180639593,0.7625717660710744,0.7601626016260162,0.9281852795596521,1.0,3/22,6.21%,NR2F2;PTEN;PLK1
prerank,positive regulation of telomerase activity (GO:0051973),-0.22684639025208136,-0.762374961745478,0.8571428571428571,0.9555216970431716,1.0,10/33,22.46%,HSP90AA1;KLF4;CCT4;DKC1;PRKCQ;HMBOX1;MAPK3;NVL;HSP90AB1;TNKS
prerank,programmed necrotic cell death (GO:0097300),0.32861594777508507,0.762226210982518,0.7538896746817539,0.9283029289027872,1.0,4/18,15.12%,LY96;CD14;MLKL;RIPK1
prerank,regulation of response to oxidative stress (GO:1902882),-0.30637136057346814,-0.7621758819717849,0.7613636363636364,0.9544974872199319,1.0,2/11,2.89%,PRKN;MCTP1
prerank,inositol phosphate-mediated signaling (GO:0048016),0.3224697234217734,0.762151138691142,0.7404129793510325,0.9280135494336135,1.0,3/19,10.07%,EDN3;HRH1;PPP3CA
prerank,RNA processing (GO:0006396),0.25355817947589776,0.762090388199621,0.884102564102564,0.9277293543454135,1.0,38/176,21.08%,RBMS1;PPP1R9B;APOBEC1;TSEN2;ATXN1;SYNCRIP;SNRNP40;DDX17;CCAR2;PABPC4;CELF1;RRAGC;NONO;DICER1;DHX8;ALKBH5;NCBP2;PRPF18;SNRNP35;ZCCHC8;RNPC3;RBM6;SETX;HNRNPUL1;DHX15;TCERG1;TUT7;PRPF3;DDX20;RBM39;SRSF2;SON;SNRPB;DUSP11;TENT4A;RBMS2;SCAF11;CDK12
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3472051307601423,0.7620886320936227,0.7262996941896025,0.9273567274831259,1.0,6/13,31.30%,SRD5A3;ALG11;ALG14;DPAGT1;ALG2;ALG8
prerank,negative regulation of lyase activity (GO:0051350),-0.2751160829636642,-0.7620209995929602,0.7948717948717948,0.9534028904067307,1.0,2/16,5.48%,PALM;GRM3
prerank,phagosome maturation (GO:0090382),0.2986092193676796,0.761870016517953,0.7713178294573644,0.9272861405384671,1.0,8/35,17.43%,RAB7A;RAB32;ATP6V1F;ATP6V1H;ATP6V1G2;RAB34;ATP6V1G1;ATP6V1D
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.22917751605126854,-0.7612321117108015,0.8325581395348837,0.9532565234988388,1.0,14/29,28.69%,ERCC5;ERCC3;UBC;CHD1L;DDB2;GTF2H2;GTF2H4;UBA52;GTF2H3;CETN2;RBX1;RPA2;PARP1;XPC
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.2920697755940202,0.7608405649774033,0.7810945273631841,0.9283203044585316,1.0,12/42,20.23%,ACTR2;SHLD3;SETD2;FBH1;PPP4R2;TIMELESS;RIF1;PPP4C;MMS19;CGAS;KDM1A;ARID2
prerank,histone modification (GO:0016570),0.2589961726277722,0.7604924614750334,0.841541755888651,0.9284038404852377,1.0,25/109,19.11%,RCOR1;MIER2;PADI2;NAA50;PRDM5;CREBBP;EHMT1;CARM1;HDAC1;TBL1X;MTA2;USP3;RUVBL1;NSD3;USP22;BAZ2A;NSD1;MTA3;PHF20;RCOR2;MAP3K12;USP36;HDAC5;KAT6B;BRMS1L
prerank,macromolecule catabolic process (GO:0009057),0.3159908995190726,0.7596538729685965,0.7856173677069199,0.9291686944423089,1.0,12/26,28.88%,CLN6;KIF16B;PIK3R4;SNX25;SMURF1;NEDD4;SH3GLB1;BECN1;CLN5;CLPX;PPT1;SIAH1
prerank,tRNA processing (GO:0008033),-0.19332229984347196,-0.7594470271355335,0.9504132231404959,0.9545501416120883,1.0,19/61,21.28%,RTCB;TRMT9B;CSTF2;DTWD2;TYW5;ELP5;FAM98B;TRDMT1;QTRT1;NSUN6;TRMT10A;LCMT2;PTCD1;CDKAL1;POP5;SARS1;TRMT10B;ADAT1;CLP1
prerank,nucleoside catabolic process (GO:0009164),-0.3055780459638066,-0.7591071186843896,0.7845744680851063,0.9537694923355631,1.0,5/11,18.00%,NT5E;UPB1;NT5C3A;DERA;NT5C
prerank,tRNA metabolic process (GO:0006399),0.33504698182561166,0.7589401701004347,0.7741935483870968,0.9297621397320749,1.0,3/17,10.05%,TRPT1;POP1;DTD1
prerank,negative regulation of neuron differentiation (GO:0045665),0.3147838776028401,0.7586420596216098,0.7605633802816901,0.9298087923076088,1.0,6/22,19.61%,NEPRO;CALR;GSK3B;BMP7;SOX2;MED1
prerank,protein localization to vacuole (GO:0072665),-0.29138802610056325,-0.758571125914317,0.8029850746268656,0.9532477089732777,1.0,3/13,11.56%,CD81;LMBRD1;RNF128
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.3175839991526683,0.7570358986566054,0.7655172413793103,0.9316075975425401,1.0,10/24,26.49%,DNAAF4;APOE;CTSC;PSMD14;TMF1;LATS1;USP14;ATP5IF1;RHBDF1;EFNA1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.2713106503541394,-0.7564830916811351,0.8206686930091185,0.9548459885700457,1.0,5/17,13.07%,NTRK2;RTN1;SORL1;IGF1;ABCA7
prerank,histone H2A monoubiquitination (GO:0035518),-0.27196093104140195,-0.7562804519218518,0.782312925170068,0.9538248389065522,1.0,2/17,1.99%,PCGF5;TRIM37
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3192100585962038,0.7560770208770966,0.7746666666666666,0.9324657047870057,1.0,5/24,15.59%,TNFAIP3;NOD1;IRAK2;CASP8;ITCH
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.33555311718971365,0.756005638959149,0.7774607703281027,0.9321829161530714,1.0,5/18,13.84%,APOE;ABCA2;MSN;CTSC;DACT1
prerank,small GTPase mediated signal transduction (GO:0007264),0.25835868646345256,0.7552755769660869,0.864406779661017,0.9327608123658395,1.0,22/103,16.29%,RASSF1;ARHGAP32;PLD1;NF1;NUCB2;RAB42;RALA;SIAH2;MAPK11;GRB2;RRAGC;BRAP;RERG;SETDB1;RALGDS;RIT1;RIN2;FGF2;ARHGEF18;RAC1;USP28;RGL1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.3428433544381672,0.7552747295511824,0.7593984962406015,0.9323873999743202,1.0,5/16,23.20%,MCM2;MCM7;TWNK;RPA1;RAD51
prerank,glycerolipid metabolic process (GO:0046486),0.36213343163912354,0.7549442573200984,0.7476635514018691,0.9324813108162079,1.0,1/11,1.24%,PDXP
prerank,negative regulation of metabolic process (GO:0009892),0.2768945931603561,0.7529126519396324,0.8202380952380952,0.9348461487708671,1.0,6/54,10.88%,ADIPOQ;LAMA4;ADAMTS5;ARRDC3;PLCL1;ACOT13
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.2856836211300874,0.7521191664977752,0.8046683046683046,0.9355028288267645,1.0,10/41,18.91%,IL34;EGF;DLG4;PTPN1;FBXW7;BTC;SRC;FCGR1A;AGT;PRNP
prerank,chromatin assembly or disassembly (GO:0006333),0.3687875412932642,0.7517271562429163,0.7483766233766234,0.9356322664524361,1.0,2/11,9.89%,NOC2L;MTA2
prerank,regulation of dendrite development (GO:0050773),0.2904707091999274,0.7516018410964922,0.7882653061224489,0.9354174264885273,1.0,10/37,15.60%,PTN;MARK1;RAP2A;SDC2;BMP5;DBN1;CAMSAP2;GSK3B;BMP7;NEDD4
prerank,negative regulation of defense response to virus (GO:0050687),0.37433419736885887,0.7509146523301076,0.7545008183306056,0.9359502172876398,1.0,2/10,15.59%,ILRUN;ITCH
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.31879667568279496,0.7503728303754829,0.7891816920943134,0.9362815644316792,1.0,3/23,4.87%,MYO10;KIF1C;HOOK2
prerank,positive regulation of glycolytic process (GO:0045821),0.32402687456945756,0.750344322776462,0.7588152327221439,0.9355702008476415,1.0,6/20,15.68%,ARNT;PFKFB4;ZBTB20;P2RX7;PSEN1;HIF1A
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.32402687456945756,0.750344322776462,0.7588152327221439,0.9355702008476415,1.0,6/20,15.68%,ARNT;PFKFB4;ZBTB20;P2RX7;PSEN1;HIF1A
prerank,ribosomal small subunit biogenesis (GO:0042274),0.2835438544145181,0.7498852659531173,0.8,0.9358064349299661,1.0,2/39,3.70%,RPSA;NOL11
prerank,regulation of supramolecular fiber organization (GO:1902903),0.31729241309766665,0.7497116124786329,0.7873239436619718,0.9356660243814049,1.0,4/22,12.60%,APOE;MAP1S;CAMSAP2;AKAP13
prerank,N-terminal protein amino acid modification (GO:0031365),0.3440233445457982,0.7496652886424039,0.7556904400606981,0.9353496269768207,1.0,5/14,27.13%,NAA50;NAA15;AANAT;METAP1;METAP1D
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2784005824214846,0.7496347294358126,0.8179640718562874,0.9346379812659714,1.0,15/50,20.96%,NUP37;PUM1;RAE1;NUP153;FMR1;NDC1;NUP35;NUP188;SEC13;POLR2L;POLR2K;NUP214;AGO2;EIF4G1;NUP107
prerank,regulation of gene silencing by RNA (GO:0060966),0.2784005824214846,0.7496347294358126,0.8179640718562874,0.9346379812659714,1.0,15/50,20.96%,NUP37;PUM1;RAE1;NUP153;FMR1;NDC1;NUP35;NUP188;SEC13;POLR2L;POLR2K;NUP214;AGO2;EIF4G1;NUP107
prerank,lipid droplet organization (GO:0034389),-0.24465973227890525,-0.7487582306812205,0.8679245283018868,0.9632028842467603,1.0,7/22,25.61%,RAB18;CDS2;BSCL2;SQLE;PPIA;PLA2G4C;FITM2
prerank,acyl-CoA metabolic process (GO:0006637),0.2957585476660042,0.74873735521838,0.7946084724005135,0.9354217766419067,1.0,8/35,18.59%,DLST;ACSF2;SUCLG2;ACOT13;ACOT9;SUCLA2;MCEE;ACACA
prerank,positive regulation of nervous system process (GO:0031646),0.3284773732343321,0.7485600036006592,0.780380673499268,0.9352789447471133,1.0,6/18,17.61%,TENM4;HCRT;DICER1;EGR2;TPPP;NCMAP
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.29846243643516235,0.7485331991479918,0.7984395318595578,0.9349400909898112,1.0,5/30,14.06%,JAK2;GRB2;ERBIN;VAV1;SRC
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.36759304171940377,0.7482997201904951,0.7371695178849145,0.9348880535672368,1.0,3/10,19.94%,IRS1;AKT1;PTH1R
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3637623848872559,0.7482131924397277,0.7727975270479135,0.9346400782625129,1.0,2/11,16.22%,RTP4;PKD1L3
prerank,error-prone translesion synthesis (GO:0042276),-0.2468495630928635,-0.7478053626838644,0.83203125,0.9631868530356921,1.0,13/21,35.17%,UBC;PCNA;RFC3;UBA52;POLH;RPA2;PRIMPOL;POLE2;RFC4;RFC2;RPA3;POLK;RFC5
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2951714021725939,0.7474391961027039,0.7944514501891551,0.9352777255133226,1.0,8/32,17.53%,LRRK2;DTNBP1;KCNMB4;HCRT;GSK3B;FMR1;MCTP2;STX1B
prerank,negative regulation of protein binding (GO:0032091),0.2622301037455564,0.7463958964843975,0.8292410714285714,0.9362275298931807,1.0,16/71,20.54%,ADIPOQ;LRRK2;DDX11;EFHB;ATP2A2;DISC1;GSK3B;GTF2F1;DACT1;ITGB1BP1;AKT1;TLE5;CTNNBIP1;KDM1A;PIN1;PRKCD
prerank,superoxide metabolic process (GO:0006801),0.29855335224891316,0.7463668646951008,0.7958387516254877,0.9359019958811544,1.0,5/29,19.23%,SH3PXD2B;PREX1;NRROS;ATP7A;CYBB
prerank,regulation of fibroblast migration (GO:0010762),0.3192975049793148,0.7462627221194181,0.7830188679245284,0.9356759785791299,1.0,7/20,19.84%,DDR2;PTK2;FGF2;RAC1;ITGB1BP1;GNA12;CORO1C
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.3387012370058536,0.74518996453833,0.7570789865871833,0.9367119150962289,1.0,3/13,12.30%,TM9SF4;SNX33;TNF
prerank,sulfur amino acid metabolic process (GO:0000096),0.3077993907022437,0.7451167408725543,0.787598944591029,0.9364516119771624,1.0,5/24,19.82%,MTHFR;AHCY;ADI1;MTRR;CDO1
prerank,intracellular pH reduction (GO:0051452),-0.22131781457280014,-0.7450776269158328,0.8785046728971962,0.9656839362122551,1.0,10/33,21.98%,DMXL2;GPR89B;GPR89A;CLCN3;ATP6V1B2;ATP6V1E1;ATP6V0B;DMXL1;ATP6V0E2;ATP6V0D1
prerank,regulation of telomere maintenance (GO:0032204),-0.23661511864091256,-0.7449977736166303,0.8823529411764706,0.9644800626515705,1.0,7/26,18.27%,MRE11;PPP1R10;RTEL1;UPF1;USP7;ERCC1;DHX36
prerank,negative regulation of protein modification process (GO:0031400),0.262214652193603,0.7443210827194473,0.8412874583795783,0.9371077375664749,1.0,23/79,21.21%,FBLN1;LRRK2;PTPN13;PTEN;LRP6;PID1;NIBAN1;WWTR1;IBTK;ZBED3;GSK3B;NTRK3;XRCC1;PRKDC;PNKP;PTPA;TPPP;MFHAS1;XDH;PRNP;CORO1C;ZC3H12A;SIRPA
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.31688230747417906,0.7441331894574331,0.7720994475138122,0.9369648600033913,1.0,7/23,20.32%,MDK;EGF;FGF2;SMO;PAX8;AGT;GDNF
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.3572259923981269,0.7433976615602291,0.770096463022508,0.9375630160655203,1.0,4/10,26.50%,IFT88;ADGRV1;PDZD7;PLS1
prerank,UV-damage excision repair (GO:0070914),0.35209208012445936,0.7428051803510534,0.7598736176935229,0.9379833523429085,1.0,3/12,17.41%,INO80;MC1R;DDB1
prerank,tRNA methylation (GO:0030488),-0.2070264759162895,-0.742720468422596,0.9186602870813397,0.9662108020474527,1.0,14/34,29.43%,ALKBH8;TRMT1L;TRDMT1;NSUN6;TRMT10A;LCMT2;TRMT5;TRMT44;METTL6;TYW3;TRMT12;TRMT112;HSD17B10;TRMO
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.35235447606450254,0.7425056308198869,0.7909090909090909,0.9372367419507329,1.0,3/12,13.21%,ANAPC11;CDC27;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.35235447606450254,0.7425056308198869,0.7909090909090909,0.9372367419507329,1.0,3/12,13.21%,ANAPC11;CDC27;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.35235447606450254,0.7425056308198869,0.7909090909090909,0.9372367419507329,1.0,3/12,13.21%,ANAPC11;CDC27;NSMCE2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.35764734059064035,0.7423356062264491,0.7507987220447284,0.9370880757094866,1.0,1/11,4.11%,PADI2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.324563211123062,0.7419961660790341,0.8014184397163121,0.937139605966705,1.0,1/19,3.78%,APOE
prerank,regulation of macrophage activation (GO:0043030),0.29498395175677106,0.7413616282963691,0.7819843342036553,0.9375947375156594,1.0,8/30,22.65%,LBP;WNT5A;PJA2;HSPD1;MFHAS1;ZC3H12A;TNIP2;IL33
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.30862884213445513,0.7412289694710799,0.8041666666666667,0.9373971379073036,1.0,3/20,8.54%,ACSL4;SCD5;HSD17B8
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3655942581598494,0.740906172833469,0.7700787401574803,0.9374416073561773,1.0,2/10,11.25%,ERLEC1;UBE2J1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3267624285024707,0.7404662759007692,0.7623762376237624,0.9376409174781266,1.0,5/17,18.45%,CPEB1;ZC3H3;NCBP2;CCNT1;CDK9
prerank,positive regulation of insulin secretion (GO:0032024),0.2833982929421523,0.7401440701607608,0.8012578616352202,0.9376994027562879,1.0,6/36,15.09%,TCF7L2;BLK;ACSL4;GCK;TRPM4;DOC2B
prerank,regulation of centriole replication (GO:0046599),0.3203961178850933,0.7396621175589688,0.7962154294032023,0.9379566371330891,1.0,2/18,5.80%,CEP295NL;ALMS1
prerank,intracellular protein transmembrane transport (GO:0065002),0.2796085085525328,0.7389021015575556,0.8107142857142857,0.9385743469799988,1.0,13/42,19.53%,PEX10;SEC63;TIMM17A;SEC61A1;HSPA5;SEC61A2;TIMM50;AIFM1;PEX6;HSPD1;PEX12;TIMM23;TOMM40L
prerank,positive regulation of TORC1 signaling (GO:1904263),0.3311228965161899,0.7383640869351269,0.779969650986343,0.938894418536441,1.0,6/16,21.25%,KLHL22;LAMTOR5;GPR137;SIK3;TELO2;CLEC16A
prerank,peroxisomal membrane transport (GO:0015919),0.3023557674362294,0.7380472167214676,0.7972972972972973,0.9389216440752131,1.0,6/27,19.40%,PEX10;RAB8B;PEX19;ALDH3A2;PEX6;PEX12
prerank,megakaryocyte differentiation (GO:0030219),0.35428712594643874,0.7379736210434665,0.7955271565495208,0.9386378135210471,1.0,2/11,10.90%,CDKN2B;UBA5
prerank,mesoderm development (GO:0007498),0.3233815899701094,0.7362171959620772,0.7890173410404624,0.9405297828108066,1.0,3/18,10.21%,JAK2;MEST;TBX3
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.31231051390309544,0.7361623488962816,0.791023842917251,0.9398640131504233,1.0,5/21,12.30%,SNAI2;BCL2;TERT;UNC5B;TNF
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.31231051390309544,0.7361623488962816,0.791023842917251,0.9398640131504233,1.0,5/21,12.30%,SNAI2;BCL2;TERT;UNC5B;TNF
prerank,nucleocytoplasmic transport (GO:0006913),0.2799787581637225,0.736077134878437,0.8108108108108109,0.9396016060804181,1.0,9/40,20.95%,ATXN1;NCBP2;ANP32A;SMN1;BACH2;DDX20;SNRPB;NEMF;XPO1
prerank,diol biosynthetic process (GO:0034312),-0.2696989557784302,-0.7358967072495076,0.8248407643312102,0.9739065977802921,1.0,3/15,5.15%,ACER2;SPTLC2;SPTLC1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.2950179262671476,0.7355965861058092,0.807741935483871,0.9398245651202629,1.0,4/31,5.97%,TNN;SUFU;CDK6;PPARG
prerank,negative regulation of transferase activity (GO:0051348),0.29297259590748054,0.7350981976627824,0.8113695090439277,0.9400630444517224,1.0,7/28,18.54%,NPRL2;PINX1;GSK3B;SRC;CDKN1B;DTX3L;FBXO5
prerank,spliceosomal snRNP assembly (GO:0000387),-0.21239011890681203,-0.7350029720208934,0.9015544041450777,0.9738156473819077,1.0,10/38,23.03%,PRPF6;GEMIN2;SNRPC;SNRPG;PRPF19;SART1;SNRPD3;PRPF8;AAR2;SNUPN
prerank,brain morphogenesis (GO:0048854),0.3470139737994979,0.7348437112040977,0.7732919254658385,0.940028573447077,1.0,3/12,12.26%,PTEN;SPEF2;FBXW11
prerank,regulation of store-operated calcium entry (GO:2001256),-0.30352463160628873,-0.7344250592252277,0.8342696629213483,0.973232271897889,1.0,3/10,14.38%,HOMER2;SLC8B1;STIM1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.3033545247867105,0.734221890014023,0.803788903924222,0.9404537824602591,1.0,5/25,14.52%,OPHN1;CSNK2A1;CSNK2A2;PSMF1;RPL11
prerank,positive regulation of cell killing (GO:0031343),0.33913563106469097,0.7341572679731274,0.779788838612368,0.9401558828449471,1.0,3/13,19.10%,WNT5A;RAC1;DVL2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.34760236536049066,0.7337968964670487,0.7726574500768049,0.9402419648406559,1.0,4/11,17.65%,NONO;FBXO7;HIF1A;ATF4
prerank,phagosome acidification (GO:0090383),0.2976918464127503,0.7333303754574596,0.8129117259552042,0.9404553089380882,1.0,6/26,17.43%,RAB7A;ATP6V1F;ATP6V1H;ATP6V1G2;ATP6V1G1;ATP6V1D
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2560127131396543,-0.7332951542950971,0.8415841584158416,0.9733752662852952,1.0,5/19,20.48%,MAOB;CAT;SOD1;PRDX2;NOX1
prerank,positive regulation of catabolic process (GO:0009896),0.2631521208697208,0.7331242495472036,0.8482758620689655,0.9403368351492134,1.0,15/65,15.60%,TNFAIP3;SMURF2;OAZ3;RAB7A;AREL1;WNT5A;CSNK2A1;ATG7;TNF;GSK3B;DACT1;CDKN1B;SMURF1;ITCH;NEDD4
prerank,regulation of protein modification process (GO:0031399),0.2739591521550804,0.7331007837722845,0.8425381903642774,0.9399920899377493,1.0,14/50,20.52%,SPRED1;ABCA2;SPRED2;CCAR2;FNIP1;PTK2;ATG7;PPP1R16A;PLXNB2;CDK9;STAT2;CORO1C;PIN1;NDUFS4
prerank,negative regulation of cellular component movement (GO:0051271),0.3369187145746061,0.7330521147888007,0.77046783625731,0.9396845258530182,1.0,2/15,8.93%,FBLN1;SP100
prerank,regulation of organelle organization (GO:0033043),0.25754238435433147,0.7329162820875945,0.8754208754208754,0.9394746561726804,1.0,15/80,17.54%,ZEB2;TAOK1;SYDE1;MYO5A;CAPN2;MSN;LMAN1;PTK2;CAMSAP2;AKAP9;PDCD10;SQSTM1;ARMH3;MAPK1;RAB33B
prerank,mRNA catabolic process (GO:0006402),0.273404978576796,0.7325019991264385,0.8380024360535931,0.9396329617625258,1.0,10/44,17.80%,ZFP36L2;METTL16;EXOSC4;DCP2;RNH1;DHX34;XRN1;DXO;THRAP3;TUT7
prerank,protein tetramerization (GO:0051262),-0.18973009521021889,-0.732079110557367,0.9363636363636364,0.9737051144206839,1.0,23/67,28.76%,KCNJ2;SAMHD1;UPB1;GRIN2B;ALDH9A1;GOLGA2;KCNJ12;GBP5;SSBP1;KCNC1;HCN1;SOD2;CBR4;GLS;USP16;APIP;KCNC3;CRYZ;PKD2L1;CTH;TRPA1;CBY1;HSD17B10
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.3577612529464718,0.7319299855059868,0.7751196172248804,0.9400019247253003,1.0,3/10,18.94%,IRAK3;PTPRC;TLE5
prerank,regulation of cell motility (GO:2000145),0.247966957767543,0.7317977852707435,0.8925184404636459,0.9397945809383147,1.0,21/121,18.10%,FBLN1;SERPINE2;FGF7;PLXNC1;AMOTL1;EGFR;KIF2A;EGF;CDK6;PLXND1;PLXNA3;MEMO1;RHOA;FGF2;BTC;RAC1;FES;FGF18;AKT1;DOCK10;PLXNB2
prerank,protein import into peroxisome matrix (GO:0016558),0.3457178357346696,0.7316777568279027,0.7891566265060241,0.939572984969235,1.0,1/12,2.13%,PEX10
prerank,mesenchymal to epithelial transition (GO:0060231),-0.3100820621831405,-0.7312782611015767,0.810958904109589,0.9733538949900835,1.0,1/10,1.76%,BMP4
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.257090565036684,0.7309014814914981,0.8737541528239202,0.9401588756123708,1.0,23/73,25.32%,TNKS1BP1;EGFR;PRKD2;RPTOR;FNIP1;SPRY2;TNF;NTRK3;AKAP9;PDCD10;STK4;AKT1;IRGM;EIF4G1;TRIM6;AXIN1;PAK1;RAF1;LATS1;TERF2IP;VEGFA;BRAF;PFN2
prerank,pentose-phosphate shunt (GO:0006098),-0.30005562312117257,-0.730820554878373,0.8055555555555556,0.9726627312271681,1.0,8/11,33.94%,RPIA;SHPK;DERA;RBKS;PGD;PGLS;PGM2;RPE
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3183636508850508,0.7306816316810542,0.7823613086770982,0.9400589401805954,1.0,7/16,26.54%,GART;PPAT;AMPD2;IMPDH2;AMPD3;IMPDH1;ADSL
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.26960646003218935,-0.730150679232935,0.8397626112759644,0.9722149757378352,1.0,3/15,11.24%,TIPIN;MRE11;HUS1
prerank,positive regulation of protein catabolic process (GO:0045732),0.2545884700335216,0.7297419684724442,0.87117903930131,0.9408357531009287,1.0,19/84,15.60%,TNFAIP3;APOE;SMURF2;OAZ3;RAB7A;MSN;AREL1;WNT5A;CSNK2A1;SNX33;SNX9;ATG7;TNF;GSK3B;DACT1;CDKN1B;SMURF1;ITCH;NEDD4
prerank,centromere complex assembly (GO:0034508),0.28465564459787285,0.7294768634286627,0.8200253485424588,0.9407868032691538,1.0,5/36,11.47%,CENPQ;CENPN;RSF1;CENPL;RUVBL1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.3303078711675498,0.7294019765657462,0.8117469879518072,0.9405085054790132,1.0,4/15,17.47%,TSEN2;TRPT1;RTRAF;DDX1
prerank,pharyngeal system development (GO:0060037),0.33739432770379557,0.7287690076771198,0.7878787878787878,0.9409358917799024,1.0,8/15,28.12%,TGFBR1;BMP5;TGFB2;BMP7;BMPR1A;BMPR2;HES1;PTCH1
prerank,T cell proliferation (GO:0042098),0.3389557610317582,0.7283793915921103,0.783206106870229,0.94106106159163,1.0,3/13,11.94%,MSN;CTPS1;TNFRSF4
prerank,histone H2A acetylation (GO:0043968),0.31898603296345185,0.7281784909454642,0.7852941176470588,0.9409546213310757,1.0,9/16,29.69%,RUVBL1;SPHK2;EP400;MEAF6;TRRAP;MORF4L2;MORF4L1;RUVBL2;ING3
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3330218493049142,0.7280026059942762,0.76793893129771,0.9408011819060578,1.0,7/13,29.93%,NOP14;BMS1;KRI1;TSR1;RCL1;RRS1;TBL3
prerank,transport along microtubule (GO:0010970),0.33854837560943374,0.7277654169674938,0.7805970149253731,0.9407256375468142,1.0,3/13,8.68%,BAG3;CDC42;COPG1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.33763650036456694,0.7276269767126419,0.8058823529411765,0.9405397146669601,1.0,3/14,10.47%,NCK1;PPP3CA;PPP2R2A
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.249881556781488,-0.7275223079232489,0.8720538720538721,0.9741819881690782,1.0,5/18,22.24%,HIP1R;ZNF205;SLC35F6;BID;CHCHD10
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.25831392969312617,0.727349970963329,0.8566473988439306,0.9404982068777477,1.0,15/63,21.99%,TNKS1BP1;E2F1;CNOT4;ATM;E2F8;CARM1;CDKN1B;PRKDC;MDM2;FBXO31;GADD45A;PLK2;CNOT2;RGCC;CNOT3
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.2807503452719323,0.7264953950576293,0.8181818181818182,0.9411945317618857,1.0,12/38,22.06%,PTEN;SFRP5;OTUD3;DRD3;PTPRJ;TRIB3;PHLPP2;AKT1;XDH;EPHA2;PPP2R5C;THEM4
prerank,gas transport (GO:0015669),-0.3055411068047583,-0.7263716934853449,0.7988668555240793,0.9743038423386361,1.0,2/10,11.58%,CA2;IPCEF1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.3258085389282826,0.7263617928773307,0.7903225806451613,0.940983555375236,1.0,6/15,25.68%,PTPN2;YTHDF3;STAT2;ISG15;YTHDF2;CNOT7
prerank,regulation of mRNA metabolic process (GO:1903311),0.3501466809092395,0.7263503272500222,0.8066037735849056,0.9406314287651785,1.0,4/11,23.15%,SAFB;SAFB2;IWS1;CDK11B
prerank,modulation by host of viral genome replication (GO:0044827),0.33486224119688957,0.7259653609207036,0.7902973395931142,0.9407375762259665,1.0,6/13,21.37%,VAPA;FMR1;TBC1D20;NUCKS1;ZC3H12A;IFI27
prerank,regulation of transferase activity (GO:0051338),0.32416888739169747,0.7256541456272282,0.7958579881656804,0.9407525540572109,1.0,3/17,8.43%,ATM;PINX1;SMG6
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3030623076009272,0.7253522504174624,0.8205128205128205,0.9407341214353944,1.0,3/25,8.07%,EXT1;EXT2;HS2ST1
prerank,inorganic ion transmembrane transport (GO:0098660),0.34656973395815627,0.7252519004877074,0.7873303167420814,0.9404979006458961,1.0,2/12,14.55%,PKD2;TRPM4
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.3046933077920592,-0.7249664811744112,0.8222222222222222,0.9746734383191015,1.0,4/10,15.17%,GALNT13;POGLUT1;POGLUT2;GALNT1
prerank,response to light stimulus (GO:0009416),-0.18965142529073642,-0.7240816961422497,0.9562043795620438,0.9744893101362776,1.0,14/55,19.93%,ERCC5;UBE2A;CIRBP;ERCC6;ERCC3;UBE2B;UVSSA;USP1;DDB2;MAPK10;GTF2H2;TRIM32;CRY2;DRD2
prerank,arachidonate transport (GO:1903963),0.35189310994532574,0.7234789740969169,0.7825370675453048,0.9418842315386361,1.0,2/10,9.77%,ANXA1;DRD3
prerank,arachidonic acid secretion (GO:0050482),0.35189310994532574,0.7234789740969169,0.7825370675453048,0.9418842315386361,1.0,2/10,9.77%,ANXA1;DRD3
prerank,regulation of histone deacetylation (GO:0031063),0.3320103709869998,0.7233934749007864,0.827893175074184,0.9416212410336479,1.0,3/13,14.64%,CAMK2D;SPHK2;NIPBL
prerank,tRNA modification (GO:0006400),-0.18074573553053883,-0.7230158011928695,0.9754098360655737,0.9745232408888818,1.0,26/62,30.56%,ALKBH8;TRMT9B;DTWD2;TYW5;ELP5;TRDMT1;PUS10;QTRT1;NSUN6;TRMT10A;LCMT2;TRMT5;CDKAL1;TRMT44;METTL6;OSGEP;TRMT6;TYW3;THUMPD1;PUS1;TRMT12;TRMT112;AARS1;TRMO;MOCS3;PUS7
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.3220093476129152,0.7229197777980013,0.8100558659217877,0.9418298913347837,1.0,4/17,13.64%,SPRED1;SPRED2;SPRY2;CALM2
prerank,oligodendrocyte development (GO:0014003),0.322471260512764,0.7223183669701241,0.7879234167893961,0.9422248180817633,1.0,1/15,2.07%,B4GALT5
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.33991339538948867,0.7220400963140015,0.7825421133231241,0.9421955541974447,1.0,2/12,8.61%,ACOX1;FADS1
prerank,cellular response to metal ion (GO:0071248),0.2426226022611875,0.7218194361914181,0.9191709844559586,0.9420945700955548,1.0,12/123,9.14%,HVCN1;LRRK2;ADCY7;EGFR;CAMK2D;PKD2;CPNE7;CPNE2;DLG4;SLC13A5;SYT2;WNT5A
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.3439703333853481,0.7215100804852195,0.7971473851030111,0.9420919259381514,1.0,4/11,11.08%,RAB21;MSN;PTPN23;EIPR1
prerank,mitochondrial gene expression (GO:0140053),0.2737978323587329,0.7213407975792786,0.8535108958837773,0.9419411565239131,1.0,10/42,16.99%,MRPL57;IARS2;FOXO3;MRPS18A;RARS2;MRPS14;MRPS2;NDUFA7;LARS2;POLRMT
prerank,positive regulation of histone acetylation (GO:0035066),0.30341894213927345,0.7210898160115932,0.8077455048409405,0.941883542586577,1.0,10/23,28.12%,TADA2B;GLYR1;SPHK2;SMAD4;PAXIP1;KAT7;RPS6KA4;TADA2A;PIH1D1;RUVBL2
prerank,negative regulation of inclusion body assembly (GO:0090084),0.3467085883729969,0.719955439148612,0.7924528301886793,0.9428731418250239,1.0,2/10,10.97%,DNAJB1;DNAJB6
prerank,protein localization to centrosome (GO:0071539),0.31259742202012447,0.7197237931826017,0.8035714285714286,0.9427792116591428,1.0,5/17,17.00%,PCM1;SNX10;CEP192;NUDCD3;CSNK1D
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.30189260447173577,-0.7190752664820018,0.8229166666666666,0.9779987848916005,1.0,4/10,23.55%,KAT5;TFAP4;RPS6KA6;TP53
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.341729169976854,0.7190425444142341,0.7955271565495208,0.9428785541579078,1.0,3/12,18.91%,FHL2;GSK3B;PRNP
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.341729169976854,0.7190425444142341,0.7955271565495208,0.9428785541579078,1.0,3/12,18.91%,FHL2;GSK3B;PRNP
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2951066600092687,0.7190271346496871,0.8200782268578879,0.9425286784981106,1.0,5/25,15.67%,OMA1;BAG6;UGGT2;UBE2W;ZYG11B
prerank,regulation of mRNA processing (GO:0050684),0.28392796647369717,0.7187681507321755,0.8377693282636248,0.9424745259145959,1.0,8/32,19.24%,ZFP36L1;KHDRBS1;METTL16;SAFB;SAFB2;RBM39;IWS1;SON
prerank,glycoprotein catabolic process (GO:0006516),0.3188696750850987,0.7179606382117193,0.8038632986627043,0.9430616306148916,1.0,4/17,13.80%,CTSL;ADAMTS12;ADAMTS9;FBXO2
prerank,cellular response to chemical stress (GO:0062197),0.24811604905898857,0.7176040039344946,0.8964401294498382,0.9431241404811923,1.0,16/96,15.71%,LRRK2;RAD52;AIF1;PKD2;ATM;ETV5;FOXO3;TMEM161A;NFE2L2;ATG7;GPX8;TXNRD1;TXNRD2;SETX;CYCS;ADNP2
prerank,ncRNA processing (GO:0034470),0.2369109808183763,0.7174933232992801,0.9436475409836066,0.9428914921478784,1.0,48/200,22.01%,C1D;SMAD2;NOL11;PES1;TRPT1;POP1;RRP1B;RRP1;WDR74;EXOSC4;MPHOSPH6;DICER1;NOP14;PELP1;PIH1D2;UTP3;RPL12;INTS1;ZCCHC8;MRM2;POP4;RPL22;RPL14;SMAD3;TEX10;RPL11;INTS4;NOLC1;SMAD1;WDR36;BYSL;RPF1;MTREX;HELQ;RPL36A;TUT7;RPS9;RPL6;RPLP2;AGO2;FARS2;UTP11;INTS8;LYAR;DHX37;BMS1;DDX10;EXOSC5
prerank,organelle fission (GO:0048285),0.2958479093695306,0.7158057351950974,0.8186738836265224,0.9445110299188733,1.0,6/24,20.02%,SEC16B;PEX19;TMCC1;PEX11A;CORO1C;WASHC5
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.3017078359681774,-0.7155551457018858,0.816,0.9808600036093887,1.0,2/10,4.91%,DLGAP1;DLGAP2
prerank,iron-sulfur cluster assembly (GO:0016226),-0.22851216950796197,-0.7149819406213547,0.8740157480314961,0.9802612457444113,1.0,14/24,30.96%,CIAPIN1;GLRX3;NFU1;CIAO2A;HSPA9;NFS1;ISCA2;GLRX5;BOLA2;ISCU;NUBPL;ISCA1;CIAO2B;CIAO3
prerank,sterol transport (GO:0015918),0.3088361937477586,0.7141310758010544,0.814866760168303,0.9461569129913959,1.0,4/19,13.62%,CD36;NPC2;OSBPL5;MSR1
prerank,in utero embryonic development (GO:0001701),0.2943510707193671,0.7138900631477437,0.8464619492656876,0.9460593194483795,1.0,3/25,9.03%,CHD7;TGFB3;TGFBR1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.34162184747186974,0.7138830844521226,0.8056426332288401,0.9457053572736693,1.0,2/11,6.22%,NOL11;DDX11
prerank,histone methylation (GO:0016571),0.28794171897728965,0.713875655802488,0.8218997361477572,0.9453481241719908,1.0,5/26,16.10%,CREBBP;EHMT1;CARM1;NSD3;NSD1
prerank,regulation of p38MAPK cascade (GO:1900744),0.2784668748172221,0.7138389661646858,0.8354591836734694,0.945025017767047,1.0,10/35,21.08%,TREM2;LGALS9;SASH1;PJA2;SPI1;MFHAS1;XDH;GADD45A;DLG1;ZC3H12A
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.2634561764256235,0.7137546430099199,0.8516284680337757,0.9447643282799313,1.0,15/48,20.96%,NUP37;RAE1;OGT;NUP153;GCK;KHK;NDC1;HIF1A;NUP35;RUBCNL;NUP188;SEC13;ZBTB7A;NUP214;NUP107
prerank,protein targeting to peroxisome (GO:0006625),0.28672956062899807,0.7135346775329848,0.8261437908496732,0.9446702123536623,1.0,7/29,19.49%,PEX10;RAB8B;PEX19;ALDH3A2;PEX6;PEX12;HACL1
prerank,regulation of TORC1 signaling (GO:1903432),0.2769235117144181,0.712490245028376,0.8445040214477212,0.9455402086940977,1.0,11/33,21.82%,KLHL22;ATM;RRAGC;KPTN;SMCR8;LAMTOR5;GPR137;SIK3;TELO2;CLEC16A;SZT2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.3381223688804775,0.7115053479432791,0.8143074581430746,0.9463285745428011,1.0,1/12,1.79%,COLEC12
prerank,innate immune response in mucosa (GO:0002227),-0.2945765322101859,-0.7113954483440778,0.8369565217391305,0.9831514616310325,1.0,1/10,6.75%,DEFA6
prerank,DNA packaging (GO:0006323),-0.2554026746198663,-0.7111964911156938,0.8719512195121951,0.98207453652872,1.0,7/16,27.64%,HAT1;CDAN1;KAT6A;TP53;BANF1;H1-0;CHAF1A
prerank,translation (GO:0006412),0.2331598852516517,0.7107798707385156,0.9574468085106383,0.9468201156802488,1.0,45/208,21.55%,RPSA;RRBP1;ASMT;TNIP1;PPA1;RPL3L;MRPL57;YARS1;ABCE1;ZC3H15;AIMP1;EEF1E1;PABPC4;IARS2;TARS1;RPL12;MRPS18A;RARS2;EEFSEC;RWDD1;RARS1;RPL22;RPL14;MRPS14;MRPS2;RPL11;GARS1;GSPT1;NDUFA7;LARS2;MRPL55;RPL36A;MRPL52;RPS9;RPL6;RPLP2;AGO2;FARS2;MRPS33;ETF1;EIF4G1;N6AMT1;NARS1;TMA7;RPS27A
prerank,negative regulation of translational initiation (GO:0045947),0.337829611342474,0.7105641070985657,0.8199404761904762,0.9466994349326197,1.0,4/13,22.82%,EIF4EBP1;FMR1;AGO2;EIF3E
prerank,cellular response to increased oxygen levels (GO:0036295),-0.28784679961397164,-0.7100706444252993,0.8284960422163589,0.9819859392852063,1.0,6/11,34.86%,CAV1;TMEM199;ATP6V0D1;ATP6V1A;ATP6AP1;FAS
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.303758882723382,0.7099585013102163,0.8221614227086184,0.9470475636685075,1.0,9/21,25.00%,MDK;DISC1;CX3CL1;KDM1A;NAP1L1;SMARCD3;FZD3;FZD9;VEGFA
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.22176813360195718,-0.709895307145057,0.9183673469387755,0.9808690496600687,1.0,6/27,13.69%,PER1;SIK1;FBXL3;USP2;MTA1;PER2
prerank,positive regulation of microtubule polymerization (GO:0031116),0.28126299146266875,0.7098789414370799,0.8380187416331994,0.9467758107370833,1.0,6/28,17.55%,NAV3;AKAP9;RAC1;FES;TOGARAM1;CKAP5
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.2809661204834365,0.7093262995040148,0.8426395939086294,0.9470836322900932,1.0,8/33,18.20%,EGF;CBL;FBXW7;PDE6H;BTC;NEU3;AKT1;AGT
prerank,response to histamine (GO:0034776),0.3367207136107126,0.7091840056332819,0.8298192771084337,0.9468967695079479,1.0,2/10,9.86%,DRD3;HRH1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.2901735476700765,-0.7083912973607401,0.8319559228650137,0.9812571100851838,1.0,4/11,23.55%,KAT5;TFAP4;RPS6KA6;TP53
prerank,intraciliary retrograde transport (GO:0035721),0.33264200585106807,0.70811958390215,0.804915514592934,0.9477569680339855,1.0,3/12,13.72%,DYNC2LI1;WDR35;DYNC2H1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.23962493300422794,-0.707376629344602,0.9037037037037037,0.9811330823383336,1.0,7/19,25.88%,ADK;POLD3;GMPR;DCK;APRT;CDA;POLD2
prerank,pre-miRNA processing (GO:0031054),-0.2730455353284284,-0.7073428780896511,0.8354037267080745,0.979881848433465,1.0,6/14,27.23%,ADAR;DROSHA;AGO3;TUT4;MRPL44;AGO4
prerank,organelle disassembly (GO:1903008),0.2810606792556807,0.7067894272310994,0.8558673469387755,0.948902133589646,1.0,7/33,17.80%,GBF1;UBA5;MTIF2;KIF5B;DDRGK1;KIF9;MCTS1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.27316284806825575,0.7061341287640673,0.8555691554467564,0.9492932650400155,1.0,6/41,12.48%,CACNA2D1;XCL1;ITPR1;PKD2;IBTK;FGF2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.2953608791413461,0.7059819957877089,0.8157894736842105,0.949096445452056,1.0,3/22,9.67%,PES1;ERI1;NOP14
prerank,B cell homeostasis (GO:0001782),0.3525938394478896,0.7059716384025465,0.7950413223140496,0.9487432342096194,1.0,1/10,2.65%,TNFAIP3
prerank,protein import (GO:0017038),0.24456563472226084,0.7059060438069819,0.9020902090209021,0.94844936579124,1.0,19/84,19.57%,APOE;STAT3;PRICKLE1;FAM53B;LAMP2;RAB8B;NUP153;SNX33;TNPO1;PEX19;E2F3;ALDH3A2;NUP188;SEC13;AKT1;TOMM22;HEATR3;PEX12;NUP214
prerank,rRNA processing (GO:0006364),0.23432062511277685,0.7057431163951307,0.9403905447070915,0.9482785142313116,1.0,43/172,22.01%,C1D;MAK16;NOL11;PES1;ERI1;RRP1B;RRP1;WDR74;EXOSC4;MPHOSPH6;NOP14;NOP2;PELP1;PIH1D2;UTP3;NAT10;RPL12;MRM2;POP4;RPL22;RPL14;TEX10;RPL11;NOLC1;WDR36;BYSL;PRKDC;RPF1;MTREX;HELQ;RPL36A;RPS9;SRFBP1;RPL6;RPLP2;UTP11;RIOK2;LYAR;DHX37;BMS1;RSL1D1;DDX10;EXOSC5
prerank,negative regulation of mRNA processing (GO:0050686),0.31756390008858837,0.7055583238449135,0.8130563798219584,0.9481117025602662,1.0,4/15,15.90%,SAP18;SFSWAP;SRSF12;RBMX
prerank,glycolipid metabolic process (GO:0006664),0.2607612223168397,0.705164208486542,0.8854415274463007,0.9481935401712016,1.0,10/47,17.90%,UGCG;PIGW;ABCA2;B4GALNT1;SMPD3;NEU3;GALC;NEU1;CTSA;CPTP
prerank,microtubule anchoring (GO:0034453),-0.2782084298666345,-0.7049222982367157,0.8675675675675676,0.9812339891716685,1.0,1/12,0.78%,BICD1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.23477994534878247,0.7042245517424128,0.9372427983539094,0.948923333428194,1.0,23/151,15.20%,TNIP1;CERS6;B4GALT5;PAM;MGST1;APOE;PRKD2;AKR1A1;HACD2;TYW1;VAPA;MOCS1;CSNK2A1;CSNK2A2;GSTK1;CSNK1G2;ELOVL6;SPHK2;CEPT1;SPTSSA;PLA2G4A;SGPL1;ALDH3A2
prerank,tryptophan catabolic process (GO:0006569),0.3335264402836092,0.7038357298614135,0.8034321372854915,0.9490141690742545,1.0,1/11,7.20%,KYAT1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.283898903246143,-0.7036307040063594,0.8351351351351352,0.9813454290115772,1.0,3/11,22.06%,SOX6;MYOCD;MEF2C
prerank,lipid biosynthetic process (GO:0008610),0.2459214685310637,0.7034125167640136,0.882803943044907,0.9491400630951206,1.0,7/77,8.76%,LIPC;PAM;MVK;SCD5;HSD17B8;FADS1;LPL
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.2852210333611245,0.7028211464781333,0.8416230366492147,0.9494706948923327,1.0,8/28,18.84%,CXCL12;DBN1;BRK1;DBNL;ARHGAP35;RASA1;CTTN;PLEKHG2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.3465020431586283,0.70270544475936,0.8296795952782462,0.9492367282629649,1.0,3/10,9.04%,SESTD1;CBARP;FKBP1B
prerank,regulation of adenylate cyclase activity (GO:0045761),0.29523602034936963,0.7006515951858706,0.8573388203017832,0.9511768109979353,1.0,3/22,9.77%,CACNA1C;NF1;DRD3
prerank,cardiac cell development (GO:0055006),0.336618957237409,0.7001836446075328,0.821917808219178,0.9513570266570909,1.0,1/11,4.21%,JAG1
prerank,dicarboxylic acid transport (GO:0006835),0.2837291808349158,0.6999727935525825,0.8421733505821475,0.9512375296668233,1.0,5/28,15.95%,SLC1A3;SLC13A5;PDPN;GIPC1;SLC25A10
prerank,ribosome assembly (GO:0042255),0.2610148443035899,0.6994435648861305,0.8638036809815951,0.9514647040362721,1.0,11/47,24.24%,RPSA;RPL3L;NOP2;MRPS2;RPL11;DHX29;RPL6;DHX37;MDN1;PPAN;EIF2A
prerank,interstrand cross-link repair (GO:0036297),-0.1854944805129644,-0.6993636219036544,0.967948717948718,0.9845252558406689,1.0,22/53,29.19%,ERCC6L2;WDR48;UBC;RFWD3;DCLRE1A;FANCI;FAAP100;USP1;FANCM;ERCC1;DCLRE1B;MUS81;FAAP20;FANCB;FANCL;UBA52;FANCG;FAN1;NEIL3;RPA2;RAD51AP2;CENPX
prerank,hemidesmosome assembly (GO:0031581),0.33183207271532617,0.6993339501772889,0.8028391167192429,0.9512230271131117,1.0,1/11,2.10%,LAMC1
prerank,cognition (GO:0050890),0.25996396872834715,0.6992540752089169,0.8778998778998779,0.9509644131520774,1.0,9/42,16.60%,CHD7;NF1;HOXA1;TNF;HRH3;TUSC3;NIPBL;CHMP2B;SOBP
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.27816406823585416,0.6992228482429709,0.8562005277044855,0.9506422049994172,1.0,7/30,14.52%,BAG6;EIF3H;CCAR2;OGT;GIPC1;DDRGK1;RPL11
prerank,sensory perception (GO:0007600),0.2652475196162684,0.698918751052788,0.862453531598513,0.950616914039118,1.0,5/45,14.17%,PTGES;MYO7A;CCL2;P2RX7;GNAS
prerank,erythrocyte development (GO:0048821),-0.29496386246969875,-0.6988958288692465,0.828042328042328,0.9837094064724241,1.0,4/10,21.32%,DMTN;ABCB10;ALAS1;NCKAP1L
prerank,cellular protein-containing complex assembly (GO:0034622),0.2311216255840919,0.6987031819988578,0.9394871794871795,0.9504894208645891,1.0,26/160,17.72%,CLTC;TCF4;SMAD2;CHMP4A;CHMP4B;NCK1;NCK2;OMA1;STXBP1;COG4;ANGPT1;COX7A2L;TTC12;NUP153;SNX9;EPS15;TRAF2;SMAD3;SRC;SMAD4;NDC1;SMAD1;PSMD11;AIFM1;HSPD1;PICALM
prerank,axonal transport of mitochondrion (GO:0019896),0.32664351109721795,0.6982843963761778,0.8153364632237872,0.9506134016140059,1.0,2/11,15.68%,TRAK1;HIF1A
prerank,cellular response to amino acid stimulus (GO:0071230),0.27677171856571303,0.6974980393963636,0.8609355246523388,0.9511272206659798,1.0,9/33,19.42%,KLHL22;CPEB1;CAPN2;RPTOR;RRAGC;CPEB4;LAMTOR5;LAMTOR3;UBR1
prerank,regulation of telomerase activity (GO:0051972),0.2623087742549025,0.6964455418016516,0.8687116564417178,0.9519582222918189,1.0,12/45,23.02%,PARM1;ATM;PINX1;SMG6;SRC;PNKP;MAPK1;PARN;PKIB;PARP4;TERF1;MAP2K7
prerank,regulation of macroautophagy (GO:0016241),0.2373968598876062,0.6960678345168957,0.9130901287553648,0.9520260074111839,1.0,22/105,18.35%,DCN;LRRK2;EXOC4;RPTOR;TRIM13;RRAGC;EXOC1;EXOC7;GAPDH;ATP6V1H;SNX5;SMCR8;ATP6V1G2;NEDD4;PRKAB1;LAMTOR5;ATP6V1G1;SH3GLB1;AKT1;ATP6V1D;USP36;LAMTOR3
prerank,rRNA metabolic process (GO:0016072),0.23193130806418416,0.695782010243914,0.9471502590673575,0.9519882223151545,1.0,37/160,22.01%,C1D;ERN2;NOL11;PES1;RRP1B;RRP1;WDR74;EXOSC4;MPHOSPH6;NOP14;PELP1;PIH1D2;UTP3;XRN1;RPL12;MRM2;POP4;RPL22;RPL14;TEX10;RPL11;NOLC1;WDR36;BYSL;RPF1;MTREX;HELQ;RPL36A;RPS9;RPL6;RPLP2;UTP11;LYAR;DHX37;BMS1;DDX10;EXOSC5
prerank,regulation of TOR signaling (GO:0032006),0.2468874590907456,0.6954445581698335,0.8980747451868629,0.9520276359484758,1.0,16/67,19.70%,TREM2;RICTOR;MIOS;NPRL2;RPTOR;RRAGC;TTI1;FNIP1;SMCR8;GPAT3;LAMTOR5;SEC13;GNA12;LAMTOR3;UBR1;TELO2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.22668839084892406,-0.6954293198283212,0.90625,0.9859819507316584,1.0,9/22,25.80%,ESR1;PSMC3;MED4;MED24;PSMC4;DHX36;TP53;MED30;SRF
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.2991759737066628,0.6952065156549307,0.8221288515406162,0.9519495641708104,1.0,4/21,13.26%,HK2;H6PD;GCK;TALDO1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.21663111589691755,-0.6947564063196862,0.9135338345864662,0.9853513612948899,1.0,11/24,31.48%,CTNNA2;MAPK12;BNIP2;BOC;MYOCD;CDH2;MEF2C;MAPK14;CAMK1;OLFM2;CDON
prerank,gliogenesis (GO:0042063),0.3092822076731011,0.6946485018521763,0.8209606986899564,0.9522125470299984,1.0,3/15,11.44%,CDK6;ANXA1;TGFB2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.299977277519053,0.6941833338433535,0.80835734870317,0.9523610627717066,1.0,4/18,12.48%,RHOJ;AKT3;ANXA1;FGF2
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.27457724622556456,0.693780638916527,0.8571428571428571,0.9524351233086285,1.0,13/33,25.73%,TNKS1BP1;ZBTB48;PINX1;TERT;CTC1;PPP6C;TELO2;RFC1;TERF1;RPA1;RAD51;TERF2IP;TERF2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.32594331813440874,0.6932863429491528,0.812874251497006,0.9526116970278686,1.0,3/12,13.64%,CAMK2D;GJD3;CALM2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.2929581377153915,0.6931435133788644,0.8569405099150141,0.9524139974595821,1.0,5/21,14.44%,JAK2;TGFB3;TGFBR1;WWTR1;SMAD4
prerank,positive regulation of protein transport (GO:0051222),0.2462011107245331,0.6927266623038358,0.8717366628830874,0.9525014904158032,1.0,10/67,12.30%,TREM2;ABCG1;PPID;TGFB3;PCM1;FRMD4A;EXOC1;PCNT;TGFB2;TNF
prerank,negative regulation of myotube differentiation (GO:0010832),-0.27247009592302035,-0.6926269737761356,0.8664772727272727,0.9863101563500175,1.0,5/12,22.35%,HDAC4;CCN3;BDNF;HDAC3;BHLHE41
prerank,global genome nucleotide-excision repair (GO:0070911),-0.21490166313982156,-0.6923857488496695,0.9170305676855895,0.9852861819529952,1.0,13/26,28.69%,ERCC3;UBC;CHD1L;DDB2;GTF2H2;ERCC1;GTF2H4;UBA52;GTF2H3;CETN2;RBX1;PARP1;XPC
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.21051342649655702,-0.6918939412269333,0.9196787148594378,0.9845061689501328,1.0,5/28,12.41%,MAP2;MAP1A;STMN2;STMN3;PRUNE1
prerank,positive regulation of cellular component movement (GO:0051272),-0.22312238212448404,-0.6915137624126808,0.9026217228464419,0.9836458314134136,1.0,9/24,32.39%,SPOCK2;CCDC25;TRIM32;RPS19;CFAP20;CSF1R;AKT2;NTN1;LYN
prerank,positive regulation of ion transport (GO:0043270),0.2541104274899042,0.6912243258847323,0.895933014354067,0.9538086855870355,1.0,14/48,20.51%,CCR1;TRPC6;CCL5;MYLK;CNKSR3;ATP2B1;P2RX7;KIF5B;SNX4;ORAI1;ANO6;STIM2;GDNF;DLG1
prerank,cellular amino acid catabolic process (GO:0009063),0.23834276555046746,0.6910491674652419,0.8945652173913043,0.9536412884239809,1.0,19/87,21.44%,SDSL;CRYM;ACADSB;HIBCH;AMT;GLDC;KYAT1;DLST;ALDH7A1;CARNS1;ECHS1;BCKDHB;MTRR;AUH;HYKK;QDPR;HIBADH;PIPOX;SLC25A21
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.26126256836689776,0.6908845978643082,0.8697788697788698,0.9534697683926021,1.0,13/41,20.96%,NUP37;RAE1;OGT;NUP153;GCK;NDC1;HIF1A;NUP35;NUP188;SEC13;ZBTB7A;NUP214;NUP107
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.3269201053798556,0.6908322824229195,0.8395245170876672,0.9531651474727556,1.0,2/13,7.56%,ABCA2;SOAT1
prerank,ribosome biogenesis (GO:0042254),0.22939298214760745,0.6905367334294862,0.9560327198364008,0.9531244152030159,1.0,47/187,22.01%,C1D;NOL11;PES1;NOC2L;ABCE1;RRP1B;RRP1;WDR74;EXOSC4;MPHOSPH6;NOP14;PELP1;NIP7;PIH1D2;GTF3A;UTP3;RPL12;LTO1;MRM2;DDX31;POP4;RPL22;RPL14;TEX10;RPL11;NOLC1;WDR36;NOP16;BYSL;RPF1;DHX29;MTREX;HELQ;RPL36A;RPS9;HEATR3;RPL6;RPLP2;UTP11;PAK1IP1;RIOK2;XPO1;LYAR;DHX37;BMS1;DDX10;EXOSC5
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.3329472985706,0.6905010191939764,0.8435483870967742,0.9528058773498557,1.0,1/10,5.50%,SEC14L1
prerank,myeloid cell development (GO:0061515),0.30255655035218454,0.6904355034324003,0.8405594405594405,0.9525099529829943,1.0,6/18,21.00%,TLR2;SRC;NRROS;MED1;FOXP1;LYAR
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3061872125813377,0.6902165609793238,0.844903988183161,0.9524016500283561,1.0,3/17,15.97%,PLA2G12A;PLA2G4A;PLA2G4E
prerank,RNA methylation (GO:0001510),0.2517491911656813,0.6898579653640455,0.8835616438356164,0.9524283352346851,1.0,13/60,19.17%,ZC3H13;METTL16;METTL1;MTERF4;THUMPD3;NOP2;MRM2;TGS1;TRMT61B;THADA;RBM15;BCDIN3D;THUMPD2
prerank,tRNA 5'-leader removal (GO:0001682),0.3196611909454184,0.6896102984930038,0.8308823529411765,0.9523317038587583,1.0,2/13,12.47%,POP1;POP4
prerank,protein catabolic process (GO:0030163),0.25206450066479097,0.6891806028382076,0.8839390386869871,0.9524666241652062,1.0,10/59,15.41%,APOE;CTSD;SIAH2;LAMP2;BAG6;ADAMTS9;CLN6;FBXO2;RIPK1;PSMA8
prerank,protein-containing complex disassembly (GO:0032984),0.25085067917595405,0.6886629287927967,0.8801897983392646,0.9526699746457215,1.0,10/54,19.10%,FZD1;STX17;LRP6;VPS4A;LAMP2;GSK3B;CSNK1A1;RUBCNL;LIX1L;DVL2
prerank,mesenchyme development (GO:0060485),0.31753720345074415,0.6881342265203513,0.8194029850746268,0.9528827934698648,1.0,5/15,23.91%,PKD2;TGFBR1;BMP7;HMGA2;BMPR2
prerank,response to prostaglandin E (GO:0034695),-0.29299063715529283,-0.6879766602573906,0.852054794520548,0.9858899108919363,1.0,1/10,1.66%,TGFBR3
prerank,protein targeting to membrane (GO:0006612),0.23878998827946396,0.6877576998923479,0.9131378935939196,0.9529534899900285,1.0,15/83,16.83%,CHMP4A;CHMP4B;ATG3;RAB8B;SSR2;SEC63;VPS37C;PEX19;SEC61A1;ZDHHC6;ZDHHC9;ALDH3A2;RTP4;SRP14;ZDHHC3
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.2534412051936698,0.6875051574762208,0.8851113716295428,0.9528610731291417,1.0,10/50,17.37%,SIAH2;SH3RF1;CSNK2A1;FNIP1;DNAJB6;TNF;SRC;LAMTOR5;AKT1;YWHAE
prerank,quinone biosynthetic process (GO:1901663),-0.2566724001037328,-0.6873624520927745,0.857566765578635,0.9852099811904789,1.0,3/14,9.12%,PDSS1;COQ2;PDSS2
prerank,positive regulation of glucose metabolic process (GO:0010907),0.31196138894158876,0.6868462379209692,0.8291233283803864,0.9531958286702581,1.0,4/14,17.41%,IRS1;PTPN2;AKT1;DDB1
prerank,piRNA metabolic process (GO:0034587),0.29313338308880577,0.686791145229284,0.8426966292134831,0.952894338426489,1.0,1/19,4.62%,MYBL1
prerank,response to ionizing radiation (GO:0010212),0.24141773092541466,0.6863619611530024,0.905638665132336,0.9530094846509481,1.0,15/70,19.28%,TNKS1BP1;BABAM2;INO80;ATM;TRIM13;GRB2;ANXA1;TANK;IKBIP;PAXIP1;USP28;CLOCK;RAD9A;SWI5;GADD45A
prerank,regulation of ATP metabolic process (GO:1903578),0.2507516179878798,0.6862815756567561,0.8816568047337278,0.9527478429731534,1.0,16/54,20.96%,NUP37;RAE1;COX7A2L;OGT;NUP153;GCK;SPHK2;NDC1;HIF1A;NUP35;NUP188;SEC13;ATP7A;ZBTB7A;NUP214;NUP107
prerank,regulation of myoblast differentiation (GO:0045661),0.27144114346976184,0.6861383029380534,0.8610421836228288,0.9525332280699437,1.0,4/32,10.21%,ZFP36L1;FLOT2;BTG1;TBX3
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.2743837780093036,0.6858802496678416,0.854251012145749,0.9524576769947198,1.0,5/26,15.83%,NAV3;AKAP9;RAC1;FES;TOGARAM1
prerank,negative regulation of DNA recombination (GO:0045910),0.25769898726883705,0.6850386915512553,0.8841099163679809,0.9530361601323895,1.0,14/43,25.73%,PARP3;SHLD3;FBH1;RIF1;ATRX;CGAS;POLR2L;POLR2K;TERF1;ZRANB3;POLR2D;MSH6;TERF2IP;TERF2
prerank,male gonad development (GO:0008584),0.2626240838411502,0.6845893316522395,0.8711734693877551,0.9531629229380594,1.0,6/34,18.07%,GATA6;WNT5A;TGFB2;ADAM21;TFAP2C;INHBA
prerank,regulation of protein sumoylation (GO:0033233),0.30793788318110243,0.6845779785812668,0.8523206751054853,0.952815860790785,1.0,3/17,12.80%,ZMIZ1;GNL3;RASD2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.2620350804962845,0.6840709482704338,0.8754716981132076,0.9529928015134339,1.0,6/35,19.15%,PAM;SCD5;HSD17B8;GGT7;ACACA;FASN
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.2887275852164597,0.6838521327696258,0.8636363636363636,0.952873941992175,1.0,6/20,20.29%,PLOD2;GGCT;CNDP2;PTDSS2;GSS;PLSCR1
prerank,ether lipid biosynthetic process (GO:0008611),-0.2873407357806772,-0.6821930649501855,0.8597014925373134,0.9888021279013816,1.0,2/10,7.38%,CHPT1;LPCAT2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.28832993736590273,0.68213048093632,0.8492392807745505,0.954342065760163,1.0,7/20,26.54%,GART;PPAT;AMPD2;IMPDH2;AMPD3;IMPDH1;ADSL
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.29174478773439794,0.6817602383870278,0.8526466380543634,0.9543739568675326,1.0,3/20,12.44%,BCL2;BCL2L2;GSK3B
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.3342785117128665,0.6807768001449022,0.8322259136212624,0.9550577037792082,1.0,1/10,3.16%,ATP5PO
prerank,snRNA metabolic process (GO:0016073),0.299345870892869,0.6806081006751028,0.8599695585996956,0.9548724735334421,1.0,5/17,20.34%,INTS1;ZCCHC8;INTS4;MTREX;INTS8
prerank,histone H3-K9 demethylation (GO:0033169),0.3288221619604636,0.6796608195378266,0.8429878048780488,0.955524557789822,1.0,6/11,26.60%,KDM1A;KDM3B;KDM7A;JMJD1C;KDM4B;KDM4D
prerank,negative regulation by host of viral transcription (GO:0043922),0.320060877976904,0.679613969270243,0.8253477588871716,0.9552143352885418,1.0,2/12,9.16%,CCL5;HDAC1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.29856618054365175,0.6783340460109675,0.8251445086705202,0.9562092091891068,1.0,4/16,19.15%,SCD5;HSD17B8;ACACA;FASN
prerank,histone H3-K36 demethylation (GO:0070544),-0.2841932282009415,-0.6776783355025683,0.8431952662721893,0.9916814314803609,1.0,2/10,10.15%,PHF8;RIOX2
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.22732533240452457,-0.6774096067861699,0.9140893470790378,0.9906128475791198,1.0,8/21,26.42%,NT5E;NUDT3;PDE4D;PDE2A;NUDT11;MLYCD;FITM2;NUDT16
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.2918575754610247,0.676894444498518,0.8543689320388349,0.9572961268733724,1.0,7/19,22.13%,STIMATE;FKBP1B;PTPRJ;PTPRC;PRNP;PTGFR;TRPM2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.26865898356914797,0.6765250548196449,0.8705583756345178,0.9573157608928433,1.0,9/31,19.53%,PEX10;TIMM17A;TIMM50;AIFM1;PEX6;HSPD1;PEX12;TIMM23;TOMM40L
prerank,maturation of LSU-rRNA (GO:0000470),0.2755996302126082,0.6762568114426327,0.8565941101152369,0.9572251100348811,1.0,3/26,10.06%,MAK16;PES1;NOP2
prerank,protein deacylation (GO:0035601),0.2855691291100344,0.6756885792767842,0.8821917808219178,0.9574499573267368,1.0,7/23,18.30%,ABHD17C;HDAC1;LYPLAL1;ABHD17B;SIRT3;LYPLA2;HDAC5
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2707476910786103,0.6756708353660202,0.8791773778920309,0.9571114967128035,1.0,6/29,15.85%,EDC4;EXOSC4;DCP2;DCP1A;PATL1;LSM7
prerank,ubiquinone metabolic process (GO:0006743),0.3024944840552216,0.6753696749309062,0.8350824587706147,0.9570507517945823,1.0,5/15,17.17%,AIFM2;COQ8B;COQ10B;COQ5;FDXR
prerank,histone H2B ubiquitination (GO:0033523),-0.2894163706151586,-0.674986209105124,0.8605263157894737,0.9915429505338696,1.0,2/10,9.07%,CTR9;LEO1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.2750623105245065,0.6749797822472328,0.8841544607190412,0.9571005388175825,1.0,8/29,21.73%,E2F1;TENT5A;DHX34;FMR1;THRAP3;AXIN2;GDNF;YBX1
prerank,glial cell differentiation (GO:0010001),0.269306114296067,0.674707441993583,0.8659658344283837,0.9570097564518623,1.0,3/28,5.93%,STAT3;SHH;PTPRZ1
prerank,response to ethanol (GO:0045471),0.31194790192966704,0.6746633646002609,0.8469696969696969,0.9567005175728842,1.0,2/14,9.77%,ADCY7;DRD3
prerank,eye photoreceptor cell development (GO:0042462),-0.2457523573952596,-0.6737675248872026,0.891640866873065,0.9913485663060574,1.0,5/15,25.14%,RORB;RP1;BBS4;RPGRIP1L;TULP1
prerank,cardiac atrium morphogenesis (GO:0003209),-0.24265603083763118,-0.6733417808442947,0.8996539792387543,0.9904882805061007,1.0,11/16,45.94%,PROX1;HEY2;ZFPM1;NOTCH1;ENG;TBX20;NOG;MYH6;NOTCH2;GATA4;ISL1
prerank,Golgi ribbon formation (GO:0090161),0.313997911367632,0.6731794270008531,0.846875,0.9578349820339421,1.0,2/13,9.08%,STX6;TRIP11
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2535728019743678,0.6725682545062829,0.8868613138686131,0.9580974381603913,1.0,13/46,21.27%,HK2;RALA;TOMM7;FBXO7;TIMM17A;TIMM50;AIFM1;HSPD1;AKT1;TOMM22;TIMM23;TOMM40L;PITRM1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.25880661132036753,-0.6725297389807166,0.8980169971671388,0.9898959402662117,1.0,7/13,37.19%,CSTF2;TUT1;CPSF2;CPSF4;NUDT21;CPSF7;CPSF4L
prerank,positive regulation of cilium assembly (GO:0045724),0.29588973610713226,0.6724365671120128,0.8457059679767104,0.9578698996530133,1.0,4/18,14.08%,ENTR1;CEP120;TAPT1;ARHGAP35
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.29972977472806783,0.671853561671723,0.8531157270029673,0.9580979350014819,1.0,4/15,21.28%,AK8;ENTPD7;ENTPD6;NME2
prerank,peptidyl-lysine modification (GO:0018205),0.2299144466388271,0.671080904257282,0.9345493562231759,0.958504778630625,1.0,20/99,18.03%,PLOD2;NUP37;RAE1;PIAS2;LOXL1;USPL1;LOXL3;SENP6;NUP153;VCPKMT;NSMCE2;EGR2;TRPM4;SIRT3;NDC1;NUP35;NUP188;P3H3;ETFBKMT;ATP7A
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.32304880520097967,0.6710433957339671,0.848297213622291,0.9581918752890177,1.0,3/11,14.54%,UBN1;ATRX;ASF1A
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.22301929322419,0.6707723092896533,0.9595435684647303,0.958106273140387,1.0,47/168,24.18%,RPSA;ZFP36L1;CTIF;TNKS1BP1;SMG7;CNOT4;ATM;ERI1;SAMD4A;SMG6;EXOSC4;DCP2;DHX34;NCBP2;PPP2R2A;XRN1;RPL12;RPL22;RPL14;RPL11;DCP1A;DXO;PATL1;GSPT1;RC3H2;THRAP3;RPL36A;TUT7;RPS9;PARN;RPL6;RPLP2;ETF1;EIF4G1;CNOT2;CSDE1;ZC3H12A;NBDY;RPS27A;CNOT3;EXOSC5;EIF3E;PATL2;POLR2D;RNPS1;SMG5;AGO1
prerank,negative regulation of GTPase activity (GO:0034260),0.28115499971700936,0.6704884718084522,0.8678474114441417,0.9580385745202017,1.0,2/22,7.54%,LRRK2;RRP1B
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.32392832121483867,0.6703527593984502,0.8351145038167939,0.9578350899377096,1.0,1/10,6.81%,DGKH
prerank,purine nucleotide catabolic process (GO:0006195),0.3095128130177725,0.669453406871172,0.8453453453453453,0.9583649240911725,1.0,4/13,21.20%,GDA;NT5C1A;XDH;HINT1
prerank,regulation of ERAD pathway (GO:1904292),-0.27109332146447335,-0.6692496001136843,0.8938992042440318,0.9915131924516539,1.0,3/11,17.63%,ATXN3;AQP11;RNF185
prerank,T-helper cell differentiation (GO:0042093),0.3082315493314107,0.6690724389006487,0.8556390977443609,0.9583916129802005,1.0,1/14,3.16%,BATF
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.26291509331220325,0.6683519749354491,0.8820577164366374,0.9587449873075427,1.0,6/36,11.12%,TCF7L2;TNRC6B;WNT5A;PPP3CA;PLCB3;MOV10
prerank,peptidyl-arginine modification (GO:0018195),0.29999300124337874,0.6683101765831359,0.8619631901840491,0.9584381117195584,1.0,1/15,4.11%,PADI2
prerank,carbohydrate transport (GO:0008643),-0.25822933502650397,-0.6681872918475421,0.8806818181818182,0.9911502976504828,1.0,6/11,48.32%,AQP11;SLC26A6;SLC2A2;AQP1;SLC2A5;AQP9
prerank,actin nucleation (GO:0045010),0.2848582627693235,0.6680882433006907,0.8703208556149733,0.9583140103182775,1.0,6/21,22.09%,ACTR2;SPIRE1;WASHC1;ARPC1B;TRIM27;ARPC2
prerank,regulation of cilium movement (GO:0003352),-0.2686266745306253,-0.6676402233406401,0.8797814207650273,0.9903435499001118,1.0,8/10,41.60%,CCDC39;CFAP298;ODAD2;DRC1;CCDC65;CFAP43;CFAP206;CCDC40
prerank,regulation of telomere capping (GO:1904353),0.2780678002630562,0.6669920414199528,0.8810810810810811,0.9590262992403797,1.0,7/23,23.02%,ATM;SMG6;TNKS2;PNKP;MAPK1;PKIB;MAP2K7
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2575227067736251,0.666860690215154,0.8948035487959443,0.9587968636977406,1.0,9/35,19.69%,ATM;ATR;CCT8;CCT3;TNKS2;PNKP;MAPK1;PARN;PKIB
prerank,metal ion homeostasis (GO:0055065),0.2552608355816406,0.6662834283801743,0.9001203369434416,0.9590018937859507,1.0,10/40,21.68%,SLC12A4;FAM20A;CYP27B1;SLC7A8;SELENON;SLC12A9;CNNM2;SLC12A8;LETM2;CNNM4
prerank,negative regulation of ATPase activity (GO:0032780),0.2973982612507482,0.6655794103142612,0.8577912254160364,0.9593100113649637,1.0,4/16,18.25%,PXK;VCPKMT;TNNT2;THADA
prerank,regulation of phosphatase activity (GO:0010921),0.2782987950695692,0.6654350501894536,0.8683127572016461,0.9590935785061783,1.0,8/24,23.98%,PPP1R36;PPP1R2;MTMR9;PTPA;HSP90B1;PPP6R2;GPATCH2;PPP1R35
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.3183388425756907,0.6649752896667951,0.8516746411483254,0.9591935966458041,1.0,3/11,19.84%,PDPN;SRC;CORO1C
prerank,cellular response to dsRNA (GO:0071359),0.2995856079694673,0.6645169668896269,0.8675595238095238,0.9592908965549716,1.0,1/15,1.79%,COLEC12
prerank,cellular macromolecule catabolic process (GO:0044265),0.2478795681168618,0.663792218450764,0.9001203369434416,0.959618842223772,1.0,10/49,17.10%,SIAH2;PABPC4;ADAMTS9;RNASEH1;SND1;RNASEH2A;FBXO2;RIPK1;SIDT2;MTREX
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.29649683413892725,0.6633585454567652,0.8655834564254062,0.9596830733421124,1.0,5/15,16.21%,RAB3GAP2;RAB10;RAB3GAP1;SEC61A1;SRP14
prerank,histone deubiquitination (GO:0016578),-0.23219024732325563,-0.6632843325121806,0.9161490683229814,0.9927710127106073,1.0,7/18,24.16%,USP49;USP7;KAT2A;USP16;TAF10;ENY2;USP15
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.3031423502343764,0.6624617217675961,0.8437978560490046,0.9601698639732908,1.0,4/15,15.70%,PRKD2;FGFR1;FGF2;FGF18
prerank,regulation of microglial cell activation (GO:1903978),0.2942400227521836,0.6618993003459662,0.843426883308715,0.9603635968487503,1.0,4/15,21.35%,TREM2;CX3CL1;PTPRC;NR1D1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.26792495914041803,0.6617073518458642,0.8717277486910995,0.9601899409262976,1.0,6/26,20.53%,CD36;TRAP1;SPHK2;COA8;CCN6;SLC18A2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.2956385972723591,0.6616788365113796,0.8408104196816208,0.9598618801900749,1.0,6/16,20.69%,ZFPM2;TBX2;FGF2;GLI1;RBPJ;BMPR1A
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.2597410940142004,0.6614752246792863,0.8946684005201561,0.9597073760985142,1.0,5/32,12.48%,TAOK1;NAV3;TPX2;CAMSAP2;FGF13
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.24854142218418895,-0.6613300271231595,0.896969696969697,0.9931857709025821,1.0,1/14,1.83%,ENTPD1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.2546219943900212,-0.661047154512282,0.9102167182662538,0.9921490623957333,1.0,3/13,11.76%,EDEM2;BCAP31;SVIP
prerank,peripheral nervous system development (GO:0007422),0.27040695561728384,0.6609460735003294,0.8876860622462788,0.9598245374791475,1.0,4/23,15.20%,PMP22;NF1;EGR2;ALDH3A2
prerank,neuron projection organization (GO:0106027),-0.235019764078247,-0.6586033261936936,0.8885245901639345,0.9929135385558292,1.0,3/15,10.93%,INSR;MAP1A;APP
prerank,mitochondrion organization (GO:0007005),0.22030382405483323,0.6580890605174498,0.9712820512820513,0.9621730856998764,1.0,32/165,18.27%,LRRK2;STOML2;PPRC1;AKT3;TRAK1;HK2;VPS13C;OMA1;ADCK1;PID1;AIFM2;MIGA2;COX7A2L;MTX2;TERT;TOMM7;ATPAF1;RAB32;FBXO7;AGTPBP1;TIMM17A;SPG7;GABPB1;MTX1;SIRT3;CYCS;TIMM50;AIFM1;POLRMT;HSPD1;ATP7A;TOMM22
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.28373980077041583,0.6574818040943515,0.8760563380281691,0.9623780714271385,1.0,5/20,17.97%,ABCA2;FBXW7;BMP5;TRIB3;PRMT3
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.2005277407523937,-0.6572521967046407,0.9665271966527197,0.9927542431287051,1.0,8/31,19.44%,PRKN;ATXN3;HSPA14;DNAJC18;ERN1;HSPB8;HSPA9;TMBIM6
prerank,regulation of T cell cytokine production (GO:0002724),0.3030731728707628,0.6570850734007054,0.873758865248227,0.9623842643518266,1.0,3/15,14.55%,XCL1;TRAF2;TRPM4
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.2835698110293704,0.657045077391126,0.8778409090909091,0.9620662744645639,1.0,5/18,18.91%,CCT8;DCP2;RUVBL1;CCT3;PARN
prerank,negative regulation of leukocyte migration (GO:0002686),0.32136465695855304,0.6567761825838968,0.847926267281106,0.9619643073729798,1.0,2/10,9.71%,EMILIN1;BMP5
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.30502237570542345,0.6567183396861745,0.8826291079812206,0.9616624897274,1.0,1/13,5.25%,VDAC2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.29079151002993153,0.6562143116780979,0.8733812949640288,0.9617729951208159,1.0,4/19,13.32%,EXT1;EXT2;HS2ST1;UGDH
prerank,female gonad development (GO:0008585),0.28504407872024756,0.6561680487985259,0.8790436005625879,0.9614680901304642,1.0,8/19,26.92%,NR2F2;INHBB;INHBA;NUP107;VEGFA;EIF2B5;INHA;FSHR
prerank,gene expression (GO:0010467),0.21274912970377574,0.655468257509177,0.9949849548645938,0.9617794170033622,1.0,56/348,18.51%,RPSA;RRBP1;RBMS1;BCL3;APOBEC1;ASMT;TNIP1;ATXN1;SYNCRIP;RPL3L;NUP37;E2F1;SNRNP40;SMG7;RAE1;DDX17;PABPC4;SMG6;RRAGC;DHX8;ALKBH5;NCBP2;NUP153;POLR3A;RPL12;MRPS18A;AGFG1;NKX2-8;RPL22;RPL14;LMF2;RBM6;MRPS14;RPL11;MMS19;NDC1;BAZ2A;SETX;GSPT1;NUP35;NUP188;TSPAN14;HNRNPUL1;SEC13;MRPL55;HSPD1;ANGPT2;RPL36A;MRPL52;POLR2L;RPS9;POLR2K;PAX8;DDX20;RBM39;SRSF2
prerank,base-excision repair (GO:0006284),0.24645729558827012,0.6550247256196992,0.9158653846153846,0.9618488556022685,1.0,11/48,22.34%,MPG;DNA2;LIG1;XRCC1;POLG;PNKP;MBD4;HMGA2;NEIL1;RFC1;RPA1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.31512304966590077,0.654866060067049,0.8507692307692307,0.9616387864377376,1.0,3/11,17.16%,ATL2;VCPIP1;LPCAT3
prerank,inorganic anion transport (GO:0015698),0.24145588274305677,0.6546293352552958,0.9070321811680572,0.961506865734645,1.0,1/53,0.33%,ENPP1
prerank,receptor recycling (GO:0001881),-0.2698320133171715,-0.6542314427781604,0.8954423592493298,0.9938852263031601,1.0,5/10,21.45%,SORL1;RAB11B;EHD3;PHETA1;PLEKHJ1
prerank,gene silencing by miRNA (GO:0035195),0.25727268766575057,0.6541333885089925,0.8996188055908514,0.9615991928078508,1.0,10/32,25.68%,PUM1;TNRC6B;DICER1;MOV10;WTIP;AGO2;SNIP1;AGO1;CNOT1;CNOT7
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.29799603702983873,0.6533738371001615,0.8668683812405447,0.9619443724293988,1.0,3/14,14.77%,PTPN1;DDRGK1;HSPA5
prerank,B cell activation (GO:0042113),0.2333193870281609,0.6533103667126154,0.9250851305334846,0.9616473041530033,1.0,15/68,18.94%,CD40;BCL2;LAT2;MS4A1;CTPS1;PTPRJ;PTPN2;CASP8;KLF6;TCF3;PTPRC;HSPD1;HDAC5;ZBTB7A;ADGRG3
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.25963114196544124,-0.6515615697934993,0.8985074626865671,0.9946611479416654,1.0,4/12,21.94%,PRPSAP2;PRPSAP1;PRPS1;PRPS1L1
prerank,lipoxygenase pathway (GO:0019372),-0.24739878959061856,-0.6512737883066833,0.9243421052631579,0.9936043394158511,1.0,2/14,13.75%,PON2;HPGD
prerank,positive regulation of JUN kinase activity (GO:0043507),0.2722915547413863,0.6511484339283395,0.868,0.963250270735073,1.0,4/23,13.07%,SASH1;TAOK3;TNF;TRAF2
prerank,protein localization to microtubule organizing center (GO:1905508),0.29188007034491303,0.650912766743508,0.8628048780487805,0.9631251125113935,1.0,4/15,17.00%,PCM1;SNX10;CEP192;CSNK1D
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.26280872848488374,-0.6508649421368399,0.8694444444444445,0.9926598362678805,1.0,2/11,4.74%,TIPIN;SMARCAL1
prerank,photoperiodism (GO:0009648),-0.20345891509744962,-0.6497305875884017,0.9658119658119658,0.9922357722330337,1.0,6/28,13.69%,PER1;SIK1;FBXL3;USP2;MTA1;PER2
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.266016438361787,-0.6496360258569164,0.8834688346883469,0.9910648916150895,1.0,3/10,15.71%,DNAJC19;ABCA3;MFSD2A
prerank,maturation of SSU-rRNA (GO:0030490),0.2497472198522406,0.6490245493041542,0.8861578266494179,0.9644872825240283,1.0,10/34,24.06%,NOL11;NOP14;UTP3;NAT10;SRFBP1;RIOK2;DHX37;BMS1;RRP36;TSR1
prerank,negative regulation of cell death (GO:0060548),0.22530533137877526,0.6486556626538351,0.9474260679079957,0.9644821942543971,1.0,23/88,22.97%,LRRK2;CCN4;CHMP4A;CHMP4B;NCK1;GPNMB;GSK3B;FGF2;TRAF2;BMP7;CCN5;ADNP2;NPAS2;AKT1;CCN6;DUS2;EIF4G1;WNT16;BECN1;VPS35;CLU;CSF1;CD200R1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.23878597600394977,0.6485579536689391,0.9262295081967213,0.9642168937204709,1.0,12/50,20.67%,TNFAIP3;NXN;PINX1;OGT;SPRY2;DTX3L;SQSTM1;AKT1;PRMT3;FBXO5;ISG15;SVBP
prerank,protein import into peroxisome membrane (GO:0045046),-0.2121382385042015,-0.6483360852535419,0.9326599326599326,0.9907965778642662,1.0,9/22,27.01%,ABCD3;PEX3;GDAP1;ACBD5;PEX14;PEX26;PEX11B;SLC25A17;PEX13
prerank,motor neuron axon guidance (GO:0008045),-0.24036257249995624,-0.648212488525507,0.9228295819935691,0.9896245823662797,1.0,6/15,20.76%,EPHA4;RHOG;TMEFF1;SLIT2;LAMC2;RHOH
prerank,ceramide catabolic process (GO:0046514),-0.24482042946661392,-0.6474242595955187,0.9333333333333333,0.988994414725107,1.0,7/14,35.81%,ACER2;ASAH2;GM2A;ASAH1;ACER3;HEXB;NEU2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.24981404632203458,-0.6472025714581853,0.8862973760932945,0.9879036665399941,1.0,8/12,42.59%,RFWD3;PLK5;TP53;RPA2;PLK3;SDE2;CCND1;WAC
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.3098470493869565,0.6468163269451989,0.8669724770642202,0.9654534614640287,1.0,2/11,10.32%,BAG6;UGGT2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.2961345924302481,0.646678898604004,0.8830409356725146,0.9652219972865995,1.0,8/15,29.74%,ACTR2;WASHC1;ARPC1B;TRIM27;ARPC2;JMY;WHAMM;ARPC3
prerank,superoxide anion generation (GO:0042554),-0.24869309462979167,-0.6463648972476719,0.9034267912772586,0.9872480161084798,1.0,8/13,47.46%,NCF2;NOX1;TAFA4;CYBA;NCF1;NOX3;NCF4;DUOX1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.21546605300945942,0.645084299478194,0.9803312629399586,0.9662940893515409,1.0,40/172,20.29%,PLD1;PIP5K1B;PTPN13;PTEN;PIP4K2A;CPNE7;PI4K2B;DGKH;PIK3R5;CSNK2A1;CSNK2A2;PGS1;PLA2G12A;FIG4;FGF2;PI4KA;GPAT3;PIK3R1;CEPT1;SACM1L;ARF1;ABHD8;PLA2G4A;MTMR9;PIK3R4;DDHD2;PIK3C3;LPCAT3;MTMR3;RUFY1;PTDSS2;PIP5K1A;CPNE3;PLEKHA2;MTMR2;MTMR6;MTMR1;MTM1;ETNK1;PLSCR1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.25550099241835894,-0.6449699093762825,0.9295774647887324,0.9869978214132781,1.0,4/12,20.87%,TOPBP1;HUS1;NAE1;ORC1
prerank,ubiquinone biosynthetic process (GO:0006744),-0.23776890083755353,-0.6449645610014878,0.904320987654321,0.9857667800382599,1.0,3/15,9.12%,PDSS1;COQ2;PDSS2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.22927250779531044,0.6444383624996232,0.9426321709786277,0.9665089858698809,1.0,12/69,16.40%,APOE;MDK;BCL2;PTPRZ1;TGFB3;NONO;CCL2;UNC5B;CPEB4;CX3CL1;HIF1A;RASA1
prerank,cGMP biosynthetic process (GO:0006182),0.31882855094821755,0.6439638693364746,0.8631921824104235,0.9665647462317831,1.0,1/10,6.15%,NPR2
prerank,response to UV-B (GO:0010224),-0.24949112544226143,-0.6439593289089536,0.9096045197740112,0.9852326655670479,1.0,2/12,10.14%,MSH2;CRIP1
prerank,negative regulation of double-strand break repair (GO:2000780),0.25230918297623384,0.6434472136321441,0.9164588528678305,0.9666611287287535,1.0,6/30,16.09%,UBR5;SHLD3;RNF169;FBH1;RIF1;CGAS
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.2753673674527717,0.6434443708258907,0.8930555555555556,0.9663103124991177,1.0,7/20,21.40%,PSEN1;PSENEN;RHBDD1;NCSTN;ADAM9;PSEN2;HM13
prerank,protein complex oligomerization (GO:0051259),0.2236987457353035,0.6430703602209754,0.9549945115257958,0.9662769895318946,1.0,13/85,16.69%,SLC9A1;STOML2;TMEM120B;PKD2;ATL2;MS4A1;RNF213;UGDH;TIFA;TMEM120A;RBMX;ALS2;TRMT61B
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.2663725938591433,-0.6424115933089791,0.8935064935064935,0.9850940501705108,1.0,1/10,1.13%,PRKCH
prerank,histone H4 acetylation (GO:0043967),0.23752341483541803,0.6420885709588712,0.9313253012048193,0.9667776918865061,1.0,16/47,25.60%,KMT2A;KANSL1;OGT;RUVBL1;PHF20;ING5;KAT7;TADA3;EP400;KANSL3;ACTL6B;MEAF6;TRRAP;MORF4L2;ATF2;MORF4L1
prerank,mitochondrial translation (GO:0032543),0.21668399459412882,0.6416767980049646,0.9637139807897546,0.9668194696477501,1.0,21/104,20.25%,MRPS26;MRPL57;MRPL48;DAP3;IARS2;MTIF2;MRPS18A;RARS2;MRPL19;MRPL15;MRPS14;MRPS2;EARS2;MTRF1L;NDUFA7;LARS2;MRPL55;MRPL52;MRPS27;MRPS33;MRPL49
prerank,snRNA transcription (GO:0009301),0.22810992732644786,0.640324639719484,0.944954128440367,0.9676446911851035,1.0,17/70,18.50%,SNAPC3;POU2F1;GTF2F2;USPL1;NCBP2;ELL2;INTS1;CDK7;GTF2F1;INTS4;CCNT1;INTS14;ICE1;POLR2L;POLR2K;CDK9;RPAP2
prerank,glycerophospholipid catabolic process (GO:0046475),0.26068290242118913,0.6392840915743684,0.9073107049608355,0.9682161892318354,1.0,5/27,15.97%,LIPC;PLA2G7;ABHD16A;PLA2G4A;PLA2G4E
prerank,positive regulation of histone deacetylation (GO:0031065),-0.25078639243437323,-0.639117484836607,0.8921832884097035,0.9861310086729026,1.0,4/12,18.66%,SAP30BP;AKAP8;PRKD1;CTBP1
prerank,mitochondrial genome maintenance (GO:0000002),0.305220772305657,0.63892746749463,0.8668730650154799,0.9681773950931357,1.0,1/11,4.37%,AKT3
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.3038134574816969,0.6375097667586873,0.8573619631901841,0.9690320932968194,1.0,5/12,25.00%,SMO;PAX8;AGT;GDNF;VEGFA
prerank,epithelial cell development (GO:0002064),0.267951564263457,0.6362072936959818,0.9006896551724138,0.9697727604593493,1.0,2/20,10.23%,SIPA1L3;SLC4A7
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.24381387746931332,0.6351595250996229,0.929559748427673,0.9703288988912143,1.0,4/37,10.03%,BBC3;NCK1;BCL2;FBH1
prerank,protein polyglutamylation (GO:0018095),0.3057697977312077,0.6338324157108489,0.8847402597402597,0.9710644679186546,1.0,2/11,9.52%,CEP41;TPGS1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.2597884286544444,0.6335122897009039,0.9042553191489362,0.9709819942949117,1.0,5/26,17.65%,LRRK2;FBXO7;NFE2L2;AKT1;ATF4
prerank,regulation of DNA recombination (GO:0000018),-0.18730737666343494,-0.6325729536417974,0.9869565217391304,0.9891788921492979,1.0,12/32,29.37%,SMARCAD1;MRE11;RTEL1;MSH2;MSH3;THOC1;RAD50;SHLD2;RPA2;H1-0;KPNA1;CHEK1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.2914438868343154,0.6320538569091908,0.8833333333333333,0.9717869647638383,1.0,4/14,20.23%,ACTR2;TIMELESS;MMS19;ARID2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.26322808718994356,0.6315355126836898,0.9074333800841514,0.971859060294367,1.0,3/23,9.64%,PABIR1;VPS4A;SETMAR
prerank,mitochondrion transport along microtubule (GO:0047497),0.2951523826264313,0.6313479997733118,0.8876923076923077,0.9716561771725403,1.0,2/13,15.68%,MAP1S;HIF1A
prerank,protein sumoylation (GO:0016925),0.23358301213071325,0.6309932859892787,0.9208972845336482,0.9715899274232863,1.0,10/49,16.22%,NUP37;RAE1;PIAS2;NUP153;NSMCE2;EGR2;TRPM4;NDC1;NUP35;NUP188
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.2348293145795525,-0.6309351608211484,0.939873417721519,0.9889849265028429,1.0,7/14,32.99%,RPL7;RPL35;RPF2;RPL7L1;WDR12;NOL9;URB1
prerank,positive regulation of DNA repair (GO:0045739),0.2329929128704868,0.6302967703052162,0.9403166869671132,0.9718206974560134,1.0,10/46,18.04%,EGFR;BABAM2;DDX11;SPIRE1;TMEM161A;TIMELESS;MGMT;XRCC1;NPAS2;SLF2
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.24901705513858696,0.6295729807019917,0.9254498714652957,0.9720475937948354,1.0,6/31,15.85%,EDC4;EXOSC4;DCP2;DCP1A;PATL1;LSM7
prerank,tRNA 5'-end processing (GO:0099116),0.28472582476431196,0.6285351997964085,0.9002932551319648,0.9725577442829627,1.0,2/15,12.47%,POP1;POP4
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.24651589361822063,-0.6282768046356231,0.9385474860335196,0.989446290255007,1.0,6/12,37.12%,B3GALT2;B3GNT2;B3GNT3;B3GNT8;B4GAT1;B3GNT6
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.2982741877729704,0.627588785256475,0.9010989010989011,0.9729741970691056,1.0,3/12,17.14%,MIA3;BMP5;AKT1
prerank,steroid hormone biosynthetic process (GO:0120178),0.2453543606051774,0.623559974186282,0.918918918918919,0.9758818843022871,1.0,5/29,19.97%,SRD5A3;HSD17B8;FDXR;MED1;SRD5A1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.252809026180454,0.6233670079725299,0.9045092838196287,0.975688049992269,1.0,2/28,3.78%,PTN;APOE
prerank,ovarian follicle development (GO:0001541),-0.23445728232053042,-0.6233150557463402,0.9237804878048781,0.9912816100723363,1.0,8/13,35.33%,KIT;EIF2B2;SOD1;FOXL2;ANG;EIF2B4;LHCGR;CEBPB
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.2982139306569932,0.6226095356047046,0.8791732909379968,0.9759290417145451,1.0,2/11,14.44%,MLIP;SMAD4
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.27823932038090343,0.6219557431756543,0.9002932551319648,0.9760896098426197,1.0,3/15,19.43%,BCL2;MDM2;KDM1A
prerank,divalent inorganic cation homeostasis (GO:0072507),0.2551748263466166,0.6206855600051508,0.9145860709592641,0.9767513441012112,1.0,3/25,10.60%,FAM20A;CYP27B1;SELENON
prerank,negative regulation of transmembrane transport (GO:0034763),0.3003825120349943,0.6205172627440145,0.8988941548183255,0.9765223690942463,1.0,3/10,17.14%,OAZ3;CTTNBP2NL;AKT1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.1974840425937399,-0.6204090513799815,0.9411764705882353,0.991846327138625,1.0,9/23,28.69%,COPS5;UBC;COPS7B;DDB2;UBA52;CETN2;RBX1;PARP1;XPC
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.29814378098967553,0.6195085190532393,0.8848,0.9769171234994716,1.0,1/11,5.04%,LGALS9
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.227414541532437,-0.6190712657919448,0.9407894736842105,0.99139873949518,1.0,8/15,35.63%,OGA;EXTL2;CHST3;RENBP;CHST7;NAGK;CHST2;CHST5
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.22509065417615248,-0.6189036669307746,0.9248366013071896,0.9902695524944666,1.0,4/15,30.55%,DERL1;UFD1;NPLOC4;TMEM129
prerank,histone monoubiquitination (GO:0010390),0.2559022748705951,0.6183011925324372,0.907202216066482,0.9775032467104631,1.0,10/24,27.59%,RNF2;SKP1;DTX3L;DDB1;UBE2E1;CDC73;RYBP;PAF1;RNF40;ATXN7L3
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.26088896643306725,0.617831529840239,0.9114927344782034,0.9775034858187983,1.0,4/24,15.31%,GFPT2;PID1;COQ10B;CYCS
prerank,mRNA transport (GO:0051028),0.21104270921009002,0.617214463931255,0.9795479009687836,0.9776291879078469,1.0,33/101,26.96%,ZFP36L1;NUP37;SMG7;RAE1;SMG6;ALKBH5;NCBP2;NUP153;AGFG1;FMR1;NDC1;NUP35;NUP188;SEC13;SRSF2;NUP214;NUP107;FYTTD1;SLU7;SRSF11;THOC5;RNPS1;FIP1L1;CPSF3;SMG5;THOC2;GLE1;KIF5C;HNRNPA2B1;NUP42;NUP155;SRSF1;CPSF1
prerank,AMP metabolic process (GO:0046033),0.28700376014725926,0.6165664864541163,0.9020217729393468,0.9777618078149746,1.0,4/13,19.83%,AMPD2;NT5C1A;XDH;AMPD3
prerank,response to unfolded protein (GO:0006986),0.23224646175641145,0.6164310004290923,0.9455864570737605,0.977513051933491,1.0,5/48,7.37%,DNAJB1;BAG3;SERPINH1;HSPE1;PTPN1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.22602675440789372,-0.6160479587808045,0.931129476584022,0.990746040773293,1.0,5/14,20.69%,NT5E;UPB1;NT5C3A;NT5C;DHODH
prerank,cardiac muscle cell differentiation (GO:0055007),-0.20591694631595572,-0.6159461101013723,0.9675090252707581,0.9895928719179123,1.0,14/21,42.83%,CXADR;SIK1;MYOCD;MEF2C;KDM6B;CBY1;MYH11;TTN;NRG1;ALPK3;TCAP;IRX3;MYH6;ALPK2
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.30190905916132915,0.6159194915863445,0.8823529411764706,0.9775449875845955,1.0,2/10,10.14%,CPEB1;NCBP2
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.22702558614815513,0.6143824585598987,0.9614485981308412,0.9783543858161033,1.0,12/54,20.67%,TNFAIP3;TRIM21;NXN;PINX1;OGT;SPRY2;RPL11;SQSTM1;AKT1;PRMT3;ISG15;SVBP
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.254137522656813,0.6140180289784977,0.9176788124156545,0.9782769651866134,1.0,9/23,22.55%,PTEN;SACM1L;MTMR9;MTMR3;MTMR2;MTMR6;MTMR1;MTM1;PIP4P2
prerank,regulation of biosynthetic process (GO:0009889),0.29133089283556746,0.6135737272806775,0.9009146341463414,0.978262196239123,1.0,2/11,18.98%,SPHK2;CCN6
prerank,telomere maintenance via telomerase (GO:0007004),0.24899887875793766,0.6132693975002167,0.9223803363518758,0.978131493336568,1.0,10/28,25.73%,TNKS1BP1;PINX1;TERT;PPP6C;TELO2;RFC1;TERF1;RPA1;TERF2IP;TERF2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.22446234769779244,0.6130166714440451,0.9523809523809523,0.9779777040700335,1.0,14/58,20.00%,BABAM2;ATM;DCLRE1C;SETMAR;HMGB2;KDM2A;MDC1;NSMCE2;RIF1;PAXIP1;PRKDC;PSMD14;ZBTB7A;SMC5
prerank,negative regulation of secretion (GO:0051048),0.29982862916479264,0.6127260682814949,0.9099378881987578,0.9778394737452972,1.0,1/10,5.75%,EGF
prerank,protein neddylation (GO:0045116),0.28396639980595706,0.6125832367744053,0.908284023668639,0.9775954509990058,1.0,2/13,8.87%,DCUN1D1;UBE2F
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.23527621586025615,-0.6123715523878265,0.9391304347826087,0.9903397191520252,1.0,2/13,11.34%,CYFIP2;PERP
prerank,regulation of dopamine secretion (GO:0014059),0.2514702436880587,0.6106849368136454,0.9046321525885559,0.9786211151252359,1.0,3/25,9.77%,DTNBP1;SYT2;DRD3
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.2686954484566485,0.6103731654864201,0.9121037463976945,0.9785022755378602,1.0,4/16,16.09%,SHLD3;FBH1;RIF1;CGAS
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.22286156148339498,0.6101184410087939,0.9589509692132269,0.9783280616090712,1.0,22/64,23.84%,POLR1E;GTF2H1;GTF2F2;SETD2;NCBP2;CDK7;GTF2F1;CCNT1;MLLT1;POLR2L;POLR2K;CDK9;IWS1;CDK13;ERCC2;CDK12;CCNH;TCEA1;POLR2D;MNAT1;CDC73;PCID2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.2874996655321362,0.609611810473512,0.91324200913242,0.9783386502354721,1.0,1/12,5.11%,NUGGC
prerank,regulation of neuron projection arborization (GO:0150011),0.2751957222807172,0.6092593093318379,0.935064935064935,0.9782394923745011,1.0,3/15,11.12%,DLG4;WNT5A;MOV10
prerank,regulation of sequestering of calcium ion (GO:0051282),0.29104836036352033,0.6086858973596034,0.9095092024539877,0.9782996350654574,1.0,3/12,15.01%,FKBP1B;UBASH3B;ANXA6
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.20416345361764152,-0.6082382582120975,0.9585987261146497,0.9913929053209808,1.0,14/20,57.56%,STARD3;STAR;HSD17B10;TSPOAP1;STARD3NL;FDX2;TSPO;HSD3B2;AKR1C1;DHRS9;AKR1D1;CYP11B1;CYP46A1;CYP11A1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2683004359682972,0.6078171135616454,0.8984034833091437,0.9785775876059795,1.0,3/16,13.91%,TOP2B;EME2;RMI1
prerank,translational termination (GO:0006415),0.2071081725881854,0.6077841403602297,0.9730603448275862,0.9782452777111629,1.0,20/95,21.49%,MRPS26;MRPL57;MRPL48;DAP3;ABCE1;MRPS18A;MRPL19;MRPL15;MRPS14;MRPS2;MTRF1L;GSPT1;MRPL55;MRPL52;MRPS27;MRPS33;ETF1;MRPL49;N6AMT1;MRPL17
prerank,response to calcium ion (GO:0051592),0.20587929987800055,0.6077251976631041,0.9807897545357525,0.9779373948915907,1.0,16/102,19.00%,SEC31A;CAMK2D;PKD2;CPNE7;CPNE2;KCNMB4;SYT2;WNT5A;PPP3CA;CALM2;KCNIP2;NEDD4;HPCA;TNNT2;CPNE3;ADGRV1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.25684005433085866,0.6065048441205172,0.9243243243243243,0.9784577093260117,1.0,6/21,18.80%,PDZD8;MICU2;MCUR1;ANXA6;MAIP1;MICU3
prerank,negative regulation of phosphatase activity (GO:0010923),0.2506828394044972,0.6056071160780125,0.929757343550447,0.978738136222664,1.0,5/25,17.13%,PPP1R36;FKBP1B;TGFB2;GSK3B;PTPA
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.25936814106572326,0.6044696618459418,0.9174690508940853,0.9791893300151282,1.0,5/19,22.61%,RPTOR;NAB2;ICE1;PRDX5;CHD8
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.21342629137271898,-0.604399716808009,0.9663299663299664,0.992283319951149,1.0,2/17,9.45%,LPGAT1;SERAC1
prerank,RNA splicing (GO:0008380),0.20867830729988435,0.6043701153602008,0.9717083786724701,0.9789148532555642,1.0,11/95,12.26%,PPP1R9B;SYNCRIP;SNRNP40;CCAR2;RRAGC;NONO;DHX8;NCBP2;PRPF18;SNRNP35;RNPC3
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.2803928346084302,0.6040996663140913,0.901386748844376,0.9787587382559704,1.0,3/13,20.43%,NT5M;MBD4;NEIL1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.2787813514345623,0.6038744245928197,0.922962962962963,0.9785661645757077,1.0,3/13,12.04%,SENP6;UBA5;ATG7
prerank,regulation of glycogen metabolic process (GO:0070873),0.28974686884624923,0.6035336808896189,0.9193037974683544,0.9784548862591498,1.0,3/12,17.14%,KHK;RUBCNL;AKT1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.2792774331539889,0.6032979767030372,0.9046920821114369,0.978259270188543,1.0,6/14,26.99%,FOXO3;EARS2;POLRMT;TWNK;TEFM;MTERF2
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.2907832784779244,0.6026625054746901,0.8928571428571429,0.9783538522830769,1.0,3/10,16.89%,NT5M;DPYD;NT5C1A
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.2612168935843766,0.6025051982185715,0.9247787610619469,0.978114590442229,1.0,5/18,17.14%,NONO;NFE2L2;TRAP1;HIF1A;AKT1
prerank,negative regulation of secretion by cell (GO:1903531),0.23081638115613046,0.6019724498996638,0.9468479604449939,0.9781222744078611,1.0,6/38,13.82%,APOE;ANXA1;DRD3;TNFRSF1A;DPH3;HRH3
prerank,regulation of blood circulation (GO:1903522),0.23595919936619242,0.600627259866847,0.941320293398533,0.9786550740489569,1.0,7/34,19.44%,TBX2;CAMK2D;KCNMB4;KCNIP2;TNNT2;AGT;TPM1
prerank,antibacterial humoral response (GO:0019731),0.2609006870553889,0.6003927288364272,0.9165424739195231,0.9784772458413183,1.0,1/16,5.65%,RNASE7
prerank,mucosal immune response (GO:0002385),-0.22152455104859978,-0.6002569748483707,0.9396825396825397,0.9931532698204372,1.0,15/15,77.87%,DEFA6;OTUD7B;IFNLR1;NOS2;RAB17;IL4;CAMP;BPIFB1;DEFB1;FFAR2;LTF;PIGR;PLA2G1B;RPL39;RNASE3
prerank,carboxylic acid catabolic process (GO:0046395),0.2832096524411873,0.5979301914996289,0.8938193343898574,0.9797888170627065,1.0,5/12,25.76%,AMDHD2;GNPDA2;NPL;PON3;GNPDA1
prerank,negative regulation of catabolic process (GO:0009895),0.22249792865386142,0.5975976222883423,0.9620403321470937,0.9796606516827745,1.0,3/47,4.15%,EGFR;IRAK3;MAD2L1
prerank,respiratory electron transport chain (GO:0022904),0.2775776853594394,0.5974256833704383,0.93202416918429,0.9794261729983438,1.0,2/14,10.07%,ETFA;SDHB
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.25927429811342934,0.5973903052017201,0.9196556671449068,0.9791026154821698,1.0,3/18,9.72%,TMEM119;HDAC1;FRS2
prerank,regulation of protein metabolic process (GO:0051246),0.22687589776896072,0.5967925466996222,0.9515738498789347,0.9791456136262252,1.0,5/44,9.92%,APOE;GSAP;SHH;SPOP;SSH1
prerank,ether lipid metabolic process (GO:0046485),0.27531579781650417,0.5965082224288211,0.9053084648493543,0.978961802745637,1.0,2/14,8.59%,DHRS7B;PLA2G7
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.24872611753627827,0.5964885489351914,0.9413333333333334,0.9786245653096111,1.0,3/22,10.32%,TRIM13;MAN1C1;UGGT2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.18324832095854143,-0.5953572841489864,0.991701244813278,0.9931311586485675,1.0,8/29,25.24%,ACBD6;GPAT4;ACLY;DBI;ACOT7;OXSM;ACSL6;MLYCD
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.18324832095854143,-0.5953572841489864,0.991701244813278,0.9931311586485675,1.0,8/29,25.24%,ACBD6;GPAT4;ACLY;DBI;ACOT7;OXSM;ACSL6;MLYCD
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2251915959313847,0.5948177755590723,0.9539951573849879,0.9793842769999233,1.0,5/45,11.65%,ATXN2;PUM1;METTL16;FOXO3;GCNT2
prerank,regulation of T cell mediated immunity (GO:0002709),0.2938924110225346,0.5936802247040999,0.8984126984126984,0.9797732810821148,1.0,10/10,70.63%,TRPM4;TNFRSF1B;FUT7;IL1B;RIPK3;WAS;HMGB1;CCR2;AGER;ZBTB1
prerank,regulation of chromatin binding (GO:0035561),0.2852629531954921,0.5932848417833761,0.9115755627009646,0.9796632973481669,1.0,3/10,18.98%,DDX11;DTX3L;WAPL
prerank,negative regulation of myoblast differentiation (GO:0045662),0.27318663138644605,0.5914471892066854,0.9089506172839507,0.9804810563926305,1.0,2/13,10.21%,PRICKLE1;TBX3
prerank,RNA modification (GO:0009451),0.21798372438307886,0.5906696960524065,0.9698025551684089,0.9806302476634647,1.0,14/54,22.93%,PUS7L;METTL1;PUS3;NOP2;ALKBH1;NAT10;MRM2;ANKRD16;RBM15;PARN;BCDIN3D;DTWD1;FTSJ3;TRMT61A
prerank,histone H2A ubiquitination (GO:0033522),0.26127000958014857,0.5902019573622629,0.9206349206349206,0.9805600179614121,1.0,4/17,17.41%,RNF2;SKP1;DTX3L;DDB1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.27464232361021235,0.589512757551676,0.9253731343283582,0.9806502731399175,1.0,6/14,24.51%,TREM2;CX3CL1;PTPRC;NR1D1;CD200R1;TNFRSF1B
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.261271100994112,0.58891328422826,0.9363905325443787,0.9806675321237266,1.0,5/17,25.46%,PTPRJ;PTPN2;PRNP;UBASH3A;THY1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.22808166101369737,-0.5883537590194369,0.9601139601139601,0.9951947349771084,1.0,6/13,37.12%,B3GALT2;B3GNT2;B3GNT3;B3GNT8;B4GAT1;B3GNT6
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.24527139773994427,-0.5881383872443884,0.9220430107526881,0.9940871878726014,1.0,5/10,26.50%,RFWD3;FEM1B;DDX39B;THOC1;RPA2
prerank,cellular response to calcium ion (GO:0071277),0.20675012788342717,0.5881182615743004,0.9765100671140939,0.980797583866548,1.0,6/67,9.14%,CAMK2D;PKD2;CPNE7;CPNE2;SYT2;WNT5A
prerank,detection of calcium ion (GO:0005513),0.26748751664519926,0.5869665303146492,0.918552036199095,0.9811305926933547,1.0,3/13,15.49%,KCNMB4;CALM2;KCNIP2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.20902696549089048,0.5858515043367585,0.9758897818599311,0.9814234945372993,1.0,16/69,18.50%,SNAPC3;POU2F1;GTF2F2;NCBP2;ELL2;INTS1;CDK7;GTF2F1;INTS4;CCNT1;INTS14;ICE1;POLR2L;POLR2K;CDK9;RPAP2
prerank,nuclear pore organization (GO:0006999),-0.21355257819119253,-0.5841071536955206,0.9688473520249221,0.9946872670572986,1.0,9/14,36.35%,NUP133;SEH1L;TMEM170A;NUP98;NUP93;AHCTF1;TPR;NUP205;RTN4
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.23366535780774497,0.5827613084538339,0.9489795918367347,0.9829068080587057,1.0,10/29,25.73%,TNKS1BP1;PINX1;TERT;PPP6C;TELO2;RFC1;TERF1;RPA1;TERF2IP;TERF2
prerank,regulation of histone methylation (GO:0031060),0.2643473857691148,0.5824112691391287,0.9078341013824884,0.982766402302726,1.0,1/13,3.82%,MTHFR
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.22543363467254646,-0.5805708254945333,0.9601139601139601,0.9949773084232769,1.0,5/13,33.20%,CPE;HEY2;RYR2;NOTCH1;NPY5R
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.23396008421838038,-0.5802401565602423,0.946524064171123,0.9938978527609598,1.0,1/10,2.62%,MALT1
prerank,protein monoubiquitination (GO:0006513),0.22380156845861163,0.5785598782822725,0.9628712871287128,0.9846837626355875,1.0,13/36,27.59%,KLHL22;TRIM21;UBE2R2;UBE2W;DTX3L;PEX12;UBE2E1;UBE3D;CDC73;KLHL12;PAF1;RNF40;ATXN7L3
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.2846032514390259,0.5771396311393657,0.9369085173501577,0.9851103572916968,1.0,1/10,5.04%,LGALS9
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.23682132303276898,-0.5770030989544287,0.9686684073107049,0.9939629329231268,1.0,5/10,42.68%,SAG;PDE6A;CNGB1;PDE6G;PDE6B
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.27496656886812676,0.5760067179682997,0.9291217257318952,0.985377449962835,1.0,4/12,21.37%,KHDRBS1;NEDD4;NUP214;IFI27
prerank,mismatch repair (GO:0006298),0.2372153432570846,0.5758146721197841,0.9534574468085106,0.9851477541106369,1.0,4/27,10.37%,LIG1;SETD2;RNASEH2A;MCM9
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.17511165749667285,-0.5751509384314785,0.9866666666666667,0.9934999758802401,1.0,19/29,51.41%,RAD21;SIRT7;P3H4;PRDM9;MEI4;REC8;TRIP13;SYCE2;MEIOB;SYCP2;TEX12;ZCWPW1;IHO1;FANCD2;RAD21L1;RNF212B;ANKRD31;HORMAD1;TERB2
prerank,ribosomal large subunit assembly (GO:0000027),0.2383662864162261,0.5751070435256378,0.9422043010752689,0.9851908380334248,1.0,4/24,14.52%,RPL3L;NOP2;DDX28;RPL11
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.2633459395838993,0.5714072344132999,0.9213973799126638,0.9868462447609706,1.0,4/13,18.27%,SRSF12;PRPF31;PRPF3;DDX20
prerank,oligodendrocyte differentiation (GO:0048709),0.244991311875495,0.5709351192887966,0.9377713458755427,0.9867394780974749,1.0,2/19,5.93%,SHH;PTPRZ1
prerank,cellular copper ion homeostasis (GO:0006878),0.2662646628770301,0.5693057214452187,0.9278195488721804,0.9872522063022288,1.0,5/14,22.96%,SLC31A1;ARF1;ATP7A;PRNP;SLC31A2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.26627478967307444,0.5689916901964107,0.9324116743471582,0.987080382641639,1.0,7/12,31.20%,GART;PPAT;IMPDH2;IMPDH1;ADSL;LHPP;ADSS2
prerank,mitochondrial transcription (GO:0006390),0.28462247994120965,0.5676196616891322,0.928343949044586,0.9874623349790357,1.0,5/10,26.99%,FOXO3;POLRMT;TWNK;TEFM;MTERF2
prerank,peptidyl-methionine modification (GO:0018206),-0.2205816353659455,-0.5672097872360266,0.9671641791044776,0.9953604840402053,1.0,2/12,13.46%,METAP2;NAA60
prerank,positive regulation of ruffle assembly (GO:1900029),0.26349251157634473,0.5661276736193851,0.9214501510574018,0.987877210486905,1.0,6/13,27.04%,NDEL1;EPS8;DEF8;P2RY12;PLEKHM1;FAM98A
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.26680113100293074,0.5656730368410313,0.926605504587156,0.9877590875390573,1.0,2/10,13.39%,DCLRE1C;RIF1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.227277517680266,0.5655982414747708,0.9594423320659062,0.9874514040857335,1.0,8/29,20.12%,TNFRSF12A;SFRP1;TNF;TRAF2;RIPK1;INHBA;AGT;TNFSF12
prerank,proteasome assembly (GO:0043248),-0.23380522690840191,-0.5649736267773884,0.9235127478753541,0.9949871680176828,1.0,5/11,35.24%,POMP;PSMD13;ADRM1;PSMD10;OTUD6B
prerank,regulation of immunoglobulin production (GO:0002637),0.23643510802315462,0.5642496143283876,0.9633152173913043,0.9877966449168754,1.0,5/23,24.69%,SASH3;TNFRSF4;PTPRC;GPI;XBP1
prerank,phospholipid dephosphorylation (GO:0046839),0.2179386098209406,0.5641412903804635,0.9664596273291925,0.9874924079164474,1.0,9/37,19.90%,EPHX2;PTEN;SACM1L;MTMR9;MTMR3;MTMR2;MTMR6;MTMR1;MTM1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.19877312348240928,-0.5636929863482771,0.9875,0.99428137593369,1.0,8/17,38.10%,DHDDS;ALG1;DOLK;ALG12;DOLPP1;MVD;ALG3;ALG9
prerank,import into nucleus (GO:0051170),0.19983071740154917,0.5634778667443218,0.9865168539325843,0.987480113735087,1.0,16/73,20.96%,STAT3;PRICKLE1;FAM53B;NUP153;TNPO1;E2F3;SMN1;NUP188;SEC13;BACH2;AKT1;DDX20;HEATR3;NUP214;SNRPB;NUP107
prerank,cell differentiation in hindbrain (GO:0021533),0.27779195828789544,0.5629926241053256,0.9385560675883257,0.9873644992510885,1.0,3/11,18.03%,OPHN1;AGTPBP1;ATP7A
prerank,cellular response to oxygen levels (GO:0071453),-0.23496404674459942,-0.56255164053371,0.9615384615384616,0.9934749172256186,1.0,5/10,31.52%,TMEM199;NDUFS2;ATP6V0D1;ATP6V1A;ATP6AP1
prerank,DNA replication checkpoint signaling (GO:0000076),0.25270479441314875,0.5617920665151174,0.9384615384615385,0.9876128295779959,1.0,3/16,17.64%,DNA2;TIMELESS;RAD9A
prerank,snRNA 3'-end processing (GO:0034472),-0.19616332062442526,-0.5611729492963552,0.9771241830065359,0.9927310718011739,1.0,6/19,21.18%,INTS2;EXOSC7;TUT1;EXOSC8;EXOSC3;TOE1
prerank,sensory perception of chemical stimulus (GO:0007606),0.25108723799185806,0.5571526763735849,0.9476831091180867,0.9895026498254066,1.0,2/15,14.17%,CD36;GNAS
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.21919036010554166,-0.5546037237194537,0.9641873278236914,0.9937598643192626,1.0,6/12,41.92%,STARD3;STAR;TSPOAP1;STARD3NL;FDX2;TSPO
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.20931109584446256,0.5544987580996669,0.9788029925187033,0.9904107306225596,1.0,7/37,17.92%,TAOK1;EFNA5;MAPRE2;GSK3B;PHLDB2;TPPP;PHLDB1
prerank,phosphate ion transmembrane transport (GO:0035435),0.2591363161077888,0.5528146382926044,0.9234303215926493,0.9908392857216858,1.0,3/12,15.95%,SLC20A1;SLC37A1;SLC25A10
prerank,aminoglycan metabolic process (GO:0006022),0.2669645728023135,0.5517743619824139,0.946969696969697,0.9909455188520054,1.0,6/10,32.01%,CLN6;B4GALT7;XYLT1;B3GAT3;GAL3ST3;XYLT2
prerank,cellular response to unfolded protein (GO:0034620),0.2263839198965879,0.5513105811022764,0.9588477366255144,0.9907926427095609,1.0,6/26,19.23%,BAG3;PTPN1;HSPA5;HSPD1;RHBDD1;HSPA13
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.2279799822823519,-0.5505429989121338,0.9526462395543176,0.9938928578410787,1.0,4/11,22.00%,LARP7;DKC1;EXOSC3;EXOSC10
prerank,carnitine metabolic process (GO:0009437),0.2598545973718288,0.5501035219070858,0.9469026548672567,0.9910101524007927,1.0,1/12,4.93%,TMLHE
prerank,regulation of microtubule-based process (GO:0032886),0.21163701284236483,0.5500501681257902,0.979565772669221,0.990678928836617,1.0,7/36,17.92%,TAOK1;EFNA5;MEMO1;GSK3B;PHLDB2;TPPP;PHLDB1
prerank,ncRNA 3'-end processing (GO:0043628),0.24455482137517906,0.5490996801377084,0.9478527607361963,0.990742360783568,1.0,4/14,24.05%,ERI1;INTS14;INTS8;INTS6L
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.1920913213802377,-0.5490584153952235,0.9642857142857143,0.9931657407571204,1.0,7/17,32.11%,RAB27A;SLC4A8;NLGN1;CACNA1I;RAB3D;SCAMP5;KCNB1
prerank,histone lysine demethylation (GO:0070076),0.22765453249271328,0.5489908643675528,0.9664429530201343,0.9904433942713476,1.0,8/25,26.60%,PHF2;KDM2A;KDM1A;KDM3B;KDM7A;JMJD1C;KDM4B;KDM4D
prerank,regulation of leukocyte migration (GO:0002685),0.24360593978672085,0.5484995942617931,0.9548104956268222,0.9903053085932035,1.0,3/16,14.73%,MIA3;ANXA1;RAC1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.22762578129479608,0.5480534796670566,0.9656992084432717,0.9901486771428736,1.0,6/25,18.24%,CBL;PDE6H;NEU3;AKT1;AGT;RBPJ
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.20346277003057936,-0.547819146109917,0.978125,0.9923464381787671,1.0,1/15,1.76%,BMP4
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.25776760834889345,0.5474938244602587,0.9344512195121951,0.9900391045335121,1.0,6/12,31.43%,SOAT1;LPCAT3;P4HB;SOAT2;APOC1;MTTP
prerank,regulation of catecholamine secretion (GO:0050433),0.22059572010367146,0.5456352164484827,0.9710144927536232,0.9904541053942217,1.0,4/29,13.82%,DTNBP1;SYT2;DRD3;HRH3
prerank,phosphate ion transport (GO:0006817),0.2419229596401274,0.5446129948556694,0.962043795620438,0.9905303756377966,1.0,3/16,15.95%,SLC20A1;SLC37A1;SLC25A10
prerank,acetyl-CoA metabolic process (GO:0006084),0.24630064627545917,0.5444331164773004,0.9466666666666667,0.990263617423849,1.0,3/15,18.59%,MVK;NUDT7;ACACA
prerank,serine family amino acid metabolic process (GO:0009069),-0.19642686776686036,-0.5440064379296553,0.9814814814814815,0.9922974830423232,1.0,5/16,28.21%,GCLC;SARS1;CBS;SEPHS2;CTH
prerank,regulation of actin nucleation (GO:0051125),-0.21280257879209133,-0.5436327806548551,0.9945945945945946,0.9912234932207269,1.0,1/12,3.22%,GSN
prerank,synaptonemal complex organization (GO:0070193),-0.20174085140304976,-0.5409725788129818,0.972318339100346,0.9896407312542734,1.0,1/15,2.33%,RAD21
prerank,synaptonemal complex assembly (GO:0007130),-0.20174085140304976,-0.5409725788129818,0.972318339100346,0.9896407312542734,1.0,1/15,2.33%,RAD21
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.23547527325542295,0.5400713486949299,0.9550072568940493,0.9916726683099779,1.0,5/17,21.69%,CCL5;TGFB2;PIEZO1;ADAM9;P2RY12
prerank,signal peptide processing (GO:0006465),0.26093182663545406,0.5385073113188988,0.9455081001472754,0.9919566480661509,1.0,6/11,26.64%,SPPL3;SEC11A;HM13;CLN5;PCSK5;FURIN
prerank,metallo-sulfur cluster assembly (GO:0031163),0.22585210155661017,0.5372630539850995,0.9577080491132333,0.9921102496530405,1.0,4/22,14.72%,FXN;LYRM4;HSCB;MMS19
prerank,peptidyl-glutamic acid modification (GO:0018200),0.22133524659371967,0.5353224747067477,0.9642857142857143,0.9925132856812756,1.0,3/24,11.46%,CEP41;TPGS1;AGTPBP1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2319681174162988,0.5306168196625345,0.9536231884057971,0.9938988480499632,1.0,2/17,7.67%,BAG6;EMC7
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.23737420097124667,0.5292985163346516,0.9644970414201184,0.9940233853089235,1.0,3/15,14.47%,CCT8;RUVBL1;CCT3
prerank,water transport (GO:0006833),0.24623301634172112,0.5292900958793777,0.9567233384853169,0.993679274466438,1.0,1/12,11.38%,PDPN
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.24224512941015366,0.5292470220477307,0.9472140762463344,0.9933454005415343,1.0,1/14,5.00%,PRKD2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.1775348915757794,0.5290068871248818,1.0,0.9930913454212378,1.0,22/132,19.73%,RPSA;RPL3L;CELF1;EIF5;DICER1;NOP2;PRPF18;RAMAC;SMN1;RPL11;SNRNP200;SETX;PRKDC;TGS1;DHX29;DDX1;MCTS1;DDX20;RPL6;PUF60;CELF5;SNRPB
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.19547117965187705,0.5280972264726373,0.9905437352245863,0.9930518809219979,1.0,4/49,7.11%,BBC3;BCL2;BCL2L2;NOC2L
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.25906247015650075,0.5243250006043737,0.9700787401574803,0.9940359891071587,1.0,2/10,16.90%,OGT;SDHAF3
prerank,RNA stabilization (GO:0043489),0.20660184691172212,0.5224011349879435,0.9767141009055628,0.9943698462858039,1.0,8/33,21.73%,E2F1;TENT5A;ZCCHC17;THRAP3;AXIN2;PARN;GDNF;YBX1
prerank,positive regulation of telomere maintenance (GO:0032206),0.20704325719289607,0.5222001594697152,0.978562421185372,0.9940919103676823,1.0,9/31,23.02%,ATM;GNL3;ATRX;TNKS2;PNKP;MAPK1;PKIB;SLX4;MAP2K7
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.21508369865562596,0.5213841251294512,0.9757412398921833,0.9940122504192632,1.0,4/23,17.16%,PLA2G12A;PLA2G4A;PLA2G4E;LPCAT3
prerank,regulation of interleukin-1 production (GO:0032652),0.23693599515731767,0.5197836725878149,0.9640804597701149,0.9942025989143077,1.0,4/15,21.82%,ANXA1;FOXP1;SIRPA;NLRP12
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.18406179351921625,-0.5187494468996214,0.973421926910299,0.9939946416667876,1.0,17/17,81.62%,DERL1;UFD1;NPLOC4;TMEM129;SEL1L;VCP;HERPUD1;SELENOS;SYVN1;AUP1;FAF2;DERL2;SEC61B;OS9;HM13;HSP90B1;RHBDD1
prerank,nuclear envelope organization (GO:0006998),0.21982631252145846,0.5184682494311196,0.9546703296703297,0.9942966908415902,1.0,4/20,18.43%,VPS4A;LEMD2;SUN1;TOR1AIP1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.17530907866574552,0.5180540631216201,0.9957716701902748,0.9940842958104248,1.0,10/117,10.01%,MTHFD1L;ACSL4;ACADSB;ALDH1A2;CD36;PPARG;LPL;CYP1A1;PANK2;ACSF2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.2598936229991813,0.5166170308285477,0.9638932496075353,0.9941975747576096,1.0,2/10,15.60%,CAMK2D;NEDD4
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.2513178109775227,0.5157057006508113,0.9557377049180328,0.9941244182962365,1.0,2/10,15.77%,EMC7;EMC1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.21166974370809882,0.5155979557663779,0.9667553191489362,0.9938124044569165,1.0,4/23,18.76%,SEC16A;LMAN1;SEC13;HSP90B1
prerank,aerobic respiration (GO:0009060),0.21931956469142458,0.5130183481424576,0.9686162624821684,0.994229166736435,1.0,5/20,18.51%,SDHB;UQCRC1;SIRT3;NDUFS7;NDUFS8
prerank,regulation of ruffle assembly (GO:1900027),0.21280485689135065,0.5126681412284539,0.9744623655913979,0.9939876772237548,1.0,8/23,27.04%,ARHGAP24;NDEL1;EPS8;DEF8;P2RY12;PFN2;PLEKHM1;FAM98A
prerank,protein K48-linked deubiquitination (GO:0071108),0.21332111080826016,0.5118445839428243,0.978319783197832,0.993892321269349,1.0,3/23,14.40%,TNFAIP3;OTUD3;VCPIP1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.2496691599751758,0.510260923109076,0.9713831478537361,0.9940121760946558,1.0,5/10,27.62%,TUT7;ISG15;RPS27A;CHFR;DIS3L2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.21918375186591757,0.5098997083861437,0.9708333333333333,0.9937749177236118,1.0,2/18,10.32%,TRIM13;UGGT2
prerank,hydrogen peroxide catabolic process (GO:0042744),0.24627263079509945,0.5077317300230734,0.9778481012658228,0.9940341574755869,1.0,1/11,8.73%,PXDN
prerank,regulation of gastrulation (GO:0010470),0.23112685275436579,0.5066967835008064,0.9717261904761905,0.9939942438744951,1.0,3/14,17.92%,TENM4;PHLDB2;PHLDB1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.1839692124569573,0.5040813577601968,0.9988479262672811,0.9943673863571085,1.0,11/55,21.19%,BBC3;BCL2;TNFRSF12A;TGFBR1;TNF;TRAF2;RIPK1;ING5;AGT;TNFSF12;BECN1
prerank,snRNA processing (GO:0016180),0.22042561485926565,0.5036199374024094,0.9741641337386018,0.9941384854808579,1.0,5/16,24.05%,INTS1;INTS4;INTS14;INTS8;INTS6L
prerank,apoptotic DNA fragmentation (GO:0006309),0.2267955163861627,0.5035617197706727,0.9723435225618632,0.9938052294504761,1.0,2/16,10.06%,DICER1;HMGB2
prerank,cellular response to cadmium ion (GO:0071276),0.2113254347971119,0.5025427924062288,0.9742895805142084,0.9937268469898716,1.0,3/24,17.14%,EGFR;MAPK1;AKT1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.2169897277957522,0.5018134868839778,0.9773049645390071,0.9935614252759771,1.0,2/18,12.77%,BCL2;SPG7
prerank,nuclear pore complex assembly (GO:0051292),0.24386445329636075,0.5012448265283346,0.9652448657187994,0.9933681588476807,1.0,3/10,20.96%,NUP153;NDC1;NUP107
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.21271860816313465,0.5007223554744386,0.9732394366197183,0.993160167017083,1.0,6/22,26.47%,PTPRJ;PTPN2;PRNP;UBASH3A;THY1;CD300A
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.2335509794073329,0.4983718567450597,0.9723926380368099,0.9934329583934117,1.0,13/13,76.66%,DOC2B;SYT10;CACNA1H;CACNA1G;ZP3;SYT4;CLTRN;STX1A;SYT1;HYAL3;KCNB1;SCAMP5;CACNA1I
prerank,cGMP metabolic process (GO:0046068),0.23577214616797412,0.4943276775527354,0.9623233908948194,0.9940891612025575,1.0,1/12,6.15%,NPR2
prerank,reticulophagy (GO:0061709),0.23260943314964458,0.49115647888993774,0.9782945736434109,0.994507760668214,1.0,2/12,13.32%,UBA5;DDRGK1
prerank,regulation of DNA recombination at telomere (GO:0072695),0.21452157530822225,0.4907166086215448,0.9818941504178273,0.9939190021601967,1.0,8/19,27.70%,ATRX;POLR2L;POLR2K;TERF1;POLR2D;TERF2IP;TERF2;TINF2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.21452157530822225,0.4907166086215448,0.9818941504178273,0.9939190021601967,1.0,8/19,27.70%,ATRX;POLR2L;POLR2K;TERF1;POLR2D;TERF2IP;TERF2;TINF2
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.1859111573645026,0.4880744578521363,0.9913473423980222,0.9941691698127326,1.0,10/40,24.29%,KMT5A;NEK4;FMR1;NPAS2;CDK9;FBXO5;HMGA2;PRKCD;ETAA1;FXR2
prerank,response to cadmium ion (GO:0046686),0.20168144487845502,0.4862931981401223,0.9798927613941019,0.994214813610476,1.0,3/26,17.14%,EGFR;MAPK1;AKT1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.15828871235537617,-0.481541809315593,0.9927272727272727,0.999516122453,1.0,13/23,44.38%,CALM1;METAP2;SAG;PDE6A;GUCA1B;CNGB1;PPEF1;PDE6G;NMT1;PDE6B;NMT2;GUCY2D;GUCY2F
prerank,telomere capping (GO:0016233),0.21052585000492885,0.4806906990593532,0.9831223628691983,0.9950831920998128,1.0,7/16,27.70%,DCLRE1C;CTC1;PRKDC;TERF1;TERF2IP;TERF2;TINF2
prerank,copper ion homeostasis (GO:0055070),0.21647376627544923,0.479593095464244,0.9832402234636871,0.9949574321282812,1.0,5/17,22.96%,SLC31A1;ARF1;ATP7A;PRNP;SLC31A2
prerank,motile cilium assembly (GO:0044458),-0.1884891263067579,-0.47859264414991415,0.9857549857549858,0.9987038513431957,1.0,7/12,50.57%,CCDC39;DNAAF3;E2F4;CCDC40;RSPH6A;DNAAF1;BBS5
prerank,vacuolar acidification (GO:0007035),0.20143858834228365,0.4760108008896129,0.9835390946502057,0.9953154878636954,1.0,3/21,12.92%,ATP6AP2;CLN6;ATP6V1H
prerank,cardiolipin metabolic process (GO:0032048),0.2183809051704811,0.47409008606404923,0.9834834834834835,0.9953247230121475,1.0,2/13,14.60%,PGS1;PLA2G4A
prerank,cellular response to alkaloid (GO:0071312),0.20566411049697556,0.47372815652266903,0.9712230215827338,0.9950457468846624,1.0,4/17,23.20%,CASP7;HTR1B;GSTM2;RAD51
prerank,fluid transport (GO:0042044),0.22239678995176465,0.4726305291483517,0.9742765273311897,0.9949036196133313,1.0,1/12,11.38%,PDPN
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.1828581121772358,-0.4689172443072941,0.9970059880239521,0.9986743429367145,1.0,3/12,24.85%,DCK;DHODH;CDA
prerank,cellular response to purine-containing compound (GO:0071415),0.221517795493064,0.46599098654801757,0.9738562091503268,0.9957336991063375,1.0,10/10,77.86%,GSTM2;TRPM2;SLC8A1;CACNA1S;RYR1;RYR3;P2RY1;RYR2;CASQ2;P2RY6
prerank,aromatic amino acid family catabolic process (GO:0009074),0.205323476904045,0.4657869820259023,0.9809663250366032,0.9954246015611212,1.0,1/15,7.20%,KYAT1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.21304199142794944,0.4644851785535306,0.9912663755458515,0.9953078233700672,1.0,4/14,25.19%,TIRAP;YBX3;HNRNPC;MYD88
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.1717101958814666,-0.4638698394935649,0.9912536443148688,0.9980696513602199,1.0,13/13,82.85%,AQP11;WFS1;NR1H2;MBTPS2;ALOX5;MANF;USP19;FCGR2B;NUPR1;NR1H3;CLU;EIF2AK3;LPCAT3
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.18243610343741118,0.4584820011748846,0.9974457215836526,0.9959195416792115,1.0,10/33,27.83%,PRKD2;PTPRJ;PTPN2;PRNP;UBASH3A;RELA;THY1;CD300A;RPS3;RAB29
prerank,regulation of DNA metabolic process (GO:0051052),0.17131243921455458,0.4567994417665478,0.9988009592326139,0.9958237695267663,1.0,12/44,25.73%,TOM1L1;SUB1;SMG6;NUCKS1;CDK9;KAT7;KPNA2;HDAC8;MPHOSPH8;SMG5;TERF2IP;TERF2
prerank,axoneme assembly (GO:0035082),-0.13792534132619816,-0.4558728361654003,1.0,0.9976520220643503,1.0,12/31,36.64%,CCDC39;RP1;TTLL3;DNAAF3;LRGUK;SPAG1;GAS8;DRC1;JHY;FOXJ1;CCDC65;DNAAF2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.20745757645633472,0.45562205286020263,0.9926470588235294,0.9956581188407981,1.0,6/15,28.85%,DDRGK1;GLI1;CDC73;KLHL18;PAF1;EZH2
prerank,leukotriene biosynthetic process (GO:0019370),0.20626930628402596,0.4527044724489794,0.9818181818181818,0.9957364251659698,1.0,2/14,15.89%,PLA2G4A;GGT7
prerank,DNA conformation change (GO:0071103),0.19580999112225642,0.4408681772359057,0.9929676511954993,0.9969769239291888,1.0,2/17,11.17%,HMGB2;TOP2B
prerank,termination of RNA polymerase II transcription (GO:0006369),0.1730698028389297,0.4373970770229811,0.9975093399750934,0.9970319002746783,1.0,8/33,24.17%,CSTF1;TTF2;NCBP2;SETX;SNRPB;PCF11;FIP1L1;CPSF3
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.17235044951739717,0.4366034177732993,0.9973924380704041,0.9967797169316414,1.0,13/29,30.71%,NOP14;UTP3;DHX37;BMS1;KRI1;RRP36;TSR1;RRS1;HELB;UTP6;TBL3;UTP4;HEATR1
prerank,nucleoside salvage (GO:0043174),-0.18096792417299604,-0.4352782056741873,0.986449864498645,0.998011239476786,1.0,10/10,81.92%,DCK;CDA;UPP1;UPP2;HPRT1;UCK1;TK2;TK1;UCK2;UCKL1
prerank,positive regulation of telomere capping (GO:1904355),0.18504579313534836,0.4191722032555393,0.9928876244665719,0.9981220866803939,1.0,5/17,23.02%,TNKS2;PNKP;MAPK1;PKIB;MAP2K7
prerank,nuclear transport (GO:0051169),0.18392464678178969,0.41572250807154465,0.995702005730659,0.9980584084427006,1.0,16/16,81.63%,ANP32A;XPO1;RSRC1;AAAS;NXT2;NXT1;RBM15B;RGS14;CITED1;PSIP1;HMGA1;NUP205;NPM1;BANF1;NUTF2;NUP98
prerank,regulation of chromosome organization (GO:0033044),0.1728575589735893,0.40899385374547986,0.9972602739726028,0.9982118169081856,1.0,7/22,25.73%,SMG6;SETMAR;WAPL;HDAC8;SMG5;TERF2IP;TERF2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.16881484484869036,0.40068683713445197,0.9986486486486487,0.9980764708959741,1.0,4/22,17.93%,ZDHHC6;ZDHHC9;ZDHHC3;CLIP3
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.16881484484869036,0.40068683713445197,0.9986486486486487,0.9980764708959741,1.0,4/22,17.93%,ZDHHC6;ZDHHC9;ZDHHC3;CLIP3
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.15352227777577965,0.38104804755476795,1.0,0.9986997829702393,1.0,4/29,17.16%,PLA2G12A;PLA2G4A;PLA2G4E;LPCAT3
